data_2l4q_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l4q _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.8 p . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.9 pt -108.14 155.04 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.808 1.243 . . . . 0.0 111.271 166.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -112.15 128.17 56.14 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.542 1.137 . . . . 0.0 109.779 176.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -124.94 152.75 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.527 1.131 . . . . 0.0 111.605 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 44.6 p -132.12 169.59 16.17 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.452 1.901 . . . . 0.0 110.919 -175.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -58.51 -27.0 64.08 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 120.909 -1.12 . . . . 0.0 113.168 176.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.11 -13.51 52.8 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.195 1.398 . . . . 0.0 114.518 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.0 p -127.5 -7.72 5.74 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 -173.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -56.01 -41.82 75.48 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.869 1.268 . . . . 0.0 112.603 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.76 -33.05 74.08 Favored 'General case' 0 CA--C 1.543 0.712 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 m -79.19 -14.96 58.75 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.784 1.634 . . . . 0.0 113.521 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -120.35 -54.55 2.08 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.127 0.971 . . . . 0.0 113.173 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.2 -51.97 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.479 0.712 . . . . 0.0 110.898 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 25.4 mt -76.96 -15.9 59.51 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.8 t -76.12 -28.91 57.66 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.414 1.486 . . . . 0.0 112.904 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.2 m -68.77 119.46 13.18 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.786 1.234 . . . . 0.0 112.418 -174.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -77.32 -20.19 55.29 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.352 1.061 . . . . 0.0 112.944 170.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -87.32 166.19 27.06 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 126.586 1.954 . . . . 0.0 111.363 173.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.62 137.24 79.09 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.135 1.89 . . . . 0.0 111.75 170.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -138.25 130.43 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.016 0.927 . . . . 0.0 111.004 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.04 113.79 27.55 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.396 1.878 . . . . 0.0 108.635 -174.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.3 t -100.19 122.73 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.547 0.739 . . . . 0.0 110.065 173.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -96.34 109.7 22.17 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.594 1.158 . . . . 0.0 110.291 166.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -81.45 115.99 21.04 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.052 1.341 . . . . 0.0 107.923 170.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -148.44 170.1 18.75 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.955 0.902 . . . . 0.0 112.536 -167.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -144.17 149.2 36.06 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.168 0.587 . . . . 0.0 112.026 161.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.7 t -63.96 -22.44 66.92 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.029 0.932 . . . . 0.0 113.291 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -78.94 -5.91 54.93 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 43.4 t -105.39 130.33 53.52 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.186 0.994 . . . . 0.0 112.142 -177.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.38 -56.98 20.39 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.408 1.004 . . . . 0.0 113.539 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -55.83 -34.71 92.16 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.024 2.483 . . . . 0.0 114.448 173.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 96.5 m -62.62 -45.97 90.4 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.04 0.836 . . . . 0.0 111.512 172.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -62.81 -33.55 75.45 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.682 1.193 . . . . 0.0 112.406 175.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 97.2 mmm -75.35 -36.64 60.95 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.383 1.073 . . . . 0.0 113.784 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.9 p -83.3 -23.36 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 119.581 1.082 . . . . 0.0 113.606 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.42 -50.51 71.02 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.98 -27.85 42.38 Favored 'Trans proline' 0 C--N 1.353 0.783 0 CA-C-N 122.538 1.942 . . . . 0.0 113.239 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.4 t -73.37 -42.94 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 121.338 -0.851 . . . . 0.0 110.385 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.1 mt -64.73 -33.28 75.59 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.77 1.228 . . . . 0.0 112.776 171.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.43 -45.44 87.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.273 1.029 . . . . 0.0 111.422 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -61.07 -47.77 84.82 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.61 -0.682 . . . . 0.0 110.889 170.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.09 -36.06 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 120.985 -1.072 . . . . 0.0 112.582 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.64 -41.85 92.15 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.172 0.989 . . . . 0.0 112.201 173.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.1 m -73.98 -35.29 64.46 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.444 0.698 . . . . 0.0 111.356 -176.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -87.57 -38.39 16.01 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.118 1.367 . . . . 0.0 114.332 -175.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -104.19 12.08 34.24 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.511 1.124 . . . . 0.0 114.027 -168.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.55 -33.42 45.61 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.564 1.545 . . . . 0.0 114.51 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 m -71.33 -25.54 62.44 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.849 1.26 . . . . 0.0 112.755 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -101.73 -36.69 8.62 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.486 1.514 . . . . 0.0 112.869 -176.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.5 pp -147.65 164.42 33.58 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.857 1.663 . . . . 0.0 111.781 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.1 m -107.95 143.18 36.95 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.463 1.105 . . . . 0.0 109.371 169.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.6 t -115.36 128.05 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 118.966 0.803 . . . . 0.0 110.559 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.76 154.25 47.4 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.179 1.792 . . . . 0.0 112.077 -172.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -123.04 135.5 54.46 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.716 1.207 . . . . 0.0 112.495 173.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.02 116.95 29.27 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.839 1.656 . . . . 0.0 108.441 168.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.7 101.11 11.94 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.889 1.275 . . . . 0.0 110.138 -176.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.7 m -66.2 -16.5 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -173.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.63 -26.17 63.35 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.366 1.067 . . . . 0.0 113.195 175.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.7 t -119.12 -20.36 8.05 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.601 1.16 . . . . 0.0 113.427 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -123.29 63.98 25.86 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.6 1.16 . . . . 0.0 112.575 170.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.59 -18.34 58.91 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.584 2.189 . . . . 0.0 112.451 171.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -60.1 -46.68 88.79 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.598 1.159 . . . . 0.0 110.931 173.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.29 -31.31 60.66 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.503 1.121 . . . . 0.0 111.893 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.21 -44.99 96.39 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 123.99 0.916 . . . . 0.0 112.321 174.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.8 ptt-85 -82.08 -22.8 36.13 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 176.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -56.29 -40.8 74.87 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.311 0.96 . . . . 0.0 113.249 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -99.0 5.22 47.24 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.467 1.107 . . . . 0.0 113.077 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 47.12 55.3 8.24 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.312 1.845 . . . . 0.0 112.277 -166.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.6 m -113.73 19.52 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.862 1.665 . . . . 0.0 112.58 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.4 m -63.0 -16.85 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.772 1.629 . . . . 0.0 114.559 -175.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.2 m -78.47 48.61 0.79 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.801 2.041 . . . . 0.0 113.384 -176.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -59.83 155.17 43.49 Favored Pre-proline 0 CA--C 1.556 1.176 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 -163.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.74 141.96 68.03 Favored 'Cis proline' 0 C--N 1.355 0.878 0 CA-C-N 118.892 0.64 . . . . 0.0 111.85 -6.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.7 m -133.17 123.98 26.63 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.617 0.767 . . . . 0.0 109.868 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.4 mp -103.5 128.6 50.67 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.494 1.518 . . . . 0.0 108.981 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.1 mm -118.09 128.42 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.174 0.99 . . . . 0.0 109.065 167.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 17.3 tp -97.82 118.98 35.6 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 165.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -96.59 150.33 20.77 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.716 1.606 . . . . 0.0 109.739 170.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -128.52 134.18 48.61 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.606 1.163 . . . . 0.0 108.939 162.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.7 t0 48.67 41.47 17.79 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.197 0.999 . . . . 0.0 113.49 -175.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.02 15.97 70.1 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 124.72 1.153 . . . . 0.0 115.429 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -123.32 136.5 27.16 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.544 1.537 . . . . 0.0 109.574 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.38 139.37 45.27 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.633 2.222 . . . . 0.0 111.41 -177.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.6 t -126.19 -40.34 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.986 1.314 . . . . 0.0 112.517 -174.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -142.26 147.85 37.13 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 119.12 0.873 . . . . 0.0 112.854 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.8 ttt180 -126.2 137.89 53.59 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.056 2.143 . . . . 0.0 111.515 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.6 145.78 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.067 1.747 . . . . 0.0 109.744 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 p -137.05 149.47 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.374 1.069 . . . . 0.0 112.087 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.52 164.33 28.34 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.303 1.43 . . . . 0.0 112.527 -173.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.68 157.51 27.08 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 121.474 -1.016 . . . . 0.0 113.358 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -130.79 149.07 52.6 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.694 1.598 . . . . 0.0 110.464 169.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.89 166.69 41.26 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 160.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -50.49 -37.36 38.4 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.895 1.278 . . . . 0.0 114.03 -177.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.7 -47.79 68.4 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.195 0.598 . . . . 0.0 112.144 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.64 -43.5 72.52 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.464 -0.772 . . . . 0.0 111.982 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.7 tp -64.48 -45.66 86.43 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 122.044 -0.41 . . . . 0.0 110.81 177.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.8 tp -74.4 -18.37 60.67 Favored 'General case' 0 C--O 1.214 -0.807 0 CA-C-O 116.798 -1.572 . . . . 0.0 113.278 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -66.75 -52.75 40.71 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 123.359 2.8 . . . . 0.0 110.933 164.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -63.17 -24.36 67.85 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 86.4 mt -98.18 -19.62 17.77 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.076 0.95 . . . . 0.0 113.461 172.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.0 t -66.52 -23.08 66.18 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 120.584 -1.322 . . . . 0.0 110.809 167.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -54.69 -16.18 2.34 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.319 1.048 . . . . 0.0 113.54 164.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.37 -11.78 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.948 1.699 . . . . 0.0 114.043 169.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 N--CA 1.479 0.991 0 C-N-CA 128.164 2.586 . . . . 0.0 109.342 173.494 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.9 p . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.6 pt -139.51 155.25 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.02 1.728 . . . . 0.0 111.598 173.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -95.8 140.41 30.62 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.446 0.699 . . . . 0.0 110.117 161.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -117.33 150.7 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.403 1.481 . . . . 0.0 110.503 171.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.7 p -127.5 165.38 19.96 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.228 1.411 . . . . 0.0 111.354 -176.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -60.25 -27.79 67.52 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.91 -13.51 57.43 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.943 1.297 . . . . 0.0 114.188 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.4 m -126.55 -13.65 5.93 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -168.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -54.33 -42.08 69.77 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.228 1.411 . . . . 0.0 112.368 -173.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.33 -34.12 75.54 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.295 -0.878 . . . . 0.0 113.085 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.7 m -79.38 -28.09 41.88 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.476 1.11 . . . . 0.0 112.919 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -92.91 -40.9 10.34 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.352 -0.843 . . . . 0.0 113.234 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.4 t -99.39 -57.26 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.811 1.245 . . . . 0.0 111.191 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.1 mt -79.86 -18.69 50.11 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -171.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.8 m -85.56 -10.49 55.86 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.127 0.971 . . . . 0.0 113.045 174.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.4 t -79.9 130.4 35.27 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.787 0.835 . . . . 0.0 112.559 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -79.72 -21.29 44.74 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.964 0.906 . . . . 0.0 112.486 170.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -79.82 148.33 68.53 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 125.84 1.656 . . . . 0.0 110.517 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -58.51 132.55 49.09 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.035 1.824 . . . . 0.0 111.674 170.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.84 130.1 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.408 1.083 . . . . 0.0 110.647 -173.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.32 114.09 26.18 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.867 1.667 . . . . 0.0 108.665 -172.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.18 124.69 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.938 0.895 . . . . 0.0 110.727 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -104.28 116.3 31.91 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.421 1.089 . . . . 0.0 111.435 173.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -84.9 110.48 18.89 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.076 1.751 . . . . 0.0 108.375 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -143.63 171.28 14.4 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.56 1.144 . . . . 0.0 112.722 -164.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.54 154.81 39.32 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.791 0.836 . . . . 0.0 111.809 163.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.4 t -64.82 -20.88 66.63 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.957 0.903 . . . . 0.0 113.183 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 -80.08 -1.56 40.55 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 50.8 t -109.77 117.31 33.53 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.226 1.01 . . . . 0.0 112.747 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.82 -47.72 89.0 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 124.363 0.983 . . . . 0.0 113.91 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -58.52 -31.6 94.73 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.925 2.417 . . . . 0.0 114.685 170.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 83.9 m -66.57 -45.02 80.68 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.481 1.037 . . . . 0.0 111.198 170.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -60.62 -29.69 69.38 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.552 0.741 . . . . 0.0 112.628 173.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 16.5 tpt -73.75 -42.64 60.81 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.757 1.223 . . . . 0.0 113.027 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.1 p -84.4 -21.33 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.32 -49.61 80.9 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -65.63 -30.13 51.41 Favored 'Trans proline' 0 C--N 1.353 0.764 0 CA-C-N 122.415 1.898 . . . . 0.0 113.003 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.4 t -68.23 -49.53 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 118.731 0.696 . . . . 0.0 110.124 175.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.5 mt -61.13 -34.93 75.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.136 0.975 . . . . 0.0 112.797 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -70.86 -40.29 72.42 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.218 0.917 . . . . 0.0 112.169 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -61.97 -42.51 99.21 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.09 -1.006 . . . . 0.0 111.516 169.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.7 mt -61.53 -43.76 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 118.771 0.714 . . . . 0.0 110.914 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.33 -37.65 81.27 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.988 0.915 . . . . 0.0 112.379 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.3 m -75.98 -47.18 26.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.776 0.83 . . . . 0.0 112.177 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -94.88 -21.81 18.42 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -167.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.41 16.61 23.72 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.591 1.556 . . . . 0.0 111.761 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.93 -27.93 47.09 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.1 1.76 . . . . 0.0 114.94 -173.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.9 p -78.35 -19.51 53.28 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.013 1.325 . . . . 0.0 113.845 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -111.17 -28.67 8.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.808 1.643 . . . . 0.0 113.57 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.7 mt -129.8 148.99 51.73 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.643 1.977 . . . . 0.0 111.04 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 57.8 m -108.62 133.01 53.32 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 153.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.0 t -103.18 130.96 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.477 0.711 . . . . 0.0 109.816 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.21 155.09 46.09 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.767 1.627 . . . . 0.0 112.011 -174.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -123.69 128.25 49.36 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.881 1.672 . . . . 0.0 110.548 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -108.16 113.86 27.31 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.6 102.24 10.52 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.116 0.966 . . . . 0.0 108.734 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.3 m -65.76 -17.18 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.887 -1.133 . . . . 0.0 112.787 -176.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -78.52 -20.0 51.72 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.941 1.296 . . . . 0.0 113.652 176.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.0 p -115.62 -22.42 9.22 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 174.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -129.46 62.61 64.01 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 125.641 1.576 . . . . 0.0 112.054 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -64.71 -20.71 65.24 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.804 2.336 . . . . 0.0 112.742 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -62.46 -39.92 94.98 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.897 0.879 . . . . 0.0 111.721 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -73.69 -37.24 65.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.842 0.857 . . . . 0.0 111.49 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.01 -43.78 95.01 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.496 0.719 . . . . 0.0 111.683 171.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.4 ttp-105 -73.74 -33.85 64.5 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -56.42 -42.43 78.03 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.505 1.122 . . . . 0.0 112.964 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -98.19 5.28 48.64 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.425 1.09 . . . . 0.0 113.334 174.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.36 15.8 pt20 46.81 25.74 0.48 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 128.298 2.639 . . . . 0.0 116.013 -168.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.2 m -80.46 39.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.744 2.017 . . . . 0.0 111.857 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.7 m -74.95 -21.66 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.966 1.306 . . . . 0.0 113.304 -172.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 54.2 m -80.92 137.94 36.13 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.773 1.229 . . . . 0.0 110.223 166.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 48.1 pt -135.71 155.16 78.32 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -167.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -68.34 141.45 61.25 Favored 'Cis proline' 0 C--N 1.353 0.786 0 CA-C-N 119.212 0.754 . . . . 0.0 111.361 -6.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.4 m -126.94 120.57 29.46 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.274 0.63 . . . . 0.0 109.399 169.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.7 mp -102.57 126.11 49.53 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.942 1.697 . . . . 0.0 107.855 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.2 tt -118.25 139.22 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.228 1.011 . . . . 0.0 109.692 171.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.0 tp -113.16 129.7 56.43 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.408 1.083 . . . . 0.0 109.671 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -113.86 151.06 32.69 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.191 1.396 . . . . 0.0 110.402 171.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -132.48 127.99 36.43 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.305 1.442 . . . . 0.0 108.972 168.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.4 t70 49.05 41.49 19.37 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.297 1.039 . . . . 0.0 113.398 -168.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.33 9.7 55.36 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.626 1.584 . . . . 0.0 115.739 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -112.61 139.39 22.68 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 125.441 1.496 . . . . 0.0 109.845 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.14 140.03 43.91 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.536 2.157 . . . . 0.0 112.299 -171.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.8 t -117.71 -46.56 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.718 1.607 . . . . 0.0 111.469 -176.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -155.13 150.23 26.92 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.308 1.043 . . . . 0.0 112.052 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 67.6 ttp85 -129.81 139.17 51.29 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.061 1.345 . . . . 0.0 111.583 167.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 30.8 mt -132.25 142.58 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 127.388 2.275 . . . . 0.0 108.354 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 p -133.61 147.78 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.286 1.035 . . . . 0.0 112.022 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.98 161.92 24.54 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.541 1.543 . . . . 0.0 112.945 -175.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.73 151.71 28.72 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -136.66 153.19 50.98 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.353 1.861 . . . . 0.0 110.373 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.49 162.02 32.91 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 160.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -55.85 -34.12 65.15 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.81 -47.58 77.55 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 118.088 0.404 . . . . 0.0 111.18 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.13 -45.99 58.34 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.495 -0.753 . . . . 0.0 112.321 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.1 tp -65.73 -44.89 84.65 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 118.879 0.763 . . . . 0.0 110.685 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 16.7 tp -69.91 -24.93 63.46 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-O 115.825 -2.036 . . . . 0.0 112.753 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -65.24 -50.47 65.68 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 124.053 3.115 . . . . 0.0 111.644 168.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -62.54 -27.23 69.02 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 80.7 mt -87.57 -28.54 21.88 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.221 1.009 . . . . 0.0 113.439 169.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.3 m -62.37 -27.88 69.38 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.309 1.443 . . . . 0.0 110.608 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -49.49 -26.79 3.65 Favored 'General case' 0 CA--C 1.56 1.344 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 165.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.0 t -111.56 -22.36 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 128.223 2.609 . . . . 0.0 112.777 172.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.479 1.024 0 C-N-CA 127.632 2.373 . . . . 0.0 110.662 -179.787 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.9 p . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.2 pt -137.27 155.27 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 126.056 1.743 . . . . 0.0 111.546 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -93.61 139.13 31.13 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.389 0.675 . . . . 0.0 110.819 167.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.1 m -125.57 150.42 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.453 1.501 . . . . 0.0 110.571 172.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.3 p -143.28 157.33 44.57 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.302 1.441 . . . . 0.0 111.115 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -52.17 -28.09 16.85 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -174.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.06 -20.1 64.1 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.8 m -136.49 -3.87 2.1 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.386 1.474 . . . . 0.0 114.062 -176.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -53.51 -41.24 66.12 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.839 1.656 . . . . 0.0 112.526 -174.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.3 -33.16 74.71 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.6 m -79.51 -31.15 42.16 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.249 1.02 . . . . 0.0 112.643 175.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -88.81 -41.43 12.51 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -176.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.9 t -105.57 -52.46 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.106 1.363 . . . . 0.0 111.253 -172.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 29.3 mt -81.82 -13.45 57.66 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -171.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 74.6 m -89.21 -9.81 49.39 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.975 0.91 . . . . 0.0 113.346 175.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.3 t -77.58 140.47 39.69 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.044 0.938 . . . . 0.0 113.323 -174.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -98.78 -5.36 31.38 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.096 1.358 . . . . 0.0 113.559 176.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -98.56 162.84 20.41 Favored Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 124.588 1.155 . . . . 0.0 110.624 164.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -57.02 138.49 86.56 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.299 1.999 . . . . 0.0 113.448 170.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.7 t -132.62 131.41 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.451 1.5 . . . . 0.0 108.895 177.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -122.98 120.03 32.17 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.194 1.398 . . . . 0.0 109.279 -172.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.6 t -119.46 126.35 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.559 0.744 . . . . 0.0 111.138 -172.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -107.0 118.68 37.33 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.959 1.304 . . . . 0.0 112.455 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -94.08 111.57 23.3 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.582 1.953 . . . . 0.0 108.518 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -143.69 172.6 12.59 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.278 1.431 . . . . 0.0 112.884 -163.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -144.59 148.62 34.59 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 163.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 m -60.09 -27.85 67.35 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.675 1.19 . . . . 0.0 112.652 174.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 6.2 p-90 -76.61 -4.19 41.67 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 53.2 t -108.16 122.69 47.44 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.701 1.2 . . . . 0.0 111.792 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.38 -48.21 86.46 Favored Glycine 0 CA--C 1.539 1.543 0 CA-C-O 118.892 -0.949 . . . . 0.0 114.079 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -56.47 -36.24 97.37 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.045 2.497 . . . . 0.0 114.302 170.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 96.9 m -64.36 -45.18 88.87 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.279 -0.888 . . . . 0.0 111.88 173.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -62.39 -31.01 71.62 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.334 1.054 . . . . 0.0 112.397 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.4 ttp -75.69 -38.3 58.8 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.976 1.31 . . . . 0.0 113.376 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.2 p -83.91 -19.06 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.64 -51.42 76.45 Favored Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 175.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.85 -30.8 39.94 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.236 1.957 . . . . 0.0 113.058 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.0 t -64.28 -48.48 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.643 0.777 . . . . 0.0 110.68 173.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 38.9 mt -66.75 -32.94 74.57 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.453 0.701 . . . . 0.0 112.566 176.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -67.41 -42.05 83.89 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.136 0.88 . . . . 0.0 112.127 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.98 -47.86 81.34 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.314 -0.866 . . . . 0.0 111.635 170.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.4 -40.16 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 118.803 0.729 . . . . 0.0 110.822 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.8 -49.63 76.97 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.403 -0.811 . . . . 0.0 111.989 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.4 m -76.29 -31.32 58.16 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.55 0.74 . . . . 0.0 112.195 -171.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -95.74 -23.55 16.91 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -112.32 17.07 19.71 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.232 1.413 . . . . 0.0 113.292 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.04 -27.72 21.07 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.607 1.563 . . . . 0.0 114.351 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.3 p -67.79 -20.36 65.19 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.791 1.636 . . . . 0.0 113.87 176.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -117.29 -46.34 2.7 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.801 1.24 . . . . 0.0 112.72 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.9 mt -99.48 148.88 23.79 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.369 1.468 . . . . 0.0 111.126 -176.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.8 m -108.91 122.15 46.61 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 149.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 75.1 t -105.14 124.71 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.281 0.632 . . . . 0.0 110.126 -175.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.72 163.59 23.17 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.452 1.501 . . . . 0.0 112.326 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -130.31 147.3 52.01 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.694 1.598 . . . . 0.0 112.071 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -125.98 117.39 23.16 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.856 1.662 . . . . 0.0 108.83 169.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -81.75 113.24 19.59 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 122.883 0.473 . . . . 0.0 110.422 174.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.8 m -70.87 -16.95 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -172.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -84.17 -39.71 19.06 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.42 1.088 . . . . 0.0 112.43 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 36.3 p -92.66 -23.6 18.92 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.183 1.393 . . . . 0.0 113.893 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -134.88 69.69 71.1 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-N 119.499 1.045 . . . . 0.0 112.055 173.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -66.76 -26.72 45.1 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.153 2.569 . . . . 0.0 114.768 -172.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -64.11 -35.7 81.62 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.608 -0.683 . . . . 0.0 111.817 -175.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.2 m -64.05 -43.26 96.04 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.311 1.044 . . . . 0.0 111.309 176.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.35 -39.61 95.01 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.737 0.815 . . . . 0.0 112.018 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.34 -45.25 63.39 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.296 177.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -63.99 -32.73 74.38 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 118.878 0.763 . . . . 0.0 112.782 -171.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -98.45 8.04 45.4 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.344 1.058 . . . . 0.0 113.746 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.1 tp60 49.88 52.59 14.34 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.462 1.905 . . . . 0.0 113.35 -177.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.1 m -132.88 48.61 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.216 1.806 . . . . 0.0 109.647 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.5 m -78.42 -21.47 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.228 1.411 . . . . 0.0 113.657 -176.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.1 m -72.09 155.73 39.97 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.747 1.219 . . . . 0.0 111.112 168.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.61 149.28 49.96 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -174.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.43 136.65 41.25 Favored 'Cis proline' 0 C--N 1.353 0.771 0 N-CA-C 110.424 -0.644 . . . . 0.0 110.424 -14.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 98.7 m -127.88 121.38 29.89 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.851 0.86 . . . . 0.0 110.485 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.0 mp -102.26 132.31 48.29 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.368 1.467 . . . . 0.0 109.223 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.9 tp -121.9 128.13 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.992 1.317 . . . . 0.0 109.376 171.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 41.3 tp -108.23 127.97 54.31 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.005 1.322 . . . . 0.0 110.309 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -113.69 144.18 43.37 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.985 1.714 . . . . 0.0 109.535 172.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -107.22 -29.75 9.15 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -150.01 40.79 0.81 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.715 2.006 . . . . 0.0 109.913 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.92 -6.07 7.06 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 125.354 1.454 . . . . 0.0 115.141 -165.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -94.63 138.2 22.33 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 118.787 1.293 . . . . 0.0 110.607 167.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.51 146.07 38.74 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.353 2.702 . . . . 0.0 112.114 -176.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.6 m -132.99 -24.99 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -177.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -153.59 143.81 22.23 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.715 1.143 . . . . 0.0 111.67 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -128.9 137.93 51.71 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.854 2.062 . . . . 0.0 110.783 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.6 mt -135.18 141.58 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.91 1.684 . . . . 0.0 108.721 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 p -133.81 142.18 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 119.398 0.999 . . . . 0.0 111.127 168.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 91.86 150.0 24.94 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.273 1.416 . . . . 0.0 112.955 -171.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.42 144.67 31.25 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.074 0.95 . . . . 0.0 113.147 -174.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -134.56 159.99 39.46 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.067 1.747 . . . . 0.0 110.7 172.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -74.88 166.36 54.86 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.429 -0.669 . . . . 0.0 111.429 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -51.0 -37.33 44.38 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.836 1.254 . . . . 0.0 113.384 -173.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.95 -49.41 52.08 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.05 0.386 . . . . 0.0 111.76 -177.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.73 -37.59 59.26 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.548 0.739 . . . . 0.0 112.792 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.29 -45.44 87.99 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.4 1.0 . . . . 0.0 109.733 174.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 21.4 tp -70.2 -20.09 63.13 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-O 116.402 -1.761 . . . . 0.0 112.989 171.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.72 -54.12 49.18 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 123.802 3.001 . . . . 0.0 110.239 166.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -63.62 -26.59 68.75 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 114.43 -1.259 . . . . 0.0 113.136 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 82.4 mt -91.34 -21.82 20.83 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 168.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 31.8 m -65.84 -20.73 66.35 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.785 -1.197 . . . . 0.0 111.214 172.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -47.1 -27.3 1.33 Allowed 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 160.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -116.79 -25.13 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.701 1.6 . . . . 0.0 113.749 177.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.484 1.235 0 C-N-CA 125.604 1.561 . . . . 0.0 112.667 171.337 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.474 0.754 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.2 pt -142.03 159.59 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 126.474 1.91 . . . . 0.0 111.278 174.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -100.04 140.15 34.68 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.64 0.776 . . . . 0.0 110.22 163.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.6 m -130.12 145.96 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.469 1.108 . . . . 0.0 111.557 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.0 p -140.35 159.27 42.57 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.39 1.476 . . . . 0.0 111.236 176.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -51.74 -27.95 13.6 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.615 1.966 . . . . 0.0 114.805 -173.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.23 -22.02 65.71 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.8 m -136.73 1.19 2.53 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.677 1.591 . . . . 0.0 113.547 -175.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -55.48 -42.68 74.71 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.461 1.504 . . . . 0.0 112.461 -170.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.12 -32.11 73.36 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.6 m -79.01 -32.76 45.23 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.493 -0.754 . . . . 0.0 111.892 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -87.97 -40.78 13.62 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t -101.52 -40.09 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.203 1.401 . . . . 0.0 112.406 -171.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -100.76 -20.07 15.73 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -170.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.8 m -94.18 8.13 42.8 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.041 1.336 . . . . 0.0 113.768 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.7 p -69.52 157.21 37.59 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.007 2.123 . . . . 0.0 114.591 -176.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -87.87 -6.57 58.02 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.525 1.13 . . . . 0.0 113.557 173.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -142.21 166.35 21.81 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 127.744 2.418 . . . . 0.0 110.769 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -56.33 148.24 62.57 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.978 2.452 . . . . 0.0 113.694 173.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.2 t -132.49 128.97 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.975 1.31 . . . . 0.0 110.347 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 tt -98.05 128.16 44.42 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.255 1.822 . . . . 0.0 108.64 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.9 t -116.02 125.42 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 119.516 1.053 . . . . 0.0 110.898 172.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -106.55 114.49 28.64 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.827 1.651 . . . . 0.0 111.315 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -92.39 109.0 20.38 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.927 2.091 . . . . 0.0 108.016 175.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -142.19 -178.5 5.75 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.1 1.36 . . . . 0.0 111.372 -163.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.61 141.14 30.49 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 166.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 46.9 m -56.73 -29.94 63.02 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.524 1.53 . . . . 0.0 112.117 172.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 35.6 p-90 -88.74 -0.9 57.76 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.85 1.66 . . . . 0.0 115.138 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 48.1 t -110.11 134.21 52.41 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.473 1.033 . . . . 0.0 113.238 -172.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.37 -57.06 14.2 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.17 1.367 . . . . 0.0 115.477 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.21 -27.36 72.53 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 CA-C-N 120.939 2.37 . . . . 0.0 112.903 175.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 93.0 m -63.76 -43.97 94.84 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.129 -0.982 . . . . 0.0 111.74 169.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.01 -30.48 71.55 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.195 0.998 . . . . 0.0 112.553 173.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 15.8 tpt -73.35 -38.47 65.73 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.657 1.183 . . . . 0.0 113.353 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.4 p -84.42 -20.82 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.09 -50.31 82.81 Favored Pre-proline 0 CA--C 1.552 1.022 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.22 -29.67 32.23 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.293 1.995 . . . . 0.0 113.147 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.9 t -65.26 -49.18 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.409 0.684 . . . . 0.0 110.21 173.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.6 mt -63.99 -33.61 76.11 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.802 0.841 . . . . 0.0 112.709 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -64.14 -44.85 90.9 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.302 0.955 . . . . 0.0 111.517 174.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -61.63 -45.39 94.28 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.325 -0.859 . . . . 0.0 111.492 173.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.4 mt -59.68 -43.74 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 121.415 -0.803 . . . . 0.0 111.068 176.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.55 -37.26 86.65 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.102 0.961 . . . . 0.0 112.642 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.4 m -73.62 -46.89 44.23 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.784 0.834 . . . . 0.0 111.236 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -87.27 -35.49 18.44 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.498 1.119 . . . . 0.0 114.004 -170.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -99.72 24.7 8.0 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.598 1.159 . . . . 0.0 113.273 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.88 -28.12 47.9 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.109 1.363 . . . . 0.0 114.311 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.0 p -83.25 -19.39 36.47 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.296 1.438 . . . . 0.0 113.834 175.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -102.62 -38.15 7.63 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.082 1.353 . . . . 0.0 112.79 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 79.8 mt -129.8 160.89 32.07 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.34 2.256 . . . . 0.0 110.944 -175.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.4 m -108.8 138.8 44.54 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 147.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.5 t -101.29 129.97 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.82 0.848 . . . . 0.0 109.5 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.4 151.83 48.3 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.275 1.43 . . . . 0.0 111.557 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -127.67 148.8 50.4 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.987 1.315 . . . . 0.0 113.123 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -135.33 114.47 12.25 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.644 1.977 . . . . 0.0 108.875 168.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -81.39 116.34 21.17 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 171.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.5 m -64.55 -20.25 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -167.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -79.88 -22.58 42.68 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 172.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.1 p -92.57 -29.1 16.34 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -171.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -145.53 92.58 5.5 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 123.932 0.893 . . . . 0.0 110.73 162.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -62.46 -26.48 76.49 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.255 2.636 . . . . 0.0 114.894 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -71.78 -31.72 66.9 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.048 -1.033 . . . . 0.0 111.858 -175.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.5 m -65.75 -41.12 92.49 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.449 0.7 . . . . 0.0 110.786 174.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.1 -35.6 80.13 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.022 0.929 . . . . 0.0 112.609 172.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.3 tpt85 -73.49 -36.63 65.81 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -65.4 -28.64 69.4 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -172.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -103.14 5.34 37.79 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.35 1.06 . . . . 0.0 113.207 174.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 48.56 57.05 6.69 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.835 1.654 . . . . 0.0 112.172 -169.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.6 m -124.81 36.03 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.645 1.978 . . . . 0.0 111.038 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.7 m -71.67 -19.3 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.344 1.058 . . . . 0.0 113.156 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.2 m -68.01 151.73 46.62 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.408 1.483 . . . . 0.0 111.507 169.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 13.5 pt -139.31 142.53 32.84 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -168.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -67.71 149.08 82.48 Favored 'Cis proline' 0 CA--C 1.54 0.797 0 CA-C-N 118.498 0.499 . . . . 0.0 111.121 -17.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 67.7 m -133.42 125.15 28.44 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.756 1.222 . . . . 0.0 109.399 171.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.6 mp -109.28 136.48 48.67 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.593 1.157 . . . . 0.0 109.334 177.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.0 tt -127.9 144.87 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.202 1.001 . . . . 0.0 110.284 169.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.5 tp -121.52 120.44 34.87 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.941 0.897 . . . . 0.0 110.54 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -98.4 131.08 44.97 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.559 1.144 . . . . 0.0 109.604 172.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -99.59 -33.49 10.61 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -175.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -154.49 57.11 0.7 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.215 1.806 . . . . 0.0 110.174 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.5 15.87 64.47 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.51 1.052 . . . . 0.0 114.551 -173.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -140.31 137.56 17.98 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 126.966 2.106 . . . . 0.0 110.546 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -76.14 142.72 24.82 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.193 2.595 . . . . 0.0 112.645 -173.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.1 t -128.66 -28.6 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.689 1.596 . . . . 0.0 112.697 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -135.16 142.15 46.06 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.07 1.348 . . . . 0.0 110.077 172.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.8 ttt85 -147.03 113.22 5.86 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.957 2.103 . . . . 0.0 109.6 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 33.9 pt -137.05 148.17 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.377 1.471 . . . . 0.0 113.152 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.9 m -121.64 145.77 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 125.637 1.575 . . . . 0.0 111.195 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.95 160.49 24.32 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 124.164 0.888 . . . . 0.0 113.557 -172.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.39 145.53 31.96 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.853 0.861 . . . . 0.0 112.769 -176.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -130.59 153.33 49.01 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.801 1.641 . . . . 0.0 110.056 169.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -74.18 165.54 54.78 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 175.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -51.69 -35.22 41.89 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.665 1.186 . . . . 0.0 113.308 -174.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.48 -53.99 29.03 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.0 0.364 . . . . 0.0 111.197 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.44 -33.13 60.87 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.53 -45.09 94.57 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.472 1.033 . . . . 0.0 109.631 171.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 25.7 tp -69.41 -24.23 63.82 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-O 115.691 -2.099 . . . . 0.0 113.112 173.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.76 -51.04 69.95 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 124.295 3.225 . . . . 0.0 111.524 167.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -57.39 -37.53 72.81 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.05 0.94 . . . . 0.0 111.73 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.8 mt -83.16 -28.35 29.43 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 172.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.4 m -62.56 -28.15 69.67 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.037 1.335 . . . . 0.0 110.641 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -52.5 -26.6 13.44 Favored 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 168.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 51.3 t -107.3 -24.41 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.886 2.074 . . . . 0.0 112.519 171.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.4 t . . . . . 0 N--CA 1.475 0.823 0 C-N-CA 126.537 1.935 . . . . 0.0 111.502 -177.587 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.6 p . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.9 pt -132.84 165.34 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 126.209 1.803 . . . . 0.0 111.413 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -117.28 145.42 43.98 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.88 0.872 . . . . 0.0 111.753 171.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.15 156.47 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 126.326 1.851 . . . . 0.0 110.964 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 65.2 p -123.85 168.57 12.58 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.912 1.685 . . . . 0.0 111.566 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -57.29 -27.58 62.28 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 121.018 -1.051 . . . . 0.0 113.136 175.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.6 -13.31 56.74 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.224 1.409 . . . . 0.0 114.515 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.1 p -128.88 -8.91 4.94 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -173.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -57.06 -47.91 79.82 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.282 1.433 . . . . 0.0 112.055 -176.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.61 -34.28 77.52 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.3 -0.875 . . . . 0.0 112.699 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.23 -8.71 59.24 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.755 1.622 . . . . 0.0 113.666 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -121.81 -47.87 2.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.501 1.12 . . . . 0.0 113.455 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.3 t -83.16 -51.45 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.15 1.38 . . . . 0.0 111.037 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 43.3 mt -84.67 -13.22 52.11 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -174.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.7 p -78.17 -18.8 55.08 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.955 1.302 . . . . 0.0 113.785 176.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.5 t -86.05 133.24 33.91 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.63 1.172 . . . . 0.0 113.459 -168.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -75.77 -31.62 59.6 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.389 1.076 . . . . 0.0 111.528 168.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -80.68 138.88 50.62 Favored Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 124.891 1.276 . . . . 0.0 108.85 174.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -59.07 142.44 99.35 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 121.388 1.392 . . . . 0.0 113.507 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.5 t -124.35 125.67 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.384 1.474 . . . . 0.0 109.354 -177.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -108.39 115.25 29.75 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.655 1.582 . . . . 0.0 109.303 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.2 t -108.76 122.42 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.186 0.994 . . . . 0.0 110.829 -175.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -92.33 109.3 20.68 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.732 1.613 . . . . 0.0 111.021 173.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -83.61 112.86 20.4 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.793 1.237 . . . . 0.0 108.497 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -146.41 168.57 20.82 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.22 1.008 . . . . 0.0 113.033 -164.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.18 155.27 38.52 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.755 1.222 . . . . 0.0 110.974 166.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.9 t -66.05 -19.18 65.77 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -75.56 -4.44 39.94 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 48.5 t -109.29 108.83 19.56 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.348 1.059 . . . . 0.0 112.535 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.59 -40.43 94.6 Favored Glycine 0 CA--C 1.54 1.633 0 CA-C-O 118.848 -0.973 . . . . 0.0 113.972 174.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -60.44 -33.08 94.42 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.44 2.093 . . . . 0.0 114.459 168.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 91.1 m -63.69 -44.75 92.76 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.812 1.187 . . . . 0.0 110.735 168.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -60.0 -36.31 76.93 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 175.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 13.2 ptm -80.44 -29.97 37.56 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.2 p -84.6 -24.01 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-N 119.8 1.182 . . . . 0.0 113.563 174.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.13 -48.72 63.45 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 176.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -65.83 -29.1 50.64 Favored 'Trans proline' 0 C--N 1.353 0.777 0 CA-C-N 122.216 1.827 . . . . 0.0 113.475 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.3 t -69.15 -51.34 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 119.374 0.988 . . . . 0.0 110.334 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.0 pp -70.22 -28.43 65.26 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -68.65 -40.22 80.31 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.147 0.979 . . . . 0.0 112.932 171.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -63.23 -47.21 83.46 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.928 -1.107 . . . . 0.0 111.348 170.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.22 -37.88 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 118.483 0.583 . . . . 0.0 110.679 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.65 -49.96 75.61 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.276 0.944 . . . . 0.0 112.752 172.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.1 m -76.05 -33.27 59.6 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.843 0.857 . . . . 0.0 111.681 -169.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -83.92 -34.08 24.57 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 176.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -108.1 27.71 9.0 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.946 1.298 . . . . 0.0 113.744 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.02 -28.33 62.39 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.4 m -69.47 -27.35 65.15 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.08 1.352 . . . . 0.0 112.523 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -103.57 -34.28 8.71 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.44 1.496 . . . . 0.0 112.816 -174.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.5 mt -129.85 152.72 49.02 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.141 2.176 . . . . 0.0 111.178 -174.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.5 m -108.65 133.85 52.18 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 150.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.5 t -110.62 121.44 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 122.993 0.517 . . . . 0.0 109.862 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -118.06 164.84 14.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.521 1.528 . . . . 0.0 112.19 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 46.0 mttm -124.86 136.53 53.89 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.066 1.747 . . . . 0.0 111.463 173.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -113.2 117.22 31.28 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.992 1.317 . . . . 0.0 108.496 167.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.81 98.07 8.3 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.905 1.282 . . . . 0.0 108.604 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.3 m -67.06 -19.29 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 O-C-N 121.362 -0.836 . . . . 0.0 112.992 -172.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -72.42 -23.22 61.05 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.429 1.092 . . . . 0.0 112.555 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.5 p -118.2 -15.56 9.79 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.469 1.508 . . . . 0.0 113.593 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -123.3 60.94 18.42 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 125.392 1.477 . . . . 0.0 111.864 176.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.69 -23.57 56.15 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.591 2.194 . . . . 0.0 112.546 178.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -64.76 -42.9 94.77 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.006 0.922 . . . . 0.0 111.815 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.68 -37.02 73.59 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.575 0.75 . . . . 0.0 111.121 176.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.83 -47.1 86.61 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.76 0.824 . . . . 0.0 112.34 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 -77.43 -24.61 50.35 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -57.49 -41.41 80.68 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.935 0.894 . . . . 0.0 112.858 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -101.1 6.02 43.1 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.892 1.277 . . . . 0.0 113.219 174.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.376 16.2 pt20 46.38 29.35 0.85 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 128.286 2.634 . . . . 0.0 115.84 -166.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.5 m -80.68 38.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 126.66 1.984 . . . . 0.0 111.93 174.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 m -75.13 -25.29 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.947 1.299 . . . . 0.0 112.606 -175.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 55.6 m -78.61 140.39 38.46 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.731 1.212 . . . . 0.0 110.051 165.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 48.9 pt -138.96 155.4 72.97 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 123.884 0.874 . . . . 0.0 113.183 -168.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.41 141.94 63.98 Favored 'Cis proline' 0 C--N 1.354 0.835 0 CA-C-N 119.393 0.819 . . . . 0.0 111.96 -5.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.6 m -131.68 121.59 24.54 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.628 0.771 . . . . 0.0 109.812 171.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.1 mp -108.07 119.46 39.54 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.856 1.662 . . . . 0.0 108.553 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.4 tt -116.64 133.2 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.413 1.085 . . . . 0.0 110.651 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.6 tt -104.43 125.0 50.23 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.036 0.934 . . . . 0.0 110.385 173.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -102.69 144.65 30.8 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.339 1.456 . . . . 0.0 109.942 166.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -130.2 129.43 43.38 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.479 1.511 . . . . 0.0 109.34 172.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.8 t0 47.62 37.59 6.92 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.359 1.064 . . . . 0.0 113.323 -167.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.15 18.68 71.33 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 125.048 1.309 . . . . 0.0 116.364 -178.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -122.92 143.1 39.65 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 119.461 1.631 . . . . 0.0 110.87 172.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.28 140.3 44.11 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.749 2.3 . . . . 0.0 112.24 -173.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.7 t -123.79 -44.79 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.124 1.37 . . . . 0.0 112.629 -175.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.6 tttm -148.83 152.52 36.64 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.944 0.793 . . . . 0.0 112.129 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -138.51 141.46 39.37 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.559 1.144 . . . . 0.0 112.382 173.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.8 mp -129.4 139.49 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 127.361 2.265 . . . . 0.0 108.393 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.3 p -132.03 142.86 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.355 1.062 . . . . 0.0 111.237 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.78 154.92 19.62 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.11 1.338 . . . . 0.0 112.549 -169.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.39 137.18 46.36 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.865 -0.785 . . . . 0.0 111.904 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -131.8 154.63 48.92 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.78 1.632 . . . . 0.0 110.946 174.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -76.13 166.53 54.41 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 172.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -54.6 -33.39 60.33 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.08 -56.06 25.31 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 123.219 0.324 . . . . 0.0 110.95 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.75 -37.89 58.92 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.313 -0.867 . . . . 0.0 113.286 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.5 tp -66.17 -36.04 82.04 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 119.905 1.23 . . . . 0.0 110.906 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 16.9 tp -74.17 -24.55 59.4 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-O 115.722 -2.085 . . . . 0.0 113.073 170.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -56.91 -54.21 49.16 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 124.319 3.236 . . . . 0.0 110.375 163.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -68.53 -26.02 65.23 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -174.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 93.3 mt -93.75 -25.6 17.35 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.043 0.937 . . . . 0.0 113.435 172.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.3 t -67.79 -21.61 65.23 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.418 1.087 . . . . 0.0 111.614 171.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -49.44 -25.69 2.76 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 161.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 70.6 t -111.07 -25.6 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 127.436 2.294 . . . . 0.0 112.496 172.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.4 t . . . . . 0 N--CA 1.482 1.14 0 C-N-CA 127.172 2.189 . . . . 0.0 111.186 177.702 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.8 p . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 45.5 pt -134.29 162.73 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 126.104 1.762 . . . . 0.0 110.484 171.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -120.04 146.6 45.74 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.579 -0.7 . . . . 0.0 112.7 165.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.3 m -120.19 155.06 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.446 1.898 . . . . 0.0 110.973 -176.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.5 p -131.79 161.99 31.6 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.793 1.237 . . . . 0.0 112.684 -174.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.83 -26.09 57.55 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.087 1.355 . . . . 0.0 114.629 -175.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.61 -16.15 52.42 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.701 1.2 . . . . 0.0 114.19 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.7 m -134.44 -5.57 2.59 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -168.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -53.97 -41.89 68.34 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.069 1.348 . . . . 0.0 112.653 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.67 -32.51 73.23 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.9 m -78.85 -32.11 45.94 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.292 1.037 . . . . 0.0 111.921 176.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -87.32 -44.54 11.32 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.5 t -98.83 -51.92 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.964 1.306 . . . . 0.0 111.592 -173.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 33.5 mt -84.56 -13.47 51.67 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -170.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.8 t -81.11 -12.07 59.34 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.263 1.025 . . . . 0.0 112.894 173.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.3 t -69.67 142.69 53.35 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -171.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.2 p-10 -94.62 3.24 55.33 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.792 1.637 . . . . 0.0 113.76 173.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -126.48 167.08 18.27 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 126.946 2.098 . . . . 0.0 111.043 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -58.21 138.78 87.71 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.318 2.012 . . . . 0.0 113.257 170.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.8 t -132.58 129.33 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.09 1.356 . . . . 0.0 109.139 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -116.93 115.52 25.64 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.359 1.464 . . . . 0.0 109.231 -173.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.7 t -110.65 121.19 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.454 0.702 . . . . 0.0 110.828 -174.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -91.24 106.34 18.44 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.539 1.535 . . . . 0.0 110.6 173.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -80.61 114.34 19.43 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.088 1.355 . . . . 0.0 108.68 173.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.6 p-90 -147.94 168.64 21.75 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.979 0.911 . . . . 0.0 113.021 -164.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.53 153.87 36.59 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.402 1.081 . . . . 0.0 110.672 161.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.3 t -65.6 -20.05 66.16 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -75.22 -10.47 59.5 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 173.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 45.2 t -98.19 110.98 23.46 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.919 0.888 . . . . 0.0 110.969 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.08 -49.03 69.77 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-O 118.768 -1.018 . . . . 0.0 113.306 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -57.62 -32.57 94.81 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.032 2.488 . . . . 0.0 114.829 172.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 68.6 m -67.24 -44.84 78.46 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.914 -1.116 . . . . 0.0 111.157 171.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -63.03 -29.66 70.99 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.284 1.034 . . . . 0.0 112.177 176.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 60.7 mtt -75.82 -36.69 59.61 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.566 1.547 . . . . 0.0 113.782 173.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -87.32 -22.81 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 119.432 1.015 . . . . 0.0 113.677 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.74 -47.31 72.36 Favored Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 174.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -66.61 -27.01 45.96 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 CA-C-N 122.338 1.871 . . . . 0.0 113.735 176.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 92.1 t -70.96 -47.02 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.452 1.024 . . . . 0.0 109.305 173.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.64 -37.62 82.1 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.219 1.408 . . . . 0.0 112.269 177.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -66.33 -39.36 89.18 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.156 0.982 . . . . 0.0 112.503 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -67.26 -44.13 80.14 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.522 -0.736 . . . . 0.0 111.64 172.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.2 mm -61.24 -39.95 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 119.548 1.067 . . . . 0.0 111.055 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.09 -46.96 86.94 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.32 -0.863 . . . . 0.0 112.104 175.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.9 m -76.32 -34.77 59.01 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.546 0.738 . . . . 0.0 112.716 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -98.92 -16.95 18.6 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -172.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 74.5 mmt-85 -121.48 21.32 11.0 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.314 1.445 . . . . 0.0 113.438 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.95 -27.63 19.81 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.68 1.592 . . . . 0.0 114.03 175.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.2 p -70.14 -21.39 63.09 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.575 1.55 . . . . 0.0 114.113 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -117.39 -35.3 4.05 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.497 1.119 . . . . 0.0 113.484 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 57.3 mt -119.5 155.17 32.62 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.978 1.711 . . . . 0.0 110.843 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 57.1 m -108.73 126.19 52.73 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 152.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.7 t -102.58 123.26 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.095 0.558 . . . . 0.0 110.404 -177.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.23 165.62 17.96 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.891 1.676 . . . . 0.0 111.769 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -126.72 140.55 52.31 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.221 1.408 . . . . 0.0 111.386 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -116.06 116.99 28.87 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.362 1.065 . . . . 0.0 108.93 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.95 97.62 7.54 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.179 1.392 . . . . 0.0 108.615 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.9 m -66.42 -19.85 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 121.391 -0.818 . . . . 0.0 113.139 -173.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -72.69 -22.94 60.83 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.123 0.969 . . . . 0.0 112.596 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.4 p -117.42 -16.02 10.26 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.601 1.561 . . . . 0.0 113.41 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -123.3 59.05 14.04 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 125.21 1.404 . . . . 0.0 112.301 176.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -65.32 -25.96 56.47 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.52 2.147 . . . . 0.0 112.542 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -63.94 -45.06 90.85 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.981 0.912 . . . . 0.0 111.533 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.3 m -66.77 -38.6 86.9 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.629 0.772 . . . . 0.0 111.363 175.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.56 -43.75 98.04 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.612 0.765 . . . . 0.0 112.686 177.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.9 ptt85 -78.09 -26.74 48.26 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -56.69 -40.83 76.29 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.184 0.994 . . . . 0.0 113.465 -177.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -98.56 4.65 48.16 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.085 0.954 . . . . 0.0 113.256 177.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 52.57 49.25 20.8 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.357 1.863 . . . . 0.0 112.944 -167.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.0 m -115.23 22.5 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.721 1.608 . . . . 0.0 113.144 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.1 m -61.79 -22.29 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.062 1.345 . . . . 0.0 113.444 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.6 m -77.38 70.15 3.73 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.404 1.881 . . . . 0.0 112.077 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.2 pt -73.37 148.01 87.97 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.14 138.35 44.0 Favored 'Cis proline' 0 C--N 1.353 0.797 0 CA-C-N 119.567 0.881 . . . . 0.0 112.798 -3.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.6 m -135.8 125.4 25.25 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.115 0.966 . . . . 0.0 109.873 167.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.2 mp -93.44 132.44 37.7 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.86 1.264 . . . . 0.0 108.16 161.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.14 126.17 73.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 168.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 40.2 tp -104.37 119.0 37.98 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.744 1.618 . . . . 0.0 109.874 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -98.08 147.75 24.23 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.595 1.558 . . . . 0.0 110.143 171.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -126.01 130.55 51.4 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.673 1.189 . . . . 0.0 109.033 165.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.7 t70 51.04 35.18 12.24 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.658 1.183 . . . . 0.0 113.592 -174.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.2 15.96 72.74 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 124.954 1.264 . . . . 0.0 115.986 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -116.68 140.73 27.14 Favored Pre-proline 0 N--CA 1.473 0.712 0 CA-C-N 119.064 1.432 . . . . 0.0 110.442 172.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.1 139.94 40.22 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.689 2.259 . . . . 0.0 111.833 -176.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 72.0 t -128.64 -43.2 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.423 1.089 . . . . 0.0 113.184 -174.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -145.48 152.47 39.82 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 119.445 1.021 . . . . 0.0 112.976 -175.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -128.08 140.17 52.1 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.862 1.665 . . . . 0.0 111.389 171.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.0 mt -133.4 139.12 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.266 1.826 . . . . 0.0 108.474 174.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.1 m -131.51 151.64 35.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 123.557 0.743 . . . . 0.0 112.987 -171.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.12 171.96 17.32 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 123.805 0.717 . . . . 0.0 113.406 -172.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.66 153.23 41.31 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.7 -0.882 . . . . 0.0 112.227 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.14 159.1 42.92 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.404 1.882 . . . . 0.0 109.855 165.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.48 161.49 50.15 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 159.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -50.75 -34.04 25.54 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -177.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.02 -49.21 75.52 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.5 -34.84 47.13 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.894 0.878 . . . . 0.0 113.091 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.03 -47.67 73.64 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.378 0.99 . . . . 0.0 110.037 175.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -62.93 -41.93 99.64 Favored 'General case' 0 C--O 1.206 -1.23 0 CA-C-O 115.497 -2.192 . . . . 0.0 110.413 171.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -53.32 -50.47 64.91 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 124.136 3.153 . . . . 0.0 112.03 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -67.63 -30.45 70.03 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.3 mt -83.09 -24.71 32.56 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.808 1.186 . . . . 0.0 113.525 169.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.9 t -72.45 -21.84 61.17 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 129.164 2.986 . . . . 0.0 111.186 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -45.94 -26.48 0.71 Allowed 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 156.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.9 t -111.13 -51.8 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 127.321 2.249 . . . . 0.0 113.022 166.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 92.3 t . . . . . 0 N--CA 1.482 1.16 0 C-N-CA 127.276 2.23 . . . . 0.0 110.829 -178.684 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.0 p . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.9 pt -129.41 155.43 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.699 1.6 . . . . 0.0 111.258 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -98.89 139.69 34.18 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.846 0.858 . . . . 0.0 111.275 170.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -126.43 155.57 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.923 1.689 . . . . 0.0 111.197 174.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 80.6 p -141.56 158.73 43.47 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.822 1.649 . . . . 0.0 110.48 173.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -52.64 -29.64 27.27 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.082 1.353 . . . . 0.0 114.254 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.09 -21.12 66.35 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.0 m -131.42 -4.43 3.79 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.623 1.569 . . . . 0.0 113.715 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -53.2 -40.67 64.6 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.29 1.836 . . . . 0.0 112.637 -175.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.23 -33.11 74.66 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.364 -0.835 . . . . 0.0 113.154 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.4 m -79.72 -31.4 41.14 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.254 1.022 . . . . 0.0 112.714 174.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -89.01 -39.46 13.67 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.302 -0.874 . . . . 0.0 113.194 -175.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.5 t -106.21 -53.43 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.116 1.366 . . . . 0.0 110.956 -173.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 46.7 mt -80.05 -18.36 50.3 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.179 1.178 . . . . 0.0 114.179 -173.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.6 m -91.92 -2.76 56.63 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.067 0.947 . . . . 0.0 113.293 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.0 t -69.39 141.0 54.23 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.046 0.939 . . . . 0.0 112.71 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.59 4.81 52.77 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.446 1.499 . . . . 0.0 112.7 176.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -130.83 166.94 23.73 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 126.918 2.087 . . . . 0.0 111.03 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.17 135.99 71.9 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 121.824 1.682 . . . . 0.0 112.164 171.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.5 p -139.46 122.73 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.443 1.097 . . . . 0.0 110.918 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.09 129.42 46.96 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.253 2.221 . . . . 0.0 108.503 -175.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.0 t -119.8 125.42 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.618 1.167 . . . . 0.0 110.162 175.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -107.23 112.97 26.1 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.607 1.163 . . . . 0.0 111.344 174.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -82.6 113.57 20.39 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.487 1.515 . . . . 0.0 108.052 174.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.463 ' CD1' ' HE3' ' A' ' 62' ' ' LYS . 1.3 p-90 -148.82 170.73 17.59 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -166.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.13 156.33 40.78 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.323 1.049 . . . . 0.0 111.7 165.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.6 p -64.47 -20.71 66.36 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.976 1.311 . . . . 0.0 113.672 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 11.8 p-90 -82.93 -4.51 58.28 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 52.6 t -107.3 119.75 40.26 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.191 0.905 . . . . 0.0 111.945 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.88 -52.26 54.29 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-O 118.877 -0.957 . . . . 0.0 113.475 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -57.73 -35.9 98.62 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.779 2.319 . . . . 0.0 114.215 173.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 99.3 m -60.49 -46.69 89.18 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.624 1.102 . . . . 0.0 111.592 171.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.62 -29.19 70.2 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.384 1.074 . . . . 0.0 112.162 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 97.4 mmm -75.98 -37.67 58.29 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.004 1.322 . . . . 0.0 114.38 173.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.8 p -84.59 -23.01 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 CA-C-N 119.951 1.251 . . . . 0.0 113.556 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.05 -48.71 78.33 Favored Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -66.17 -30.24 46.59 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 CA-C-N 122.61 1.968 . . . . 0.0 113.37 176.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.9 t -67.23 -49.59 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-N 118.806 0.73 . . . . 0.0 109.834 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.7 mt -61.08 -37.36 82.41 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.343 1.057 . . . . 0.0 112.574 174.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -70.3 -40.44 74.25 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.969 0.908 . . . . 0.0 112.371 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -60.53 -47.2 87.21 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.514 -0.741 . . . . 0.0 111.085 168.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 76.0 mt -63.42 -36.82 77.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 O-C-N 121.649 -0.657 . . . . 0.0 111.286 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.13 -48.46 81.54 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 120.996 -1.065 . . . . 0.0 112.107 172.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.0 m -76.68 -32.92 58.21 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.171 0.988 . . . . 0.0 112.394 -172.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -99.29 -18.19 17.7 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.7 mmt-85 -122.45 28.27 7.48 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.056 1.342 . . . . 0.0 113.712 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.2 -27.68 22.91 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.889 0.876 . . . . 0.0 113.226 168.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.1 p -66.31 -26.92 67.54 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.057 2.143 . . . . 0.0 114.602 173.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -118.94 -23.71 6.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.363 1.465 . . . . 0.0 113.347 -171.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 80.5 mt -137.03 157.01 47.68 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.075 2.55 . . . . 0.0 110.258 -176.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 48.8 m -108.74 138.72 44.6 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 148.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.6 t -121.61 124.22 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 119.402 1.001 . . . . 0.0 110.68 -176.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -124.3 153.77 41.25 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.457 1.903 . . . . 0.0 112.632 -171.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.463 ' HE3' ' CD1' ' A' ' 33' ' ' TRP . 31.0 mmmt -116.39 132.81 56.57 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.775 2.03 . . . . 0.0 109.7 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -117.35 109.92 17.42 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.912 1.285 . . . . 0.0 108.169 170.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -82.62 100.27 10.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.598 -176.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.0 m -66.56 -16.24 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 120.771 -1.206 . . . . 0.0 112.753 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -70.69 -21.85 62.53 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.689 1.196 . . . . 0.0 113.268 171.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.0 p -118.79 -30.98 4.94 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -140.48 79.53 20.29 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 124.416 1.086 . . . . 0.0 111.279 175.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -70.76 -7.63 21.79 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.072 2.515 . . . . 0.0 113.249 174.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -56.82 -43.49 81.09 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.304 1.441 . . . . 0.0 112.816 -175.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.5 m -64.35 -44.53 91.17 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.54 0.736 . . . . 0.0 111.808 176.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.1 -35.89 82.58 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.537 -0.727 . . . . 0.0 112.358 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.5 ttp-105 -75.85 -34.23 60.05 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.554 0.742 . . . . 0.0 112.889 175.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -58.44 -37.47 75.49 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.38 1.072 . . . . 0.0 112.631 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -96.72 6.24 49.08 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.578 1.151 . . . . 0.0 113.376 174.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 59.94 -13.78 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 129.184 2.994 . . . . 0.0 116.814 -177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.4 m -78.77 55.59 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 126.979 2.111 . . . . 0.0 113.599 -177.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 m -72.94 -9.76 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.762 1.625 . . . . 0.0 114.677 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.6 m -78.29 65.4 3.63 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.974 1.709 . . . . 0.0 112.776 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.4 pt -57.35 153.37 27.54 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 125.616 1.566 . . . . 0.0 114.831 -171.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.98 140.46 64.4 Favored 'Cis proline' 0 C--N 1.354 0.85 0 CA-C-N 119.495 0.855 . . . . 0.0 112.132 -3.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 33.6 m -128.97 121.04 27.16 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.677 0.791 . . . . 0.0 109.468 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.1 mp -107.8 125.75 51.8 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.982 1.313 . . . . 0.0 108.318 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.6 tt -128.21 130.1 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.201 1.0 . . . . 0.0 110.309 176.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.0 tp -108.16 128.22 54.51 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.823 1.249 . . . . 0.0 109.737 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -108.53 152.87 24.16 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.43 1.492 . . . . 0.0 110.205 170.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -135.26 122.31 21.37 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.261 1.824 . . . . 0.0 108.792 173.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.3 t70 50.9 35.64 12.92 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.172 0.989 . . . . 0.0 113.097 -168.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.2 7.75 68.21 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 125.604 1.573 . . . . 0.0 116.396 -176.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -106.42 137.67 19.5 Favored Pre-proline 0 N--CA 1.474 0.758 0 CA-C-N 119.541 1.671 . . . . 0.0 110.356 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.35 139.48 45.66 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.194 1.929 . . . . 0.0 112.0 -176.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.1 m -132.63 -18.41 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 125.163 1.385 . . . . 0.0 114.608 -176.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.9 tppm? -154.48 145.73 22.9 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.739 1.154 . . . . 0.0 111.006 171.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -138.33 134.94 34.88 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.142 0.977 . . . . 0.0 111.736 167.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.8 mp -130.44 144.27 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.34 2.256 . . . . 0.0 109.0 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.4 p -133.25 141.15 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.603 1.161 . . . . 0.0 110.336 170.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.26 156.14 27.59 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.506 1.05 . . . . 0.0 112.898 -167.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.31 141.59 41.56 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.744 0.817 . . . . 0.0 112.961 -175.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -132.85 148.94 52.3 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.97 1.708 . . . . 0.0 110.802 174.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.93 168.66 54.26 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 123.911 0.767 . . . . 0.0 111.318 173.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -56.35 -33.36 65.59 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -173.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.36 -53.75 47.7 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.924 0.392 . . . . 0.0 110.558 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.12 -34.91 66.41 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.515 -0.741 . . . . 0.0 112.776 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.3 tp -67.05 -38.48 85.92 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 120.136 1.335 . . . . 0.0 111.177 173.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . 0.254 0.1 OUTLIER -75.96 -11.1 59.9 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 116.863 -1.541 . . . . 0.0 113.99 169.182 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.79 -56.6 11.09 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 124.045 3.111 . . . . 0.0 110.607 158.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.19 -36.33 70.69 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.825 1.25 . . . . 0.0 111.997 -176.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 70.7 mt -91.47 -28.16 17.8 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 117.185 -1.388 . . . . 0.0 113.425 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 84.4 p -66.52 -18.69 65.51 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 121.793 2.088 . . . . 0.0 112.416 175.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -50.16 -22.34 1.66 Allowed 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 162.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.9 t -115.75 -34.08 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 127.876 2.47 . . . . 0.0 112.988 171.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 N--CA 1.477 0.899 0 C-N-CA 127.16 2.184 . . . . 0.0 110.997 -172.528 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.7 p . . . . . 0 N--CA 1.476 0.858 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.1 pt -115.25 152.77 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.272 1.029 . . . . 0.0 111.864 172.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -92.26 138.17 31.75 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.907 0.883 . . . . 0.0 110.286 169.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.4 m -123.87 151.02 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.849 1.26 . . . . 0.0 110.746 171.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 81.4 p -135.96 158.52 44.21 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.299 1.44 . . . . 0.0 111.128 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.67 -27.53 62.95 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.907 1.076 . . . . 0.0 113.907 -172.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.33 -16.82 58.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.842 1.257 . . . . 0.0 114.348 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -131.45 -6.06 3.74 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.162 1.385 . . . . 0.0 113.844 -173.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -52.85 -40.7 63.6 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.715 1.606 . . . . 0.0 113.011 -175.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.11 -32.79 74.18 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.6 m -79.53 -32.89 42.32 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.824 0.849 . . . . 0.0 112.266 174.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -85.79 -41.28 15.19 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -174.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -105.83 -51.12 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.141 1.377 . . . . 0.0 111.211 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.3 mt -82.92 -13.2 56.51 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -170.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.9 m -95.88 5.9 50.17 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.583 1.153 . . . . 0.0 113.532 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.9 p -70.2 150.7 46.18 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.012 1.725 . . . . 0.0 114.94 -172.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.42 19.33 13.41 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 126.007 1.723 . . . . 0.0 111.854 172.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -143.99 146.18 33.15 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 128.927 2.891 . . . . 0.0 107.124 173.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -59.27 144.06 99.53 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 121.934 1.756 . . . . 0.0 113.255 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.9 t -128.21 125.09 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.339 1.456 . . . . 0.0 110.07 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 48.7 mt -87.92 135.0 33.59 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.388 0.675 . . . . 0.0 109.772 165.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.4 t -119.82 118.15 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 123.966 0.906 . . . . 0.0 109.366 168.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -89.89 109.27 20.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.625 1.57 . . . . 0.0 110.455 172.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -89.34 109.49 20.38 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.909 1.684 . . . . 0.0 108.64 171.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.9 p-90 -142.58 174.3 10.76 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.025 1.33 . . . . 0.0 111.757 -164.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.47 145.51 35.32 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.857 -0.527 . . . . 0.0 112.406 159.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.4 t -64.33 -22.6 67.01 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 -78.18 -4.64 48.63 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 174.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.8 t -107.17 129.36 54.86 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.242 1.017 . . . . 0.0 112.95 -173.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.62 -60.15 9.45 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.156 1.36 . . . . 0.0 114.499 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -61.84 -28.72 81.76 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 CA-C-N 120.386 2.093 . . . . 0.0 113.351 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 89.5 m -62.08 -48.55 79.71 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.511 1.051 . . . . 0.0 111.558 169.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -60.58 -34.37 74.1 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.116 0.966 . . . . 0.0 112.19 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 26.2 mmt -75.47 -36.01 60.74 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 p -87.28 -21.8 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 119.627 1.103 . . . . 0.0 113.52 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.55 -50.16 60.45 Favored Pre-proline 0 CA--C 1.551 1.007 0 CA-C-O 117.288 -1.339 . . . . 0.0 114.32 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -65.71 -30.19 50.67 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 CA-C-N 122.338 1.871 . . . . 0.0 113.666 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.1 t -68.21 -51.32 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 119.031 0.832 . . . . 0.0 110.771 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.9 pp -72.01 -22.74 61.37 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -69.99 -35.29 74.3 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.107 -0.996 . . . . 0.0 112.512 168.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -64.89 -42.87 94.42 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.868 -1.145 . . . . 0.0 111.508 166.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.4 mm -55.41 -45.95 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-N 119.969 1.259 . . . . 0.0 110.821 170.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.66 -42.85 93.74 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.052 0.941 . . . . 0.0 112.823 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.7 m -74.55 -40.73 61.52 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.66 0.784 . . . . 0.0 111.61 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -86.79 -23.56 25.36 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -173.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.3 mmt-85 -123.04 20.76 9.89 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 114.59 1.329 . . . . 0.0 114.59 -173.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.11 -27.74 15.22 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.311 1.444 . . . . 0.0 114.5 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.3 p -74.56 -23.07 58.72 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.072 1.349 . . . . 0.0 114.142 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -117.74 -25.85 6.72 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.614 1.166 . . . . 0.0 113.952 -176.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 82.6 mt -125.78 153.02 44.62 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.51 1.924 . . . . 0.0 110.248 172.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 38.3 m -101.16 138.48 38.14 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 151.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.4 t -118.68 117.76 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 118.59 0.632 . . . . 0.0 109.475 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -119.52 159.33 24.52 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.121 1.768 . . . . 0.0 112.246 -174.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -127.71 136.23 51.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.635 1.574 . . . . 0.0 111.664 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -125.93 113.46 17.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.831 2.052 . . . . 0.0 107.926 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -81.36 120.15 24.58 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.452 -0.78 . . . . 0.0 110.311 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.9 m -67.35 -17.38 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.13 -30.18 43.56 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.29 1.036 . . . . 0.0 112.711 173.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.2 p -97.21 -30.83 12.77 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.191 0.996 . . . . 0.0 112.608 -176.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -130.39 63.09 68.11 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 125.775 1.63 . . . . 0.0 111.442 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -61.66 -21.66 72.61 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.93 2.42 . . . . 0.0 113.307 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -61.9 -45.47 93.59 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.466 1.106 . . . . 0.0 111.443 174.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 m -71.77 -32.3 67.52 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.553 0.741 . . . . 0.0 111.442 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.09 -44.74 91.42 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.927 0.891 . . . . 0.0 112.607 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -77.88 -28.38 49.91 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -57.01 -42.8 81.01 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.924 0.89 . . . . 0.0 113.282 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -99.69 7.86 44.79 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.599 1.16 . . . . 0.0 113.404 176.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.321 15.5 pt20 42.07 47.08 3.82 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.072 1.749 . . . . 0.0 113.571 -166.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.0 m -98.97 36.76 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 127.604 2.362 . . . . 0.0 109.904 172.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.9 p -78.64 -25.17 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.08 1.752 . . . . 0.0 112.417 -173.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 51.0 m -74.35 144.37 44.48 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.443 1.097 . . . . 0.0 110.318 163.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.73 149.3 56.18 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 124.163 0.985 . . . . 0.0 113.332 -168.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.13 142.01 71.44 Favored 'Cis proline' 0 C--N 1.352 0.755 0 CA-C-N 119.021 0.686 . . . . 0.0 111.336 -8.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 51.7 m -132.28 121.64 23.9 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.201 1.0 . . . . 0.0 109.947 172.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.9 mp -96.52 135.99 37.65 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.38 1.072 . . . . 0.0 109.251 171.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 26.5 mm -115.62 135.56 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.626 1.171 . . . . 0.0 109.212 167.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.7 tp -92.67 117.32 29.86 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 123.223 0.327 . . . . 0.0 110.423 162.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -96.41 115.26 27.14 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.625 1.17 . . . . 0.0 108.343 165.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.7 tttm -100.31 108.6 20.69 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 50.03 43.55 25.58 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.688 1.195 . . . . 0.0 113.094 -167.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.16 15.19 80.79 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 117.059 1.584 . . . . 0.0 117.059 173.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -126.43 140.11 36.41 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-N 119.373 1.587 . . . . 0.0 111.41 168.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -69.29 138.93 40.54 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.778 2.318 . . . . 0.0 112.249 -174.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.4 t -130.5 -33.94 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 125.267 1.427 . . . . 0.0 113.072 -176.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -141.3 145.15 35.13 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.272 1.029 . . . . 0.0 111.753 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -123.05 136.15 54.71 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.927 2.091 . . . . 0.0 110.595 171.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.1 mt -129.75 130.78 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.91 1.684 . . . . 0.0 107.457 171.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.3 143.83 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 119.507 1.048 . . . . 0.0 111.845 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.17 157.66 28.36 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.188 1.375 . . . . 0.0 112.72 -169.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.6 138.1 48.48 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.839 -0.801 . . . . 0.0 112.033 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -131.98 153.99 49.77 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.875 1.67 . . . . 0.0 111.113 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.63 164.15 51.86 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 174.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -55.08 -34.12 63.35 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.823 1.249 . . . . 0.0 113.197 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.02 -37.63 66.85 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.17 -46.25 43.4 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.259 1.024 . . . . 0.0 111.36 177.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 40.4 tp -64.6 -46.56 82.15 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.706 175.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 32.3 tp -69.78 -26.51 64.32 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-O 115.121 -2.371 . . . . 0.0 113.389 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -69.72 -44.04 71.13 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 125.005 3.548 . . . . 0.0 112.26 169.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -64.61 -23.43 67.26 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.4 mt -93.85 -26.64 16.83 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.061 1.344 . . . . 0.0 113.772 168.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.4 m -61.29 -25.8 67.36 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 120.269 1.395 . . . . 0.0 110.413 173.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -53.25 -23.14 8.08 Favored 'General case' 0 CA--C 1.558 1.265 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 166.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 68.8 t -114.51 -50.26 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 127.522 2.329 . . . . 0.0 111.344 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 N--CA 1.471 0.605 0 C-N-CA 128.146 2.578 . . . . 0.0 108.699 178.882 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.264 19.4 p . . . . . 0 N--CA 1.483 1.224 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.0 pt -134.49 157.37 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.486 1.914 . . . . 0.0 110.631 172.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -105.44 139.08 40.6 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.62 0.768 . . . . 0.0 110.678 169.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.9 m -124.89 153.21 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.574 1.55 . . . . 0.0 111.058 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.6 p -132.48 170.59 14.93 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.474 1.51 . . . . 0.0 111.601 -174.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -56.5 -25.26 50.92 Favored 'General case' 0 CA--C 1.55 0.952 0 O-C-N 121.151 -0.968 . . . . 0.0 113.106 171.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.85 -13.52 50.75 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 115.043 1.498 . . . . 0.0 115.043 175.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.9 p -134.22 -12.49 2.46 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 -169.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -54.46 -42.77 71.04 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.898 1.279 . . . . 0.0 112.208 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.29 -36.34 82.7 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.298 -0.877 . . . . 0.0 112.95 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.0 m -79.2 -24.44 43.16 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.432 1.093 . . . . 0.0 113.139 -177.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -97.09 -46.97 5.96 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.351 -0.843 . . . . 0.0 113.084 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.07 -51.95 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.311 1.044 . . . . 0.0 112.046 -172.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.4 mt -84.19 -26.48 28.74 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -172.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.9 m -80.59 -11.08 59.7 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.569 1.148 . . . . 0.0 113.637 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.5 m -74.93 127.6 33.59 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.704 1.202 . . . . 0.0 112.32 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -71.62 -28.39 63.75 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.323 1.049 . . . . 0.0 112.113 172.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -84.64 164.31 43.08 Favored Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 125.384 1.473 . . . . 0.0 111.977 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.78 141.41 94.79 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.658 2.239 . . . . 0.0 113.351 170.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.0 t -135.68 126.12 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.554 1.142 . . . . 0.0 110.041 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 tt -100.43 121.31 41.32 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.543 1.937 . . . . 0.0 108.427 177.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 t -111.28 126.74 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 118.999 0.818 . . . . 0.0 111.129 174.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -99.06 111.41 23.82 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.456 1.502 . . . . 0.0 110.881 172.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -83.85 112.44 20.12 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.493 1.517 . . . . 0.0 108.657 173.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.3 p-90 -144.76 169.48 17.95 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.393 1.077 . . . . 0.0 113.017 -166.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.63 154.66 35.8 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.67 1.188 . . . . 0.0 111.015 163.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 t -67.91 -12.99 61.79 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 13.2 p-90 -79.77 -3.68 48.69 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 50.5 t -111.06 117.52 33.52 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.429 1.091 . . . . 0.0 112.398 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.88 -48.34 86.57 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-O 118.72 -1.044 . . . . 0.0 113.097 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -56.78 -33.08 93.5 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.747 2.298 . . . . 0.0 114.765 170.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 89.7 m -64.12 -46.33 84.66 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.821 1.191 . . . . 0.0 111.384 170.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -58.46 -35.69 72.55 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.211 1.004 . . . . 0.0 111.865 173.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.8 mtt -73.3 -39.0 65.66 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.883 1.273 . . . . 0.0 113.954 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.8 p -83.08 -23.83 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 CA-C-N 119.661 1.118 . . . . 0.0 113.655 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.55 -49.04 80.47 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.17 -29.25 39.72 Favored 'Trans proline' 0 C--N 1.354 0.819 0 CA-C-N 122.387 1.888 . . . . 0.0 113.215 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.4 t -69.73 -45.43 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 121.51 -0.744 . . . . 0.0 110.22 175.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.3 mt -60.99 -36.14 78.68 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.415 1.086 . . . . 0.0 112.421 172.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -68.69 -39.05 80.72 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.089 0.859 . . . . 0.0 112.194 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -63.91 -46.12 86.22 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.189 -0.944 . . . . 0.0 111.62 170.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.2 mm -56.9 -42.97 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 121.674 -0.641 . . . . 0.0 110.941 173.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.56 -42.18 98.46 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.8 0.84 . . . . 0.0 112.261 177.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.2 m -69.52 -42.38 74.76 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.312 1.045 . . . . 0.0 111.299 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -95.01 -23.22 17.47 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -170.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -109.87 14.22 23.24 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.79 1.636 . . . . 0.0 113.403 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.99 -33.19 36.96 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.019 1.327 . . . . 0.0 114.268 -177.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.1 m -72.19 -26.05 61.91 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.054 1.342 . . . . 0.0 112.75 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -102.39 -34.15 9.29 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.479 1.512 . . . . 0.0 113.06 -175.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.0 pp -149.08 163.06 38.64 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.539 1.536 . . . . 0.0 112.185 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 58.5 m -108.31 138.51 44.46 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.194 0.998 . . . . 0.0 109.344 167.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.9 t -102.59 128.89 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.519 0.728 . . . . 0.0 110.398 175.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.45 158.77 36.47 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.553 1.941 . . . . 0.0 111.455 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -127.62 134.78 49.65 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.556 1.142 . . . . 0.0 111.697 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -113.64 117.25 31.06 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.742 1.617 . . . . 0.0 108.937 173.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.43 97.58 7.82 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.034 1.333 . . . . 0.0 108.757 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.5 m -65.01 -20.72 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -172.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -74.19 -22.49 59.37 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.135 0.974 . . . . 0.0 112.753 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.3 t -119.22 -13.6 9.32 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.931 1.292 . . . . 0.0 113.518 174.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -119.22 60.75 5.4 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 124.958 1.303 . . . . 0.0 112.076 171.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -65.46 -24.62 56.56 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.368 2.045 . . . . 0.0 112.29 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -66.91 -43.39 83.45 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.478 -0.764 . . . . 0.0 111.422 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 m -68.22 -38.36 81.8 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.163 0.985 . . . . 0.0 111.466 175.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.2 -38.52 91.48 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.419 0.688 . . . . 0.0 112.668 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 22.7 ttm105 -76.44 -35.75 58.33 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.361 0.664 . . . . 0.0 112.758 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -54.96 -39.02 68.49 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.866 1.267 . . . . 0.0 113.67 -175.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -99.93 1.79 43.05 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.088 0.955 . . . . 0.0 113.37 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 51.56 60.09 4.11 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.182 1.793 . . . . 0.0 112.322 -167.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.5 m -127.58 32.18 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 126.529 1.932 . . . . 0.0 111.491 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.6 m -70.88 -23.67 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.595 1.158 . . . . 0.0 113.726 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 54.0 m -79.51 139.49 37.56 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.479 1.112 . . . . 0.0 110.193 168.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 48.4 pt -136.9 152.64 74.5 Favored Pre-proline 0 N--CA 1.475 0.817 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -167.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.37 140.73 64.16 Favored 'Cis proline' 0 C--N 1.353 0.789 0 CA-C-N 119.322 0.794 . . . . 0.0 111.81 -4.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.4 m -127.55 121.31 30.28 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.815 0.846 . . . . 0.0 109.443 169.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.3 mp -102.42 130.3 49.16 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.494 1.518 . . . . 0.0 107.942 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.22 130.69 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.824 0.849 . . . . 0.0 108.931 175.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.5 tp -106.54 120.91 43.18 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.401 1.08 . . . . 0.0 109.901 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -96.51 147.34 23.95 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.297 1.439 . . . . 0.0 109.834 169.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -119.9 130.11 54.67 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.721 1.208 . . . . 0.0 108.951 161.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.4 t0 47.82 44.57 18.14 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.303 1.041 . . . . 0.0 113.067 -174.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.39 10.86 58.33 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.11 1.338 . . . . 0.0 116.14 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -117.74 136.48 23.69 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 125.434 1.493 . . . . 0.0 110.071 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -70.56 139.74 38.11 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.71 2.273 . . . . 0.0 112.325 -171.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.5 t -128.83 -38.76 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.564 1.146 . . . . 0.0 113.198 -175.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -142.19 144.38 33.38 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.289 1.036 . . . . 0.0 111.682 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -129.27 139.71 51.7 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.669 1.588 . . . . 0.0 111.457 170.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.8 mt -133.87 139.06 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 126.946 2.098 . . . . 0.0 108.403 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.1 p -131.79 142.15 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.288 0.949 . . . . 0.0 110.882 171.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.11 153.47 24.48 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.632 1.11 . . . . 0.0 112.563 -167.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.68 143.03 48.25 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.975 -0.721 . . . . 0.0 112.487 -176.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -130.46 143.78 50.98 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.694 1.598 . . . . 0.0 110.409 173.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -78.6 170.29 54.72 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.154 0.883 . . . . 0.0 111.299 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -53.13 -35.84 60.15 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -175.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.35 -53.01 59.2 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 122.834 0.453 . . . . 0.0 111.375 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.67 -37.4 59.63 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.489 1.115 . . . . 0.0 113.241 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.7 tp -67.82 -35.17 78.12 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.248 0.931 . . . . 0.0 110.97 173.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.6 tp -74.14 -24.95 59.49 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-O 116.138 -1.887 . . . . 0.0 112.867 169.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 46.6 mmt-85 -59.84 -51.29 70.37 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 124.203 3.183 . . . . 0.0 110.572 164.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -61.0 -32.21 71.8 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.7 mt -99.03 -23.4 15.3 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.4 t -68.91 -21.28 64.23 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.326 0.966 . . . . 0.0 111.025 168.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -53.7 -20.02 4.89 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.333 1.053 . . . . 0.0 113.088 162.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.8 t -112.85 -28.89 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 127.143 2.177 . . . . 0.0 112.3 171.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.481 1.092 0 C-N-CA 127.139 2.176 . . . . 0.0 110.882 179.067 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.4 p . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.7 pt -118.77 152.5 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.078 1.351 . . . . 0.0 111.33 170.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -97.65 132.67 43.09 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.231 1.012 . . . . 0.0 109.928 172.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.9 m -137.01 150.06 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.337 1.055 . . . . 0.0 112.112 -176.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 73.2 p -141.23 164.92 28.95 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.654 1.581 . . . . 0.0 111.399 176.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -51.25 -28.35 11.5 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.658 1.983 . . . . 0.0 114.673 -176.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.31 -22.46 65.62 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.0 m -135.26 -0.66 2.69 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.318 1.447 . . . . 0.0 114.224 -175.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -53.16 -42.57 66.28 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.674 1.99 . . . . 0.0 112.921 -175.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.12 -32.23 72.38 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.321 -0.862 . . . . 0.0 113.109 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.8 m -79.49 -30.22 41.94 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.279 1.431 . . . . 0.0 112.849 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -97.03 -41.44 8.37 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -171.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.7 m -124.4 -29.89 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -169.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.4 mt -80.7 -13.21 59.21 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.518 1.054 . . . . 0.0 113.258 170.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.9 p -75.62 -21.04 58.1 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -169.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.2 t -100.76 141.47 33.59 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -168.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -82.93 -13.89 55.19 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.801 1.24 . . . . 0.0 113.174 170.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -68.64 151.78 97.05 Favored Pre-proline 0 N--CA 1.473 0.722 0 C-N-CA 125.263 1.425 . . . . 0.0 109.15 162.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -65.15 134.41 39.3 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 CA-C-N 120.795 1.319 . . . . 0.0 111.297 171.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.6 t -135.69 121.92 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 124.045 0.938 . . . . 0.0 109.311 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 tt -104.42 130.42 52.31 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.226 2.21 . . . . 0.0 109.378 -169.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.4 t -120.63 125.48 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.353 1.061 . . . . 0.0 111.009 177.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -103.94 120.13 40.39 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.472 1.509 . . . . 0.0 112.04 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -100.48 112.81 25.21 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.959 2.104 . . . . 0.0 108.964 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 11.4 p-90 -143.51 177.12 8.68 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.894 1.278 . . . . 0.0 111.934 -168.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.98 143.72 32.04 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.398 -0.814 . . . . 0.0 112.641 165.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.5 t -63.25 -21.73 66.42 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 172.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 -83.3 -3.65 57.68 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 174.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 46.2 t -106.55 120.1 41.03 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.233 1.013 . . . . 0.0 112.189 -174.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.79 -46.78 92.93 Favored Glycine 0 CA--C 1.54 1.615 0 CA-C-O 118.861 -0.966 . . . . 0.0 114.317 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -58.88 -31.78 96.03 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.788 2.325 . . . . 0.0 114.087 170.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 93.8 m -65.45 -47.13 77.19 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.961 0.801 . . . . 0.0 111.428 170.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -59.23 -31.93 69.5 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 118.712 0.687 . . . . 0.0 112.407 174.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -70.33 -48.45 56.41 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.9 1.28 . . . . 0.0 112.545 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.3 p -81.21 -23.21 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.91 -54.2 30.28 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-O 116.864 -1.541 . . . . 0.0 114.01 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.92 -26.71 66.79 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.367 2.045 . . . . 0.0 113.516 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.0 t -66.71 -51.74 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 119.04 0.836 . . . . 0.0 109.93 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . 0.25 4.2 pp -73.22 -19.09 61.16 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -65.67 -41.97 91.86 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.507 1.123 . . . . 0.0 111.577 166.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -64.92 -44.42 89.58 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.45 -0.781 . . . . 0.0 111.143 169.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.5 mm -54.1 -46.99 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 119.896 1.225 . . . . 0.0 110.88 172.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.58 -44.46 96.19 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.8 m -76.23 -37.45 57.68 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.643 0.777 . . . . 0.0 112.025 -175.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -86.72 -40.17 15.3 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -176.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -98.86 11.67 38.09 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.804 1.242 . . . . 0.0 113.316 -169.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.58 -32.15 39.68 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.48 1.512 . . . . 0.0 114.859 -173.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.8 p -82.99 -19.6 36.74 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.76 1.224 . . . . 0.0 113.619 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -94.12 -39.97 10.3 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.364 1.466 . . . . 0.0 112.217 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.9 pp -149.05 153.35 37.72 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.546 1.939 . . . . 0.0 111.893 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 31.8 m -99.47 138.94 35.86 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.15 -0.969 . . . . 0.0 109.502 175.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.7 t -113.3 131.11 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 119.348 0.976 . . . . 0.0 111.675 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.24 152.43 44.6 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.75 2.02 . . . . 0.0 111.503 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -130.67 140.25 50.37 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.7 1.2 . . . . 0.0 112.466 -175.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -134.6 116.31 14.86 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.946 2.098 . . . . 0.0 109.065 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -82.78 119.53 24.46 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 170.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.2 m -67.87 -16.94 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 121.386 -0.821 . . . . 0.0 112.976 -175.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -79.22 -28.07 42.51 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.261 1.024 . . . . 0.0 112.903 172.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.2 p -92.57 -29.04 16.38 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.73 0.812 . . . . 0.0 112.505 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -145.02 103.05 4.43 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 123.942 0.897 . . . . 0.0 111.191 161.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.68 -21.95 12.38 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.848 2.366 . . . . 0.0 113.805 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -72.78 -28.08 62.38 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.809 -1.182 . . . . 0.0 112.16 -175.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 m -64.2 -42.14 96.76 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.715 0.806 . . . . 0.0 110.886 171.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.19 -37.11 80.57 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.079 0.952 . . . . 0.0 112.909 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -68.06 -43.89 77.6 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.178 0.991 . . . . 0.0 112.499 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -59.56 -37.84 79.52 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.155 0.982 . . . . 0.0 113.583 -172.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -99.5 5.66 46.08 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.45 1.1 . . . . 0.0 113.692 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 49.56 60.63 3.64 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.209 1.804 . . . . 0.0 112.645 -172.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.6 m -129.18 30.25 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.256 1.823 . . . . 0.0 111.398 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.5 m -71.88 -14.56 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.011 1.324 . . . . 0.0 114.395 -173.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.5 m -68.69 -40.45 80.07 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -165.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . 0.294 14.2 pt 56.07 147.34 0.05 OUTLIER Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 130.552 3.541 . . . . 0.0 119.051 177.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.9 136.78 24.94 Favored 'Cis proline' 0 C--N 1.354 0.818 0 N-CA-C 110.218 -0.724 . . . . 0.0 110.218 -16.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 25.7 m -135.7 121.19 19.33 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.597 0.759 . . . . 0.0 109.477 -177.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.0 mp -109.88 138.99 45.47 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.7 1.2 . . . . 0.0 108.797 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.1 tt -129.19 145.06 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.69 0.796 . . . . 0.0 110.715 169.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 32.5 tp -116.65 132.65 56.63 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.625 1.17 . . . . 0.0 109.854 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -112.08 148.02 34.81 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.714 1.606 . . . . 0.0 111.787 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -132.87 126.12 31.49 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.589 1.556 . . . . 0.0 109.007 159.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.0 t70 51.32 37.68 19.47 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.747 1.219 . . . . 0.0 113.358 -177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.23 -0.19 49.04 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.204 1.383 . . . . 0.0 115.735 -176.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -95.13 143.89 26.87 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 124.92 1.288 . . . . 0.0 110.153 178.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.51 140.81 40.7 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.716 2.277 . . . . 0.0 112.092 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 52.0 t -121.09 -45.61 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.925 1.69 . . . . 0.0 111.276 -174.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -143.9 150.75 38.87 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.09 1.756 . . . . 0.0 110.634 173.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -133.77 134.22 42.65 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.435 1.894 . . . . 0.0 109.77 167.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.9 mt -131.0 138.97 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.918 1.687 . . . . 0.0 108.625 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.3 p -133.68 141.51 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.037 0.935 . . . . 0.0 110.788 167.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.7 155.87 27.91 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.403 1.002 . . . . 0.0 112.746 -168.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.51 139.67 45.85 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.573 0.749 . . . . 0.0 112.577 -175.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -130.67 145.05 51.83 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.012 1.725 . . . . 0.0 110.56 173.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.72 166.5 53.24 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 123.83 0.729 . . . . 0.0 111.687 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.3 tmtp? -51.98 -34.43 42.38 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.056 1.342 . . . . 0.0 113.861 -174.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.04 -53.28 26.9 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 122.267 0.227 . . . . 0.0 110.97 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.1 -40.59 78.27 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.717 0.807 . . . . 0.0 112.757 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.98 -41.04 91.67 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.725 0.693 . . . . 0.0 110.523 176.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 20.1 tp -72.78 -24.88 60.99 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-O 115.69 -2.1 . . . . 0.0 113.399 172.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -63.64 -49.08 74.66 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 124.651 3.387 . . . . 0.0 111.002 166.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -54.56 -37.87 65.97 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.603 1.161 . . . . 0.0 112.735 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.4 mt -92.3 -25.99 18.32 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.0 t -66.74 -22.85 66.04 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.537 1.135 . . . . 0.0 110.99 175.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -51.1 -28.65 11.12 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 163.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 77.0 t -105.01 -24.64 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 127.278 2.231 . . . . 0.0 112.522 172.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.477 0.885 0 C-N-CA 127.428 2.291 . . . . 0.0 110.168 178.871 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.9 p . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.9 pt -141.43 157.5 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 126.342 1.857 . . . . 0.0 111.667 173.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -99.89 145.59 27.61 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.388 1.075 . . . . 0.0 111.186 162.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.3 m -131.11 151.55 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.459 1.503 . . . . 0.0 111.426 174.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.9 p -123.82 167.81 13.58 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.202 1.801 . . . . 0.0 110.592 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -59.91 -23.64 63.67 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 120.846 -1.159 . . . . 0.0 112.904 174.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.77 -13.72 50.35 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.45 1.5 . . . . 0.0 114.962 175.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.9 p -128.12 -12.16 5.21 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -173.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -52.83 -41.37 64.15 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.24 1.416 . . . . 0.0 112.459 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.12 -36.57 82.19 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.251 -0.906 . . . . 0.0 113.148 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.0 m -79.47 -26.02 41.77 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.25 1.02 . . . . 0.0 113.261 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -100.17 -37.47 8.92 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.5 t -99.34 -58.6 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.516 1.127 . . . . 0.0 111.308 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.8 mt -76.08 -22.14 55.94 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -171.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.0 m -81.55 -11.05 59.3 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.358 1.063 . . . . 0.0 113.392 175.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.5 t -84.28 132.9 34.58 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -174.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -90.49 -4.89 56.63 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.001 1.32 . . . . 0.0 113.027 171.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -90.02 144.12 30.9 Favored Pre-proline 0 N--CA 1.472 0.651 0 C-N-CA 125.152 1.381 . . . . 0.0 109.396 169.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -54.17 131.06 42.85 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.214 1.943 . . . . 0.0 111.872 168.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.0 p -139.37 130.16 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.853 1.261 . . . . 0.0 110.096 -172.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.2 tt -120.23 111.95 18.45 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.295 1.038 . . . . 0.0 109.622 -165.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.0 t -103.13 124.62 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.019 0.928 . . . . 0.0 111.223 -173.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -97.09 113.22 24.76 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.748 1.619 . . . . 0.0 110.787 172.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -87.32 109.39 19.49 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.265 1.826 . . . . 0.0 108.569 173.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -149.63 172.69 14.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.153 0.981 . . . . 0.0 113.333 -163.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -145.4 153.73 41.51 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.374 0.67 . . . . 0.0 112.611 159.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.6 p -58.19 -29.41 65.62 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.593 1.557 . . . . 0.0 113.263 174.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 15.4 p-90 -80.66 -6.4 58.31 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.3 t -102.12 116.25 32.27 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.044 0.938 . . . . 0.0 111.227 -176.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.24 -46.53 94.08 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-O 118.484 -1.176 . . . . 0.0 114.028 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -60.37 -32.49 94.07 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 CA-C-N 120.813 2.306 . . . . 0.0 114.305 172.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 97.3 m -65.31 -47.74 75.52 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.244 -0.91 . . . . 0.0 110.954 171.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.8 tptt -57.21 -32.55 66.62 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.947 1.699 . . . . 0.0 112.669 172.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 57.1 mtt -72.97 -42.2 63.59 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.45 1.1 . . . . 0.0 113.107 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -84.09 -23.15 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -47.24 -50.74 46.22 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 177.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.51 -30.01 52.59 Favored 'Trans proline' 0 C--N 1.352 0.713 0 CA-C-N 122.036 1.763 . . . . 0.0 113.105 176.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.9 t -73.53 -44.92 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.289 -0.882 . . . . 0.0 110.849 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.2 pp -72.67 -24.24 61.0 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.481 -0.762 . . . . 0.0 113.019 174.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -71.74 -36.11 70.33 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.162 0.892 . . . . 0.0 112.42 168.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -61.75 -42.53 99.09 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.553 -1.342 . . . . 0.0 111.256 167.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.33 -42.11 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 119.52 1.055 . . . . 0.0 111.559 170.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.78 -37.78 80.04 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.344 0.974 . . . . 0.0 112.937 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.1 m -82.23 -47.1 12.85 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.997 0.919 . . . . 0.0 112.095 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -85.97 -25.46 26.01 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -171.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -104.69 16.96 25.01 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.202 1.401 . . . . 0.0 112.455 176.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.02 -27.87 21.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.857 1.663 . . . . 0.0 114.549 -177.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.2 p -72.35 -20.11 61.53 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.375 1.47 . . . . 0.0 114.115 176.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -115.66 -39.33 3.54 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.094 1.358 . . . . 0.0 112.833 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.6 mt -113.73 148.02 37.19 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.453 1.901 . . . . 0.0 111.278 -175.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.8 m -112.59 134.41 54.14 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 152.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.1 t -99.56 138.3 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 123.734 0.814 . . . . 0.0 110.081 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.6 156.06 42.87 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.32 1.448 . . . . 0.0 111.991 -177.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -120.09 124.25 45.37 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.056 1.743 . . . . 0.0 110.743 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -109.47 114.51 28.22 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.279 1.031 . . . . 0.0 108.385 165.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -82.36 103.51 11.99 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.446 1.099 . . . . 0.0 109.615 -176.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 m -66.85 -17.5 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 O-C-N 120.703 -1.248 . . . . 0.0 113.024 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -71.74 -23.54 61.63 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.84 1.256 . . . . 0.0 113.107 175.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.3 p -118.61 -24.78 6.62 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -130.27 79.6 72.29 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 119.504 1.047 . . . . 0.0 113.521 168.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -66.93 -16.29 49.33 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.191 1.927 . . . . 0.0 112.927 166.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.1 mp0 -64.84 -42.3 95.03 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.901 -1.124 . . . . 0.0 111.439 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.5 m -70.92 -36.15 72.54 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.989 0.915 . . . . 0.0 111.436 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.3 -39.32 90.03 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.546 0.739 . . . . 0.0 112.196 171.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -72.85 -40.34 65.79 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 175.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -61.93 -34.71 76.59 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.307 1.043 . . . . 0.0 113.81 -174.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -96.76 1.4 50.8 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 175.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 52.22 56.4 7.79 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.908 1.683 . . . . 0.0 112.566 -170.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.47 36.81 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 127.082 2.153 . . . . 0.0 110.974 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.8 m -71.74 -22.29 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.654 1.182 . . . . 0.0 113.479 -176.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.2 m -70.78 145.56 50.32 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.363 1.065 . . . . 0.0 110.513 166.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 20.3 pt -137.26 145.48 50.04 Favored Pre-proline 0 N--CA 1.474 0.774 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -169.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.38 148.73 74.48 Favored 'Cis proline' 0 C--N 1.351 0.707 0 CA-C-N 118.678 0.564 . . . . 0.0 111.552 -12.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.1 m -131.86 124.04 28.74 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.413 0.685 . . . . 0.0 110.015 167.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.8 mp -99.39 132.49 44.68 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.512 1.525 . . . . 0.0 108.638 174.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.6 mm -115.67 132.42 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.873 1.269 . . . . 0.0 108.767 168.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.0 tp -96.26 125.32 40.7 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.276 0.23 . . . . 0.0 110.625 163.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -102.62 139.34 38.34 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.161 1.384 . . . . 0.0 108.966 163.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -99.75 -35.79 9.68 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -152.57 58.28 0.81 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.675 1.99 . . . . 0.0 109.393 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.69 16.41 58.93 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 124.93 1.252 . . . . 0.0 114.893 -172.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -134.7 133.71 21.5 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 126.522 1.929 . . . . 0.0 110.308 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.42 140.89 34.12 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.471 2.781 . . . . 0.0 112.02 -172.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.3 m -129.81 -23.67 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.079 1.352 . . . . 0.0 114.496 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -148.08 145.8 28.57 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.234 1.014 . . . . 0.0 111.789 175.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -123.72 135.1 53.66 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.388 1.875 . . . . 0.0 110.575 169.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.9 mt -131.68 129.51 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.621 1.569 . . . . 0.0 109.108 176.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.7 m -127.27 144.61 36.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 123.939 0.896 . . . . 0.0 112.3 -169.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.67 164.66 7.97 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.327 0.965 . . . . 0.0 112.951 -171.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.84 150.41 37.39 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.436 -1.037 . . . . 0.0 113.388 -175.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.6 mmtm -133.71 146.69 51.03 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.142 1.777 . . . . 0.0 110.838 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.62 164.16 34.28 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 162.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -51.27 -36.21 41.05 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.696 1.198 . . . . 0.0 113.894 -178.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.21 -36.58 71.94 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.64 -47.8 24.87 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.085 0.954 . . . . 0.0 111.489 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.6 tp -64.72 -44.04 91.48 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.908 -0.495 . . . . 0.0 110.835 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 23.0 tp -75.59 -25.57 57.13 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-O 115.207 -2.33 . . . . 0.0 113.392 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -65.85 -44.42 85.54 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 125.131 3.605 . . . . 0.0 111.185 166.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -66.11 -25.49 67.02 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.2 mt -103.18 -17.52 15.32 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 175.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.8 t -72.36 -22.2 61.19 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 120.962 -1.086 . . . . 0.0 110.633 166.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -52.56 -21.08 3.45 Favored 'General case' 0 CA--C 1.555 1.17 0 O-C-N 121.114 -0.991 . . . . 0.0 113.455 159.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 89.1 t -107.67 -34.15 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 126.999 2.12 . . . . 0.0 112.137 172.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.481 1.122 0 C-N-CA 127.254 2.222 . . . . 0.0 110.594 177.432 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.9 p . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 120.458 0.171 . . . . 0.0 111.415 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.9 pt -129.19 155.12 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 125.827 1.651 . . . . 0.0 112.29 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -93.07 140.05 29.9 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.092 0.957 . . . . 0.0 111.497 173.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.4 150.34 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 125.08 1.352 . . . . 0.0 111.217 170.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 65.2 p -143.45 159.93 41.49 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.415 1.886 . . . . 0.0 110.338 178.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -51.45 -31.7 24.2 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.055 1.342 . . . . 0.0 114.55 -174.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.85 -21.44 66.8 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.9 m -131.69 -1.3 3.83 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.655 1.582 . . . . 0.0 113.711 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -59.51 -42.02 91.26 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.853 1.261 . . . . 0.0 112.514 -170.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.63 -32.4 72.23 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.8 m -79.18 -29.81 43.12 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.699 1.2 . . . . 0.0 112.578 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -94.71 -53.69 3.77 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.641 0.776 . . . . 0.0 112.803 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.3 -60.2 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.82 1.248 . . . . 0.0 110.732 -175.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.6 mt -75.43 -15.97 60.39 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -169.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.8 t -70.23 -22.91 62.86 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.566 1.146 . . . . 0.0 112.537 172.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.2 t -79.39 133.22 36.57 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -170.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -81.21 -23.84 37.84 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.584 1.154 . . . . 0.0 111.929 168.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -74.59 147.03 84.3 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 125.288 1.435 . . . . 0.0 110.044 176.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.88 132.43 51.63 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.196 1.931 . . . . 0.0 111.777 172.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.25 123.31 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.801 0.81 . . . . 0.0 110.798 -174.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 tt -101.93 132.07 47.95 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.581 1.952 . . . . 0.0 108.182 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 t -123.11 127.25 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.109 0.964 . . . . 0.0 110.6 174.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -100.24 118.84 37.37 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.487 1.515 . . . . 0.0 111.752 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -99.66 109.26 21.75 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.156 2.182 . . . . 0.0 108.286 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.2 p-90 -142.61 178.46 7.6 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.954 1.302 . . . . 0.0 111.96 -164.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.53 140.03 30.06 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 121.521 -0.737 . . . . 0.0 112.971 167.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.7 t -64.98 -18.58 65.39 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 173.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -88.89 0.13 56.86 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 174.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.1 t -111.5 123.23 49.79 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.41 1.084 . . . . 0.0 112.893 -173.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.55 -49.44 73.57 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-O 118.868 -0.962 . . . . 0.0 114.348 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -58.16 -32.02 94.71 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.911 2.407 . . . . 0.0 114.04 171.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.4 ' HG ' ' HB3' ' A' ' 81' ' ' PRO . 97.4 m -65.1 -46.46 80.99 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.066 -1.022 . . . . 0.0 111.558 170.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -60.47 -29.95 69.37 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.766 0.712 . . . . 0.0 112.72 173.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.5 ttt -72.49 -44.23 62.55 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.556 1.142 . . . . 0.0 112.853 177.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.9 p -88.62 -24.67 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -176.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.23 -48.57 73.63 Favored Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.18 -29.01 47.81 Favored 'Trans proline' 0 C--N 1.352 0.73 0 CA-C-N 122.14 1.8 . . . . 0.0 113.324 176.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.5 t -70.11 -49.42 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 119.375 0.989 . . . . 0.0 110.565 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.1 pp -72.07 -26.85 62.33 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -72.52 -35.14 68.01 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.203 0.911 . . . . 0.0 112.931 171.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -61.76 -46.91 87.55 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 120.771 -1.206 . . . . 0.0 111.075 165.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 70.0 mt -58.23 -41.45 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 119.139 0.881 . . . . 0.0 110.942 174.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.47 -44.62 92.97 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.116 0.966 . . . . 0.0 113.506 175.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.4 m -76.65 -41.15 46.77 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.81 0.844 . . . . 0.0 111.718 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -86.04 -21.75 27.58 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -174.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -114.75 27.61 9.31 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.021 1.728 . . . . 0.0 113.273 176.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.84 -27.52 30.22 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.4 m -73.28 -37.0 66.41 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.584 1.154 . . . . 0.0 112.75 174.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -94.19 -29.61 15.03 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.724 1.21 . . . . 0.0 113.339 -174.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.1 mt -129.56 149.34 51.36 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.953 2.101 . . . . 0.0 110.6 -177.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.2 m -103.24 138.14 40.44 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 150.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.8 t -127.89 126.95 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.808 0.731 . . . . 0.0 111.381 -173.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.71 165.75 18.67 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.853 1.661 . . . . 0.0 113.145 -172.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -129.73 141.27 50.91 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.617 1.967 . . . . 0.0 112.455 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -133.65 113.69 12.66 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.113 2.165 . . . . 0.0 108.595 169.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -81.51 120.61 25.25 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 169.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.7 m -65.85 -16.32 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -169.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -83.16 -20.16 35.24 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 119.294 0.952 . . . . 0.0 113.334 171.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 43.1 p -92.03 -28.82 16.94 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -169.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -148.76 76.21 9.83 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 123.579 0.752 . . . . 0.0 110.602 166.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.97 -27.38 78.92 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 124.027 3.151 . . . . 0.0 115.47 -169.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -62.36 -26.0 68.21 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.761 0.824 . . . . 0.0 112.924 176.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -64.23 -46.91 81.77 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.998 0.817 . . . . 0.0 110.653 175.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.53 -37.0 86.05 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.667 0.787 . . . . 0.0 112.19 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -70.78 -45.96 63.74 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.455 0.702 . . . . 0.0 112.603 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -69.82 -27.02 64.52 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -174.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -99.75 10.14 41.85 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.673 1.189 . . . . 0.0 113.563 172.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 62.68 -8.51 0.12 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 128.542 2.737 . . . . 0.0 116.225 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.9 m -79.61 56.52 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 126.536 1.934 . . . . 0.0 112.889 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.7 m -76.22 -21.46 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.925 1.29 . . . . 0.0 113.539 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 51.1 m -67.85 150.29 48.77 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.448 1.099 . . . . 0.0 111.26 170.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.3 pt -139.69 145.8 44.79 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -174.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.4 ' HB3' ' HG ' ' A' ' 40' ' ' CYS . 60.2 Cg_endo -64.58 146.11 64.81 Favored 'Cis proline' 0 CA--C 1.538 0.685 0 O-C-N 122.034 0.492 . . . . 0.0 111.44 -17.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 83.4 m -135.18 126.32 28.0 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.88 0.872 . . . . 0.0 110.872 171.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.8 134.2 39.03 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.535 1.134 . . . . 0.0 108.007 167.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.6 tt -117.36 143.97 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.485 1.114 . . . . 0.0 108.891 165.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.7 tt -123.71 134.66 53.66 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.663 0.785 . . . . 0.0 110.361 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -114.24 147.36 39.11 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.835 1.654 . . . . 0.0 111.344 173.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -126.49 135.09 50.9 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.6 1.16 . . . . 0.0 109.528 161.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.0 t0 47.0 41.8 11.55 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.639 1.176 . . . . 0.0 113.411 -174.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.38 14.06 63.72 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.138 1.352 . . . . 0.0 115.884 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -118.35 140.81 28.64 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 125.715 1.606 . . . . 0.0 109.88 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.81 140.36 42.31 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.798 2.332 . . . . 0.0 112.308 -174.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.2 t -125.94 -39.26 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.983 1.713 . . . . 0.0 112.185 -173.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -145.11 145.34 31.37 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.756 0.823 . . . . 0.0 111.89 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -129.26 132.31 47.17 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.072 1.749 . . . . 0.0 109.814 161.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.3 mt -135.55 129.53 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.618 1.567 . . . . 0.0 108.994 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.0 m -127.63 145.48 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 123.744 0.818 . . . . 0.0 112.568 -170.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.24 166.63 26.52 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.22 0.914 . . . . 0.0 113.506 -174.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.35 132.77 35.22 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.729 -0.865 . . . . 0.0 112.489 -176.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -133.83 156.53 47.87 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.912 1.685 . . . . 0.0 111.144 172.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -79.18 167.91 52.76 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 123.873 0.749 . . . . 0.0 112.169 173.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -47.91 -38.18 15.86 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.854 1.662 . . . . 0.0 114.673 -176.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.26 -49.57 54.93 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.78 0.324 . . . . 0.0 111.759 -177.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.42 -39.31 59.09 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.731 -0.606 . . . . 0.0 112.516 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.9 tp -68.07 -42.03 81.05 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.921 0.782 . . . . 0.0 111.052 176.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 23.6 tp -70.24 -24.68 63.12 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-O 115.513 -2.184 . . . . 0.0 112.315 171.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 44.6 mmt-85 -64.31 -49.51 71.49 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 124.51 3.323 . . . . 0.0 112.219 167.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.37 -31.22 65.56 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.464 0.706 . . . . 0.0 112.839 176.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 53.3 mt -97.26 -22.56 16.62 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 52.3 p -73.96 -20.2 60.43 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.893 1.277 . . . . 0.0 111.114 174.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -52.91 -27.83 20.52 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 160.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 93.3 t -100.86 -32.71 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 126.66 1.984 . . . . 0.0 112.008 171.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 28.5 t . . . . . 0 N--CA 1.477 0.903 0 C-N-CA 126.913 2.085 . . . . 0.0 110.942 -176.893 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.3 p . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.2 pt -138.25 172.53 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 126.545 1.938 . . . . 0.0 111.381 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -125.48 142.91 51.25 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.106 0.962 . . . . 0.0 111.209 169.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -139.36 150.23 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.375 1.47 . . . . 0.0 111.0 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.7 p -139.51 161.48 37.38 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.15 1.38 . . . . 0.0 111.672 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -51.15 -30.38 16.41 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.936 2.095 . . . . 0.0 114.718 -176.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.0 -20.19 66.11 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 178.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.6 m -137.96 9.85 2.82 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.456 1.502 . . . . 0.0 113.411 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -63.13 -44.74 94.72 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.178 -0.951 . . . . 0.0 112.486 -168.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.26 -32.81 74.45 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.682 -0.636 . . . . 0.0 112.504 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.5 -9.46 59.62 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.84 1.656 . . . . 0.0 114.16 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -124.17 -50.86 1.78 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.18 0.992 . . . . 0.0 113.241 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.1 t -81.72 -52.97 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.356 1.062 . . . . 0.0 110.799 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 28.9 mt -81.33 -13.35 58.48 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -175.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.0 p -77.68 -21.61 51.79 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.805 1.242 . . . . 0.0 113.192 173.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.9 m -75.49 126.7 31.53 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.188 1.395 . . . . 0.0 112.544 -173.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -76.95 -25.14 52.5 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.319 0.647 . . . . 0.0 111.85 169.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -74.99 145.23 80.75 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 125.853 1.661 . . . . 0.0 110.255 173.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.33 137.28 77.56 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.156 1.904 . . . . 0.0 112.14 172.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.5 p -136.53 130.35 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.6 1.16 . . . . 0.0 110.526 -176.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 tt -112.47 116.84 30.91 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.021 1.728 . . . . 0.0 108.228 -174.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.65 124.94 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.445 0.698 . . . . 0.0 110.501 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -107.47 116.39 31.86 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.585 1.554 . . . . 0.0 111.481 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -93.4 108.85 20.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.466 1.906 . . . . 0.0 108.351 177.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -142.26 173.13 11.81 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.851 1.261 . . . . 0.0 112.347 -163.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.74 145.16 29.86 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.54 -0.725 . . . . 0.0 112.275 158.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -65.43 -19.53 65.98 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.8 p-90 -78.51 -13.62 59.75 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 175.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.8 t -98.16 129.84 44.93 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.143 0.977 . . . . 0.0 111.572 -174.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.13 -55.91 27.6 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.298 0.951 . . . . 0.0 113.721 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -57.65 -31.73 92.65 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.439 2.759 . . . . 0.0 114.531 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 96.3 m -67.64 -45.33 75.62 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.137 -0.977 . . . . 0.0 111.44 173.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.1 tppt? -61.37 -33.57 73.87 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.475 1.11 . . . . 0.0 111.819 172.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 50.8 ttm -70.01 -42.72 72.65 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.031 1.332 . . . . 0.0 112.942 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.2 p -81.34 -24.49 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.96 -49.97 77.5 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.9 -27.27 37.15 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.174 1.916 . . . . 0.0 113.125 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.9 t -72.47 -41.35 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.714 0.805 . . . . 0.0 110.525 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.3 mt -67.19 -35.9 80.63 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.111 0.964 . . . . 0.0 112.613 170.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -66.12 -40.58 90.81 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.223 0.92 . . . . 0.0 111.468 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -58.26 -49.54 76.75 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.743 168.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 tp -66.82 -33.28 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 120.34 1.427 . . . . 0.0 112.652 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.79 -40.0 93.66 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.212 -0.93 . . . . 0.0 111.954 172.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.3 m -76.07 -49.0 18.66 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.723 0.809 . . . . 0.0 112.092 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -85.57 -21.61 28.45 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -170.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -116.92 31.52 6.7 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.357 1.863 . . . . 0.0 112.657 173.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.75 -28.18 14.42 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 176.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.5 p -81.61 -29.44 33.27 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.68 1.592 . . . . 0.0 114.292 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -102.16 -27.06 13.11 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.734 1.214 . . . . 0.0 113.742 -175.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 81.5 mt -129.67 148.71 51.58 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.357 1.863 . . . . 0.0 110.196 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.5 m -109.02 131.61 54.91 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 153.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 83.1 t -106.35 130.19 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.494 0.718 . . . . 0.0 109.858 -175.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.35 146.86 50.31 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.897 1.279 . . . . 0.0 112.419 -171.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -120.16 136.39 54.64 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.333 1.453 . . . . 0.0 111.986 -176.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -130.65 116.81 18.59 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.598 1.559 . . . . 0.0 109.744 171.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.77 105.72 13.13 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.261 1.024 . . . . 0.0 110.594 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.5 m -65.14 -20.42 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -73.76 -27.83 61.37 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.322 1.449 . . . . 0.0 113.271 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.7 p -112.73 -22.02 10.92 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.38 1.072 . . . . 0.0 113.59 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -133.27 92.71 24.01 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.256 1.023 . . . . 0.0 111.577 168.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -71.26 -19.61 29.09 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.238 2.625 . . . . 0.0 113.844 172.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -67.61 -42.38 82.5 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.142 -0.973 . . . . 0.0 112.126 -171.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.6 m -67.15 -35.02 78.81 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.85 0.86 . . . . 0.0 111.248 176.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.26 -45.6 80.0 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.227 0.611 . . . . 0.0 111.955 174.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.0 ttm105 -72.57 -41.59 65.53 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -174.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -62.1 -38.33 88.45 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -96.89 7.53 46.41 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.364 1.066 . . . . 0.0 113.122 176.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.318 14.8 pt20 44.02 34.45 0.95 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.95 2.1 . . . . 0.0 114.415 -169.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.8 m -85.56 43.85 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 126.654 1.982 . . . . 0.0 110.406 175.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.4 m -85.23 -14.2 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.698 1.599 . . . . 0.0 113.993 -168.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.0 t -71.55 155.31 40.7 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.559 0.743 . . . . 0.0 111.038 170.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 14.4 pt -129.49 121.49 20.32 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -167.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -67.24 161.8 76.76 Favored 'Cis proline' 0 CA--C 1.54 0.8 0 CA-C-N 118.831 0.618 . . . . 0.0 111.709 -16.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.1 m -127.16 134.39 50.18 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.5 1.12 . . . . 0.0 108.713 161.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.4 mp -113.42 131.93 55.82 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.856 1.262 . . . . 0.0 108.709 174.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.5 tp -116.1 146.3 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.868 1.267 . . . . 0.0 109.307 167.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.4 tt -123.92 132.85 53.8 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.681 -0.637 . . . . 0.0 110.451 165.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -111.95 143.77 42.38 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.223 1.409 . . . . 0.0 110.368 170.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -126.94 125.48 41.62 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.391 1.476 . . . . 0.0 109.17 171.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.8 t70 50.41 34.34 9.04 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 124.41 1.084 . . . . 0.0 113.526 -168.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.12 8.48 61.76 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 125.781 1.658 . . . . 0.0 116.171 -175.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -102.34 141.3 22.25 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 119.364 1.582 . . . . 0.0 110.488 172.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -70.08 140.38 41.32 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.83 2.353 . . . . 0.0 112.592 -176.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 75.3 t -127.72 -36.49 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 125.854 1.662 . . . . 0.0 112.709 -175.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -142.14 139.14 32.04 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.687 1.195 . . . . 0.0 111.115 -177.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 24.5 ttt85 -141.4 115.83 9.51 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.62 1.968 . . . . 0.0 110.194 171.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.27 150.73 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.223 1.409 . . . . 0.0 112.8 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.8 m -124.08 155.65 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.474 1.51 . . . . 0.0 111.911 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.25 163.11 11.27 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.257 0.932 . . . . 0.0 112.983 -174.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.5 156.07 30.84 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.191 -1.182 . . . . 0.0 113.706 -176.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.81 147.58 52.49 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.587 1.555 . . . . 0.0 110.049 165.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.69 167.22 44.14 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 162.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.4 tmtp? -52.75 -34.29 52.26 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.769 1.228 . . . . 0.0 113.618 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.59 -53.97 34.31 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.91 0.484 . . . . 0.0 111.754 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.1 -36.27 66.76 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.465 -0.772 . . . . 0.0 112.601 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.1 tp -63.44 -40.23 96.61 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.644 -0.66 . . . . 0.0 110.179 172.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 26.5 tp -72.74 -23.76 60.88 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-O 117.041 -1.457 . . . . 0.0 113.298 173.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -58.52 -55.61 32.79 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 122.951 2.614 . . . . 0.0 109.988 164.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -69.56 -26.57 64.55 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -174.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 88.9 mt -97.06 -28.76 14.0 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 176.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.9 t -69.58 -24.37 63.68 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 120.584 1.538 . . . . 0.0 111.194 170.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.63 -22.7 47.02 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 164.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.5 t -100.53 -28.28 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 127.056 2.142 . . . . 0.0 111.805 171.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 32.9 t . . . . . 0 N--CA 1.475 0.789 0 C-N-CA 127.389 2.276 . . . . 0.0 111.13 -170.955 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.6 p . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.1 pt -115.85 155.11 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.642 1.577 . . . . 0.0 111.551 171.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -108.8 136.4 48.43 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.517 1.127 . . . . 0.0 110.479 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.9 m -132.14 154.25 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.664 1.186 . . . . 0.0 112.857 -172.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 66.5 p -142.22 161.3 38.36 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.289 1.835 . . . . 0.0 110.854 175.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -57.17 -28.57 62.9 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -172.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.33 -17.3 62.45 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.553 1.141 . . . . 0.0 114.074 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.1 m -136.06 3.2 2.89 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.302 1.441 . . . . 0.0 113.552 -175.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -56.09 -40.57 73.86 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.119 1.367 . . . . 0.0 112.533 -174.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.03 -34.6 78.46 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.317 -0.864 . . . . 0.0 113.044 177.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.8 m -79.51 -29.6 41.62 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.511 1.124 . . . . 0.0 112.846 177.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -94.63 -39.46 10.33 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.1 t -97.23 -64.85 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.186 1.394 . . . . 0.0 109.859 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.9 mt -73.82 -14.62 61.13 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -165.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.0 m -85.08 -3.67 58.88 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.659 1.184 . . . . 0.0 113.997 176.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.1 m -60.65 142.09 56.04 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.925 1.29 . . . . 0.0 113.565 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.8 p-10 -82.93 -3.99 57.68 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.797 1.239 . . . . 0.0 114.2 176.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -141.13 163.33 42.81 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 127.833 2.453 . . . . 0.0 110.558 176.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -53.45 147.08 39.12 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.231 2.621 . . . . 0.0 112.836 177.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.39 133.39 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.633 1.173 . . . . 0.0 111.711 -174.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.02 117.05 32.73 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.876 2.071 . . . . 0.0 108.422 -176.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.2 t -107.63 127.31 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.693 0.797 . . . . 0.0 110.396 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -104.53 117.08 33.26 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.0 1.32 . . . . 0.0 111.173 175.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -91.8 107.22 19.06 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.272 1.829 . . . . 0.0 107.964 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.467 ' CD1' ' HE3' ' A' ' 62' ' ' LYS . 2.1 p-90 -143.93 164.47 30.48 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -159.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.47 151.92 36.01 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.865 0.866 . . . . 0.0 111.359 162.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.3 t -66.19 -20.99 66.3 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 12.6 p-90 -75.39 -8.64 57.23 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 173.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 43.1 t -100.34 116.46 32.38 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.406 1.082 . . . . 0.0 110.914 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.62 -44.3 98.13 Favored Glycine 0 CA--C 1.54 1.642 0 CA-C-O 118.801 -1.0 . . . . 0.0 114.022 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -56.88 -39.51 90.89 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.863 2.376 . . . . 0.0 113.941 169.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 87.1 m -61.57 -43.34 99.03 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.989 -1.069 . . . . 0.0 111.503 171.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -62.97 -29.74 71.05 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.379 1.072 . . . . 0.0 112.512 176.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -74.96 -45.71 40.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.229 1.412 . . . . 0.0 112.681 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.1 p -81.37 -24.11 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.78 -50.06 79.82 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -65.91 -28.36 50.42 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 CA-C-N 122.353 1.876 . . . . 0.0 113.177 176.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.6 t -70.02 -45.98 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.479 -0.763 . . . . 0.0 110.154 175.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.8 mt -62.35 -34.26 76.33 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.258 1.023 . . . . 0.0 112.672 172.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -66.3 -41.33 89.89 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.987 0.915 . . . . 0.0 111.758 175.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -63.75 -44.86 92.23 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.382 -0.824 . . . . 0.0 111.648 170.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.3 mm -59.01 -43.37 88.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 119.248 0.931 . . . . 0.0 110.956 174.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.45 -42.66 92.45 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.836 0.854 . . . . 0.0 112.016 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.2 m -74.61 -42.61 58.31 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.979 0.912 . . . . 0.0 112.062 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -95.42 -22.07 17.94 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -169.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -112.26 17.97 19.0 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.654 1.581 . . . . 0.0 112.633 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.85 -28.46 50.01 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.981 1.313 . . . . 0.0 114.455 -176.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.9 p -69.21 -22.75 63.86 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.931 1.692 . . . . 0.0 114.1 174.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -117.83 -29.52 5.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.883 1.673 . . . . 0.0 112.98 -171.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.0 mt -130.16 149.34 51.91 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.69 1.996 . . . . 0.0 111.125 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.2 m -99.79 139.03 36.05 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 151.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 52.2 t -117.0 129.23 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 119.397 0.999 . . . . 0.0 110.3 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.32 157.73 41.74 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.698 1.599 . . . . 0.0 112.697 -170.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.467 ' HE3' ' CD1' ' A' ' 33' ' ' TRP . 30.8 mmmt -126.77 124.3 39.39 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.179 1.792 . . . . 0.0 110.422 -175.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -109.95 114.03 27.24 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.642 1.177 . . . . 0.0 108.908 169.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.72 99.4 9.61 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.613 1.165 . . . . 0.0 109.369 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.9 m -66.7 -17.06 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 O-C-N 120.856 -1.152 . . . . 0.0 113.156 -176.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -74.23 -24.84 59.37 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.339 1.056 . . . . 0.0 113.206 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.2 p -119.25 -25.51 6.11 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -133.31 74.16 72.69 Favored Pre-proline 0 CA--C 1.55 0.977 0 CA-C-N 119.598 1.09 . . . . 0.0 112.141 171.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -67.46 -11.57 32.62 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 122.846 2.364 . . . . 0.0 112.675 168.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -57.24 -41.73 80.13 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.834 1.253 . . . . 0.0 112.223 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.2 m -66.02 -42.71 89.27 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.742 0.701 . . . . 0.0 111.046 174.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.75 -37.98 86.29 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.516 -0.74 . . . . 0.0 112.994 -178.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -78.74 -38.6 38.4 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 173.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -69.09 -36.67 77.85 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.245 0.93 . . . . 0.0 112.607 -178.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -93.3 9.15 37.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.819 1.248 . . . . 0.0 112.482 174.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 61.16 -10.29 0.06 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 128.737 2.815 . . . . 0.0 116.87 177.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.3 m -76.73 52.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 126.317 1.847 . . . . 0.0 113.449 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.8 p -75.9 -20.97 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.428 1.491 . . . . 0.0 113.067 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.5 p -70.9 129.33 38.77 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.188 0.995 . . . . 0.0 110.821 165.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.4 pt -138.5 149.62 63.4 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 125.068 1.347 . . . . 0.0 112.809 -163.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -66.51 149.4 79.18 Favored 'Cis proline' 0 C--N 1.354 0.829 0 CA-C-N 119.373 0.812 . . . . 0.0 113.246 -2.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.1 m -128.67 130.28 46.98 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.271 1.028 . . . . 0.0 110.895 169.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.3 mp -103.49 119.32 38.66 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.828 1.651 . . . . 0.0 107.227 161.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.3 tp -120.39 126.48 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.701 1.201 . . . . 0.0 109.713 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.9 tp -110.24 121.04 44.34 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.153 1.381 . . . . 0.0 110.464 -172.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -106.8 131.13 54.26 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.864 1.665 . . . . 0.0 109.172 175.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -99.72 -29.74 12.48 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -175.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -154.45 56.93 0.7 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.786 1.634 . . . . 0.0 110.785 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.73 17.82 65.37 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.315 0.959 . . . . 0.0 114.554 -175.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -141.91 138.41 16.97 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 126.83 2.052 . . . . 0.0 110.139 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.86 142.69 35.62 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.254 2.636 . . . . 0.0 111.96 -174.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.8 t -129.6 -40.06 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.497 1.119 . . . . 0.0 112.939 -176.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -142.3 133.14 25.65 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.081 0.855 . . . . 0.0 111.791 -173.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -117.83 134.01 55.36 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.284 1.434 . . . . 0.0 110.841 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.11 144.12 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 126.422 1.889 . . . . 0.0 108.713 169.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.8 m -133.67 144.84 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 124.834 1.254 . . . . 0.0 111.001 -174.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.08 -162.84 46.73 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 122.869 0.271 . . . . 0.0 112.624 -167.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.8 139.68 51.96 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.89 1.276 . . . . 0.0 112.28 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -135.23 154.35 51.61 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.611 1.565 . . . . 0.0 112.129 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -80.73 171.12 53.76 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.415 1.007 . . . . 0.0 112.455 173.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -51.84 -37.42 51.86 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.437 1.495 . . . . 0.0 114.628 -175.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.9 -53.43 32.22 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 123.407 0.442 . . . . 0.0 110.924 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.39 -38.76 68.37 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 36.9 tp -63.76 -42.57 97.8 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 119.399 0.999 . . . . 0.0 111.043 173.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.7 tp -70.18 -25.03 63.24 Favored 'General case' 0 C--O 1.214 -0.786 0 CA-C-O 115.857 -2.021 . . . . 0.0 113.014 174.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -64.49 -49.96 69.3 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 124.258 3.208 . . . . 0.0 111.962 166.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.49 -28.63 68.51 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.499 0.72 . . . . 0.0 112.882 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 89.8 mt -91.52 -28.21 17.73 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.396 1.078 . . . . 0.0 113.303 172.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.3 m -60.18 -28.79 68.24 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.82 1.248 . . . . 0.0 110.669 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -52.69 -20.47 3.14 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 168.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.9 t -118.59 -27.32 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 127.407 2.283 . . . . 0.0 112.633 173.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.475 0.814 0 C-N-CA 127.092 2.157 . . . . 0.0 110.939 -174.186 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.4 pt -132.62 157.24 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 126.112 1.765 . . . . 0.0 111.353 169.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -112.06 140.38 46.79 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.636 1.174 . . . . 0.0 110.597 171.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.9 m -132.11 155.46 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.701 1.2 . . . . 0.0 112.509 -175.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.7 p -142.11 160.81 39.49 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.466 1.907 . . . . 0.0 110.577 176.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -57.95 -27.64 63.59 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -173.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.36 -19.56 63.03 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.0 m -132.77 -2.85 3.29 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.181 1.392 . . . . 0.0 114.17 -174.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -55.26 -40.39 70.91 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.257 1.423 . . . . 0.0 112.642 -174.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.38 -33.6 75.53 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.972 0.731 . . . . 0.0 112.972 177.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.7 m -79.51 -29.69 41.63 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.725 1.21 . . . . 0.0 112.873 176.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -92.64 -45.04 8.27 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -176.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.11 -59.05 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.916 1.286 . . . . 0.0 110.636 -176.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.4 mt -75.66 -18.72 59.56 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -169.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.8 m -79.38 -10.84 59.89 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.3 t -81.64 130.05 34.92 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.788 0.835 . . . . 0.0 112.469 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -81.6 -21.12 38.55 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.242 1.017 . . . . 0.0 112.341 170.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -75.36 147.74 82.79 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.354 1.462 . . . . 0.0 110.062 174.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -58.03 133.23 54.32 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.103 1.869 . . . . 0.0 111.396 171.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.88 132.51 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.225 1.01 . . . . 0.0 110.18 -174.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -122.73 113.84 19.74 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.171 1.389 . . . . 0.0 109.7 -170.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.61 125.19 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.888 1.275 . . . . 0.0 110.224 -173.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -103.88 120.78 41.71 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.267 1.027 . . . . 0.0 112.009 174.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -93.09 113.37 25.61 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.987 2.115 . . . . 0.0 108.076 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 6.8 p-90 -144.83 172.5 12.93 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.439 1.096 . . . . 0.0 113.235 -165.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -145.77 152.83 40.19 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.916 0.886 . . . . 0.0 112.419 167.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.9 p -63.71 -27.29 69.1 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.622 1.169 . . . . 0.0 113.119 174.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 10.7 p-90 -79.0 -3.69 46.29 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 48.5 t -107.5 123.74 48.87 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.865 0.866 . . . . 0.0 113.271 -170.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.31 -58.4 14.79 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.205 1.384 . . . . 0.0 114.02 178.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.7 -27.09 68.47 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 CA-C-N 120.482 2.141 . . . . 0.0 113.534 177.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 85.3 m -61.91 -46.68 88.33 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.116 1.326 . . . . 0.0 111.238 168.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.89 -33.18 72.71 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.014 0.926 . . . . 0.0 112.631 175.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.4 mtt -74.77 -37.7 62.38 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.542 1.137 . . . . 0.0 113.83 177.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.4 p -88.13 -20.77 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.47 -49.38 77.98 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 174.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.5 -27.23 46.59 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 CA-C-N 122.303 1.858 . . . . 0.0 113.476 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 95.3 t -71.29 -49.46 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 119.059 0.845 . . . . 0.0 110.322 173.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.9 mt -61.52 -34.32 75.32 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.954 0.902 . . . . 0.0 113.029 176.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -62.61 -39.99 95.54 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.889 0.876 . . . . 0.0 111.504 173.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -71.34 -36.96 71.73 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.154 -0.966 . . . . 0.0 112.655 173.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.6 mm -61.21 -43.8 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 120.542 1.519 . . . . 0.0 110.559 171.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.27 -35.31 79.92 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.891 0.876 . . . . 0.0 112.504 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.4 m -73.46 -49.04 28.89 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.807 0.843 . . . . 0.0 112.012 176.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -92.7 -34.39 13.96 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -165.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -97.72 19.58 13.4 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.142 0.977 . . . . 0.0 113.328 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.37 -28.2 18.65 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.3 m -75.02 -31.68 61.41 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.767 1.227 . . . . 0.0 112.936 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -97.48 -34.89 10.83 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.035 1.334 . . . . 0.0 112.786 -174.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.3 mt -129.83 152.37 49.39 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.671 2.388 . . . . 0.0 110.518 -174.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.5 m -106.34 129.64 54.31 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 153.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.8 t -99.42 133.03 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.148 0.579 . . . . 0.0 110.193 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.2 155.94 44.73 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.359 1.464 . . . . 0.0 112.217 -173.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -127.64 134.54 49.64 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.305 1.442 . . . . 0.0 112.104 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -124.55 116.43 22.45 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.917 1.687 . . . . 0.0 109.08 169.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -81.94 113.03 19.58 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.482 0.713 . . . . 0.0 109.984 174.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.5 m -71.76 -16.56 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -177.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -85.84 -39.03 17.49 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.792 0.837 . . . . 0.0 111.991 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 72.3 p -96.38 -19.98 18.8 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -137.67 77.13 40.07 Favored Pre-proline 0 CA--C 1.552 1.021 0 CA-C-N 120.159 1.345 . . . . 0.0 111.82 163.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -65.56 -18.9 60.29 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.43 2.753 . . . . 0.0 113.871 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -63.61 -37.38 87.12 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.35 -0.844 . . . . 0.0 113.104 -174.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 m -65.06 -43.61 91.71 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.633 1.106 . . . . 0.0 111.256 174.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.7 -36.66 83.65 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.532 0.733 . . . . 0.0 112.08 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -70.1 -46.76 64.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.845 0.858 . . . . 0.0 112.12 173.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -63.05 -37.12 85.92 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.386 1.474 . . . . 0.0 112.617 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -96.48 8.8 43.2 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.497 1.119 . . . . 0.0 112.917 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 59.98 -11.43 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 128.539 2.736 . . . . 0.0 116.588 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.5 m -76.74 59.96 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.579 1.952 . . . . 0.0 112.667 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.0 m -74.84 -19.9 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.989 1.316 . . . . 0.0 113.423 176.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.6 t -79.27 148.09 32.28 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.555 1.142 . . . . 0.0 111.165 170.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 46.7 pt -143.49 155.64 60.55 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -167.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.74 140.82 59.5 Favored 'Cis proline' 0 C--N 1.353 0.793 0 CA-C-N 119.093 0.712 . . . . 0.0 111.033 -9.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 98.2 m -133.34 120.96 21.68 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.432 0.634 . . . . 0.0 110.65 174.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 mp -96.62 134.93 39.23 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.782 1.633 . . . . 0.0 108.42 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.0 tt -130.57 129.24 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.775 1.23 . . . . 0.0 110.727 171.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.9 tt -103.46 133.69 48.09 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.914 1.286 . . . . 0.0 110.531 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -117.22 148.28 41.77 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.233 1.413 . . . . 0.0 111.228 171.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -124.77 131.03 53.49 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.007 1.323 . . . . 0.0 108.991 164.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.6 t70 49.13 33.27 4.73 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.22 13.36 83.69 Favored Glycine 0 CA--C 1.536 1.371 0 N-CA-C 116.909 1.524 . . . . 0.0 116.909 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -116.25 145.76 35.77 Favored Pre-proline 0 N--CA 1.474 0.743 0 CA-C-N 119.36 1.58 . . . . 0.0 111.588 167.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -72.18 148.71 50.48 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.381 2.721 . . . . 0.0 112.408 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.2 t -131.89 -43.2 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.325 1.45 . . . . 0.0 112.829 -168.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -148.84 146.55 28.02 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.083 1.353 . . . . 0.0 110.968 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 -129.02 144.59 51.24 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.513 1.525 . . . . 0.0 112.067 167.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.5 mt -136.51 136.36 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 126.369 1.868 . . . . 0.0 107.893 175.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 p -133.46 142.89 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 119.664 1.12 . . . . 0.0 111.685 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.16 161.11 30.47 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.017 1.294 . . . . 0.0 113.248 -171.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.85 134.39 39.04 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.792 -0.828 . . . . 0.0 112.57 -177.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -133.07 149.65 52.14 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.936 1.694 . . . . 0.0 109.905 172.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.77 167.01 54.7 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -45.11 -40.06 6.56 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.36 1.464 . . . . 0.0 114.62 -175.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.77 -48.86 57.74 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.037 0.535 . . . . 0.0 111.984 -177.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.57 -36.98 60.24 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.91 0.884 . . . . 0.0 112.712 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.72 -46.53 75.22 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.914 0.886 . . . . 0.0 110.046 175.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -66.12 -30.02 70.44 Favored 'General case' 0 C--O 1.208 -1.124 0 CA-C-O 115.651 -2.118 . . . . 0.0 111.587 171.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 4.5 mmt180 -62.2 -49.11 77.1 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 124.382 3.264 . . . . 0.0 112.849 171.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -59.05 -33.01 70.28 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.323 1.049 . . . . 0.0 112.434 177.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.4 mt -85.62 -22.95 27.74 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 169.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.4 p -67.38 -25.99 66.23 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.807 1.643 . . . . 0.0 110.096 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -49.6 -26.25 3.44 Favored 'General case' 0 CA--C 1.556 1.193 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 164.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.5 t -111.57 -23.52 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 127.337 2.255 . . . . 0.0 112.931 172.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.48 1.046 0 C-N-CA 127.858 2.463 . . . . 0.0 109.798 177.205 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.0 p . . . . . 0 N--CA 1.478 0.933 0 CA-C-O 121.201 0.524 . . . . 0.0 112.387 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.1 pt -125.02 164.52 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.57 1.548 . . . . 0.0 110.189 164.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -123.5 138.13 54.64 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.902 -1.124 . . . . 0.0 110.816 172.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.87 150.72 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.235 1.414 . . . . 0.0 112.085 -168.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.0 p -139.89 161.94 36.37 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.545 1.538 . . . . 0.0 111.496 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -51.6 -31.48 25.05 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.318 1.447 . . . . 0.0 114.599 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.71 -20.18 65.91 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.8 m -133.64 4.96 3.66 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.477 1.511 . . . . 0.0 113.425 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -59.45 -39.81 84.82 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.685 1.194 . . . . 0.0 112.969 -171.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.91 -32.64 74.04 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.533 -0.729 . . . . 0.0 112.889 175.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.1 m -79.62 -27.49 41.01 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.215 1.406 . . . . 0.0 113.234 177.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -101.34 -34.01 9.79 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -176.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.45 -54.47 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.843 1.257 . . . . 0.0 111.503 -172.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.4 mt -74.9 -12.59 60.4 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -176.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.5 p -71.16 -15.83 62.51 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.261 1.824 . . . . 0.0 113.942 173.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.7 p -66.75 149.05 51.1 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.804 1.642 . . . . 0.0 114.335 -172.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -109.62 -16.83 13.86 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.931 1.292 . . . . 0.0 112.225 160.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -90.53 166.6 18.96 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 125.95 1.7 . . . . 0.0 111.195 171.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.49 138.68 85.38 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.29 1.994 . . . . 0.0 112.863 167.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.71 124.84 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.571 1.148 . . . . 0.0 111.104 172.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tt -100.3 128.73 46.3 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.796 2.038 . . . . 0.0 108.44 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.1 t -120.03 129.24 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.364 1.065 . . . . 0.0 110.571 173.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -106.8 116.93 32.78 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.061 1.344 . . . . 0.0 111.615 175.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.5 m-30 -88.22 111.69 21.93 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.992 1.717 . . . . 0.0 108.841 171.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 24.6 p-90 -134.23 170.96 14.91 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.236 1.414 . . . . 0.0 112.194 -171.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.86 140.27 24.46 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.83 0.852 . . . . 0.0 110.914 170.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 t -65.47 -12.5 53.13 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -168.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 55.3 p-90 -84.21 -14.02 51.15 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 172.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.2 t -90.7 106.49 18.54 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.1 0.96 . . . . 0.0 112.721 -166.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -52.75 -49.66 52.88 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.351 0.977 . . . . 0.0 114.234 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -60.59 -29.32 88.25 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.559 2.173 . . . . 0.0 114.487 174.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.73 -39.36 70.15 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.255 0.934 . . . . 0.0 111.294 172.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -63.45 -29.81 71.04 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.552 0.741 . . . . 0.0 112.308 172.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.6 mtt -71.02 -42.5 69.48 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.261 1.024 . . . . 0.0 113.11 174.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.6 p -86.09 -21.65 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.51 -49.09 79.92 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 176.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.86 -27.95 43.23 Favored 'Trans proline' 0 C--N 1.353 0.764 0 CA-C-N 122.32 1.864 . . . . 0.0 112.828 176.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.8 t -72.16 -46.04 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 121.601 -0.687 . . . . 0.0 110.371 176.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.4 mt -57.55 -40.53 79.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.422 1.089 . . . . 0.0 112.078 170.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.43 -41.02 85.47 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.179 0.992 . . . . 0.0 112.327 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -62.93 -49.35 75.11 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.299 -0.876 . . . . 0.0 111.692 169.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 17.0 mm -56.61 -42.09 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.44 0.696 . . . . 0.0 110.94 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.06 -49.96 75.58 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.992 0.917 . . . . 0.0 112.117 174.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.6 m -77.34 -32.86 55.44 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.706 0.802 . . . . 0.0 112.247 -170.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -86.14 -38.69 17.47 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.571 1.148 . . . . 0.0 113.916 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -107.52 26.75 9.87 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.542 1.137 . . . . 0.0 113.8 -173.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.75 -27.99 45.17 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.9 p -77.19 -19.88 56.14 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.416 1.487 . . . . 0.0 113.902 175.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -104.68 -35.53 7.77 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.268 1.427 . . . . 0.0 112.718 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.9 mt -129.61 149.14 51.5 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.168 2.187 . . . . 0.0 110.231 -176.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.8 m -99.54 138.87 36.02 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 150.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.7 t -125.02 127.9 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.247 0.931 . . . . 0.0 110.583 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -128.07 154.08 46.09 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.013 1.725 . . . . 0.0 112.915 -169.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -125.7 145.01 50.36 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.406 1.482 . . . . 0.0 112.916 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -135.98 118.58 15.96 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.499 1.92 . . . . 0.0 109.95 173.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -83.81 109.96 17.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.225 0.61 . . . . 0.0 110.727 174.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.4 m -70.7 -12.18 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -74.11 -19.33 60.62 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.734 1.152 . . . . 0.0 112.119 166.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.1 p -101.18 -43.76 5.89 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.615 1.166 . . . . 0.0 112.718 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -142.41 65.42 17.75 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 125.226 1.41 . . . . 0.0 111.311 -171.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -63.56 -23.17 70.58 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.617 2.878 . . . . 0.0 113.696 -176.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -57.0 -28.0 62.07 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.48 1.112 . . . . 0.0 112.576 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -66.79 -44.96 79.94 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.102 0.961 . . . . 0.0 112.06 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.55 -31.84 63.86 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.322 1.049 . . . . 0.0 112.651 173.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -71.1 -32.24 68.8 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.617 1.167 . . . . 0.0 113.496 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.6 t-20 -60.25 -41.81 93.97 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.757 1.223 . . . . 0.0 112.068 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -82.72 -8.38 59.59 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.026 0.93 . . . . 0.0 113.195 172.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 55.14 45.63 25.61 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.133 2.173 . . . . 0.0 113.056 -170.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.02 61.78 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.974 1.31 . . . . 0.0 109.507 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.9 p -82.55 -13.9 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -168.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.4 t -64.89 153.22 40.96 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.563 1.145 . . . . 0.0 112.849 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.7 mt -133.0 138.73 32.48 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 123.601 0.76 . . . . 0.0 112.371 -158.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.19 145.39 75.66 Favored 'Cis proline' 0 C--N 1.352 0.745 0 CA-C-N 119.183 0.744 . . . . 0.0 110.764 -16.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.4 m -117.03 122.28 43.75 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.577 0.751 . . . . 0.0 109.59 166.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.3 mp -102.97 120.14 40.09 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 171.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.8 tt -119.65 130.32 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.525 1.13 . . . . 0.0 110.162 176.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.3 tp -108.26 126.51 52.91 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.567 1.147 . . . . 0.0 109.766 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -105.21 152.07 23.3 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.472 1.509 . . . . 0.0 110.022 169.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -134.95 130.98 36.65 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.334 1.454 . . . . 0.0 108.682 166.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.5 t70 50.74 39.04 21.0 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.604 0.762 . . . . 0.0 113.002 -170.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.51 15.46 66.15 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.407 1.48 . . . . 0.0 115.777 -178.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -123.3 140.07 33.08 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 125.606 1.562 . . . . 0.0 110.133 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.32 141.24 46.47 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.95 2.433 . . . . 0.0 113.055 -172.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.8 t -127.94 -38.16 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.972 1.709 . . . . 0.0 112.943 -175.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -141.86 149.33 40.14 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.691 1.196 . . . . 0.0 111.582 175.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -130.69 136.44 48.79 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.028 1.331 . . . . 0.0 110.554 161.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.7 mt -130.1 145.52 35.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 127.089 2.155 . . . . 0.0 108.574 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.5 p -134.03 148.09 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.433 1.093 . . . . 0.0 111.877 171.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.16 164.6 30.39 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.771 1.177 . . . . 0.0 113.286 -176.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.3 146.52 39.22 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -174.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -136.03 145.97 46.62 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.278 1.831 . . . . 0.0 110.084 174.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.81 167.6 38.57 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 123.882 0.753 . . . . 0.0 111.336 166.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -50.82 -38.14 46.99 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.929 1.292 . . . . 0.0 113.742 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.29 -53.76 39.16 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.765 0.426 . . . . 0.0 111.572 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.07 -44.29 69.42 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.594 -0.691 . . . . 0.0 112.479 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.37 -44.64 94.18 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-O 119.076 -0.488 . . . . 0.0 110.254 177.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.1 tp -63.7 -36.64 84.51 Favored 'General case' 0 C--O 1.209 -1.04 0 CA-C-O 114.936 -2.459 . . . . 0.0 111.831 175.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.4 mmm-85 -63.13 -48.41 78.62 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 124.281 3.219 . . . . 0.0 112.599 176.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -57.57 -32.73 67.44 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 176.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 86.5 mt -85.79 -25.17 26.51 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.428 1.091 . . . . 0.0 113.577 171.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.6 p -67.9 -25.12 65.34 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.424 1.889 . . . . 0.0 110.163 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -55.34 -21.99 17.36 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 164.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 66.9 t -112.96 -20.57 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 127.434 2.294 . . . . 0.0 112.441 173.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 17.2 t . . . . . 0 N--CA 1.477 0.918 0 C-N-CA 127.729 2.412 . . . . 0.0 109.244 172.131 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.3 p . . . . . 0 N--CA 1.476 0.831 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.4 pt -130.27 159.83 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 126.193 1.797 . . . . 0.0 111.781 176.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -105.76 143.84 33.34 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.185 0.994 . . . . 0.0 111.208 169.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.5 m -131.27 155.06 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.788 1.635 . . . . 0.0 111.215 176.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 60.3 p -137.44 168.41 19.7 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.331 1.852 . . . . 0.0 111.646 -172.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -61.36 -20.71 63.3 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.23 -13.51 49.64 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.364 1.466 . . . . 0.0 114.789 172.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 87.0 p -132.41 -12.58 3.1 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -168.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -56.02 -41.45 74.95 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.55 1.14 . . . . 0.0 112.649 -173.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.69 -36.76 83.26 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.252 -0.905 . . . . 0.0 112.921 178.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.5 m -79.6 -21.13 45.37 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.655 1.582 . . . . 0.0 113.784 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -111.33 -32.33 6.77 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 t -101.86 -59.12 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.645 1.178 . . . . 0.0 111.231 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 46.3 mt -73.67 -14.02 61.09 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -173.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 83.8 p -72.33 -19.23 61.68 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.273 1.829 . . . . 0.0 113.822 171.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.4 t -77.56 124.47 27.95 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.179 0.992 . . . . 0.0 113.223 -164.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -85.82 -14.62 44.5 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.793 1.237 . . . . 0.0 113.291 170.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -94.13 158.93 35.23 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 125.834 1.653 . . . . 0.0 110.346 168.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -57.06 138.52 86.65 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 121.282 1.321 . . . . 0.0 112.118 171.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.34 129.16 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.333 1.053 . . . . 0.0 110.243 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.71 115.73 29.57 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.458 1.903 . . . . 0.0 108.526 -170.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.0 t -110.02 125.72 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.44 0.696 . . . . 0.0 110.666 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -99.27 120.07 38.94 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.402 1.081 . . . . 0.0 110.849 169.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -86.79 116.71 25.05 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.36 1.464 . . . . 0.0 108.502 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -136.89 172.91 12.3 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.775 1.23 . . . . 0.0 112.928 -167.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.75 156.73 43.38 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.797 0.839 . . . . 0.0 111.934 168.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.2 p -58.5 -30.33 66.94 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.215 1.006 . . . . 0.0 112.572 170.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 29.8 p-90 -82.41 -8.04 59.63 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 177.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.1 t -97.0 93.34 6.55 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 119.642 1.11 . . . . 0.0 112.712 -173.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.77 -42.04 67.66 Favored Glycine 0 CA--C 1.541 1.689 0 CA-C-O 118.556 -1.135 . . . . 0.0 114.153 173.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -61.91 -31.08 84.59 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 CA-C-N 120.586 2.193 . . . . 0.0 114.287 171.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 72.3 m -66.62 -41.65 88.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.606 1.094 . . . . 0.0 110.88 169.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -61.23 -29.68 69.98 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 118.715 0.689 . . . . 0.0 112.759 172.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 88.6 mtp -72.78 -39.84 66.43 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.183 0.993 . . . . 0.0 113.432 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.1 p -86.07 -19.29 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 177.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.22 -48.31 80.27 Favored Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 176.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.58 -27.28 45.98 Favored 'Trans proline' 0 C--N 1.352 0.712 0 CA-C-N 122.4 1.893 . . . . 0.0 113.013 176.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.8 t -71.93 -46.14 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.476 -0.765 . . . . 0.0 110.059 175.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.9 mt -59.78 -37.24 78.51 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.457 1.103 . . . . 0.0 112.623 171.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -63.38 -39.98 96.0 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.206 0.602 . . . . 0.0 111.593 175.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -69.46 -40.11 77.34 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.043 -1.035 . . . . 0.0 112.416 173.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 36.5 mm -56.51 -44.48 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.784 1.174 . . . . 0.0 110.547 171.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.06 -47.34 85.13 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.618 0.767 . . . . 0.0 111.642 175.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.1 m -62.19 -41.78 98.66 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.948 1.299 . . . . 0.0 111.332 -177.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -89.4 -36.96 15.18 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -173.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -108.02 16.4 23.43 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -172.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.39 -34.23 23.51 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -178.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.6 t -72.65 -25.15 61.17 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.544 1.138 . . . . 0.0 113.016 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -95.0 -51.6 4.59 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.743 1.217 . . . . 0.0 111.664 178.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.16 153.15 52.07 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.286 1.434 . . . . 0.0 113.178 -174.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.3 m -104.23 137.45 42.13 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.288 1.035 . . . . 0.0 109.385 175.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.4 t -109.71 129.56 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.831 0.852 . . . . 0.0 110.5 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -132.55 160.03 37.73 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.9 1.68 . . . . 0.0 113.048 -169.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt -127.56 129.49 47.42 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.277 1.831 . . . . 0.0 111.741 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -117.8 116.47 27.06 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.204 1.402 . . . . 0.0 108.974 169.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -82.73 104.52 13.04 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.414 0.686 . . . . 0.0 110.879 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 m -65.46 -18.86 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -175.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -78.25 -19.41 53.76 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.412 0.685 . . . . 0.0 112.679 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 t -119.06 -18.68 8.69 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 175.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -123.55 59.31 15.7 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 125.415 1.486 . . . . 0.0 111.36 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -64.99 -27.97 57.92 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.002 2.468 . . . . 0.0 113.296 -174.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -72.12 -27.7 62.8 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.19 -0.944 . . . . 0.0 112.644 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.4 m -69.46 -39.14 77.93 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.348 -0.845 . . . . 0.0 111.155 171.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.14 -37.1 86.23 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.44 0.696 . . . . 0.0 112.294 171.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -71.7 -39.49 70.13 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.507 0.723 . . . . 0.0 112.653 177.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -56.71 -40.74 76.2 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.14 1.376 . . . . 0.0 113.874 -172.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -96.9 3.99 51.84 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.269 1.028 . . . . 0.0 113.052 178.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 48.0 54.97 9.28 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.202 1.801 . . . . 0.0 112.169 -167.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.9 m -113.67 15.0 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.772 1.629 . . . . 0.0 112.657 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.2 m -59.03 -23.07 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.763 1.625 . . . . 0.0 114.466 -174.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.4 m -79.83 53.05 1.57 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.666 1.986 . . . . 0.0 113.413 -174.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.5 pt -63.93 152.15 87.87 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -167.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -64.37 135.22 20.81 Favored 'Cis proline' 0 C--N 1.357 0.982 0 CA-C-N 119.855 0.984 . . . . 0.0 113.376 1.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.1 m -136.14 120.79 18.36 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.12 0.568 . . . . 0.0 110.186 172.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.1 mp -107.92 129.71 55.08 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.818 1.647 . . . . 0.0 107.93 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.46 132.49 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.965 0.906 . . . . 0.0 109.405 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.5 tp -110.23 129.32 55.74 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.008 1.323 . . . . 0.0 109.464 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -110.2 152.69 25.77 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.368 1.467 . . . . 0.0 111.044 173.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -130.77 137.07 49.29 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.651 1.58 . . . . 0.0 109.446 157.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.1 t70 51.17 33.38 9.35 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.505 1.122 . . . . 0.0 113.522 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.29 10.39 65.92 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.222 1.391 . . . . 0.0 116.093 -175.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -111.82 143.39 28.55 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 119.184 1.492 . . . . 0.0 111.236 176.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -58.92 144.86 98.72 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.358 2.706 . . . . 0.0 114.641 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 94.2 t -128.29 -48.74 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 126.1 1.76 . . . . 0.0 111.603 -178.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -142.19 148.92 39.0 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.688 1.595 . . . . 0.0 111.253 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -135.43 134.18 39.37 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.804 1.641 . . . . 0.0 110.737 171.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.6 mp -134.75 140.85 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 126.0 1.72 . . . . 0.0 109.594 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.5 m -130.44 144.46 37.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.794 1.238 . . . . 0.0 111.656 -176.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.7 161.42 8.4 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.368 0.985 . . . . 0.0 113.281 -170.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.14 152.1 33.94 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.693 -0.887 . . . . 0.0 112.99 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -136.18 152.3 50.64 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.969 1.708 . . . . 0.0 111.207 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.73 166.9 33.1 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.403 1.001 . . . . 0.0 111.46 163.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -52.62 -35.9 55.41 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.055 1.342 . . . . 0.0 113.736 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.28 -49.8 58.03 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 122.916 0.487 . . . . 0.0 111.829 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.45 -43.36 70.01 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.609 -0.682 . . . . 0.0 111.965 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.3 tp -63.45 -44.16 95.29 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 119.055 -0.498 . . . . 0.0 110.78 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 20.1 tp -71.76 -24.62 61.79 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-O 116.549 -1.691 . . . . 0.0 113.208 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 -61.24 -54.12 48.22 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 123.883 3.038 . . . . 0.0 110.859 166.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -61.47 -30.31 70.52 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.7 mt -90.26 -31.91 16.78 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 175.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.4 t -71.24 -11.11 60.75 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.704 1.602 . . . . 0.0 112.242 175.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -46.85 -27.6 1.29 Allowed 'General case' 0 CA--C 1.558 1.269 0 O-C-N 121.227 -0.921 . . . . 0.0 113.076 153.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.07 -49.67 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 128.156 2.582 . . . . 0.0 112.502 174.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.7 t . . . . . 0 N--CA 1.482 1.145 0 C-N-CA 125.793 1.637 . . . . 0.0 113.632 -170.1 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.8 t . . . . . 0 N--CA 1.473 0.677 0 CA-C-O 120.495 0.188 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.3 pt -135.17 148.88 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.998 1.719 . . . . 0.0 110.61 176.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -92.66 139.62 30.37 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.651 -0.656 . . . . 0.0 110.581 168.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -115.46 164.15 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.732 1.213 . . . . 0.0 111.961 173.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 54.8 p -139.71 159.62 41.75 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.137 1.775 . . . . 0.0 110.681 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -58.7 -27.84 65.23 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 121.131 -0.981 . . . . 0.0 113.536 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.36 -18.18 52.94 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.9 m -128.8 -3.81 5.23 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.763 1.225 . . . . 0.0 114.052 -172.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -53.5 -41.35 66.21 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.351 1.461 . . . . 0.0 112.55 -177.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.77 -33.01 74.67 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.457 -0.777 . . . . 0.0 113.092 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.6 m -79.54 -30.83 41.91 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.397 1.079 . . . . 0.0 112.706 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -93.39 -32.97 14.04 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -174.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -111.13 -57.75 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.296 1.438 . . . . 0.0 110.707 -175.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 33.8 mt -76.63 -13.27 60.07 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -170.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.3 m -83.31 -13.1 55.84 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.62 0.971 . . . . 0.0 113.62 176.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.7 m -81.86 130.39 35.05 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.043 1.337 . . . . 0.0 112.817 -173.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -79.56 -23.55 42.73 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.266 0.626 . . . . 0.0 112.308 171.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -74.09 143.29 80.33 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 125.238 1.415 . . . . 0.0 109.485 171.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -53.44 138.95 65.81 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 121.805 1.67 . . . . 0.0 112.205 166.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p -136.41 132.32 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 C-N-CA 125.129 1.371 . . . . 0.0 110.337 -173.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.23 126.38 55.17 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.517 1.927 . . . . 0.0 108.441 -175.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.1 t -119.7 124.36 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.11 0.964 . . . . 0.0 110.557 177.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -101.16 113.38 26.37 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.954 1.702 . . . . 0.0 111.159 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -92.82 112.41 24.36 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.685 1.594 . . . . 0.0 108.734 176.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -143.13 171.94 13.39 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.766 1.226 . . . . 0.0 111.909 -166.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.41 151.16 40.05 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.867 0.867 . . . . 0.0 112.896 170.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 28.0 p -65.46 -25.56 67.56 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.604 1.162 . . . . 0.0 113.241 172.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 13.3 p-90 -88.62 4.62 46.4 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.509 1.524 . . . . 0.0 114.934 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.1 t -122.38 127.25 49.5 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.311 1.044 . . . . 0.0 112.953 -173.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.24 -53.69 40.35 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 118.7 -1.056 . . . . 0.0 114.882 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.78 -23.8 68.92 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 CA-C-N 121.079 2.44 . . . . 0.0 113.293 174.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 86.2 m -65.39 -46.46 79.98 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.827 -1.171 . . . . 0.0 111.615 167.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -59.31 -29.89 67.95 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.842 0.857 . . . . 0.0 112.932 172.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.6 mtt -74.09 -39.09 63.65 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 176.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -90.88 -29.42 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -175.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.93 -46.47 87.67 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.77 -25.94 28.03 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.357 2.038 . . . . 0.0 113.79 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.38 -45.52 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 119.44 1.018 . . . . 0.0 108.688 175.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -67.4 -31.65 72.02 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.996 1.318 . . . . 0.0 112.372 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -73.65 -36.94 65.43 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.037 0.835 . . . . 0.0 112.945 174.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -59.68 -45.16 92.92 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.995 -1.065 . . . . 0.0 111.162 165.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.4 mt -62.59 -40.21 87.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 O-C-N 121.603 -0.685 . . . . 0.0 110.594 176.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.76 -32.42 73.91 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.553 -1.342 . . . . 0.0 113.252 173.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.4 m -74.38 -48.08 30.18 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.752 0.821 . . . . 0.0 111.554 176.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -90.96 -24.71 20.05 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -169.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -117.01 15.13 15.12 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.152 1.381 . . . . 0.0 114.597 -172.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.4 -28.03 11.65 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 175.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.4 p -84.06 -21.89 31.4 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.658 1.583 . . . . 0.0 114.304 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -98.58 -31.97 11.68 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.217 1.407 . . . . 0.0 112.585 178.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.9 mt -139.18 149.35 44.32 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.203 2.601 . . . . 0.0 109.977 -177.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.4 m -91.22 134.96 34.13 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 157.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.1 t -128.63 120.13 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 121.516 -0.74 . . . . 0.0 109.987 -169.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.45 159.86 35.8 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.978 1.311 . . . . 0.0 113.422 -168.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -119.75 140.27 50.99 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.287 1.835 . . . . 0.0 111.56 176.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -122.64 111.15 16.41 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.223 1.409 . . . . 0.0 107.824 164.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -82.09 110.57 17.43 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.0 m -67.1 -16.37 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -174.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -76.87 -23.46 52.63 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.414 0.686 . . . . 0.0 112.569 171.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.5 p -93.57 -31.97 14.31 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.866 1.266 . . . . 0.0 112.563 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -138.43 79.98 28.63 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.324 1.449 . . . . 0.0 111.688 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -61.89 -28.73 81.49 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.809 2.339 . . . . 0.0 113.609 175.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -66.56 -41.39 88.69 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.077 0.951 . . . . 0.0 112.411 -176.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -61.86 -37.98 86.54 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.477 0.711 . . . . 0.0 111.651 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.99 -45.12 95.02 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.75 0.82 . . . . 0.0 112.496 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.9 ptm85 -78.13 -31.19 49.76 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -62.57 -41.43 98.92 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.284 1.034 . . . . 0.0 111.995 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -98.47 5.9 47.63 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 50.1 59.58 4.44 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.582 1.953 . . . . 0.0 113.169 -177.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.2 m -133.3 31.89 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 125.946 1.699 . . . . 0.0 111.45 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 m -70.68 -19.86 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.543 1.537 . . . . 0.0 115.005 -171.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 21.4 m -82.3 50.38 1.6 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.719 1.607 . . . . 0.0 113.767 -169.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -57.33 150.22 44.19 Favored Pre-proline 0 CA--C 1.556 1.205 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 -161.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.94 141.5 66.59 Favored 'Cis proline' 0 C--N 1.356 0.934 0 CA-C-N 118.758 0.592 . . . . 0.0 112.165 -4.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.9 m -136.39 137.79 40.9 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.968 0.907 . . . . 0.0 109.771 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.5 mp -122.5 140.63 52.53 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.146 0.978 . . . . 0.0 110.203 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.1 tp -127.9 131.3 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 124.82 1.248 . . . . 0.0 108.999 175.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.1 tt -111.56 129.52 56.04 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.425 1.09 . . . . 0.0 109.217 172.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -111.63 152.01 28.14 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.739 1.616 . . . . 0.0 109.863 172.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -134.92 126.91 29.62 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.324 1.45 . . . . 0.0 109.457 173.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t70 50.03 36.61 12.26 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.262 1.025 . . . . 0.0 113.365 -165.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.02 5.9 42.73 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.941 1.734 . . . . 0.0 116.032 -174.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 55.4 mm-40 -97.62 137.27 21.03 Favored Pre-proline 0 N--CA 1.472 0.643 0 CA-C-N 119.359 1.579 . . . . 0.0 109.573 175.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.63 139.54 48.88 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.025 1.816 . . . . 0.0 111.826 -178.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.3 t -123.43 -46.84 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.221 1.408 . . . . 0.0 112.331 -174.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -146.71 132.39 18.88 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.631 0.772 . . . . 0.0 112.539 -177.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -111.41 135.82 51.42 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.066 1.746 . . . . 0.0 110.484 168.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.9 mt -129.75 143.24 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.623 1.969 . . . . 0.0 108.57 -178.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.39 143.16 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.569 1.148 . . . . 0.0 111.224 174.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.83 158.97 29.95 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.925 1.25 . . . . 0.0 113.043 -171.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.43 140.88 39.95 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.905 -0.762 . . . . 0.0 112.509 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -130.7 146.43 52.18 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.88 1.672 . . . . 0.0 109.809 170.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.37 166.49 54.73 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 123.819 0.723 . . . . 0.0 111.62 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? -51.7 -33.99 36.76 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.974 1.31 . . . . 0.0 113.641 -175.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.85 -50.98 37.34 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.407 0.549 . . . . 0.0 111.752 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.14 -36.55 69.4 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.368 1.067 . . . . 0.0 112.549 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -41.14 93.86 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.517 -0.74 . . . . 0.0 110.127 171.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 29.8 tp -69.27 -23.19 63.81 Favored 'General case' 0 C--O 1.213 -0.821 0 CA-C-O 116.07 -1.919 . . . . 0.0 113.143 171.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.6 mmt-85 -64.35 -49.09 73.03 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 123.991 3.087 . . . . 0.0 111.542 165.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -59.23 -30.69 68.44 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 93.6 mt -93.33 -27.82 16.56 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.684 1.193 . . . . 0.0 113.927 173.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.8 p -67.07 -24.48 65.97 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.627 1.558 . . . . 0.0 110.922 177.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -51.39 -22.68 3.13 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 125.256 1.423 . . . . 0.0 113.978 163.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 69.5 t -112.97 -30.09 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 128.07 2.548 . . . . 0.0 111.992 172.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.478 0.973 0 C-N-CA 127.967 2.507 . . . . 0.0 110.346 -175.771 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 p . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.2 pt -140.07 165.17 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 127.092 2.157 . . . . 0.0 110.84 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -119.05 152.44 36.44 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 164.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.3 m -122.6 169.81 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 126.485 1.914 . . . . 0.0 110.823 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 43.2 p -137.62 173.94 11.12 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.826 1.65 . . . . 0.0 111.39 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -54.98 -28.13 49.32 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.87 -1.144 . . . . 0.0 113.037 170.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.0 -13.34 57.54 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.852 1.261 . . . . 0.0 114.278 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.7 p -132.86 -4.92 3.17 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -174.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -60.21 -46.14 90.77 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 120.011 1.278 . . . . 0.0 111.636 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.42 -39.32 77.94 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.959 -1.088 . . . . 0.0 112.812 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.28 -16.62 56.13 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.614 1.566 . . . . 0.0 114.726 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -103.24 -50.85 3.37 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.17 0.988 . . . . 0.0 112.677 173.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.2 t -83.49 -59.22 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.536 1.134 . . . . 0.0 111.146 -173.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.2 mt -77.31 -25.98 51.75 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -172.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.4 m -79.17 -9.06 59.46 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.96 1.304 . . . . 0.0 113.677 175.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -67.23 139.93 57.39 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.812 0.845 . . . . 0.0 113.185 -177.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -86.69 2.28 49.07 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.234 1.413 . . . . 0.0 113.724 173.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -131.72 165.87 32.45 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 126.397 1.879 . . . . 0.0 111.357 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -66.44 144.2 72.57 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.188 1.925 . . . . 0.0 112.207 176.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.2 p -144.12 127.26 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.335 1.054 . . . . 0.0 111.694 -173.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 tt -99.71 129.46 45.84 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.259 2.224 . . . . 0.0 108.323 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 t -119.8 127.26 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.437 1.095 . . . . 0.0 110.443 173.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -105.02 115.09 29.68 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.079 1.352 . . . . 0.0 111.793 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -83.42 114.08 21.2 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.376 1.87 . . . . 0.0 108.93 171.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -145.99 177.21 9.12 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.301 1.041 . . . . 0.0 112.205 -165.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.94 148.1 30.42 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 122.774 0.43 . . . . 0.0 112.051 163.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -64.8 -18.54 65.19 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 173.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 9.5 p-90 -82.03 -4.39 56.66 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 173.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 33.8 t -107.07 119.9 40.64 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 119.316 0.962 . . . . 0.0 113.493 -168.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.71 -52.18 53.53 Favored Glycine 0 CA--C 1.54 1.606 0 C-N-CA 124.701 1.143 . . . . 0.0 115.182 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.77 -24.44 54.52 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 CA-C-N 121.006 2.403 . . . . 0.0 113.265 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 75.9 m -65.81 -45.19 83.26 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.693 -1.254 . . . . 0.0 111.602 167.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -61.25 -30.91 70.74 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.638 0.653 . . . . 0.0 112.418 172.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.3 ttt -70.3 -43.1 71.06 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.305 1.042 . . . . 0.0 113.162 176.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 p -86.98 -23.25 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.82 -49.64 72.54 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 176.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.51 -29.01 45.18 Favored 'Trans proline' 0 C--N 1.352 0.74 0 CA-C-N 122.376 1.884 . . . . 0.0 112.806 177.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.0 t -71.93 -45.63 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 O-C-N 121.554 -0.716 . . . . 0.0 110.181 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.1 mt -62.53 -33.73 75.48 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.937 0.895 . . . . 0.0 112.682 172.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -68.83 -38.73 80.04 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.119 0.872 . . . . 0.0 112.058 175.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -63.24 -45.28 92.32 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 121.344 -0.847 . . . . 0.0 111.649 168.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.0 mm -58.88 -41.93 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 119.497 1.044 . . . . 0.0 110.605 174.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.93 -46.74 87.21 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.289 -0.882 . . . . 0.0 111.971 176.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.7 m -76.36 -37.73 56.84 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.926 0.89 . . . . 0.0 112.409 -175.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -97.25 -21.79 17.06 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -172.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -111.45 19.84 17.81 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.633 1.573 . . . . 0.0 113.065 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.26 -28.08 25.77 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.062 1.345 . . . . 0.0 113.833 174.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.7 p -66.43 -23.89 66.37 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.837 1.655 . . . . 0.0 114.042 175.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -125.98 -23.46 3.94 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.634 1.574 . . . . 0.0 113.924 -169.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.4 mt -134.26 153.75 51.68 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.299 2.239 . . . . 0.0 110.56 -178.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 49.0 m -108.79 138.76 44.6 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 149.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.1 t -112.79 122.92 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 118.904 0.775 . . . . 0.0 110.549 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -124.49 165.4 17.85 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.695 1.998 . . . . 0.0 112.145 -176.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.2 mttt -130.7 152.28 50.23 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.175 1.79 . . . . 0.0 112.658 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.76 114.28 12.48 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.424 1.089 . . . . 0.0 108.597 162.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -80.9 118.65 22.58 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.2 m -67.82 -18.32 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -172.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -80.6 -25.75 38.27 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.929 0.892 . . . . 0.0 112.677 170.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.2 p -92.17 -26.74 18.08 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.989 0.916 . . . . 0.0 112.694 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -140.54 86.96 11.93 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.656 1.182 . . . . 0.0 111.305 171.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.07 -18.62 35.46 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.524 2.149 . . . . 0.0 113.097 177.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -68.56 -46.37 69.64 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.189 -0.945 . . . . 0.0 112.055 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 m -73.65 -29.86 62.58 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.49 -0.757 . . . . 0.0 112.162 175.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.66 -40.98 85.02 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.24 0.616 . . . . 0.0 112.424 169.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.2 ttm105 -75.98 -39.29 56.23 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.323 0.649 . . . . 0.0 112.475 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -54.31 -40.61 68.12 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.189 1.396 . . . . 0.0 114.506 -170.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -100.31 7.19 44.53 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.014 0.925 . . . . 0.0 113.479 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 49.78 59.53 4.45 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.355 1.462 . . . . 0.0 111.287 -164.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.9 m -125.33 28.65 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.414 1.886 . . . . 0.0 111.439 -176.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -68.55 -25.64 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.792 1.237 . . . . 0.0 112.349 175.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 52.7 m -79.96 136.53 36.65 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.265 1.426 . . . . 0.0 110.325 166.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 29.0 pt -143.15 154.66 61.54 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -166.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.33 140.66 60.53 Favored 'Cis proline' 0 C--N 1.355 0.872 0 CA-C-N 119.412 0.826 . . . . 0.0 111.923 -5.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.0 m -134.72 126.64 29.42 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.173 0.989 . . . . 0.0 109.709 174.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.8 mp -108.19 136.08 48.46 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.685 1.594 . . . . 0.0 108.908 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.0 tp -120.74 138.54 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.268 1.427 . . . . 0.0 108.703 167.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.9 tp -126.59 125.15 41.48 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.071 0.949 . . . . 0.0 110.095 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -105.87 143.37 34.1 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.734 2.013 . . . . 0.0 110.447 177.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -114.42 119.21 36.11 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.558 1.543 . . . . 0.0 107.929 168.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.4 t70 51.2 39.0 22.65 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.731 1.212 . . . . 0.0 113.631 -172.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.55 9.54 74.08 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 125.163 1.363 . . . . 0.0 116.125 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -109.35 134.26 20.55 Favored Pre-proline 0 N--CA 1.473 0.715 0 CA-C-N 119.514 1.657 . . . . 0.0 110.356 171.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.56 139.57 45.06 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.465 2.11 . . . . 0.0 111.991 -173.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.3 m -130.21 -27.84 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -177.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -152.28 139.55 19.4 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.721 1.146 . . . . 0.0 111.855 -177.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -129.13 140.05 51.7 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.43 1.892 . . . . 0.0 111.034 173.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.9 mt -137.24 143.17 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.965 1.706 . . . . 0.0 108.883 -178.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 p -133.85 143.64 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 119.723 1.147 . . . . 0.0 111.24 170.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.75 156.68 29.32 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.277 1.418 . . . . 0.0 113.248 -172.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.1 140.08 41.66 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.914 -0.757 . . . . 0.0 112.666 -176.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -132.63 145.45 51.09 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.87 1.668 . . . . 0.0 110.729 174.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -79.94 167.68 51.51 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.355 0.979 . . . . 0.0 110.896 173.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -50.22 -37.02 33.34 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -170.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.97 -47.99 55.85 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.173 0.511 . . . . 0.0 111.468 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.83 -44.77 69.26 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.377 1.071 . . . . 0.0 111.908 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.3 tp -64.89 -44.38 89.83 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.944 176.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 31.4 tp -69.93 -31.62 69.47 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-O 115.048 -2.406 . . . . 0.0 112.807 177.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -65.38 -42.93 92.17 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 124.861 3.482 . . . . 0.0 111.926 169.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -62.32 -32.07 72.78 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 178.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.4 mt -91.65 -24.98 19.35 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.888 1.275 . . . . 0.0 113.196 173.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.3 t -66.16 -25.41 66.94 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.983 1.313 . . . . 0.0 110.264 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -52.71 -22.14 4.87 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.519 1.128 . . . . 0.0 113.578 164.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.7 t -108.92 -24.95 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 127.487 2.315 . . . . 0.0 112.371 170.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.3 t . . . . . 0 N--CA 1.48 1.046 0 C-N-CA 127.888 2.475 . . . . 0.0 111.797 -175.365 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.9 p . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 45.0 pt -135.06 160.08 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.704 1.602 . . . . 0.0 111.091 169.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -108.01 139.03 43.25 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.906 0.882 . . . . 0.0 110.591 168.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.2 m -133.6 150.69 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.963 1.305 . . . . 0.0 110.934 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.1 p -141.05 174.24 10.71 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.783 1.633 . . . . 0.0 111.095 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -52.6 -26.15 12.68 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 120.919 -1.113 . . . . 0.0 113.611 172.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.26 -13.37 52.77 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 176.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.3 p -137.1 -12.66 1.65 Allowed 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -169.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -56.28 -41.96 76.71 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.405 1.482 . . . . 0.0 112.82 -174.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.53 -34.55 78.53 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 121.134 -0.979 . . . . 0.0 112.894 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.5 m -79.46 -14.33 58.98 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.535 1.534 . . . . 0.0 113.77 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -118.7 -32.36 4.57 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.92 -51.92 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.156 1.382 . . . . 0.0 111.452 -176.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.6 mt -78.53 -13.53 59.79 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.6 p -76.56 -11.04 59.81 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.209 1.804 . . . . 0.0 113.995 174.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.7 p -67.09 149.15 50.95 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 -164.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -118.19 15.64 14.05 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 126.401 1.88 . . . . 0.0 112.089 171.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -142.86 164.25 33.36 Favored Pre-proline 0 N--CA 1.475 0.782 0 C-N-CA 129.416 3.086 . . . . 0.0 108.809 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.76 138.56 54.05 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 CA-C-N 121.103 1.43 . . . . 0.0 111.257 166.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.8 m -136.63 138.53 46.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 126.317 1.847 . . . . 0.0 110.536 -177.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tt -118.68 115.7 25.05 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.79 1.236 . . . . 0.0 109.637 -167.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.11 126.96 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.999 0.92 . . . . 0.0 110.943 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -107.0 111.9 24.61 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.513 1.525 . . . . 0.0 111.48 177.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -84.25 108.66 17.25 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.909 1.684 . . . . 0.0 108.681 173.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -136.08 163.81 29.47 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.348 1.059 . . . . 0.0 113.14 -165.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.31 145.8 47.84 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.2 p -59.94 -29.99 68.77 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.356 1.862 . . . . 0.0 113.206 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.5 p-90 -86.94 -12.4 47.71 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 41.9 t -90.77 119.18 30.78 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -164.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.07 -49.33 76.15 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.879 1.228 . . . . 0.0 113.329 176.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -57.66 -29.47 85.51 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.922 2.414 . . . . 0.0 114.548 170.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 94.9 m -64.88 -44.37 89.87 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.781 1.173 . . . . 0.0 111.187 167.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -60.56 -29.44 69.16 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 172.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.3 mtt -71.64 -43.3 66.36 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.641 0.776 . . . . 0.0 112.859 176.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.8 p -88.74 -25.75 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.81 -48.09 92.44 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.72 -27.86 37.69 Favored 'Trans proline' 0 C--N 1.353 0.776 0 CA-C-N 122.448 1.91 . . . . 0.0 112.683 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.9 t -71.67 -46.01 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 121.572 -0.705 . . . . 0.0 110.288 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.0 mt -60.92 -35.69 77.36 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.073 0.949 . . . . 0.0 112.353 171.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -67.96 -38.49 82.85 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.015 0.825 . . . . 0.0 112.052 176.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -62.64 -45.35 93.22 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.018 -1.051 . . . . 0.0 111.537 169.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.3 mm -59.12 -43.05 88.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.656 1.117 . . . . 0.0 110.898 174.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.97 -35.31 78.09 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.181 0.992 . . . . 0.0 112.843 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.1 m -78.51 -48.85 14.45 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.412 0.685 . . . . 0.0 111.906 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -85.24 -32.83 22.38 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -169.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -108.02 16.69 23.17 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.313 1.445 . . . . 0.0 112.834 -171.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.66 -33.12 32.33 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.378 1.471 . . . . 0.0 114.363 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.8 m -68.03 -29.57 68.6 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.913 1.285 . . . . 0.0 112.389 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -102.61 -39.84 6.89 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.562 1.545 . . . . 0.0 112.66 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.5 mt -125.37 148.85 48.61 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 126.927 2.091 . . . . 0.0 110.663 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.4 m -109.14 127.2 53.99 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 157.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.6 t -99.51 128.97 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.585 0.754 . . . . 0.0 109.512 -177.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.26 150.73 48.23 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.89 1.676 . . . . 0.0 111.771 -173.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -128.63 143.45 50.95 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.434 1.094 . . . . 0.0 112.504 176.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -133.55 122.42 23.54 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.866 1.666 . . . . 0.0 110.033 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.63 96.89 7.64 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.18 1.792 . . . . 0.0 109.844 -176.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.8 m -69.49 -13.41 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 O-C-N 120.491 -1.381 . . . . 0.0 113.188 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -67.66 -27.49 66.9 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.756 0.822 . . . . 0.0 112.761 171.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.9 p -119.11 -29.74 5.16 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -136.99 76.09 46.58 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 124.646 1.178 . . . . 0.0 111.11 173.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -68.16 -13.88 39.15 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.196 2.598 . . . . 0.0 113.719 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -58.67 -33.05 69.69 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.673 1.189 . . . . 0.0 113.771 -172.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.5 m -64.21 -45.26 89.08 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.636 1.107 . . . . 0.0 111.856 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.12 -32.55 65.01 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.758 0.823 . . . . 0.0 112.47 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -73.26 -32.26 64.59 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.518 1.127 . . . . 0.0 113.022 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -58.31 -37.11 74.43 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.519 1.128 . . . . 0.0 112.596 175.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -96.74 9.91 40.32 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.067 1.347 . . . . 0.0 113.124 175.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.307 5.7 pt20 54.27 -9.19 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 130.15 3.38 . . . . 0.0 117.892 -173.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.6 m -80.27 58.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.549 1.94 . . . . 0.0 111.778 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.9 p -79.02 -4.22 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 126.004 1.721 . . . . 0.0 113.744 -174.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.3 m -57.06 157.19 6.11 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.599 1.96 . . . . 0.0 112.805 170.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 23.2 mt -140.14 137.46 18.07 Favored Pre-proline 0 N--CA 1.477 0.9 0 O-C-N 121.339 -0.85 . . . . 0.0 112.312 -164.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.98 143.58 66.48 Favored 'Cis proline' 0 C--N 1.353 0.787 0 CA-C-N 119.495 0.855 . . . . 0.0 110.628 -17.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 28.3 m -119.98 121.37 38.81 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.444 0.697 . . . . 0.0 110.078 169.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.9 mp -99.7 119.46 38.16 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.516 1.527 . . . . 0.0 107.749 172.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.7 tp -117.96 124.21 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 125.088 1.355 . . . . 0.0 109.073 176.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.6 tp -107.4 125.99 51.92 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.647 1.579 . . . . 0.0 108.908 -176.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -112.44 155.34 24.39 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.412 1.485 . . . . 0.0 109.987 174.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -141.75 126.56 18.12 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.998 1.719 . . . . 0.0 108.829 174.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.6 t70 54.79 25.36 6.53 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -169.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.72 5.39 68.84 Favored Glycine 0 CA--C 1.541 1.67 0 O-C-N 120.535 -1.353 . . . . 0.0 116.091 -172.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -95.16 140.46 22.43 Favored Pre-proline 0 N--CA 1.474 0.766 0 CA-C-N 119.815 1.807 . . . . 0.0 110.048 167.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -67.66 139.6 48.94 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.133 1.889 . . . . 0.0 111.11 176.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.1 m -127.61 -27.63 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 114.814 1.412 . . . . 0.0 114.814 -176.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -156.08 147.86 22.99 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.736 1.153 . . . . 0.0 111.575 175.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.0 ttp-105 -127.95 141.52 51.51 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.001 1.32 . . . . 0.0 111.511 167.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.4 mp -129.48 140.99 47.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 126.638 1.975 . . . . 0.0 108.278 171.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.6 p -132.42 140.8 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.161 0.984 . . . . 0.0 110.286 169.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.24 155.14 30.07 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.32 0.962 . . . . 0.0 112.608 -165.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.16 142.33 43.55 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.503 0.721 . . . . 0.0 112.791 -175.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -130.76 144.54 51.52 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.789 1.636 . . . . 0.0 110.553 172.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -79.31 170.67 54.58 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.391 0.996 . . . . 0.0 111.518 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -52.56 -36.47 55.88 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -175.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.95 -50.91 64.54 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.701 0.4 . . . . 0.0 111.33 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.47 -39.73 58.31 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.898 1.279 . . . . 0.0 113.142 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.3 tp -66.36 -36.36 82.68 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.244 -0.91 . . . . 0.0 110.737 173.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 28.1 tp -73.04 -24.93 60.77 Favored 'General case' 0 C--O 1.216 -0.68 0 CA-C-O 116.123 -1.894 . . . . 0.0 112.955 169.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -58.65 -53.84 53.86 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 123.972 3.078 . . . . 0.0 109.741 164.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -60.91 -32.09 71.58 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.799 1.24 . . . . 0.0 113.382 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.3 mt -97.42 -29.95 13.2 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.621 1.168 . . . . 0.0 113.745 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.6 t -61.33 -30.48 70.53 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 120.182 1.356 . . . . 0.0 110.63 171.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -54.86 -18.25 4.63 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 166.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.0 t -117.72 -18.8 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 127.781 2.433 . . . . 0.0 112.578 174.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t . . . . . 0 N--CA 1.475 0.798 0 C-N-CA 127.472 2.309 . . . . 0.0 110.432 -173.371 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.5 0.19 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.7 t -140.5 161.69 37.13 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.504 1.122 . . . . 0.0 112.37 176.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -151.4 151.35 31.59 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.977 1.711 . . . . 0.0 110.955 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 63.8 p -65.04 -16.77 63.83 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -108.12 9.72 28.21 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.417 1.487 . . . . 0.0 113.369 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -66.66 -25.16 66.44 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 121.007 -1.058 . . . . 0.0 113.443 177.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.9 t -127.44 154.88 44.52 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.378 1.871 . . . . 0.0 112.01 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -114.62 18.24 16.8 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.331 1.452 . . . . 0.0 113.314 167.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.8 p -76.68 157.16 32.01 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 120.96 -1.088 . . . . 0.0 112.619 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.9 pt -108.14 155.04 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.808 1.243 . . . . 0.0 111.271 166.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -112.15 128.17 56.14 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.542 1.137 . . . . 0.0 109.779 176.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -124.94 152.75 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.527 1.131 . . . . 0.0 111.605 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 44.6 p -132.12 169.59 16.17 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.452 1.901 . . . . 0.0 110.919 -175.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -58.51 -27.0 64.08 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 120.909 -1.12 . . . . 0.0 113.168 176.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.11 -13.51 52.8 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.195 1.398 . . . . 0.0 114.518 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.0 p -127.5 -7.72 5.74 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 -173.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -56.01 -41.82 75.48 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.869 1.268 . . . . 0.0 112.603 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.76 -33.05 74.08 Favored 'General case' 0 CA--C 1.543 0.712 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 m -79.19 -14.96 58.75 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.784 1.634 . . . . 0.0 113.521 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -120.35 -54.55 2.08 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.127 0.971 . . . . 0.0 113.173 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.2 -51.97 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.479 0.712 . . . . 0.0 110.898 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 25.4 mt -76.96 -15.9 59.51 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.8 t -76.12 -28.91 57.66 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.414 1.486 . . . . 0.0 112.904 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.2 m -68.77 119.46 13.18 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.786 1.234 . . . . 0.0 112.418 -174.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -77.32 -20.19 55.29 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.352 1.061 . . . . 0.0 112.944 170.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -87.32 166.19 27.06 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 126.586 1.954 . . . . 0.0 111.363 173.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.62 137.24 79.09 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.135 1.89 . . . . 0.0 111.75 170.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -138.25 130.43 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.016 0.927 . . . . 0.0 111.004 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.04 113.79 27.55 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.396 1.878 . . . . 0.0 108.635 -174.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.3 t -100.19 122.73 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.547 0.739 . . . . 0.0 110.065 173.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -96.34 109.7 22.17 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.594 1.158 . . . . 0.0 110.291 166.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -81.45 115.99 21.04 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.052 1.341 . . . . 0.0 107.923 170.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -148.44 170.1 18.75 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.955 0.902 . . . . 0.0 112.536 -167.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -144.17 149.2 36.06 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.168 0.587 . . . . 0.0 112.026 161.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.7 t -63.96 -22.44 66.92 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.029 0.932 . . . . 0.0 113.291 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -78.94 -5.91 54.93 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 43.4 t -105.39 130.33 53.52 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.186 0.994 . . . . 0.0 112.142 -177.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.38 -56.98 20.39 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.408 1.004 . . . . 0.0 113.539 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -55.83 -34.71 92.16 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.024 2.483 . . . . 0.0 114.448 173.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 96.5 m -62.62 -45.97 90.4 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.04 0.836 . . . . 0.0 111.512 172.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -62.81 -33.55 75.45 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.682 1.193 . . . . 0.0 112.406 175.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 97.2 mmm -75.35 -36.64 60.95 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.383 1.073 . . . . 0.0 113.784 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.9 p -83.3 -23.36 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 119.581 1.082 . . . . 0.0 113.606 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.42 -50.51 71.02 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.98 -27.85 42.38 Favored 'Trans proline' 0 C--N 1.353 0.783 0 CA-C-N 122.538 1.942 . . . . 0.0 113.239 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.4 t -73.37 -42.94 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 121.338 -0.851 . . . . 0.0 110.385 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.1 mt -64.73 -33.28 75.59 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.77 1.228 . . . . 0.0 112.776 171.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.43 -45.44 87.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.273 1.029 . . . . 0.0 111.422 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -61.07 -47.77 84.82 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.61 -0.682 . . . . 0.0 110.889 170.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.09 -36.06 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 120.985 -1.072 . . . . 0.0 112.582 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.64 -41.85 92.15 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.172 0.989 . . . . 0.0 112.201 173.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.1 m -73.98 -35.29 64.46 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.444 0.698 . . . . 0.0 111.356 -176.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -87.57 -38.39 16.01 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.118 1.367 . . . . 0.0 114.332 -175.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -104.19 12.08 34.24 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.511 1.124 . . . . 0.0 114.027 -168.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.55 -33.42 45.61 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.564 1.545 . . . . 0.0 114.51 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 m -71.33 -25.54 62.44 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.849 1.26 . . . . 0.0 112.755 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -101.73 -36.69 8.62 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.486 1.514 . . . . 0.0 112.869 -176.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.5 pp -147.65 164.42 33.58 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.857 1.663 . . . . 0.0 111.781 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.1 m -107.95 143.18 36.95 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.463 1.105 . . . . 0.0 109.371 169.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.6 t -115.36 128.05 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 118.966 0.803 . . . . 0.0 110.559 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.76 154.25 47.4 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.179 1.792 . . . . 0.0 112.077 -172.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -123.04 135.5 54.46 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.716 1.207 . . . . 0.0 112.495 173.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.02 116.95 29.27 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.839 1.656 . . . . 0.0 108.441 168.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.7 101.11 11.94 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.889 1.275 . . . . 0.0 110.138 -176.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.7 m -66.2 -16.5 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -173.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.63 -26.17 63.35 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.366 1.067 . . . . 0.0 113.195 175.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.7 t -119.12 -20.36 8.05 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.601 1.16 . . . . 0.0 113.427 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.5 m120 -123.29 63.98 25.86 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.6 1.16 . . . . 0.0 112.575 170.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.59 -18.34 58.91 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.584 2.189 . . . . 0.0 112.451 171.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -60.1 -46.68 88.79 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.598 1.159 . . . . 0.0 110.931 173.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.29 -31.31 60.66 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.503 1.121 . . . . 0.0 111.893 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.21 -44.99 96.39 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 123.99 0.916 . . . . 0.0 112.321 174.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.8 ptt-85 -82.08 -22.8 36.13 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 176.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -56.29 -40.8 74.87 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.311 0.96 . . . . 0.0 113.249 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -99.0 5.22 47.24 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.467 1.107 . . . . 0.0 113.077 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 47.12 55.3 8.24 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.312 1.845 . . . . 0.0 112.277 -166.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.6 m -113.73 19.52 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.862 1.665 . . . . 0.0 112.58 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.4 m -63.0 -16.85 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.772 1.629 . . . . 0.0 114.559 -175.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.2 m -78.47 48.61 0.79 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.801 2.041 . . . . 0.0 113.384 -176.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -59.83 155.17 43.49 Favored Pre-proline 0 CA--C 1.556 1.176 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 -163.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.74 141.96 68.03 Favored 'Cis proline' 0 C--N 1.355 0.878 0 CA-C-N 118.892 0.64 . . . . 0.0 111.85 -6.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.7 m -133.17 123.98 26.63 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.617 0.767 . . . . 0.0 109.868 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.4 mp -103.5 128.6 50.67 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.494 1.518 . . . . 0.0 108.981 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.1 mm -118.09 128.42 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.174 0.99 . . . . 0.0 109.065 167.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 17.3 tp -97.82 118.98 35.6 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 165.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -96.59 150.33 20.77 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.716 1.606 . . . . 0.0 109.739 170.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -128.52 134.18 48.61 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.606 1.163 . . . . 0.0 108.939 162.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.7 t0 48.67 41.47 17.79 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.197 0.999 . . . . 0.0 113.49 -175.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.02 15.97 70.1 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 124.72 1.153 . . . . 0.0 115.429 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -123.32 136.5 27.16 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.544 1.537 . . . . 0.0 109.574 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.38 139.37 45.27 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.633 2.222 . . . . 0.0 111.41 -177.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.6 t -126.19 -40.34 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.986 1.314 . . . . 0.0 112.517 -174.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -142.26 147.85 37.13 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 119.12 0.873 . . . . 0.0 112.854 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.8 ttt180 -126.2 137.89 53.59 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.056 2.143 . . . . 0.0 111.515 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.6 145.78 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.067 1.747 . . . . 0.0 109.744 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 p -137.05 149.47 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.374 1.069 . . . . 0.0 112.087 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.52 164.33 28.34 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.303 1.43 . . . . 0.0 112.527 -173.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.68 157.51 27.08 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 121.474 -1.016 . . . . 0.0 113.358 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -130.79 149.07 52.6 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.694 1.598 . . . . 0.0 110.464 169.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.89 166.69 41.26 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 160.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -50.49 -37.36 38.4 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.895 1.278 . . . . 0.0 114.03 -177.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.7 -47.79 68.4 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.195 0.598 . . . . 0.0 112.144 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.64 -43.5 72.52 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.464 -0.772 . . . . 0.0 111.982 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.7 tp -64.48 -45.66 86.43 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 122.044 -0.41 . . . . 0.0 110.81 177.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.8 tp -74.4 -18.37 60.67 Favored 'General case' 0 C--O 1.214 -0.807 0 CA-C-O 116.798 -1.572 . . . . 0.0 113.278 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -66.75 -52.75 40.71 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 123.359 2.8 . . . . 0.0 110.933 164.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -63.17 -24.36 67.85 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 86.4 mt -98.18 -19.62 17.77 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.076 0.95 . . . . 0.0 113.461 172.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.0 t -66.52 -23.08 66.18 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 120.584 -1.322 . . . . 0.0 110.809 167.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -54.69 -16.18 2.34 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.319 1.048 . . . . 0.0 113.54 164.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.37 -11.78 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.948 1.699 . . . . 0.0 114.043 169.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.7 t -117.98 78.43 12.97 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 128.164 2.586 . . . . 0.0 109.342 173.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -66.03 -6.38 14.31 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.915 2.41 . . . . 0.0 113.887 -176.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -71.93 -38.01 69.93 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.192 0.997 . . . . 0.0 113.259 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.2 tp -162.75 140.75 8.31 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.684 1.594 . . . . 0.0 109.937 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 . . . . . 0 C--O 1.251 1.178 0 C-N-CA 130.44 3.496 . . . . 0.0 112.126 -2.985 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.8 ptm . . . . . 0 N--CA 1.487 1.411 0 N-CA-C 111.244 0.09 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.2 m 60.7 -73.2 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 127.674 2.389 . . . . 0.0 114.579 176.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -67.38 -21.81 65.59 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.85 -1.156 . . . . 0.0 112.818 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 78.5 p -85.95 -6.0 59.13 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.802 1.641 . . . . 0.0 113.986 170.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -119.81 -15.9 8.81 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.419 1.488 . . . . 0.0 114.144 -171.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -76.87 161.8 28.13 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.372 1.469 . . . . 0.0 113.777 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.7 m -68.03 132.97 48.24 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.51 1.124 . . . . 0.0 111.873 176.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.74 58.95 4.51 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 121.583 -0.698 . . . . 0.0 111.676 175.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.9 p -104.03 142.49 34.36 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.854 1.662 . . . . 0.0 112.969 -177.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.6 pt -139.51 155.25 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.02 1.728 . . . . 0.0 111.598 173.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -95.8 140.41 30.62 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.446 0.699 . . . . 0.0 110.117 161.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -117.33 150.7 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.403 1.481 . . . . 0.0 110.503 171.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.7 p -127.5 165.38 19.96 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.228 1.411 . . . . 0.0 111.354 -176.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -60.25 -27.79 67.52 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.91 -13.51 57.43 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.943 1.297 . . . . 0.0 114.188 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.4 m -126.55 -13.65 5.93 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -168.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -54.33 -42.08 69.77 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.228 1.411 . . . . 0.0 112.368 -173.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.33 -34.12 75.54 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.295 -0.878 . . . . 0.0 113.085 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.7 m -79.38 -28.09 41.88 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.476 1.11 . . . . 0.0 112.919 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -92.91 -40.9 10.34 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.352 -0.843 . . . . 0.0 113.234 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.4 t -99.39 -57.26 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.811 1.245 . . . . 0.0 111.191 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.1 mt -79.86 -18.69 50.11 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -171.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.8 m -85.56 -10.49 55.86 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.127 0.971 . . . . 0.0 113.045 174.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.4 t -79.9 130.4 35.27 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.787 0.835 . . . . 0.0 112.559 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -79.72 -21.29 44.74 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.964 0.906 . . . . 0.0 112.486 170.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -79.82 148.33 68.53 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 125.84 1.656 . . . . 0.0 110.517 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -58.51 132.55 49.09 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.035 1.824 . . . . 0.0 111.674 170.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.84 130.1 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.408 1.083 . . . . 0.0 110.647 -173.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.32 114.09 26.18 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.867 1.667 . . . . 0.0 108.665 -172.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.18 124.69 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.938 0.895 . . . . 0.0 110.727 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -104.28 116.3 31.91 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.421 1.089 . . . . 0.0 111.435 173.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -84.9 110.48 18.89 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.076 1.751 . . . . 0.0 108.375 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -143.63 171.28 14.4 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.56 1.144 . . . . 0.0 112.722 -164.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.54 154.81 39.32 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.791 0.836 . . . . 0.0 111.809 163.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.4 t -64.82 -20.88 66.63 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.957 0.903 . . . . 0.0 113.183 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 -80.08 -1.56 40.55 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 50.8 t -109.77 117.31 33.53 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.226 1.01 . . . . 0.0 112.747 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.82 -47.72 89.0 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 124.363 0.983 . . . . 0.0 113.91 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -58.52 -31.6 94.73 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.925 2.417 . . . . 0.0 114.685 170.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 83.9 m -66.57 -45.02 80.68 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.481 1.037 . . . . 0.0 111.198 170.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -60.62 -29.69 69.38 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.552 0.741 . . . . 0.0 112.628 173.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 16.5 tpt -73.75 -42.64 60.81 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.757 1.223 . . . . 0.0 113.027 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.1 p -84.4 -21.33 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.32 -49.61 80.9 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -65.63 -30.13 51.41 Favored 'Trans proline' 0 C--N 1.353 0.764 0 CA-C-N 122.415 1.898 . . . . 0.0 113.003 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.4 t -68.23 -49.53 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 118.731 0.696 . . . . 0.0 110.124 175.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.5 mt -61.13 -34.93 75.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.136 0.975 . . . . 0.0 112.797 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -70.86 -40.29 72.42 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.218 0.917 . . . . 0.0 112.169 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -61.97 -42.51 99.21 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.09 -1.006 . . . . 0.0 111.516 169.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.7 mt -61.53 -43.76 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 118.771 0.714 . . . . 0.0 110.914 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.33 -37.65 81.27 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.988 0.915 . . . . 0.0 112.379 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.3 m -75.98 -47.18 26.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.776 0.83 . . . . 0.0 112.177 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -94.88 -21.81 18.42 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -167.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.41 16.61 23.72 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.591 1.556 . . . . 0.0 111.761 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.93 -27.93 47.09 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.1 1.76 . . . . 0.0 114.94 -173.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.9 p -78.35 -19.51 53.28 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.013 1.325 . . . . 0.0 113.845 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -111.17 -28.67 8.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.808 1.643 . . . . 0.0 113.57 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.7 mt -129.8 148.99 51.73 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.643 1.977 . . . . 0.0 111.04 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 57.8 m -108.62 133.01 53.32 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 153.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.0 t -103.18 130.96 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.477 0.711 . . . . 0.0 109.816 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.21 155.09 46.09 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.767 1.627 . . . . 0.0 112.011 -174.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -123.69 128.25 49.36 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.881 1.672 . . . . 0.0 110.548 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -108.16 113.86 27.31 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.6 102.24 10.52 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.116 0.966 . . . . 0.0 108.734 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.3 m -65.76 -17.18 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.887 -1.133 . . . . 0.0 112.787 -176.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -78.52 -20.0 51.72 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.941 1.296 . . . . 0.0 113.652 176.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.0 p -115.62 -22.42 9.22 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 174.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -129.46 62.61 64.01 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 125.641 1.576 . . . . 0.0 112.054 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -64.71 -20.71 65.24 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.804 2.336 . . . . 0.0 112.742 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -62.46 -39.92 94.98 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.897 0.879 . . . . 0.0 111.721 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -73.69 -37.24 65.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.842 0.857 . . . . 0.0 111.49 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.01 -43.78 95.01 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.496 0.719 . . . . 0.0 111.683 171.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.4 ttp-105 -73.74 -33.85 64.5 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -56.42 -42.43 78.03 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.505 1.122 . . . . 0.0 112.964 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -98.19 5.28 48.64 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.425 1.09 . . . . 0.0 113.334 174.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.36 15.8 pt20 46.81 25.74 0.48 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 128.298 2.639 . . . . 0.0 116.013 -168.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.2 m -80.46 39.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.744 2.017 . . . . 0.0 111.857 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.7 m -74.95 -21.66 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.966 1.306 . . . . 0.0 113.304 -172.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 54.2 m -80.92 137.94 36.13 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.773 1.229 . . . . 0.0 110.223 166.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 48.1 pt -135.71 155.16 78.32 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -167.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -68.34 141.45 61.25 Favored 'Cis proline' 0 C--N 1.353 0.786 0 CA-C-N 119.212 0.754 . . . . 0.0 111.361 -6.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.4 m -126.94 120.57 29.46 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.274 0.63 . . . . 0.0 109.399 169.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.7 mp -102.57 126.11 49.53 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.942 1.697 . . . . 0.0 107.855 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.2 tt -118.25 139.22 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.228 1.011 . . . . 0.0 109.692 171.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.0 tp -113.16 129.7 56.43 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.408 1.083 . . . . 0.0 109.671 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -113.86 151.06 32.69 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.191 1.396 . . . . 0.0 110.402 171.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -132.48 127.99 36.43 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.305 1.442 . . . . 0.0 108.972 168.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.4 t70 49.05 41.49 19.37 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.297 1.039 . . . . 0.0 113.398 -168.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.33 9.7 55.36 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.626 1.584 . . . . 0.0 115.739 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -112.61 139.39 22.68 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 125.441 1.496 . . . . 0.0 109.845 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.14 140.03 43.91 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.536 2.157 . . . . 0.0 112.299 -171.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.8 t -117.71 -46.56 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.718 1.607 . . . . 0.0 111.469 -176.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -155.13 150.23 26.92 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.308 1.043 . . . . 0.0 112.052 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 67.6 ttp85 -129.81 139.17 51.29 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.061 1.345 . . . . 0.0 111.583 167.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 30.8 mt -132.25 142.58 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 127.388 2.275 . . . . 0.0 108.354 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 p -133.61 147.78 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.286 1.035 . . . . 0.0 112.022 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.98 161.92 24.54 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.541 1.543 . . . . 0.0 112.945 -175.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.73 151.71 28.72 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -136.66 153.19 50.98 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.353 1.861 . . . . 0.0 110.373 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.49 162.02 32.91 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 160.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -55.85 -34.12 65.15 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.81 -47.58 77.55 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 118.088 0.404 . . . . 0.0 111.18 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.13 -45.99 58.34 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.495 -0.753 . . . . 0.0 112.321 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.1 tp -65.73 -44.89 84.65 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 118.879 0.763 . . . . 0.0 110.685 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 16.7 tp -69.91 -24.93 63.46 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-O 115.825 -2.036 . . . . 0.0 112.753 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -65.24 -50.47 65.68 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 124.053 3.115 . . . . 0.0 111.644 168.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -62.54 -27.23 69.02 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 80.7 mt -87.57 -28.54 21.88 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.221 1.009 . . . . 0.0 113.439 169.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.3 m -62.37 -27.88 69.38 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.309 1.443 . . . . 0.0 110.608 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -49.49 -26.79 3.65 Favored 'General case' 0 CA--C 1.56 1.344 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 165.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.0 t -111.56 -22.36 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 128.223 2.609 . . . . 0.0 112.777 172.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.9 t -112.04 75.55 1.59 Allowed Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 127.632 2.373 . . . . 0.0 110.662 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -70.38 3.23 3.19 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.883 3.056 . . . . 0.0 114.214 -177.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -61.25 -27.43 68.45 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.788 0.835 . . . . 0.0 112.709 172.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.6 tp -93.52 132.73 37.53 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.773 0.829 . . . . 0.0 110.482 162.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 33.5 m120 . . . . . 0 C--O 1.25 1.095 0 C-N-CA 125.095 1.358 . . . . 0.0 111.804 175.451 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.4 mtm . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 120.419 0.152 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.6 t -141.62 163.03 34.01 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.407 1.083 . . . . 0.0 112.511 177.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -150.15 151.81 33.72 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.086 1.754 . . . . 0.0 111.046 -177.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.3 m -59.38 -21.81 60.42 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -108.86 8.72 26.69 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.324 1.45 . . . . 0.0 113.554 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -66.48 133.73 51.01 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.321 1.048 . . . . 0.0 111.701 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.1 p -87.04 156.54 19.7 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.198 1.399 . . . . 0.0 113.033 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -99.28 26.44 5.97 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -168.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.9 p -89.34 154.51 20.02 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 121.013 -1.055 . . . . 0.0 112.964 177.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.2 pt -137.27 155.27 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 126.056 1.743 . . . . 0.0 111.546 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -93.61 139.13 31.13 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.389 0.675 . . . . 0.0 110.819 167.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.1 m -125.57 150.42 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.453 1.501 . . . . 0.0 110.571 172.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.3 p -143.28 157.33 44.57 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.302 1.441 . . . . 0.0 111.115 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -52.17 -28.09 16.85 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -174.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.06 -20.1 64.1 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.8 m -136.49 -3.87 2.1 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.386 1.474 . . . . 0.0 114.062 -176.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -53.51 -41.24 66.12 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.839 1.656 . . . . 0.0 112.526 -174.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.3 -33.16 74.71 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.6 m -79.51 -31.15 42.16 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.249 1.02 . . . . 0.0 112.643 175.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -88.81 -41.43 12.51 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -176.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.9 t -105.57 -52.46 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.106 1.363 . . . . 0.0 111.253 -172.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 29.3 mt -81.82 -13.45 57.66 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -171.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 74.6 m -89.21 -9.81 49.39 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.975 0.91 . . . . 0.0 113.346 175.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.3 t -77.58 140.47 39.69 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.044 0.938 . . . . 0.0 113.323 -174.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -98.78 -5.36 31.38 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.096 1.358 . . . . 0.0 113.559 176.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -98.56 162.84 20.41 Favored Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 124.588 1.155 . . . . 0.0 110.624 164.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -57.02 138.49 86.56 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.299 1.999 . . . . 0.0 113.448 170.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.7 t -132.62 131.41 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.451 1.5 . . . . 0.0 108.895 177.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -122.98 120.03 32.17 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.194 1.398 . . . . 0.0 109.279 -172.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.6 t -119.46 126.35 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.559 0.744 . . . . 0.0 111.138 -172.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -107.0 118.68 37.33 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.959 1.304 . . . . 0.0 112.455 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -94.08 111.57 23.3 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.582 1.953 . . . . 0.0 108.518 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -143.69 172.6 12.59 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.278 1.431 . . . . 0.0 112.884 -163.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -144.59 148.62 34.59 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 163.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 m -60.09 -27.85 67.35 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.675 1.19 . . . . 0.0 112.652 174.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 6.2 p-90 -76.61 -4.19 41.67 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 53.2 t -108.16 122.69 47.44 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.701 1.2 . . . . 0.0 111.792 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.38 -48.21 86.46 Favored Glycine 0 CA--C 1.539 1.543 0 CA-C-O 118.892 -0.949 . . . . 0.0 114.079 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -56.47 -36.24 97.37 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.045 2.497 . . . . 0.0 114.302 170.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 96.9 m -64.36 -45.18 88.87 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.279 -0.888 . . . . 0.0 111.88 173.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -62.39 -31.01 71.62 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.334 1.054 . . . . 0.0 112.397 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.4 ttp -75.69 -38.3 58.8 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.976 1.31 . . . . 0.0 113.376 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.2 p -83.91 -19.06 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.64 -51.42 76.45 Favored Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 175.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.85 -30.8 39.94 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.236 1.957 . . . . 0.0 113.058 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.0 t -64.28 -48.48 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.643 0.777 . . . . 0.0 110.68 173.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 38.9 mt -66.75 -32.94 74.57 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.453 0.701 . . . . 0.0 112.566 176.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -67.41 -42.05 83.89 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.136 0.88 . . . . 0.0 112.127 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.98 -47.86 81.34 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.314 -0.866 . . . . 0.0 111.635 170.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.4 -40.16 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 118.803 0.729 . . . . 0.0 110.822 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.8 -49.63 76.97 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.403 -0.811 . . . . 0.0 111.989 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.4 m -76.29 -31.32 58.16 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.55 0.74 . . . . 0.0 112.195 -171.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -95.74 -23.55 16.91 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -112.32 17.07 19.71 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.232 1.413 . . . . 0.0 113.292 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.04 -27.72 21.07 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.607 1.563 . . . . 0.0 114.351 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.3 p -67.79 -20.36 65.19 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.791 1.636 . . . . 0.0 113.87 176.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -117.29 -46.34 2.7 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.801 1.24 . . . . 0.0 112.72 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.9 mt -99.48 148.88 23.79 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.369 1.468 . . . . 0.0 111.126 -176.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.8 m -108.91 122.15 46.61 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 149.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 75.1 t -105.14 124.71 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.281 0.632 . . . . 0.0 110.126 -175.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.72 163.59 23.17 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.452 1.501 . . . . 0.0 112.326 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -130.31 147.3 52.01 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.694 1.598 . . . . 0.0 112.071 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -125.98 117.39 23.16 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.856 1.662 . . . . 0.0 108.83 169.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -81.75 113.24 19.59 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 122.883 0.473 . . . . 0.0 110.422 174.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.8 m -70.87 -16.95 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -172.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -84.17 -39.71 19.06 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.42 1.088 . . . . 0.0 112.43 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 36.3 p -92.66 -23.6 18.92 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.183 1.393 . . . . 0.0 113.893 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -134.88 69.69 71.1 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-N 119.499 1.045 . . . . 0.0 112.055 173.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -66.76 -26.72 45.1 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.153 2.569 . . . . 0.0 114.768 -172.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -64.11 -35.7 81.62 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.608 -0.683 . . . . 0.0 111.817 -175.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.2 m -64.05 -43.26 96.04 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.311 1.044 . . . . 0.0 111.309 176.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.35 -39.61 95.01 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.737 0.815 . . . . 0.0 112.018 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.34 -45.25 63.39 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.296 177.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -63.99 -32.73 74.38 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 118.878 0.763 . . . . 0.0 112.782 -171.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -98.45 8.04 45.4 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.344 1.058 . . . . 0.0 113.746 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.1 tp60 49.88 52.59 14.34 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.462 1.905 . . . . 0.0 113.35 -177.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.1 m -132.88 48.61 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.216 1.806 . . . . 0.0 109.647 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.5 m -78.42 -21.47 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.228 1.411 . . . . 0.0 113.657 -176.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.1 m -72.09 155.73 39.97 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.747 1.219 . . . . 0.0 111.112 168.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.61 149.28 49.96 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -174.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.43 136.65 41.25 Favored 'Cis proline' 0 C--N 1.353 0.771 0 N-CA-C 110.424 -0.644 . . . . 0.0 110.424 -14.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 98.7 m -127.88 121.38 29.89 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.851 0.86 . . . . 0.0 110.485 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.0 mp -102.26 132.31 48.29 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.368 1.467 . . . . 0.0 109.223 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.9 tp -121.9 128.13 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.992 1.317 . . . . 0.0 109.376 171.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 41.3 tp -108.23 127.97 54.31 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.005 1.322 . . . . 0.0 110.309 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -113.69 144.18 43.37 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.985 1.714 . . . . 0.0 109.535 172.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -107.22 -29.75 9.15 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -150.01 40.79 0.81 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.715 2.006 . . . . 0.0 109.913 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.92 -6.07 7.06 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 125.354 1.454 . . . . 0.0 115.141 -165.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -94.63 138.2 22.33 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 118.787 1.293 . . . . 0.0 110.607 167.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.51 146.07 38.74 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.353 2.702 . . . . 0.0 112.114 -176.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.6 m -132.99 -24.99 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -177.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -153.59 143.81 22.23 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.715 1.143 . . . . 0.0 111.67 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -128.9 137.93 51.71 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.854 2.062 . . . . 0.0 110.783 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.6 mt -135.18 141.58 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.91 1.684 . . . . 0.0 108.721 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 p -133.81 142.18 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 119.398 0.999 . . . . 0.0 111.127 168.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 91.86 150.0 24.94 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.273 1.416 . . . . 0.0 112.955 -171.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.42 144.67 31.25 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.074 0.95 . . . . 0.0 113.147 -174.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -134.56 159.99 39.46 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.067 1.747 . . . . 0.0 110.7 172.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -74.88 166.36 54.86 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.429 -0.669 . . . . 0.0 111.429 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -51.0 -37.33 44.38 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.836 1.254 . . . . 0.0 113.384 -173.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.95 -49.41 52.08 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.05 0.386 . . . . 0.0 111.76 -177.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.73 -37.59 59.26 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.548 0.739 . . . . 0.0 112.792 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.29 -45.44 87.99 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.4 1.0 . . . . 0.0 109.733 174.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 21.4 tp -70.2 -20.09 63.13 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-O 116.402 -1.761 . . . . 0.0 112.989 171.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.72 -54.12 49.18 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 123.802 3.001 . . . . 0.0 110.239 166.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -63.62 -26.59 68.75 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 114.43 -1.259 . . . . 0.0 113.136 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 82.4 mt -91.34 -21.82 20.83 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 168.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 31.8 m -65.84 -20.73 66.35 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.785 -1.197 . . . . 0.0 111.214 172.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -47.1 -27.3 1.33 Allowed 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 160.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -116.79 -25.13 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.701 1.6 . . . . 0.0 113.749 177.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.45 78.22 10.97 Favored Pre-proline 0 N--CA 1.484 1.235 0 C-N-CA 125.604 1.561 . . . . 0.0 112.667 171.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -62.79 -6.23 8.81 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.607 2.871 . . . . 0.0 115.662 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -61.99 -8.42 5.2 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.208 1.403 . . . . 0.0 114.451 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.3 tp -59.87 -31.39 69.74 Favored 'General case' 0 CA--C 1.55 0.946 0 O-C-N 120.934 -1.103 . . . . 0.0 112.524 165.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.253 1.25 0 C-N-CA 126.001 1.72 . . . . 0.0 112.313 -177.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 119.077 -0.487 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.0 t -161.79 155.98 22.16 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.892 1.277 . . . . 0.0 111.405 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -87.25 -30.26 21.05 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.349 1.059 . . . . 0.0 112.66 172.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.9 m -63.68 122.36 16.17 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.654 1.182 . . . . 0.0 113.538 -160.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 53.24 23.9 3.42 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.039 1.736 . . . . 0.0 114.267 -177.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -133.51 -58.49 0.88 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.183 1.393 . . . . 0.0 113.235 -167.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.2 m -97.66 139.19 33.93 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 124.741 1.217 . . . . 0.0 112.879 -168.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.87 58.34 3.82 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.212 0.605 . . . . 0.0 111.663 172.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.8 p -106.29 144.26 33.23 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.59 1.556 . . . . 0.0 113.38 -176.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.2 pt -142.03 159.59 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 126.474 1.91 . . . . 0.0 111.278 174.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -100.04 140.15 34.68 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.64 0.776 . . . . 0.0 110.22 163.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.6 m -130.12 145.96 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.469 1.108 . . . . 0.0 111.557 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.0 p -140.35 159.27 42.57 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.39 1.476 . . . . 0.0 111.236 176.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -51.74 -27.95 13.6 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.615 1.966 . . . . 0.0 114.805 -173.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.23 -22.02 65.71 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.8 m -136.73 1.19 2.53 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.677 1.591 . . . . 0.0 113.547 -175.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -55.48 -42.68 74.71 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.461 1.504 . . . . 0.0 112.461 -170.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.12 -32.11 73.36 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.6 m -79.01 -32.76 45.23 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.493 -0.754 . . . . 0.0 111.892 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -87.97 -40.78 13.62 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t -101.52 -40.09 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.203 1.401 . . . . 0.0 112.406 -171.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -100.76 -20.07 15.73 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -170.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.8 m -94.18 8.13 42.8 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.041 1.336 . . . . 0.0 113.768 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.7 p -69.52 157.21 37.59 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.007 2.123 . . . . 0.0 114.591 -176.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -87.87 -6.57 58.02 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.525 1.13 . . . . 0.0 113.557 173.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -142.21 166.35 21.81 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 127.744 2.418 . . . . 0.0 110.769 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -56.33 148.24 62.57 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.978 2.452 . . . . 0.0 113.694 173.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.2 t -132.49 128.97 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.975 1.31 . . . . 0.0 110.347 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 tt -98.05 128.16 44.42 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.255 1.822 . . . . 0.0 108.64 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.9 t -116.02 125.42 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 119.516 1.053 . . . . 0.0 110.898 172.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -106.55 114.49 28.64 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.827 1.651 . . . . 0.0 111.315 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -92.39 109.0 20.38 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.927 2.091 . . . . 0.0 108.016 175.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -142.19 -178.5 5.75 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.1 1.36 . . . . 0.0 111.372 -163.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.61 141.14 30.49 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 166.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 46.9 m -56.73 -29.94 63.02 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.524 1.53 . . . . 0.0 112.117 172.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 35.6 p-90 -88.74 -0.9 57.76 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.85 1.66 . . . . 0.0 115.138 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 48.1 t -110.11 134.21 52.41 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.473 1.033 . . . . 0.0 113.238 -172.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.37 -57.06 14.2 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.17 1.367 . . . . 0.0 115.477 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.21 -27.36 72.53 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 CA-C-N 120.939 2.37 . . . . 0.0 112.903 175.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 93.0 m -63.76 -43.97 94.84 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.129 -0.982 . . . . 0.0 111.74 169.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.01 -30.48 71.55 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.195 0.998 . . . . 0.0 112.553 173.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 15.8 tpt -73.35 -38.47 65.73 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.657 1.183 . . . . 0.0 113.353 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.4 p -84.42 -20.82 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.09 -50.31 82.81 Favored Pre-proline 0 CA--C 1.552 1.022 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.22 -29.67 32.23 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.293 1.995 . . . . 0.0 113.147 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.9 t -65.26 -49.18 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.409 0.684 . . . . 0.0 110.21 173.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.6 mt -63.99 -33.61 76.11 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.802 0.841 . . . . 0.0 112.709 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -64.14 -44.85 90.9 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.302 0.955 . . . . 0.0 111.517 174.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -61.63 -45.39 94.28 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.325 -0.859 . . . . 0.0 111.492 173.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.4 mt -59.68 -43.74 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 121.415 -0.803 . . . . 0.0 111.068 176.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.55 -37.26 86.65 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.102 0.961 . . . . 0.0 112.642 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.4 m -73.62 -46.89 44.23 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.784 0.834 . . . . 0.0 111.236 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -87.27 -35.49 18.44 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.498 1.119 . . . . 0.0 114.004 -170.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -99.72 24.7 8.0 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.598 1.159 . . . . 0.0 113.273 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.88 -28.12 47.9 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.109 1.363 . . . . 0.0 114.311 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.0 p -83.25 -19.39 36.47 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.296 1.438 . . . . 0.0 113.834 175.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -102.62 -38.15 7.63 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.082 1.353 . . . . 0.0 112.79 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 79.8 mt -129.8 160.89 32.07 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.34 2.256 . . . . 0.0 110.944 -175.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.4 m -108.8 138.8 44.54 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 147.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.5 t -101.29 129.97 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.82 0.848 . . . . 0.0 109.5 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.4 151.83 48.3 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.275 1.43 . . . . 0.0 111.557 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -127.67 148.8 50.4 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.987 1.315 . . . . 0.0 113.123 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -135.33 114.47 12.25 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.644 1.977 . . . . 0.0 108.875 168.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -81.39 116.34 21.17 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 171.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.5 m -64.55 -20.25 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -167.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -79.88 -22.58 42.68 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 172.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.1 p -92.57 -29.1 16.34 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -171.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -145.53 92.58 5.5 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 123.932 0.893 . . . . 0.0 110.73 162.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -62.46 -26.48 76.49 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.255 2.636 . . . . 0.0 114.894 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -71.78 -31.72 66.9 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.048 -1.033 . . . . 0.0 111.858 -175.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.5 m -65.75 -41.12 92.49 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.449 0.7 . . . . 0.0 110.786 174.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.1 -35.6 80.13 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.022 0.929 . . . . 0.0 112.609 172.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.3 tpt85 -73.49 -36.63 65.81 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -65.4 -28.64 69.4 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -172.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -103.14 5.34 37.79 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.35 1.06 . . . . 0.0 113.207 174.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 48.56 57.05 6.69 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.835 1.654 . . . . 0.0 112.172 -169.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.6 m -124.81 36.03 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.645 1.978 . . . . 0.0 111.038 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.7 m -71.67 -19.3 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.344 1.058 . . . . 0.0 113.156 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.2 m -68.01 151.73 46.62 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.408 1.483 . . . . 0.0 111.507 169.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 13.5 pt -139.31 142.53 32.84 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -168.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -67.71 149.08 82.48 Favored 'Cis proline' 0 CA--C 1.54 0.797 0 CA-C-N 118.498 0.499 . . . . 0.0 111.121 -17.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 67.7 m -133.42 125.15 28.44 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.756 1.222 . . . . 0.0 109.399 171.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.6 mp -109.28 136.48 48.67 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.593 1.157 . . . . 0.0 109.334 177.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.0 tt -127.9 144.87 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.202 1.001 . . . . 0.0 110.284 169.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.5 tp -121.52 120.44 34.87 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.941 0.897 . . . . 0.0 110.54 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -98.4 131.08 44.97 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.559 1.144 . . . . 0.0 109.604 172.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -99.59 -33.49 10.61 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -175.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -154.49 57.11 0.7 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.215 1.806 . . . . 0.0 110.174 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.5 15.87 64.47 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.51 1.052 . . . . 0.0 114.551 -173.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -140.31 137.56 17.98 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 126.966 2.106 . . . . 0.0 110.546 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -76.14 142.72 24.82 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.193 2.595 . . . . 0.0 112.645 -173.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.1 t -128.66 -28.6 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.689 1.596 . . . . 0.0 112.697 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -135.16 142.15 46.06 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.07 1.348 . . . . 0.0 110.077 172.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.8 ttt85 -147.03 113.22 5.86 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.957 2.103 . . . . 0.0 109.6 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 33.9 pt -137.05 148.17 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.377 1.471 . . . . 0.0 113.152 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.9 m -121.64 145.77 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 125.637 1.575 . . . . 0.0 111.195 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.95 160.49 24.32 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 124.164 0.888 . . . . 0.0 113.557 -172.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.39 145.53 31.96 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.853 0.861 . . . . 0.0 112.769 -176.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -130.59 153.33 49.01 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.801 1.641 . . . . 0.0 110.056 169.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -74.18 165.54 54.78 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 175.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -51.69 -35.22 41.89 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.665 1.186 . . . . 0.0 113.308 -174.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.48 -53.99 29.03 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.0 0.364 . . . . 0.0 111.197 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.44 -33.13 60.87 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.53 -45.09 94.57 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.472 1.033 . . . . 0.0 109.631 171.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 25.7 tp -69.41 -24.23 63.82 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-O 115.691 -2.099 . . . . 0.0 113.112 173.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.76 -51.04 69.95 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 124.295 3.225 . . . . 0.0 111.524 167.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -57.39 -37.53 72.81 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.05 0.94 . . . . 0.0 111.73 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.8 mt -83.16 -28.35 29.43 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 172.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.4 m -62.56 -28.15 69.67 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.037 1.335 . . . . 0.0 110.641 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -52.5 -26.6 13.44 Favored 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 168.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 51.3 t -107.3 -24.41 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.886 2.074 . . . . 0.0 112.519 171.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.4 t -118.01 77.57 12.38 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 126.537 1.935 . . . . 0.0 111.502 -177.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.26 -24.97 62.43 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.769 2.313 . . . . 0.0 113.196 169.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -75.64 37.81 0.15 Allowed 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 127.2 2.2 . . . . 0.0 113.004 173.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -59.73 -22.02 61.46 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -170.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 45.3 t30 . . . . . 0 C--O 1.253 1.282 0 C-N-CA 126.299 1.839 . . . . 0.0 111.427 179.353 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.5 p -74.01 156.29 37.68 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.744 1.218 . . . . 0.0 113.008 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -147.78 149.02 31.58 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.333 1.453 . . . . 0.0 111.46 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.3 t -151.23 148.77 28.62 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.849 1.259 . . . . 0.0 111.936 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -93.98 -2.57 52.91 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.951 1.3 . . . . 0.0 113.303 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -71.14 146.04 49.4 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.58 1.152 . . . . 0.0 112.527 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.5 p -80.5 161.48 24.82 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.366 1.466 . . . . 0.0 113.151 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -99.37 24.5 7.99 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -173.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.6 p -89.24 152.04 21.79 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 121.089 -1.007 . . . . 0.0 112.856 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.9 pt -132.84 165.34 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 126.209 1.803 . . . . 0.0 111.413 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -117.28 145.42 43.98 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.88 0.872 . . . . 0.0 111.753 171.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.15 156.47 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 126.326 1.851 . . . . 0.0 110.964 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 65.2 p -123.85 168.57 12.58 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.912 1.685 . . . . 0.0 111.566 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -57.29 -27.58 62.28 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 121.018 -1.051 . . . . 0.0 113.136 175.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.6 -13.31 56.74 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.224 1.409 . . . . 0.0 114.515 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.1 p -128.88 -8.91 4.94 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -173.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -57.06 -47.91 79.82 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.282 1.433 . . . . 0.0 112.055 -176.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.61 -34.28 77.52 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.3 -0.875 . . . . 0.0 112.699 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.23 -8.71 59.24 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.755 1.622 . . . . 0.0 113.666 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -121.81 -47.87 2.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.501 1.12 . . . . 0.0 113.455 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.3 t -83.16 -51.45 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.15 1.38 . . . . 0.0 111.037 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 43.3 mt -84.67 -13.22 52.11 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -174.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.7 p -78.17 -18.8 55.08 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.955 1.302 . . . . 0.0 113.785 176.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.5 t -86.05 133.24 33.91 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.63 1.172 . . . . 0.0 113.459 -168.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -75.77 -31.62 59.6 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.389 1.076 . . . . 0.0 111.528 168.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -80.68 138.88 50.62 Favored Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 124.891 1.276 . . . . 0.0 108.85 174.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -59.07 142.44 99.35 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 121.388 1.392 . . . . 0.0 113.507 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.5 t -124.35 125.67 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.384 1.474 . . . . 0.0 109.354 -177.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -108.39 115.25 29.75 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.655 1.582 . . . . 0.0 109.303 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.2 t -108.76 122.42 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.186 0.994 . . . . 0.0 110.829 -175.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -92.33 109.3 20.68 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.732 1.613 . . . . 0.0 111.021 173.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -83.61 112.86 20.4 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.793 1.237 . . . . 0.0 108.497 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -146.41 168.57 20.82 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.22 1.008 . . . . 0.0 113.033 -164.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.18 155.27 38.52 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.755 1.222 . . . . 0.0 110.974 166.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.9 t -66.05 -19.18 65.77 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -75.56 -4.44 39.94 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 48.5 t -109.29 108.83 19.56 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.348 1.059 . . . . 0.0 112.535 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.59 -40.43 94.6 Favored Glycine 0 CA--C 1.54 1.633 0 CA-C-O 118.848 -0.973 . . . . 0.0 113.972 174.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -60.44 -33.08 94.42 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.44 2.093 . . . . 0.0 114.459 168.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 91.1 m -63.69 -44.75 92.76 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.812 1.187 . . . . 0.0 110.735 168.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -60.0 -36.31 76.93 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 175.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 13.2 ptm -80.44 -29.97 37.56 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.2 p -84.6 -24.01 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-N 119.8 1.182 . . . . 0.0 113.563 174.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.13 -48.72 63.45 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 176.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -65.83 -29.1 50.64 Favored 'Trans proline' 0 C--N 1.353 0.777 0 CA-C-N 122.216 1.827 . . . . 0.0 113.475 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.3 t -69.15 -51.34 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 119.374 0.988 . . . . 0.0 110.334 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.0 pp -70.22 -28.43 65.26 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -68.65 -40.22 80.31 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.147 0.979 . . . . 0.0 112.932 171.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -63.23 -47.21 83.46 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.928 -1.107 . . . . 0.0 111.348 170.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.22 -37.88 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 118.483 0.583 . . . . 0.0 110.679 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.65 -49.96 75.61 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.276 0.944 . . . . 0.0 112.752 172.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.1 m -76.05 -33.27 59.6 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.843 0.857 . . . . 0.0 111.681 -169.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -83.92 -34.08 24.57 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 176.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -108.1 27.71 9.0 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.946 1.298 . . . . 0.0 113.744 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.02 -28.33 62.39 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.4 m -69.47 -27.35 65.15 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.08 1.352 . . . . 0.0 112.523 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -103.57 -34.28 8.71 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.44 1.496 . . . . 0.0 112.816 -174.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.5 mt -129.85 152.72 49.02 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.141 2.176 . . . . 0.0 111.178 -174.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.5 m -108.65 133.85 52.18 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 150.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.5 t -110.62 121.44 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 122.993 0.517 . . . . 0.0 109.862 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -118.06 164.84 14.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.521 1.528 . . . . 0.0 112.19 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 46.0 mttm -124.86 136.53 53.89 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.066 1.747 . . . . 0.0 111.463 173.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -113.2 117.22 31.28 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.992 1.317 . . . . 0.0 108.496 167.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.81 98.07 8.3 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.905 1.282 . . . . 0.0 108.604 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.3 m -67.06 -19.29 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 O-C-N 121.362 -0.836 . . . . 0.0 112.992 -172.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -72.42 -23.22 61.05 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.429 1.092 . . . . 0.0 112.555 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.5 p -118.2 -15.56 9.79 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.469 1.508 . . . . 0.0 113.593 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -123.3 60.94 18.42 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 125.392 1.477 . . . . 0.0 111.864 176.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.69 -23.57 56.15 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.591 2.194 . . . . 0.0 112.546 178.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -64.76 -42.9 94.77 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.006 0.922 . . . . 0.0 111.815 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.68 -37.02 73.59 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.575 0.75 . . . . 0.0 111.121 176.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.83 -47.1 86.61 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.76 0.824 . . . . 0.0 112.34 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 -77.43 -24.61 50.35 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -57.49 -41.41 80.68 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.935 0.894 . . . . 0.0 112.858 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -101.1 6.02 43.1 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.892 1.277 . . . . 0.0 113.219 174.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.376 16.2 pt20 46.38 29.35 0.85 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 128.286 2.634 . . . . 0.0 115.84 -166.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.5 m -80.68 38.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 126.66 1.984 . . . . 0.0 111.93 174.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 m -75.13 -25.29 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.947 1.299 . . . . 0.0 112.606 -175.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 55.6 m -78.61 140.39 38.46 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.731 1.212 . . . . 0.0 110.051 165.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 48.9 pt -138.96 155.4 72.97 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 123.884 0.874 . . . . 0.0 113.183 -168.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.41 141.94 63.98 Favored 'Cis proline' 0 C--N 1.354 0.835 0 CA-C-N 119.393 0.819 . . . . 0.0 111.96 -5.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.6 m -131.68 121.59 24.54 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.628 0.771 . . . . 0.0 109.812 171.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.1 mp -108.07 119.46 39.54 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.856 1.662 . . . . 0.0 108.553 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.4 tt -116.64 133.2 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.413 1.085 . . . . 0.0 110.651 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.6 tt -104.43 125.0 50.23 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.036 0.934 . . . . 0.0 110.385 173.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -102.69 144.65 30.8 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.339 1.456 . . . . 0.0 109.942 166.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -130.2 129.43 43.38 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.479 1.511 . . . . 0.0 109.34 172.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.8 t0 47.62 37.59 6.92 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.359 1.064 . . . . 0.0 113.323 -167.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.15 18.68 71.33 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 125.048 1.309 . . . . 0.0 116.364 -178.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -122.92 143.1 39.65 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 119.461 1.631 . . . . 0.0 110.87 172.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.28 140.3 44.11 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.749 2.3 . . . . 0.0 112.24 -173.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.7 t -123.79 -44.79 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.124 1.37 . . . . 0.0 112.629 -175.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.6 tttm -148.83 152.52 36.64 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.944 0.793 . . . . 0.0 112.129 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -138.51 141.46 39.37 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.559 1.144 . . . . 0.0 112.382 173.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.8 mp -129.4 139.49 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 127.361 2.265 . . . . 0.0 108.393 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.3 p -132.03 142.86 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.355 1.062 . . . . 0.0 111.237 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.78 154.92 19.62 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.11 1.338 . . . . 0.0 112.549 -169.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.39 137.18 46.36 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.865 -0.785 . . . . 0.0 111.904 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -131.8 154.63 48.92 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.78 1.632 . . . . 0.0 110.946 174.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -76.13 166.53 54.41 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 172.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -54.6 -33.39 60.33 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.08 -56.06 25.31 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 123.219 0.324 . . . . 0.0 110.95 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.75 -37.89 58.92 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.313 -0.867 . . . . 0.0 113.286 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.5 tp -66.17 -36.04 82.04 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 119.905 1.23 . . . . 0.0 110.906 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 16.9 tp -74.17 -24.55 59.4 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-O 115.722 -2.085 . . . . 0.0 113.073 170.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -56.91 -54.21 49.16 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 124.319 3.236 . . . . 0.0 110.375 163.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -68.53 -26.02 65.23 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -174.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 93.3 mt -93.75 -25.6 17.35 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.043 0.937 . . . . 0.0 113.435 172.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.3 t -67.79 -21.61 65.23 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.418 1.087 . . . . 0.0 111.614 171.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -49.44 -25.69 2.76 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 161.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 70.6 t -111.07 -25.6 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 127.436 2.294 . . . . 0.0 112.496 172.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.4 t -112.56 71.77 1.24 Allowed Pre-proline 0 N--CA 1.482 1.14 0 C-N-CA 127.172 2.189 . . . . 0.0 111.186 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.37 -6.98 18.85 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.082 2.521 . . . . 0.0 113.931 -176.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -72.46 -22.68 61.04 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.7 tp -149.43 132.71 16.47 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.189 0.995 . . . . 0.0 111.995 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 . . . . . 0 C--O 1.253 1.255 0 C-N-CA 125.818 1.647 . . . . 0.0 111.348 175.83 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 tpt . . . . . 0 N--CA 1.486 1.373 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.4 m -62.25 -33.83 75.35 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -171.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -78.36 -21.93 48.7 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -176.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.7 p -134.41 4.08 3.38 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.228 1.411 . . . . 0.0 114.787 -168.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 59.32 -68.39 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 127.707 2.403 . . . . 0.0 113.506 -164.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -76.44 135.37 39.41 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.761 1.224 . . . . 0.0 111.1 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.2 m -81.21 160.53 24.29 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.339 1.456 . . . . 0.0 112.19 173.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.41 29.68 0.43 Allowed 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 -164.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.8 p -89.37 155.94 19.02 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.002 1.321 . . . . 0.0 112.492 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 45.5 pt -134.29 162.73 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 126.104 1.762 . . . . 0.0 110.484 171.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -120.04 146.6 45.74 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.579 -0.7 . . . . 0.0 112.7 165.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.3 m -120.19 155.06 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.446 1.898 . . . . 0.0 110.973 -176.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.5 p -131.79 161.99 31.6 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.793 1.237 . . . . 0.0 112.684 -174.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.83 -26.09 57.55 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.087 1.355 . . . . 0.0 114.629 -175.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.61 -16.15 52.42 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.701 1.2 . . . . 0.0 114.19 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.7 m -134.44 -5.57 2.59 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -168.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -53.97 -41.89 68.34 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.069 1.348 . . . . 0.0 112.653 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.67 -32.51 73.23 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.9 m -78.85 -32.11 45.94 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.292 1.037 . . . . 0.0 111.921 176.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -87.32 -44.54 11.32 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.5 t -98.83 -51.92 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.964 1.306 . . . . 0.0 111.592 -173.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 33.5 mt -84.56 -13.47 51.67 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -170.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.8 t -81.11 -12.07 59.34 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.263 1.025 . . . . 0.0 112.894 173.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.3 t -69.67 142.69 53.35 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -171.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.2 p-10 -94.62 3.24 55.33 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.792 1.637 . . . . 0.0 113.76 173.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -126.48 167.08 18.27 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 126.946 2.098 . . . . 0.0 111.043 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -58.21 138.78 87.71 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.318 2.012 . . . . 0.0 113.257 170.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.8 t -132.58 129.33 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.09 1.356 . . . . 0.0 109.139 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -116.93 115.52 25.64 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.359 1.464 . . . . 0.0 109.231 -173.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.7 t -110.65 121.19 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.454 0.702 . . . . 0.0 110.828 -174.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -91.24 106.34 18.44 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.539 1.535 . . . . 0.0 110.6 173.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -80.61 114.34 19.43 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.088 1.355 . . . . 0.0 108.68 173.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.6 p-90 -147.94 168.64 21.75 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.979 0.911 . . . . 0.0 113.021 -164.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.53 153.87 36.59 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.402 1.081 . . . . 0.0 110.672 161.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.3 t -65.6 -20.05 66.16 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -75.22 -10.47 59.5 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 173.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 45.2 t -98.19 110.98 23.46 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.919 0.888 . . . . 0.0 110.969 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.08 -49.03 69.77 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-O 118.768 -1.018 . . . . 0.0 113.306 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -57.62 -32.57 94.81 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.032 2.488 . . . . 0.0 114.829 172.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 68.6 m -67.24 -44.84 78.46 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.914 -1.116 . . . . 0.0 111.157 171.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -63.03 -29.66 70.99 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.284 1.034 . . . . 0.0 112.177 176.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 60.7 mtt -75.82 -36.69 59.61 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.566 1.547 . . . . 0.0 113.782 173.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -87.32 -22.81 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 119.432 1.015 . . . . 0.0 113.677 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.74 -47.31 72.36 Favored Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 174.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -66.61 -27.01 45.96 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 CA-C-N 122.338 1.871 . . . . 0.0 113.735 176.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 92.1 t -70.96 -47.02 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.452 1.024 . . . . 0.0 109.305 173.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.64 -37.62 82.1 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.219 1.408 . . . . 0.0 112.269 177.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -66.33 -39.36 89.18 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.156 0.982 . . . . 0.0 112.503 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -67.26 -44.13 80.14 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.522 -0.736 . . . . 0.0 111.64 172.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.2 mm -61.24 -39.95 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 119.548 1.067 . . . . 0.0 111.055 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.09 -46.96 86.94 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.32 -0.863 . . . . 0.0 112.104 175.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.9 m -76.32 -34.77 59.01 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.546 0.738 . . . . 0.0 112.716 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -98.92 -16.95 18.6 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -172.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 74.5 mmt-85 -121.48 21.32 11.0 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.314 1.445 . . . . 0.0 113.438 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.95 -27.63 19.81 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.68 1.592 . . . . 0.0 114.03 175.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.2 p -70.14 -21.39 63.09 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.575 1.55 . . . . 0.0 114.113 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -117.39 -35.3 4.05 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.497 1.119 . . . . 0.0 113.484 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 57.3 mt -119.5 155.17 32.62 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.978 1.711 . . . . 0.0 110.843 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 57.1 m -108.73 126.19 52.73 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 152.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.7 t -102.58 123.26 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.095 0.558 . . . . 0.0 110.404 -177.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.23 165.62 17.96 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.891 1.676 . . . . 0.0 111.769 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -126.72 140.55 52.31 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.221 1.408 . . . . 0.0 111.386 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -116.06 116.99 28.87 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.362 1.065 . . . . 0.0 108.93 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.95 97.62 7.54 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.179 1.392 . . . . 0.0 108.615 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.9 m -66.42 -19.85 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 121.391 -0.818 . . . . 0.0 113.139 -173.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -72.69 -22.94 60.83 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.123 0.969 . . . . 0.0 112.596 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.4 p -117.42 -16.02 10.26 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.601 1.561 . . . . 0.0 113.41 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -123.3 59.05 14.04 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 125.21 1.404 . . . . 0.0 112.301 176.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -65.32 -25.96 56.47 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.52 2.147 . . . . 0.0 112.542 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -63.94 -45.06 90.85 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.981 0.912 . . . . 0.0 111.533 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.3 m -66.77 -38.6 86.9 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.629 0.772 . . . . 0.0 111.363 175.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.56 -43.75 98.04 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.612 0.765 . . . . 0.0 112.686 177.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.9 ptt85 -78.09 -26.74 48.26 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -56.69 -40.83 76.29 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.184 0.994 . . . . 0.0 113.465 -177.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -98.56 4.65 48.16 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.085 0.954 . . . . 0.0 113.256 177.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 52.57 49.25 20.8 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.357 1.863 . . . . 0.0 112.944 -167.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.0 m -115.23 22.5 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.721 1.608 . . . . 0.0 113.144 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.1 m -61.79 -22.29 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.062 1.345 . . . . 0.0 113.444 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.6 m -77.38 70.15 3.73 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.404 1.881 . . . . 0.0 112.077 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.2 pt -73.37 148.01 87.97 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.14 138.35 44.0 Favored 'Cis proline' 0 C--N 1.353 0.797 0 CA-C-N 119.567 0.881 . . . . 0.0 112.798 -3.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.6 m -135.8 125.4 25.25 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.115 0.966 . . . . 0.0 109.873 167.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.2 mp -93.44 132.44 37.7 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.86 1.264 . . . . 0.0 108.16 161.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.14 126.17 73.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 168.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 40.2 tp -104.37 119.0 37.98 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.744 1.618 . . . . 0.0 109.874 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -98.08 147.75 24.23 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.595 1.558 . . . . 0.0 110.143 171.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -126.01 130.55 51.4 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.673 1.189 . . . . 0.0 109.033 165.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.7 t70 51.04 35.18 12.24 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.658 1.183 . . . . 0.0 113.592 -174.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.2 15.96 72.74 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 124.954 1.264 . . . . 0.0 115.986 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -116.68 140.73 27.14 Favored Pre-proline 0 N--CA 1.473 0.712 0 CA-C-N 119.064 1.432 . . . . 0.0 110.442 172.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.1 139.94 40.22 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.689 2.259 . . . . 0.0 111.833 -176.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 72.0 t -128.64 -43.2 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.423 1.089 . . . . 0.0 113.184 -174.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -145.48 152.47 39.82 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 119.445 1.021 . . . . 0.0 112.976 -175.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -128.08 140.17 52.1 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.862 1.665 . . . . 0.0 111.389 171.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.0 mt -133.4 139.12 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.266 1.826 . . . . 0.0 108.474 174.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.1 m -131.51 151.64 35.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 123.557 0.743 . . . . 0.0 112.987 -171.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.12 171.96 17.32 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 123.805 0.717 . . . . 0.0 113.406 -172.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.66 153.23 41.31 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.7 -0.882 . . . . 0.0 112.227 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.14 159.1 42.92 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.404 1.882 . . . . 0.0 109.855 165.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.48 161.49 50.15 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 159.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -50.75 -34.04 25.54 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -177.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.02 -49.21 75.52 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.5 -34.84 47.13 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.894 0.878 . . . . 0.0 113.091 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.03 -47.67 73.64 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.378 0.99 . . . . 0.0 110.037 175.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -62.93 -41.93 99.64 Favored 'General case' 0 C--O 1.206 -1.23 0 CA-C-O 115.497 -2.192 . . . . 0.0 110.413 171.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -53.32 -50.47 64.91 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 124.136 3.153 . . . . 0.0 112.03 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -67.63 -30.45 70.03 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.3 mt -83.09 -24.71 32.56 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.808 1.186 . . . . 0.0 113.525 169.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.9 t -72.45 -21.84 61.17 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 129.164 2.986 . . . . 0.0 111.186 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -45.94 -26.48 0.71 Allowed 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 156.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.9 t -111.13 -51.8 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 127.321 2.249 . . . . 0.0 113.022 166.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 92.3 t -67.17 112.16 9.17 Favored Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 127.276 2.23 . . . . 0.0 110.829 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -71.38 -4.62 15.34 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 121.369 1.379 . . . . 0.0 112.848 177.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.7 t30 68.71 150.67 0.08 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 128.656 2.782 . . . . 0.0 115.877 170.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 94.3 mt -119.24 78.24 1.28 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.956 1.302 . . . . 0.0 111.406 175.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 . . . . . 0 C--O 1.251 1.173 0 C-N-CA 128.52 2.728 . . . . 0.0 112.022 -7.22 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.0 ttm . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.6 p -59.43 -33.15 70.9 Favored 'General case' 0 N--CA 1.482 1.175 0 O-C-N 120.683 -1.26 . . . . 0.0 112.563 170.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -66.38 -19.02 65.69 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.248 1.419 . . . . 0.0 113.691 173.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.4 m -75.56 -12.25 60.18 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.589 1.155 . . . . 0.0 113.488 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -83.05 29.32 0.48 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.6 1.56 . . . . 0.0 114.065 -169.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -77.17 -15.01 59.69 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.768 -1.207 . . . . 0.0 114.105 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.2 p -127.41 157.65 39.43 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.729 2.012 . . . . 0.0 112.281 175.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -104.94 35.69 2.71 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 -168.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.0 p -88.87 156.13 19.11 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.376 1.07 . . . . 0.0 112.433 174.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.9 pt -129.41 155.43 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.699 1.6 . . . . 0.0 111.258 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -98.89 139.69 34.18 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.846 0.858 . . . . 0.0 111.275 170.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -126.43 155.57 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.923 1.689 . . . . 0.0 111.197 174.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 80.6 p -141.56 158.73 43.47 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.822 1.649 . . . . 0.0 110.48 173.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -52.64 -29.64 27.27 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.082 1.353 . . . . 0.0 114.254 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.09 -21.12 66.35 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.0 m -131.42 -4.43 3.79 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.623 1.569 . . . . 0.0 113.715 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -53.2 -40.67 64.6 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.29 1.836 . . . . 0.0 112.637 -175.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.23 -33.11 74.66 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.364 -0.835 . . . . 0.0 113.154 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.4 m -79.72 -31.4 41.14 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.254 1.022 . . . . 0.0 112.714 174.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -89.01 -39.46 13.67 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.302 -0.874 . . . . 0.0 113.194 -175.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.5 t -106.21 -53.43 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.116 1.366 . . . . 0.0 110.956 -173.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 46.7 mt -80.05 -18.36 50.3 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.179 1.178 . . . . 0.0 114.179 -173.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.6 m -91.92 -2.76 56.63 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.067 0.947 . . . . 0.0 113.293 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.0 t -69.39 141.0 54.23 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.046 0.939 . . . . 0.0 112.71 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.59 4.81 52.77 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.446 1.499 . . . . 0.0 112.7 176.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -130.83 166.94 23.73 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 126.918 2.087 . . . . 0.0 111.03 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.17 135.99 71.9 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 121.824 1.682 . . . . 0.0 112.164 171.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.5 p -139.46 122.73 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.443 1.097 . . . . 0.0 110.918 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.09 129.42 46.96 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.253 2.221 . . . . 0.0 108.503 -175.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.0 t -119.8 125.42 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.618 1.167 . . . . 0.0 110.162 175.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -107.23 112.97 26.1 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.607 1.163 . . . . 0.0 111.344 174.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -82.6 113.57 20.39 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.487 1.515 . . . . 0.0 108.052 174.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.463 ' CD1' ' HE3' ' A' ' 62' ' ' LYS . 1.3 p-90 -148.82 170.73 17.59 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -166.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.13 156.33 40.78 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.323 1.049 . . . . 0.0 111.7 165.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.6 p -64.47 -20.71 66.36 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.976 1.311 . . . . 0.0 113.672 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 11.8 p-90 -82.93 -4.51 58.28 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 52.6 t -107.3 119.75 40.26 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.191 0.905 . . . . 0.0 111.945 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.88 -52.26 54.29 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-O 118.877 -0.957 . . . . 0.0 113.475 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -57.73 -35.9 98.62 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.779 2.319 . . . . 0.0 114.215 173.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 99.3 m -60.49 -46.69 89.18 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.624 1.102 . . . . 0.0 111.592 171.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.62 -29.19 70.2 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.384 1.074 . . . . 0.0 112.162 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 97.4 mmm -75.98 -37.67 58.29 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.004 1.322 . . . . 0.0 114.38 173.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.8 p -84.59 -23.01 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 CA-C-N 119.951 1.251 . . . . 0.0 113.556 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.05 -48.71 78.33 Favored Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -66.17 -30.24 46.59 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 CA-C-N 122.61 1.968 . . . . 0.0 113.37 176.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.9 t -67.23 -49.59 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-N 118.806 0.73 . . . . 0.0 109.834 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.7 mt -61.08 -37.36 82.41 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.343 1.057 . . . . 0.0 112.574 174.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -70.3 -40.44 74.25 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.969 0.908 . . . . 0.0 112.371 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -60.53 -47.2 87.21 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.514 -0.741 . . . . 0.0 111.085 168.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 76.0 mt -63.42 -36.82 77.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 O-C-N 121.649 -0.657 . . . . 0.0 111.286 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.13 -48.46 81.54 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 120.996 -1.065 . . . . 0.0 112.107 172.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.0 m -76.68 -32.92 58.21 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.171 0.988 . . . . 0.0 112.394 -172.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -99.29 -18.19 17.7 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.7 mmt-85 -122.45 28.27 7.48 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.056 1.342 . . . . 0.0 113.712 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.2 -27.68 22.91 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.889 0.876 . . . . 0.0 113.226 168.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.1 p -66.31 -26.92 67.54 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.057 2.143 . . . . 0.0 114.602 173.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -118.94 -23.71 6.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.363 1.465 . . . . 0.0 113.347 -171.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 80.5 mt -137.03 157.01 47.68 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.075 2.55 . . . . 0.0 110.258 -176.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 48.8 m -108.74 138.72 44.6 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 148.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.6 t -121.61 124.22 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 119.402 1.001 . . . . 0.0 110.68 -176.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -124.3 153.77 41.25 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.457 1.903 . . . . 0.0 112.632 -171.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.463 ' HE3' ' CD1' ' A' ' 33' ' ' TRP . 31.0 mmmt -116.39 132.81 56.57 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.775 2.03 . . . . 0.0 109.7 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -117.35 109.92 17.42 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.912 1.285 . . . . 0.0 108.169 170.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -82.62 100.27 10.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.598 -176.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.0 m -66.56 -16.24 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 120.771 -1.206 . . . . 0.0 112.753 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -70.69 -21.85 62.53 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.689 1.196 . . . . 0.0 113.268 171.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.0 p -118.79 -30.98 4.94 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -140.48 79.53 20.29 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 124.416 1.086 . . . . 0.0 111.279 175.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -70.76 -7.63 21.79 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.072 2.515 . . . . 0.0 113.249 174.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -56.82 -43.49 81.09 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.304 1.441 . . . . 0.0 112.816 -175.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.5 m -64.35 -44.53 91.17 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.54 0.736 . . . . 0.0 111.808 176.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.1 -35.89 82.58 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.537 -0.727 . . . . 0.0 112.358 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.5 ttp-105 -75.85 -34.23 60.05 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.554 0.742 . . . . 0.0 112.889 175.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -58.44 -37.47 75.49 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.38 1.072 . . . . 0.0 112.631 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -96.72 6.24 49.08 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.578 1.151 . . . . 0.0 113.376 174.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 59.94 -13.78 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 129.184 2.994 . . . . 0.0 116.814 -177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.4 m -78.77 55.59 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 126.979 2.111 . . . . 0.0 113.599 -177.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 m -72.94 -9.76 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.762 1.625 . . . . 0.0 114.677 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.6 m -78.29 65.4 3.63 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.974 1.709 . . . . 0.0 112.776 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.4 pt -57.35 153.37 27.54 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 125.616 1.566 . . . . 0.0 114.831 -171.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.98 140.46 64.4 Favored 'Cis proline' 0 C--N 1.354 0.85 0 CA-C-N 119.495 0.855 . . . . 0.0 112.132 -3.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 33.6 m -128.97 121.04 27.16 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.677 0.791 . . . . 0.0 109.468 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.1 mp -107.8 125.75 51.8 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.982 1.313 . . . . 0.0 108.318 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.6 tt -128.21 130.1 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.201 1.0 . . . . 0.0 110.309 176.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.0 tp -108.16 128.22 54.51 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.823 1.249 . . . . 0.0 109.737 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -108.53 152.87 24.16 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.43 1.492 . . . . 0.0 110.205 170.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -135.26 122.31 21.37 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.261 1.824 . . . . 0.0 108.792 173.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.3 t70 50.9 35.64 12.92 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.172 0.989 . . . . 0.0 113.097 -168.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.2 7.75 68.21 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 125.604 1.573 . . . . 0.0 116.396 -176.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -106.42 137.67 19.5 Favored Pre-proline 0 N--CA 1.474 0.758 0 CA-C-N 119.541 1.671 . . . . 0.0 110.356 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.35 139.48 45.66 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.194 1.929 . . . . 0.0 112.0 -176.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.1 m -132.63 -18.41 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 125.163 1.385 . . . . 0.0 114.608 -176.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.9 tppm? -154.48 145.73 22.9 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.739 1.154 . . . . 0.0 111.006 171.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -138.33 134.94 34.88 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.142 0.977 . . . . 0.0 111.736 167.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.8 mp -130.44 144.27 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.34 2.256 . . . . 0.0 109.0 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.4 p -133.25 141.15 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.603 1.161 . . . . 0.0 110.336 170.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.26 156.14 27.59 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.506 1.05 . . . . 0.0 112.898 -167.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.31 141.59 41.56 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.744 0.817 . . . . 0.0 112.961 -175.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -132.85 148.94 52.3 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.97 1.708 . . . . 0.0 110.802 174.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.93 168.66 54.26 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 123.911 0.767 . . . . 0.0 111.318 173.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -56.35 -33.36 65.59 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -173.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.36 -53.75 47.7 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.924 0.392 . . . . 0.0 110.558 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.12 -34.91 66.41 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.515 -0.741 . . . . 0.0 112.776 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.3 tp -67.05 -38.48 85.92 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 120.136 1.335 . . . . 0.0 111.177 173.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . 0.254 0.1 OUTLIER -75.96 -11.1 59.9 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 116.863 -1.541 . . . . 0.0 113.99 169.182 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.79 -56.6 11.09 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 124.045 3.111 . . . . 0.0 110.607 158.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.19 -36.33 70.69 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.825 1.25 . . . . 0.0 111.997 -176.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 70.7 mt -91.47 -28.16 17.8 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 117.185 -1.388 . . . . 0.0 113.425 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 84.4 p -66.52 -18.69 65.51 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 121.793 2.088 . . . . 0.0 112.416 175.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -50.16 -22.34 1.66 Allowed 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 162.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.9 t -115.75 -34.08 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 127.876 2.47 . . . . 0.0 112.988 171.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.32 98.44 6.72 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 127.16 2.184 . . . . 0.0 110.997 -172.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -66.83 -16.1 49.08 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.138 1.892 . . . . 0.0 112.468 173.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -76.99 60.69 1.85 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.731 2.012 . . . . 0.0 111.463 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.3 tp -57.57 153.2 13.51 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.526 1.53 . . . . 0.0 112.706 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.232 0 C-N-CA 125.404 1.481 . . . . 0.0 110.878 171.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 tpt . . . . . 0 N--CA 1.486 1.366 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.1 t -147.19 159.81 43.2 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.647 1.179 . . . . 0.0 112.142 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -76.26 -24.47 54.51 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.926 1.291 . . . . 0.0 112.72 173.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.4 m -70.95 126.96 31.01 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.255 1.022 . . . . 0.0 111.937 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 52.37 34.2 14.52 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.062 1.345 . . . . 0.0 113.862 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -66.4 166.17 12.86 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.323 1.449 . . . . 0.0 114.375 -176.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.7 m 54.89 50.38 15.72 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.277 1.831 . . . . 0.0 113.152 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.42 37.91 0.53 Allowed 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -168.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.7 p -83.35 151.96 25.3 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.27 1.028 . . . . 0.0 111.67 172.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.1 pt -115.25 152.77 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.272 1.029 . . . . 0.0 111.864 172.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -92.26 138.17 31.75 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.907 0.883 . . . . 0.0 110.286 169.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.4 m -123.87 151.02 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.849 1.26 . . . . 0.0 110.746 171.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 81.4 p -135.96 158.52 44.21 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.299 1.44 . . . . 0.0 111.128 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.67 -27.53 62.95 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.907 1.076 . . . . 0.0 113.907 -172.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.33 -16.82 58.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.842 1.257 . . . . 0.0 114.348 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -131.45 -6.06 3.74 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.162 1.385 . . . . 0.0 113.844 -173.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -52.85 -40.7 63.6 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.715 1.606 . . . . 0.0 113.011 -175.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.11 -32.79 74.18 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.6 m -79.53 -32.89 42.32 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.824 0.849 . . . . 0.0 112.266 174.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -85.79 -41.28 15.19 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -174.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -105.83 -51.12 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.141 1.377 . . . . 0.0 111.211 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.3 mt -82.92 -13.2 56.51 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -170.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.9 m -95.88 5.9 50.17 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.583 1.153 . . . . 0.0 113.532 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.9 p -70.2 150.7 46.18 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.012 1.725 . . . . 0.0 114.94 -172.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.42 19.33 13.41 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 126.007 1.723 . . . . 0.0 111.854 172.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -143.99 146.18 33.15 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 128.927 2.891 . . . . 0.0 107.124 173.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -59.27 144.06 99.53 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 121.934 1.756 . . . . 0.0 113.255 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.9 t -128.21 125.09 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.339 1.456 . . . . 0.0 110.07 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 48.7 mt -87.92 135.0 33.59 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.388 0.675 . . . . 0.0 109.772 165.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.4 t -119.82 118.15 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 123.966 0.906 . . . . 0.0 109.366 168.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -89.89 109.27 20.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.625 1.57 . . . . 0.0 110.455 172.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -89.34 109.49 20.38 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.909 1.684 . . . . 0.0 108.64 171.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.9 p-90 -142.58 174.3 10.76 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.025 1.33 . . . . 0.0 111.757 -164.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.47 145.51 35.32 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.857 -0.527 . . . . 0.0 112.406 159.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.4 t -64.33 -22.6 67.01 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 -78.18 -4.64 48.63 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 174.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.8 t -107.17 129.36 54.86 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.242 1.017 . . . . 0.0 112.95 -173.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.62 -60.15 9.45 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.156 1.36 . . . . 0.0 114.499 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -61.84 -28.72 81.76 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 CA-C-N 120.386 2.093 . . . . 0.0 113.351 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 89.5 m -62.08 -48.55 79.71 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.511 1.051 . . . . 0.0 111.558 169.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -60.58 -34.37 74.1 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.116 0.966 . . . . 0.0 112.19 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 26.2 mmt -75.47 -36.01 60.74 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 p -87.28 -21.8 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 119.627 1.103 . . . . 0.0 113.52 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.55 -50.16 60.45 Favored Pre-proline 0 CA--C 1.551 1.007 0 CA-C-O 117.288 -1.339 . . . . 0.0 114.32 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -65.71 -30.19 50.67 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 CA-C-N 122.338 1.871 . . . . 0.0 113.666 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.1 t -68.21 -51.32 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 119.031 0.832 . . . . 0.0 110.771 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.9 pp -72.01 -22.74 61.37 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -69.99 -35.29 74.3 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.107 -0.996 . . . . 0.0 112.512 168.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -64.89 -42.87 94.42 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.868 -1.145 . . . . 0.0 111.508 166.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.4 mm -55.41 -45.95 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-N 119.969 1.259 . . . . 0.0 110.821 170.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.66 -42.85 93.74 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.052 0.941 . . . . 0.0 112.823 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.7 m -74.55 -40.73 61.52 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.66 0.784 . . . . 0.0 111.61 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -86.79 -23.56 25.36 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -173.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.3 mmt-85 -123.04 20.76 9.89 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 114.59 1.329 . . . . 0.0 114.59 -173.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.11 -27.74 15.22 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.311 1.444 . . . . 0.0 114.5 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.3 p -74.56 -23.07 58.72 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.072 1.349 . . . . 0.0 114.142 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -117.74 -25.85 6.72 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.614 1.166 . . . . 0.0 113.952 -176.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 82.6 mt -125.78 153.02 44.62 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.51 1.924 . . . . 0.0 110.248 172.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 38.3 m -101.16 138.48 38.14 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 151.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.4 t -118.68 117.76 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 118.59 0.632 . . . . 0.0 109.475 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -119.52 159.33 24.52 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.121 1.768 . . . . 0.0 112.246 -174.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -127.71 136.23 51.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.635 1.574 . . . . 0.0 111.664 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -125.93 113.46 17.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.831 2.052 . . . . 0.0 107.926 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -81.36 120.15 24.58 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.452 -0.78 . . . . 0.0 110.311 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.9 m -67.35 -17.38 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.13 -30.18 43.56 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.29 1.036 . . . . 0.0 112.711 173.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.2 p -97.21 -30.83 12.77 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.191 0.996 . . . . 0.0 112.608 -176.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -130.39 63.09 68.11 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 125.775 1.63 . . . . 0.0 111.442 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -61.66 -21.66 72.61 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.93 2.42 . . . . 0.0 113.307 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -61.9 -45.47 93.59 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.466 1.106 . . . . 0.0 111.443 174.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 m -71.77 -32.3 67.52 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.553 0.741 . . . . 0.0 111.442 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.09 -44.74 91.42 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.927 0.891 . . . . 0.0 112.607 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -77.88 -28.38 49.91 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -57.01 -42.8 81.01 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.924 0.89 . . . . 0.0 113.282 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -99.69 7.86 44.79 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.599 1.16 . . . . 0.0 113.404 176.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.321 15.5 pt20 42.07 47.08 3.82 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.072 1.749 . . . . 0.0 113.571 -166.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.0 m -98.97 36.76 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 127.604 2.362 . . . . 0.0 109.904 172.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.9 p -78.64 -25.17 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.08 1.752 . . . . 0.0 112.417 -173.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 51.0 m -74.35 144.37 44.48 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.443 1.097 . . . . 0.0 110.318 163.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.73 149.3 56.18 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 124.163 0.985 . . . . 0.0 113.332 -168.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.13 142.01 71.44 Favored 'Cis proline' 0 C--N 1.352 0.755 0 CA-C-N 119.021 0.686 . . . . 0.0 111.336 -8.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 51.7 m -132.28 121.64 23.9 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.201 1.0 . . . . 0.0 109.947 172.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.9 mp -96.52 135.99 37.65 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.38 1.072 . . . . 0.0 109.251 171.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 26.5 mm -115.62 135.56 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.626 1.171 . . . . 0.0 109.212 167.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.7 tp -92.67 117.32 29.86 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 123.223 0.327 . . . . 0.0 110.423 162.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -96.41 115.26 27.14 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.625 1.17 . . . . 0.0 108.343 165.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.7 tttm -100.31 108.6 20.69 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 50.03 43.55 25.58 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.688 1.195 . . . . 0.0 113.094 -167.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.16 15.19 80.79 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 117.059 1.584 . . . . 0.0 117.059 173.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -126.43 140.11 36.41 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-N 119.373 1.587 . . . . 0.0 111.41 168.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -69.29 138.93 40.54 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.778 2.318 . . . . 0.0 112.249 -174.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.4 t -130.5 -33.94 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 125.267 1.427 . . . . 0.0 113.072 -176.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -141.3 145.15 35.13 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.272 1.029 . . . . 0.0 111.753 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -123.05 136.15 54.71 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.927 2.091 . . . . 0.0 110.595 171.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.1 mt -129.75 130.78 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.91 1.684 . . . . 0.0 107.457 171.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.3 143.83 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 119.507 1.048 . . . . 0.0 111.845 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.17 157.66 28.36 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.188 1.375 . . . . 0.0 112.72 -169.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.6 138.1 48.48 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.839 -0.801 . . . . 0.0 112.033 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -131.98 153.99 49.77 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.875 1.67 . . . . 0.0 111.113 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.63 164.15 51.86 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 174.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -55.08 -34.12 63.35 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.823 1.249 . . . . 0.0 113.197 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.02 -37.63 66.85 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.17 -46.25 43.4 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.259 1.024 . . . . 0.0 111.36 177.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 40.4 tp -64.6 -46.56 82.15 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.706 175.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 32.3 tp -69.78 -26.51 64.32 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-O 115.121 -2.371 . . . . 0.0 113.389 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -69.72 -44.04 71.13 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 125.005 3.548 . . . . 0.0 112.26 169.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -64.61 -23.43 67.26 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.4 mt -93.85 -26.64 16.83 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.061 1.344 . . . . 0.0 113.772 168.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.4 m -61.29 -25.8 67.36 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 120.269 1.395 . . . . 0.0 110.413 173.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -53.25 -23.14 8.08 Favored 'General case' 0 CA--C 1.558 1.265 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 166.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 68.8 t -114.51 -50.26 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 127.522 2.329 . . . . 0.0 111.344 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.2 t -79.79 115.87 56.94 Favored Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 128.146 2.578 . . . . 0.0 108.699 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -66.82 -6.03 14.72 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 121.523 1.482 . . . . 0.0 112.993 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 62.1 t30 68.2 151.76 0.08 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 128.483 2.713 . . . . 0.0 116.185 168.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.8 mt -120.04 -33.05 4.04 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -172.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 C--O 1.252 1.221 0 C-N-CA 126.265 1.826 . . . . 0.0 112.605 -179.132 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.8 ptm . . . . . 0 N--CA 1.485 1.301 0 N-CA-C 110.924 -0.028 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.9 m 55.5 38.28 30.02 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.811 1.244 . . . . 0.0 112.596 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -80.23 156.07 27.06 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.274 1.429 . . . . 0.0 112.922 -174.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 65.2 p -148.11 144.57 27.92 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.393 1.477 . . . . 0.0 111.248 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -77.14 -31.92 55.98 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.212 0.605 . . . . 0.0 112.258 178.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.0 pttm 38.96 45.24 0.95 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 127.799 2.44 . . . . 0.0 115.717 171.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.7 m -61.07 146.24 48.01 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.49 1.116 . . . . 0.0 113.464 -175.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -138.83 179.91 6.21 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.419 1.487 . . . . 0.0 112.729 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.264 19.4 p 74.33 149.91 0.11 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 129.686 3.195 . . . . 0.0 114.976 -171.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.0 pt -134.49 157.37 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.486 1.914 . . . . 0.0 110.631 172.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -105.44 139.08 40.6 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.62 0.768 . . . . 0.0 110.678 169.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.9 m -124.89 153.21 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.574 1.55 . . . . 0.0 111.058 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.6 p -132.48 170.59 14.93 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.474 1.51 . . . . 0.0 111.601 -174.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -56.5 -25.26 50.92 Favored 'General case' 0 CA--C 1.55 0.952 0 O-C-N 121.151 -0.968 . . . . 0.0 113.106 171.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.85 -13.52 50.75 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 115.043 1.498 . . . . 0.0 115.043 175.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.9 p -134.22 -12.49 2.46 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 -169.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -54.46 -42.77 71.04 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.898 1.279 . . . . 0.0 112.208 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.29 -36.34 82.7 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.298 -0.877 . . . . 0.0 112.95 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.0 m -79.2 -24.44 43.16 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.432 1.093 . . . . 0.0 113.139 -177.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -97.09 -46.97 5.96 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.351 -0.843 . . . . 0.0 113.084 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.07 -51.95 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.311 1.044 . . . . 0.0 112.046 -172.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.4 mt -84.19 -26.48 28.74 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -172.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.9 m -80.59 -11.08 59.7 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.569 1.148 . . . . 0.0 113.637 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.5 m -74.93 127.6 33.59 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.704 1.202 . . . . 0.0 112.32 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -71.62 -28.39 63.75 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.323 1.049 . . . . 0.0 112.113 172.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -84.64 164.31 43.08 Favored Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 125.384 1.473 . . . . 0.0 111.977 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.78 141.41 94.79 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.658 2.239 . . . . 0.0 113.351 170.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.0 t -135.68 126.12 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.554 1.142 . . . . 0.0 110.041 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 tt -100.43 121.31 41.32 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.543 1.937 . . . . 0.0 108.427 177.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 t -111.28 126.74 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 118.999 0.818 . . . . 0.0 111.129 174.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -99.06 111.41 23.82 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.456 1.502 . . . . 0.0 110.881 172.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -83.85 112.44 20.12 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.493 1.517 . . . . 0.0 108.657 173.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.3 p-90 -144.76 169.48 17.95 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.393 1.077 . . . . 0.0 113.017 -166.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.63 154.66 35.8 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.67 1.188 . . . . 0.0 111.015 163.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 t -67.91 -12.99 61.79 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 13.2 p-90 -79.77 -3.68 48.69 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 50.5 t -111.06 117.52 33.52 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.429 1.091 . . . . 0.0 112.398 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.88 -48.34 86.57 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-O 118.72 -1.044 . . . . 0.0 113.097 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -56.78 -33.08 93.5 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.747 2.298 . . . . 0.0 114.765 170.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 89.7 m -64.12 -46.33 84.66 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.821 1.191 . . . . 0.0 111.384 170.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -58.46 -35.69 72.55 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.211 1.004 . . . . 0.0 111.865 173.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.8 mtt -73.3 -39.0 65.66 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.883 1.273 . . . . 0.0 113.954 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.8 p -83.08 -23.83 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 CA-C-N 119.661 1.118 . . . . 0.0 113.655 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.55 -49.04 80.47 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.17 -29.25 39.72 Favored 'Trans proline' 0 C--N 1.354 0.819 0 CA-C-N 122.387 1.888 . . . . 0.0 113.215 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.4 t -69.73 -45.43 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 121.51 -0.744 . . . . 0.0 110.22 175.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.3 mt -60.99 -36.14 78.68 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.415 1.086 . . . . 0.0 112.421 172.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -68.69 -39.05 80.72 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.089 0.859 . . . . 0.0 112.194 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -63.91 -46.12 86.22 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.189 -0.944 . . . . 0.0 111.62 170.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.2 mm -56.9 -42.97 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 121.674 -0.641 . . . . 0.0 110.941 173.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.56 -42.18 98.46 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.8 0.84 . . . . 0.0 112.261 177.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.2 m -69.52 -42.38 74.76 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.312 1.045 . . . . 0.0 111.299 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -95.01 -23.22 17.47 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -170.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -109.87 14.22 23.24 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.79 1.636 . . . . 0.0 113.403 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.99 -33.19 36.96 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.019 1.327 . . . . 0.0 114.268 -177.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.1 m -72.19 -26.05 61.91 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.054 1.342 . . . . 0.0 112.75 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -102.39 -34.15 9.29 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.479 1.512 . . . . 0.0 113.06 -175.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.0 pp -149.08 163.06 38.64 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.539 1.536 . . . . 0.0 112.185 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 58.5 m -108.31 138.51 44.46 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.194 0.998 . . . . 0.0 109.344 167.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.9 t -102.59 128.89 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.519 0.728 . . . . 0.0 110.398 175.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.45 158.77 36.47 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.553 1.941 . . . . 0.0 111.455 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -127.62 134.78 49.65 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.556 1.142 . . . . 0.0 111.697 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -113.64 117.25 31.06 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.742 1.617 . . . . 0.0 108.937 173.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.43 97.58 7.82 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.034 1.333 . . . . 0.0 108.757 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.5 m -65.01 -20.72 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -172.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -74.19 -22.49 59.37 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.135 0.974 . . . . 0.0 112.753 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.3 t -119.22 -13.6 9.32 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.931 1.292 . . . . 0.0 113.518 174.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -119.22 60.75 5.4 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 124.958 1.303 . . . . 0.0 112.076 171.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -65.46 -24.62 56.56 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.368 2.045 . . . . 0.0 112.29 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -66.91 -43.39 83.45 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.478 -0.764 . . . . 0.0 111.422 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 m -68.22 -38.36 81.8 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.163 0.985 . . . . 0.0 111.466 175.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.2 -38.52 91.48 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.419 0.688 . . . . 0.0 112.668 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 22.7 ttm105 -76.44 -35.75 58.33 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.361 0.664 . . . . 0.0 112.758 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -54.96 -39.02 68.49 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.866 1.267 . . . . 0.0 113.67 -175.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -99.93 1.79 43.05 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.088 0.955 . . . . 0.0 113.37 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 51.56 60.09 4.11 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.182 1.793 . . . . 0.0 112.322 -167.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.5 m -127.58 32.18 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 126.529 1.932 . . . . 0.0 111.491 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.6 m -70.88 -23.67 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.595 1.158 . . . . 0.0 113.726 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 54.0 m -79.51 139.49 37.56 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.479 1.112 . . . . 0.0 110.193 168.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 48.4 pt -136.9 152.64 74.5 Favored Pre-proline 0 N--CA 1.475 0.817 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -167.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.37 140.73 64.16 Favored 'Cis proline' 0 C--N 1.353 0.789 0 CA-C-N 119.322 0.794 . . . . 0.0 111.81 -4.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.4 m -127.55 121.31 30.28 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.815 0.846 . . . . 0.0 109.443 169.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.3 mp -102.42 130.3 49.16 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.494 1.518 . . . . 0.0 107.942 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.22 130.69 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.824 0.849 . . . . 0.0 108.931 175.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.5 tp -106.54 120.91 43.18 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.401 1.08 . . . . 0.0 109.901 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -96.51 147.34 23.95 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.297 1.439 . . . . 0.0 109.834 169.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -119.9 130.11 54.67 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.721 1.208 . . . . 0.0 108.951 161.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.4 t0 47.82 44.57 18.14 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.303 1.041 . . . . 0.0 113.067 -174.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.39 10.86 58.33 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.11 1.338 . . . . 0.0 116.14 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -117.74 136.48 23.69 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 125.434 1.493 . . . . 0.0 110.071 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -70.56 139.74 38.11 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.71 2.273 . . . . 0.0 112.325 -171.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.5 t -128.83 -38.76 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.564 1.146 . . . . 0.0 113.198 -175.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -142.19 144.38 33.38 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.289 1.036 . . . . 0.0 111.682 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -129.27 139.71 51.7 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.669 1.588 . . . . 0.0 111.457 170.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.8 mt -133.87 139.06 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 126.946 2.098 . . . . 0.0 108.403 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.1 p -131.79 142.15 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.288 0.949 . . . . 0.0 110.882 171.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.11 153.47 24.48 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.632 1.11 . . . . 0.0 112.563 -167.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.68 143.03 48.25 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.975 -0.721 . . . . 0.0 112.487 -176.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -130.46 143.78 50.98 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.694 1.598 . . . . 0.0 110.409 173.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -78.6 170.29 54.72 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.154 0.883 . . . . 0.0 111.299 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -53.13 -35.84 60.15 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -175.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.35 -53.01 59.2 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 122.834 0.453 . . . . 0.0 111.375 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.67 -37.4 59.63 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.489 1.115 . . . . 0.0 113.241 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.7 tp -67.82 -35.17 78.12 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.248 0.931 . . . . 0.0 110.97 173.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.6 tp -74.14 -24.95 59.49 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-O 116.138 -1.887 . . . . 0.0 112.867 169.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 46.6 mmt-85 -59.84 -51.29 70.37 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 124.203 3.183 . . . . 0.0 110.572 164.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -61.0 -32.21 71.8 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.7 mt -99.03 -23.4 15.3 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.4 t -68.91 -21.28 64.23 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.326 0.966 . . . . 0.0 111.025 168.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -53.7 -20.02 4.89 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.333 1.053 . . . . 0.0 113.088 162.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.8 t -112.85 -28.89 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 127.143 2.177 . . . . 0.0 112.3 171.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.0 t -115.88 72.98 4.48 Favored Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 127.139 2.176 . . . . 0.0 110.882 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.03 -4.57 12.76 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.528 2.819 . . . . 0.0 114.012 -175.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -69.16 -24.29 64.05 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 177.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 71.7 mt 59.29 -50.27 0.07 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 128.84 2.856 . . . . 0.0 115.772 -173.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.24 0 C-N-CA 124.969 1.308 . . . . 0.0 110.913 166.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.7 t -159.2 167.78 28.21 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.519 1.128 . . . . 0.0 112.134 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -78.89 157.98 28.17 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.843 1.657 . . . . 0.0 113.675 176.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.2 m -128.95 157.51 41.42 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.667 1.587 . . . . 0.0 112.579 176.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -112.43 -2.55 14.69 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.591 1.157 . . . . 0.0 113.6 176.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -91.87 -7.0 50.55 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.883 1.673 . . . . 0.0 113.439 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 91.8 p -71.15 167.16 19.93 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.064 1.746 . . . . 0.0 113.398 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.88 56.54 1.57 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.057 0.943 . . . . 0.0 112.169 173.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.4 p -116.63 158.99 22.84 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.794 1.638 . . . . 0.0 112.627 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.7 pt -118.77 152.5 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.078 1.351 . . . . 0.0 111.33 170.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -97.65 132.67 43.09 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.231 1.012 . . . . 0.0 109.928 172.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.9 m -137.01 150.06 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.337 1.055 . . . . 0.0 112.112 -176.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 73.2 p -141.23 164.92 28.95 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.654 1.581 . . . . 0.0 111.399 176.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -51.25 -28.35 11.5 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.658 1.983 . . . . 0.0 114.673 -176.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.31 -22.46 65.62 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.0 m -135.26 -0.66 2.69 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.318 1.447 . . . . 0.0 114.224 -175.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -53.16 -42.57 66.28 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.674 1.99 . . . . 0.0 112.921 -175.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.12 -32.23 72.38 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.321 -0.862 . . . . 0.0 113.109 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.8 m -79.49 -30.22 41.94 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.279 1.431 . . . . 0.0 112.849 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -97.03 -41.44 8.37 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -171.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.7 m -124.4 -29.89 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -169.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.4 mt -80.7 -13.21 59.21 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.518 1.054 . . . . 0.0 113.258 170.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.9 p -75.62 -21.04 58.1 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -169.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.2 t -100.76 141.47 33.59 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -168.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -82.93 -13.89 55.19 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.801 1.24 . . . . 0.0 113.174 170.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -68.64 151.78 97.05 Favored Pre-proline 0 N--CA 1.473 0.722 0 C-N-CA 125.263 1.425 . . . . 0.0 109.15 162.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -65.15 134.41 39.3 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 CA-C-N 120.795 1.319 . . . . 0.0 111.297 171.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.6 t -135.69 121.92 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 124.045 0.938 . . . . 0.0 109.311 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 tt -104.42 130.42 52.31 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.226 2.21 . . . . 0.0 109.378 -169.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.4 t -120.63 125.48 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.353 1.061 . . . . 0.0 111.009 177.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -103.94 120.13 40.39 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.472 1.509 . . . . 0.0 112.04 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -100.48 112.81 25.21 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.959 2.104 . . . . 0.0 108.964 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 11.4 p-90 -143.51 177.12 8.68 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.894 1.278 . . . . 0.0 111.934 -168.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.98 143.72 32.04 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.398 -0.814 . . . . 0.0 112.641 165.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.5 t -63.25 -21.73 66.42 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 172.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 -83.3 -3.65 57.68 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 174.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 46.2 t -106.55 120.1 41.03 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.233 1.013 . . . . 0.0 112.189 -174.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.79 -46.78 92.93 Favored Glycine 0 CA--C 1.54 1.615 0 CA-C-O 118.861 -0.966 . . . . 0.0 114.317 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -58.88 -31.78 96.03 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.788 2.325 . . . . 0.0 114.087 170.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 93.8 m -65.45 -47.13 77.19 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.961 0.801 . . . . 0.0 111.428 170.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -59.23 -31.93 69.5 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 118.712 0.687 . . . . 0.0 112.407 174.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -70.33 -48.45 56.41 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.9 1.28 . . . . 0.0 112.545 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.3 p -81.21 -23.21 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.91 -54.2 30.28 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-O 116.864 -1.541 . . . . 0.0 114.01 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.92 -26.71 66.79 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.367 2.045 . . . . 0.0 113.516 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.0 t -66.71 -51.74 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 119.04 0.836 . . . . 0.0 109.93 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . 0.25 4.2 pp -73.22 -19.09 61.16 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -65.67 -41.97 91.86 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.507 1.123 . . . . 0.0 111.577 166.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -64.92 -44.42 89.58 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.45 -0.781 . . . . 0.0 111.143 169.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.5 mm -54.1 -46.99 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 119.896 1.225 . . . . 0.0 110.88 172.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.58 -44.46 96.19 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.8 m -76.23 -37.45 57.68 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.643 0.777 . . . . 0.0 112.025 -175.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -86.72 -40.17 15.3 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -176.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -98.86 11.67 38.09 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.804 1.242 . . . . 0.0 113.316 -169.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.58 -32.15 39.68 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.48 1.512 . . . . 0.0 114.859 -173.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.8 p -82.99 -19.6 36.74 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.76 1.224 . . . . 0.0 113.619 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -94.12 -39.97 10.3 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.364 1.466 . . . . 0.0 112.217 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.9 pp -149.05 153.35 37.72 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.546 1.939 . . . . 0.0 111.893 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 31.8 m -99.47 138.94 35.86 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.15 -0.969 . . . . 0.0 109.502 175.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.7 t -113.3 131.11 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 119.348 0.976 . . . . 0.0 111.675 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.24 152.43 44.6 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.75 2.02 . . . . 0.0 111.503 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -130.67 140.25 50.37 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.7 1.2 . . . . 0.0 112.466 -175.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -134.6 116.31 14.86 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.946 2.098 . . . . 0.0 109.065 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -82.78 119.53 24.46 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 170.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.2 m -67.87 -16.94 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 121.386 -0.821 . . . . 0.0 112.976 -175.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -79.22 -28.07 42.51 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.261 1.024 . . . . 0.0 112.903 172.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.2 p -92.57 -29.04 16.38 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.73 0.812 . . . . 0.0 112.505 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -145.02 103.05 4.43 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 123.942 0.897 . . . . 0.0 111.191 161.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.68 -21.95 12.38 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.848 2.366 . . . . 0.0 113.805 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -72.78 -28.08 62.38 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.809 -1.182 . . . . 0.0 112.16 -175.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 m -64.2 -42.14 96.76 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.715 0.806 . . . . 0.0 110.886 171.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.19 -37.11 80.57 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.079 0.952 . . . . 0.0 112.909 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -68.06 -43.89 77.6 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.178 0.991 . . . . 0.0 112.499 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -59.56 -37.84 79.52 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.155 0.982 . . . . 0.0 113.583 -172.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -99.5 5.66 46.08 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.45 1.1 . . . . 0.0 113.692 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 49.56 60.63 3.64 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.209 1.804 . . . . 0.0 112.645 -172.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.6 m -129.18 30.25 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.256 1.823 . . . . 0.0 111.398 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.5 m -71.88 -14.56 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.011 1.324 . . . . 0.0 114.395 -173.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.5 m -68.69 -40.45 80.07 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -165.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . 0.294 14.2 pt 56.07 147.34 0.05 OUTLIER Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 130.552 3.541 . . . . 0.0 119.051 177.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.9 136.78 24.94 Favored 'Cis proline' 0 C--N 1.354 0.818 0 N-CA-C 110.218 -0.724 . . . . 0.0 110.218 -16.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 25.7 m -135.7 121.19 19.33 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.597 0.759 . . . . 0.0 109.477 -177.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.0 mp -109.88 138.99 45.47 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.7 1.2 . . . . 0.0 108.797 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.1 tt -129.19 145.06 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.69 0.796 . . . . 0.0 110.715 169.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 32.5 tp -116.65 132.65 56.63 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.625 1.17 . . . . 0.0 109.854 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -112.08 148.02 34.81 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.714 1.606 . . . . 0.0 111.787 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -132.87 126.12 31.49 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.589 1.556 . . . . 0.0 109.007 159.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.0 t70 51.32 37.68 19.47 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.747 1.219 . . . . 0.0 113.358 -177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.23 -0.19 49.04 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.204 1.383 . . . . 0.0 115.735 -176.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -95.13 143.89 26.87 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 124.92 1.288 . . . . 0.0 110.153 178.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.51 140.81 40.7 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.716 2.277 . . . . 0.0 112.092 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 52.0 t -121.09 -45.61 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.925 1.69 . . . . 0.0 111.276 -174.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -143.9 150.75 38.87 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.09 1.756 . . . . 0.0 110.634 173.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -133.77 134.22 42.65 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.435 1.894 . . . . 0.0 109.77 167.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.9 mt -131.0 138.97 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.918 1.687 . . . . 0.0 108.625 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.3 p -133.68 141.51 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.037 0.935 . . . . 0.0 110.788 167.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.7 155.87 27.91 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.403 1.002 . . . . 0.0 112.746 -168.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.51 139.67 45.85 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.573 0.749 . . . . 0.0 112.577 -175.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -130.67 145.05 51.83 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.012 1.725 . . . . 0.0 110.56 173.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.72 166.5 53.24 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 123.83 0.729 . . . . 0.0 111.687 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.3 tmtp? -51.98 -34.43 42.38 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.056 1.342 . . . . 0.0 113.861 -174.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.04 -53.28 26.9 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 122.267 0.227 . . . . 0.0 110.97 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.1 -40.59 78.27 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.717 0.807 . . . . 0.0 112.757 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.98 -41.04 91.67 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.725 0.693 . . . . 0.0 110.523 176.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 20.1 tp -72.78 -24.88 60.99 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-O 115.69 -2.1 . . . . 0.0 113.399 172.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -63.64 -49.08 74.66 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 124.651 3.387 . . . . 0.0 111.002 166.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -54.56 -37.87 65.97 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.603 1.161 . . . . 0.0 112.735 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.4 mt -92.3 -25.99 18.32 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.0 t -66.74 -22.85 66.04 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.537 1.135 . . . . 0.0 110.99 175.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -51.1 -28.65 11.12 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 163.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 77.0 t -105.01 -24.64 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 127.278 2.231 . . . . 0.0 112.522 172.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.28 77.55 2.99 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 127.428 2.291 . . . . 0.0 110.168 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -73.32 20.42 0.36 Allowed 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 124.469 3.446 . . . . 0.0 113.77 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -61.54 -31.86 71.9 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.197 0.999 . . . . 0.0 111.772 172.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.8 mp -91.12 154.1 19.6 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.801 1.24 . . . . 0.0 111.629 167.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.036 0 C-N-CA 125.361 1.464 . . . . 0.0 110.986 170.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.487 1.41 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.2 p -66.97 -27.1 67.18 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.107 0.963 . . . . 0.0 113.309 176.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -85.21 -0.53 54.93 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.784 1.634 . . . . 0.0 113.358 173.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.8 t 62.99 143.57 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 128.301 2.64 . . . . 0.0 114.85 -166.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -68.42 -26.88 65.75 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.942 0.897 . . . . 0.0 111.315 167.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.276 16.8 pttm 42.63 30.83 0.25 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 128.08 2.552 . . . . 0.0 117.204 171.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.6 t -86.14 124.69 32.84 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.295 1.038 . . . . 0.0 110.866 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.23 66.54 9.6 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.409 0.55 . . . . 0.0 111.79 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.9 p -111.95 144.84 40.62 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.359 1.463 . . . . 0.0 113.351 -178.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.9 pt -141.43 157.5 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 126.342 1.857 . . . . 0.0 111.667 173.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -99.89 145.59 27.61 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.388 1.075 . . . . 0.0 111.186 162.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.3 m -131.11 151.55 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.459 1.503 . . . . 0.0 111.426 174.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.9 p -123.82 167.81 13.58 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.202 1.801 . . . . 0.0 110.592 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -59.91 -23.64 63.67 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 120.846 -1.159 . . . . 0.0 112.904 174.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.77 -13.72 50.35 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.45 1.5 . . . . 0.0 114.962 175.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.9 p -128.12 -12.16 5.21 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -173.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -52.83 -41.37 64.15 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.24 1.416 . . . . 0.0 112.459 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.12 -36.57 82.19 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.251 -0.906 . . . . 0.0 113.148 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.0 m -79.47 -26.02 41.77 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.25 1.02 . . . . 0.0 113.261 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -100.17 -37.47 8.92 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.5 t -99.34 -58.6 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.516 1.127 . . . . 0.0 111.308 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.8 mt -76.08 -22.14 55.94 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -171.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.0 m -81.55 -11.05 59.3 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.358 1.063 . . . . 0.0 113.392 175.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.5 t -84.28 132.9 34.58 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -174.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -90.49 -4.89 56.63 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.001 1.32 . . . . 0.0 113.027 171.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -90.02 144.12 30.9 Favored Pre-proline 0 N--CA 1.472 0.651 0 C-N-CA 125.152 1.381 . . . . 0.0 109.396 169.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -54.17 131.06 42.85 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.214 1.943 . . . . 0.0 111.872 168.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.0 p -139.37 130.16 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.853 1.261 . . . . 0.0 110.096 -172.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.2 tt -120.23 111.95 18.45 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.295 1.038 . . . . 0.0 109.622 -165.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.0 t -103.13 124.62 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.019 0.928 . . . . 0.0 111.223 -173.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -97.09 113.22 24.76 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.748 1.619 . . . . 0.0 110.787 172.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -87.32 109.39 19.49 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.265 1.826 . . . . 0.0 108.569 173.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -149.63 172.69 14.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.153 0.981 . . . . 0.0 113.333 -163.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -145.4 153.73 41.51 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.374 0.67 . . . . 0.0 112.611 159.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.6 p -58.19 -29.41 65.62 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.593 1.557 . . . . 0.0 113.263 174.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 15.4 p-90 -80.66 -6.4 58.31 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.3 t -102.12 116.25 32.27 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.044 0.938 . . . . 0.0 111.227 -176.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.24 -46.53 94.08 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-O 118.484 -1.176 . . . . 0.0 114.028 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -60.37 -32.49 94.07 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 CA-C-N 120.813 2.306 . . . . 0.0 114.305 172.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 97.3 m -65.31 -47.74 75.52 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.244 -0.91 . . . . 0.0 110.954 171.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.8 tptt -57.21 -32.55 66.62 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.947 1.699 . . . . 0.0 112.669 172.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 57.1 mtt -72.97 -42.2 63.59 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.45 1.1 . . . . 0.0 113.107 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -84.09 -23.15 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -47.24 -50.74 46.22 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 177.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.51 -30.01 52.59 Favored 'Trans proline' 0 C--N 1.352 0.713 0 CA-C-N 122.036 1.763 . . . . 0.0 113.105 176.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.9 t -73.53 -44.92 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.289 -0.882 . . . . 0.0 110.849 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.2 pp -72.67 -24.24 61.0 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.481 -0.762 . . . . 0.0 113.019 174.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -71.74 -36.11 70.33 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.162 0.892 . . . . 0.0 112.42 168.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -61.75 -42.53 99.09 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.553 -1.342 . . . . 0.0 111.256 167.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.33 -42.11 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 119.52 1.055 . . . . 0.0 111.559 170.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.78 -37.78 80.04 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.344 0.974 . . . . 0.0 112.937 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.1 m -82.23 -47.1 12.85 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.997 0.919 . . . . 0.0 112.095 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -85.97 -25.46 26.01 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -171.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -104.69 16.96 25.01 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.202 1.401 . . . . 0.0 112.455 176.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.02 -27.87 21.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.857 1.663 . . . . 0.0 114.549 -177.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.2 p -72.35 -20.11 61.53 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.375 1.47 . . . . 0.0 114.115 176.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -115.66 -39.33 3.54 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.094 1.358 . . . . 0.0 112.833 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.6 mt -113.73 148.02 37.19 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.453 1.901 . . . . 0.0 111.278 -175.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.8 m -112.59 134.41 54.14 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 152.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.1 t -99.56 138.3 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 123.734 0.814 . . . . 0.0 110.081 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.6 156.06 42.87 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.32 1.448 . . . . 0.0 111.991 -177.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -120.09 124.25 45.37 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.056 1.743 . . . . 0.0 110.743 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -109.47 114.51 28.22 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.279 1.031 . . . . 0.0 108.385 165.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -82.36 103.51 11.99 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.446 1.099 . . . . 0.0 109.615 -176.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 m -66.85 -17.5 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 O-C-N 120.703 -1.248 . . . . 0.0 113.024 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -71.74 -23.54 61.63 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.84 1.256 . . . . 0.0 113.107 175.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.3 p -118.61 -24.78 6.62 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -130.27 79.6 72.29 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 119.504 1.047 . . . . 0.0 113.521 168.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -66.93 -16.29 49.33 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.191 1.927 . . . . 0.0 112.927 166.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.1 mp0 -64.84 -42.3 95.03 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.901 -1.124 . . . . 0.0 111.439 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.5 m -70.92 -36.15 72.54 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.989 0.915 . . . . 0.0 111.436 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.3 -39.32 90.03 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.546 0.739 . . . . 0.0 112.196 171.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -72.85 -40.34 65.79 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 175.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -61.93 -34.71 76.59 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.307 1.043 . . . . 0.0 113.81 -174.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -96.76 1.4 50.8 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 175.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 52.22 56.4 7.79 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.908 1.683 . . . . 0.0 112.566 -170.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.47 36.81 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 127.082 2.153 . . . . 0.0 110.974 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.8 m -71.74 -22.29 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.654 1.182 . . . . 0.0 113.479 -176.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.2 m -70.78 145.56 50.32 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.363 1.065 . . . . 0.0 110.513 166.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 20.3 pt -137.26 145.48 50.04 Favored Pre-proline 0 N--CA 1.474 0.774 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -169.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.38 148.73 74.48 Favored 'Cis proline' 0 C--N 1.351 0.707 0 CA-C-N 118.678 0.564 . . . . 0.0 111.552 -12.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.1 m -131.86 124.04 28.74 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.413 0.685 . . . . 0.0 110.015 167.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.8 mp -99.39 132.49 44.68 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.512 1.525 . . . . 0.0 108.638 174.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.6 mm -115.67 132.42 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.873 1.269 . . . . 0.0 108.767 168.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.0 tp -96.26 125.32 40.7 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.276 0.23 . . . . 0.0 110.625 163.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -102.62 139.34 38.34 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.161 1.384 . . . . 0.0 108.966 163.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -99.75 -35.79 9.68 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -152.57 58.28 0.81 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.675 1.99 . . . . 0.0 109.393 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.69 16.41 58.93 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 124.93 1.252 . . . . 0.0 114.893 -172.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -134.7 133.71 21.5 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 126.522 1.929 . . . . 0.0 110.308 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.42 140.89 34.12 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.471 2.781 . . . . 0.0 112.02 -172.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.3 m -129.81 -23.67 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.079 1.352 . . . . 0.0 114.496 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -148.08 145.8 28.57 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.234 1.014 . . . . 0.0 111.789 175.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -123.72 135.1 53.66 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.388 1.875 . . . . 0.0 110.575 169.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.9 mt -131.68 129.51 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.621 1.569 . . . . 0.0 109.108 176.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.7 m -127.27 144.61 36.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 123.939 0.896 . . . . 0.0 112.3 -169.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.67 164.66 7.97 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.327 0.965 . . . . 0.0 112.951 -171.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.84 150.41 37.39 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.436 -1.037 . . . . 0.0 113.388 -175.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.6 mmtm -133.71 146.69 51.03 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.142 1.777 . . . . 0.0 110.838 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.62 164.16 34.28 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 162.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -51.27 -36.21 41.05 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.696 1.198 . . . . 0.0 113.894 -178.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.21 -36.58 71.94 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.64 -47.8 24.87 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.085 0.954 . . . . 0.0 111.489 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.6 tp -64.72 -44.04 91.48 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.908 -0.495 . . . . 0.0 110.835 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 23.0 tp -75.59 -25.57 57.13 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-O 115.207 -2.33 . . . . 0.0 113.392 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -65.85 -44.42 85.54 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 125.131 3.605 . . . . 0.0 111.185 166.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -66.11 -25.49 67.02 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.2 mt -103.18 -17.52 15.32 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 175.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.8 t -72.36 -22.2 61.19 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 120.962 -1.086 . . . . 0.0 110.633 166.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -52.56 -21.08 3.45 Favored 'General case' 0 CA--C 1.555 1.17 0 O-C-N 121.114 -0.991 . . . . 0.0 113.455 159.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 89.1 t -107.67 -34.15 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 126.999 2.12 . . . . 0.0 112.137 172.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.7 t -115.42 76.54 5.27 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 127.254 2.222 . . . . 0.0 110.594 177.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.16 -2.59 10.01 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.65 2.9 . . . . 0.0 113.857 -174.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -69.24 -23.78 63.91 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.4 mt 59.59 -50.8 0.07 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 128.817 2.847 . . . . 0.0 115.71 -173.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.175 0 C-N-CA 124.702 1.201 . . . . 0.0 110.653 164.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mmt . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 119.236 -0.412 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.9 p -69.46 -35.95 76.13 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.849 0.86 . . . . 0.0 112.121 174.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -101.3 151.44 21.88 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.025 1.73 . . . . 0.0 110.653 162.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.0 t -149.87 155.27 39.75 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.539 1.136 . . . . 0.0 112.04 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -91.7 10.69 27.25 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.28 1.432 . . . . 0.0 114.152 -171.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -63.52 140.75 58.9 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.82 1.248 . . . . 0.0 112.851 -175.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.5 p -89.72 161.97 15.8 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.859 1.663 . . . . 0.0 113.444 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -125.94 108.17 11.16 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.366 1.067 . . . . 0.0 113.012 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.9 p -143.73 162.29 36.37 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 126.262 1.825 . . . . 0.0 111.415 170.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.9 pt -129.19 155.12 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 125.827 1.651 . . . . 0.0 112.29 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -93.07 140.05 29.9 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.092 0.957 . . . . 0.0 111.497 173.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.4 150.34 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 125.08 1.352 . . . . 0.0 111.217 170.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 65.2 p -143.45 159.93 41.49 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.415 1.886 . . . . 0.0 110.338 178.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -51.45 -31.7 24.2 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.055 1.342 . . . . 0.0 114.55 -174.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.85 -21.44 66.8 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.9 m -131.69 -1.3 3.83 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.655 1.582 . . . . 0.0 113.711 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -59.51 -42.02 91.26 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.853 1.261 . . . . 0.0 112.514 -170.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.63 -32.4 72.23 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.8 m -79.18 -29.81 43.12 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.699 1.2 . . . . 0.0 112.578 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -94.71 -53.69 3.77 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.641 0.776 . . . . 0.0 112.803 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.3 -60.2 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.82 1.248 . . . . 0.0 110.732 -175.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.6 mt -75.43 -15.97 60.39 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -169.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.8 t -70.23 -22.91 62.86 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.566 1.146 . . . . 0.0 112.537 172.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.2 t -79.39 133.22 36.57 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -170.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -81.21 -23.84 37.84 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.584 1.154 . . . . 0.0 111.929 168.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -74.59 147.03 84.3 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 125.288 1.435 . . . . 0.0 110.044 176.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.88 132.43 51.63 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.196 1.931 . . . . 0.0 111.777 172.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.25 123.31 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.801 0.81 . . . . 0.0 110.798 -174.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 tt -101.93 132.07 47.95 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.581 1.952 . . . . 0.0 108.182 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 t -123.11 127.25 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.109 0.964 . . . . 0.0 110.6 174.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -100.24 118.84 37.37 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.487 1.515 . . . . 0.0 111.752 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -99.66 109.26 21.75 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.156 2.182 . . . . 0.0 108.286 176.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.2 p-90 -142.61 178.46 7.6 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.954 1.302 . . . . 0.0 111.96 -164.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.53 140.03 30.06 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 121.521 -0.737 . . . . 0.0 112.971 167.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.7 t -64.98 -18.58 65.39 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 173.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -88.89 0.13 56.86 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 174.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.1 t -111.5 123.23 49.79 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.41 1.084 . . . . 0.0 112.893 -173.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.55 -49.44 73.57 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-O 118.868 -0.962 . . . . 0.0 114.348 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -58.16 -32.02 94.71 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.911 2.407 . . . . 0.0 114.04 171.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.4 ' HG ' ' HB3' ' A' ' 81' ' ' PRO . 97.4 m -65.1 -46.46 80.99 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.066 -1.022 . . . . 0.0 111.558 170.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -60.47 -29.95 69.37 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.766 0.712 . . . . 0.0 112.72 173.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.5 ttt -72.49 -44.23 62.55 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.556 1.142 . . . . 0.0 112.853 177.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.9 p -88.62 -24.67 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -176.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.23 -48.57 73.63 Favored Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.18 -29.01 47.81 Favored 'Trans proline' 0 C--N 1.352 0.73 0 CA-C-N 122.14 1.8 . . . . 0.0 113.324 176.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.5 t -70.11 -49.42 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 119.375 0.989 . . . . 0.0 110.565 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.1 pp -72.07 -26.85 62.33 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -72.52 -35.14 68.01 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.203 0.911 . . . . 0.0 112.931 171.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -61.76 -46.91 87.55 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 120.771 -1.206 . . . . 0.0 111.075 165.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 70.0 mt -58.23 -41.45 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 119.139 0.881 . . . . 0.0 110.942 174.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.47 -44.62 92.97 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.116 0.966 . . . . 0.0 113.506 175.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.4 m -76.65 -41.15 46.77 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.81 0.844 . . . . 0.0 111.718 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -86.04 -21.75 27.58 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -174.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -114.75 27.61 9.31 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.021 1.728 . . . . 0.0 113.273 176.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.84 -27.52 30.22 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.4 m -73.28 -37.0 66.41 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.584 1.154 . . . . 0.0 112.75 174.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -94.19 -29.61 15.03 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.724 1.21 . . . . 0.0 113.339 -174.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.1 mt -129.56 149.34 51.36 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.953 2.101 . . . . 0.0 110.6 -177.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.2 m -103.24 138.14 40.44 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 150.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.8 t -127.89 126.95 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.808 0.731 . . . . 0.0 111.381 -173.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.71 165.75 18.67 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.853 1.661 . . . . 0.0 113.145 -172.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -129.73 141.27 50.91 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.617 1.967 . . . . 0.0 112.455 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -133.65 113.69 12.66 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.113 2.165 . . . . 0.0 108.595 169.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -81.51 120.61 25.25 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 169.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.7 m -65.85 -16.32 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -169.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -83.16 -20.16 35.24 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 119.294 0.952 . . . . 0.0 113.334 171.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 43.1 p -92.03 -28.82 16.94 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -169.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -148.76 76.21 9.83 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 123.579 0.752 . . . . 0.0 110.602 166.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.97 -27.38 78.92 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 124.027 3.151 . . . . 0.0 115.47 -169.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -62.36 -26.0 68.21 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.761 0.824 . . . . 0.0 112.924 176.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -64.23 -46.91 81.77 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.998 0.817 . . . . 0.0 110.653 175.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.53 -37.0 86.05 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.667 0.787 . . . . 0.0 112.19 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -70.78 -45.96 63.74 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.455 0.702 . . . . 0.0 112.603 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -69.82 -27.02 64.52 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -174.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -99.75 10.14 41.85 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.673 1.189 . . . . 0.0 113.563 172.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 62.68 -8.51 0.12 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 128.542 2.737 . . . . 0.0 116.225 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.9 m -79.61 56.52 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 126.536 1.934 . . . . 0.0 112.889 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.7 m -76.22 -21.46 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.925 1.29 . . . . 0.0 113.539 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 51.1 m -67.85 150.29 48.77 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.448 1.099 . . . . 0.0 111.26 170.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.3 pt -139.69 145.8 44.79 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -174.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.4 ' HB3' ' HG ' ' A' ' 40' ' ' CYS . 60.2 Cg_endo -64.58 146.11 64.81 Favored 'Cis proline' 0 CA--C 1.538 0.685 0 O-C-N 122.034 0.492 . . . . 0.0 111.44 -17.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 83.4 m -135.18 126.32 28.0 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.88 0.872 . . . . 0.0 110.872 171.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.8 134.2 39.03 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.535 1.134 . . . . 0.0 108.007 167.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.6 tt -117.36 143.97 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.485 1.114 . . . . 0.0 108.891 165.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.7 tt -123.71 134.66 53.66 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.663 0.785 . . . . 0.0 110.361 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -114.24 147.36 39.11 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.835 1.654 . . . . 0.0 111.344 173.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -126.49 135.09 50.9 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.6 1.16 . . . . 0.0 109.528 161.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.0 t0 47.0 41.8 11.55 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.639 1.176 . . . . 0.0 113.411 -174.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.38 14.06 63.72 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.138 1.352 . . . . 0.0 115.884 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -118.35 140.81 28.64 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 125.715 1.606 . . . . 0.0 109.88 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.81 140.36 42.31 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.798 2.332 . . . . 0.0 112.308 -174.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.2 t -125.94 -39.26 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.983 1.713 . . . . 0.0 112.185 -173.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -145.11 145.34 31.37 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.756 0.823 . . . . 0.0 111.89 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -129.26 132.31 47.17 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.072 1.749 . . . . 0.0 109.814 161.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.3 mt -135.55 129.53 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.618 1.567 . . . . 0.0 108.994 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.0 m -127.63 145.48 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 123.744 0.818 . . . . 0.0 112.568 -170.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.24 166.63 26.52 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.22 0.914 . . . . 0.0 113.506 -174.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.35 132.77 35.22 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.729 -0.865 . . . . 0.0 112.489 -176.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -133.83 156.53 47.87 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.912 1.685 . . . . 0.0 111.144 172.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -79.18 167.91 52.76 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 123.873 0.749 . . . . 0.0 112.169 173.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -47.91 -38.18 15.86 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.854 1.662 . . . . 0.0 114.673 -176.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.26 -49.57 54.93 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.78 0.324 . . . . 0.0 111.759 -177.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.42 -39.31 59.09 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.731 -0.606 . . . . 0.0 112.516 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.9 tp -68.07 -42.03 81.05 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.921 0.782 . . . . 0.0 111.052 176.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 23.6 tp -70.24 -24.68 63.12 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-O 115.513 -2.184 . . . . 0.0 112.315 171.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 44.6 mmt-85 -64.31 -49.51 71.49 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 124.51 3.323 . . . . 0.0 112.219 167.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.37 -31.22 65.56 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.464 0.706 . . . . 0.0 112.839 176.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 53.3 mt -97.26 -22.56 16.62 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 52.3 p -73.96 -20.2 60.43 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.893 1.277 . . . . 0.0 111.114 174.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -52.91 -27.83 20.52 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 160.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 93.3 t -100.86 -32.71 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 126.66 1.984 . . . . 0.0 112.008 171.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 28.5 t -110.1 79.77 1.65 Allowed Pre-proline 0 N--CA 1.477 0.903 0 C-N-CA 126.913 2.085 . . . . 0.0 110.942 -176.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.66 -16.7 54.59 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.784 2.323 . . . . 0.0 112.946 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -65.7 -18.3 65.23 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.821 1.648 . . . . 0.0 113.708 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.2 tp -137.54 42.15 2.35 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.61 1.164 . . . . 0.0 111.273 172.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.124 0 C-N-CA 124.73 1.212 . . . . 0.0 111.831 175.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.4 p -75.82 159.92 30.51 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.731 1.212 . . . . 0.0 112.618 175.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -143.7 150.86 39.29 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.279 1.432 . . . . 0.0 111.767 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.5 m -79.34 -1.36 36.56 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -176.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 58.56 32.21 21.89 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.22 1.808 . . . . 0.0 113.867 -177.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.5 163.06 28.64 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.079 1.352 . . . . 0.0 113.558 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.7 m -61.28 134.66 57.21 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.935 1.294 . . . . 0.0 112.139 176.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.49 57.85 3.45 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.665 -0.647 . . . . 0.0 112.053 176.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.3 p -102.65 138.36 39.65 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.371 1.468 . . . . 0.0 113.128 -174.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.2 pt -138.25 172.53 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 126.545 1.938 . . . . 0.0 111.381 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -125.48 142.91 51.25 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.106 0.962 . . . . 0.0 111.209 169.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -139.36 150.23 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.375 1.47 . . . . 0.0 111.0 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.7 p -139.51 161.48 37.38 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.15 1.38 . . . . 0.0 111.672 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -51.15 -30.38 16.41 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.936 2.095 . . . . 0.0 114.718 -176.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.0 -20.19 66.11 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 178.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.6 m -137.96 9.85 2.82 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.456 1.502 . . . . 0.0 113.411 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -63.13 -44.74 94.72 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.178 -0.951 . . . . 0.0 112.486 -168.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.26 -32.81 74.45 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.682 -0.636 . . . . 0.0 112.504 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.5 -9.46 59.62 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.84 1.656 . . . . 0.0 114.16 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -124.17 -50.86 1.78 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.18 0.992 . . . . 0.0 113.241 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.1 t -81.72 -52.97 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.356 1.062 . . . . 0.0 110.799 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 28.9 mt -81.33 -13.35 58.48 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -175.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.0 p -77.68 -21.61 51.79 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.805 1.242 . . . . 0.0 113.192 173.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.9 m -75.49 126.7 31.53 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.188 1.395 . . . . 0.0 112.544 -173.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -76.95 -25.14 52.5 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.319 0.647 . . . . 0.0 111.85 169.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -74.99 145.23 80.75 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 125.853 1.661 . . . . 0.0 110.255 173.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.33 137.28 77.56 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.156 1.904 . . . . 0.0 112.14 172.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.5 p -136.53 130.35 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.6 1.16 . . . . 0.0 110.526 -176.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 tt -112.47 116.84 30.91 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.021 1.728 . . . . 0.0 108.228 -174.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.65 124.94 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.445 0.698 . . . . 0.0 110.501 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -107.47 116.39 31.86 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.585 1.554 . . . . 0.0 111.481 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -93.4 108.85 20.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.466 1.906 . . . . 0.0 108.351 177.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -142.26 173.13 11.81 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.851 1.261 . . . . 0.0 112.347 -163.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.74 145.16 29.86 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.54 -0.725 . . . . 0.0 112.275 158.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -65.43 -19.53 65.98 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.8 p-90 -78.51 -13.62 59.75 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 175.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.8 t -98.16 129.84 44.93 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.143 0.977 . . . . 0.0 111.572 -174.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.13 -55.91 27.6 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.298 0.951 . . . . 0.0 113.721 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -57.65 -31.73 92.65 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.439 2.759 . . . . 0.0 114.531 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 96.3 m -67.64 -45.33 75.62 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.137 -0.977 . . . . 0.0 111.44 173.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.1 tppt? -61.37 -33.57 73.87 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.475 1.11 . . . . 0.0 111.819 172.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 50.8 ttm -70.01 -42.72 72.65 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.031 1.332 . . . . 0.0 112.942 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.2 p -81.34 -24.49 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.96 -49.97 77.5 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.9 -27.27 37.15 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.174 1.916 . . . . 0.0 113.125 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.9 t -72.47 -41.35 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.714 0.805 . . . . 0.0 110.525 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.3 mt -67.19 -35.9 80.63 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.111 0.964 . . . . 0.0 112.613 170.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -66.12 -40.58 90.81 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.223 0.92 . . . . 0.0 111.468 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -58.26 -49.54 76.75 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.743 168.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 tp -66.82 -33.28 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 120.34 1.427 . . . . 0.0 112.652 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.79 -40.0 93.66 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.212 -0.93 . . . . 0.0 111.954 172.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.3 m -76.07 -49.0 18.66 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.723 0.809 . . . . 0.0 112.092 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -85.57 -21.61 28.45 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -170.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -116.92 31.52 6.7 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.357 1.863 . . . . 0.0 112.657 173.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.75 -28.18 14.42 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 176.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.5 p -81.61 -29.44 33.27 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.68 1.592 . . . . 0.0 114.292 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -102.16 -27.06 13.11 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.734 1.214 . . . . 0.0 113.742 -175.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 81.5 mt -129.67 148.71 51.58 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.357 1.863 . . . . 0.0 110.196 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.5 m -109.02 131.61 54.91 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 153.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 83.1 t -106.35 130.19 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.494 0.718 . . . . 0.0 109.858 -175.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.35 146.86 50.31 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.897 1.279 . . . . 0.0 112.419 -171.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -120.16 136.39 54.64 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.333 1.453 . . . . 0.0 111.986 -176.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -130.65 116.81 18.59 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.598 1.559 . . . . 0.0 109.744 171.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.77 105.72 13.13 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.261 1.024 . . . . 0.0 110.594 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.5 m -65.14 -20.42 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -73.76 -27.83 61.37 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.322 1.449 . . . . 0.0 113.271 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.7 p -112.73 -22.02 10.92 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.38 1.072 . . . . 0.0 113.59 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -133.27 92.71 24.01 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.256 1.023 . . . . 0.0 111.577 168.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -71.26 -19.61 29.09 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.238 2.625 . . . . 0.0 113.844 172.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -67.61 -42.38 82.5 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.142 -0.973 . . . . 0.0 112.126 -171.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.6 m -67.15 -35.02 78.81 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.85 0.86 . . . . 0.0 111.248 176.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.26 -45.6 80.0 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.227 0.611 . . . . 0.0 111.955 174.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.0 ttm105 -72.57 -41.59 65.53 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -174.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -62.1 -38.33 88.45 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -96.89 7.53 46.41 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.364 1.066 . . . . 0.0 113.122 176.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.318 14.8 pt20 44.02 34.45 0.95 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.95 2.1 . . . . 0.0 114.415 -169.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.8 m -85.56 43.85 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 126.654 1.982 . . . . 0.0 110.406 175.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.4 m -85.23 -14.2 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.698 1.599 . . . . 0.0 113.993 -168.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.0 t -71.55 155.31 40.7 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.559 0.743 . . . . 0.0 111.038 170.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 14.4 pt -129.49 121.49 20.32 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -167.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -67.24 161.8 76.76 Favored 'Cis proline' 0 CA--C 1.54 0.8 0 CA-C-N 118.831 0.618 . . . . 0.0 111.709 -16.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.1 m -127.16 134.39 50.18 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.5 1.12 . . . . 0.0 108.713 161.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.4 mp -113.42 131.93 55.82 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.856 1.262 . . . . 0.0 108.709 174.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.5 tp -116.1 146.3 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.868 1.267 . . . . 0.0 109.307 167.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.4 tt -123.92 132.85 53.8 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.681 -0.637 . . . . 0.0 110.451 165.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -111.95 143.77 42.38 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.223 1.409 . . . . 0.0 110.368 170.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -126.94 125.48 41.62 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.391 1.476 . . . . 0.0 109.17 171.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.8 t70 50.41 34.34 9.04 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 124.41 1.084 . . . . 0.0 113.526 -168.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.12 8.48 61.76 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 125.781 1.658 . . . . 0.0 116.171 -175.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -102.34 141.3 22.25 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 119.364 1.582 . . . . 0.0 110.488 172.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -70.08 140.38 41.32 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.83 2.353 . . . . 0.0 112.592 -176.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 75.3 t -127.72 -36.49 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 125.854 1.662 . . . . 0.0 112.709 -175.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -142.14 139.14 32.04 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.687 1.195 . . . . 0.0 111.115 -177.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 24.5 ttt85 -141.4 115.83 9.51 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.62 1.968 . . . . 0.0 110.194 171.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.27 150.73 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.223 1.409 . . . . 0.0 112.8 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.8 m -124.08 155.65 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.474 1.51 . . . . 0.0 111.911 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.25 163.11 11.27 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.257 0.932 . . . . 0.0 112.983 -174.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.5 156.07 30.84 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.191 -1.182 . . . . 0.0 113.706 -176.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.81 147.58 52.49 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.587 1.555 . . . . 0.0 110.049 165.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.69 167.22 44.14 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 162.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.4 tmtp? -52.75 -34.29 52.26 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.769 1.228 . . . . 0.0 113.618 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.59 -53.97 34.31 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.91 0.484 . . . . 0.0 111.754 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.1 -36.27 66.76 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.465 -0.772 . . . . 0.0 112.601 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.1 tp -63.44 -40.23 96.61 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.644 -0.66 . . . . 0.0 110.179 172.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 26.5 tp -72.74 -23.76 60.88 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-O 117.041 -1.457 . . . . 0.0 113.298 173.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -58.52 -55.61 32.79 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 122.951 2.614 . . . . 0.0 109.988 164.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -69.56 -26.57 64.55 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -174.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 88.9 mt -97.06 -28.76 14.0 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 176.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.9 t -69.58 -24.37 63.68 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 120.584 1.538 . . . . 0.0 111.194 170.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.63 -22.7 47.02 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 164.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.5 t -100.53 -28.28 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 127.056 2.142 . . . . 0.0 111.805 171.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 32.9 t -126.62 84.77 61.88 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 127.389 2.276 . . . . 0.0 111.13 -170.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -63.08 -9.81 18.4 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.452 2.768 . . . . 0.0 114.868 176.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -64.94 -15.66 62.4 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -177.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 93.3 mt -114.79 14.4 17.41 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.176 1.391 . . . . 0.0 113.59 174.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.208 0 C-N-CA 125.108 1.363 . . . . 0.0 112.005 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.3 tpp . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 39.2 p -78.31 144.37 36.13 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.294 1.038 . . . . 0.0 112.558 179.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -79.89 86.04 5.46 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.593 1.157 . . . . 0.0 111.088 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.5 t -152.86 -179.2 7.43 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.686 1.594 . . . . 0.0 111.191 -177.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -74.14 102.72 4.34 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.511 1.524 . . . . 0.0 110.787 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.412 ' HA ' ' HE2' ' A' ' 6' ' ' LYS . 8.1 mmpt? -78.72 -11.79 59.99 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -172.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.7 t -127.36 155.73 43.13 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.379 1.472 . . . . 0.0 113.172 -174.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -105.8 14.4 28.24 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.724 1.61 . . . . 0.0 113.351 172.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.6 p -83.24 157.36 22.71 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 121.165 -0.959 . . . . 0.0 113.38 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.1 pt -115.85 155.11 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.642 1.577 . . . . 0.0 111.551 171.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -108.8 136.4 48.43 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.517 1.127 . . . . 0.0 110.479 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.9 m -132.14 154.25 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.664 1.186 . . . . 0.0 112.857 -172.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 66.5 p -142.22 161.3 38.36 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.289 1.835 . . . . 0.0 110.854 175.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -57.17 -28.57 62.9 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -172.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.33 -17.3 62.45 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.553 1.141 . . . . 0.0 114.074 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.1 m -136.06 3.2 2.89 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.302 1.441 . . . . 0.0 113.552 -175.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -56.09 -40.57 73.86 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.119 1.367 . . . . 0.0 112.533 -174.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.03 -34.6 78.46 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.317 -0.864 . . . . 0.0 113.044 177.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.8 m -79.51 -29.6 41.62 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.511 1.124 . . . . 0.0 112.846 177.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -94.63 -39.46 10.33 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.1 t -97.23 -64.85 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.186 1.394 . . . . 0.0 109.859 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.9 mt -73.82 -14.62 61.13 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -165.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.0 m -85.08 -3.67 58.88 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.659 1.184 . . . . 0.0 113.997 176.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.1 m -60.65 142.09 56.04 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.925 1.29 . . . . 0.0 113.565 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.8 p-10 -82.93 -3.99 57.68 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.797 1.239 . . . . 0.0 114.2 176.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -141.13 163.33 42.81 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 127.833 2.453 . . . . 0.0 110.558 176.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -53.45 147.08 39.12 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.231 2.621 . . . . 0.0 112.836 177.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.39 133.39 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.633 1.173 . . . . 0.0 111.711 -174.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.02 117.05 32.73 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.876 2.071 . . . . 0.0 108.422 -176.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.2 t -107.63 127.31 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.693 0.797 . . . . 0.0 110.396 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -104.53 117.08 33.26 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.0 1.32 . . . . 0.0 111.173 175.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -91.8 107.22 19.06 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.272 1.829 . . . . 0.0 107.964 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.467 ' CD1' ' HE3' ' A' ' 62' ' ' LYS . 2.1 p-90 -143.93 164.47 30.48 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -159.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.47 151.92 36.01 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.865 0.866 . . . . 0.0 111.359 162.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.3 t -66.19 -20.99 66.3 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 12.6 p-90 -75.39 -8.64 57.23 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 173.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 43.1 t -100.34 116.46 32.38 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.406 1.082 . . . . 0.0 110.914 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.62 -44.3 98.13 Favored Glycine 0 CA--C 1.54 1.642 0 CA-C-O 118.801 -1.0 . . . . 0.0 114.022 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -56.88 -39.51 90.89 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.863 2.376 . . . . 0.0 113.941 169.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 87.1 m -61.57 -43.34 99.03 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.989 -1.069 . . . . 0.0 111.503 171.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -62.97 -29.74 71.05 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.379 1.072 . . . . 0.0 112.512 176.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -74.96 -45.71 40.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.229 1.412 . . . . 0.0 112.681 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.1 p -81.37 -24.11 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.78 -50.06 79.82 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -65.91 -28.36 50.42 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 CA-C-N 122.353 1.876 . . . . 0.0 113.177 176.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.6 t -70.02 -45.98 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.479 -0.763 . . . . 0.0 110.154 175.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.8 mt -62.35 -34.26 76.33 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.258 1.023 . . . . 0.0 112.672 172.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -66.3 -41.33 89.89 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.987 0.915 . . . . 0.0 111.758 175.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -63.75 -44.86 92.23 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.382 -0.824 . . . . 0.0 111.648 170.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.3 mm -59.01 -43.37 88.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 119.248 0.931 . . . . 0.0 110.956 174.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.45 -42.66 92.45 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.836 0.854 . . . . 0.0 112.016 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.2 m -74.61 -42.61 58.31 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.979 0.912 . . . . 0.0 112.062 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -95.42 -22.07 17.94 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -169.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -112.26 17.97 19.0 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.654 1.581 . . . . 0.0 112.633 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.85 -28.46 50.01 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.981 1.313 . . . . 0.0 114.455 -176.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.9 p -69.21 -22.75 63.86 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.931 1.692 . . . . 0.0 114.1 174.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -117.83 -29.52 5.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.883 1.673 . . . . 0.0 112.98 -171.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.0 mt -130.16 149.34 51.91 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.69 1.996 . . . . 0.0 111.125 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.2 m -99.79 139.03 36.05 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 151.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 52.2 t -117.0 129.23 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 119.397 0.999 . . . . 0.0 110.3 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.32 157.73 41.74 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.698 1.599 . . . . 0.0 112.697 -170.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.467 ' HE3' ' CD1' ' A' ' 33' ' ' TRP . 30.8 mmmt -126.77 124.3 39.39 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.179 1.792 . . . . 0.0 110.422 -175.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -109.95 114.03 27.24 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.642 1.177 . . . . 0.0 108.908 169.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.72 99.4 9.61 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.613 1.165 . . . . 0.0 109.369 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.9 m -66.7 -17.06 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 O-C-N 120.856 -1.152 . . . . 0.0 113.156 -176.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -74.23 -24.84 59.37 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.339 1.056 . . . . 0.0 113.206 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.2 p -119.25 -25.51 6.11 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -133.31 74.16 72.69 Favored Pre-proline 0 CA--C 1.55 0.977 0 CA-C-N 119.598 1.09 . . . . 0.0 112.141 171.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -67.46 -11.57 32.62 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 122.846 2.364 . . . . 0.0 112.675 168.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -57.24 -41.73 80.13 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.834 1.253 . . . . 0.0 112.223 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.2 m -66.02 -42.71 89.27 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.742 0.701 . . . . 0.0 111.046 174.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.75 -37.98 86.29 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.516 -0.74 . . . . 0.0 112.994 -178.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -78.74 -38.6 38.4 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 173.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -69.09 -36.67 77.85 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.245 0.93 . . . . 0.0 112.607 -178.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -93.3 9.15 37.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.819 1.248 . . . . 0.0 112.482 174.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 61.16 -10.29 0.06 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 128.737 2.815 . . . . 0.0 116.87 177.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.3 m -76.73 52.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 126.317 1.847 . . . . 0.0 113.449 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.8 p -75.9 -20.97 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.428 1.491 . . . . 0.0 113.067 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.5 p -70.9 129.33 38.77 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.188 0.995 . . . . 0.0 110.821 165.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.4 pt -138.5 149.62 63.4 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 125.068 1.347 . . . . 0.0 112.809 -163.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -66.51 149.4 79.18 Favored 'Cis proline' 0 C--N 1.354 0.829 0 CA-C-N 119.373 0.812 . . . . 0.0 113.246 -2.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.1 m -128.67 130.28 46.98 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.271 1.028 . . . . 0.0 110.895 169.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.3 mp -103.49 119.32 38.66 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.828 1.651 . . . . 0.0 107.227 161.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.3 tp -120.39 126.48 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.701 1.201 . . . . 0.0 109.713 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.9 tp -110.24 121.04 44.34 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.153 1.381 . . . . 0.0 110.464 -172.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -106.8 131.13 54.26 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.864 1.665 . . . . 0.0 109.172 175.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -99.72 -29.74 12.48 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -175.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -154.45 56.93 0.7 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.786 1.634 . . . . 0.0 110.785 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.73 17.82 65.37 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.315 0.959 . . . . 0.0 114.554 -175.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -141.91 138.41 16.97 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 126.83 2.052 . . . . 0.0 110.139 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.86 142.69 35.62 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.254 2.636 . . . . 0.0 111.96 -174.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.8 t -129.6 -40.06 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.497 1.119 . . . . 0.0 112.939 -176.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -142.3 133.14 25.65 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.081 0.855 . . . . 0.0 111.791 -173.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -117.83 134.01 55.36 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.284 1.434 . . . . 0.0 110.841 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.11 144.12 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 126.422 1.889 . . . . 0.0 108.713 169.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.8 m -133.67 144.84 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 124.834 1.254 . . . . 0.0 111.001 -174.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.08 -162.84 46.73 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 122.869 0.271 . . . . 0.0 112.624 -167.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.8 139.68 51.96 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.89 1.276 . . . . 0.0 112.28 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -135.23 154.35 51.61 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.611 1.565 . . . . 0.0 112.129 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -80.73 171.12 53.76 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.415 1.007 . . . . 0.0 112.455 173.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -51.84 -37.42 51.86 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.437 1.495 . . . . 0.0 114.628 -175.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.9 -53.43 32.22 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 123.407 0.442 . . . . 0.0 110.924 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.39 -38.76 68.37 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 36.9 tp -63.76 -42.57 97.8 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 119.399 0.999 . . . . 0.0 111.043 173.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.7 tp -70.18 -25.03 63.24 Favored 'General case' 0 C--O 1.214 -0.786 0 CA-C-O 115.857 -2.021 . . . . 0.0 113.014 174.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -64.49 -49.96 69.3 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 124.258 3.208 . . . . 0.0 111.962 166.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.49 -28.63 68.51 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.499 0.72 . . . . 0.0 112.882 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 89.8 mt -91.52 -28.21 17.73 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.396 1.078 . . . . 0.0 113.303 172.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.3 m -60.18 -28.79 68.24 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.82 1.248 . . . . 0.0 110.669 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -52.69 -20.47 3.14 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 168.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.9 t -118.59 -27.32 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 127.407 2.283 . . . . 0.0 112.633 173.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.6 t -106.6 96.11 13.43 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 127.092 2.157 . . . . 0.0 110.939 -174.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -70.97 -9.89 26.55 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.707 2.271 . . . . 0.0 113.178 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -70.73 5.74 1.78 Allowed 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.561 1.544 . . . . 0.0 114.619 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.3 tt -63.54 -31.54 72.74 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 120.431 -1.418 . . . . 0.0 111.612 161.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.254 1.299 0 C-N-CA 125.814 1.645 . . . . 0.0 111.842 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.485 1.278 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.0 t -135.99 149.39 48.83 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.033 1.333 . . . . 0.0 111.608 173.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -99.55 -8.34 24.68 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.029 1.331 . . . . 0.0 113.42 169.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 72.7 m -81.83 -24.82 35.62 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.35 1.06 . . . . 0.0 113.548 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 61.55 -32.96 0.09 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 129.217 3.007 . . . . 0.0 119.047 168.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -95.17 108.74 20.88 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.204 1.402 . . . . 0.0 112.132 -168.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.9 m -70.98 133.05 46.06 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.453 1.501 . . . . 0.0 112.939 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.51 71.67 3.69 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.799 0.84 . . . . 0.0 110.682 167.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.5 p -108.62 150.57 27.34 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.046 1.338 . . . . 0.0 113.883 -175.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.4 pt -132.62 157.24 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 126.112 1.765 . . . . 0.0 111.353 169.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -112.06 140.38 46.79 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.636 1.174 . . . . 0.0 110.597 171.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.9 m -132.11 155.46 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.701 1.2 . . . . 0.0 112.509 -175.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.7 p -142.11 160.81 39.49 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.466 1.907 . . . . 0.0 110.577 176.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -57.95 -27.64 63.59 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -173.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.36 -19.56 63.03 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.0 m -132.77 -2.85 3.29 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.181 1.392 . . . . 0.0 114.17 -174.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -55.26 -40.39 70.91 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.257 1.423 . . . . 0.0 112.642 -174.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.38 -33.6 75.53 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.972 0.731 . . . . 0.0 112.972 177.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.7 m -79.51 -29.69 41.63 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.725 1.21 . . . . 0.0 112.873 176.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -92.64 -45.04 8.27 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -176.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.11 -59.05 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.916 1.286 . . . . 0.0 110.636 -176.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.4 mt -75.66 -18.72 59.56 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -169.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.8 m -79.38 -10.84 59.89 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.3 t -81.64 130.05 34.92 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.788 0.835 . . . . 0.0 112.469 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -81.6 -21.12 38.55 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.242 1.017 . . . . 0.0 112.341 170.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -75.36 147.74 82.79 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.354 1.462 . . . . 0.0 110.062 174.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -58.03 133.23 54.32 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.103 1.869 . . . . 0.0 111.396 171.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.88 132.51 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.225 1.01 . . . . 0.0 110.18 -174.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -122.73 113.84 19.74 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.171 1.389 . . . . 0.0 109.7 -170.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.61 125.19 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.888 1.275 . . . . 0.0 110.224 -173.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -103.88 120.78 41.71 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.267 1.027 . . . . 0.0 112.009 174.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -93.09 113.37 25.61 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.987 2.115 . . . . 0.0 108.076 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 6.8 p-90 -144.83 172.5 12.93 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.439 1.096 . . . . 0.0 113.235 -165.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -145.77 152.83 40.19 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.916 0.886 . . . . 0.0 112.419 167.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.9 p -63.71 -27.29 69.1 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.622 1.169 . . . . 0.0 113.119 174.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 10.7 p-90 -79.0 -3.69 46.29 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 48.5 t -107.5 123.74 48.87 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.865 0.866 . . . . 0.0 113.271 -170.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.31 -58.4 14.79 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.205 1.384 . . . . 0.0 114.02 178.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.7 -27.09 68.47 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 CA-C-N 120.482 2.141 . . . . 0.0 113.534 177.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 85.3 m -61.91 -46.68 88.33 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.116 1.326 . . . . 0.0 111.238 168.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.89 -33.18 72.71 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.014 0.926 . . . . 0.0 112.631 175.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.4 mtt -74.77 -37.7 62.38 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.542 1.137 . . . . 0.0 113.83 177.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.4 p -88.13 -20.77 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.47 -49.38 77.98 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 174.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.5 -27.23 46.59 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 CA-C-N 122.303 1.858 . . . . 0.0 113.476 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 95.3 t -71.29 -49.46 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 119.059 0.845 . . . . 0.0 110.322 173.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.9 mt -61.52 -34.32 75.32 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.954 0.902 . . . . 0.0 113.029 176.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -62.61 -39.99 95.54 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.889 0.876 . . . . 0.0 111.504 173.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -71.34 -36.96 71.73 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.154 -0.966 . . . . 0.0 112.655 173.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.6 mm -61.21 -43.8 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 120.542 1.519 . . . . 0.0 110.559 171.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.27 -35.31 79.92 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.891 0.876 . . . . 0.0 112.504 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.4 m -73.46 -49.04 28.89 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.807 0.843 . . . . 0.0 112.012 176.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -92.7 -34.39 13.96 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -165.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -97.72 19.58 13.4 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.142 0.977 . . . . 0.0 113.328 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.37 -28.2 18.65 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.3 m -75.02 -31.68 61.41 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.767 1.227 . . . . 0.0 112.936 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -97.48 -34.89 10.83 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.035 1.334 . . . . 0.0 112.786 -174.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.3 mt -129.83 152.37 49.39 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.671 2.388 . . . . 0.0 110.518 -174.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.5 m -106.34 129.64 54.31 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 153.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.8 t -99.42 133.03 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.148 0.579 . . . . 0.0 110.193 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.2 155.94 44.73 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.359 1.464 . . . . 0.0 112.217 -173.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -127.64 134.54 49.64 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.305 1.442 . . . . 0.0 112.104 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -124.55 116.43 22.45 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.917 1.687 . . . . 0.0 109.08 169.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -81.94 113.03 19.58 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.482 0.713 . . . . 0.0 109.984 174.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.5 m -71.76 -16.56 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -177.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -85.84 -39.03 17.49 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.792 0.837 . . . . 0.0 111.991 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 72.3 p -96.38 -19.98 18.8 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -137.67 77.13 40.07 Favored Pre-proline 0 CA--C 1.552 1.021 0 CA-C-N 120.159 1.345 . . . . 0.0 111.82 163.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -65.56 -18.9 60.29 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.43 2.753 . . . . 0.0 113.871 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -63.61 -37.38 87.12 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.35 -0.844 . . . . 0.0 113.104 -174.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 m -65.06 -43.61 91.71 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.633 1.106 . . . . 0.0 111.256 174.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.7 -36.66 83.65 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.532 0.733 . . . . 0.0 112.08 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -70.1 -46.76 64.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.845 0.858 . . . . 0.0 112.12 173.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -63.05 -37.12 85.92 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.386 1.474 . . . . 0.0 112.617 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -96.48 8.8 43.2 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.497 1.119 . . . . 0.0 112.917 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 59.98 -11.43 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 128.539 2.736 . . . . 0.0 116.588 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.5 m -76.74 59.96 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.579 1.952 . . . . 0.0 112.667 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.0 m -74.84 -19.9 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.989 1.316 . . . . 0.0 113.423 176.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.6 t -79.27 148.09 32.28 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.555 1.142 . . . . 0.0 111.165 170.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 46.7 pt -143.49 155.64 60.55 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -167.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.74 140.82 59.5 Favored 'Cis proline' 0 C--N 1.353 0.793 0 CA-C-N 119.093 0.712 . . . . 0.0 111.033 -9.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 98.2 m -133.34 120.96 21.68 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.432 0.634 . . . . 0.0 110.65 174.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 mp -96.62 134.93 39.23 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.782 1.633 . . . . 0.0 108.42 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.0 tt -130.57 129.24 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.775 1.23 . . . . 0.0 110.727 171.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.9 tt -103.46 133.69 48.09 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.914 1.286 . . . . 0.0 110.531 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -117.22 148.28 41.77 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.233 1.413 . . . . 0.0 111.228 171.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -124.77 131.03 53.49 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.007 1.323 . . . . 0.0 108.991 164.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.6 t70 49.13 33.27 4.73 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.22 13.36 83.69 Favored Glycine 0 CA--C 1.536 1.371 0 N-CA-C 116.909 1.524 . . . . 0.0 116.909 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -116.25 145.76 35.77 Favored Pre-proline 0 N--CA 1.474 0.743 0 CA-C-N 119.36 1.58 . . . . 0.0 111.588 167.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -72.18 148.71 50.48 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.381 2.721 . . . . 0.0 112.408 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.2 t -131.89 -43.2 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.325 1.45 . . . . 0.0 112.829 -168.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -148.84 146.55 28.02 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.083 1.353 . . . . 0.0 110.968 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 -129.02 144.59 51.24 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.513 1.525 . . . . 0.0 112.067 167.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.5 mt -136.51 136.36 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 126.369 1.868 . . . . 0.0 107.893 175.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 p -133.46 142.89 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 119.664 1.12 . . . . 0.0 111.685 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.16 161.11 30.47 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.017 1.294 . . . . 0.0 113.248 -171.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.85 134.39 39.04 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.792 -0.828 . . . . 0.0 112.57 -177.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -133.07 149.65 52.14 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.936 1.694 . . . . 0.0 109.905 172.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.77 167.01 54.7 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -45.11 -40.06 6.56 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.36 1.464 . . . . 0.0 114.62 -175.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.77 -48.86 57.74 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.037 0.535 . . . . 0.0 111.984 -177.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.57 -36.98 60.24 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.91 0.884 . . . . 0.0 112.712 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.72 -46.53 75.22 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.914 0.886 . . . . 0.0 110.046 175.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -66.12 -30.02 70.44 Favored 'General case' 0 C--O 1.208 -1.124 0 CA-C-O 115.651 -2.118 . . . . 0.0 111.587 171.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 4.5 mmt180 -62.2 -49.11 77.1 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 124.382 3.264 . . . . 0.0 112.849 171.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -59.05 -33.01 70.28 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.323 1.049 . . . . 0.0 112.434 177.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.4 mt -85.62 -22.95 27.74 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 169.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.4 p -67.38 -25.99 66.23 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.807 1.643 . . . . 0.0 110.096 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -49.6 -26.25 3.44 Favored 'General case' 0 CA--C 1.556 1.193 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 164.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.5 t -111.57 -23.52 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 127.337 2.255 . . . . 0.0 112.931 172.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.05 69.19 0.65 Allowed Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 127.858 2.463 . . . . 0.0 109.798 177.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -67.94 -13.38 38.2 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.274 2.65 . . . . 0.0 113.056 -176.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -73.67 -3.23 26.89 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.146 1.378 . . . . 0.0 113.842 170.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 tp 57.55 -154.64 0.35 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.299 1.84 . . . . 0.0 112.985 174.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 36.3 t30 . . . . . 0 C--O 1.253 1.288 0 C-N-CA 125.558 1.543 . . . . 0.0 112.342 -177.765 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ttt . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 119.323 -0.37 . . . . 0.0 110.361 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 66.9 p 43.02 -110.03 0.14 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 126.683 1.993 . . . . 0.0 113.696 173.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -156.16 -40.13 0.08 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.62 1.168 . . . . 0.0 113.183 174.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.6 p -131.4 166.14 21.95 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.683 1.193 . . . . 0.0 113.198 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -69.82 -23.83 63.38 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.455 0.702 . . . . 0.0 112.2 172.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -82.56 -41.32 19.75 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.696 1.199 . . . . 0.0 113.886 -176.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.1 p -121.37 162.62 20.06 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -163.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -101.93 34.48 2.66 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.886 0.875 . . . . 0.0 112.961 166.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.0 p -84.33 160.83 20.61 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.371 -0.83 . . . . 0.0 112.387 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.1 pt -125.02 164.52 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.57 1.548 . . . . 0.0 110.189 164.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -123.5 138.13 54.64 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.902 -1.124 . . . . 0.0 110.816 172.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.87 150.72 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.235 1.414 . . . . 0.0 112.085 -168.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.0 p -139.89 161.94 36.37 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.545 1.538 . . . . 0.0 111.496 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -51.6 -31.48 25.05 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.318 1.447 . . . . 0.0 114.599 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.71 -20.18 65.91 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.8 m -133.64 4.96 3.66 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.477 1.511 . . . . 0.0 113.425 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -59.45 -39.81 84.82 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.685 1.194 . . . . 0.0 112.969 -171.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.91 -32.64 74.04 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.533 -0.729 . . . . 0.0 112.889 175.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.1 m -79.62 -27.49 41.01 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.215 1.406 . . . . 0.0 113.234 177.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -101.34 -34.01 9.79 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -176.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.45 -54.47 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.843 1.257 . . . . 0.0 111.503 -172.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.4 mt -74.9 -12.59 60.4 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -176.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.5 p -71.16 -15.83 62.51 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.261 1.824 . . . . 0.0 113.942 173.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.7 p -66.75 149.05 51.1 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.804 1.642 . . . . 0.0 114.335 -172.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -109.62 -16.83 13.86 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.931 1.292 . . . . 0.0 112.225 160.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -90.53 166.6 18.96 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 125.95 1.7 . . . . 0.0 111.195 171.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.49 138.68 85.38 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.29 1.994 . . . . 0.0 112.863 167.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.71 124.84 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.571 1.148 . . . . 0.0 111.104 172.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tt -100.3 128.73 46.3 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.796 2.038 . . . . 0.0 108.44 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.1 t -120.03 129.24 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.364 1.065 . . . . 0.0 110.571 173.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -106.8 116.93 32.78 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.061 1.344 . . . . 0.0 111.615 175.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.5 m-30 -88.22 111.69 21.93 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.992 1.717 . . . . 0.0 108.841 171.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 24.6 p-90 -134.23 170.96 14.91 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.236 1.414 . . . . 0.0 112.194 -171.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.86 140.27 24.46 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.83 0.852 . . . . 0.0 110.914 170.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 t -65.47 -12.5 53.13 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -168.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 55.3 p-90 -84.21 -14.02 51.15 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 172.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.2 t -90.7 106.49 18.54 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.1 0.96 . . . . 0.0 112.721 -166.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -52.75 -49.66 52.88 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.351 0.977 . . . . 0.0 114.234 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -60.59 -29.32 88.25 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.559 2.173 . . . . 0.0 114.487 174.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.73 -39.36 70.15 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.255 0.934 . . . . 0.0 111.294 172.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -63.45 -29.81 71.04 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.552 0.741 . . . . 0.0 112.308 172.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.6 mtt -71.02 -42.5 69.48 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.261 1.024 . . . . 0.0 113.11 174.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.6 p -86.09 -21.65 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.51 -49.09 79.92 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 176.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.86 -27.95 43.23 Favored 'Trans proline' 0 C--N 1.353 0.764 0 CA-C-N 122.32 1.864 . . . . 0.0 112.828 176.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.8 t -72.16 -46.04 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 121.601 -0.687 . . . . 0.0 110.371 176.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.4 mt -57.55 -40.53 79.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.422 1.089 . . . . 0.0 112.078 170.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.43 -41.02 85.47 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.179 0.992 . . . . 0.0 112.327 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -62.93 -49.35 75.11 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.299 -0.876 . . . . 0.0 111.692 169.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 17.0 mm -56.61 -42.09 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.44 0.696 . . . . 0.0 110.94 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.06 -49.96 75.58 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.992 0.917 . . . . 0.0 112.117 174.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.6 m -77.34 -32.86 55.44 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.706 0.802 . . . . 0.0 112.247 -170.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -86.14 -38.69 17.47 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.571 1.148 . . . . 0.0 113.916 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -107.52 26.75 9.87 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.542 1.137 . . . . 0.0 113.8 -173.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.75 -27.99 45.17 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.9 p -77.19 -19.88 56.14 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.416 1.487 . . . . 0.0 113.902 175.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -104.68 -35.53 7.77 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.268 1.427 . . . . 0.0 112.718 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.9 mt -129.61 149.14 51.5 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.168 2.187 . . . . 0.0 110.231 -176.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.8 m -99.54 138.87 36.02 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 150.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.7 t -125.02 127.9 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.247 0.931 . . . . 0.0 110.583 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -128.07 154.08 46.09 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.013 1.725 . . . . 0.0 112.915 -169.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -125.7 145.01 50.36 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.406 1.482 . . . . 0.0 112.916 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -135.98 118.58 15.96 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.499 1.92 . . . . 0.0 109.95 173.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -83.81 109.96 17.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.225 0.61 . . . . 0.0 110.727 174.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.4 m -70.7 -12.18 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -74.11 -19.33 60.62 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.734 1.152 . . . . 0.0 112.119 166.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.1 p -101.18 -43.76 5.89 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.615 1.166 . . . . 0.0 112.718 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -142.41 65.42 17.75 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 125.226 1.41 . . . . 0.0 111.311 -171.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -63.56 -23.17 70.58 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.617 2.878 . . . . 0.0 113.696 -176.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -57.0 -28.0 62.07 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.48 1.112 . . . . 0.0 112.576 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -66.79 -44.96 79.94 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.102 0.961 . . . . 0.0 112.06 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.55 -31.84 63.86 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.322 1.049 . . . . 0.0 112.651 173.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -71.1 -32.24 68.8 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.617 1.167 . . . . 0.0 113.496 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.6 t-20 -60.25 -41.81 93.97 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.757 1.223 . . . . 0.0 112.068 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -82.72 -8.38 59.59 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.026 0.93 . . . . 0.0 113.195 172.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 55.14 45.63 25.61 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.133 2.173 . . . . 0.0 113.056 -170.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.02 61.78 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.974 1.31 . . . . 0.0 109.507 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.9 p -82.55 -13.9 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -168.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.4 t -64.89 153.22 40.96 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.563 1.145 . . . . 0.0 112.849 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.7 mt -133.0 138.73 32.48 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 123.601 0.76 . . . . 0.0 112.371 -158.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.19 145.39 75.66 Favored 'Cis proline' 0 C--N 1.352 0.745 0 CA-C-N 119.183 0.744 . . . . 0.0 110.764 -16.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.4 m -117.03 122.28 43.75 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.577 0.751 . . . . 0.0 109.59 166.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.3 mp -102.97 120.14 40.09 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 171.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.8 tt -119.65 130.32 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.525 1.13 . . . . 0.0 110.162 176.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.3 tp -108.26 126.51 52.91 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.567 1.147 . . . . 0.0 109.766 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -105.21 152.07 23.3 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.472 1.509 . . . . 0.0 110.022 169.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -134.95 130.98 36.65 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.334 1.454 . . . . 0.0 108.682 166.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.5 t70 50.74 39.04 21.0 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.604 0.762 . . . . 0.0 113.002 -170.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.51 15.46 66.15 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.407 1.48 . . . . 0.0 115.777 -178.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -123.3 140.07 33.08 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 125.606 1.562 . . . . 0.0 110.133 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.32 141.24 46.47 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.95 2.433 . . . . 0.0 113.055 -172.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.8 t -127.94 -38.16 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.972 1.709 . . . . 0.0 112.943 -175.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -141.86 149.33 40.14 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.691 1.196 . . . . 0.0 111.582 175.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -130.69 136.44 48.79 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.028 1.331 . . . . 0.0 110.554 161.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.7 mt -130.1 145.52 35.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 127.089 2.155 . . . . 0.0 108.574 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.5 p -134.03 148.09 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.433 1.093 . . . . 0.0 111.877 171.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.16 164.6 30.39 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.771 1.177 . . . . 0.0 113.286 -176.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.3 146.52 39.22 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -174.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -136.03 145.97 46.62 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.278 1.831 . . . . 0.0 110.084 174.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.81 167.6 38.57 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 123.882 0.753 . . . . 0.0 111.336 166.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -50.82 -38.14 46.99 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.929 1.292 . . . . 0.0 113.742 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.29 -53.76 39.16 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.765 0.426 . . . . 0.0 111.572 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.07 -44.29 69.42 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.594 -0.691 . . . . 0.0 112.479 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.37 -44.64 94.18 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-O 119.076 -0.488 . . . . 0.0 110.254 177.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.1 tp -63.7 -36.64 84.51 Favored 'General case' 0 C--O 1.209 -1.04 0 CA-C-O 114.936 -2.459 . . . . 0.0 111.831 175.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.4 mmm-85 -63.13 -48.41 78.62 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 124.281 3.219 . . . . 0.0 112.599 176.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -57.57 -32.73 67.44 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 176.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 86.5 mt -85.79 -25.17 26.51 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.428 1.091 . . . . 0.0 113.577 171.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.6 p -67.9 -25.12 65.34 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.424 1.889 . . . . 0.0 110.163 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -55.34 -21.99 17.36 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 164.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 66.9 t -112.96 -20.57 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 127.434 2.294 . . . . 0.0 112.441 173.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 17.2 t -109.01 72.4 0.48 Allowed Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 127.729 2.412 . . . . 0.0 109.244 172.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -64.02 -13.39 37.26 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.513 2.809 . . . . 0.0 113.131 -175.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -61.35 -23.96 66.13 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.774 1.23 . . . . 0.0 113.083 174.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 76.6 mt -126.52 26.78 6.26 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.525 1.53 . . . . 0.0 112.6 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 . . . . . 0 C--O 1.252 1.193 0 C-N-CA 125.744 1.618 . . . . 0.0 112.373 -177.44 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 mmt . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.9 p -77.29 -36.11 54.47 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 121.137 -0.977 . . . . 0.0 113.33 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -90.0 -26.93 20.09 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.566 1.147 . . . . 0.0 113.616 -178.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 78.9 p -149.51 153.82 37.81 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.902 1.681 . . . . 0.0 111.748 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 51.36 51.86 15.98 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.758 1.223 . . . . 0.0 112.23 -175.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.77 -4.0 59.05 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -171.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.6 t -68.99 154.54 41.89 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.196 0.999 . . . . 0.0 113.156 -174.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -106.04 18.43 22.08 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.157 1.383 . . . . 0.0 113.367 171.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.3 p -76.58 151.66 36.21 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.056 -1.028 . . . . 0.0 113.478 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.4 pt -130.27 159.83 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 126.193 1.797 . . . . 0.0 111.781 176.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -105.76 143.84 33.34 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.185 0.994 . . . . 0.0 111.208 169.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.5 m -131.27 155.06 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.788 1.635 . . . . 0.0 111.215 176.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 60.3 p -137.44 168.41 19.7 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.331 1.852 . . . . 0.0 111.646 -172.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -61.36 -20.71 63.3 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.23 -13.51 49.64 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.364 1.466 . . . . 0.0 114.789 172.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 87.0 p -132.41 -12.58 3.1 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -168.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -56.02 -41.45 74.95 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.55 1.14 . . . . 0.0 112.649 -173.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.69 -36.76 83.26 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.252 -0.905 . . . . 0.0 112.921 178.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.5 m -79.6 -21.13 45.37 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.655 1.582 . . . . 0.0 113.784 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -111.33 -32.33 6.77 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 t -101.86 -59.12 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.645 1.178 . . . . 0.0 111.231 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 46.3 mt -73.67 -14.02 61.09 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -173.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 83.8 p -72.33 -19.23 61.68 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.273 1.829 . . . . 0.0 113.822 171.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.4 t -77.56 124.47 27.95 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.179 0.992 . . . . 0.0 113.223 -164.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -85.82 -14.62 44.5 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.793 1.237 . . . . 0.0 113.291 170.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -94.13 158.93 35.23 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 125.834 1.653 . . . . 0.0 110.346 168.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -57.06 138.52 86.65 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 121.282 1.321 . . . . 0.0 112.118 171.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.34 129.16 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.333 1.053 . . . . 0.0 110.243 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.71 115.73 29.57 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.458 1.903 . . . . 0.0 108.526 -170.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.0 t -110.02 125.72 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.44 0.696 . . . . 0.0 110.666 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -99.27 120.07 38.94 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.402 1.081 . . . . 0.0 110.849 169.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -86.79 116.71 25.05 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.36 1.464 . . . . 0.0 108.502 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -136.89 172.91 12.3 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.775 1.23 . . . . 0.0 112.928 -167.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.75 156.73 43.38 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.797 0.839 . . . . 0.0 111.934 168.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.2 p -58.5 -30.33 66.94 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.215 1.006 . . . . 0.0 112.572 170.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 29.8 p-90 -82.41 -8.04 59.63 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 177.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.1 t -97.0 93.34 6.55 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 119.642 1.11 . . . . 0.0 112.712 -173.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.77 -42.04 67.66 Favored Glycine 0 CA--C 1.541 1.689 0 CA-C-O 118.556 -1.135 . . . . 0.0 114.153 173.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -61.91 -31.08 84.59 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 CA-C-N 120.586 2.193 . . . . 0.0 114.287 171.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 72.3 m -66.62 -41.65 88.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.606 1.094 . . . . 0.0 110.88 169.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -61.23 -29.68 69.98 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 118.715 0.689 . . . . 0.0 112.759 172.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 88.6 mtp -72.78 -39.84 66.43 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.183 0.993 . . . . 0.0 113.432 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.1 p -86.07 -19.29 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 177.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.22 -48.31 80.27 Favored Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 176.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.58 -27.28 45.98 Favored 'Trans proline' 0 C--N 1.352 0.712 0 CA-C-N 122.4 1.893 . . . . 0.0 113.013 176.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.8 t -71.93 -46.14 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.476 -0.765 . . . . 0.0 110.059 175.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.9 mt -59.78 -37.24 78.51 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.457 1.103 . . . . 0.0 112.623 171.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -63.38 -39.98 96.0 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.206 0.602 . . . . 0.0 111.593 175.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -69.46 -40.11 77.34 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.043 -1.035 . . . . 0.0 112.416 173.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 36.5 mm -56.51 -44.48 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.784 1.174 . . . . 0.0 110.547 171.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.06 -47.34 85.13 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.618 0.767 . . . . 0.0 111.642 175.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.1 m -62.19 -41.78 98.66 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.948 1.299 . . . . 0.0 111.332 -177.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -89.4 -36.96 15.18 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -173.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -108.02 16.4 23.43 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -172.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.39 -34.23 23.51 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -178.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.6 t -72.65 -25.15 61.17 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.544 1.138 . . . . 0.0 113.016 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -95.0 -51.6 4.59 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.743 1.217 . . . . 0.0 111.664 178.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.16 153.15 52.07 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.286 1.434 . . . . 0.0 113.178 -174.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.3 m -104.23 137.45 42.13 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.288 1.035 . . . . 0.0 109.385 175.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.4 t -109.71 129.56 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.831 0.852 . . . . 0.0 110.5 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -132.55 160.03 37.73 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.9 1.68 . . . . 0.0 113.048 -169.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt -127.56 129.49 47.42 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.277 1.831 . . . . 0.0 111.741 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -117.8 116.47 27.06 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.204 1.402 . . . . 0.0 108.974 169.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -82.73 104.52 13.04 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.414 0.686 . . . . 0.0 110.879 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 m -65.46 -18.86 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -175.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -78.25 -19.41 53.76 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.412 0.685 . . . . 0.0 112.679 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 t -119.06 -18.68 8.69 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 175.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -123.55 59.31 15.7 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 125.415 1.486 . . . . 0.0 111.36 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -64.99 -27.97 57.92 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.002 2.468 . . . . 0.0 113.296 -174.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -72.12 -27.7 62.8 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.19 -0.944 . . . . 0.0 112.644 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.4 m -69.46 -39.14 77.93 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.348 -0.845 . . . . 0.0 111.155 171.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.14 -37.1 86.23 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.44 0.696 . . . . 0.0 112.294 171.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -71.7 -39.49 70.13 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.507 0.723 . . . . 0.0 112.653 177.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -56.71 -40.74 76.2 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.14 1.376 . . . . 0.0 113.874 -172.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -96.9 3.99 51.84 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.269 1.028 . . . . 0.0 113.052 178.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 48.0 54.97 9.28 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.202 1.801 . . . . 0.0 112.169 -167.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.9 m -113.67 15.0 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.772 1.629 . . . . 0.0 112.657 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.2 m -59.03 -23.07 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.763 1.625 . . . . 0.0 114.466 -174.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.4 m -79.83 53.05 1.57 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.666 1.986 . . . . 0.0 113.413 -174.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.5 pt -63.93 152.15 87.87 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -167.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -64.37 135.22 20.81 Favored 'Cis proline' 0 C--N 1.357 0.982 0 CA-C-N 119.855 0.984 . . . . 0.0 113.376 1.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.1 m -136.14 120.79 18.36 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.12 0.568 . . . . 0.0 110.186 172.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.1 mp -107.92 129.71 55.08 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.818 1.647 . . . . 0.0 107.93 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.46 132.49 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.965 0.906 . . . . 0.0 109.405 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.5 tp -110.23 129.32 55.74 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.008 1.323 . . . . 0.0 109.464 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -110.2 152.69 25.77 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.368 1.467 . . . . 0.0 111.044 173.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -130.77 137.07 49.29 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.651 1.58 . . . . 0.0 109.446 157.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.1 t70 51.17 33.38 9.35 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.505 1.122 . . . . 0.0 113.522 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.29 10.39 65.92 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.222 1.391 . . . . 0.0 116.093 -175.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -111.82 143.39 28.55 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 119.184 1.492 . . . . 0.0 111.236 176.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -58.92 144.86 98.72 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.358 2.706 . . . . 0.0 114.641 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 94.2 t -128.29 -48.74 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 126.1 1.76 . . . . 0.0 111.603 -178.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -142.19 148.92 39.0 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.688 1.595 . . . . 0.0 111.253 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -135.43 134.18 39.37 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.804 1.641 . . . . 0.0 110.737 171.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.6 mp -134.75 140.85 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 126.0 1.72 . . . . 0.0 109.594 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.5 m -130.44 144.46 37.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.794 1.238 . . . . 0.0 111.656 -176.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.7 161.42 8.4 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.368 0.985 . . . . 0.0 113.281 -170.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.14 152.1 33.94 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.693 -0.887 . . . . 0.0 112.99 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -136.18 152.3 50.64 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.969 1.708 . . . . 0.0 111.207 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.73 166.9 33.1 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.403 1.001 . . . . 0.0 111.46 163.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -52.62 -35.9 55.41 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.055 1.342 . . . . 0.0 113.736 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.28 -49.8 58.03 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 122.916 0.487 . . . . 0.0 111.829 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.45 -43.36 70.01 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.609 -0.682 . . . . 0.0 111.965 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.3 tp -63.45 -44.16 95.29 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 119.055 -0.498 . . . . 0.0 110.78 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 20.1 tp -71.76 -24.62 61.79 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-O 116.549 -1.691 . . . . 0.0 113.208 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 -61.24 -54.12 48.22 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 123.883 3.038 . . . . 0.0 110.859 166.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -61.47 -30.31 70.52 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.7 mt -90.26 -31.91 16.78 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 175.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.4 t -71.24 -11.11 60.75 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.704 1.602 . . . . 0.0 112.242 175.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -46.85 -27.6 1.29 Allowed 'General case' 0 CA--C 1.558 1.269 0 O-C-N 121.227 -0.921 . . . . 0.0 113.076 153.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.07 -49.67 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 128.156 2.582 . . . . 0.0 112.502 174.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.7 t -139.92 120.27 9.2 Favored Pre-proline 0 N--CA 1.482 1.145 0 C-N-CA 125.793 1.637 . . . . 0.0 113.632 -170.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -90.82 8.25 65.38 Favored 'Cis proline' 0 CA--C 1.538 0.716 0 N-CA-C 114.959 1.1 . . . . 0.0 114.959 9.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 49.0 t30 56.51 36.43 27.56 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.285 1.034 . . . . 0.0 111.293 -154.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 34.0 tp -134.76 149.56 50.44 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.725 1.61 . . . . 0.0 112.212 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.143 0 C-N-CA 126.124 1.77 . . . . 0.0 110.656 175.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 110.553 -0.166 . . . . 0.0 110.553 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.4 p -153.48 171.11 19.2 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.956 1.702 . . . . 0.0 110.944 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -70.09 -21.85 63.09 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 167.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.5 p -78.33 -26.37 46.82 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.054 0.942 . . . . 0.0 112.941 172.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -86.27 11.41 12.18 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.038 1.735 . . . . 0.0 112.489 164.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.385 0.0 OUTLIER 54.78 -28.09 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 131.462 3.905 . . . . 0.0 118.605 -170.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 72.2 m -82.82 84.46 7.36 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.811 1.244 . . . . 0.0 110.173 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.96 43.95 0.45 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.593 1.557 . . . . 0.0 113.952 -172.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.8 t -89.65 170.41 10.49 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.318 1.447 . . . . 0.0 111.177 169.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.3 pt -135.17 148.88 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.998 1.719 . . . . 0.0 110.61 176.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -92.66 139.62 30.37 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.651 -0.656 . . . . 0.0 110.581 168.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -115.46 164.15 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.732 1.213 . . . . 0.0 111.961 173.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 54.8 p -139.71 159.62 41.75 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.137 1.775 . . . . 0.0 110.681 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -58.7 -27.84 65.23 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 121.131 -0.981 . . . . 0.0 113.536 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.36 -18.18 52.94 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.9 m -128.8 -3.81 5.23 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.763 1.225 . . . . 0.0 114.052 -172.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -53.5 -41.35 66.21 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.351 1.461 . . . . 0.0 112.55 -177.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.77 -33.01 74.67 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.457 -0.777 . . . . 0.0 113.092 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.6 m -79.54 -30.83 41.91 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.397 1.079 . . . . 0.0 112.706 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -93.39 -32.97 14.04 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -174.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -111.13 -57.75 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.296 1.438 . . . . 0.0 110.707 -175.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 33.8 mt -76.63 -13.27 60.07 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -170.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.3 m -83.31 -13.1 55.84 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.62 0.971 . . . . 0.0 113.62 176.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.7 m -81.86 130.39 35.05 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.043 1.337 . . . . 0.0 112.817 -173.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -79.56 -23.55 42.73 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.266 0.626 . . . . 0.0 112.308 171.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -74.09 143.29 80.33 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 125.238 1.415 . . . . 0.0 109.485 171.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -53.44 138.95 65.81 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 121.805 1.67 . . . . 0.0 112.205 166.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p -136.41 132.32 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 C-N-CA 125.129 1.371 . . . . 0.0 110.337 -173.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.23 126.38 55.17 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.517 1.927 . . . . 0.0 108.441 -175.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.1 t -119.7 124.36 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.11 0.964 . . . . 0.0 110.557 177.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -101.16 113.38 26.37 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.954 1.702 . . . . 0.0 111.159 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -92.82 112.41 24.36 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.685 1.594 . . . . 0.0 108.734 176.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -143.13 171.94 13.39 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.766 1.226 . . . . 0.0 111.909 -166.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.41 151.16 40.05 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.867 0.867 . . . . 0.0 112.896 170.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 28.0 p -65.46 -25.56 67.56 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.604 1.162 . . . . 0.0 113.241 172.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 13.3 p-90 -88.62 4.62 46.4 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.509 1.524 . . . . 0.0 114.934 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.1 t -122.38 127.25 49.5 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.311 1.044 . . . . 0.0 112.953 -173.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.24 -53.69 40.35 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 118.7 -1.056 . . . . 0.0 114.882 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.78 -23.8 68.92 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 CA-C-N 121.079 2.44 . . . . 0.0 113.293 174.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 86.2 m -65.39 -46.46 79.98 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.827 -1.171 . . . . 0.0 111.615 167.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -59.31 -29.89 67.95 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.842 0.857 . . . . 0.0 112.932 172.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.6 mtt -74.09 -39.09 63.65 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 176.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -90.88 -29.42 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -175.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.93 -46.47 87.67 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.77 -25.94 28.03 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.357 2.038 . . . . 0.0 113.79 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.38 -45.52 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 119.44 1.018 . . . . 0.0 108.688 175.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -67.4 -31.65 72.02 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.996 1.318 . . . . 0.0 112.372 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -73.65 -36.94 65.43 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.037 0.835 . . . . 0.0 112.945 174.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -59.68 -45.16 92.92 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.995 -1.065 . . . . 0.0 111.162 165.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.4 mt -62.59 -40.21 87.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 O-C-N 121.603 -0.685 . . . . 0.0 110.594 176.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.76 -32.42 73.91 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.553 -1.342 . . . . 0.0 113.252 173.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.4 m -74.38 -48.08 30.18 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.752 0.821 . . . . 0.0 111.554 176.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -90.96 -24.71 20.05 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -169.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -117.01 15.13 15.12 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.152 1.381 . . . . 0.0 114.597 -172.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.4 -28.03 11.65 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 175.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.4 p -84.06 -21.89 31.4 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.658 1.583 . . . . 0.0 114.304 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -98.58 -31.97 11.68 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.217 1.407 . . . . 0.0 112.585 178.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.9 mt -139.18 149.35 44.32 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.203 2.601 . . . . 0.0 109.977 -177.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.4 m -91.22 134.96 34.13 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 157.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.1 t -128.63 120.13 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 121.516 -0.74 . . . . 0.0 109.987 -169.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.45 159.86 35.8 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.978 1.311 . . . . 0.0 113.422 -168.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -119.75 140.27 50.99 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.287 1.835 . . . . 0.0 111.56 176.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -122.64 111.15 16.41 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.223 1.409 . . . . 0.0 107.824 164.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -82.09 110.57 17.43 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.0 m -67.1 -16.37 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -174.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -76.87 -23.46 52.63 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.414 0.686 . . . . 0.0 112.569 171.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.5 p -93.57 -31.97 14.31 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.866 1.266 . . . . 0.0 112.563 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -138.43 79.98 28.63 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.324 1.449 . . . . 0.0 111.688 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -61.89 -28.73 81.49 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.809 2.339 . . . . 0.0 113.609 175.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -66.56 -41.39 88.69 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.077 0.951 . . . . 0.0 112.411 -176.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -61.86 -37.98 86.54 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.477 0.711 . . . . 0.0 111.651 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.99 -45.12 95.02 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.75 0.82 . . . . 0.0 112.496 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.9 ptm85 -78.13 -31.19 49.76 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -62.57 -41.43 98.92 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.284 1.034 . . . . 0.0 111.995 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -98.47 5.9 47.63 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 50.1 59.58 4.44 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.582 1.953 . . . . 0.0 113.169 -177.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.2 m -133.3 31.89 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 125.946 1.699 . . . . 0.0 111.45 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 m -70.68 -19.86 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.543 1.537 . . . . 0.0 115.005 -171.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 21.4 m -82.3 50.38 1.6 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.719 1.607 . . . . 0.0 113.767 -169.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -57.33 150.22 44.19 Favored Pre-proline 0 CA--C 1.556 1.205 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 -161.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.94 141.5 66.59 Favored 'Cis proline' 0 C--N 1.356 0.934 0 CA-C-N 118.758 0.592 . . . . 0.0 112.165 -4.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.9 m -136.39 137.79 40.9 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.968 0.907 . . . . 0.0 109.771 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.5 mp -122.5 140.63 52.53 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.146 0.978 . . . . 0.0 110.203 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.1 tp -127.9 131.3 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 124.82 1.248 . . . . 0.0 108.999 175.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.1 tt -111.56 129.52 56.04 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.425 1.09 . . . . 0.0 109.217 172.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -111.63 152.01 28.14 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.739 1.616 . . . . 0.0 109.863 172.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -134.92 126.91 29.62 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.324 1.45 . . . . 0.0 109.457 173.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t70 50.03 36.61 12.26 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.262 1.025 . . . . 0.0 113.365 -165.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.02 5.9 42.73 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.941 1.734 . . . . 0.0 116.032 -174.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 55.4 mm-40 -97.62 137.27 21.03 Favored Pre-proline 0 N--CA 1.472 0.643 0 CA-C-N 119.359 1.579 . . . . 0.0 109.573 175.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.63 139.54 48.88 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.025 1.816 . . . . 0.0 111.826 -178.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.3 t -123.43 -46.84 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.221 1.408 . . . . 0.0 112.331 -174.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -146.71 132.39 18.88 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.631 0.772 . . . . 0.0 112.539 -177.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -111.41 135.82 51.42 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.066 1.746 . . . . 0.0 110.484 168.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.9 mt -129.75 143.24 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.623 1.969 . . . . 0.0 108.57 -178.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.39 143.16 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.569 1.148 . . . . 0.0 111.224 174.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.83 158.97 29.95 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.925 1.25 . . . . 0.0 113.043 -171.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.43 140.88 39.95 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.905 -0.762 . . . . 0.0 112.509 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -130.7 146.43 52.18 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.88 1.672 . . . . 0.0 109.809 170.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.37 166.49 54.73 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 123.819 0.723 . . . . 0.0 111.62 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? -51.7 -33.99 36.76 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.974 1.31 . . . . 0.0 113.641 -175.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.85 -50.98 37.34 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.407 0.549 . . . . 0.0 111.752 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.14 -36.55 69.4 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.368 1.067 . . . . 0.0 112.549 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -41.14 93.86 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.517 -0.74 . . . . 0.0 110.127 171.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 29.8 tp -69.27 -23.19 63.81 Favored 'General case' 0 C--O 1.213 -0.821 0 CA-C-O 116.07 -1.919 . . . . 0.0 113.143 171.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.6 mmt-85 -64.35 -49.09 73.03 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 123.991 3.087 . . . . 0.0 111.542 165.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -59.23 -30.69 68.44 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 93.6 mt -93.33 -27.82 16.56 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.684 1.193 . . . . 0.0 113.927 173.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.8 p -67.07 -24.48 65.97 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.627 1.558 . . . . 0.0 110.922 177.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -51.39 -22.68 3.13 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 125.256 1.423 . . . . 0.0 113.978 163.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 69.5 t -112.97 -30.09 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 128.07 2.548 . . . . 0.0 111.992 172.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.2 t -110.34 87.86 6.73 Favored Pre-proline 0 N--CA 1.478 0.973 0 C-N-CA 127.967 2.507 . . . . 0.0 110.346 -175.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.1 -8.85 23.06 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.879 2.386 . . . . 0.0 113.346 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -83.05 23.67 0.84 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.359 1.864 . . . . 0.0 113.644 178.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -58.12 -22.44 50.95 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -174.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.26 0 C-N-CA 126.202 1.801 . . . . 0.0 111.087 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.487 1.425 0 N-CA-C 111.16 0.059 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 18.3 p -80.11 -36.69 35.02 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.206 1.002 . . . . 0.0 112.807 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -144.8 154.1 42.34 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.682 1.993 . . . . 0.0 110.843 176.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.3 t -79.18 -30.61 43.53 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.754 0.821 . . . . 0.0 112.9 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 56.06 32.48 20.08 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.286 1.834 . . . . 0.0 115.258 173.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -84.73 -14.36 48.56 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -176.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.9 p -98.56 157.29 16.33 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.154 1.782 . . . . 0.0 112.699 177.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -104.04 32.07 4.17 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -171.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 p -89.64 153.33 20.83 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.723 1.209 . . . . 0.0 113.227 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.2 pt -140.07 165.17 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 127.092 2.157 . . . . 0.0 110.84 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -119.05 152.44 36.44 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 164.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.3 m -122.6 169.81 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 126.485 1.914 . . . . 0.0 110.823 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 43.2 p -137.62 173.94 11.12 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.826 1.65 . . . . 0.0 111.39 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -54.98 -28.13 49.32 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.87 -1.144 . . . . 0.0 113.037 170.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.0 -13.34 57.54 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.852 1.261 . . . . 0.0 114.278 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.7 p -132.86 -4.92 3.17 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -174.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -60.21 -46.14 90.77 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 120.011 1.278 . . . . 0.0 111.636 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.42 -39.32 77.94 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.959 -1.088 . . . . 0.0 112.812 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.28 -16.62 56.13 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.614 1.566 . . . . 0.0 114.726 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -103.24 -50.85 3.37 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.17 0.988 . . . . 0.0 112.677 173.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.2 t -83.49 -59.22 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.536 1.134 . . . . 0.0 111.146 -173.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.2 mt -77.31 -25.98 51.75 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -172.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.4 m -79.17 -9.06 59.46 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.96 1.304 . . . . 0.0 113.677 175.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -67.23 139.93 57.39 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.812 0.845 . . . . 0.0 113.185 -177.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -86.69 2.28 49.07 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.234 1.413 . . . . 0.0 113.724 173.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -131.72 165.87 32.45 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 126.397 1.879 . . . . 0.0 111.357 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -66.44 144.2 72.57 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.188 1.925 . . . . 0.0 112.207 176.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.2 p -144.12 127.26 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.335 1.054 . . . . 0.0 111.694 -173.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 tt -99.71 129.46 45.84 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.259 2.224 . . . . 0.0 108.323 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 t -119.8 127.26 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.437 1.095 . . . . 0.0 110.443 173.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -105.02 115.09 29.68 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.079 1.352 . . . . 0.0 111.793 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -83.42 114.08 21.2 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.376 1.87 . . . . 0.0 108.93 171.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -145.99 177.21 9.12 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.301 1.041 . . . . 0.0 112.205 -165.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.94 148.1 30.42 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 122.774 0.43 . . . . 0.0 112.051 163.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -64.8 -18.54 65.19 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 173.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 9.5 p-90 -82.03 -4.39 56.66 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 173.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 33.8 t -107.07 119.9 40.64 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 119.316 0.962 . . . . 0.0 113.493 -168.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.71 -52.18 53.53 Favored Glycine 0 CA--C 1.54 1.606 0 C-N-CA 124.701 1.143 . . . . 0.0 115.182 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.77 -24.44 54.52 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 CA-C-N 121.006 2.403 . . . . 0.0 113.265 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 75.9 m -65.81 -45.19 83.26 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.693 -1.254 . . . . 0.0 111.602 167.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -61.25 -30.91 70.74 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.638 0.653 . . . . 0.0 112.418 172.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.3 ttt -70.3 -43.1 71.06 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.305 1.042 . . . . 0.0 113.162 176.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 p -86.98 -23.25 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.82 -49.64 72.54 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 176.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.51 -29.01 45.18 Favored 'Trans proline' 0 C--N 1.352 0.74 0 CA-C-N 122.376 1.884 . . . . 0.0 112.806 177.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.0 t -71.93 -45.63 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 O-C-N 121.554 -0.716 . . . . 0.0 110.181 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.1 mt -62.53 -33.73 75.48 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.937 0.895 . . . . 0.0 112.682 172.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -68.83 -38.73 80.04 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.119 0.872 . . . . 0.0 112.058 175.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -63.24 -45.28 92.32 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 121.344 -0.847 . . . . 0.0 111.649 168.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.0 mm -58.88 -41.93 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 119.497 1.044 . . . . 0.0 110.605 174.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.93 -46.74 87.21 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.289 -0.882 . . . . 0.0 111.971 176.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.7 m -76.36 -37.73 56.84 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.926 0.89 . . . . 0.0 112.409 -175.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -97.25 -21.79 17.06 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -172.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -111.45 19.84 17.81 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.633 1.573 . . . . 0.0 113.065 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.26 -28.08 25.77 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.062 1.345 . . . . 0.0 113.833 174.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.7 p -66.43 -23.89 66.37 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.837 1.655 . . . . 0.0 114.042 175.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -125.98 -23.46 3.94 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.634 1.574 . . . . 0.0 113.924 -169.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.4 mt -134.26 153.75 51.68 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.299 2.239 . . . . 0.0 110.56 -178.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 49.0 m -108.79 138.76 44.6 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 149.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.1 t -112.79 122.92 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 118.904 0.775 . . . . 0.0 110.549 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -124.49 165.4 17.85 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.695 1.998 . . . . 0.0 112.145 -176.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.2 mttt -130.7 152.28 50.23 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.175 1.79 . . . . 0.0 112.658 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.76 114.28 12.48 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.424 1.089 . . . . 0.0 108.597 162.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -80.9 118.65 22.58 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.2 m -67.82 -18.32 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -172.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -80.6 -25.75 38.27 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.929 0.892 . . . . 0.0 112.677 170.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.2 p -92.17 -26.74 18.08 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.989 0.916 . . . . 0.0 112.694 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -140.54 86.96 11.93 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.656 1.182 . . . . 0.0 111.305 171.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.07 -18.62 35.46 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.524 2.149 . . . . 0.0 113.097 177.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -68.56 -46.37 69.64 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.189 -0.945 . . . . 0.0 112.055 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 m -73.65 -29.86 62.58 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.49 -0.757 . . . . 0.0 112.162 175.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.66 -40.98 85.02 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.24 0.616 . . . . 0.0 112.424 169.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.2 ttm105 -75.98 -39.29 56.23 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.323 0.649 . . . . 0.0 112.475 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -54.31 -40.61 68.12 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.189 1.396 . . . . 0.0 114.506 -170.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -100.31 7.19 44.53 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.014 0.925 . . . . 0.0 113.479 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 49.78 59.53 4.45 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.355 1.462 . . . . 0.0 111.287 -164.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.9 m -125.33 28.65 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.414 1.886 . . . . 0.0 111.439 -176.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -68.55 -25.64 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.792 1.237 . . . . 0.0 112.349 175.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 52.7 m -79.96 136.53 36.65 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.265 1.426 . . . . 0.0 110.325 166.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 29.0 pt -143.15 154.66 61.54 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -166.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.33 140.66 60.53 Favored 'Cis proline' 0 C--N 1.355 0.872 0 CA-C-N 119.412 0.826 . . . . 0.0 111.923 -5.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.0 m -134.72 126.64 29.42 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.173 0.989 . . . . 0.0 109.709 174.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.8 mp -108.19 136.08 48.46 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.685 1.594 . . . . 0.0 108.908 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.0 tp -120.74 138.54 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.268 1.427 . . . . 0.0 108.703 167.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.9 tp -126.59 125.15 41.48 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.071 0.949 . . . . 0.0 110.095 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -105.87 143.37 34.1 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.734 2.013 . . . . 0.0 110.447 177.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -114.42 119.21 36.11 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.558 1.543 . . . . 0.0 107.929 168.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.4 t70 51.2 39.0 22.65 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.731 1.212 . . . . 0.0 113.631 -172.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.55 9.54 74.08 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 125.163 1.363 . . . . 0.0 116.125 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -109.35 134.26 20.55 Favored Pre-proline 0 N--CA 1.473 0.715 0 CA-C-N 119.514 1.657 . . . . 0.0 110.356 171.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.56 139.57 45.06 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.465 2.11 . . . . 0.0 111.991 -173.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.3 m -130.21 -27.84 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -177.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -152.28 139.55 19.4 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.721 1.146 . . . . 0.0 111.855 -177.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -129.13 140.05 51.7 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.43 1.892 . . . . 0.0 111.034 173.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.9 mt -137.24 143.17 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.965 1.706 . . . . 0.0 108.883 -178.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 p -133.85 143.64 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 119.723 1.147 . . . . 0.0 111.24 170.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.75 156.68 29.32 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.277 1.418 . . . . 0.0 113.248 -172.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.1 140.08 41.66 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.914 -0.757 . . . . 0.0 112.666 -176.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -132.63 145.45 51.09 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.87 1.668 . . . . 0.0 110.729 174.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -79.94 167.68 51.51 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.355 0.979 . . . . 0.0 110.896 173.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -50.22 -37.02 33.34 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -170.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.97 -47.99 55.85 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.173 0.511 . . . . 0.0 111.468 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.83 -44.77 69.26 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.377 1.071 . . . . 0.0 111.908 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.3 tp -64.89 -44.38 89.83 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.944 176.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 31.4 tp -69.93 -31.62 69.47 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-O 115.048 -2.406 . . . . 0.0 112.807 177.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -65.38 -42.93 92.17 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 124.861 3.482 . . . . 0.0 111.926 169.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -62.32 -32.07 72.78 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 178.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.4 mt -91.65 -24.98 19.35 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.888 1.275 . . . . 0.0 113.196 173.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.3 t -66.16 -25.41 66.94 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.983 1.313 . . . . 0.0 110.264 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -52.71 -22.14 4.87 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.519 1.128 . . . . 0.0 113.578 164.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.7 t -108.92 -24.95 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 127.487 2.315 . . . . 0.0 112.371 170.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.3 t -118.73 84.15 24.28 Favored Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 127.888 2.475 . . . . 0.0 111.797 -175.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -64.25 -12.79 34.48 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.063 2.509 . . . . 0.0 114.853 175.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -68.56 -28.28 66.82 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -172.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 28.0 tp -150.3 138.67 20.45 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.09 0.956 . . . . 0.0 112.008 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.6 t30 . . . . . 0 C--O 1.253 1.272 0 C-N-CA 126.206 1.802 . . . . 0.0 111.362 174.4 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.565 0.222 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.2 p -75.34 158.45 32.78 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.647 1.179 . . . . 0.0 112.497 174.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -145.32 146.4 31.61 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.146 1.378 . . . . 0.0 111.433 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 63.4 p -98.1 -3.97 36.79 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -174.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -123.91 7.97 8.7 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.495 1.518 . . . . 0.0 113.51 -174.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.05 2.41 20.66 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -177.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 65.1 p -71.06 149.63 46.35 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.29 1.436 . . . . 0.0 111.872 171.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -88.18 54.37 3.05 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.092 -1.005 . . . . 0.0 112.207 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.9 p -89.71 151.62 21.75 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.511 1.124 . . . . 0.0 112.475 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 45.0 pt -135.06 160.08 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.704 1.602 . . . . 0.0 111.091 169.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -108.01 139.03 43.25 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.906 0.882 . . . . 0.0 110.591 168.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.2 m -133.6 150.69 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.963 1.305 . . . . 0.0 110.934 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.1 p -141.05 174.24 10.71 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.783 1.633 . . . . 0.0 111.095 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -52.6 -26.15 12.68 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 120.919 -1.113 . . . . 0.0 113.611 172.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.26 -13.37 52.77 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 176.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.3 p -137.1 -12.66 1.65 Allowed 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -169.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -56.28 -41.96 76.71 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.405 1.482 . . . . 0.0 112.82 -174.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.53 -34.55 78.53 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 121.134 -0.979 . . . . 0.0 112.894 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.5 m -79.46 -14.33 58.98 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.535 1.534 . . . . 0.0 113.77 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -118.7 -32.36 4.57 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.92 -51.92 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.156 1.382 . . . . 0.0 111.452 -176.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.6 mt -78.53 -13.53 59.79 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.6 p -76.56 -11.04 59.81 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.209 1.804 . . . . 0.0 113.995 174.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.7 p -67.09 149.15 50.95 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 -164.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -118.19 15.64 14.05 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 126.401 1.88 . . . . 0.0 112.089 171.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -142.86 164.25 33.36 Favored Pre-proline 0 N--CA 1.475 0.782 0 C-N-CA 129.416 3.086 . . . . 0.0 108.809 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.76 138.56 54.05 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 CA-C-N 121.103 1.43 . . . . 0.0 111.257 166.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.8 m -136.63 138.53 46.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 126.317 1.847 . . . . 0.0 110.536 -177.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tt -118.68 115.7 25.05 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.79 1.236 . . . . 0.0 109.637 -167.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.11 126.96 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.999 0.92 . . . . 0.0 110.943 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -107.0 111.9 24.61 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.513 1.525 . . . . 0.0 111.48 177.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -84.25 108.66 17.25 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.909 1.684 . . . . 0.0 108.681 173.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -136.08 163.81 29.47 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.348 1.059 . . . . 0.0 113.14 -165.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.31 145.8 47.84 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.2 p -59.94 -29.99 68.77 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.356 1.862 . . . . 0.0 113.206 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.5 p-90 -86.94 -12.4 47.71 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 41.9 t -90.77 119.18 30.78 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -164.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.07 -49.33 76.15 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.879 1.228 . . . . 0.0 113.329 176.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -57.66 -29.47 85.51 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.922 2.414 . . . . 0.0 114.548 170.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 94.9 m -64.88 -44.37 89.87 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.781 1.173 . . . . 0.0 111.187 167.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -60.56 -29.44 69.16 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 172.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.3 mtt -71.64 -43.3 66.36 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.641 0.776 . . . . 0.0 112.859 176.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.8 p -88.74 -25.75 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.81 -48.09 92.44 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.72 -27.86 37.69 Favored 'Trans proline' 0 C--N 1.353 0.776 0 CA-C-N 122.448 1.91 . . . . 0.0 112.683 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.9 t -71.67 -46.01 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 121.572 -0.705 . . . . 0.0 110.288 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.0 mt -60.92 -35.69 77.36 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.073 0.949 . . . . 0.0 112.353 171.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -67.96 -38.49 82.85 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.015 0.825 . . . . 0.0 112.052 176.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -62.64 -45.35 93.22 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.018 -1.051 . . . . 0.0 111.537 169.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.3 mm -59.12 -43.05 88.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.656 1.117 . . . . 0.0 110.898 174.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.97 -35.31 78.09 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.181 0.992 . . . . 0.0 112.843 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.1 m -78.51 -48.85 14.45 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.412 0.685 . . . . 0.0 111.906 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -85.24 -32.83 22.38 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -169.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -108.02 16.69 23.17 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.313 1.445 . . . . 0.0 112.834 -171.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.66 -33.12 32.33 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.378 1.471 . . . . 0.0 114.363 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.8 m -68.03 -29.57 68.6 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.913 1.285 . . . . 0.0 112.389 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -102.61 -39.84 6.89 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.562 1.545 . . . . 0.0 112.66 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.5 mt -125.37 148.85 48.61 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 126.927 2.091 . . . . 0.0 110.663 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.4 m -109.14 127.2 53.99 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 157.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.6 t -99.51 128.97 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.585 0.754 . . . . 0.0 109.512 -177.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.26 150.73 48.23 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.89 1.676 . . . . 0.0 111.771 -173.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -128.63 143.45 50.95 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.434 1.094 . . . . 0.0 112.504 176.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -133.55 122.42 23.54 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.866 1.666 . . . . 0.0 110.033 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.63 96.89 7.64 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.18 1.792 . . . . 0.0 109.844 -176.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.8 m -69.49 -13.41 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 O-C-N 120.491 -1.381 . . . . 0.0 113.188 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -67.66 -27.49 66.9 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.756 0.822 . . . . 0.0 112.761 171.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.9 p -119.11 -29.74 5.16 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -136.99 76.09 46.58 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 124.646 1.178 . . . . 0.0 111.11 173.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -68.16 -13.88 39.15 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.196 2.598 . . . . 0.0 113.719 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -58.67 -33.05 69.69 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.673 1.189 . . . . 0.0 113.771 -172.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.5 m -64.21 -45.26 89.08 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.636 1.107 . . . . 0.0 111.856 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.12 -32.55 65.01 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.758 0.823 . . . . 0.0 112.47 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -73.26 -32.26 64.59 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.518 1.127 . . . . 0.0 113.022 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -58.31 -37.11 74.43 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.519 1.128 . . . . 0.0 112.596 175.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -96.74 9.91 40.32 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.067 1.347 . . . . 0.0 113.124 175.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.307 5.7 pt20 54.27 -9.19 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 130.15 3.38 . . . . 0.0 117.892 -173.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.6 m -80.27 58.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.549 1.94 . . . . 0.0 111.778 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.9 p -79.02 -4.22 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 126.004 1.721 . . . . 0.0 113.744 -174.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.3 m -57.06 157.19 6.11 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.599 1.96 . . . . 0.0 112.805 170.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 23.2 mt -140.14 137.46 18.07 Favored Pre-proline 0 N--CA 1.477 0.9 0 O-C-N 121.339 -0.85 . . . . 0.0 112.312 -164.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.98 143.58 66.48 Favored 'Cis proline' 0 C--N 1.353 0.787 0 CA-C-N 119.495 0.855 . . . . 0.0 110.628 -17.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 28.3 m -119.98 121.37 38.81 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.444 0.697 . . . . 0.0 110.078 169.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.9 mp -99.7 119.46 38.16 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.516 1.527 . . . . 0.0 107.749 172.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.7 tp -117.96 124.21 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 125.088 1.355 . . . . 0.0 109.073 176.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.6 tp -107.4 125.99 51.92 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.647 1.579 . . . . 0.0 108.908 -176.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -112.44 155.34 24.39 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.412 1.485 . . . . 0.0 109.987 174.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -141.75 126.56 18.12 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.998 1.719 . . . . 0.0 108.829 174.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.6 t70 54.79 25.36 6.53 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -169.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.72 5.39 68.84 Favored Glycine 0 CA--C 1.541 1.67 0 O-C-N 120.535 -1.353 . . . . 0.0 116.091 -172.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -95.16 140.46 22.43 Favored Pre-proline 0 N--CA 1.474 0.766 0 CA-C-N 119.815 1.807 . . . . 0.0 110.048 167.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -67.66 139.6 48.94 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.133 1.889 . . . . 0.0 111.11 176.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.1 m -127.61 -27.63 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 114.814 1.412 . . . . 0.0 114.814 -176.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -156.08 147.86 22.99 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.736 1.153 . . . . 0.0 111.575 175.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.0 ttp-105 -127.95 141.52 51.51 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.001 1.32 . . . . 0.0 111.511 167.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.4 mp -129.48 140.99 47.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 126.638 1.975 . . . . 0.0 108.278 171.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.6 p -132.42 140.8 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.161 0.984 . . . . 0.0 110.286 169.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.24 155.14 30.07 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.32 0.962 . . . . 0.0 112.608 -165.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.16 142.33 43.55 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.503 0.721 . . . . 0.0 112.791 -175.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -130.76 144.54 51.52 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.789 1.636 . . . . 0.0 110.553 172.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -79.31 170.67 54.58 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.391 0.996 . . . . 0.0 111.518 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -52.56 -36.47 55.88 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -175.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.95 -50.91 64.54 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.701 0.4 . . . . 0.0 111.33 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.47 -39.73 58.31 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.898 1.279 . . . . 0.0 113.142 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.3 tp -66.36 -36.36 82.68 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.244 -0.91 . . . . 0.0 110.737 173.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 28.1 tp -73.04 -24.93 60.77 Favored 'General case' 0 C--O 1.216 -0.68 0 CA-C-O 116.123 -1.894 . . . . 0.0 112.955 169.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -58.65 -53.84 53.86 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 123.972 3.078 . . . . 0.0 109.741 164.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -60.91 -32.09 71.58 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.799 1.24 . . . . 0.0 113.382 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.3 mt -97.42 -29.95 13.2 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.621 1.168 . . . . 0.0 113.745 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.6 t -61.33 -30.48 70.53 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 120.182 1.356 . . . . 0.0 110.63 171.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -54.86 -18.25 4.63 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 166.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.0 t -117.72 -18.8 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 127.781 2.433 . . . . 0.0 112.578 174.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -123.63 89.77 51.06 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 127.472 2.309 . . . . 0.0 110.432 -173.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -65.27 -7.93 17.19 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.453 2.768 . . . . 0.0 114.936 175.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -63.51 -27.7 69.45 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.52 1.128 . . . . 0.0 113.328 -175.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 49.6 tp -146.82 143.47 28.63 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.504 1.122 . . . . 0.0 111.044 167.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 . . . . . 0 C--O 1.253 1.257 0 C-N-CA 125.775 1.63 . . . . 0.0 111.422 173.867 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.8 p . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.9 pt -108.14 155.04 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.808 1.243 . . . . 0.0 111.271 166.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -112.15 128.17 56.14 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.542 1.137 . . . . 0.0 109.779 176.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -124.94 152.75 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.527 1.131 . . . . 0.0 111.605 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 44.6 p -132.12 169.59 16.17 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.452 1.901 . . . . 0.0 110.919 -175.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -58.51 -27.0 64.08 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 120.909 -1.12 . . . . 0.0 113.168 176.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.11 -13.51 52.8 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.195 1.398 . . . . 0.0 114.518 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.0 p -127.5 -7.72 5.74 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 -173.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -56.01 -41.82 75.48 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.869 1.268 . . . . 0.0 112.603 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.76 -33.05 74.08 Favored 'General case' 0 CA--C 1.543 0.712 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 m -79.19 -14.96 58.75 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.784 1.634 . . . . 0.0 113.521 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -120.35 -54.55 2.08 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.127 0.971 . . . . 0.0 113.173 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.2 -51.97 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.479 0.712 . . . . 0.0 110.898 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 25.4 mt -76.96 -15.9 59.51 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.8 t -76.12 -28.91 57.66 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.414 1.486 . . . . 0.0 112.904 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.2 m -68.77 119.46 13.18 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.786 1.234 . . . . 0.0 112.418 -174.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -77.32 -20.19 55.29 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.352 1.061 . . . . 0.0 112.944 170.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -87.32 166.19 27.06 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 126.586 1.954 . . . . 0.0 111.363 173.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.62 137.24 79.09 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.135 1.89 . . . . 0.0 111.75 170.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -138.25 130.43 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.016 0.927 . . . . 0.0 111.004 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.04 113.79 27.55 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.396 1.878 . . . . 0.0 108.635 -174.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.3 t -100.19 122.73 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.547 0.739 . . . . 0.0 110.065 173.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -96.34 109.7 22.17 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.594 1.158 . . . . 0.0 110.291 166.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -81.45 115.99 21.04 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.052 1.341 . . . . 0.0 107.923 170.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -148.44 170.1 18.75 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.955 0.902 . . . . 0.0 112.536 -167.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -144.17 149.2 36.06 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.168 0.587 . . . . 0.0 112.026 161.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.7 t -63.96 -22.44 66.92 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.029 0.932 . . . . 0.0 113.291 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -78.94 -5.91 54.93 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 43.4 t -105.39 130.33 53.52 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.186 0.994 . . . . 0.0 112.142 -177.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.38 -56.98 20.39 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.408 1.004 . . . . 0.0 113.539 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -55.83 -34.71 92.16 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.024 2.483 . . . . 0.0 114.448 173.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 96.5 m -62.62 -45.97 90.4 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.04 0.836 . . . . 0.0 111.512 172.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -62.81 -33.55 75.45 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.682 1.193 . . . . 0.0 112.406 175.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 97.2 mmm -75.35 -36.64 60.95 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.383 1.073 . . . . 0.0 113.784 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.9 p -83.3 -23.36 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 119.581 1.082 . . . . 0.0 113.606 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.42 -50.51 71.02 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.98 -27.85 42.38 Favored 'Trans proline' 0 C--N 1.353 0.783 0 CA-C-N 122.538 1.942 . . . . 0.0 113.239 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.4 t -73.37 -42.94 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 121.338 -0.851 . . . . 0.0 110.385 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.1 mt -64.73 -33.28 75.59 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.77 1.228 . . . . 0.0 112.776 171.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.43 -45.44 87.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.273 1.029 . . . . 0.0 111.422 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -61.07 -47.77 84.82 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.61 -0.682 . . . . 0.0 110.889 170.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.09 -36.06 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 120.985 -1.072 . . . . 0.0 112.582 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.64 -41.85 92.15 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.172 0.989 . . . . 0.0 112.201 173.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.1 m -73.98 -35.29 64.46 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.444 0.698 . . . . 0.0 111.356 -176.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -87.57 -38.39 16.01 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.118 1.367 . . . . 0.0 114.332 -175.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -104.19 12.08 34.24 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.511 1.124 . . . . 0.0 114.027 -168.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.55 -33.42 45.61 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.564 1.545 . . . . 0.0 114.51 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 m -71.33 -25.54 62.44 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.849 1.26 . . . . 0.0 112.755 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -101.73 -36.69 8.62 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.486 1.514 . . . . 0.0 112.869 -176.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.5 pp -147.65 164.42 33.58 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.857 1.663 . . . . 0.0 111.781 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.1 m -107.95 143.18 36.95 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.463 1.105 . . . . 0.0 109.371 169.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.6 t -115.36 128.05 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 118.966 0.803 . . . . 0.0 110.559 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.76 154.25 47.4 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.179 1.792 . . . . 0.0 112.077 -172.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -123.04 135.5 54.46 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.716 1.207 . . . . 0.0 112.495 173.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.02 116.95 29.27 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.839 1.656 . . . . 0.0 108.441 168.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.7 101.11 11.94 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.889 1.275 . . . . 0.0 110.138 -176.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.7 m -66.2 -16.5 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -173.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.63 -26.17 63.35 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.366 1.067 . . . . 0.0 113.195 175.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.7 t -119.12 -20.36 8.05 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.601 1.16 . . . . 0.0 113.427 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -123.29 63.98 25.86 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.6 1.16 . . . . 0.0 112.575 170.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.59 -18.34 58.91 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.584 2.189 . . . . 0.0 112.451 171.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -60.1 -46.68 88.79 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.598 1.159 . . . . 0.0 110.931 173.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.29 -31.31 60.66 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.503 1.121 . . . . 0.0 111.893 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.21 -44.99 96.39 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 123.99 0.916 . . . . 0.0 112.321 174.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.8 ptt-85 -82.08 -22.8 36.13 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 176.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -56.29 -40.8 74.87 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.311 0.96 . . . . 0.0 113.249 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -99.0 5.22 47.24 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.467 1.107 . . . . 0.0 113.077 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 47.12 55.3 8.24 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.312 1.845 . . . . 0.0 112.277 -166.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.6 m -113.73 19.52 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.862 1.665 . . . . 0.0 112.58 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.4 m -63.0 -16.85 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.772 1.629 . . . . 0.0 114.559 -175.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.2 m -78.47 48.61 0.79 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.801 2.041 . . . . 0.0 113.384 -176.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -59.83 155.17 43.49 Favored Pre-proline 0 CA--C 1.556 1.176 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 -163.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.74 141.96 68.03 Favored 'Cis proline' 0 C--N 1.355 0.878 0 CA-C-N 118.892 0.64 . . . . 0.0 111.85 -6.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.7 m -133.17 123.98 26.63 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.617 0.767 . . . . 0.0 109.868 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.4 mp -103.5 128.6 50.67 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.494 1.518 . . . . 0.0 108.981 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.1 mm -118.09 128.42 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.174 0.99 . . . . 0.0 109.065 167.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 17.3 tp -97.82 118.98 35.6 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 165.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -96.59 150.33 20.77 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.716 1.606 . . . . 0.0 109.739 170.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -128.52 134.18 48.61 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.606 1.163 . . . . 0.0 108.939 162.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.7 t0 48.67 41.47 17.79 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.197 0.999 . . . . 0.0 113.49 -175.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.02 15.97 70.1 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 124.72 1.153 . . . . 0.0 115.429 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -123.32 136.5 27.16 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.544 1.537 . . . . 0.0 109.574 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.38 139.37 45.27 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.633 2.222 . . . . 0.0 111.41 -177.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.6 t -126.19 -40.34 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.986 1.314 . . . . 0.0 112.517 -174.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -142.26 147.85 37.13 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 119.12 0.873 . . . . 0.0 112.854 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.8 ttt180 -126.2 137.89 53.59 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.056 2.143 . . . . 0.0 111.515 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.6 145.78 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.067 1.747 . . . . 0.0 109.744 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 p -137.05 149.47 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.374 1.069 . . . . 0.0 112.087 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.52 164.33 28.34 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.303 1.43 . . . . 0.0 112.527 -173.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.68 157.51 27.08 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 121.474 -1.016 . . . . 0.0 113.358 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -130.79 149.07 52.6 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.694 1.598 . . . . 0.0 110.464 169.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.89 166.69 41.26 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 160.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -50.49 -37.36 38.4 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.895 1.278 . . . . 0.0 114.03 -177.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.7 -47.79 68.4 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.195 0.598 . . . . 0.0 112.144 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.64 -43.5 72.52 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.464 -0.772 . . . . 0.0 111.982 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.7 tp -64.48 -45.66 86.43 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 122.044 -0.41 . . . . 0.0 110.81 177.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.8 tp -74.4 -18.37 60.67 Favored 'General case' 0 C--O 1.214 -0.807 0 CA-C-O 116.798 -1.572 . . . . 0.0 113.278 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -66.75 -52.75 40.71 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 123.359 2.8 . . . . 0.0 110.933 164.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -63.17 -24.36 67.85 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 86.4 mt -98.18 -19.62 17.77 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.076 0.95 . . . . 0.0 113.461 172.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.0 t -66.52 -23.08 66.18 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 120.584 -1.322 . . . . 0.0 110.809 167.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -54.69 -16.18 2.34 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.319 1.048 . . . . 0.0 113.54 164.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.37 -11.78 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.948 1.699 . . . . 0.0 114.043 169.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 N--CA 1.479 0.991 0 C-N-CA 128.164 2.586 . . . . 0.0 109.342 173.494 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.9 p . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.6 pt -139.51 155.25 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.02 1.728 . . . . 0.0 111.598 173.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -95.8 140.41 30.62 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.446 0.699 . . . . 0.0 110.117 161.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -117.33 150.7 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.403 1.481 . . . . 0.0 110.503 171.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.7 p -127.5 165.38 19.96 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.228 1.411 . . . . 0.0 111.354 -176.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -60.25 -27.79 67.52 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.91 -13.51 57.43 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.943 1.297 . . . . 0.0 114.188 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.4 m -126.55 -13.65 5.93 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -168.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -54.33 -42.08 69.77 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.228 1.411 . . . . 0.0 112.368 -173.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.33 -34.12 75.54 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.295 -0.878 . . . . 0.0 113.085 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.7 m -79.38 -28.09 41.88 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.476 1.11 . . . . 0.0 112.919 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -92.91 -40.9 10.34 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.352 -0.843 . . . . 0.0 113.234 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.4 t -99.39 -57.26 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.811 1.245 . . . . 0.0 111.191 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.1 mt -79.86 -18.69 50.11 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -171.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.8 m -85.56 -10.49 55.86 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.127 0.971 . . . . 0.0 113.045 174.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.4 t -79.9 130.4 35.27 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.787 0.835 . . . . 0.0 112.559 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -79.72 -21.29 44.74 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.964 0.906 . . . . 0.0 112.486 170.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -79.82 148.33 68.53 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 125.84 1.656 . . . . 0.0 110.517 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -58.51 132.55 49.09 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.035 1.824 . . . . 0.0 111.674 170.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.84 130.1 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.408 1.083 . . . . 0.0 110.647 -173.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.32 114.09 26.18 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.867 1.667 . . . . 0.0 108.665 -172.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.18 124.69 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.938 0.895 . . . . 0.0 110.727 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -104.28 116.3 31.91 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.421 1.089 . . . . 0.0 111.435 173.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -84.9 110.48 18.89 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.076 1.751 . . . . 0.0 108.375 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -143.63 171.28 14.4 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.56 1.144 . . . . 0.0 112.722 -164.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.54 154.81 39.32 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.791 0.836 . . . . 0.0 111.809 163.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.4 t -64.82 -20.88 66.63 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.957 0.903 . . . . 0.0 113.183 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.5 ' CZ3' HD11 ' A' ' 80' ' ' ILE . 11.7 p-90 -80.08 -1.56 40.55 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 177.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 50.8 t -109.77 117.31 33.53 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.226 1.01 . . . . 0.0 112.747 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.82 -47.72 89.0 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 124.363 0.983 . . . . 0.0 113.91 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -58.52 -31.6 94.73 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.925 2.417 . . . . 0.0 114.685 170.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 83.9 m -66.57 -45.02 80.68 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.481 1.037 . . . . 0.0 111.198 170.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -60.62 -29.69 69.38 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.552 0.741 . . . . 0.0 112.628 173.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 16.5 tpt -73.75 -42.64 60.81 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.757 1.223 . . . . 0.0 113.027 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.1 p -84.4 -21.33 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.32 -49.61 80.9 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -65.63 -30.13 51.41 Favored 'Trans proline' 0 C--N 1.353 0.764 0 CA-C-N 122.415 1.898 . . . . 0.0 113.003 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.4 t -68.23 -49.53 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 118.731 0.696 . . . . 0.0 110.124 175.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.5 mt -61.13 -34.93 75.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.136 0.975 . . . . 0.0 112.797 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -70.86 -40.29 72.42 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.218 0.917 . . . . 0.0 112.169 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -61.97 -42.51 99.21 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.09 -1.006 . . . . 0.0 111.516 169.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.7 mt -61.53 -43.76 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 118.771 0.714 . . . . 0.0 110.914 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.33 -37.65 81.27 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.988 0.915 . . . . 0.0 112.379 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.3 m -75.98 -47.18 26.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.776 0.83 . . . . 0.0 112.177 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -94.88 -21.81 18.42 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -167.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.41 16.61 23.72 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.591 1.556 . . . . 0.0 111.761 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.93 -27.93 47.09 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.1 1.76 . . . . 0.0 114.94 -173.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.9 p -78.35 -19.51 53.28 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.013 1.325 . . . . 0.0 113.845 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -111.17 -28.67 8.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.808 1.643 . . . . 0.0 113.57 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.7 mt -129.8 148.99 51.73 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.643 1.977 . . . . 0.0 111.04 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 57.8 m -108.62 133.01 53.32 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 153.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.0 t -103.18 130.96 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.477 0.711 . . . . 0.0 109.816 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.21 155.09 46.09 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.767 1.627 . . . . 0.0 112.011 -174.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -123.69 128.25 49.36 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.881 1.672 . . . . 0.0 110.548 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -108.16 113.86 27.31 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.6 102.24 10.52 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.116 0.966 . . . . 0.0 108.734 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.3 m -65.76 -17.18 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.887 -1.133 . . . . 0.0 112.787 -176.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -78.52 -20.0 51.72 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.941 1.296 . . . . 0.0 113.652 176.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.0 p -115.62 -22.42 9.22 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 174.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -129.46 62.61 64.01 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 125.641 1.576 . . . . 0.0 112.054 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -64.71 -20.71 65.24 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.804 2.336 . . . . 0.0 112.742 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -62.46 -39.92 94.98 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.897 0.879 . . . . 0.0 111.721 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -73.69 -37.24 65.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.842 0.857 . . . . 0.0 111.49 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.01 -43.78 95.01 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.496 0.719 . . . . 0.0 111.683 171.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.4 ttp-105 -73.74 -33.85 64.5 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -56.42 -42.43 78.03 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.505 1.122 . . . . 0.0 112.964 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -98.19 5.28 48.64 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.425 1.09 . . . . 0.0 113.334 174.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.36 15.8 pt20 46.81 25.74 0.48 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 128.298 2.639 . . . . 0.0 116.013 -168.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.2 m -80.46 39.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.744 2.017 . . . . 0.0 111.857 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.7 m -74.95 -21.66 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.966 1.306 . . . . 0.0 113.304 -172.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 54.2 m -80.92 137.94 36.13 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.773 1.229 . . . . 0.0 110.223 166.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.5 HD11 ' CZ3' ' A' ' 36' ' ' TRP . 48.1 pt -135.71 155.16 78.32 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -167.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -68.34 141.45 61.25 Favored 'Cis proline' 0 C--N 1.353 0.786 0 CA-C-N 119.212 0.754 . . . . 0.0 111.361 -6.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.4 m -126.94 120.57 29.46 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.274 0.63 . . . . 0.0 109.399 169.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.7 mp -102.57 126.11 49.53 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.942 1.697 . . . . 0.0 107.855 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.2 tt -118.25 139.22 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.228 1.011 . . . . 0.0 109.692 171.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.0 tp -113.16 129.7 56.43 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.408 1.083 . . . . 0.0 109.671 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -113.86 151.06 32.69 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.191 1.396 . . . . 0.0 110.402 171.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -132.48 127.99 36.43 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.305 1.442 . . . . 0.0 108.972 168.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.4 t70 49.05 41.49 19.37 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.297 1.039 . . . . 0.0 113.398 -168.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.33 9.7 55.36 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.626 1.584 . . . . 0.0 115.739 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -112.61 139.39 22.68 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 125.441 1.496 . . . . 0.0 109.845 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.14 140.03 43.91 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.536 2.157 . . . . 0.0 112.299 -171.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.8 t -117.71 -46.56 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.718 1.607 . . . . 0.0 111.469 -176.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -155.13 150.23 26.92 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.308 1.043 . . . . 0.0 112.052 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 67.6 ttp85 -129.81 139.17 51.29 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.061 1.345 . . . . 0.0 111.583 167.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 30.8 mt -132.25 142.58 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 127.388 2.275 . . . . 0.0 108.354 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 p -133.61 147.78 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.286 1.035 . . . . 0.0 112.022 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.98 161.92 24.54 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.541 1.543 . . . . 0.0 112.945 -175.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.73 151.71 28.72 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -136.66 153.19 50.98 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.353 1.861 . . . . 0.0 110.373 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.49 162.02 32.91 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 160.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -55.85 -34.12 65.15 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.81 -47.58 77.55 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 118.088 0.404 . . . . 0.0 111.18 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.13 -45.99 58.34 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.495 -0.753 . . . . 0.0 112.321 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.1 tp -65.73 -44.89 84.65 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 118.879 0.763 . . . . 0.0 110.685 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 16.7 tp -69.91 -24.93 63.46 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-O 115.825 -2.036 . . . . 0.0 112.753 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -65.24 -50.47 65.68 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 124.053 3.115 . . . . 0.0 111.644 168.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -62.54 -27.23 69.02 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 80.7 mt -87.57 -28.54 21.88 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.221 1.009 . . . . 0.0 113.439 169.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.3 m -62.37 -27.88 69.38 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.309 1.443 . . . . 0.0 110.608 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -49.49 -26.79 3.65 Favored 'General case' 0 CA--C 1.56 1.344 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 165.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.0 t -111.56 -22.36 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 128.223 2.609 . . . . 0.0 112.777 172.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.479 1.024 0 C-N-CA 127.632 2.373 . . . . 0.0 110.662 -179.787 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.9 p . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.2 pt -137.27 155.27 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 126.056 1.743 . . . . 0.0 111.546 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -93.61 139.13 31.13 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.389 0.675 . . . . 0.0 110.819 167.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.1 m -125.57 150.42 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.453 1.501 . . . . 0.0 110.571 172.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.3 p -143.28 157.33 44.57 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.302 1.441 . . . . 0.0 111.115 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -52.17 -28.09 16.85 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -174.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.06 -20.1 64.1 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.8 m -136.49 -3.87 2.1 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.386 1.474 . . . . 0.0 114.062 -176.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -53.51 -41.24 66.12 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.839 1.656 . . . . 0.0 112.526 -174.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.3 -33.16 74.71 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.6 m -79.51 -31.15 42.16 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.249 1.02 . . . . 0.0 112.643 175.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -88.81 -41.43 12.51 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -176.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.9 t -105.57 -52.46 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.106 1.363 . . . . 0.0 111.253 -172.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 29.3 mt -81.82 -13.45 57.66 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -171.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 74.6 m -89.21 -9.81 49.39 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.975 0.91 . . . . 0.0 113.346 175.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.3 t -77.58 140.47 39.69 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.044 0.938 . . . . 0.0 113.323 -174.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -98.78 -5.36 31.38 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.096 1.358 . . . . 0.0 113.559 176.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -98.56 162.84 20.41 Favored Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 124.588 1.155 . . . . 0.0 110.624 164.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -57.02 138.49 86.56 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.299 1.999 . . . . 0.0 113.448 170.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.7 t -132.62 131.41 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.451 1.5 . . . . 0.0 108.895 177.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -122.98 120.03 32.17 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.194 1.398 . . . . 0.0 109.279 -172.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.6 t -119.46 126.35 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.559 0.744 . . . . 0.0 111.138 -172.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -107.0 118.68 37.33 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.959 1.304 . . . . 0.0 112.455 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -94.08 111.57 23.3 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.582 1.953 . . . . 0.0 108.518 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -143.69 172.6 12.59 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.278 1.431 . . . . 0.0 112.884 -163.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -144.59 148.62 34.59 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 163.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 m -60.09 -27.85 67.35 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.675 1.19 . . . . 0.0 112.652 174.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 6.2 p-90 -76.61 -4.19 41.67 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 53.2 t -108.16 122.69 47.44 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.701 1.2 . . . . 0.0 111.792 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.38 -48.21 86.46 Favored Glycine 0 CA--C 1.539 1.543 0 CA-C-O 118.892 -0.949 . . . . 0.0 114.079 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -56.47 -36.24 97.37 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.045 2.497 . . . . 0.0 114.302 170.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 96.9 m -64.36 -45.18 88.87 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.279 -0.888 . . . . 0.0 111.88 173.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -62.39 -31.01 71.62 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.334 1.054 . . . . 0.0 112.397 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.4 ttp -75.69 -38.3 58.8 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.976 1.31 . . . . 0.0 113.376 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.2 p -83.91 -19.06 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.64 -51.42 76.45 Favored Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 175.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.85 -30.8 39.94 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.236 1.957 . . . . 0.0 113.058 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.521 HG13 ' HA ' ' A' ' 101' ' ' LYS . 30.0 t -64.28 -48.48 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.643 0.777 . . . . 0.0 110.68 173.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 38.9 mt -66.75 -32.94 74.57 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.453 0.701 . . . . 0.0 112.566 176.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -67.41 -42.05 83.89 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.136 0.88 . . . . 0.0 112.127 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.98 -47.86 81.34 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.314 -0.866 . . . . 0.0 111.635 170.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.4 -40.16 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 118.803 0.729 . . . . 0.0 110.822 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.8 -49.63 76.97 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.403 -0.811 . . . . 0.0 111.989 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.4 m -76.29 -31.32 58.16 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.55 0.74 . . . . 0.0 112.195 -171.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -95.74 -23.55 16.91 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -112.32 17.07 19.71 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.232 1.413 . . . . 0.0 113.292 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.04 -27.72 21.07 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.607 1.563 . . . . 0.0 114.351 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.3 p -67.79 -20.36 65.19 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.791 1.636 . . . . 0.0 113.87 176.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -117.29 -46.34 2.7 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.801 1.24 . . . . 0.0 112.72 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.9 mt -99.48 148.88 23.79 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.369 1.468 . . . . 0.0 111.126 -176.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.8 m -108.91 122.15 46.61 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 149.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 75.1 t -105.14 124.71 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.281 0.632 . . . . 0.0 110.126 -175.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.72 163.59 23.17 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.452 1.501 . . . . 0.0 112.326 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -130.31 147.3 52.01 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.694 1.598 . . . . 0.0 112.071 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -125.98 117.39 23.16 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.856 1.662 . . . . 0.0 108.83 169.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -81.75 113.24 19.59 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 122.883 0.473 . . . . 0.0 110.422 174.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.8 m -70.87 -16.95 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -172.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -84.17 -39.71 19.06 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.42 1.088 . . . . 0.0 112.43 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 36.3 p -92.66 -23.6 18.92 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.183 1.393 . . . . 0.0 113.893 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -134.88 69.69 71.1 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-N 119.499 1.045 . . . . 0.0 112.055 173.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -66.76 -26.72 45.1 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.153 2.569 . . . . 0.0 114.768 -172.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -64.11 -35.7 81.62 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.608 -0.683 . . . . 0.0 111.817 -175.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.2 m -64.05 -43.26 96.04 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.311 1.044 . . . . 0.0 111.309 176.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.35 -39.61 95.01 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.737 0.815 . . . . 0.0 112.018 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.34 -45.25 63.39 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.296 177.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -63.99 -32.73 74.38 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 118.878 0.763 . . . . 0.0 112.782 -171.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -98.45 8.04 45.4 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.344 1.058 . . . . 0.0 113.746 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.1 tp60 49.88 52.59 14.34 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.462 1.905 . . . . 0.0 113.35 -177.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.1 m -132.88 48.61 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.216 1.806 . . . . 0.0 109.647 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.5 m -78.42 -21.47 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.228 1.411 . . . . 0.0 113.657 -176.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.1 m -72.09 155.73 39.97 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.747 1.219 . . . . 0.0 111.112 168.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.61 149.28 49.96 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -174.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.43 136.65 41.25 Favored 'Cis proline' 0 C--N 1.353 0.771 0 N-CA-C 110.424 -0.644 . . . . 0.0 110.424 -14.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 98.7 m -127.88 121.38 29.89 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.851 0.86 . . . . 0.0 110.485 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.0 mp -102.26 132.31 48.29 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.368 1.467 . . . . 0.0 109.223 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.9 tp -121.9 128.13 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.992 1.317 . . . . 0.0 109.376 171.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 41.3 tp -108.23 127.97 54.31 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.005 1.322 . . . . 0.0 110.309 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -113.69 144.18 43.37 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.985 1.714 . . . . 0.0 109.535 172.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -107.22 -29.75 9.15 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -150.01 40.79 0.81 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.715 2.006 . . . . 0.0 109.913 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.92 -6.07 7.06 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 125.354 1.454 . . . . 0.0 115.141 -165.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -94.63 138.2 22.33 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 118.787 1.293 . . . . 0.0 110.607 167.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.51 146.07 38.74 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.353 2.702 . . . . 0.0 112.114 -176.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.6 m -132.99 -24.99 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -177.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 107' ' ' GLU . 33.0 tttp -153.59 143.81 22.23 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.715 1.143 . . . . 0.0 111.67 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -128.9 137.93 51.71 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.854 2.062 . . . . 0.0 110.783 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.6 mt -135.18 141.58 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.91 1.684 . . . . 0.0 108.721 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 p -133.81 142.18 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 119.398 0.999 . . . . 0.0 111.127 168.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 91.86 150.0 24.94 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.273 1.416 . . . . 0.0 112.955 -171.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.42 144.67 31.25 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.074 0.95 . . . . 0.0 113.147 -174.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -134.56 159.99 39.46 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.067 1.747 . . . . 0.0 110.7 172.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -74.88 166.36 54.86 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.429 -0.669 . . . . 0.0 111.429 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.521 ' HA ' HG13 ' A' ' 46' ' ' VAL . 3.0 tmtp? -51.0 -37.33 44.38 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.836 1.254 . . . . 0.0 113.384 -173.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.95 -49.41 52.08 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.05 0.386 . . . . 0.0 111.76 -177.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.73 -37.59 59.26 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.548 0.739 . . . . 0.0 112.792 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.29 -45.44 87.99 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.4 1.0 . . . . 0.0 109.733 174.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 21.4 tp -70.2 -20.09 63.13 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-O 116.402 -1.761 . . . . 0.0 112.989 171.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.72 -54.12 49.18 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 123.802 3.001 . . . . 0.0 110.239 166.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.407 ' HB3' ' HE2' ' A' ' 93' ' ' LYS . 40.3 mm-40 -63.62 -26.59 68.75 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 114.43 -1.259 . . . . 0.0 113.136 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 82.4 mt -91.34 -21.82 20.83 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 168.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 31.8 m -65.84 -20.73 66.35 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.785 -1.197 . . . . 0.0 111.214 172.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -47.1 -27.3 1.33 Allowed 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 160.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -116.79 -25.13 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.701 1.6 . . . . 0.0 113.749 177.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.484 1.235 0 C-N-CA 125.604 1.561 . . . . 0.0 112.667 171.337 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.474 0.754 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.2 pt -142.03 159.59 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 126.474 1.91 . . . . 0.0 111.278 174.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -100.04 140.15 34.68 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.64 0.776 . . . . 0.0 110.22 163.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.6 m -130.12 145.96 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.469 1.108 . . . . 0.0 111.557 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.0 p -140.35 159.27 42.57 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.39 1.476 . . . . 0.0 111.236 176.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -51.74 -27.95 13.6 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.615 1.966 . . . . 0.0 114.805 -173.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.23 -22.02 65.71 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.8 m -136.73 1.19 2.53 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.677 1.591 . . . . 0.0 113.547 -175.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -55.48 -42.68 74.71 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.461 1.504 . . . . 0.0 112.461 -170.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.12 -32.11 73.36 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.6 m -79.01 -32.76 45.23 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.493 -0.754 . . . . 0.0 111.892 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -87.97 -40.78 13.62 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t -101.52 -40.09 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.203 1.401 . . . . 0.0 112.406 -171.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -100.76 -20.07 15.73 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -170.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.8 m -94.18 8.13 42.8 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.041 1.336 . . . . 0.0 113.768 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.7 p -69.52 157.21 37.59 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.007 2.123 . . . . 0.0 114.591 -176.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -87.87 -6.57 58.02 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.525 1.13 . . . . 0.0 113.557 173.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -142.21 166.35 21.81 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 127.744 2.418 . . . . 0.0 110.769 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -56.33 148.24 62.57 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.978 2.452 . . . . 0.0 113.694 173.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.2 t -132.49 128.97 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.975 1.31 . . . . 0.0 110.347 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 tt -98.05 128.16 44.42 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.255 1.822 . . . . 0.0 108.64 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.9 t -116.02 125.42 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 119.516 1.053 . . . . 0.0 110.898 172.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -106.55 114.49 28.64 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.827 1.651 . . . . 0.0 111.315 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -92.39 109.0 20.38 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.927 2.091 . . . . 0.0 108.016 175.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -142.19 -178.5 5.75 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.1 1.36 . . . . 0.0 111.372 -163.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.61 141.14 30.49 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 166.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 46.9 m -56.73 -29.94 63.02 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.524 1.53 . . . . 0.0 112.117 172.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 35.6 p-90 -88.74 -0.9 57.76 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.85 1.66 . . . . 0.0 115.138 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 48.1 t -110.11 134.21 52.41 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.473 1.033 . . . . 0.0 113.238 -172.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.37 -57.06 14.2 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.17 1.367 . . . . 0.0 115.477 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.21 -27.36 72.53 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 CA-C-N 120.939 2.37 . . . . 0.0 112.903 175.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 93.0 m -63.76 -43.97 94.84 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.129 -0.982 . . . . 0.0 111.74 169.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.01 -30.48 71.55 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.195 0.998 . . . . 0.0 112.553 173.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 15.8 tpt -73.35 -38.47 65.73 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.657 1.183 . . . . 0.0 113.353 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.4 p -84.42 -20.82 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.09 -50.31 82.81 Favored Pre-proline 0 CA--C 1.552 1.022 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.22 -29.67 32.23 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.293 1.995 . . . . 0.0 113.147 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.466 HG13 ' HA ' ' A' ' 101' ' ' LYS . 41.9 t -65.26 -49.18 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.409 0.684 . . . . 0.0 110.21 173.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.6 mt -63.99 -33.61 76.11 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.802 0.841 . . . . 0.0 112.709 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -64.14 -44.85 90.9 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.302 0.955 . . . . 0.0 111.517 174.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -61.63 -45.39 94.28 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.325 -0.859 . . . . 0.0 111.492 173.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.4 mt -59.68 -43.74 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 121.415 -0.803 . . . . 0.0 111.068 176.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.55 -37.26 86.65 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.102 0.961 . . . . 0.0 112.642 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.4 m -73.62 -46.89 44.23 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.784 0.834 . . . . 0.0 111.236 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -87.27 -35.49 18.44 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.498 1.119 . . . . 0.0 114.004 -170.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -99.72 24.7 8.0 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.598 1.159 . . . . 0.0 113.273 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.88 -28.12 47.9 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.109 1.363 . . . . 0.0 114.311 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.0 p -83.25 -19.39 36.47 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.296 1.438 . . . . 0.0 113.834 175.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -102.62 -38.15 7.63 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.082 1.353 . . . . 0.0 112.79 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 79.8 mt -129.8 160.89 32.07 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.34 2.256 . . . . 0.0 110.944 -175.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.4 m -108.8 138.8 44.54 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 147.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.5 t -101.29 129.97 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.82 0.848 . . . . 0.0 109.5 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.4 151.83 48.3 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.275 1.43 . . . . 0.0 111.557 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -127.67 148.8 50.4 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.987 1.315 . . . . 0.0 113.123 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -135.33 114.47 12.25 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.644 1.977 . . . . 0.0 108.875 168.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -81.39 116.34 21.17 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 171.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.5 m -64.55 -20.25 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -167.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -79.88 -22.58 42.68 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 172.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.1 p -92.57 -29.1 16.34 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -171.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -145.53 92.58 5.5 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 123.932 0.893 . . . . 0.0 110.73 162.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -62.46 -26.48 76.49 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.255 2.636 . . . . 0.0 114.894 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -71.78 -31.72 66.9 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.048 -1.033 . . . . 0.0 111.858 -175.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.5 m -65.75 -41.12 92.49 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.449 0.7 . . . . 0.0 110.786 174.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.1 -35.6 80.13 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.022 0.929 . . . . 0.0 112.609 172.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.3 tpt85 -73.49 -36.63 65.81 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -65.4 -28.64 69.4 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -172.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -103.14 5.34 37.79 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.35 1.06 . . . . 0.0 113.207 174.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 48.56 57.05 6.69 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.835 1.654 . . . . 0.0 112.172 -169.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.6 m -124.81 36.03 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.645 1.978 . . . . 0.0 111.038 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.7 m -71.67 -19.3 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.344 1.058 . . . . 0.0 113.156 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.2 m -68.01 151.73 46.62 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.408 1.483 . . . . 0.0 111.507 169.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 13.5 pt -139.31 142.53 32.84 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -168.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -67.71 149.08 82.48 Favored 'Cis proline' 0 CA--C 1.54 0.797 0 CA-C-N 118.498 0.499 . . . . 0.0 111.121 -17.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 67.7 m -133.42 125.15 28.44 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.756 1.222 . . . . 0.0 109.399 171.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.6 mp -109.28 136.48 48.67 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.593 1.157 . . . . 0.0 109.334 177.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.0 tt -127.9 144.87 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.202 1.001 . . . . 0.0 110.284 169.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.5 tp -121.52 120.44 34.87 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.941 0.897 . . . . 0.0 110.54 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -98.4 131.08 44.97 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.559 1.144 . . . . 0.0 109.604 172.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -99.59 -33.49 10.61 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -175.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -154.49 57.11 0.7 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.215 1.806 . . . . 0.0 110.174 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.5 15.87 64.47 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.51 1.052 . . . . 0.0 114.551 -173.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -140.31 137.56 17.98 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 126.966 2.106 . . . . 0.0 110.546 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -76.14 142.72 24.82 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.193 2.595 . . . . 0.0 112.645 -173.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.1 t -128.66 -28.6 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.689 1.596 . . . . 0.0 112.697 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -135.16 142.15 46.06 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.07 1.348 . . . . 0.0 110.077 172.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.8 ttt85 -147.03 113.22 5.86 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.957 2.103 . . . . 0.0 109.6 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 33.9 pt -137.05 148.17 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.377 1.471 . . . . 0.0 113.152 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.9 m -121.64 145.77 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 125.637 1.575 . . . . 0.0 111.195 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.95 160.49 24.32 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 124.164 0.888 . . . . 0.0 113.557 -172.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.39 145.53 31.96 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.853 0.861 . . . . 0.0 112.769 -176.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -130.59 153.33 49.01 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.801 1.641 . . . . 0.0 110.056 169.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -74.18 165.54 54.78 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 175.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.466 ' HA ' HG13 ' A' ' 46' ' ' VAL . 3.0 tmtp? -51.69 -35.22 41.89 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.665 1.186 . . . . 0.0 113.308 -174.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.48 -53.99 29.03 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.0 0.364 . . . . 0.0 111.197 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.44 -33.13 60.87 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.53 -45.09 94.57 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.472 1.033 . . . . 0.0 109.631 171.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 25.7 tp -69.41 -24.23 63.82 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-O 115.691 -2.099 . . . . 0.0 113.112 173.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.76 -51.04 69.95 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 124.295 3.225 . . . . 0.0 111.524 167.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -57.39 -37.53 72.81 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.05 0.94 . . . . 0.0 111.73 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.8 mt -83.16 -28.35 29.43 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 172.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.4 m -62.56 -28.15 69.67 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.037 1.335 . . . . 0.0 110.641 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -52.5 -26.6 13.44 Favored 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 168.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 51.3 t -107.3 -24.41 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.886 2.074 . . . . 0.0 112.519 171.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.4 t . . . . . 0 N--CA 1.475 0.823 0 C-N-CA 126.537 1.935 . . . . 0.0 111.502 -177.587 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.6 p . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.9 pt -132.84 165.34 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 126.209 1.803 . . . . 0.0 111.413 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -117.28 145.42 43.98 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.88 0.872 . . . . 0.0 111.753 171.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.15 156.47 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 126.326 1.851 . . . . 0.0 110.964 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 65.2 p -123.85 168.57 12.58 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.912 1.685 . . . . 0.0 111.566 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -57.29 -27.58 62.28 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 121.018 -1.051 . . . . 0.0 113.136 175.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.6 -13.31 56.74 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.224 1.409 . . . . 0.0 114.515 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.1 p -128.88 -8.91 4.94 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -173.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -57.06 -47.91 79.82 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.282 1.433 . . . . 0.0 112.055 -176.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.61 -34.28 77.52 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.3 -0.875 . . . . 0.0 112.699 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.23 -8.71 59.24 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.755 1.622 . . . . 0.0 113.666 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -121.81 -47.87 2.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.501 1.12 . . . . 0.0 113.455 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.3 t -83.16 -51.45 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.15 1.38 . . . . 0.0 111.037 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 43.3 mt -84.67 -13.22 52.11 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -174.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.7 p -78.17 -18.8 55.08 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.955 1.302 . . . . 0.0 113.785 176.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.5 t -86.05 133.24 33.91 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.63 1.172 . . . . 0.0 113.459 -168.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -75.77 -31.62 59.6 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.389 1.076 . . . . 0.0 111.528 168.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -80.68 138.88 50.62 Favored Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 124.891 1.276 . . . . 0.0 108.85 174.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -59.07 142.44 99.35 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 121.388 1.392 . . . . 0.0 113.507 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.5 t -124.35 125.67 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.384 1.474 . . . . 0.0 109.354 -177.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -108.39 115.25 29.75 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.655 1.582 . . . . 0.0 109.303 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.2 t -108.76 122.42 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.186 0.994 . . . . 0.0 110.829 -175.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -92.33 109.3 20.68 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.732 1.613 . . . . 0.0 111.021 173.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -83.61 112.86 20.4 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.793 1.237 . . . . 0.0 108.497 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -146.41 168.57 20.82 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.22 1.008 . . . . 0.0 113.033 -164.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.18 155.27 38.52 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.755 1.222 . . . . 0.0 110.974 166.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.9 t -66.05 -19.18 65.77 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -75.56 -4.44 39.94 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 48.5 t -109.29 108.83 19.56 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.348 1.059 . . . . 0.0 112.535 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.59 -40.43 94.6 Favored Glycine 0 CA--C 1.54 1.633 0 CA-C-O 118.848 -0.973 . . . . 0.0 113.972 174.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -60.44 -33.08 94.42 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.44 2.093 . . . . 0.0 114.459 168.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 91.1 m -63.69 -44.75 92.76 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.812 1.187 . . . . 0.0 110.735 168.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -60.0 -36.31 76.93 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 175.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 13.2 ptm -80.44 -29.97 37.56 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.2 p -84.6 -24.01 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-N 119.8 1.182 . . . . 0.0 113.563 174.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.13 -48.72 63.45 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 176.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -65.83 -29.1 50.64 Favored 'Trans proline' 0 C--N 1.353 0.777 0 CA-C-N 122.216 1.827 . . . . 0.0 113.475 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.3 t -69.15 -51.34 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 119.374 0.988 . . . . 0.0 110.334 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.0 pp -70.22 -28.43 65.26 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -68.65 -40.22 80.31 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.147 0.979 . . . . 0.0 112.932 171.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -63.23 -47.21 83.46 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.928 -1.107 . . . . 0.0 111.348 170.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.22 -37.88 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 118.483 0.583 . . . . 0.0 110.679 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.65 -49.96 75.61 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.276 0.944 . . . . 0.0 112.752 172.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.1 m -76.05 -33.27 59.6 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.843 0.857 . . . . 0.0 111.681 -169.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -83.92 -34.08 24.57 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 176.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -108.1 27.71 9.0 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.946 1.298 . . . . 0.0 113.744 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.02 -28.33 62.39 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.4 m -69.47 -27.35 65.15 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.08 1.352 . . . . 0.0 112.523 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -103.57 -34.28 8.71 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.44 1.496 . . . . 0.0 112.816 -174.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.5 mt -129.85 152.72 49.02 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.141 2.176 . . . . 0.0 111.178 -174.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.5 m -108.65 133.85 52.18 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 150.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.5 t -110.62 121.44 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 122.993 0.517 . . . . 0.0 109.862 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -118.06 164.84 14.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.521 1.528 . . . . 0.0 112.19 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 46.0 mttm -124.86 136.53 53.89 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.066 1.747 . . . . 0.0 111.463 173.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -113.2 117.22 31.28 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.992 1.317 . . . . 0.0 108.496 167.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.81 98.07 8.3 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.905 1.282 . . . . 0.0 108.604 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.3 m -67.06 -19.29 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 O-C-N 121.362 -0.836 . . . . 0.0 112.992 -172.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -72.42 -23.22 61.05 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.429 1.092 . . . . 0.0 112.555 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.5 p -118.2 -15.56 9.79 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.469 1.508 . . . . 0.0 113.593 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -123.3 60.94 18.42 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 125.392 1.477 . . . . 0.0 111.864 176.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.69 -23.57 56.15 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.591 2.194 . . . . 0.0 112.546 178.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -64.76 -42.9 94.77 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.006 0.922 . . . . 0.0 111.815 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.68 -37.02 73.59 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.575 0.75 . . . . 0.0 111.121 176.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.83 -47.1 86.61 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.76 0.824 . . . . 0.0 112.34 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 -77.43 -24.61 50.35 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -57.49 -41.41 80.68 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.935 0.894 . . . . 0.0 112.858 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -101.1 6.02 43.1 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.892 1.277 . . . . 0.0 113.219 174.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.376 16.2 pt20 46.38 29.35 0.85 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 128.286 2.634 . . . . 0.0 115.84 -166.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.5 m -80.68 38.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 126.66 1.984 . . . . 0.0 111.93 174.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 m -75.13 -25.29 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.947 1.299 . . . . 0.0 112.606 -175.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 55.6 m -78.61 140.39 38.46 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.731 1.212 . . . . 0.0 110.051 165.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 48.9 pt -138.96 155.4 72.97 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 123.884 0.874 . . . . 0.0 113.183 -168.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.41 141.94 63.98 Favored 'Cis proline' 0 C--N 1.354 0.835 0 CA-C-N 119.393 0.819 . . . . 0.0 111.96 -5.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.6 m -131.68 121.59 24.54 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.628 0.771 . . . . 0.0 109.812 171.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.1 mp -108.07 119.46 39.54 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.856 1.662 . . . . 0.0 108.553 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.4 tt -116.64 133.2 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.413 1.085 . . . . 0.0 110.651 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.6 tt -104.43 125.0 50.23 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.036 0.934 . . . . 0.0 110.385 173.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -102.69 144.65 30.8 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.339 1.456 . . . . 0.0 109.942 166.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -130.2 129.43 43.38 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.479 1.511 . . . . 0.0 109.34 172.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.8 t0 47.62 37.59 6.92 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.359 1.064 . . . . 0.0 113.323 -167.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.15 18.68 71.33 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 125.048 1.309 . . . . 0.0 116.364 -178.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -122.92 143.1 39.65 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 119.461 1.631 . . . . 0.0 110.87 172.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.28 140.3 44.11 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.749 2.3 . . . . 0.0 112.24 -173.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.7 t -123.79 -44.79 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.124 1.37 . . . . 0.0 112.629 -175.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.6 tttm -148.83 152.52 36.64 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.944 0.793 . . . . 0.0 112.129 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -138.51 141.46 39.37 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.559 1.144 . . . . 0.0 112.382 173.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.8 mp -129.4 139.49 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 127.361 2.265 . . . . 0.0 108.393 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.3 p -132.03 142.86 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.355 1.062 . . . . 0.0 111.237 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.78 154.92 19.62 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.11 1.338 . . . . 0.0 112.549 -169.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.39 137.18 46.36 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.865 -0.785 . . . . 0.0 111.904 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -131.8 154.63 48.92 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.78 1.632 . . . . 0.0 110.946 174.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -76.13 166.53 54.41 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 172.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -54.6 -33.39 60.33 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.08 -56.06 25.31 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 123.219 0.324 . . . . 0.0 110.95 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.75 -37.89 58.92 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.313 -0.867 . . . . 0.0 113.286 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.5 tp -66.17 -36.04 82.04 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 119.905 1.23 . . . . 0.0 110.906 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 16.9 tp -74.17 -24.55 59.4 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-O 115.722 -2.085 . . . . 0.0 113.073 170.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -56.91 -54.21 49.16 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 124.319 3.236 . . . . 0.0 110.375 163.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -68.53 -26.02 65.23 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -174.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 93.3 mt -93.75 -25.6 17.35 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.043 0.937 . . . . 0.0 113.435 172.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.3 t -67.79 -21.61 65.23 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.418 1.087 . . . . 0.0 111.614 171.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -49.44 -25.69 2.76 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 161.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 70.6 t -111.07 -25.6 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 127.436 2.294 . . . . 0.0 112.496 172.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.4 t . . . . . 0 N--CA 1.482 1.14 0 C-N-CA 127.172 2.189 . . . . 0.0 111.186 177.702 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.8 p . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 45.5 pt -134.29 162.73 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 126.104 1.762 . . . . 0.0 110.484 171.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -120.04 146.6 45.74 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.579 -0.7 . . . . 0.0 112.7 165.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.3 m -120.19 155.06 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.446 1.898 . . . . 0.0 110.973 -176.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.5 p -131.79 161.99 31.6 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.793 1.237 . . . . 0.0 112.684 -174.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.83 -26.09 57.55 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.087 1.355 . . . . 0.0 114.629 -175.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.61 -16.15 52.42 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.701 1.2 . . . . 0.0 114.19 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.7 m -134.44 -5.57 2.59 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -168.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -53.97 -41.89 68.34 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.069 1.348 . . . . 0.0 112.653 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.67 -32.51 73.23 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.9 m -78.85 -32.11 45.94 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.292 1.037 . . . . 0.0 111.921 176.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -87.32 -44.54 11.32 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.5 t -98.83 -51.92 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.964 1.306 . . . . 0.0 111.592 -173.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 33.5 mt -84.56 -13.47 51.67 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -170.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.8 t -81.11 -12.07 59.34 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.263 1.025 . . . . 0.0 112.894 173.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.3 t -69.67 142.69 53.35 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -171.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.2 p-10 -94.62 3.24 55.33 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.792 1.637 . . . . 0.0 113.76 173.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -126.48 167.08 18.27 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 126.946 2.098 . . . . 0.0 111.043 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -58.21 138.78 87.71 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.318 2.012 . . . . 0.0 113.257 170.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.8 t -132.58 129.33 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.09 1.356 . . . . 0.0 109.139 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -116.93 115.52 25.64 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.359 1.464 . . . . 0.0 109.231 -173.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.7 t -110.65 121.19 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.454 0.702 . . . . 0.0 110.828 -174.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -91.24 106.34 18.44 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.539 1.535 . . . . 0.0 110.6 173.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -80.61 114.34 19.43 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.088 1.355 . . . . 0.0 108.68 173.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.6 p-90 -147.94 168.64 21.75 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.979 0.911 . . . . 0.0 113.021 -164.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.53 153.87 36.59 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.402 1.081 . . . . 0.0 110.672 161.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.3 t -65.6 -20.05 66.16 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -75.22 -10.47 59.5 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 173.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 45.2 t -98.19 110.98 23.46 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.919 0.888 . . . . 0.0 110.969 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.08 -49.03 69.77 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-O 118.768 -1.018 . . . . 0.0 113.306 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -57.62 -32.57 94.81 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.032 2.488 . . . . 0.0 114.829 172.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 68.6 m -67.24 -44.84 78.46 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.914 -1.116 . . . . 0.0 111.157 171.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -63.03 -29.66 70.99 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.284 1.034 . . . . 0.0 112.177 176.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 60.7 mtt -75.82 -36.69 59.61 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.566 1.547 . . . . 0.0 113.782 173.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -87.32 -22.81 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 119.432 1.015 . . . . 0.0 113.677 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.74 -47.31 72.36 Favored Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 174.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -66.61 -27.01 45.96 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 CA-C-N 122.338 1.871 . . . . 0.0 113.735 176.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 92.1 t -70.96 -47.02 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.452 1.024 . . . . 0.0 109.305 173.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.64 -37.62 82.1 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.219 1.408 . . . . 0.0 112.269 177.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -66.33 -39.36 89.18 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.156 0.982 . . . . 0.0 112.503 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -67.26 -44.13 80.14 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.522 -0.736 . . . . 0.0 111.64 172.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.2 mm -61.24 -39.95 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 119.548 1.067 . . . . 0.0 111.055 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.09 -46.96 86.94 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.32 -0.863 . . . . 0.0 112.104 175.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.9 m -76.32 -34.77 59.01 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.546 0.738 . . . . 0.0 112.716 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -98.92 -16.95 18.6 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -172.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 74.5 mmt-85 -121.48 21.32 11.0 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.314 1.445 . . . . 0.0 113.438 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.95 -27.63 19.81 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.68 1.592 . . . . 0.0 114.03 175.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.2 p -70.14 -21.39 63.09 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.575 1.55 . . . . 0.0 114.113 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -117.39 -35.3 4.05 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.497 1.119 . . . . 0.0 113.484 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 57.3 mt -119.5 155.17 32.62 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.978 1.711 . . . . 0.0 110.843 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 57.1 m -108.73 126.19 52.73 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 152.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.7 t -102.58 123.26 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.095 0.558 . . . . 0.0 110.404 -177.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.23 165.62 17.96 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.891 1.676 . . . . 0.0 111.769 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -126.72 140.55 52.31 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.221 1.408 . . . . 0.0 111.386 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -116.06 116.99 28.87 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.362 1.065 . . . . 0.0 108.93 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.95 97.62 7.54 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.179 1.392 . . . . 0.0 108.615 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.9 m -66.42 -19.85 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 121.391 -0.818 . . . . 0.0 113.139 -173.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -72.69 -22.94 60.83 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.123 0.969 . . . . 0.0 112.596 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.4 p -117.42 -16.02 10.26 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.601 1.561 . . . . 0.0 113.41 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -123.3 59.05 14.04 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 125.21 1.404 . . . . 0.0 112.301 176.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -65.32 -25.96 56.47 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.52 2.147 . . . . 0.0 112.542 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -63.94 -45.06 90.85 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.981 0.912 . . . . 0.0 111.533 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.3 m -66.77 -38.6 86.9 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.629 0.772 . . . . 0.0 111.363 175.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.56 -43.75 98.04 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.612 0.765 . . . . 0.0 112.686 177.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.9 ptt85 -78.09 -26.74 48.26 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -56.69 -40.83 76.29 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.184 0.994 . . . . 0.0 113.465 -177.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -98.56 4.65 48.16 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.085 0.954 . . . . 0.0 113.256 177.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 52.57 49.25 20.8 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.357 1.863 . . . . 0.0 112.944 -167.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.0 m -115.23 22.5 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.721 1.608 . . . . 0.0 113.144 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.1 m -61.79 -22.29 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.062 1.345 . . . . 0.0 113.444 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.6 m -77.38 70.15 3.73 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.404 1.881 . . . . 0.0 112.077 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.2 pt -73.37 148.01 87.97 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.14 138.35 44.0 Favored 'Cis proline' 0 C--N 1.353 0.797 0 CA-C-N 119.567 0.881 . . . . 0.0 112.798 -3.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.6 m -135.8 125.4 25.25 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.115 0.966 . . . . 0.0 109.873 167.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.2 mp -93.44 132.44 37.7 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.86 1.264 . . . . 0.0 108.16 161.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.14 126.17 73.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 168.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 40.2 tp -104.37 119.0 37.98 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.744 1.618 . . . . 0.0 109.874 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -98.08 147.75 24.23 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.595 1.558 . . . . 0.0 110.143 171.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -126.01 130.55 51.4 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.673 1.189 . . . . 0.0 109.033 165.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.7 t70 51.04 35.18 12.24 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.658 1.183 . . . . 0.0 113.592 -174.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.2 15.96 72.74 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 124.954 1.264 . . . . 0.0 115.986 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -116.68 140.73 27.14 Favored Pre-proline 0 N--CA 1.473 0.712 0 CA-C-N 119.064 1.432 . . . . 0.0 110.442 172.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.1 139.94 40.22 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.689 2.259 . . . . 0.0 111.833 -176.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 72.0 t -128.64 -43.2 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.423 1.089 . . . . 0.0 113.184 -174.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -145.48 152.47 39.82 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 119.445 1.021 . . . . 0.0 112.976 -175.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -128.08 140.17 52.1 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.862 1.665 . . . . 0.0 111.389 171.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.0 mt -133.4 139.12 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.266 1.826 . . . . 0.0 108.474 174.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.1 m -131.51 151.64 35.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 123.557 0.743 . . . . 0.0 112.987 -171.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.12 171.96 17.32 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 123.805 0.717 . . . . 0.0 113.406 -172.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.66 153.23 41.31 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.7 -0.882 . . . . 0.0 112.227 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.14 159.1 42.92 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.404 1.882 . . . . 0.0 109.855 165.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.48 161.49 50.15 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 159.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -50.75 -34.04 25.54 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -177.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.02 -49.21 75.52 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.5 -34.84 47.13 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.894 0.878 . . . . 0.0 113.091 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.03 -47.67 73.64 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.378 0.99 . . . . 0.0 110.037 175.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -62.93 -41.93 99.64 Favored 'General case' 0 C--O 1.206 -1.23 0 CA-C-O 115.497 -2.192 . . . . 0.0 110.413 171.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -53.32 -50.47 64.91 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 124.136 3.153 . . . . 0.0 112.03 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -67.63 -30.45 70.03 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.3 mt -83.09 -24.71 32.56 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.808 1.186 . . . . 0.0 113.525 169.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.9 t -72.45 -21.84 61.17 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 129.164 2.986 . . . . 0.0 111.186 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -45.94 -26.48 0.71 Allowed 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 156.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.9 t -111.13 -51.8 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 127.321 2.249 . . . . 0.0 113.022 166.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 92.3 t . . . . . 0 N--CA 1.482 1.16 0 C-N-CA 127.276 2.23 . . . . 0.0 110.829 -178.684 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.0 p . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.9 pt -129.41 155.43 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.699 1.6 . . . . 0.0 111.258 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -98.89 139.69 34.18 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.846 0.858 . . . . 0.0 111.275 170.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -126.43 155.57 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.923 1.689 . . . . 0.0 111.197 174.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 80.6 p -141.56 158.73 43.47 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.822 1.649 . . . . 0.0 110.48 173.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -52.64 -29.64 27.27 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.082 1.353 . . . . 0.0 114.254 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.09 -21.12 66.35 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.0 m -131.42 -4.43 3.79 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.623 1.569 . . . . 0.0 113.715 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -53.2 -40.67 64.6 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.29 1.836 . . . . 0.0 112.637 -175.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.23 -33.11 74.66 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.364 -0.835 . . . . 0.0 113.154 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.4 m -79.72 -31.4 41.14 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.254 1.022 . . . . 0.0 112.714 174.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -89.01 -39.46 13.67 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.302 -0.874 . . . . 0.0 113.194 -175.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.5 t -106.21 -53.43 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.116 1.366 . . . . 0.0 110.956 -173.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 46.7 mt -80.05 -18.36 50.3 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.179 1.178 . . . . 0.0 114.179 -173.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.6 m -91.92 -2.76 56.63 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.067 0.947 . . . . 0.0 113.293 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.0 t -69.39 141.0 54.23 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.046 0.939 . . . . 0.0 112.71 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.59 4.81 52.77 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.446 1.499 . . . . 0.0 112.7 176.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -130.83 166.94 23.73 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 126.918 2.087 . . . . 0.0 111.03 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.17 135.99 71.9 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 121.824 1.682 . . . . 0.0 112.164 171.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.5 p -139.46 122.73 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.443 1.097 . . . . 0.0 110.918 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.09 129.42 46.96 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.253 2.221 . . . . 0.0 108.503 -175.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.0 t -119.8 125.42 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.618 1.167 . . . . 0.0 110.162 175.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -107.23 112.97 26.1 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.607 1.163 . . . . 0.0 111.344 174.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -82.6 113.57 20.39 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.487 1.515 . . . . 0.0 108.052 174.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.467 ' CD1' ' HE3' ' A' ' 62' ' ' LYS . 1.3 p-90 -148.82 170.73 17.59 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -166.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.13 156.33 40.78 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.323 1.049 . . . . 0.0 111.7 165.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.6 p -64.47 -20.71 66.36 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.976 1.311 . . . . 0.0 113.672 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.454 ' CZ3' HD11 ' A' ' 80' ' ' ILE . 11.8 p-90 -82.93 -4.51 58.28 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 52.6 t -107.3 119.75 40.26 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.191 0.905 . . . . 0.0 111.945 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.88 -52.26 54.29 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-O 118.877 -0.957 . . . . 0.0 113.475 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -57.73 -35.9 98.62 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.779 2.319 . . . . 0.0 114.215 173.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 99.3 m -60.49 -46.69 89.18 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.624 1.102 . . . . 0.0 111.592 171.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.62 -29.19 70.2 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.384 1.074 . . . . 0.0 112.162 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 97.4 mmm -75.98 -37.67 58.29 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.004 1.322 . . . . 0.0 114.38 173.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.8 p -84.59 -23.01 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 CA-C-N 119.951 1.251 . . . . 0.0 113.556 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.05 -48.71 78.33 Favored Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -66.17 -30.24 46.59 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 CA-C-N 122.61 1.968 . . . . 0.0 113.37 176.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.9 t -67.23 -49.59 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-N 118.806 0.73 . . . . 0.0 109.834 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.7 mt -61.08 -37.36 82.41 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.343 1.057 . . . . 0.0 112.574 174.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -70.3 -40.44 74.25 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.969 0.908 . . . . 0.0 112.371 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -60.53 -47.2 87.21 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.514 -0.741 . . . . 0.0 111.085 168.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 76.0 mt -63.42 -36.82 77.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 O-C-N 121.649 -0.657 . . . . 0.0 111.286 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.13 -48.46 81.54 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 120.996 -1.065 . . . . 0.0 112.107 172.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.0 m -76.68 -32.92 58.21 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.171 0.988 . . . . 0.0 112.394 -172.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -99.29 -18.19 17.7 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.7 mmt-85 -122.45 28.27 7.48 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.056 1.342 . . . . 0.0 113.712 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.2 -27.68 22.91 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.889 0.876 . . . . 0.0 113.226 168.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.1 p -66.31 -26.92 67.54 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.057 2.143 . . . . 0.0 114.602 173.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -118.94 -23.71 6.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.363 1.465 . . . . 0.0 113.347 -171.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 80.5 mt -137.03 157.01 47.68 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.075 2.55 . . . . 0.0 110.258 -176.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 48.8 m -108.74 138.72 44.6 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 148.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.6 t -121.61 124.22 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 119.402 1.001 . . . . 0.0 110.68 -176.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -124.3 153.77 41.25 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.457 1.903 . . . . 0.0 112.632 -171.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.467 ' HE3' ' CD1' ' A' ' 33' ' ' TRP . 31.0 mmmt -116.39 132.81 56.57 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.775 2.03 . . . . 0.0 109.7 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -117.35 109.92 17.42 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.912 1.285 . . . . 0.0 108.169 170.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -82.62 100.27 10.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.598 -176.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.0 m -66.56 -16.24 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 120.771 -1.206 . . . . 0.0 112.753 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -70.69 -21.85 62.53 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.689 1.196 . . . . 0.0 113.268 171.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.0 p -118.79 -30.98 4.94 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -140.48 79.53 20.29 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 124.416 1.086 . . . . 0.0 111.279 175.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -70.76 -7.63 21.79 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.072 2.515 . . . . 0.0 113.249 174.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -56.82 -43.49 81.09 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.304 1.441 . . . . 0.0 112.816 -175.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.5 m -64.35 -44.53 91.17 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.54 0.736 . . . . 0.0 111.808 176.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.1 -35.89 82.58 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.537 -0.727 . . . . 0.0 112.358 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.5 ttp-105 -75.85 -34.23 60.05 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.554 0.742 . . . . 0.0 112.889 175.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -58.44 -37.47 75.49 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.38 1.072 . . . . 0.0 112.631 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -96.72 6.24 49.08 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.578 1.151 . . . . 0.0 113.376 174.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 59.94 -13.78 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 129.184 2.994 . . . . 0.0 116.814 -177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.4 m -78.77 55.59 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 126.979 2.111 . . . . 0.0 113.599 -177.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 m -72.94 -9.76 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.762 1.625 . . . . 0.0 114.677 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.6 m -78.29 65.4 3.63 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.974 1.709 . . . . 0.0 112.776 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.454 HD11 ' CZ3' ' A' ' 36' ' ' TRP . 39.4 pt -57.35 153.37 27.54 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 125.616 1.566 . . . . 0.0 114.831 -171.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.98 140.46 64.4 Favored 'Cis proline' 0 C--N 1.354 0.85 0 CA-C-N 119.495 0.855 . . . . 0.0 112.132 -3.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 33.6 m -128.97 121.04 27.16 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.677 0.791 . . . . 0.0 109.468 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.1 mp -107.8 125.75 51.8 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.982 1.313 . . . . 0.0 108.318 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.6 tt -128.21 130.1 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.201 1.0 . . . . 0.0 110.309 176.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.0 tp -108.16 128.22 54.51 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.823 1.249 . . . . 0.0 109.737 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -108.53 152.87 24.16 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.43 1.492 . . . . 0.0 110.205 170.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -135.26 122.31 21.37 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.261 1.824 . . . . 0.0 108.792 173.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.3 t70 50.9 35.64 12.92 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.172 0.989 . . . . 0.0 113.097 -168.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.2 7.75 68.21 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 125.604 1.573 . . . . 0.0 116.396 -176.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -106.42 137.67 19.5 Favored Pre-proline 0 N--CA 1.474 0.758 0 CA-C-N 119.541 1.671 . . . . 0.0 110.356 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.35 139.48 45.66 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.194 1.929 . . . . 0.0 112.0 -176.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.1 m -132.63 -18.41 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 125.163 1.385 . . . . 0.0 114.608 -176.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.9 tppm? -154.48 145.73 22.9 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.739 1.154 . . . . 0.0 111.006 171.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -138.33 134.94 34.88 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.142 0.977 . . . . 0.0 111.736 167.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.8 mp -130.44 144.27 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.34 2.256 . . . . 0.0 109.0 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.4 p -133.25 141.15 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.603 1.161 . . . . 0.0 110.336 170.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.26 156.14 27.59 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.506 1.05 . . . . 0.0 112.898 -167.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.31 141.59 41.56 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.744 0.817 . . . . 0.0 112.961 -175.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -132.85 148.94 52.3 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.97 1.708 . . . . 0.0 110.802 174.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.93 168.66 54.26 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 123.911 0.767 . . . . 0.0 111.318 173.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -56.35 -33.36 65.59 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -173.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.36 -53.75 47.7 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.924 0.392 . . . . 0.0 110.558 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.12 -34.91 66.41 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.515 -0.741 . . . . 0.0 112.776 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.3 tp -67.05 -38.48 85.92 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 120.136 1.335 . . . . 0.0 111.177 173.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . 0.254 0.1 OUTLIER -75.96 -11.1 59.9 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 116.863 -1.541 . . . . 0.0 113.99 169.182 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.79 -56.6 11.09 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 124.045 3.111 . . . . 0.0 110.607 158.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.19 -36.33 70.69 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.825 1.25 . . . . 0.0 111.997 -176.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 70.7 mt -91.47 -28.16 17.8 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 117.185 -1.388 . . . . 0.0 113.425 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 84.4 p -66.52 -18.69 65.51 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 121.793 2.088 . . . . 0.0 112.416 175.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -50.16 -22.34 1.66 Allowed 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 162.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.9 t -115.75 -34.08 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 127.876 2.47 . . . . 0.0 112.988 171.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 N--CA 1.477 0.899 0 C-N-CA 127.16 2.184 . . . . 0.0 110.997 -172.528 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.7 p . . . . . 0 N--CA 1.476 0.858 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.1 pt -115.25 152.77 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.272 1.029 . . . . 0.0 111.864 172.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -92.26 138.17 31.75 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.907 0.883 . . . . 0.0 110.286 169.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.4 m -123.87 151.02 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.849 1.26 . . . . 0.0 110.746 171.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 81.4 p -135.96 158.52 44.21 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.299 1.44 . . . . 0.0 111.128 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.67 -27.53 62.95 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.907 1.076 . . . . 0.0 113.907 -172.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.33 -16.82 58.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.842 1.257 . . . . 0.0 114.348 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -131.45 -6.06 3.74 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.162 1.385 . . . . 0.0 113.844 -173.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -52.85 -40.7 63.6 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.715 1.606 . . . . 0.0 113.011 -175.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.11 -32.79 74.18 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.6 m -79.53 -32.89 42.32 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.824 0.849 . . . . 0.0 112.266 174.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -85.79 -41.28 15.19 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -174.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -105.83 -51.12 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.141 1.377 . . . . 0.0 111.211 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.3 mt -82.92 -13.2 56.51 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -170.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.9 m -95.88 5.9 50.17 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.583 1.153 . . . . 0.0 113.532 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.9 p -70.2 150.7 46.18 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.012 1.725 . . . . 0.0 114.94 -172.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.42 19.33 13.41 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 126.007 1.723 . . . . 0.0 111.854 172.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -143.99 146.18 33.15 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 128.927 2.891 . . . . 0.0 107.124 173.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -59.27 144.06 99.53 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 121.934 1.756 . . . . 0.0 113.255 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.9 t -128.21 125.09 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.339 1.456 . . . . 0.0 110.07 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 48.7 mt -87.92 135.0 33.59 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.388 0.675 . . . . 0.0 109.772 165.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.4 t -119.82 118.15 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 123.966 0.906 . . . . 0.0 109.366 168.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -89.89 109.27 20.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.625 1.57 . . . . 0.0 110.455 172.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -89.34 109.49 20.38 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.909 1.684 . . . . 0.0 108.64 171.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.9 p-90 -142.58 174.3 10.76 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.025 1.33 . . . . 0.0 111.757 -164.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.47 145.51 35.32 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.857 -0.527 . . . . 0.0 112.406 159.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.4 t -64.33 -22.6 67.01 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 -78.18 -4.64 48.63 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 174.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.8 t -107.17 129.36 54.86 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.242 1.017 . . . . 0.0 112.95 -173.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.62 -60.15 9.45 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.156 1.36 . . . . 0.0 114.499 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -61.84 -28.72 81.76 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 CA-C-N 120.386 2.093 . . . . 0.0 113.351 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 89.5 m -62.08 -48.55 79.71 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.511 1.051 . . . . 0.0 111.558 169.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -60.58 -34.37 74.1 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.116 0.966 . . . . 0.0 112.19 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 26.2 mmt -75.47 -36.01 60.74 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 p -87.28 -21.8 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 119.627 1.103 . . . . 0.0 113.52 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.55 -50.16 60.45 Favored Pre-proline 0 CA--C 1.551 1.007 0 CA-C-O 117.288 -1.339 . . . . 0.0 114.32 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -65.71 -30.19 50.67 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 CA-C-N 122.338 1.871 . . . . 0.0 113.666 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.408 HG13 ' HA ' ' A' ' 101' ' ' LYS . 13.1 t -68.21 -51.32 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 119.031 0.832 . . . . 0.0 110.771 177.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.9 pp -72.01 -22.74 61.37 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -69.99 -35.29 74.3 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.107 -0.996 . . . . 0.0 112.512 168.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -64.89 -42.87 94.42 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.868 -1.145 . . . . 0.0 111.508 166.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.4 mm -55.41 -45.95 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-N 119.969 1.259 . . . . 0.0 110.821 170.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.66 -42.85 93.74 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.052 0.941 . . . . 0.0 112.823 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.7 m -74.55 -40.73 61.52 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.66 0.784 . . . . 0.0 111.61 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -86.79 -23.56 25.36 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -173.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.3 mmt-85 -123.04 20.76 9.89 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 114.59 1.329 . . . . 0.0 114.59 -173.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.11 -27.74 15.22 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.311 1.444 . . . . 0.0 114.5 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.3 p -74.56 -23.07 58.72 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.072 1.349 . . . . 0.0 114.142 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -117.74 -25.85 6.72 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.614 1.166 . . . . 0.0 113.952 -176.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 82.6 mt -125.78 153.02 44.62 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.51 1.924 . . . . 0.0 110.248 172.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 38.3 m -101.16 138.48 38.14 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 151.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.4 t -118.68 117.76 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 118.59 0.632 . . . . 0.0 109.475 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -119.52 159.33 24.52 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.121 1.768 . . . . 0.0 112.246 -174.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -127.71 136.23 51.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.635 1.574 . . . . 0.0 111.664 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -125.93 113.46 17.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.831 2.052 . . . . 0.0 107.926 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -81.36 120.15 24.58 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.452 -0.78 . . . . 0.0 110.311 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.9 m -67.35 -17.38 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.13 -30.18 43.56 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.29 1.036 . . . . 0.0 112.711 173.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.2 p -97.21 -30.83 12.77 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.191 0.996 . . . . 0.0 112.608 -176.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -130.39 63.09 68.11 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 125.775 1.63 . . . . 0.0 111.442 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -61.66 -21.66 72.61 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.93 2.42 . . . . 0.0 113.307 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -61.9 -45.47 93.59 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.466 1.106 . . . . 0.0 111.443 174.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 m -71.77 -32.3 67.52 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.553 0.741 . . . . 0.0 111.442 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.09 -44.74 91.42 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.927 0.891 . . . . 0.0 112.607 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -77.88 -28.38 49.91 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -57.01 -42.8 81.01 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.924 0.89 . . . . 0.0 113.282 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -99.69 7.86 44.79 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.599 1.16 . . . . 0.0 113.404 176.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.321 15.5 pt20 42.07 47.08 3.82 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.072 1.749 . . . . 0.0 113.571 -166.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.0 m -98.97 36.76 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 127.604 2.362 . . . . 0.0 109.904 172.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.9 p -78.64 -25.17 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.08 1.752 . . . . 0.0 112.417 -173.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 51.0 m -74.35 144.37 44.48 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.443 1.097 . . . . 0.0 110.318 163.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.73 149.3 56.18 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 124.163 0.985 . . . . 0.0 113.332 -168.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.13 142.01 71.44 Favored 'Cis proline' 0 C--N 1.352 0.755 0 CA-C-N 119.021 0.686 . . . . 0.0 111.336 -8.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 51.7 m -132.28 121.64 23.9 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.201 1.0 . . . . 0.0 109.947 172.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.9 mp -96.52 135.99 37.65 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.38 1.072 . . . . 0.0 109.251 171.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 26.5 mm -115.62 135.56 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.626 1.171 . . . . 0.0 109.212 167.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.7 tp -92.67 117.32 29.86 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 123.223 0.327 . . . . 0.0 110.423 162.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -96.41 115.26 27.14 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.625 1.17 . . . . 0.0 108.343 165.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.7 tttm -100.31 108.6 20.69 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 50.03 43.55 25.58 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.688 1.195 . . . . 0.0 113.094 -167.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.16 15.19 80.79 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 117.059 1.584 . . . . 0.0 117.059 173.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -126.43 140.11 36.41 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-N 119.373 1.587 . . . . 0.0 111.41 168.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -69.29 138.93 40.54 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.778 2.318 . . . . 0.0 112.249 -174.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.4 t -130.5 -33.94 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 125.267 1.427 . . . . 0.0 113.072 -176.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -141.3 145.15 35.13 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.272 1.029 . . . . 0.0 111.753 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -123.05 136.15 54.71 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.927 2.091 . . . . 0.0 110.595 171.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.1 mt -129.75 130.78 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.91 1.684 . . . . 0.0 107.457 171.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.3 143.83 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 119.507 1.048 . . . . 0.0 111.845 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.17 157.66 28.36 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.188 1.375 . . . . 0.0 112.72 -169.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.6 138.1 48.48 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.839 -0.801 . . . . 0.0 112.033 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -131.98 153.99 49.77 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.875 1.67 . . . . 0.0 111.113 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.63 164.15 51.86 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 174.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.408 ' HA ' HG13 ' A' ' 46' ' ' VAL . 3.6 tmtp? -55.08 -34.12 63.35 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.823 1.249 . . . . 0.0 113.197 -178.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.02 -37.63 66.85 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.17 -46.25 43.4 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.259 1.024 . . . . 0.0 111.36 177.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 40.4 tp -64.6 -46.56 82.15 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.706 175.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 32.3 tp -69.78 -26.51 64.32 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-O 115.121 -2.371 . . . . 0.0 113.389 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -69.72 -44.04 71.13 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 125.005 3.548 . . . . 0.0 112.26 169.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -64.61 -23.43 67.26 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.4 mt -93.85 -26.64 16.83 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.061 1.344 . . . . 0.0 113.772 168.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.4 m -61.29 -25.8 67.36 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 120.269 1.395 . . . . 0.0 110.413 173.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -53.25 -23.14 8.08 Favored 'General case' 0 CA--C 1.558 1.265 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 166.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 68.8 t -114.51 -50.26 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 127.522 2.329 . . . . 0.0 111.344 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 N--CA 1.471 0.605 0 C-N-CA 128.146 2.578 . . . . 0.0 108.699 178.882 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.264 19.4 p . . . . . 0 N--CA 1.483 1.224 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.0 pt -134.49 157.37 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.486 1.914 . . . . 0.0 110.631 172.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -105.44 139.08 40.6 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.62 0.768 . . . . 0.0 110.678 169.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.9 m -124.89 153.21 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.574 1.55 . . . . 0.0 111.058 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.6 p -132.48 170.59 14.93 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.474 1.51 . . . . 0.0 111.601 -174.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -56.5 -25.26 50.92 Favored 'General case' 0 CA--C 1.55 0.952 0 O-C-N 121.151 -0.968 . . . . 0.0 113.106 171.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.85 -13.52 50.75 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 115.043 1.498 . . . . 0.0 115.043 175.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.9 p -134.22 -12.49 2.46 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 -169.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -54.46 -42.77 71.04 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.898 1.279 . . . . 0.0 112.208 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.29 -36.34 82.7 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.298 -0.877 . . . . 0.0 112.95 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.0 m -79.2 -24.44 43.16 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.432 1.093 . . . . 0.0 113.139 -177.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -97.09 -46.97 5.96 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.351 -0.843 . . . . 0.0 113.084 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.07 -51.95 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.311 1.044 . . . . 0.0 112.046 -172.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.4 mt -84.19 -26.48 28.74 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -172.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.9 m -80.59 -11.08 59.7 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.569 1.148 . . . . 0.0 113.637 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.5 m -74.93 127.6 33.59 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.704 1.202 . . . . 0.0 112.32 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -71.62 -28.39 63.75 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.323 1.049 . . . . 0.0 112.113 172.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -84.64 164.31 43.08 Favored Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 125.384 1.473 . . . . 0.0 111.977 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.78 141.41 94.79 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.658 2.239 . . . . 0.0 113.351 170.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.0 t -135.68 126.12 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.554 1.142 . . . . 0.0 110.041 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 tt -100.43 121.31 41.32 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.543 1.937 . . . . 0.0 108.427 177.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 t -111.28 126.74 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 118.999 0.818 . . . . 0.0 111.129 174.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -99.06 111.41 23.82 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.456 1.502 . . . . 0.0 110.881 172.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -83.85 112.44 20.12 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.493 1.517 . . . . 0.0 108.657 173.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.3 p-90 -144.76 169.48 17.95 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.393 1.077 . . . . 0.0 113.017 -166.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.63 154.66 35.8 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.67 1.188 . . . . 0.0 111.015 163.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 t -67.91 -12.99 61.79 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.417 ' CZ3' HD11 ' A' ' 80' ' ' ILE . 13.2 p-90 -79.77 -3.68 48.69 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 174.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 50.5 t -111.06 117.52 33.52 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.429 1.091 . . . . 0.0 112.398 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.88 -48.34 86.57 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-O 118.72 -1.044 . . . . 0.0 113.097 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -56.78 -33.08 93.5 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.747 2.298 . . . . 0.0 114.765 170.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 89.7 m -64.12 -46.33 84.66 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.821 1.191 . . . . 0.0 111.384 170.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -58.46 -35.69 72.55 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.211 1.004 . . . . 0.0 111.865 173.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.8 mtt -73.3 -39.0 65.66 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.883 1.273 . . . . 0.0 113.954 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.8 p -83.08 -23.83 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 CA-C-N 119.661 1.118 . . . . 0.0 113.655 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.55 -49.04 80.47 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.17 -29.25 39.72 Favored 'Trans proline' 0 C--N 1.354 0.819 0 CA-C-N 122.387 1.888 . . . . 0.0 113.215 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.4 t -69.73 -45.43 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 121.51 -0.744 . . . . 0.0 110.22 175.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.3 mt -60.99 -36.14 78.68 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.415 1.086 . . . . 0.0 112.421 172.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -68.69 -39.05 80.72 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.089 0.859 . . . . 0.0 112.194 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -63.91 -46.12 86.22 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.189 -0.944 . . . . 0.0 111.62 170.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.2 mm -56.9 -42.97 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 121.674 -0.641 . . . . 0.0 110.941 173.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.56 -42.18 98.46 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.8 0.84 . . . . 0.0 112.261 177.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.2 m -69.52 -42.38 74.76 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.312 1.045 . . . . 0.0 111.299 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -95.01 -23.22 17.47 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -170.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -109.87 14.22 23.24 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.79 1.636 . . . . 0.0 113.403 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.99 -33.19 36.96 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.019 1.327 . . . . 0.0 114.268 -177.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.1 m -72.19 -26.05 61.91 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.054 1.342 . . . . 0.0 112.75 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -102.39 -34.15 9.29 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.479 1.512 . . . . 0.0 113.06 -175.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.0 pp -149.08 163.06 38.64 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.539 1.536 . . . . 0.0 112.185 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 58.5 m -108.31 138.51 44.46 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.194 0.998 . . . . 0.0 109.344 167.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.9 t -102.59 128.89 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.519 0.728 . . . . 0.0 110.398 175.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.45 158.77 36.47 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.553 1.941 . . . . 0.0 111.455 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -127.62 134.78 49.65 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.556 1.142 . . . . 0.0 111.697 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -113.64 117.25 31.06 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.742 1.617 . . . . 0.0 108.937 173.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.43 97.58 7.82 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.034 1.333 . . . . 0.0 108.757 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.5 m -65.01 -20.72 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -172.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -74.19 -22.49 59.37 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.135 0.974 . . . . 0.0 112.753 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.3 t -119.22 -13.6 9.32 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.931 1.292 . . . . 0.0 113.518 174.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -119.22 60.75 5.4 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 124.958 1.303 . . . . 0.0 112.076 171.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -65.46 -24.62 56.56 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.368 2.045 . . . . 0.0 112.29 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -66.91 -43.39 83.45 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.478 -0.764 . . . . 0.0 111.422 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 m -68.22 -38.36 81.8 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.163 0.985 . . . . 0.0 111.466 175.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.2 -38.52 91.48 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.419 0.688 . . . . 0.0 112.668 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 22.7 ttm105 -76.44 -35.75 58.33 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.361 0.664 . . . . 0.0 112.758 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -54.96 -39.02 68.49 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.866 1.267 . . . . 0.0 113.67 -175.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -99.93 1.79 43.05 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.088 0.955 . . . . 0.0 113.37 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 51.56 60.09 4.11 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.182 1.793 . . . . 0.0 112.322 -167.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.5 m -127.58 32.18 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 126.529 1.932 . . . . 0.0 111.491 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.6 m -70.88 -23.67 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.595 1.158 . . . . 0.0 113.726 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 54.0 m -79.51 139.49 37.56 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.479 1.112 . . . . 0.0 110.193 168.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.417 HD11 ' CZ3' ' A' ' 36' ' ' TRP . 48.4 pt -136.9 152.64 74.5 Favored Pre-proline 0 N--CA 1.475 0.817 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -167.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.37 140.73 64.16 Favored 'Cis proline' 0 C--N 1.353 0.789 0 CA-C-N 119.322 0.794 . . . . 0.0 111.81 -4.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.4 m -127.55 121.31 30.28 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.815 0.846 . . . . 0.0 109.443 169.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.3 mp -102.42 130.3 49.16 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.494 1.518 . . . . 0.0 107.942 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.22 130.69 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.824 0.849 . . . . 0.0 108.931 175.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.5 tp -106.54 120.91 43.18 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.401 1.08 . . . . 0.0 109.901 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -96.51 147.34 23.95 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.297 1.439 . . . . 0.0 109.834 169.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -119.9 130.11 54.67 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.721 1.208 . . . . 0.0 108.951 161.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.4 t0 47.82 44.57 18.14 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.303 1.041 . . . . 0.0 113.067 -174.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.39 10.86 58.33 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.11 1.338 . . . . 0.0 116.14 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -117.74 136.48 23.69 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 125.434 1.493 . . . . 0.0 110.071 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -70.56 139.74 38.11 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.71 2.273 . . . . 0.0 112.325 -171.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.5 t -128.83 -38.76 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.564 1.146 . . . . 0.0 113.198 -175.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -142.19 144.38 33.38 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.289 1.036 . . . . 0.0 111.682 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -129.27 139.71 51.7 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.669 1.588 . . . . 0.0 111.457 170.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.8 mt -133.87 139.06 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 126.946 2.098 . . . . 0.0 108.403 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.1 p -131.79 142.15 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.288 0.949 . . . . 0.0 110.882 171.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.11 153.47 24.48 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.632 1.11 . . . . 0.0 112.563 -167.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.68 143.03 48.25 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.975 -0.721 . . . . 0.0 112.487 -176.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -130.46 143.78 50.98 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.694 1.598 . . . . 0.0 110.409 173.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -78.6 170.29 54.72 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.154 0.883 . . . . 0.0 111.299 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -53.13 -35.84 60.15 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -175.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.35 -53.01 59.2 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 122.834 0.453 . . . . 0.0 111.375 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.67 -37.4 59.63 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.489 1.115 . . . . 0.0 113.241 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.7 tp -67.82 -35.17 78.12 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.248 0.931 . . . . 0.0 110.97 173.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.6 tp -74.14 -24.95 59.49 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-O 116.138 -1.887 . . . . 0.0 112.867 169.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 46.6 mmt-85 -59.84 -51.29 70.37 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 124.203 3.183 . . . . 0.0 110.572 164.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -61.0 -32.21 71.8 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.7 mt -99.03 -23.4 15.3 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.4 t -68.91 -21.28 64.23 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.326 0.966 . . . . 0.0 111.025 168.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -53.7 -20.02 4.89 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.333 1.053 . . . . 0.0 113.088 162.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.8 t -112.85 -28.89 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 127.143 2.177 . . . . 0.0 112.3 171.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.481 1.092 0 C-N-CA 127.139 2.176 . . . . 0.0 110.882 179.067 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.4 p . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.7 pt -118.77 152.5 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.078 1.351 . . . . 0.0 111.33 170.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -97.65 132.67 43.09 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.231 1.012 . . . . 0.0 109.928 172.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.9 m -137.01 150.06 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.337 1.055 . . . . 0.0 112.112 -176.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 73.2 p -141.23 164.92 28.95 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.654 1.581 . . . . 0.0 111.399 176.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -51.25 -28.35 11.5 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.658 1.983 . . . . 0.0 114.673 -176.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.31 -22.46 65.62 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.0 m -135.26 -0.66 2.69 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.318 1.447 . . . . 0.0 114.224 -175.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -53.16 -42.57 66.28 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.674 1.99 . . . . 0.0 112.921 -175.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.12 -32.23 72.38 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.321 -0.862 . . . . 0.0 113.109 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.8 m -79.49 -30.22 41.94 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.279 1.431 . . . . 0.0 112.849 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -97.03 -41.44 8.37 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -171.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.7 m -124.4 -29.89 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -169.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.4 mt -80.7 -13.21 59.21 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.518 1.054 . . . . 0.0 113.258 170.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.9 p -75.62 -21.04 58.1 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -169.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.2 t -100.76 141.47 33.59 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -168.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -82.93 -13.89 55.19 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.801 1.24 . . . . 0.0 113.174 170.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -68.64 151.78 97.05 Favored Pre-proline 0 N--CA 1.473 0.722 0 C-N-CA 125.263 1.425 . . . . 0.0 109.15 162.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -65.15 134.41 39.3 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 CA-C-N 120.795 1.319 . . . . 0.0 111.297 171.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.6 t -135.69 121.92 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 124.045 0.938 . . . . 0.0 109.311 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 tt -104.42 130.42 52.31 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.226 2.21 . . . . 0.0 109.378 -169.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.4 t -120.63 125.48 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.353 1.061 . . . . 0.0 111.009 177.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -103.94 120.13 40.39 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.472 1.509 . . . . 0.0 112.04 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -100.48 112.81 25.21 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.959 2.104 . . . . 0.0 108.964 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 11.4 p-90 -143.51 177.12 8.68 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.894 1.278 . . . . 0.0 111.934 -168.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.98 143.72 32.04 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.398 -0.814 . . . . 0.0 112.641 165.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.5 t -63.25 -21.73 66.42 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 172.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.478 ' CZ3' HD11 ' A' ' 80' ' ' ILE . 6.3 p-90 -83.3 -3.65 57.68 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 174.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 46.2 t -106.55 120.1 41.03 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.233 1.013 . . . . 0.0 112.189 -174.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.79 -46.78 92.93 Favored Glycine 0 CA--C 1.54 1.615 0 CA-C-O 118.861 -0.966 . . . . 0.0 114.317 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -58.88 -31.78 96.03 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.788 2.325 . . . . 0.0 114.087 170.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 93.8 m -65.45 -47.13 77.19 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.961 0.801 . . . . 0.0 111.428 170.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -59.23 -31.93 69.5 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 118.712 0.687 . . . . 0.0 112.407 174.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -70.33 -48.45 56.41 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.9 1.28 . . . . 0.0 112.545 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.3 p -81.21 -23.21 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.91 -54.2 30.28 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-O 116.864 -1.541 . . . . 0.0 114.01 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.92 -26.71 66.79 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.367 2.045 . . . . 0.0 113.516 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.0 t -66.71 -51.74 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 119.04 0.836 . . . . 0.0 109.93 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . 0.25 4.2 pp -73.22 -19.09 61.16 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -65.67 -41.97 91.86 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.507 1.123 . . . . 0.0 111.577 166.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -64.92 -44.42 89.58 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.45 -0.781 . . . . 0.0 111.143 169.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.5 mm -54.1 -46.99 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 119.896 1.225 . . . . 0.0 110.88 172.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.58 -44.46 96.19 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.8 m -76.23 -37.45 57.68 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.643 0.777 . . . . 0.0 112.025 -175.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -86.72 -40.17 15.3 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -176.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -98.86 11.67 38.09 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.804 1.242 . . . . 0.0 113.316 -169.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.58 -32.15 39.68 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.48 1.512 . . . . 0.0 114.859 -173.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.8 p -82.99 -19.6 36.74 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.76 1.224 . . . . 0.0 113.619 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -94.12 -39.97 10.3 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.364 1.466 . . . . 0.0 112.217 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.9 pp -149.05 153.35 37.72 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.546 1.939 . . . . 0.0 111.893 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 31.8 m -99.47 138.94 35.86 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.15 -0.969 . . . . 0.0 109.502 175.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.7 t -113.3 131.11 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 119.348 0.976 . . . . 0.0 111.675 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.24 152.43 44.6 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.75 2.02 . . . . 0.0 111.503 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -130.67 140.25 50.37 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.7 1.2 . . . . 0.0 112.466 -175.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -134.6 116.31 14.86 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.946 2.098 . . . . 0.0 109.065 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -82.78 119.53 24.46 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 170.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.416 HG12 ' HB2' ' A' ' 72' ' ' ALA . 11.2 m -67.87 -16.94 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 121.386 -0.821 . . . . 0.0 112.976 -175.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -79.22 -28.07 42.51 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.261 1.024 . . . . 0.0 112.903 172.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.2 p -92.57 -29.04 16.38 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.73 0.812 . . . . 0.0 112.505 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -145.02 103.05 4.43 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 123.942 0.897 . . . . 0.0 111.191 161.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.68 -21.95 12.38 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.848 2.366 . . . . 0.0 113.805 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -72.78 -28.08 62.38 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.809 -1.182 . . . . 0.0 112.16 -175.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 m -64.2 -42.14 96.76 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.715 0.806 . . . . 0.0 110.886 171.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.416 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -68.19 -37.11 80.57 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.079 0.952 . . . . 0.0 112.909 174.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -68.06 -43.89 77.6 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.178 0.991 . . . . 0.0 112.499 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -59.56 -37.84 79.52 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.155 0.982 . . . . 0.0 113.583 -172.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -99.5 5.66 46.08 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.45 1.1 . . . . 0.0 113.692 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 49.56 60.63 3.64 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.209 1.804 . . . . 0.0 112.645 -172.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.6 m -129.18 30.25 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.256 1.823 . . . . 0.0 111.398 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.5 m -71.88 -14.56 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.011 1.324 . . . . 0.0 114.395 -173.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.5 m -68.69 -40.45 80.07 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -165.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.478 HD11 ' CZ3' ' A' ' 36' ' ' TRP 0.294 14.2 pt 56.07 147.34 0.05 OUTLIER Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 130.552 3.541 . . . . 0.0 119.051 177.394 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.9 136.78 24.94 Favored 'Cis proline' 0 C--N 1.354 0.818 0 N-CA-C 110.218 -0.724 . . . . 0.0 110.218 -16.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 25.7 m -135.7 121.19 19.33 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.597 0.759 . . . . 0.0 109.477 -177.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.0 mp -109.88 138.99 45.47 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.7 1.2 . . . . 0.0 108.797 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.1 tt -129.19 145.06 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.69 0.796 . . . . 0.0 110.715 169.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 32.5 tp -116.65 132.65 56.63 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.625 1.17 . . . . 0.0 109.854 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -112.08 148.02 34.81 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.714 1.606 . . . . 0.0 111.787 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -132.87 126.12 31.49 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.589 1.556 . . . . 0.0 109.007 159.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.0 t70 51.32 37.68 19.47 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.747 1.219 . . . . 0.0 113.358 -177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.23 -0.19 49.04 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.204 1.383 . . . . 0.0 115.735 -176.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -95.13 143.89 26.87 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 124.92 1.288 . . . . 0.0 110.153 178.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.51 140.81 40.7 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.716 2.277 . . . . 0.0 112.092 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 52.0 t -121.09 -45.61 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.925 1.69 . . . . 0.0 111.276 -174.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -143.9 150.75 38.87 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.09 1.756 . . . . 0.0 110.634 173.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -133.77 134.22 42.65 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.435 1.894 . . . . 0.0 109.77 167.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.9 mt -131.0 138.97 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.918 1.687 . . . . 0.0 108.625 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.3 p -133.68 141.51 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.037 0.935 . . . . 0.0 110.788 167.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.7 155.87 27.91 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.403 1.002 . . . . 0.0 112.746 -168.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.51 139.67 45.85 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.573 0.749 . . . . 0.0 112.577 -175.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -130.67 145.05 51.83 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.012 1.725 . . . . 0.0 110.56 173.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.72 166.5 53.24 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 123.83 0.729 . . . . 0.0 111.687 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.3 tmtp? -51.98 -34.43 42.38 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.056 1.342 . . . . 0.0 113.861 -174.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.04 -53.28 26.9 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 122.267 0.227 . . . . 0.0 110.97 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.1 -40.59 78.27 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.717 0.807 . . . . 0.0 112.757 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.98 -41.04 91.67 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.725 0.693 . . . . 0.0 110.523 176.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 20.1 tp -72.78 -24.88 60.99 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-O 115.69 -2.1 . . . . 0.0 113.399 172.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -63.64 -49.08 74.66 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 124.651 3.387 . . . . 0.0 111.002 166.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -54.56 -37.87 65.97 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.603 1.161 . . . . 0.0 112.735 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.4 mt -92.3 -25.99 18.32 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.0 t -66.74 -22.85 66.04 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.537 1.135 . . . . 0.0 110.99 175.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -51.1 -28.65 11.12 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 163.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 77.0 t -105.01 -24.64 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 127.278 2.231 . . . . 0.0 112.522 172.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.477 0.885 0 C-N-CA 127.428 2.291 . . . . 0.0 110.168 178.871 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.9 p . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.9 pt -141.43 157.5 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 126.342 1.857 . . . . 0.0 111.667 173.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -99.89 145.59 27.61 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.388 1.075 . . . . 0.0 111.186 162.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.3 m -131.11 151.55 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.459 1.503 . . . . 0.0 111.426 174.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.9 p -123.82 167.81 13.58 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.202 1.801 . . . . 0.0 110.592 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -59.91 -23.64 63.67 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 120.846 -1.159 . . . . 0.0 112.904 174.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.77 -13.72 50.35 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.45 1.5 . . . . 0.0 114.962 175.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.9 p -128.12 -12.16 5.21 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -173.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -52.83 -41.37 64.15 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.24 1.416 . . . . 0.0 112.459 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.12 -36.57 82.19 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.251 -0.906 . . . . 0.0 113.148 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.0 m -79.47 -26.02 41.77 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.25 1.02 . . . . 0.0 113.261 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -100.17 -37.47 8.92 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.5 t -99.34 -58.6 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.516 1.127 . . . . 0.0 111.308 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.8 mt -76.08 -22.14 55.94 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -171.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.0 m -81.55 -11.05 59.3 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.358 1.063 . . . . 0.0 113.392 175.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.5 t -84.28 132.9 34.58 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -174.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -90.49 -4.89 56.63 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.001 1.32 . . . . 0.0 113.027 171.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -90.02 144.12 30.9 Favored Pre-proline 0 N--CA 1.472 0.651 0 C-N-CA 125.152 1.381 . . . . 0.0 109.396 169.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -54.17 131.06 42.85 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.214 1.943 . . . . 0.0 111.872 168.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.0 p -139.37 130.16 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.853 1.261 . . . . 0.0 110.096 -172.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.2 tt -120.23 111.95 18.45 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.295 1.038 . . . . 0.0 109.622 -165.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.0 t -103.13 124.62 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.019 0.928 . . . . 0.0 111.223 -173.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -97.09 113.22 24.76 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.748 1.619 . . . . 0.0 110.787 172.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -87.32 109.39 19.49 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.265 1.826 . . . . 0.0 108.569 173.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -149.63 172.69 14.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.153 0.981 . . . . 0.0 113.333 -163.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -145.4 153.73 41.51 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.374 0.67 . . . . 0.0 112.611 159.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.6 p -58.19 -29.41 65.62 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.593 1.557 . . . . 0.0 113.263 174.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 15.4 p-90 -80.66 -6.4 58.31 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.3 t -102.12 116.25 32.27 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.044 0.938 . . . . 0.0 111.227 -176.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.24 -46.53 94.08 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-O 118.484 -1.176 . . . . 0.0 114.028 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -60.37 -32.49 94.07 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 CA-C-N 120.813 2.306 . . . . 0.0 114.305 172.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 97.3 m -65.31 -47.74 75.52 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.244 -0.91 . . . . 0.0 110.954 171.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.8 tptt -57.21 -32.55 66.62 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.947 1.699 . . . . 0.0 112.669 172.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 57.1 mtt -72.97 -42.2 63.59 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.45 1.1 . . . . 0.0 113.107 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -84.09 -23.15 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -47.24 -50.74 46.22 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 177.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.51 -30.01 52.59 Favored 'Trans proline' 0 C--N 1.352 0.713 0 CA-C-N 122.036 1.763 . . . . 0.0 113.105 176.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.9 t -73.53 -44.92 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.289 -0.882 . . . . 0.0 110.849 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.2 pp -72.67 -24.24 61.0 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.481 -0.762 . . . . 0.0 113.019 174.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -71.74 -36.11 70.33 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.162 0.892 . . . . 0.0 112.42 168.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -61.75 -42.53 99.09 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.553 -1.342 . . . . 0.0 111.256 167.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.33 -42.11 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 119.52 1.055 . . . . 0.0 111.559 170.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.78 -37.78 80.04 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.344 0.974 . . . . 0.0 112.937 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.1 m -82.23 -47.1 12.85 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.997 0.919 . . . . 0.0 112.095 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -85.97 -25.46 26.01 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -171.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -104.69 16.96 25.01 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.202 1.401 . . . . 0.0 112.455 176.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.02 -27.87 21.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.857 1.663 . . . . 0.0 114.549 -177.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.2 p -72.35 -20.11 61.53 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.375 1.47 . . . . 0.0 114.115 176.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -115.66 -39.33 3.54 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.094 1.358 . . . . 0.0 112.833 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.6 mt -113.73 148.02 37.19 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.453 1.901 . . . . 0.0 111.278 -175.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.8 m -112.59 134.41 54.14 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 152.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.1 t -99.56 138.3 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 123.734 0.814 . . . . 0.0 110.081 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.6 156.06 42.87 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.32 1.448 . . . . 0.0 111.991 -177.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -120.09 124.25 45.37 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.056 1.743 . . . . 0.0 110.743 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -109.47 114.51 28.22 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.279 1.031 . . . . 0.0 108.385 165.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -82.36 103.51 11.99 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.446 1.099 . . . . 0.0 109.615 -176.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 m -66.85 -17.5 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 O-C-N 120.703 -1.248 . . . . 0.0 113.024 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -71.74 -23.54 61.63 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.84 1.256 . . . . 0.0 113.107 175.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.3 p -118.61 -24.78 6.62 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -130.27 79.6 72.29 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 119.504 1.047 . . . . 0.0 113.521 168.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -66.93 -16.29 49.33 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.191 1.927 . . . . 0.0 112.927 166.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.1 mp0 -64.84 -42.3 95.03 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.901 -1.124 . . . . 0.0 111.439 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.5 m -70.92 -36.15 72.54 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.989 0.915 . . . . 0.0 111.436 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.3 -39.32 90.03 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.546 0.739 . . . . 0.0 112.196 171.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -72.85 -40.34 65.79 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 175.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -61.93 -34.71 76.59 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.307 1.043 . . . . 0.0 113.81 -174.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -96.76 1.4 50.8 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 175.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 52.22 56.4 7.79 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.908 1.683 . . . . 0.0 112.566 -170.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.47 36.81 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 127.082 2.153 . . . . 0.0 110.974 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.8 m -71.74 -22.29 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.654 1.182 . . . . 0.0 113.479 -176.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.2 m -70.78 145.56 50.32 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.363 1.065 . . . . 0.0 110.513 166.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 20.3 pt -137.26 145.48 50.04 Favored Pre-proline 0 N--CA 1.474 0.774 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -169.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.38 148.73 74.48 Favored 'Cis proline' 0 C--N 1.351 0.707 0 CA-C-N 118.678 0.564 . . . . 0.0 111.552 -12.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.1 m -131.86 124.04 28.74 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.413 0.685 . . . . 0.0 110.015 167.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.8 mp -99.39 132.49 44.68 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.512 1.525 . . . . 0.0 108.638 174.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.6 mm -115.67 132.42 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.873 1.269 . . . . 0.0 108.767 168.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.0 tp -96.26 125.32 40.7 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.276 0.23 . . . . 0.0 110.625 163.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -102.62 139.34 38.34 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.161 1.384 . . . . 0.0 108.966 163.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -99.75 -35.79 9.68 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -152.57 58.28 0.81 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.675 1.99 . . . . 0.0 109.393 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.69 16.41 58.93 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 124.93 1.252 . . . . 0.0 114.893 -172.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -134.7 133.71 21.5 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 126.522 1.929 . . . . 0.0 110.308 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.42 140.89 34.12 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.471 2.781 . . . . 0.0 112.02 -172.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.3 m -129.81 -23.67 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.079 1.352 . . . . 0.0 114.496 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -148.08 145.8 28.57 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.234 1.014 . . . . 0.0 111.789 175.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -123.72 135.1 53.66 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.388 1.875 . . . . 0.0 110.575 169.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.9 mt -131.68 129.51 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.621 1.569 . . . . 0.0 109.108 176.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.7 m -127.27 144.61 36.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 123.939 0.896 . . . . 0.0 112.3 -169.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.67 164.66 7.97 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.327 0.965 . . . . 0.0 112.951 -171.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.84 150.41 37.39 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.436 -1.037 . . . . 0.0 113.388 -175.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.6 mmtm -133.71 146.69 51.03 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.142 1.777 . . . . 0.0 110.838 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.62 164.16 34.28 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 162.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -51.27 -36.21 41.05 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.696 1.198 . . . . 0.0 113.894 -178.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.21 -36.58 71.94 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.64 -47.8 24.87 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.085 0.954 . . . . 0.0 111.489 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.6 tp -64.72 -44.04 91.48 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.908 -0.495 . . . . 0.0 110.835 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 23.0 tp -75.59 -25.57 57.13 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-O 115.207 -2.33 . . . . 0.0 113.392 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -65.85 -44.42 85.54 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 125.131 3.605 . . . . 0.0 111.185 166.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -66.11 -25.49 67.02 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.2 mt -103.18 -17.52 15.32 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 175.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.8 t -72.36 -22.2 61.19 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 120.962 -1.086 . . . . 0.0 110.633 166.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -52.56 -21.08 3.45 Favored 'General case' 0 CA--C 1.555 1.17 0 O-C-N 121.114 -0.991 . . . . 0.0 113.455 159.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 89.1 t -107.67 -34.15 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 126.999 2.12 . . . . 0.0 112.137 172.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.481 1.122 0 C-N-CA 127.254 2.222 . . . . 0.0 110.594 177.432 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.9 p . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 120.458 0.171 . . . . 0.0 111.415 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.9 pt -129.19 155.12 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 125.827 1.651 . . . . 0.0 112.29 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -93.07 140.05 29.9 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.092 0.957 . . . . 0.0 111.497 173.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.4 150.34 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 125.08 1.352 . . . . 0.0 111.217 170.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 65.2 p -143.45 159.93 41.49 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.415 1.886 . . . . 0.0 110.338 178.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -51.45 -31.7 24.2 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.055 1.342 . . . . 0.0 114.55 -174.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.85 -21.44 66.8 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.9 m -131.69 -1.3 3.83 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.655 1.582 . . . . 0.0 113.711 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -59.51 -42.02 91.26 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.853 1.261 . . . . 0.0 112.514 -170.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.63 -32.4 72.23 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.8 m -79.18 -29.81 43.12 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.699 1.2 . . . . 0.0 112.578 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -94.71 -53.69 3.77 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.641 0.776 . . . . 0.0 112.803 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.3 -60.2 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.82 1.248 . . . . 0.0 110.732 -175.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.6 mt -75.43 -15.97 60.39 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -169.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.8 t -70.23 -22.91 62.86 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.566 1.146 . . . . 0.0 112.537 172.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.2 t -79.39 133.22 36.57 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -170.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -81.21 -23.84 37.84 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.584 1.154 . . . . 0.0 111.929 168.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -74.59 147.03 84.3 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 125.288 1.435 . . . . 0.0 110.044 176.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.88 132.43 51.63 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.196 1.931 . . . . 0.0 111.777 172.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.25 123.31 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.801 0.81 . . . . 0.0 110.798 -174.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 tt -101.93 132.07 47.95 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.581 1.952 . . . . 0.0 108.182 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 t -123.11 127.25 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.109 0.964 . . . . 0.0 110.6 174.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -100.24 118.84 37.37 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.487 1.515 . . . . 0.0 111.752 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.426 ' CD2' HD12 ' A' ' 63' ' ' LEU . 21.1 m-85 -99.66 109.26 21.75 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.156 2.182 . . . . 0.0 108.286 176.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.2 p-90 -142.61 178.46 7.6 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.954 1.302 . . . . 0.0 111.96 -164.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.53 140.03 30.06 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 121.521 -0.737 . . . . 0.0 112.971 167.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.7 t -64.98 -18.58 65.39 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 173.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -88.89 0.13 56.86 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 174.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.1 t -111.5 123.23 49.79 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.41 1.084 . . . . 0.0 112.893 -173.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.55 -49.44 73.57 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-O 118.868 -0.962 . . . . 0.0 114.348 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -58.16 -32.02 94.71 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.911 2.407 . . . . 0.0 114.04 171.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 97.4 m -65.1 -46.46 80.99 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.066 -1.022 . . . . 0.0 111.558 170.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -60.47 -29.95 69.37 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.766 0.712 . . . . 0.0 112.72 173.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.5 ttt -72.49 -44.23 62.55 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.556 1.142 . . . . 0.0 112.853 177.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.9 p -88.62 -24.67 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -176.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.23 -48.57 73.63 Favored Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.18 -29.01 47.81 Favored 'Trans proline' 0 C--N 1.352 0.73 0 CA-C-N 122.14 1.8 . . . . 0.0 113.324 176.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.5 t -70.11 -49.42 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 119.375 0.989 . . . . 0.0 110.565 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.1 pp -72.07 -26.85 62.33 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -72.52 -35.14 68.01 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.203 0.911 . . . . 0.0 112.931 171.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -61.76 -46.91 87.55 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 120.771 -1.206 . . . . 0.0 111.075 165.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 70.0 mt -58.23 -41.45 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 119.139 0.881 . . . . 0.0 110.942 174.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.47 -44.62 92.97 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.116 0.966 . . . . 0.0 113.506 175.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.4 m -76.65 -41.15 46.77 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.81 0.844 . . . . 0.0 111.718 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -86.04 -21.75 27.58 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -174.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -114.75 27.61 9.31 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.021 1.728 . . . . 0.0 113.273 176.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.84 -27.52 30.22 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.4 m -73.28 -37.0 66.41 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.584 1.154 . . . . 0.0 112.75 174.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -94.19 -29.61 15.03 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.724 1.21 . . . . 0.0 113.339 -174.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.1 mt -129.56 149.34 51.36 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.953 2.101 . . . . 0.0 110.6 -177.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.2 m -103.24 138.14 40.44 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 150.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.8 t -127.89 126.95 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.808 0.731 . . . . 0.0 111.381 -173.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.71 165.75 18.67 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.853 1.661 . . . . 0.0 113.145 -172.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -129.73 141.27 50.91 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.617 1.967 . . . . 0.0 112.455 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.426 HD12 ' CD2' ' A' ' 32' ' ' PHE . 2.7 tm? -133.65 113.69 12.66 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.113 2.165 . . . . 0.0 108.595 169.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -81.51 120.61 25.25 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 169.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.7 m -65.85 -16.32 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -169.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -83.16 -20.16 35.24 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 119.294 0.952 . . . . 0.0 113.334 171.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 43.1 p -92.03 -28.82 16.94 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -169.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -148.76 76.21 9.83 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 123.579 0.752 . . . . 0.0 110.602 166.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.97 -27.38 78.92 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 124.027 3.151 . . . . 0.0 115.47 -169.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -62.36 -26.0 68.21 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.761 0.824 . . . . 0.0 112.924 176.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -64.23 -46.91 81.77 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.998 0.817 . . . . 0.0 110.653 175.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.53 -37.0 86.05 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.667 0.787 . . . . 0.0 112.19 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -70.78 -45.96 63.74 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.455 0.702 . . . . 0.0 112.603 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -69.82 -27.02 64.52 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -174.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -99.75 10.14 41.85 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.673 1.189 . . . . 0.0 113.563 172.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 62.68 -8.51 0.12 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 128.542 2.737 . . . . 0.0 116.225 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.9 m -79.61 56.52 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 126.536 1.934 . . . . 0.0 112.889 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.7 m -76.22 -21.46 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.925 1.29 . . . . 0.0 113.539 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 51.1 m -67.85 150.29 48.77 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.448 1.099 . . . . 0.0 111.26 170.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.3 pt -139.69 145.8 44.79 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -174.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.58 146.11 64.81 Favored 'Cis proline' 0 CA--C 1.538 0.685 0 O-C-N 122.034 0.492 . . . . 0.0 111.44 -17.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 83.4 m -135.18 126.32 28.0 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.88 0.872 . . . . 0.0 110.872 171.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.8 134.2 39.03 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.535 1.134 . . . . 0.0 108.007 167.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.6 tt -117.36 143.97 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.485 1.114 . . . . 0.0 108.891 165.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.7 tt -123.71 134.66 53.66 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.663 0.785 . . . . 0.0 110.361 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -114.24 147.36 39.11 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.835 1.654 . . . . 0.0 111.344 173.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -126.49 135.09 50.9 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.6 1.16 . . . . 0.0 109.528 161.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.0 t0 47.0 41.8 11.55 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.639 1.176 . . . . 0.0 113.411 -174.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.38 14.06 63.72 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.138 1.352 . . . . 0.0 115.884 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -118.35 140.81 28.64 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 125.715 1.606 . . . . 0.0 109.88 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.81 140.36 42.31 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.798 2.332 . . . . 0.0 112.308 -174.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.2 t -125.94 -39.26 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.983 1.713 . . . . 0.0 112.185 -173.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -145.11 145.34 31.37 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.756 0.823 . . . . 0.0 111.89 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -129.26 132.31 47.17 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.072 1.749 . . . . 0.0 109.814 161.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.3 mt -135.55 129.53 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.618 1.567 . . . . 0.0 108.994 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.0 m -127.63 145.48 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 123.744 0.818 . . . . 0.0 112.568 -170.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.24 166.63 26.52 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.22 0.914 . . . . 0.0 113.506 -174.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.35 132.77 35.22 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.729 -0.865 . . . . 0.0 112.489 -176.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -133.83 156.53 47.87 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.912 1.685 . . . . 0.0 111.144 172.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -79.18 167.91 52.76 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 123.873 0.749 . . . . 0.0 112.169 173.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -47.91 -38.18 15.86 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.854 1.662 . . . . 0.0 114.673 -176.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.26 -49.57 54.93 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.78 0.324 . . . . 0.0 111.759 -177.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.42 -39.31 59.09 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.731 -0.606 . . . . 0.0 112.516 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.9 tp -68.07 -42.03 81.05 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.921 0.782 . . . . 0.0 111.052 176.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 23.6 tp -70.24 -24.68 63.12 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-O 115.513 -2.184 . . . . 0.0 112.315 171.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 44.6 mmt-85 -64.31 -49.51 71.49 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 124.51 3.323 . . . . 0.0 112.219 167.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.37 -31.22 65.56 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.464 0.706 . . . . 0.0 112.839 176.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 53.3 mt -97.26 -22.56 16.62 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 52.3 p -73.96 -20.2 60.43 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.893 1.277 . . . . 0.0 111.114 174.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -52.91 -27.83 20.52 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 160.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 93.3 t -100.86 -32.71 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 126.66 1.984 . . . . 0.0 112.008 171.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 28.5 t . . . . . 0 N--CA 1.477 0.903 0 C-N-CA 126.913 2.085 . . . . 0.0 110.942 -176.893 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.3 p . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.2 pt -138.25 172.53 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 126.545 1.938 . . . . 0.0 111.381 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -125.48 142.91 51.25 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.106 0.962 . . . . 0.0 111.209 169.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -139.36 150.23 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.375 1.47 . . . . 0.0 111.0 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.7 p -139.51 161.48 37.38 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.15 1.38 . . . . 0.0 111.672 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -51.15 -30.38 16.41 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.936 2.095 . . . . 0.0 114.718 -176.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.0 -20.19 66.11 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 178.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.6 m -137.96 9.85 2.82 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.456 1.502 . . . . 0.0 113.411 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -63.13 -44.74 94.72 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.178 -0.951 . . . . 0.0 112.486 -168.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.26 -32.81 74.45 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.682 -0.636 . . . . 0.0 112.504 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.5 -9.46 59.62 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.84 1.656 . . . . 0.0 114.16 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -124.17 -50.86 1.78 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.18 0.992 . . . . 0.0 113.241 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.1 t -81.72 -52.97 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.356 1.062 . . . . 0.0 110.799 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 28.9 mt -81.33 -13.35 58.48 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -175.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.0 p -77.68 -21.61 51.79 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.805 1.242 . . . . 0.0 113.192 173.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.9 m -75.49 126.7 31.53 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.188 1.395 . . . . 0.0 112.544 -173.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -76.95 -25.14 52.5 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.319 0.647 . . . . 0.0 111.85 169.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -74.99 145.23 80.75 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 125.853 1.661 . . . . 0.0 110.255 173.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.33 137.28 77.56 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.156 1.904 . . . . 0.0 112.14 172.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.5 p -136.53 130.35 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.6 1.16 . . . . 0.0 110.526 -176.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 tt -112.47 116.84 30.91 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.021 1.728 . . . . 0.0 108.228 -174.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.65 124.94 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.445 0.698 . . . . 0.0 110.501 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -107.47 116.39 31.86 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.585 1.554 . . . . 0.0 111.481 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -93.4 108.85 20.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.466 1.906 . . . . 0.0 108.351 177.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -142.26 173.13 11.81 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.851 1.261 . . . . 0.0 112.347 -163.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.74 145.16 29.86 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.54 -0.725 . . . . 0.0 112.275 158.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -65.43 -19.53 65.98 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.8 p-90 -78.51 -13.62 59.75 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 175.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.8 t -98.16 129.84 44.93 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.143 0.977 . . . . 0.0 111.572 -174.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.13 -55.91 27.6 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.298 0.951 . . . . 0.0 113.721 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -57.65 -31.73 92.65 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.439 2.759 . . . . 0.0 114.531 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 96.3 m -67.64 -45.33 75.62 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.137 -0.977 . . . . 0.0 111.44 173.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.1 tppt? -61.37 -33.57 73.87 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.475 1.11 . . . . 0.0 111.819 172.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 50.8 ttm -70.01 -42.72 72.65 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.031 1.332 . . . . 0.0 112.942 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.2 p -81.34 -24.49 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.96 -49.97 77.5 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.9 -27.27 37.15 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.174 1.916 . . . . 0.0 113.125 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.9 t -72.47 -41.35 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.714 0.805 . . . . 0.0 110.525 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.3 mt -67.19 -35.9 80.63 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.111 0.964 . . . . 0.0 112.613 170.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -66.12 -40.58 90.81 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.223 0.92 . . . . 0.0 111.468 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -58.26 -49.54 76.75 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.743 168.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 tp -66.82 -33.28 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 120.34 1.427 . . . . 0.0 112.652 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.79 -40.0 93.66 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.212 -0.93 . . . . 0.0 111.954 172.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.3 m -76.07 -49.0 18.66 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.723 0.809 . . . . 0.0 112.092 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -85.57 -21.61 28.45 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -170.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -116.92 31.52 6.7 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.357 1.863 . . . . 0.0 112.657 173.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.75 -28.18 14.42 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 176.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.5 p -81.61 -29.44 33.27 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.68 1.592 . . . . 0.0 114.292 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -102.16 -27.06 13.11 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.734 1.214 . . . . 0.0 113.742 -175.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 81.5 mt -129.67 148.71 51.58 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.357 1.863 . . . . 0.0 110.196 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.5 m -109.02 131.61 54.91 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 153.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 83.1 t -106.35 130.19 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.494 0.718 . . . . 0.0 109.858 -175.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.35 146.86 50.31 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.897 1.279 . . . . 0.0 112.419 -171.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -120.16 136.39 54.64 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.333 1.453 . . . . 0.0 111.986 -176.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -130.65 116.81 18.59 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.598 1.559 . . . . 0.0 109.744 171.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.77 105.72 13.13 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.261 1.024 . . . . 0.0 110.594 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.5 m -65.14 -20.42 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -73.76 -27.83 61.37 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.322 1.449 . . . . 0.0 113.271 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.7 p -112.73 -22.02 10.92 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.38 1.072 . . . . 0.0 113.59 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -133.27 92.71 24.01 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.256 1.023 . . . . 0.0 111.577 168.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -71.26 -19.61 29.09 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.238 2.625 . . . . 0.0 113.844 172.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -67.61 -42.38 82.5 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.142 -0.973 . . . . 0.0 112.126 -171.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.6 m -67.15 -35.02 78.81 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.85 0.86 . . . . 0.0 111.248 176.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.26 -45.6 80.0 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.227 0.611 . . . . 0.0 111.955 174.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.0 ttm105 -72.57 -41.59 65.53 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -174.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -62.1 -38.33 88.45 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -96.89 7.53 46.41 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.364 1.066 . . . . 0.0 113.122 176.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.318 14.8 pt20 44.02 34.45 0.95 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.95 2.1 . . . . 0.0 114.415 -169.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.8 m -85.56 43.85 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 126.654 1.982 . . . . 0.0 110.406 175.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.4 m -85.23 -14.2 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.698 1.599 . . . . 0.0 113.993 -168.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.0 t -71.55 155.31 40.7 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.559 0.743 . . . . 0.0 111.038 170.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 14.4 pt -129.49 121.49 20.32 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -167.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -67.24 161.8 76.76 Favored 'Cis proline' 0 CA--C 1.54 0.8 0 CA-C-N 118.831 0.618 . . . . 0.0 111.709 -16.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.1 m -127.16 134.39 50.18 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.5 1.12 . . . . 0.0 108.713 161.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.4 mp -113.42 131.93 55.82 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.856 1.262 . . . . 0.0 108.709 174.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.5 tp -116.1 146.3 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.868 1.267 . . . . 0.0 109.307 167.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.4 tt -123.92 132.85 53.8 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.681 -0.637 . . . . 0.0 110.451 165.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -111.95 143.77 42.38 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.223 1.409 . . . . 0.0 110.368 170.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -126.94 125.48 41.62 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.391 1.476 . . . . 0.0 109.17 171.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.8 t70 50.41 34.34 9.04 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 124.41 1.084 . . . . 0.0 113.526 -168.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.12 8.48 61.76 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 125.781 1.658 . . . . 0.0 116.171 -175.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -102.34 141.3 22.25 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 119.364 1.582 . . . . 0.0 110.488 172.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -70.08 140.38 41.32 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.83 2.353 . . . . 0.0 112.592 -176.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 75.3 t -127.72 -36.49 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 125.854 1.662 . . . . 0.0 112.709 -175.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -142.14 139.14 32.04 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.687 1.195 . . . . 0.0 111.115 -177.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 24.5 ttt85 -141.4 115.83 9.51 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.62 1.968 . . . . 0.0 110.194 171.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.27 150.73 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.223 1.409 . . . . 0.0 112.8 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.8 m -124.08 155.65 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.474 1.51 . . . . 0.0 111.911 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.25 163.11 11.27 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.257 0.932 . . . . 0.0 112.983 -174.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.5 156.07 30.84 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.191 -1.182 . . . . 0.0 113.706 -176.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.81 147.58 52.49 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.587 1.555 . . . . 0.0 110.049 165.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.69 167.22 44.14 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 162.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.4 tmtp? -52.75 -34.29 52.26 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.769 1.228 . . . . 0.0 113.618 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.59 -53.97 34.31 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.91 0.484 . . . . 0.0 111.754 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.1 -36.27 66.76 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.465 -0.772 . . . . 0.0 112.601 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.1 tp -63.44 -40.23 96.61 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.644 -0.66 . . . . 0.0 110.179 172.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 26.5 tp -72.74 -23.76 60.88 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-O 117.041 -1.457 . . . . 0.0 113.298 173.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -58.52 -55.61 32.79 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 122.951 2.614 . . . . 0.0 109.988 164.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -69.56 -26.57 64.55 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -174.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 88.9 mt -97.06 -28.76 14.0 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 176.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.9 t -69.58 -24.37 63.68 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 120.584 1.538 . . . . 0.0 111.194 170.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.63 -22.7 47.02 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 164.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.5 t -100.53 -28.28 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 127.056 2.142 . . . . 0.0 111.805 171.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 32.9 t . . . . . 0 N--CA 1.475 0.789 0 C-N-CA 127.389 2.276 . . . . 0.0 111.13 -170.955 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.6 p . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.1 pt -115.85 155.11 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.642 1.577 . . . . 0.0 111.551 171.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -108.8 136.4 48.43 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.517 1.127 . . . . 0.0 110.479 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.9 m -132.14 154.25 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.664 1.186 . . . . 0.0 112.857 -172.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 66.5 p -142.22 161.3 38.36 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.289 1.835 . . . . 0.0 110.854 175.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -57.17 -28.57 62.9 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -172.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.33 -17.3 62.45 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.553 1.141 . . . . 0.0 114.074 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.1 m -136.06 3.2 2.89 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.302 1.441 . . . . 0.0 113.552 -175.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -56.09 -40.57 73.86 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.119 1.367 . . . . 0.0 112.533 -174.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.03 -34.6 78.46 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.317 -0.864 . . . . 0.0 113.044 177.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.8 m -79.51 -29.6 41.62 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.511 1.124 . . . . 0.0 112.846 177.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -94.63 -39.46 10.33 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.1 t -97.23 -64.85 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.186 1.394 . . . . 0.0 109.859 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.9 mt -73.82 -14.62 61.13 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -165.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.0 m -85.08 -3.67 58.88 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.659 1.184 . . . . 0.0 113.997 176.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.1 m -60.65 142.09 56.04 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.925 1.29 . . . . 0.0 113.565 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.8 p-10 -82.93 -3.99 57.68 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.797 1.239 . . . . 0.0 114.2 176.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -141.13 163.33 42.81 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 127.833 2.453 . . . . 0.0 110.558 176.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -53.45 147.08 39.12 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.231 2.621 . . . . 0.0 112.836 177.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.39 133.39 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.633 1.173 . . . . 0.0 111.711 -174.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.02 117.05 32.73 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.876 2.071 . . . . 0.0 108.422 -176.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.2 t -107.63 127.31 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.693 0.797 . . . . 0.0 110.396 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -104.53 117.08 33.26 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.0 1.32 . . . . 0.0 111.173 175.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -91.8 107.22 19.06 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.272 1.829 . . . . 0.0 107.964 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.466 ' CD1' ' HE3' ' A' ' 62' ' ' LYS . 2.1 p-90 -143.93 164.47 30.48 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -159.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.47 151.92 36.01 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.865 0.866 . . . . 0.0 111.359 162.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.3 t -66.19 -20.99 66.3 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 12.6 p-90 -75.39 -8.64 57.23 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 173.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 43.1 t -100.34 116.46 32.38 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.406 1.082 . . . . 0.0 110.914 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.62 -44.3 98.13 Favored Glycine 0 CA--C 1.54 1.642 0 CA-C-O 118.801 -1.0 . . . . 0.0 114.022 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -56.88 -39.51 90.89 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.863 2.376 . . . . 0.0 113.941 169.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 87.1 m -61.57 -43.34 99.03 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.989 -1.069 . . . . 0.0 111.503 171.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -62.97 -29.74 71.05 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.379 1.072 . . . . 0.0 112.512 176.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -74.96 -45.71 40.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.229 1.412 . . . . 0.0 112.681 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.1 p -81.37 -24.11 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.78 -50.06 79.82 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -65.91 -28.36 50.42 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 CA-C-N 122.353 1.876 . . . . 0.0 113.177 176.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.6 t -70.02 -45.98 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.479 -0.763 . . . . 0.0 110.154 175.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.8 mt -62.35 -34.26 76.33 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.258 1.023 . . . . 0.0 112.672 172.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -66.3 -41.33 89.89 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.987 0.915 . . . . 0.0 111.758 175.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -63.75 -44.86 92.23 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.382 -0.824 . . . . 0.0 111.648 170.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.3 mm -59.01 -43.37 88.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 119.248 0.931 . . . . 0.0 110.956 174.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.45 -42.66 92.45 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.836 0.854 . . . . 0.0 112.016 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.2 m -74.61 -42.61 58.31 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.979 0.912 . . . . 0.0 112.062 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -95.42 -22.07 17.94 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -169.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -112.26 17.97 19.0 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.654 1.581 . . . . 0.0 112.633 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.85 -28.46 50.01 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.981 1.313 . . . . 0.0 114.455 -176.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.9 p -69.21 -22.75 63.86 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.931 1.692 . . . . 0.0 114.1 174.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -117.83 -29.52 5.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.883 1.673 . . . . 0.0 112.98 -171.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.0 mt -130.16 149.34 51.91 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.69 1.996 . . . . 0.0 111.125 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.2 m -99.79 139.03 36.05 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 151.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 52.2 t -117.0 129.23 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 119.397 0.999 . . . . 0.0 110.3 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.32 157.73 41.74 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.698 1.599 . . . . 0.0 112.697 -170.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.466 ' HE3' ' CD1' ' A' ' 33' ' ' TRP . 30.8 mmmt -126.77 124.3 39.39 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.179 1.792 . . . . 0.0 110.422 -175.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -109.95 114.03 27.24 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.642 1.177 . . . . 0.0 108.908 169.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.72 99.4 9.61 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.613 1.165 . . . . 0.0 109.369 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.9 m -66.7 -17.06 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 O-C-N 120.856 -1.152 . . . . 0.0 113.156 -176.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -74.23 -24.84 59.37 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.339 1.056 . . . . 0.0 113.206 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.2 p -119.25 -25.51 6.11 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -133.31 74.16 72.69 Favored Pre-proline 0 CA--C 1.55 0.977 0 CA-C-N 119.598 1.09 . . . . 0.0 112.141 171.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -67.46 -11.57 32.62 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 122.846 2.364 . . . . 0.0 112.675 168.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -57.24 -41.73 80.13 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.834 1.253 . . . . 0.0 112.223 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.2 m -66.02 -42.71 89.27 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.742 0.701 . . . . 0.0 111.046 174.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.75 -37.98 86.29 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.516 -0.74 . . . . 0.0 112.994 -178.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -78.74 -38.6 38.4 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 173.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -69.09 -36.67 77.85 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.245 0.93 . . . . 0.0 112.607 -178.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -93.3 9.15 37.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.819 1.248 . . . . 0.0 112.482 174.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 61.16 -10.29 0.06 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 128.737 2.815 . . . . 0.0 116.87 177.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.3 m -76.73 52.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 126.317 1.847 . . . . 0.0 113.449 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.8 p -75.9 -20.97 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.428 1.491 . . . . 0.0 113.067 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.5 p -70.9 129.33 38.77 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.188 0.995 . . . . 0.0 110.821 165.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.4 pt -138.5 149.62 63.4 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 125.068 1.347 . . . . 0.0 112.809 -163.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -66.51 149.4 79.18 Favored 'Cis proline' 0 C--N 1.354 0.829 0 CA-C-N 119.373 0.812 . . . . 0.0 113.246 -2.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.1 m -128.67 130.28 46.98 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.271 1.028 . . . . 0.0 110.895 169.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.3 mp -103.49 119.32 38.66 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.828 1.651 . . . . 0.0 107.227 161.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.3 tp -120.39 126.48 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.701 1.201 . . . . 0.0 109.713 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.9 tp -110.24 121.04 44.34 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.153 1.381 . . . . 0.0 110.464 -172.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -106.8 131.13 54.26 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.864 1.665 . . . . 0.0 109.172 175.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -99.72 -29.74 12.48 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -175.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -154.45 56.93 0.7 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.786 1.634 . . . . 0.0 110.785 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.73 17.82 65.37 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.315 0.959 . . . . 0.0 114.554 -175.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -141.91 138.41 16.97 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 126.83 2.052 . . . . 0.0 110.139 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.86 142.69 35.62 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.254 2.636 . . . . 0.0 111.96 -174.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.8 t -129.6 -40.06 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.497 1.119 . . . . 0.0 112.939 -176.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -142.3 133.14 25.65 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.081 0.855 . . . . 0.0 111.791 -173.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -117.83 134.01 55.36 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.284 1.434 . . . . 0.0 110.841 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.11 144.12 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 126.422 1.889 . . . . 0.0 108.713 169.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.8 m -133.67 144.84 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 124.834 1.254 . . . . 0.0 111.001 -174.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.08 -162.84 46.73 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 122.869 0.271 . . . . 0.0 112.624 -167.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.8 139.68 51.96 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.89 1.276 . . . . 0.0 112.28 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -135.23 154.35 51.61 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.611 1.565 . . . . 0.0 112.129 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -80.73 171.12 53.76 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.415 1.007 . . . . 0.0 112.455 173.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -51.84 -37.42 51.86 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.437 1.495 . . . . 0.0 114.628 -175.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.9 -53.43 32.22 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 123.407 0.442 . . . . 0.0 110.924 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.39 -38.76 68.37 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 36.9 tp -63.76 -42.57 97.8 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 119.399 0.999 . . . . 0.0 111.043 173.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.7 tp -70.18 -25.03 63.24 Favored 'General case' 0 C--O 1.214 -0.786 0 CA-C-O 115.857 -2.021 . . . . 0.0 113.014 174.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -64.49 -49.96 69.3 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 124.258 3.208 . . . . 0.0 111.962 166.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.49 -28.63 68.51 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.499 0.72 . . . . 0.0 112.882 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 89.8 mt -91.52 -28.21 17.73 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.396 1.078 . . . . 0.0 113.303 172.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.3 m -60.18 -28.79 68.24 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.82 1.248 . . . . 0.0 110.669 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -52.69 -20.47 3.14 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 168.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.9 t -118.59 -27.32 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 127.407 2.283 . . . . 0.0 112.633 173.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.475 0.814 0 C-N-CA 127.092 2.157 . . . . 0.0 110.939 -174.186 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.4 pt -132.62 157.24 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 126.112 1.765 . . . . 0.0 111.353 169.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -112.06 140.38 46.79 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.636 1.174 . . . . 0.0 110.597 171.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.9 m -132.11 155.46 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.701 1.2 . . . . 0.0 112.509 -175.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.7 p -142.11 160.81 39.49 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.466 1.907 . . . . 0.0 110.577 176.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -57.95 -27.64 63.59 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -173.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.36 -19.56 63.03 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.0 m -132.77 -2.85 3.29 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.181 1.392 . . . . 0.0 114.17 -174.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -55.26 -40.39 70.91 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.257 1.423 . . . . 0.0 112.642 -174.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.38 -33.6 75.53 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.972 0.731 . . . . 0.0 112.972 177.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.7 m -79.51 -29.69 41.63 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.725 1.21 . . . . 0.0 112.873 176.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -92.64 -45.04 8.27 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -176.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.11 -59.05 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.916 1.286 . . . . 0.0 110.636 -176.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.4 mt -75.66 -18.72 59.56 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -169.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.8 m -79.38 -10.84 59.89 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.3 t -81.64 130.05 34.92 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.788 0.835 . . . . 0.0 112.469 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -81.6 -21.12 38.55 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.242 1.017 . . . . 0.0 112.341 170.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -75.36 147.74 82.79 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.354 1.462 . . . . 0.0 110.062 174.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -58.03 133.23 54.32 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.103 1.869 . . . . 0.0 111.396 171.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.88 132.51 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.225 1.01 . . . . 0.0 110.18 -174.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -122.73 113.84 19.74 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.171 1.389 . . . . 0.0 109.7 -170.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.61 125.19 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.888 1.275 . . . . 0.0 110.224 -173.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -103.88 120.78 41.71 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.267 1.027 . . . . 0.0 112.009 174.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -93.09 113.37 25.61 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.987 2.115 . . . . 0.0 108.076 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 6.8 p-90 -144.83 172.5 12.93 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.439 1.096 . . . . 0.0 113.235 -165.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -145.77 152.83 40.19 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.916 0.886 . . . . 0.0 112.419 167.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.9 p -63.71 -27.29 69.1 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.622 1.169 . . . . 0.0 113.119 174.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.501 ' CZ3' HD11 ' A' ' 80' ' ' ILE . 10.7 p-90 -79.0 -3.69 46.29 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 48.5 t -107.5 123.74 48.87 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.865 0.866 . . . . 0.0 113.271 -170.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.31 -58.4 14.79 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.205 1.384 . . . . 0.0 114.02 178.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.7 -27.09 68.47 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 CA-C-N 120.482 2.141 . . . . 0.0 113.534 177.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 85.3 m -61.91 -46.68 88.33 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.116 1.326 . . . . 0.0 111.238 168.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.89 -33.18 72.71 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.014 0.926 . . . . 0.0 112.631 175.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.4 mtt -74.77 -37.7 62.38 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.542 1.137 . . . . 0.0 113.83 177.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.4 p -88.13 -20.77 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.47 -49.38 77.98 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 174.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.5 -27.23 46.59 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 CA-C-N 122.303 1.858 . . . . 0.0 113.476 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 95.3 t -71.29 -49.46 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 119.059 0.845 . . . . 0.0 110.322 173.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.9 mt -61.52 -34.32 75.32 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.954 0.902 . . . . 0.0 113.029 176.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -62.61 -39.99 95.54 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.889 0.876 . . . . 0.0 111.504 173.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -71.34 -36.96 71.73 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.154 -0.966 . . . . 0.0 112.655 173.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.6 mm -61.21 -43.8 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 120.542 1.519 . . . . 0.0 110.559 171.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.27 -35.31 79.92 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.891 0.876 . . . . 0.0 112.504 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.4 m -73.46 -49.04 28.89 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.807 0.843 . . . . 0.0 112.012 176.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -92.7 -34.39 13.96 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -165.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -97.72 19.58 13.4 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.142 0.977 . . . . 0.0 113.328 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.37 -28.2 18.65 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.3 m -75.02 -31.68 61.41 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.767 1.227 . . . . 0.0 112.936 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -97.48 -34.89 10.83 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.035 1.334 . . . . 0.0 112.786 -174.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.3 mt -129.83 152.37 49.39 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.671 2.388 . . . . 0.0 110.518 -174.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.5 m -106.34 129.64 54.31 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 153.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.8 t -99.42 133.03 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.148 0.579 . . . . 0.0 110.193 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.2 155.94 44.73 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.359 1.464 . . . . 0.0 112.217 -173.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -127.64 134.54 49.64 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.305 1.442 . . . . 0.0 112.104 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -124.55 116.43 22.45 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.917 1.687 . . . . 0.0 109.08 169.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -81.94 113.03 19.58 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.482 0.713 . . . . 0.0 109.984 174.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.5 m -71.76 -16.56 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -177.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -85.84 -39.03 17.49 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.792 0.837 . . . . 0.0 111.991 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 72.3 p -96.38 -19.98 18.8 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -137.67 77.13 40.07 Favored Pre-proline 0 CA--C 1.552 1.021 0 CA-C-N 120.159 1.345 . . . . 0.0 111.82 163.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -65.56 -18.9 60.29 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.43 2.753 . . . . 0.0 113.871 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -63.61 -37.38 87.12 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.35 -0.844 . . . . 0.0 113.104 -174.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 m -65.06 -43.61 91.71 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.633 1.106 . . . . 0.0 111.256 174.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.7 -36.66 83.65 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.532 0.733 . . . . 0.0 112.08 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -70.1 -46.76 64.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.845 0.858 . . . . 0.0 112.12 173.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -63.05 -37.12 85.92 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.386 1.474 . . . . 0.0 112.617 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -96.48 8.8 43.2 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.497 1.119 . . . . 0.0 112.917 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 59.98 -11.43 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 128.539 2.736 . . . . 0.0 116.588 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.5 m -76.74 59.96 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.579 1.952 . . . . 0.0 112.667 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.0 m -74.84 -19.9 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.989 1.316 . . . . 0.0 113.423 176.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.6 t -79.27 148.09 32.28 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.555 1.142 . . . . 0.0 111.165 170.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.501 HD11 ' CZ3' ' A' ' 36' ' ' TRP . 46.7 pt -143.49 155.64 60.55 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -167.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.74 140.82 59.5 Favored 'Cis proline' 0 C--N 1.353 0.793 0 CA-C-N 119.093 0.712 . . . . 0.0 111.033 -9.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 98.2 m -133.34 120.96 21.68 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.432 0.634 . . . . 0.0 110.65 174.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 mp -96.62 134.93 39.23 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.782 1.633 . . . . 0.0 108.42 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.0 tt -130.57 129.24 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.775 1.23 . . . . 0.0 110.727 171.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.9 tt -103.46 133.69 48.09 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.914 1.286 . . . . 0.0 110.531 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -117.22 148.28 41.77 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.233 1.413 . . . . 0.0 111.228 171.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -124.77 131.03 53.49 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.007 1.323 . . . . 0.0 108.991 164.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.6 t70 49.13 33.27 4.73 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.22 13.36 83.69 Favored Glycine 0 CA--C 1.536 1.371 0 N-CA-C 116.909 1.524 . . . . 0.0 116.909 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -116.25 145.76 35.77 Favored Pre-proline 0 N--CA 1.474 0.743 0 CA-C-N 119.36 1.58 . . . . 0.0 111.588 167.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -72.18 148.71 50.48 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.381 2.721 . . . . 0.0 112.408 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.2 t -131.89 -43.2 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.325 1.45 . . . . 0.0 112.829 -168.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -148.84 146.55 28.02 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.083 1.353 . . . . 0.0 110.968 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 -129.02 144.59 51.24 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.513 1.525 . . . . 0.0 112.067 167.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.5 mt -136.51 136.36 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 126.369 1.868 . . . . 0.0 107.893 175.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 p -133.46 142.89 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 119.664 1.12 . . . . 0.0 111.685 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.16 161.11 30.47 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.017 1.294 . . . . 0.0 113.248 -171.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.85 134.39 39.04 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.792 -0.828 . . . . 0.0 112.57 -177.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -133.07 149.65 52.14 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.936 1.694 . . . . 0.0 109.905 172.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.77 167.01 54.7 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -45.11 -40.06 6.56 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.36 1.464 . . . . 0.0 114.62 -175.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.77 -48.86 57.74 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.037 0.535 . . . . 0.0 111.984 -177.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.57 -36.98 60.24 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.91 0.884 . . . . 0.0 112.712 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.72 -46.53 75.22 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.914 0.886 . . . . 0.0 110.046 175.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -66.12 -30.02 70.44 Favored 'General case' 0 C--O 1.208 -1.124 0 CA-C-O 115.651 -2.118 . . . . 0.0 111.587 171.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 4.5 mmt180 -62.2 -49.11 77.1 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 124.382 3.264 . . . . 0.0 112.849 171.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -59.05 -33.01 70.28 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.323 1.049 . . . . 0.0 112.434 177.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.4 mt -85.62 -22.95 27.74 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 169.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.4 p -67.38 -25.99 66.23 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.807 1.643 . . . . 0.0 110.096 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -49.6 -26.25 3.44 Favored 'General case' 0 CA--C 1.556 1.193 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 164.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.5 t -111.57 -23.52 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 127.337 2.255 . . . . 0.0 112.931 172.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.48 1.046 0 C-N-CA 127.858 2.463 . . . . 0.0 109.798 177.205 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.0 p . . . . . 0 N--CA 1.478 0.933 0 CA-C-O 121.201 0.524 . . . . 0.0 112.387 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.1 pt -125.02 164.52 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.57 1.548 . . . . 0.0 110.189 164.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -123.5 138.13 54.64 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.902 -1.124 . . . . 0.0 110.816 172.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.87 150.72 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.235 1.414 . . . . 0.0 112.085 -168.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.0 p -139.89 161.94 36.37 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.545 1.538 . . . . 0.0 111.496 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -51.6 -31.48 25.05 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.318 1.447 . . . . 0.0 114.599 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.71 -20.18 65.91 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.8 m -133.64 4.96 3.66 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.477 1.511 . . . . 0.0 113.425 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -59.45 -39.81 84.82 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.685 1.194 . . . . 0.0 112.969 -171.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.91 -32.64 74.04 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.533 -0.729 . . . . 0.0 112.889 175.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.1 m -79.62 -27.49 41.01 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.215 1.406 . . . . 0.0 113.234 177.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -101.34 -34.01 9.79 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -176.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.45 -54.47 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.843 1.257 . . . . 0.0 111.503 -172.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.4 mt -74.9 -12.59 60.4 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -176.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.5 p -71.16 -15.83 62.51 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.261 1.824 . . . . 0.0 113.942 173.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.7 p -66.75 149.05 51.1 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.804 1.642 . . . . 0.0 114.335 -172.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -109.62 -16.83 13.86 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.931 1.292 . . . . 0.0 112.225 160.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -90.53 166.6 18.96 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 125.95 1.7 . . . . 0.0 111.195 171.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.442 ' HB2' HD23 ' A' ' 58' ' ' LEU . 51.0 Cg_exo -59.49 138.68 85.38 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.29 1.994 . . . . 0.0 112.863 167.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.71 124.84 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.571 1.148 . . . . 0.0 111.104 172.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tt -100.3 128.73 46.3 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.796 2.038 . . . . 0.0 108.44 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.1 t -120.03 129.24 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.364 1.065 . . . . 0.0 110.571 173.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -106.8 116.93 32.78 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.061 1.344 . . . . 0.0 111.615 175.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.5 m-30 -88.22 111.69 21.93 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.992 1.717 . . . . 0.0 108.841 171.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 24.6 p-90 -134.23 170.96 14.91 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.236 1.414 . . . . 0.0 112.194 -171.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.86 140.27 24.46 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.83 0.852 . . . . 0.0 110.914 170.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 t -65.47 -12.5 53.13 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -168.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 55.3 p-90 -84.21 -14.02 51.15 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 172.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.2 t -90.7 106.49 18.54 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.1 0.96 . . . . 0.0 112.721 -166.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -52.75 -49.66 52.88 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.351 0.977 . . . . 0.0 114.234 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -60.59 -29.32 88.25 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.559 2.173 . . . . 0.0 114.487 174.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.73 -39.36 70.15 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.255 0.934 . . . . 0.0 111.294 172.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -63.45 -29.81 71.04 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.552 0.741 . . . . 0.0 112.308 172.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.6 mtt -71.02 -42.5 69.48 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.261 1.024 . . . . 0.0 113.11 174.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.6 p -86.09 -21.65 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.51 -49.09 79.92 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 176.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.86 -27.95 43.23 Favored 'Trans proline' 0 C--N 1.353 0.764 0 CA-C-N 122.32 1.864 . . . . 0.0 112.828 176.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.8 t -72.16 -46.04 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 121.601 -0.687 . . . . 0.0 110.371 176.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.4 mt -57.55 -40.53 79.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.422 1.089 . . . . 0.0 112.078 170.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.43 -41.02 85.47 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.179 0.992 . . . . 0.0 112.327 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -62.93 -49.35 75.11 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.299 -0.876 . . . . 0.0 111.692 169.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 17.0 mm -56.61 -42.09 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.44 0.696 . . . . 0.0 110.94 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.06 -49.96 75.58 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.992 0.917 . . . . 0.0 112.117 174.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.6 m -77.34 -32.86 55.44 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.706 0.802 . . . . 0.0 112.247 -170.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -86.14 -38.69 17.47 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.571 1.148 . . . . 0.0 113.916 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -107.52 26.75 9.87 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.542 1.137 . . . . 0.0 113.8 -173.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.75 -27.99 45.17 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.9 p -77.19 -19.88 56.14 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.416 1.487 . . . . 0.0 113.902 175.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -104.68 -35.53 7.77 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.268 1.427 . . . . 0.0 112.718 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.442 HD23 ' HB2' ' A' ' 27' ' ' PRO . 85.9 mt -129.61 149.14 51.5 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.168 2.187 . . . . 0.0 110.231 -176.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.8 m -99.54 138.87 36.02 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 150.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.7 t -125.02 127.9 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.247 0.931 . . . . 0.0 110.583 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -128.07 154.08 46.09 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.013 1.725 . . . . 0.0 112.915 -169.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -125.7 145.01 50.36 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.406 1.482 . . . . 0.0 112.916 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -135.98 118.58 15.96 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.499 1.92 . . . . 0.0 109.95 173.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -83.81 109.96 17.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.225 0.61 . . . . 0.0 110.727 174.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.4 m -70.7 -12.18 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -74.11 -19.33 60.62 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.734 1.152 . . . . 0.0 112.119 166.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.1 p -101.18 -43.76 5.89 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.615 1.166 . . . . 0.0 112.718 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -142.41 65.42 17.75 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 125.226 1.41 . . . . 0.0 111.311 -171.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -63.56 -23.17 70.58 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.617 2.878 . . . . 0.0 113.696 -176.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -57.0 -28.0 62.07 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.48 1.112 . . . . 0.0 112.576 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -66.79 -44.96 79.94 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.102 0.961 . . . . 0.0 112.06 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.55 -31.84 63.86 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.322 1.049 . . . . 0.0 112.651 173.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -71.1 -32.24 68.8 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.617 1.167 . . . . 0.0 113.496 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.6 t-20 -60.25 -41.81 93.97 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.757 1.223 . . . . 0.0 112.068 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -82.72 -8.38 59.59 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.026 0.93 . . . . 0.0 113.195 172.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 55.14 45.63 25.61 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.133 2.173 . . . . 0.0 113.056 -170.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.02 61.78 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.974 1.31 . . . . 0.0 109.507 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.9 p -82.55 -13.9 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -168.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.4 t -64.89 153.22 40.96 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.563 1.145 . . . . 0.0 112.849 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.7 mt -133.0 138.73 32.48 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 123.601 0.76 . . . . 0.0 112.371 -158.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.19 145.39 75.66 Favored 'Cis proline' 0 C--N 1.352 0.745 0 CA-C-N 119.183 0.744 . . . . 0.0 110.764 -16.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.4 m -117.03 122.28 43.75 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.577 0.751 . . . . 0.0 109.59 166.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.3 mp -102.97 120.14 40.09 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 171.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.8 tt -119.65 130.32 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.525 1.13 . . . . 0.0 110.162 176.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.3 tp -108.26 126.51 52.91 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.567 1.147 . . . . 0.0 109.766 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -105.21 152.07 23.3 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.472 1.509 . . . . 0.0 110.022 169.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -134.95 130.98 36.65 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.334 1.454 . . . . 0.0 108.682 166.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.5 t70 50.74 39.04 21.0 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.604 0.762 . . . . 0.0 113.002 -170.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.51 15.46 66.15 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.407 1.48 . . . . 0.0 115.777 -178.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -123.3 140.07 33.08 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 125.606 1.562 . . . . 0.0 110.133 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.32 141.24 46.47 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.95 2.433 . . . . 0.0 113.055 -172.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.8 t -127.94 -38.16 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.972 1.709 . . . . 0.0 112.943 -175.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -141.86 149.33 40.14 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.691 1.196 . . . . 0.0 111.582 175.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -130.69 136.44 48.79 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.028 1.331 . . . . 0.0 110.554 161.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.7 mt -130.1 145.52 35.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 127.089 2.155 . . . . 0.0 108.574 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.5 p -134.03 148.09 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.433 1.093 . . . . 0.0 111.877 171.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.16 164.6 30.39 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.771 1.177 . . . . 0.0 113.286 -176.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.3 146.52 39.22 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -174.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -136.03 145.97 46.62 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.278 1.831 . . . . 0.0 110.084 174.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.81 167.6 38.57 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 123.882 0.753 . . . . 0.0 111.336 166.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -50.82 -38.14 46.99 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.929 1.292 . . . . 0.0 113.742 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.29 -53.76 39.16 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.765 0.426 . . . . 0.0 111.572 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.07 -44.29 69.42 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.594 -0.691 . . . . 0.0 112.479 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.37 -44.64 94.18 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-O 119.076 -0.488 . . . . 0.0 110.254 177.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.1 tp -63.7 -36.64 84.51 Favored 'General case' 0 C--O 1.209 -1.04 0 CA-C-O 114.936 -2.459 . . . . 0.0 111.831 175.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.4 mmm-85 -63.13 -48.41 78.62 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 124.281 3.219 . . . . 0.0 112.599 176.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -57.57 -32.73 67.44 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 176.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 86.5 mt -85.79 -25.17 26.51 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.428 1.091 . . . . 0.0 113.577 171.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.6 p -67.9 -25.12 65.34 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.424 1.889 . . . . 0.0 110.163 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -55.34 -21.99 17.36 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 164.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 66.9 t -112.96 -20.57 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 127.434 2.294 . . . . 0.0 112.441 173.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 17.2 t . . . . . 0 N--CA 1.477 0.918 0 C-N-CA 127.729 2.412 . . . . 0.0 109.244 172.131 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.3 p . . . . . 0 N--CA 1.476 0.831 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.4 pt -130.27 159.83 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 126.193 1.797 . . . . 0.0 111.781 176.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -105.76 143.84 33.34 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.185 0.994 . . . . 0.0 111.208 169.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.5 m -131.27 155.06 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.788 1.635 . . . . 0.0 111.215 176.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 60.3 p -137.44 168.41 19.7 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.331 1.852 . . . . 0.0 111.646 -172.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -61.36 -20.71 63.3 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.23 -13.51 49.64 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.364 1.466 . . . . 0.0 114.789 172.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 87.0 p -132.41 -12.58 3.1 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -168.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -56.02 -41.45 74.95 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.55 1.14 . . . . 0.0 112.649 -173.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.69 -36.76 83.26 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.252 -0.905 . . . . 0.0 112.921 178.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.5 m -79.6 -21.13 45.37 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.655 1.582 . . . . 0.0 113.784 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -111.33 -32.33 6.77 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 t -101.86 -59.12 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.645 1.178 . . . . 0.0 111.231 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 46.3 mt -73.67 -14.02 61.09 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -173.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 83.8 p -72.33 -19.23 61.68 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.273 1.829 . . . . 0.0 113.822 171.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.4 t -77.56 124.47 27.95 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.179 0.992 . . . . 0.0 113.223 -164.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -85.82 -14.62 44.5 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.793 1.237 . . . . 0.0 113.291 170.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -94.13 158.93 35.23 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 125.834 1.653 . . . . 0.0 110.346 168.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -57.06 138.52 86.65 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 121.282 1.321 . . . . 0.0 112.118 171.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.34 129.16 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.333 1.053 . . . . 0.0 110.243 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.71 115.73 29.57 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.458 1.903 . . . . 0.0 108.526 -170.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.0 t -110.02 125.72 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.44 0.696 . . . . 0.0 110.666 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -99.27 120.07 38.94 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.402 1.081 . . . . 0.0 110.849 169.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -86.79 116.71 25.05 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.36 1.464 . . . . 0.0 108.502 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -136.89 172.91 12.3 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.775 1.23 . . . . 0.0 112.928 -167.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.75 156.73 43.38 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.797 0.839 . . . . 0.0 111.934 168.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.2 p -58.5 -30.33 66.94 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.215 1.006 . . . . 0.0 112.572 170.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 29.8 p-90 -82.41 -8.04 59.63 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 177.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.1 t -97.0 93.34 6.55 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 119.642 1.11 . . . . 0.0 112.712 -173.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.77 -42.04 67.66 Favored Glycine 0 CA--C 1.541 1.689 0 CA-C-O 118.556 -1.135 . . . . 0.0 114.153 173.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -61.91 -31.08 84.59 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 CA-C-N 120.586 2.193 . . . . 0.0 114.287 171.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 72.3 m -66.62 -41.65 88.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.606 1.094 . . . . 0.0 110.88 169.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -61.23 -29.68 69.98 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 118.715 0.689 . . . . 0.0 112.759 172.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 88.6 mtp -72.78 -39.84 66.43 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.183 0.993 . . . . 0.0 113.432 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.1 p -86.07 -19.29 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 177.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.22 -48.31 80.27 Favored Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 176.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.58 -27.28 45.98 Favored 'Trans proline' 0 C--N 1.352 0.712 0 CA-C-N 122.4 1.893 . . . . 0.0 113.013 176.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.8 t -71.93 -46.14 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.476 -0.765 . . . . 0.0 110.059 175.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.9 mt -59.78 -37.24 78.51 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.457 1.103 . . . . 0.0 112.623 171.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -63.38 -39.98 96.0 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.206 0.602 . . . . 0.0 111.593 175.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -69.46 -40.11 77.34 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.043 -1.035 . . . . 0.0 112.416 173.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 36.5 mm -56.51 -44.48 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.784 1.174 . . . . 0.0 110.547 171.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.06 -47.34 85.13 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.618 0.767 . . . . 0.0 111.642 175.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.1 m -62.19 -41.78 98.66 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.948 1.299 . . . . 0.0 111.332 -177.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -89.4 -36.96 15.18 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -173.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -108.02 16.4 23.43 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -172.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.39 -34.23 23.51 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -178.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.6 t -72.65 -25.15 61.17 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.544 1.138 . . . . 0.0 113.016 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -95.0 -51.6 4.59 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.743 1.217 . . . . 0.0 111.664 178.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.16 153.15 52.07 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.286 1.434 . . . . 0.0 113.178 -174.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.3 m -104.23 137.45 42.13 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.288 1.035 . . . . 0.0 109.385 175.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.4 t -109.71 129.56 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.831 0.852 . . . . 0.0 110.5 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -132.55 160.03 37.73 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.9 1.68 . . . . 0.0 113.048 -169.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt -127.56 129.49 47.42 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.277 1.831 . . . . 0.0 111.741 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -117.8 116.47 27.06 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.204 1.402 . . . . 0.0 108.974 169.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -82.73 104.52 13.04 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.414 0.686 . . . . 0.0 110.879 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.409 HG12 ' HB2' ' A' ' 72' ' ' ALA . 4.3 m -65.46 -18.86 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -175.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -78.25 -19.41 53.76 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.412 0.685 . . . . 0.0 112.679 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 t -119.06 -18.68 8.69 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 175.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -123.55 59.31 15.7 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 125.415 1.486 . . . . 0.0 111.36 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -64.99 -27.97 57.92 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.002 2.468 . . . . 0.0 113.296 -174.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -72.12 -27.7 62.8 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.19 -0.944 . . . . 0.0 112.644 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.4 m -69.46 -39.14 77.93 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.348 -0.845 . . . . 0.0 111.155 171.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.409 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -64.14 -37.1 86.23 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.44 0.696 . . . . 0.0 112.294 171.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -71.7 -39.49 70.13 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.507 0.723 . . . . 0.0 112.653 177.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -56.71 -40.74 76.2 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.14 1.376 . . . . 0.0 113.874 -172.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -96.9 3.99 51.84 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.269 1.028 . . . . 0.0 113.052 178.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 48.0 54.97 9.28 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.202 1.801 . . . . 0.0 112.169 -167.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.9 m -113.67 15.0 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.772 1.629 . . . . 0.0 112.657 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.2 m -59.03 -23.07 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.763 1.625 . . . . 0.0 114.466 -174.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.4 m -79.83 53.05 1.57 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.666 1.986 . . . . 0.0 113.413 -174.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.5 pt -63.93 152.15 87.87 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -167.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -64.37 135.22 20.81 Favored 'Cis proline' 0 C--N 1.357 0.982 0 CA-C-N 119.855 0.984 . . . . 0.0 113.376 1.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.1 m -136.14 120.79 18.36 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.12 0.568 . . . . 0.0 110.186 172.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.1 mp -107.92 129.71 55.08 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.818 1.647 . . . . 0.0 107.93 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.46 132.49 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.965 0.906 . . . . 0.0 109.405 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.5 tp -110.23 129.32 55.74 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.008 1.323 . . . . 0.0 109.464 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -110.2 152.69 25.77 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.368 1.467 . . . . 0.0 111.044 173.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -130.77 137.07 49.29 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.651 1.58 . . . . 0.0 109.446 157.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.1 t70 51.17 33.38 9.35 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.505 1.122 . . . . 0.0 113.522 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.29 10.39 65.92 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.222 1.391 . . . . 0.0 116.093 -175.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -111.82 143.39 28.55 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 119.184 1.492 . . . . 0.0 111.236 176.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -58.92 144.86 98.72 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.358 2.706 . . . . 0.0 114.641 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 94.2 t -128.29 -48.74 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 126.1 1.76 . . . . 0.0 111.603 -178.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -142.19 148.92 39.0 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.688 1.595 . . . . 0.0 111.253 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -135.43 134.18 39.37 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.804 1.641 . . . . 0.0 110.737 171.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.6 mp -134.75 140.85 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 126.0 1.72 . . . . 0.0 109.594 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.5 m -130.44 144.46 37.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.794 1.238 . . . . 0.0 111.656 -176.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.7 161.42 8.4 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.368 0.985 . . . . 0.0 113.281 -170.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.14 152.1 33.94 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.693 -0.887 . . . . 0.0 112.99 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -136.18 152.3 50.64 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.969 1.708 . . . . 0.0 111.207 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.73 166.9 33.1 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.403 1.001 . . . . 0.0 111.46 163.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -52.62 -35.9 55.41 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.055 1.342 . . . . 0.0 113.736 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.28 -49.8 58.03 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 122.916 0.487 . . . . 0.0 111.829 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.45 -43.36 70.01 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.609 -0.682 . . . . 0.0 111.965 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.3 tp -63.45 -44.16 95.29 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 119.055 -0.498 . . . . 0.0 110.78 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 20.1 tp -71.76 -24.62 61.79 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-O 116.549 -1.691 . . . . 0.0 113.208 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 -61.24 -54.12 48.22 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 123.883 3.038 . . . . 0.0 110.859 166.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -61.47 -30.31 70.52 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.7 mt -90.26 -31.91 16.78 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 175.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.4 t -71.24 -11.11 60.75 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.704 1.602 . . . . 0.0 112.242 175.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -46.85 -27.6 1.29 Allowed 'General case' 0 CA--C 1.558 1.269 0 O-C-N 121.227 -0.921 . . . . 0.0 113.076 153.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.07 -49.67 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 128.156 2.582 . . . . 0.0 112.502 174.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.7 t . . . . . 0 N--CA 1.482 1.145 0 C-N-CA 125.793 1.637 . . . . 0.0 113.632 -170.1 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.8 t . . . . . 0 N--CA 1.473 0.677 0 CA-C-O 120.495 0.188 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.3 pt -135.17 148.88 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.998 1.719 . . . . 0.0 110.61 176.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -92.66 139.62 30.37 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.651 -0.656 . . . . 0.0 110.581 168.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -115.46 164.15 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.732 1.213 . . . . 0.0 111.961 173.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 54.8 p -139.71 159.62 41.75 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.137 1.775 . . . . 0.0 110.681 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -58.7 -27.84 65.23 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 121.131 -0.981 . . . . 0.0 113.536 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.36 -18.18 52.94 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.9 m -128.8 -3.81 5.23 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.763 1.225 . . . . 0.0 114.052 -172.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -53.5 -41.35 66.21 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.351 1.461 . . . . 0.0 112.55 -177.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.77 -33.01 74.67 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.457 -0.777 . . . . 0.0 113.092 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.6 m -79.54 -30.83 41.91 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.397 1.079 . . . . 0.0 112.706 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -93.39 -32.97 14.04 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -174.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -111.13 -57.75 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.296 1.438 . . . . 0.0 110.707 -175.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 33.8 mt -76.63 -13.27 60.07 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -170.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.3 m -83.31 -13.1 55.84 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.62 0.971 . . . . 0.0 113.62 176.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.7 m -81.86 130.39 35.05 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.043 1.337 . . . . 0.0 112.817 -173.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -79.56 -23.55 42.73 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.266 0.626 . . . . 0.0 112.308 171.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -74.09 143.29 80.33 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 125.238 1.415 . . . . 0.0 109.485 171.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -53.44 138.95 65.81 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 121.805 1.67 . . . . 0.0 112.205 166.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p -136.41 132.32 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 C-N-CA 125.129 1.371 . . . . 0.0 110.337 -173.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.23 126.38 55.17 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.517 1.927 . . . . 0.0 108.441 -175.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.1 t -119.7 124.36 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.11 0.964 . . . . 0.0 110.557 177.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -101.16 113.38 26.37 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.954 1.702 . . . . 0.0 111.159 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -92.82 112.41 24.36 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.685 1.594 . . . . 0.0 108.734 176.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -143.13 171.94 13.39 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.766 1.226 . . . . 0.0 111.909 -166.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.41 151.16 40.05 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.867 0.867 . . . . 0.0 112.896 170.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 28.0 p -65.46 -25.56 67.56 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.604 1.162 . . . . 0.0 113.241 172.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 13.3 p-90 -88.62 4.62 46.4 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.509 1.524 . . . . 0.0 114.934 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.1 t -122.38 127.25 49.5 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.311 1.044 . . . . 0.0 112.953 -173.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.24 -53.69 40.35 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 118.7 -1.056 . . . . 0.0 114.882 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.78 -23.8 68.92 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 CA-C-N 121.079 2.44 . . . . 0.0 113.293 174.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 86.2 m -65.39 -46.46 79.98 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.827 -1.171 . . . . 0.0 111.615 167.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -59.31 -29.89 67.95 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.842 0.857 . . . . 0.0 112.932 172.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.6 mtt -74.09 -39.09 63.65 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 176.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -90.88 -29.42 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -175.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.93 -46.47 87.67 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.77 -25.94 28.03 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.357 2.038 . . . . 0.0 113.79 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.38 -45.52 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 119.44 1.018 . . . . 0.0 108.688 175.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -67.4 -31.65 72.02 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.996 1.318 . . . . 0.0 112.372 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -73.65 -36.94 65.43 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.037 0.835 . . . . 0.0 112.945 174.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -59.68 -45.16 92.92 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.995 -1.065 . . . . 0.0 111.162 165.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.4 mt -62.59 -40.21 87.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 O-C-N 121.603 -0.685 . . . . 0.0 110.594 176.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.76 -32.42 73.91 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.553 -1.342 . . . . 0.0 113.252 173.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.4 m -74.38 -48.08 30.18 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.752 0.821 . . . . 0.0 111.554 176.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -90.96 -24.71 20.05 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -169.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -117.01 15.13 15.12 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.152 1.381 . . . . 0.0 114.597 -172.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.4 -28.03 11.65 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 175.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.4 p -84.06 -21.89 31.4 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.658 1.583 . . . . 0.0 114.304 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -98.58 -31.97 11.68 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.217 1.407 . . . . 0.0 112.585 178.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.9 mt -139.18 149.35 44.32 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.203 2.601 . . . . 0.0 109.977 -177.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.4 m -91.22 134.96 34.13 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 157.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.1 t -128.63 120.13 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 121.516 -0.74 . . . . 0.0 109.987 -169.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.45 159.86 35.8 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.978 1.311 . . . . 0.0 113.422 -168.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -119.75 140.27 50.99 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.287 1.835 . . . . 0.0 111.56 176.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -122.64 111.15 16.41 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.223 1.409 . . . . 0.0 107.824 164.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -82.09 110.57 17.43 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.0 m -67.1 -16.37 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -174.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -76.87 -23.46 52.63 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.414 0.686 . . . . 0.0 112.569 171.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.5 p -93.57 -31.97 14.31 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.866 1.266 . . . . 0.0 112.563 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -138.43 79.98 28.63 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.324 1.449 . . . . 0.0 111.688 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -61.89 -28.73 81.49 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.809 2.339 . . . . 0.0 113.609 175.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -66.56 -41.39 88.69 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.077 0.951 . . . . 0.0 112.411 -176.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -61.86 -37.98 86.54 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.477 0.711 . . . . 0.0 111.651 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.99 -45.12 95.02 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.75 0.82 . . . . 0.0 112.496 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.9 ptm85 -78.13 -31.19 49.76 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -62.57 -41.43 98.92 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.284 1.034 . . . . 0.0 111.995 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -98.47 5.9 47.63 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 50.1 59.58 4.44 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.582 1.953 . . . . 0.0 113.169 -177.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.2 m -133.3 31.89 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 125.946 1.699 . . . . 0.0 111.45 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 m -70.68 -19.86 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.543 1.537 . . . . 0.0 115.005 -171.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 21.4 m -82.3 50.38 1.6 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.719 1.607 . . . . 0.0 113.767 -169.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -57.33 150.22 44.19 Favored Pre-proline 0 CA--C 1.556 1.205 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 -161.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.94 141.5 66.59 Favored 'Cis proline' 0 C--N 1.356 0.934 0 CA-C-N 118.758 0.592 . . . . 0.0 112.165 -4.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.9 m -136.39 137.79 40.9 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.968 0.907 . . . . 0.0 109.771 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.5 mp -122.5 140.63 52.53 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.146 0.978 . . . . 0.0 110.203 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.1 tp -127.9 131.3 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 124.82 1.248 . . . . 0.0 108.999 175.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.1 tt -111.56 129.52 56.04 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.425 1.09 . . . . 0.0 109.217 172.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -111.63 152.01 28.14 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.739 1.616 . . . . 0.0 109.863 172.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -134.92 126.91 29.62 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.324 1.45 . . . . 0.0 109.457 173.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t70 50.03 36.61 12.26 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.262 1.025 . . . . 0.0 113.365 -165.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.02 5.9 42.73 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.941 1.734 . . . . 0.0 116.032 -174.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 55.4 mm-40 -97.62 137.27 21.03 Favored Pre-proline 0 N--CA 1.472 0.643 0 CA-C-N 119.359 1.579 . . . . 0.0 109.573 175.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.63 139.54 48.88 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.025 1.816 . . . . 0.0 111.826 -178.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.3 t -123.43 -46.84 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.221 1.408 . . . . 0.0 112.331 -174.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -146.71 132.39 18.88 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.631 0.772 . . . . 0.0 112.539 -177.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -111.41 135.82 51.42 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.066 1.746 . . . . 0.0 110.484 168.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.9 mt -129.75 143.24 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.623 1.969 . . . . 0.0 108.57 -178.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.39 143.16 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.569 1.148 . . . . 0.0 111.224 174.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.83 158.97 29.95 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.925 1.25 . . . . 0.0 113.043 -171.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.43 140.88 39.95 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.905 -0.762 . . . . 0.0 112.509 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -130.7 146.43 52.18 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.88 1.672 . . . . 0.0 109.809 170.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.37 166.49 54.73 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 123.819 0.723 . . . . 0.0 111.62 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? -51.7 -33.99 36.76 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.974 1.31 . . . . 0.0 113.641 -175.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.85 -50.98 37.34 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.407 0.549 . . . . 0.0 111.752 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.14 -36.55 69.4 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.368 1.067 . . . . 0.0 112.549 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -41.14 93.86 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.517 -0.74 . . . . 0.0 110.127 171.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 29.8 tp -69.27 -23.19 63.81 Favored 'General case' 0 C--O 1.213 -0.821 0 CA-C-O 116.07 -1.919 . . . . 0.0 113.143 171.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.6 mmt-85 -64.35 -49.09 73.03 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 123.991 3.087 . . . . 0.0 111.542 165.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -59.23 -30.69 68.44 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 93.6 mt -93.33 -27.82 16.56 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.684 1.193 . . . . 0.0 113.927 173.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.8 p -67.07 -24.48 65.97 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.627 1.558 . . . . 0.0 110.922 177.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -51.39 -22.68 3.13 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 125.256 1.423 . . . . 0.0 113.978 163.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 69.5 t -112.97 -30.09 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 128.07 2.548 . . . . 0.0 111.992 172.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.478 0.973 0 C-N-CA 127.967 2.507 . . . . 0.0 110.346 -175.771 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 p . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.2 pt -140.07 165.17 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 127.092 2.157 . . . . 0.0 110.84 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -119.05 152.44 36.44 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 164.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.3 m -122.6 169.81 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 126.485 1.914 . . . . 0.0 110.823 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 43.2 p -137.62 173.94 11.12 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.826 1.65 . . . . 0.0 111.39 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -54.98 -28.13 49.32 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.87 -1.144 . . . . 0.0 113.037 170.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.0 -13.34 57.54 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.852 1.261 . . . . 0.0 114.278 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.7 p -132.86 -4.92 3.17 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -174.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -60.21 -46.14 90.77 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 120.011 1.278 . . . . 0.0 111.636 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.42 -39.32 77.94 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.959 -1.088 . . . . 0.0 112.812 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.28 -16.62 56.13 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.614 1.566 . . . . 0.0 114.726 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -103.24 -50.85 3.37 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.17 0.988 . . . . 0.0 112.677 173.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.2 t -83.49 -59.22 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.536 1.134 . . . . 0.0 111.146 -173.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.2 mt -77.31 -25.98 51.75 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -172.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.4 m -79.17 -9.06 59.46 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.96 1.304 . . . . 0.0 113.677 175.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -67.23 139.93 57.39 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.812 0.845 . . . . 0.0 113.185 -177.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -86.69 2.28 49.07 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.234 1.413 . . . . 0.0 113.724 173.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -131.72 165.87 32.45 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 126.397 1.879 . . . . 0.0 111.357 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -66.44 144.2 72.57 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.188 1.925 . . . . 0.0 112.207 176.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.2 p -144.12 127.26 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.335 1.054 . . . . 0.0 111.694 -173.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 tt -99.71 129.46 45.84 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.259 2.224 . . . . 0.0 108.323 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 t -119.8 127.26 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.437 1.095 . . . . 0.0 110.443 173.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -105.02 115.09 29.68 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.079 1.352 . . . . 0.0 111.793 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -83.42 114.08 21.2 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.376 1.87 . . . . 0.0 108.93 171.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -145.99 177.21 9.12 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.301 1.041 . . . . 0.0 112.205 -165.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.94 148.1 30.42 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 122.774 0.43 . . . . 0.0 112.051 163.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -64.8 -18.54 65.19 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 173.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 9.5 p-90 -82.03 -4.39 56.66 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 173.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 33.8 t -107.07 119.9 40.64 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 119.316 0.962 . . . . 0.0 113.493 -168.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.71 -52.18 53.53 Favored Glycine 0 CA--C 1.54 1.606 0 C-N-CA 124.701 1.143 . . . . 0.0 115.182 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.77 -24.44 54.52 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 CA-C-N 121.006 2.403 . . . . 0.0 113.265 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 75.9 m -65.81 -45.19 83.26 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.693 -1.254 . . . . 0.0 111.602 167.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -61.25 -30.91 70.74 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.638 0.653 . . . . 0.0 112.418 172.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.3 ttt -70.3 -43.1 71.06 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.305 1.042 . . . . 0.0 113.162 176.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 p -86.98 -23.25 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.82 -49.64 72.54 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 176.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.51 -29.01 45.18 Favored 'Trans proline' 0 C--N 1.352 0.74 0 CA-C-N 122.376 1.884 . . . . 0.0 112.806 177.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.0 t -71.93 -45.63 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 O-C-N 121.554 -0.716 . . . . 0.0 110.181 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.1 mt -62.53 -33.73 75.48 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.937 0.895 . . . . 0.0 112.682 172.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -68.83 -38.73 80.04 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.119 0.872 . . . . 0.0 112.058 175.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -63.24 -45.28 92.32 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 121.344 -0.847 . . . . 0.0 111.649 168.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.0 mm -58.88 -41.93 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 119.497 1.044 . . . . 0.0 110.605 174.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.93 -46.74 87.21 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.289 -0.882 . . . . 0.0 111.971 176.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.7 m -76.36 -37.73 56.84 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.926 0.89 . . . . 0.0 112.409 -175.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -97.25 -21.79 17.06 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -172.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -111.45 19.84 17.81 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.633 1.573 . . . . 0.0 113.065 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.26 -28.08 25.77 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.062 1.345 . . . . 0.0 113.833 174.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.7 p -66.43 -23.89 66.37 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.837 1.655 . . . . 0.0 114.042 175.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -125.98 -23.46 3.94 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.634 1.574 . . . . 0.0 113.924 -169.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.4 mt -134.26 153.75 51.68 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.299 2.239 . . . . 0.0 110.56 -178.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 49.0 m -108.79 138.76 44.6 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 149.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.1 t -112.79 122.92 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 118.904 0.775 . . . . 0.0 110.549 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -124.49 165.4 17.85 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.695 1.998 . . . . 0.0 112.145 -176.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.2 mttt -130.7 152.28 50.23 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.175 1.79 . . . . 0.0 112.658 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.76 114.28 12.48 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.424 1.089 . . . . 0.0 108.597 162.076 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -80.9 118.65 22.58 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.2 m -67.82 -18.32 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -172.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -80.6 -25.75 38.27 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.929 0.892 . . . . 0.0 112.677 170.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.2 p -92.17 -26.74 18.08 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.989 0.916 . . . . 0.0 112.694 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -140.54 86.96 11.93 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.656 1.182 . . . . 0.0 111.305 171.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.07 -18.62 35.46 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.524 2.149 . . . . 0.0 113.097 177.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -68.56 -46.37 69.64 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.189 -0.945 . . . . 0.0 112.055 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 m -73.65 -29.86 62.58 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.49 -0.757 . . . . 0.0 112.162 175.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.66 -40.98 85.02 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.24 0.616 . . . . 0.0 112.424 169.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.2 ttm105 -75.98 -39.29 56.23 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.323 0.649 . . . . 0.0 112.475 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -54.31 -40.61 68.12 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.189 1.396 . . . . 0.0 114.506 -170.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -100.31 7.19 44.53 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.014 0.925 . . . . 0.0 113.479 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 49.78 59.53 4.45 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.355 1.462 . . . . 0.0 111.287 -164.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.9 m -125.33 28.65 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.414 1.886 . . . . 0.0 111.439 -176.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -68.55 -25.64 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.792 1.237 . . . . 0.0 112.349 175.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 52.7 m -79.96 136.53 36.65 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.265 1.426 . . . . 0.0 110.325 166.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 29.0 pt -143.15 154.66 61.54 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -166.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.33 140.66 60.53 Favored 'Cis proline' 0 C--N 1.355 0.872 0 CA-C-N 119.412 0.826 . . . . 0.0 111.923 -5.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.0 m -134.72 126.64 29.42 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.173 0.989 . . . . 0.0 109.709 174.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.8 mp -108.19 136.08 48.46 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.685 1.594 . . . . 0.0 108.908 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.0 tp -120.74 138.54 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.268 1.427 . . . . 0.0 108.703 167.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.9 tp -126.59 125.15 41.48 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.071 0.949 . . . . 0.0 110.095 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -105.87 143.37 34.1 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.734 2.013 . . . . 0.0 110.447 177.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -114.42 119.21 36.11 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.558 1.543 . . . . 0.0 107.929 168.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.4 t70 51.2 39.0 22.65 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.731 1.212 . . . . 0.0 113.631 -172.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.55 9.54 74.08 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 125.163 1.363 . . . . 0.0 116.125 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -109.35 134.26 20.55 Favored Pre-proline 0 N--CA 1.473 0.715 0 CA-C-N 119.514 1.657 . . . . 0.0 110.356 171.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.56 139.57 45.06 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.465 2.11 . . . . 0.0 111.991 -173.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.3 m -130.21 -27.84 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -177.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -152.28 139.55 19.4 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.721 1.146 . . . . 0.0 111.855 -177.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -129.13 140.05 51.7 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.43 1.892 . . . . 0.0 111.034 173.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.9 mt -137.24 143.17 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.965 1.706 . . . . 0.0 108.883 -178.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 p -133.85 143.64 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 119.723 1.147 . . . . 0.0 111.24 170.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.75 156.68 29.32 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.277 1.418 . . . . 0.0 113.248 -172.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.1 140.08 41.66 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.914 -0.757 . . . . 0.0 112.666 -176.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -132.63 145.45 51.09 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.87 1.668 . . . . 0.0 110.729 174.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -79.94 167.68 51.51 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.355 0.979 . . . . 0.0 110.896 173.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -50.22 -37.02 33.34 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -170.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.97 -47.99 55.85 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.173 0.511 . . . . 0.0 111.468 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.83 -44.77 69.26 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.377 1.071 . . . . 0.0 111.908 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.3 tp -64.89 -44.38 89.83 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.944 176.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 31.4 tp -69.93 -31.62 69.47 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-O 115.048 -2.406 . . . . 0.0 112.807 177.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -65.38 -42.93 92.17 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 124.861 3.482 . . . . 0.0 111.926 169.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -62.32 -32.07 72.78 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 178.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.4 mt -91.65 -24.98 19.35 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.888 1.275 . . . . 0.0 113.196 173.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.3 t -66.16 -25.41 66.94 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.983 1.313 . . . . 0.0 110.264 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -52.71 -22.14 4.87 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.519 1.128 . . . . 0.0 113.578 164.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.7 t -108.92 -24.95 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 127.487 2.315 . . . . 0.0 112.371 170.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.3 t . . . . . 0 N--CA 1.48 1.046 0 C-N-CA 127.888 2.475 . . . . 0.0 111.797 -175.365 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.9 p . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 45.0 pt -135.06 160.08 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.704 1.602 . . . . 0.0 111.091 169.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -108.01 139.03 43.25 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.906 0.882 . . . . 0.0 110.591 168.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.2 m -133.6 150.69 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.963 1.305 . . . . 0.0 110.934 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.1 p -141.05 174.24 10.71 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.783 1.633 . . . . 0.0 111.095 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -52.6 -26.15 12.68 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 120.919 -1.113 . . . . 0.0 113.611 172.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.26 -13.37 52.77 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 176.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.3 p -137.1 -12.66 1.65 Allowed 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -169.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -56.28 -41.96 76.71 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.405 1.482 . . . . 0.0 112.82 -174.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.53 -34.55 78.53 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 121.134 -0.979 . . . . 0.0 112.894 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.5 m -79.46 -14.33 58.98 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.535 1.534 . . . . 0.0 113.77 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -118.7 -32.36 4.57 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.92 -51.92 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.156 1.382 . . . . 0.0 111.452 -176.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.6 mt -78.53 -13.53 59.79 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.6 p -76.56 -11.04 59.81 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.209 1.804 . . . . 0.0 113.995 174.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.7 p -67.09 149.15 50.95 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 -164.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -118.19 15.64 14.05 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 126.401 1.88 . . . . 0.0 112.089 171.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -142.86 164.25 33.36 Favored Pre-proline 0 N--CA 1.475 0.782 0 C-N-CA 129.416 3.086 . . . . 0.0 108.809 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.76 138.56 54.05 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 CA-C-N 121.103 1.43 . . . . 0.0 111.257 166.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.8 m -136.63 138.53 46.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 126.317 1.847 . . . . 0.0 110.536 -177.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tt -118.68 115.7 25.05 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.79 1.236 . . . . 0.0 109.637 -167.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.11 126.96 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.999 0.92 . . . . 0.0 110.943 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -107.0 111.9 24.61 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.513 1.525 . . . . 0.0 111.48 177.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -84.25 108.66 17.25 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.909 1.684 . . . . 0.0 108.681 173.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -136.08 163.81 29.47 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.348 1.059 . . . . 0.0 113.14 -165.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.31 145.8 47.84 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.2 p -59.94 -29.99 68.77 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.356 1.862 . . . . 0.0 113.206 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.5 p-90 -86.94 -12.4 47.71 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 41.9 t -90.77 119.18 30.78 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -164.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.07 -49.33 76.15 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.879 1.228 . . . . 0.0 113.329 176.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -57.66 -29.47 85.51 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.922 2.414 . . . . 0.0 114.548 170.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 94.9 m -64.88 -44.37 89.87 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.781 1.173 . . . . 0.0 111.187 167.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -60.56 -29.44 69.16 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 172.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.3 mtt -71.64 -43.3 66.36 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.641 0.776 . . . . 0.0 112.859 176.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.8 p -88.74 -25.75 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.81 -48.09 92.44 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.72 -27.86 37.69 Favored 'Trans proline' 0 C--N 1.353 0.776 0 CA-C-N 122.448 1.91 . . . . 0.0 112.683 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.9 t -71.67 -46.01 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 121.572 -0.705 . . . . 0.0 110.288 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.0 mt -60.92 -35.69 77.36 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.073 0.949 . . . . 0.0 112.353 171.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -67.96 -38.49 82.85 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.015 0.825 . . . . 0.0 112.052 176.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -62.64 -45.35 93.22 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.018 -1.051 . . . . 0.0 111.537 169.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.3 mm -59.12 -43.05 88.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.656 1.117 . . . . 0.0 110.898 174.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.97 -35.31 78.09 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.181 0.992 . . . . 0.0 112.843 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.1 m -78.51 -48.85 14.45 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.412 0.685 . . . . 0.0 111.906 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -85.24 -32.83 22.38 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -169.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -108.02 16.69 23.17 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.313 1.445 . . . . 0.0 112.834 -171.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.66 -33.12 32.33 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.378 1.471 . . . . 0.0 114.363 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.8 m -68.03 -29.57 68.6 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.913 1.285 . . . . 0.0 112.389 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -102.61 -39.84 6.89 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.562 1.545 . . . . 0.0 112.66 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.5 mt -125.37 148.85 48.61 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 126.927 2.091 . . . . 0.0 110.663 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.4 m -109.14 127.2 53.99 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 157.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.6 t -99.51 128.97 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.585 0.754 . . . . 0.0 109.512 -177.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.26 150.73 48.23 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.89 1.676 . . . . 0.0 111.771 -173.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -128.63 143.45 50.95 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.434 1.094 . . . . 0.0 112.504 176.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -133.55 122.42 23.54 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.866 1.666 . . . . 0.0 110.033 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.63 96.89 7.64 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.18 1.792 . . . . 0.0 109.844 -176.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.8 m -69.49 -13.41 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 O-C-N 120.491 -1.381 . . . . 0.0 113.188 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -67.66 -27.49 66.9 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.756 0.822 . . . . 0.0 112.761 171.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.9 p -119.11 -29.74 5.16 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -136.99 76.09 46.58 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 124.646 1.178 . . . . 0.0 111.11 173.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -68.16 -13.88 39.15 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.196 2.598 . . . . 0.0 113.719 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -58.67 -33.05 69.69 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.673 1.189 . . . . 0.0 113.771 -172.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.5 m -64.21 -45.26 89.08 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.636 1.107 . . . . 0.0 111.856 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.12 -32.55 65.01 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.758 0.823 . . . . 0.0 112.47 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -73.26 -32.26 64.59 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.518 1.127 . . . . 0.0 113.022 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -58.31 -37.11 74.43 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.519 1.128 . . . . 0.0 112.596 175.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -96.74 9.91 40.32 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.067 1.347 . . . . 0.0 113.124 175.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.307 5.7 pt20 54.27 -9.19 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 130.15 3.38 . . . . 0.0 117.892 -173.247 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.6 m -80.27 58.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.549 1.94 . . . . 0.0 111.778 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.9 p -79.02 -4.22 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 126.004 1.721 . . . . 0.0 113.744 -174.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.3 m -57.06 157.19 6.11 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.599 1.96 . . . . 0.0 112.805 170.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 23.2 mt -140.14 137.46 18.07 Favored Pre-proline 0 N--CA 1.477 0.9 0 O-C-N 121.339 -0.85 . . . . 0.0 112.312 -164.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.98 143.58 66.48 Favored 'Cis proline' 0 C--N 1.353 0.787 0 CA-C-N 119.495 0.855 . . . . 0.0 110.628 -17.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 28.3 m -119.98 121.37 38.81 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.444 0.697 . . . . 0.0 110.078 169.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.9 mp -99.7 119.46 38.16 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.516 1.527 . . . . 0.0 107.749 172.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.7 tp -117.96 124.21 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 125.088 1.355 . . . . 0.0 109.073 176.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.6 tp -107.4 125.99 51.92 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.647 1.579 . . . . 0.0 108.908 -176.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -112.44 155.34 24.39 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.412 1.485 . . . . 0.0 109.987 174.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -141.75 126.56 18.12 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.998 1.719 . . . . 0.0 108.829 174.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.6 t70 54.79 25.36 6.53 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -169.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.72 5.39 68.84 Favored Glycine 0 CA--C 1.541 1.67 0 O-C-N 120.535 -1.353 . . . . 0.0 116.091 -172.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -95.16 140.46 22.43 Favored Pre-proline 0 N--CA 1.474 0.766 0 CA-C-N 119.815 1.807 . . . . 0.0 110.048 167.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -67.66 139.6 48.94 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.133 1.889 . . . . 0.0 111.11 176.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.1 m -127.61 -27.63 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 114.814 1.412 . . . . 0.0 114.814 -176.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -156.08 147.86 22.99 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.736 1.153 . . . . 0.0 111.575 175.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.0 ttp-105 -127.95 141.52 51.51 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.001 1.32 . . . . 0.0 111.511 167.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.4 mp -129.48 140.99 47.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 126.638 1.975 . . . . 0.0 108.278 171.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.6 p -132.42 140.8 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.161 0.984 . . . . 0.0 110.286 169.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.24 155.14 30.07 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.32 0.962 . . . . 0.0 112.608 -165.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.16 142.33 43.55 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.503 0.721 . . . . 0.0 112.791 -175.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -130.76 144.54 51.52 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.789 1.636 . . . . 0.0 110.553 172.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -79.31 170.67 54.58 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.391 0.996 . . . . 0.0 111.518 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -52.56 -36.47 55.88 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -175.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.95 -50.91 64.54 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.701 0.4 . . . . 0.0 111.33 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.47 -39.73 58.31 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.898 1.279 . . . . 0.0 113.142 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.3 tp -66.36 -36.36 82.68 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.244 -0.91 . . . . 0.0 110.737 173.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 28.1 tp -73.04 -24.93 60.77 Favored 'General case' 0 C--O 1.216 -0.68 0 CA-C-O 116.123 -1.894 . . . . 0.0 112.955 169.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -58.65 -53.84 53.86 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 123.972 3.078 . . . . 0.0 109.741 164.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -60.91 -32.09 71.58 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.799 1.24 . . . . 0.0 113.382 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.3 mt -97.42 -29.95 13.2 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.621 1.168 . . . . 0.0 113.745 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.6 t -61.33 -30.48 70.53 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 120.182 1.356 . . . . 0.0 110.63 171.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -54.86 -18.25 4.63 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 166.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.0 t -117.72 -18.8 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 127.781 2.433 . . . . 0.0 112.578 174.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t . . . . . 0 N--CA 1.475 0.798 0 C-N-CA 127.472 2.309 . . . . 0.0 110.432 -173.371 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.5 0.19 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.7 t -140.5 161.69 37.13 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.504 1.122 . . . . 0.0 112.37 176.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -151.4 151.35 31.59 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.977 1.711 . . . . 0.0 110.955 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 63.8 p -65.04 -16.77 63.83 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -108.12 9.72 28.21 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.417 1.487 . . . . 0.0 113.369 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -66.66 -25.16 66.44 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 121.007 -1.058 . . . . 0.0 113.443 177.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.9 t -127.44 154.88 44.52 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.378 1.871 . . . . 0.0 112.01 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -114.62 18.24 16.8 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.331 1.452 . . . . 0.0 113.314 167.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.8 p -76.68 157.16 32.01 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 120.96 -1.088 . . . . 0.0 112.619 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.9 pt -108.14 155.04 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.808 1.243 . . . . 0.0 111.271 166.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -112.15 128.17 56.14 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.542 1.137 . . . . 0.0 109.779 176.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -124.94 152.75 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.527 1.131 . . . . 0.0 111.605 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 44.6 p -132.12 169.59 16.17 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.452 1.901 . . . . 0.0 110.919 -175.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -58.51 -27.0 64.08 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 120.909 -1.12 . . . . 0.0 113.168 176.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.11 -13.51 52.8 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.195 1.398 . . . . 0.0 114.518 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.0 p -127.5 -7.72 5.74 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 -173.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -56.01 -41.82 75.48 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.869 1.268 . . . . 0.0 112.603 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.76 -33.05 74.08 Favored 'General case' 0 CA--C 1.543 0.712 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 m -79.19 -14.96 58.75 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.784 1.634 . . . . 0.0 113.521 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -120.35 -54.55 2.08 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.127 0.971 . . . . 0.0 113.173 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.2 -51.97 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.479 0.712 . . . . 0.0 110.898 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 25.4 mt -76.96 -15.9 59.51 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.8 t -76.12 -28.91 57.66 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.414 1.486 . . . . 0.0 112.904 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.2 m -68.77 119.46 13.18 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.786 1.234 . . . . 0.0 112.418 -174.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -77.32 -20.19 55.29 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.352 1.061 . . . . 0.0 112.944 170.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -87.32 166.19 27.06 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 126.586 1.954 . . . . 0.0 111.363 173.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.62 137.24 79.09 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.135 1.89 . . . . 0.0 111.75 170.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -138.25 130.43 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.016 0.927 . . . . 0.0 111.004 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.04 113.79 27.55 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.396 1.878 . . . . 0.0 108.635 -174.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.3 t -100.19 122.73 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.547 0.739 . . . . 0.0 110.065 173.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -96.34 109.7 22.17 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.594 1.158 . . . . 0.0 110.291 166.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -81.45 115.99 21.04 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.052 1.341 . . . . 0.0 107.923 170.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -148.44 170.1 18.75 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.955 0.902 . . . . 0.0 112.536 -167.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -144.17 149.2 36.06 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.168 0.587 . . . . 0.0 112.026 161.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.7 t -63.96 -22.44 66.92 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.029 0.932 . . . . 0.0 113.291 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -78.94 -5.91 54.93 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 43.4 t -105.39 130.33 53.52 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.186 0.994 . . . . 0.0 112.142 -177.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.38 -56.98 20.39 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.408 1.004 . . . . 0.0 113.539 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -55.83 -34.71 92.16 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.024 2.483 . . . . 0.0 114.448 173.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 96.5 m -62.62 -45.97 90.4 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.04 0.836 . . . . 0.0 111.512 172.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -62.81 -33.55 75.45 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.682 1.193 . . . . 0.0 112.406 175.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 97.2 mmm -75.35 -36.64 60.95 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.383 1.073 . . . . 0.0 113.784 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.9 p -83.3 -23.36 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 119.581 1.082 . . . . 0.0 113.606 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.42 -50.51 71.02 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.98 -27.85 42.38 Favored 'Trans proline' 0 C--N 1.353 0.783 0 CA-C-N 122.538 1.942 . . . . 0.0 113.239 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.4 t -73.37 -42.94 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 121.338 -0.851 . . . . 0.0 110.385 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.1 mt -64.73 -33.28 75.59 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.77 1.228 . . . . 0.0 112.776 171.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.43 -45.44 87.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.273 1.029 . . . . 0.0 111.422 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -61.07 -47.77 84.82 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.61 -0.682 . . . . 0.0 110.889 170.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.09 -36.06 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 120.985 -1.072 . . . . 0.0 112.582 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.64 -41.85 92.15 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.172 0.989 . . . . 0.0 112.201 173.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.1 m -73.98 -35.29 64.46 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.444 0.698 . . . . 0.0 111.356 -176.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -87.57 -38.39 16.01 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.118 1.367 . . . . 0.0 114.332 -175.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -104.19 12.08 34.24 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.511 1.124 . . . . 0.0 114.027 -168.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.55 -33.42 45.61 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.564 1.545 . . . . 0.0 114.51 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 m -71.33 -25.54 62.44 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.849 1.26 . . . . 0.0 112.755 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -101.73 -36.69 8.62 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.486 1.514 . . . . 0.0 112.869 -176.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.5 pp -147.65 164.42 33.58 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.857 1.663 . . . . 0.0 111.781 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.1 m -107.95 143.18 36.95 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.463 1.105 . . . . 0.0 109.371 169.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.6 t -115.36 128.05 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 118.966 0.803 . . . . 0.0 110.559 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.76 154.25 47.4 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.179 1.792 . . . . 0.0 112.077 -172.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -123.04 135.5 54.46 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.716 1.207 . . . . 0.0 112.495 173.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.02 116.95 29.27 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.839 1.656 . . . . 0.0 108.441 168.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.7 101.11 11.94 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.889 1.275 . . . . 0.0 110.138 -176.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.7 m -66.2 -16.5 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -173.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.63 -26.17 63.35 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.366 1.067 . . . . 0.0 113.195 175.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.7 t -119.12 -20.36 8.05 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.601 1.16 . . . . 0.0 113.427 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -123.29 63.98 25.86 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.6 1.16 . . . . 0.0 112.575 170.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.59 -18.34 58.91 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.584 2.189 . . . . 0.0 112.451 171.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -60.1 -46.68 88.79 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.598 1.159 . . . . 0.0 110.931 173.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.29 -31.31 60.66 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.503 1.121 . . . . 0.0 111.893 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.21 -44.99 96.39 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 123.99 0.916 . . . . 0.0 112.321 174.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.8 ptt-85 -82.08 -22.8 36.13 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 176.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -56.29 -40.8 74.87 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.311 0.96 . . . . 0.0 113.249 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -99.0 5.22 47.24 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.467 1.107 . . . . 0.0 113.077 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 47.12 55.3 8.24 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.312 1.845 . . . . 0.0 112.277 -166.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.6 m -113.73 19.52 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.862 1.665 . . . . 0.0 112.58 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.4 m -63.0 -16.85 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.772 1.629 . . . . 0.0 114.559 -175.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.2 m -78.47 48.61 0.79 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.801 2.041 . . . . 0.0 113.384 -176.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -59.83 155.17 43.49 Favored Pre-proline 0 CA--C 1.556 1.176 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 -163.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.74 141.96 68.03 Favored 'Cis proline' 0 C--N 1.355 0.878 0 CA-C-N 118.892 0.64 . . . . 0.0 111.85 -6.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.7 m -133.17 123.98 26.63 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.617 0.767 . . . . 0.0 109.868 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.4 mp -103.5 128.6 50.67 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.494 1.518 . . . . 0.0 108.981 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.1 mm -118.09 128.42 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.174 0.99 . . . . 0.0 109.065 167.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 17.3 tp -97.82 118.98 35.6 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 165.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -96.59 150.33 20.77 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.716 1.606 . . . . 0.0 109.739 170.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -128.52 134.18 48.61 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.606 1.163 . . . . 0.0 108.939 162.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.7 t0 48.67 41.47 17.79 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.197 0.999 . . . . 0.0 113.49 -175.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.02 15.97 70.1 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 124.72 1.153 . . . . 0.0 115.429 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -123.32 136.5 27.16 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.544 1.537 . . . . 0.0 109.574 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.38 139.37 45.27 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.633 2.222 . . . . 0.0 111.41 -177.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.6 t -126.19 -40.34 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.986 1.314 . . . . 0.0 112.517 -174.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -142.26 147.85 37.13 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 119.12 0.873 . . . . 0.0 112.854 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.8 ttt180 -126.2 137.89 53.59 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.056 2.143 . . . . 0.0 111.515 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.6 145.78 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.067 1.747 . . . . 0.0 109.744 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 p -137.05 149.47 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.374 1.069 . . . . 0.0 112.087 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.52 164.33 28.34 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.303 1.43 . . . . 0.0 112.527 -173.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.68 157.51 27.08 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 121.474 -1.016 . . . . 0.0 113.358 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -130.79 149.07 52.6 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.694 1.598 . . . . 0.0 110.464 169.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.89 166.69 41.26 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 160.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -50.49 -37.36 38.4 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.895 1.278 . . . . 0.0 114.03 -177.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.7 -47.79 68.4 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.195 0.598 . . . . 0.0 112.144 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.64 -43.5 72.52 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.464 -0.772 . . . . 0.0 111.982 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.7 tp -64.48 -45.66 86.43 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 122.044 -0.41 . . . . 0.0 110.81 177.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.8 tp -74.4 -18.37 60.67 Favored 'General case' 0 C--O 1.214 -0.807 0 CA-C-O 116.798 -1.572 . . . . 0.0 113.278 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -66.75 -52.75 40.71 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 123.359 2.8 . . . . 0.0 110.933 164.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -63.17 -24.36 67.85 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 86.4 mt -98.18 -19.62 17.77 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.076 0.95 . . . . 0.0 113.461 172.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.0 t -66.52 -23.08 66.18 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 120.584 -1.322 . . . . 0.0 110.809 167.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -54.69 -16.18 2.34 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.319 1.048 . . . . 0.0 113.54 164.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.37 -11.78 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.948 1.699 . . . . 0.0 114.043 169.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.7 t -117.98 78.43 12.97 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 128.164 2.586 . . . . 0.0 109.342 173.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -66.03 -6.38 14.31 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.915 2.41 . . . . 0.0 113.887 -176.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -71.93 -38.01 69.93 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.192 0.997 . . . . 0.0 113.259 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.2 tp -162.75 140.75 8.31 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.684 1.594 . . . . 0.0 109.937 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 . . . . . 0 C--O 1.251 1.178 0 C-N-CA 130.44 3.496 . . . . 0.0 112.126 -2.985 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.8 ptm . . . . . 0 N--CA 1.487 1.411 0 N-CA-C 111.244 0.09 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.2 m 60.7 -73.2 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 127.674 2.389 . . . . 0.0 114.579 176.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -67.38 -21.81 65.59 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.85 -1.156 . . . . 0.0 112.818 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 78.5 p -85.95 -6.0 59.13 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.802 1.641 . . . . 0.0 113.986 170.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -119.81 -15.9 8.81 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.419 1.488 . . . . 0.0 114.144 -171.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -76.87 161.8 28.13 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.372 1.469 . . . . 0.0 113.777 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.7 m -68.03 132.97 48.24 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.51 1.124 . . . . 0.0 111.873 176.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.74 58.95 4.51 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 121.583 -0.698 . . . . 0.0 111.676 175.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.9 p -104.03 142.49 34.36 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.854 1.662 . . . . 0.0 112.969 -177.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.6 pt -139.51 155.25 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.02 1.728 . . . . 0.0 111.598 173.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -95.8 140.41 30.62 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.446 0.699 . . . . 0.0 110.117 161.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -117.33 150.7 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.403 1.481 . . . . 0.0 110.503 171.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.7 p -127.5 165.38 19.96 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.228 1.411 . . . . 0.0 111.354 -176.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -60.25 -27.79 67.52 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.91 -13.51 57.43 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.943 1.297 . . . . 0.0 114.188 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.4 m -126.55 -13.65 5.93 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -168.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -54.33 -42.08 69.77 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.228 1.411 . . . . 0.0 112.368 -173.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.33 -34.12 75.54 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.295 -0.878 . . . . 0.0 113.085 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.7 m -79.38 -28.09 41.88 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.476 1.11 . . . . 0.0 112.919 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -92.91 -40.9 10.34 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.352 -0.843 . . . . 0.0 113.234 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.4 t -99.39 -57.26 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.811 1.245 . . . . 0.0 111.191 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.1 mt -79.86 -18.69 50.11 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -171.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.8 m -85.56 -10.49 55.86 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.127 0.971 . . . . 0.0 113.045 174.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.4 t -79.9 130.4 35.27 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.787 0.835 . . . . 0.0 112.559 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -79.72 -21.29 44.74 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.964 0.906 . . . . 0.0 112.486 170.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -79.82 148.33 68.53 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 125.84 1.656 . . . . 0.0 110.517 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -58.51 132.55 49.09 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.035 1.824 . . . . 0.0 111.674 170.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.84 130.1 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.408 1.083 . . . . 0.0 110.647 -173.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.32 114.09 26.18 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.867 1.667 . . . . 0.0 108.665 -172.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.18 124.69 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.938 0.895 . . . . 0.0 110.727 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -104.28 116.3 31.91 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.421 1.089 . . . . 0.0 111.435 173.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -84.9 110.48 18.89 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.076 1.751 . . . . 0.0 108.375 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -143.63 171.28 14.4 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.56 1.144 . . . . 0.0 112.722 -164.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.54 154.81 39.32 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.791 0.836 . . . . 0.0 111.809 163.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.4 t -64.82 -20.88 66.63 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.957 0.903 . . . . 0.0 113.183 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.5 ' CZ3' HD11 ' A' ' 80' ' ' ILE . 11.7 p-90 -80.08 -1.56 40.55 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 177.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 50.8 t -109.77 117.31 33.53 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.226 1.01 . . . . 0.0 112.747 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.82 -47.72 89.0 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 124.363 0.983 . . . . 0.0 113.91 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -58.52 -31.6 94.73 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.925 2.417 . . . . 0.0 114.685 170.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 83.9 m -66.57 -45.02 80.68 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.481 1.037 . . . . 0.0 111.198 170.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -60.62 -29.69 69.38 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.552 0.741 . . . . 0.0 112.628 173.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 16.5 tpt -73.75 -42.64 60.81 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.757 1.223 . . . . 0.0 113.027 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.1 p -84.4 -21.33 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.32 -49.61 80.9 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -65.63 -30.13 51.41 Favored 'Trans proline' 0 C--N 1.353 0.764 0 CA-C-N 122.415 1.898 . . . . 0.0 113.003 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.4 t -68.23 -49.53 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 118.731 0.696 . . . . 0.0 110.124 175.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.5 mt -61.13 -34.93 75.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.136 0.975 . . . . 0.0 112.797 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -70.86 -40.29 72.42 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.218 0.917 . . . . 0.0 112.169 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -61.97 -42.51 99.21 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.09 -1.006 . . . . 0.0 111.516 169.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.7 mt -61.53 -43.76 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 118.771 0.714 . . . . 0.0 110.914 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.33 -37.65 81.27 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.988 0.915 . . . . 0.0 112.379 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.3 m -75.98 -47.18 26.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.776 0.83 . . . . 0.0 112.177 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -94.88 -21.81 18.42 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -167.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.41 16.61 23.72 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.591 1.556 . . . . 0.0 111.761 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.93 -27.93 47.09 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.1 1.76 . . . . 0.0 114.94 -173.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.9 p -78.35 -19.51 53.28 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.013 1.325 . . . . 0.0 113.845 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -111.17 -28.67 8.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.808 1.643 . . . . 0.0 113.57 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.7 mt -129.8 148.99 51.73 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.643 1.977 . . . . 0.0 111.04 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 57.8 m -108.62 133.01 53.32 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 153.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.0 t -103.18 130.96 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.477 0.711 . . . . 0.0 109.816 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.21 155.09 46.09 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.767 1.627 . . . . 0.0 112.011 -174.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -123.69 128.25 49.36 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.881 1.672 . . . . 0.0 110.548 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -108.16 113.86 27.31 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.6 102.24 10.52 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.116 0.966 . . . . 0.0 108.734 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.3 m -65.76 -17.18 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.887 -1.133 . . . . 0.0 112.787 -176.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -78.52 -20.0 51.72 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.941 1.296 . . . . 0.0 113.652 176.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.0 p -115.62 -22.42 9.22 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 174.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -129.46 62.61 64.01 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 125.641 1.576 . . . . 0.0 112.054 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -64.71 -20.71 65.24 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.804 2.336 . . . . 0.0 112.742 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -62.46 -39.92 94.98 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.897 0.879 . . . . 0.0 111.721 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -73.69 -37.24 65.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.842 0.857 . . . . 0.0 111.49 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.01 -43.78 95.01 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.496 0.719 . . . . 0.0 111.683 171.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.4 ttp-105 -73.74 -33.85 64.5 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -56.42 -42.43 78.03 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.505 1.122 . . . . 0.0 112.964 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -98.19 5.28 48.64 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.425 1.09 . . . . 0.0 113.334 174.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.36 15.8 pt20 46.81 25.74 0.48 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 128.298 2.639 . . . . 0.0 116.013 -168.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.2 m -80.46 39.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.744 2.017 . . . . 0.0 111.857 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.7 m -74.95 -21.66 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.966 1.306 . . . . 0.0 113.304 -172.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 54.2 m -80.92 137.94 36.13 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.773 1.229 . . . . 0.0 110.223 166.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.5 HD11 ' CZ3' ' A' ' 36' ' ' TRP . 48.1 pt -135.71 155.16 78.32 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -167.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -68.34 141.45 61.25 Favored 'Cis proline' 0 C--N 1.353 0.786 0 CA-C-N 119.212 0.754 . . . . 0.0 111.361 -6.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.4 m -126.94 120.57 29.46 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.274 0.63 . . . . 0.0 109.399 169.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.7 mp -102.57 126.11 49.53 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.942 1.697 . . . . 0.0 107.855 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.2 tt -118.25 139.22 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.228 1.011 . . . . 0.0 109.692 171.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.0 tp -113.16 129.7 56.43 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.408 1.083 . . . . 0.0 109.671 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -113.86 151.06 32.69 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.191 1.396 . . . . 0.0 110.402 171.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -132.48 127.99 36.43 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.305 1.442 . . . . 0.0 108.972 168.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.4 t70 49.05 41.49 19.37 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.297 1.039 . . . . 0.0 113.398 -168.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.33 9.7 55.36 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.626 1.584 . . . . 0.0 115.739 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -112.61 139.39 22.68 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 125.441 1.496 . . . . 0.0 109.845 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.14 140.03 43.91 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.536 2.157 . . . . 0.0 112.299 -171.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.8 t -117.71 -46.56 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.718 1.607 . . . . 0.0 111.469 -176.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -155.13 150.23 26.92 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.308 1.043 . . . . 0.0 112.052 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 67.6 ttp85 -129.81 139.17 51.29 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.061 1.345 . . . . 0.0 111.583 167.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 30.8 mt -132.25 142.58 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 127.388 2.275 . . . . 0.0 108.354 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 p -133.61 147.78 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.286 1.035 . . . . 0.0 112.022 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.98 161.92 24.54 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.541 1.543 . . . . 0.0 112.945 -175.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.73 151.71 28.72 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -136.66 153.19 50.98 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.353 1.861 . . . . 0.0 110.373 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.49 162.02 32.91 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 160.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -55.85 -34.12 65.15 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.81 -47.58 77.55 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 118.088 0.404 . . . . 0.0 111.18 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.13 -45.99 58.34 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.495 -0.753 . . . . 0.0 112.321 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.1 tp -65.73 -44.89 84.65 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 118.879 0.763 . . . . 0.0 110.685 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 16.7 tp -69.91 -24.93 63.46 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-O 115.825 -2.036 . . . . 0.0 112.753 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -65.24 -50.47 65.68 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 124.053 3.115 . . . . 0.0 111.644 168.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -62.54 -27.23 69.02 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 80.7 mt -87.57 -28.54 21.88 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.221 1.009 . . . . 0.0 113.439 169.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.3 m -62.37 -27.88 69.38 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.309 1.443 . . . . 0.0 110.608 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -49.49 -26.79 3.65 Favored 'General case' 0 CA--C 1.56 1.344 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 165.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.0 t -111.56 -22.36 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 128.223 2.609 . . . . 0.0 112.777 172.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.9 t -112.04 75.55 1.59 Allowed Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 127.632 2.373 . . . . 0.0 110.662 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -70.38 3.23 3.19 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.883 3.056 . . . . 0.0 114.214 -177.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -61.25 -27.43 68.45 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.788 0.835 . . . . 0.0 112.709 172.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.6 tp -93.52 132.73 37.53 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.773 0.829 . . . . 0.0 110.482 162.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 33.5 m120 . . . . . 0 C--O 1.25 1.095 0 C-N-CA 125.095 1.358 . . . . 0.0 111.804 175.451 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.4 mtm . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 120.419 0.152 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.6 t -141.62 163.03 34.01 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.407 1.083 . . . . 0.0 112.511 177.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -150.15 151.81 33.72 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.086 1.754 . . . . 0.0 111.046 -177.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.3 m -59.38 -21.81 60.42 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -108.86 8.72 26.69 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.324 1.45 . . . . 0.0 113.554 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -66.48 133.73 51.01 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.321 1.048 . . . . 0.0 111.701 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.1 p -87.04 156.54 19.7 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.198 1.399 . . . . 0.0 113.033 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -99.28 26.44 5.97 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -168.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.9 p -89.34 154.51 20.02 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 121.013 -1.055 . . . . 0.0 112.964 177.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.2 pt -137.27 155.27 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 126.056 1.743 . . . . 0.0 111.546 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -93.61 139.13 31.13 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.389 0.675 . . . . 0.0 110.819 167.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.1 m -125.57 150.42 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.453 1.501 . . . . 0.0 110.571 172.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.3 p -143.28 157.33 44.57 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.302 1.441 . . . . 0.0 111.115 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -52.17 -28.09 16.85 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -174.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.06 -20.1 64.1 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.8 m -136.49 -3.87 2.1 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.386 1.474 . . . . 0.0 114.062 -176.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -53.51 -41.24 66.12 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.839 1.656 . . . . 0.0 112.526 -174.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.3 -33.16 74.71 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.6 m -79.51 -31.15 42.16 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.249 1.02 . . . . 0.0 112.643 175.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -88.81 -41.43 12.51 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -176.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.9 t -105.57 -52.46 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.106 1.363 . . . . 0.0 111.253 -172.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 29.3 mt -81.82 -13.45 57.66 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -171.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 74.6 m -89.21 -9.81 49.39 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.975 0.91 . . . . 0.0 113.346 175.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.3 t -77.58 140.47 39.69 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.044 0.938 . . . . 0.0 113.323 -174.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -98.78 -5.36 31.38 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.096 1.358 . . . . 0.0 113.559 176.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -98.56 162.84 20.41 Favored Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 124.588 1.155 . . . . 0.0 110.624 164.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -57.02 138.49 86.56 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.299 1.999 . . . . 0.0 113.448 170.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.7 t -132.62 131.41 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.451 1.5 . . . . 0.0 108.895 177.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -122.98 120.03 32.17 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.194 1.398 . . . . 0.0 109.279 -172.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.6 t -119.46 126.35 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.559 0.744 . . . . 0.0 111.138 -172.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -107.0 118.68 37.33 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.959 1.304 . . . . 0.0 112.455 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -94.08 111.57 23.3 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.582 1.953 . . . . 0.0 108.518 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -143.69 172.6 12.59 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.278 1.431 . . . . 0.0 112.884 -163.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -144.59 148.62 34.59 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 163.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 m -60.09 -27.85 67.35 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.675 1.19 . . . . 0.0 112.652 174.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 6.2 p-90 -76.61 -4.19 41.67 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 53.2 t -108.16 122.69 47.44 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.701 1.2 . . . . 0.0 111.792 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.38 -48.21 86.46 Favored Glycine 0 CA--C 1.539 1.543 0 CA-C-O 118.892 -0.949 . . . . 0.0 114.079 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -56.47 -36.24 97.37 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.045 2.497 . . . . 0.0 114.302 170.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 96.9 m -64.36 -45.18 88.87 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.279 -0.888 . . . . 0.0 111.88 173.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -62.39 -31.01 71.62 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.334 1.054 . . . . 0.0 112.397 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.4 ttp -75.69 -38.3 58.8 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.976 1.31 . . . . 0.0 113.376 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.2 p -83.91 -19.06 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.64 -51.42 76.45 Favored Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 175.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.85 -30.8 39.94 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.236 1.957 . . . . 0.0 113.058 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.521 HG13 ' HA ' ' A' ' 101' ' ' LYS . 30.0 t -64.28 -48.48 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.643 0.777 . . . . 0.0 110.68 173.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 38.9 mt -66.75 -32.94 74.57 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.453 0.701 . . . . 0.0 112.566 176.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -67.41 -42.05 83.89 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.136 0.88 . . . . 0.0 112.127 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.98 -47.86 81.34 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.314 -0.866 . . . . 0.0 111.635 170.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.4 -40.16 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 118.803 0.729 . . . . 0.0 110.822 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.8 -49.63 76.97 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.403 -0.811 . . . . 0.0 111.989 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.4 m -76.29 -31.32 58.16 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.55 0.74 . . . . 0.0 112.195 -171.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -95.74 -23.55 16.91 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -112.32 17.07 19.71 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.232 1.413 . . . . 0.0 113.292 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.04 -27.72 21.07 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.607 1.563 . . . . 0.0 114.351 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.3 p -67.79 -20.36 65.19 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.791 1.636 . . . . 0.0 113.87 176.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -117.29 -46.34 2.7 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.801 1.24 . . . . 0.0 112.72 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.9 mt -99.48 148.88 23.79 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.369 1.468 . . . . 0.0 111.126 -176.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.8 m -108.91 122.15 46.61 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 149.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 75.1 t -105.14 124.71 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.281 0.632 . . . . 0.0 110.126 -175.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.72 163.59 23.17 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.452 1.501 . . . . 0.0 112.326 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -130.31 147.3 52.01 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.694 1.598 . . . . 0.0 112.071 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -125.98 117.39 23.16 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.856 1.662 . . . . 0.0 108.83 169.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -81.75 113.24 19.59 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 122.883 0.473 . . . . 0.0 110.422 174.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.8 m -70.87 -16.95 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -172.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -84.17 -39.71 19.06 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.42 1.088 . . . . 0.0 112.43 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 36.3 p -92.66 -23.6 18.92 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.183 1.393 . . . . 0.0 113.893 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -134.88 69.69 71.1 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-N 119.499 1.045 . . . . 0.0 112.055 173.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -66.76 -26.72 45.1 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.153 2.569 . . . . 0.0 114.768 -172.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -64.11 -35.7 81.62 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.608 -0.683 . . . . 0.0 111.817 -175.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.2 m -64.05 -43.26 96.04 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.311 1.044 . . . . 0.0 111.309 176.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.35 -39.61 95.01 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.737 0.815 . . . . 0.0 112.018 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.34 -45.25 63.39 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.296 177.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -63.99 -32.73 74.38 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 118.878 0.763 . . . . 0.0 112.782 -171.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -98.45 8.04 45.4 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.344 1.058 . . . . 0.0 113.746 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.1 tp60 49.88 52.59 14.34 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.462 1.905 . . . . 0.0 113.35 -177.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.1 m -132.88 48.61 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.216 1.806 . . . . 0.0 109.647 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.5 m -78.42 -21.47 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.228 1.411 . . . . 0.0 113.657 -176.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.1 m -72.09 155.73 39.97 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.747 1.219 . . . . 0.0 111.112 168.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.61 149.28 49.96 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -174.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.43 136.65 41.25 Favored 'Cis proline' 0 C--N 1.353 0.771 0 N-CA-C 110.424 -0.644 . . . . 0.0 110.424 -14.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 98.7 m -127.88 121.38 29.89 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.851 0.86 . . . . 0.0 110.485 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.0 mp -102.26 132.31 48.29 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.368 1.467 . . . . 0.0 109.223 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.9 tp -121.9 128.13 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.992 1.317 . . . . 0.0 109.376 171.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 41.3 tp -108.23 127.97 54.31 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.005 1.322 . . . . 0.0 110.309 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -113.69 144.18 43.37 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.985 1.714 . . . . 0.0 109.535 172.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -107.22 -29.75 9.15 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -150.01 40.79 0.81 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.715 2.006 . . . . 0.0 109.913 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.92 -6.07 7.06 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 125.354 1.454 . . . . 0.0 115.141 -165.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -94.63 138.2 22.33 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 118.787 1.293 . . . . 0.0 110.607 167.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.51 146.07 38.74 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.353 2.702 . . . . 0.0 112.114 -176.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.6 m -132.99 -24.99 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -177.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 107' ' ' GLU . 33.0 tttp -153.59 143.81 22.23 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.715 1.143 . . . . 0.0 111.67 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -128.9 137.93 51.71 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.854 2.062 . . . . 0.0 110.783 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.6 mt -135.18 141.58 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.91 1.684 . . . . 0.0 108.721 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 p -133.81 142.18 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 119.398 0.999 . . . . 0.0 111.127 168.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 91.86 150.0 24.94 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.273 1.416 . . . . 0.0 112.955 -171.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.42 144.67 31.25 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.074 0.95 . . . . 0.0 113.147 -174.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -134.56 159.99 39.46 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.067 1.747 . . . . 0.0 110.7 172.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -74.88 166.36 54.86 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.429 -0.669 . . . . 0.0 111.429 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.521 ' HA ' HG13 ' A' ' 46' ' ' VAL . 3.0 tmtp? -51.0 -37.33 44.38 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.836 1.254 . . . . 0.0 113.384 -173.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.95 -49.41 52.08 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.05 0.386 . . . . 0.0 111.76 -177.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.73 -37.59 59.26 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.548 0.739 . . . . 0.0 112.792 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.29 -45.44 87.99 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.4 1.0 . . . . 0.0 109.733 174.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 21.4 tp -70.2 -20.09 63.13 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-O 116.402 -1.761 . . . . 0.0 112.989 171.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.72 -54.12 49.18 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 123.802 3.001 . . . . 0.0 110.239 166.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.407 ' HB3' ' HE2' ' A' ' 93' ' ' LYS . 40.3 mm-40 -63.62 -26.59 68.75 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 114.43 -1.259 . . . . 0.0 113.136 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 82.4 mt -91.34 -21.82 20.83 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 168.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 31.8 m -65.84 -20.73 66.35 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.785 -1.197 . . . . 0.0 111.214 172.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -47.1 -27.3 1.33 Allowed 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 160.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -116.79 -25.13 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.701 1.6 . . . . 0.0 113.749 177.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.45 78.22 10.97 Favored Pre-proline 0 N--CA 1.484 1.235 0 C-N-CA 125.604 1.561 . . . . 0.0 112.667 171.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -62.79 -6.23 8.81 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.607 2.871 . . . . 0.0 115.662 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -61.99 -8.42 5.2 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.208 1.403 . . . . 0.0 114.451 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.3 tp -59.87 -31.39 69.74 Favored 'General case' 0 CA--C 1.55 0.946 0 O-C-N 120.934 -1.103 . . . . 0.0 112.524 165.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.253 1.25 0 C-N-CA 126.001 1.72 . . . . 0.0 112.313 -177.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 119.077 -0.487 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.0 t -161.79 155.98 22.16 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.892 1.277 . . . . 0.0 111.405 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -87.25 -30.26 21.05 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.349 1.059 . . . . 0.0 112.66 172.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.9 m -63.68 122.36 16.17 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.654 1.182 . . . . 0.0 113.538 -160.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 53.24 23.9 3.42 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.039 1.736 . . . . 0.0 114.267 -177.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -133.51 -58.49 0.88 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.183 1.393 . . . . 0.0 113.235 -167.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.2 m -97.66 139.19 33.93 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 124.741 1.217 . . . . 0.0 112.879 -168.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.87 58.34 3.82 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.212 0.605 . . . . 0.0 111.663 172.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.8 p -106.29 144.26 33.23 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.59 1.556 . . . . 0.0 113.38 -176.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.2 pt -142.03 159.59 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 126.474 1.91 . . . . 0.0 111.278 174.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -100.04 140.15 34.68 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.64 0.776 . . . . 0.0 110.22 163.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.6 m -130.12 145.96 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.469 1.108 . . . . 0.0 111.557 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.0 p -140.35 159.27 42.57 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.39 1.476 . . . . 0.0 111.236 176.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -51.74 -27.95 13.6 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.615 1.966 . . . . 0.0 114.805 -173.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.23 -22.02 65.71 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.8 m -136.73 1.19 2.53 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.677 1.591 . . . . 0.0 113.547 -175.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -55.48 -42.68 74.71 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.461 1.504 . . . . 0.0 112.461 -170.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.12 -32.11 73.36 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.6 m -79.01 -32.76 45.23 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.493 -0.754 . . . . 0.0 111.892 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -87.97 -40.78 13.62 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t -101.52 -40.09 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.203 1.401 . . . . 0.0 112.406 -171.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -100.76 -20.07 15.73 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -170.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.8 m -94.18 8.13 42.8 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.041 1.336 . . . . 0.0 113.768 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.7 p -69.52 157.21 37.59 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.007 2.123 . . . . 0.0 114.591 -176.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -87.87 -6.57 58.02 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.525 1.13 . . . . 0.0 113.557 173.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -142.21 166.35 21.81 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 127.744 2.418 . . . . 0.0 110.769 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -56.33 148.24 62.57 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.978 2.452 . . . . 0.0 113.694 173.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.2 t -132.49 128.97 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.975 1.31 . . . . 0.0 110.347 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 tt -98.05 128.16 44.42 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.255 1.822 . . . . 0.0 108.64 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.9 t -116.02 125.42 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 119.516 1.053 . . . . 0.0 110.898 172.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -106.55 114.49 28.64 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.827 1.651 . . . . 0.0 111.315 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -92.39 109.0 20.38 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.927 2.091 . . . . 0.0 108.016 175.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -142.19 -178.5 5.75 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.1 1.36 . . . . 0.0 111.372 -163.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.61 141.14 30.49 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 166.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 46.9 m -56.73 -29.94 63.02 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.524 1.53 . . . . 0.0 112.117 172.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 35.6 p-90 -88.74 -0.9 57.76 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.85 1.66 . . . . 0.0 115.138 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 48.1 t -110.11 134.21 52.41 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.473 1.033 . . . . 0.0 113.238 -172.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.37 -57.06 14.2 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.17 1.367 . . . . 0.0 115.477 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.21 -27.36 72.53 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 CA-C-N 120.939 2.37 . . . . 0.0 112.903 175.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 93.0 m -63.76 -43.97 94.84 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.129 -0.982 . . . . 0.0 111.74 169.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.01 -30.48 71.55 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.195 0.998 . . . . 0.0 112.553 173.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 15.8 tpt -73.35 -38.47 65.73 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.657 1.183 . . . . 0.0 113.353 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.4 p -84.42 -20.82 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.09 -50.31 82.81 Favored Pre-proline 0 CA--C 1.552 1.022 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.22 -29.67 32.23 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.293 1.995 . . . . 0.0 113.147 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.466 HG13 ' HA ' ' A' ' 101' ' ' LYS . 41.9 t -65.26 -49.18 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.409 0.684 . . . . 0.0 110.21 173.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.6 mt -63.99 -33.61 76.11 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.802 0.841 . . . . 0.0 112.709 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -64.14 -44.85 90.9 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.302 0.955 . . . . 0.0 111.517 174.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -61.63 -45.39 94.28 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.325 -0.859 . . . . 0.0 111.492 173.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.4 mt -59.68 -43.74 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 121.415 -0.803 . . . . 0.0 111.068 176.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.55 -37.26 86.65 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.102 0.961 . . . . 0.0 112.642 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.4 m -73.62 -46.89 44.23 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.784 0.834 . . . . 0.0 111.236 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -87.27 -35.49 18.44 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.498 1.119 . . . . 0.0 114.004 -170.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -99.72 24.7 8.0 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.598 1.159 . . . . 0.0 113.273 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.88 -28.12 47.9 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.109 1.363 . . . . 0.0 114.311 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.0 p -83.25 -19.39 36.47 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.296 1.438 . . . . 0.0 113.834 175.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -102.62 -38.15 7.63 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.082 1.353 . . . . 0.0 112.79 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 79.8 mt -129.8 160.89 32.07 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.34 2.256 . . . . 0.0 110.944 -175.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.4 m -108.8 138.8 44.54 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 147.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.5 t -101.29 129.97 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.82 0.848 . . . . 0.0 109.5 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.4 151.83 48.3 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.275 1.43 . . . . 0.0 111.557 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -127.67 148.8 50.4 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.987 1.315 . . . . 0.0 113.123 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -135.33 114.47 12.25 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.644 1.977 . . . . 0.0 108.875 168.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -81.39 116.34 21.17 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 171.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.5 m -64.55 -20.25 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -167.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -79.88 -22.58 42.68 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 172.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.1 p -92.57 -29.1 16.34 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -171.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -145.53 92.58 5.5 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 123.932 0.893 . . . . 0.0 110.73 162.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -62.46 -26.48 76.49 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.255 2.636 . . . . 0.0 114.894 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -71.78 -31.72 66.9 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.048 -1.033 . . . . 0.0 111.858 -175.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.5 m -65.75 -41.12 92.49 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.449 0.7 . . . . 0.0 110.786 174.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.1 -35.6 80.13 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.022 0.929 . . . . 0.0 112.609 172.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.3 tpt85 -73.49 -36.63 65.81 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -65.4 -28.64 69.4 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -172.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -103.14 5.34 37.79 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.35 1.06 . . . . 0.0 113.207 174.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 48.56 57.05 6.69 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.835 1.654 . . . . 0.0 112.172 -169.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.6 m -124.81 36.03 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.645 1.978 . . . . 0.0 111.038 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.7 m -71.67 -19.3 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.344 1.058 . . . . 0.0 113.156 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.2 m -68.01 151.73 46.62 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.408 1.483 . . . . 0.0 111.507 169.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 13.5 pt -139.31 142.53 32.84 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -168.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -67.71 149.08 82.48 Favored 'Cis proline' 0 CA--C 1.54 0.797 0 CA-C-N 118.498 0.499 . . . . 0.0 111.121 -17.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 67.7 m -133.42 125.15 28.44 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.756 1.222 . . . . 0.0 109.399 171.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.6 mp -109.28 136.48 48.67 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.593 1.157 . . . . 0.0 109.334 177.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.0 tt -127.9 144.87 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.202 1.001 . . . . 0.0 110.284 169.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.5 tp -121.52 120.44 34.87 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.941 0.897 . . . . 0.0 110.54 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -98.4 131.08 44.97 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.559 1.144 . . . . 0.0 109.604 172.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -99.59 -33.49 10.61 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -175.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -154.49 57.11 0.7 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.215 1.806 . . . . 0.0 110.174 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.5 15.87 64.47 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.51 1.052 . . . . 0.0 114.551 -173.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -140.31 137.56 17.98 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 126.966 2.106 . . . . 0.0 110.546 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -76.14 142.72 24.82 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.193 2.595 . . . . 0.0 112.645 -173.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.1 t -128.66 -28.6 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.689 1.596 . . . . 0.0 112.697 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -135.16 142.15 46.06 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.07 1.348 . . . . 0.0 110.077 172.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.8 ttt85 -147.03 113.22 5.86 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.957 2.103 . . . . 0.0 109.6 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 33.9 pt -137.05 148.17 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.377 1.471 . . . . 0.0 113.152 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.9 m -121.64 145.77 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 125.637 1.575 . . . . 0.0 111.195 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.95 160.49 24.32 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 124.164 0.888 . . . . 0.0 113.557 -172.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.39 145.53 31.96 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.853 0.861 . . . . 0.0 112.769 -176.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -130.59 153.33 49.01 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.801 1.641 . . . . 0.0 110.056 169.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -74.18 165.54 54.78 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 175.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.466 ' HA ' HG13 ' A' ' 46' ' ' VAL . 3.0 tmtp? -51.69 -35.22 41.89 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.665 1.186 . . . . 0.0 113.308 -174.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.48 -53.99 29.03 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.0 0.364 . . . . 0.0 111.197 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.44 -33.13 60.87 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.53 -45.09 94.57 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.472 1.033 . . . . 0.0 109.631 171.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 25.7 tp -69.41 -24.23 63.82 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-O 115.691 -2.099 . . . . 0.0 113.112 173.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.76 -51.04 69.95 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 124.295 3.225 . . . . 0.0 111.524 167.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -57.39 -37.53 72.81 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.05 0.94 . . . . 0.0 111.73 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.8 mt -83.16 -28.35 29.43 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 172.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.4 m -62.56 -28.15 69.67 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.037 1.335 . . . . 0.0 110.641 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -52.5 -26.6 13.44 Favored 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 168.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 51.3 t -107.3 -24.41 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.886 2.074 . . . . 0.0 112.519 171.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.4 t -118.01 77.57 12.38 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 126.537 1.935 . . . . 0.0 111.502 -177.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.26 -24.97 62.43 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.769 2.313 . . . . 0.0 113.196 169.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -75.64 37.81 0.15 Allowed 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 127.2 2.2 . . . . 0.0 113.004 173.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -59.73 -22.02 61.46 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -170.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 45.3 t30 . . . . . 0 C--O 1.253 1.282 0 C-N-CA 126.299 1.839 . . . . 0.0 111.427 179.353 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.5 p -74.01 156.29 37.68 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.744 1.218 . . . . 0.0 113.008 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -147.78 149.02 31.58 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.333 1.453 . . . . 0.0 111.46 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.3 t -151.23 148.77 28.62 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.849 1.259 . . . . 0.0 111.936 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -93.98 -2.57 52.91 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.951 1.3 . . . . 0.0 113.303 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -71.14 146.04 49.4 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.58 1.152 . . . . 0.0 112.527 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.5 p -80.5 161.48 24.82 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.366 1.466 . . . . 0.0 113.151 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -99.37 24.5 7.99 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -173.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.6 p -89.24 152.04 21.79 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 121.089 -1.007 . . . . 0.0 112.856 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.9 pt -132.84 165.34 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 126.209 1.803 . . . . 0.0 111.413 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -117.28 145.42 43.98 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.88 0.872 . . . . 0.0 111.753 171.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.15 156.47 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 126.326 1.851 . . . . 0.0 110.964 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 65.2 p -123.85 168.57 12.58 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.912 1.685 . . . . 0.0 111.566 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -57.29 -27.58 62.28 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 121.018 -1.051 . . . . 0.0 113.136 175.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.6 -13.31 56.74 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.224 1.409 . . . . 0.0 114.515 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.1 p -128.88 -8.91 4.94 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -173.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -57.06 -47.91 79.82 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.282 1.433 . . . . 0.0 112.055 -176.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.61 -34.28 77.52 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.3 -0.875 . . . . 0.0 112.699 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.23 -8.71 59.24 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.755 1.622 . . . . 0.0 113.666 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -121.81 -47.87 2.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.501 1.12 . . . . 0.0 113.455 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.3 t -83.16 -51.45 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.15 1.38 . . . . 0.0 111.037 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 43.3 mt -84.67 -13.22 52.11 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -174.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.7 p -78.17 -18.8 55.08 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.955 1.302 . . . . 0.0 113.785 176.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.5 t -86.05 133.24 33.91 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.63 1.172 . . . . 0.0 113.459 -168.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -75.77 -31.62 59.6 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.389 1.076 . . . . 0.0 111.528 168.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -80.68 138.88 50.62 Favored Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 124.891 1.276 . . . . 0.0 108.85 174.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -59.07 142.44 99.35 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 121.388 1.392 . . . . 0.0 113.507 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.5 t -124.35 125.67 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.384 1.474 . . . . 0.0 109.354 -177.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -108.39 115.25 29.75 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.655 1.582 . . . . 0.0 109.303 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.2 t -108.76 122.42 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.186 0.994 . . . . 0.0 110.829 -175.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -92.33 109.3 20.68 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.732 1.613 . . . . 0.0 111.021 173.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -83.61 112.86 20.4 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.793 1.237 . . . . 0.0 108.497 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -146.41 168.57 20.82 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.22 1.008 . . . . 0.0 113.033 -164.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.18 155.27 38.52 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.755 1.222 . . . . 0.0 110.974 166.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.9 t -66.05 -19.18 65.77 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -75.56 -4.44 39.94 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 48.5 t -109.29 108.83 19.56 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.348 1.059 . . . . 0.0 112.535 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.59 -40.43 94.6 Favored Glycine 0 CA--C 1.54 1.633 0 CA-C-O 118.848 -0.973 . . . . 0.0 113.972 174.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -60.44 -33.08 94.42 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.44 2.093 . . . . 0.0 114.459 168.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 91.1 m -63.69 -44.75 92.76 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.812 1.187 . . . . 0.0 110.735 168.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -60.0 -36.31 76.93 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 175.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 13.2 ptm -80.44 -29.97 37.56 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.2 p -84.6 -24.01 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-N 119.8 1.182 . . . . 0.0 113.563 174.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.13 -48.72 63.45 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 176.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -65.83 -29.1 50.64 Favored 'Trans proline' 0 C--N 1.353 0.777 0 CA-C-N 122.216 1.827 . . . . 0.0 113.475 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.3 t -69.15 -51.34 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 119.374 0.988 . . . . 0.0 110.334 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.0 pp -70.22 -28.43 65.26 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -68.65 -40.22 80.31 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.147 0.979 . . . . 0.0 112.932 171.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -63.23 -47.21 83.46 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.928 -1.107 . . . . 0.0 111.348 170.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.22 -37.88 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 118.483 0.583 . . . . 0.0 110.679 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.65 -49.96 75.61 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.276 0.944 . . . . 0.0 112.752 172.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.1 m -76.05 -33.27 59.6 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.843 0.857 . . . . 0.0 111.681 -169.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -83.92 -34.08 24.57 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 176.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -108.1 27.71 9.0 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.946 1.298 . . . . 0.0 113.744 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.02 -28.33 62.39 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.4 m -69.47 -27.35 65.15 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.08 1.352 . . . . 0.0 112.523 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -103.57 -34.28 8.71 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.44 1.496 . . . . 0.0 112.816 -174.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.5 mt -129.85 152.72 49.02 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.141 2.176 . . . . 0.0 111.178 -174.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.5 m -108.65 133.85 52.18 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 150.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.5 t -110.62 121.44 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 122.993 0.517 . . . . 0.0 109.862 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -118.06 164.84 14.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.521 1.528 . . . . 0.0 112.19 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 46.0 mttm -124.86 136.53 53.89 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.066 1.747 . . . . 0.0 111.463 173.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -113.2 117.22 31.28 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.992 1.317 . . . . 0.0 108.496 167.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.81 98.07 8.3 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.905 1.282 . . . . 0.0 108.604 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.3 m -67.06 -19.29 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 O-C-N 121.362 -0.836 . . . . 0.0 112.992 -172.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -72.42 -23.22 61.05 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.429 1.092 . . . . 0.0 112.555 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.5 p -118.2 -15.56 9.79 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.469 1.508 . . . . 0.0 113.593 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -123.3 60.94 18.42 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 125.392 1.477 . . . . 0.0 111.864 176.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.69 -23.57 56.15 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.591 2.194 . . . . 0.0 112.546 178.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -64.76 -42.9 94.77 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.006 0.922 . . . . 0.0 111.815 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.68 -37.02 73.59 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.575 0.75 . . . . 0.0 111.121 176.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.83 -47.1 86.61 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.76 0.824 . . . . 0.0 112.34 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 -77.43 -24.61 50.35 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -57.49 -41.41 80.68 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.935 0.894 . . . . 0.0 112.858 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -101.1 6.02 43.1 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.892 1.277 . . . . 0.0 113.219 174.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.376 16.2 pt20 46.38 29.35 0.85 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 128.286 2.634 . . . . 0.0 115.84 -166.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.5 m -80.68 38.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 126.66 1.984 . . . . 0.0 111.93 174.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 m -75.13 -25.29 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.947 1.299 . . . . 0.0 112.606 -175.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 55.6 m -78.61 140.39 38.46 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.731 1.212 . . . . 0.0 110.051 165.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 48.9 pt -138.96 155.4 72.97 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 123.884 0.874 . . . . 0.0 113.183 -168.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.41 141.94 63.98 Favored 'Cis proline' 0 C--N 1.354 0.835 0 CA-C-N 119.393 0.819 . . . . 0.0 111.96 -5.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.6 m -131.68 121.59 24.54 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.628 0.771 . . . . 0.0 109.812 171.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.1 mp -108.07 119.46 39.54 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.856 1.662 . . . . 0.0 108.553 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.4 tt -116.64 133.2 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.413 1.085 . . . . 0.0 110.651 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.6 tt -104.43 125.0 50.23 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.036 0.934 . . . . 0.0 110.385 173.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -102.69 144.65 30.8 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.339 1.456 . . . . 0.0 109.942 166.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -130.2 129.43 43.38 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.479 1.511 . . . . 0.0 109.34 172.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.8 t0 47.62 37.59 6.92 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.359 1.064 . . . . 0.0 113.323 -167.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.15 18.68 71.33 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 125.048 1.309 . . . . 0.0 116.364 -178.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -122.92 143.1 39.65 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 119.461 1.631 . . . . 0.0 110.87 172.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.28 140.3 44.11 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.749 2.3 . . . . 0.0 112.24 -173.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.7 t -123.79 -44.79 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.124 1.37 . . . . 0.0 112.629 -175.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.6 tttm -148.83 152.52 36.64 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.944 0.793 . . . . 0.0 112.129 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -138.51 141.46 39.37 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.559 1.144 . . . . 0.0 112.382 173.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.8 mp -129.4 139.49 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 127.361 2.265 . . . . 0.0 108.393 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.3 p -132.03 142.86 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.355 1.062 . . . . 0.0 111.237 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.78 154.92 19.62 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.11 1.338 . . . . 0.0 112.549 -169.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.39 137.18 46.36 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.865 -0.785 . . . . 0.0 111.904 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -131.8 154.63 48.92 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.78 1.632 . . . . 0.0 110.946 174.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -76.13 166.53 54.41 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 172.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -54.6 -33.39 60.33 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.08 -56.06 25.31 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 123.219 0.324 . . . . 0.0 110.95 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.75 -37.89 58.92 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.313 -0.867 . . . . 0.0 113.286 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.5 tp -66.17 -36.04 82.04 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 119.905 1.23 . . . . 0.0 110.906 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 16.9 tp -74.17 -24.55 59.4 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-O 115.722 -2.085 . . . . 0.0 113.073 170.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -56.91 -54.21 49.16 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 124.319 3.236 . . . . 0.0 110.375 163.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -68.53 -26.02 65.23 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -174.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 93.3 mt -93.75 -25.6 17.35 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.043 0.937 . . . . 0.0 113.435 172.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.3 t -67.79 -21.61 65.23 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.418 1.087 . . . . 0.0 111.614 171.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -49.44 -25.69 2.76 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 161.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 70.6 t -111.07 -25.6 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 127.436 2.294 . . . . 0.0 112.496 172.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.4 t -112.56 71.77 1.24 Allowed Pre-proline 0 N--CA 1.482 1.14 0 C-N-CA 127.172 2.189 . . . . 0.0 111.186 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.37 -6.98 18.85 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.082 2.521 . . . . 0.0 113.931 -176.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -72.46 -22.68 61.04 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.7 tp -149.43 132.71 16.47 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.189 0.995 . . . . 0.0 111.995 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 . . . . . 0 C--O 1.253 1.255 0 C-N-CA 125.818 1.647 . . . . 0.0 111.348 175.83 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 tpt . . . . . 0 N--CA 1.486 1.373 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.4 m -62.25 -33.83 75.35 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -171.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -78.36 -21.93 48.7 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -176.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.7 p -134.41 4.08 3.38 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.228 1.411 . . . . 0.0 114.787 -168.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 59.32 -68.39 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 127.707 2.403 . . . . 0.0 113.506 -164.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -76.44 135.37 39.41 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.761 1.224 . . . . 0.0 111.1 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.2 m -81.21 160.53 24.29 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.339 1.456 . . . . 0.0 112.19 173.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.41 29.68 0.43 Allowed 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 -164.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.8 p -89.37 155.94 19.02 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.002 1.321 . . . . 0.0 112.492 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 45.5 pt -134.29 162.73 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 126.104 1.762 . . . . 0.0 110.484 171.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -120.04 146.6 45.74 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.579 -0.7 . . . . 0.0 112.7 165.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.3 m -120.19 155.06 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.446 1.898 . . . . 0.0 110.973 -176.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.5 p -131.79 161.99 31.6 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.793 1.237 . . . . 0.0 112.684 -174.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.83 -26.09 57.55 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.087 1.355 . . . . 0.0 114.629 -175.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.61 -16.15 52.42 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.701 1.2 . . . . 0.0 114.19 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.7 m -134.44 -5.57 2.59 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -168.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -53.97 -41.89 68.34 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.069 1.348 . . . . 0.0 112.653 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.67 -32.51 73.23 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.9 m -78.85 -32.11 45.94 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.292 1.037 . . . . 0.0 111.921 176.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -87.32 -44.54 11.32 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.5 t -98.83 -51.92 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.964 1.306 . . . . 0.0 111.592 -173.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 33.5 mt -84.56 -13.47 51.67 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -170.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.8 t -81.11 -12.07 59.34 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.263 1.025 . . . . 0.0 112.894 173.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.3 t -69.67 142.69 53.35 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -171.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.2 p-10 -94.62 3.24 55.33 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.792 1.637 . . . . 0.0 113.76 173.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -126.48 167.08 18.27 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 126.946 2.098 . . . . 0.0 111.043 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -58.21 138.78 87.71 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.318 2.012 . . . . 0.0 113.257 170.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.8 t -132.58 129.33 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.09 1.356 . . . . 0.0 109.139 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -116.93 115.52 25.64 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.359 1.464 . . . . 0.0 109.231 -173.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.7 t -110.65 121.19 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.454 0.702 . . . . 0.0 110.828 -174.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -91.24 106.34 18.44 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.539 1.535 . . . . 0.0 110.6 173.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -80.61 114.34 19.43 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.088 1.355 . . . . 0.0 108.68 173.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.6 p-90 -147.94 168.64 21.75 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.979 0.911 . . . . 0.0 113.021 -164.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.53 153.87 36.59 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.402 1.081 . . . . 0.0 110.672 161.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.3 t -65.6 -20.05 66.16 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -75.22 -10.47 59.5 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 173.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 45.2 t -98.19 110.98 23.46 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.919 0.888 . . . . 0.0 110.969 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.08 -49.03 69.77 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-O 118.768 -1.018 . . . . 0.0 113.306 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -57.62 -32.57 94.81 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.032 2.488 . . . . 0.0 114.829 172.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 68.6 m -67.24 -44.84 78.46 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.914 -1.116 . . . . 0.0 111.157 171.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -63.03 -29.66 70.99 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.284 1.034 . . . . 0.0 112.177 176.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 60.7 mtt -75.82 -36.69 59.61 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.566 1.547 . . . . 0.0 113.782 173.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -87.32 -22.81 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 119.432 1.015 . . . . 0.0 113.677 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.74 -47.31 72.36 Favored Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 174.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -66.61 -27.01 45.96 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 CA-C-N 122.338 1.871 . . . . 0.0 113.735 176.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 92.1 t -70.96 -47.02 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.452 1.024 . . . . 0.0 109.305 173.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.64 -37.62 82.1 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.219 1.408 . . . . 0.0 112.269 177.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -66.33 -39.36 89.18 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.156 0.982 . . . . 0.0 112.503 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -67.26 -44.13 80.14 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.522 -0.736 . . . . 0.0 111.64 172.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.2 mm -61.24 -39.95 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 119.548 1.067 . . . . 0.0 111.055 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.09 -46.96 86.94 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.32 -0.863 . . . . 0.0 112.104 175.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.9 m -76.32 -34.77 59.01 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.546 0.738 . . . . 0.0 112.716 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -98.92 -16.95 18.6 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -172.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 74.5 mmt-85 -121.48 21.32 11.0 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.314 1.445 . . . . 0.0 113.438 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.95 -27.63 19.81 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.68 1.592 . . . . 0.0 114.03 175.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.2 p -70.14 -21.39 63.09 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.575 1.55 . . . . 0.0 114.113 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -117.39 -35.3 4.05 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.497 1.119 . . . . 0.0 113.484 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 57.3 mt -119.5 155.17 32.62 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.978 1.711 . . . . 0.0 110.843 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 57.1 m -108.73 126.19 52.73 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 152.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.7 t -102.58 123.26 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.095 0.558 . . . . 0.0 110.404 -177.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.23 165.62 17.96 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.891 1.676 . . . . 0.0 111.769 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -126.72 140.55 52.31 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.221 1.408 . . . . 0.0 111.386 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -116.06 116.99 28.87 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.362 1.065 . . . . 0.0 108.93 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.95 97.62 7.54 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.179 1.392 . . . . 0.0 108.615 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.9 m -66.42 -19.85 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 121.391 -0.818 . . . . 0.0 113.139 -173.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -72.69 -22.94 60.83 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.123 0.969 . . . . 0.0 112.596 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.4 p -117.42 -16.02 10.26 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.601 1.561 . . . . 0.0 113.41 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -123.3 59.05 14.04 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 125.21 1.404 . . . . 0.0 112.301 176.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -65.32 -25.96 56.47 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.52 2.147 . . . . 0.0 112.542 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -63.94 -45.06 90.85 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.981 0.912 . . . . 0.0 111.533 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.3 m -66.77 -38.6 86.9 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.629 0.772 . . . . 0.0 111.363 175.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.56 -43.75 98.04 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.612 0.765 . . . . 0.0 112.686 177.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.9 ptt85 -78.09 -26.74 48.26 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -56.69 -40.83 76.29 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.184 0.994 . . . . 0.0 113.465 -177.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -98.56 4.65 48.16 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.085 0.954 . . . . 0.0 113.256 177.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 52.57 49.25 20.8 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.357 1.863 . . . . 0.0 112.944 -167.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.0 m -115.23 22.5 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.721 1.608 . . . . 0.0 113.144 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.1 m -61.79 -22.29 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.062 1.345 . . . . 0.0 113.444 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.6 m -77.38 70.15 3.73 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.404 1.881 . . . . 0.0 112.077 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.2 pt -73.37 148.01 87.97 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.14 138.35 44.0 Favored 'Cis proline' 0 C--N 1.353 0.797 0 CA-C-N 119.567 0.881 . . . . 0.0 112.798 -3.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.6 m -135.8 125.4 25.25 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.115 0.966 . . . . 0.0 109.873 167.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.2 mp -93.44 132.44 37.7 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.86 1.264 . . . . 0.0 108.16 161.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.14 126.17 73.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 168.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 40.2 tp -104.37 119.0 37.98 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.744 1.618 . . . . 0.0 109.874 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -98.08 147.75 24.23 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.595 1.558 . . . . 0.0 110.143 171.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -126.01 130.55 51.4 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.673 1.189 . . . . 0.0 109.033 165.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.7 t70 51.04 35.18 12.24 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.658 1.183 . . . . 0.0 113.592 -174.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.2 15.96 72.74 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 124.954 1.264 . . . . 0.0 115.986 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -116.68 140.73 27.14 Favored Pre-proline 0 N--CA 1.473 0.712 0 CA-C-N 119.064 1.432 . . . . 0.0 110.442 172.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.1 139.94 40.22 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.689 2.259 . . . . 0.0 111.833 -176.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 72.0 t -128.64 -43.2 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.423 1.089 . . . . 0.0 113.184 -174.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -145.48 152.47 39.82 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 119.445 1.021 . . . . 0.0 112.976 -175.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -128.08 140.17 52.1 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.862 1.665 . . . . 0.0 111.389 171.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.0 mt -133.4 139.12 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.266 1.826 . . . . 0.0 108.474 174.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.1 m -131.51 151.64 35.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 123.557 0.743 . . . . 0.0 112.987 -171.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.12 171.96 17.32 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 123.805 0.717 . . . . 0.0 113.406 -172.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.66 153.23 41.31 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.7 -0.882 . . . . 0.0 112.227 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.14 159.1 42.92 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.404 1.882 . . . . 0.0 109.855 165.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.48 161.49 50.15 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 159.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -50.75 -34.04 25.54 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -177.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.02 -49.21 75.52 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.5 -34.84 47.13 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.894 0.878 . . . . 0.0 113.091 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.03 -47.67 73.64 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.378 0.99 . . . . 0.0 110.037 175.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -62.93 -41.93 99.64 Favored 'General case' 0 C--O 1.206 -1.23 0 CA-C-O 115.497 -2.192 . . . . 0.0 110.413 171.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -53.32 -50.47 64.91 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 124.136 3.153 . . . . 0.0 112.03 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -67.63 -30.45 70.03 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.3 mt -83.09 -24.71 32.56 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.808 1.186 . . . . 0.0 113.525 169.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.9 t -72.45 -21.84 61.17 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 129.164 2.986 . . . . 0.0 111.186 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -45.94 -26.48 0.71 Allowed 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 156.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.9 t -111.13 -51.8 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 127.321 2.249 . . . . 0.0 113.022 166.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 92.3 t -67.17 112.16 9.17 Favored Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 127.276 2.23 . . . . 0.0 110.829 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -71.38 -4.62 15.34 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 121.369 1.379 . . . . 0.0 112.848 177.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.7 t30 68.71 150.67 0.08 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 128.656 2.782 . . . . 0.0 115.877 170.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 94.3 mt -119.24 78.24 1.28 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.956 1.302 . . . . 0.0 111.406 175.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 . . . . . 0 C--O 1.251 1.173 0 C-N-CA 128.52 2.728 . . . . 0.0 112.022 -7.22 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.0 ttm . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.6 p -59.43 -33.15 70.9 Favored 'General case' 0 N--CA 1.482 1.175 0 O-C-N 120.683 -1.26 . . . . 0.0 112.563 170.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -66.38 -19.02 65.69 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.248 1.419 . . . . 0.0 113.691 173.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.4 m -75.56 -12.25 60.18 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.589 1.155 . . . . 0.0 113.488 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -83.05 29.32 0.48 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.6 1.56 . . . . 0.0 114.065 -169.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -77.17 -15.01 59.69 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.768 -1.207 . . . . 0.0 114.105 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.2 p -127.41 157.65 39.43 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.729 2.012 . . . . 0.0 112.281 175.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -104.94 35.69 2.71 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 -168.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.0 p -88.87 156.13 19.11 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.376 1.07 . . . . 0.0 112.433 174.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.9 pt -129.41 155.43 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.699 1.6 . . . . 0.0 111.258 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -98.89 139.69 34.18 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.846 0.858 . . . . 0.0 111.275 170.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -126.43 155.57 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.923 1.689 . . . . 0.0 111.197 174.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 80.6 p -141.56 158.73 43.47 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.822 1.649 . . . . 0.0 110.48 173.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -52.64 -29.64 27.27 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.082 1.353 . . . . 0.0 114.254 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.09 -21.12 66.35 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.0 m -131.42 -4.43 3.79 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.623 1.569 . . . . 0.0 113.715 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -53.2 -40.67 64.6 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.29 1.836 . . . . 0.0 112.637 -175.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.23 -33.11 74.66 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.364 -0.835 . . . . 0.0 113.154 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.4 m -79.72 -31.4 41.14 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.254 1.022 . . . . 0.0 112.714 174.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -89.01 -39.46 13.67 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.302 -0.874 . . . . 0.0 113.194 -175.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.5 t -106.21 -53.43 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.116 1.366 . . . . 0.0 110.956 -173.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 46.7 mt -80.05 -18.36 50.3 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.179 1.178 . . . . 0.0 114.179 -173.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.6 m -91.92 -2.76 56.63 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.067 0.947 . . . . 0.0 113.293 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.0 t -69.39 141.0 54.23 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.046 0.939 . . . . 0.0 112.71 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.59 4.81 52.77 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.446 1.499 . . . . 0.0 112.7 176.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -130.83 166.94 23.73 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 126.918 2.087 . . . . 0.0 111.03 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.17 135.99 71.9 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 121.824 1.682 . . . . 0.0 112.164 171.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.5 p -139.46 122.73 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.443 1.097 . . . . 0.0 110.918 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.09 129.42 46.96 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.253 2.221 . . . . 0.0 108.503 -175.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.0 t -119.8 125.42 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.618 1.167 . . . . 0.0 110.162 175.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -107.23 112.97 26.1 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.607 1.163 . . . . 0.0 111.344 174.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -82.6 113.57 20.39 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.487 1.515 . . . . 0.0 108.052 174.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.467 ' CD1' ' HE3' ' A' ' 62' ' ' LYS . 1.3 p-90 -148.82 170.73 17.59 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -166.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.13 156.33 40.78 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.323 1.049 . . . . 0.0 111.7 165.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.6 p -64.47 -20.71 66.36 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.976 1.311 . . . . 0.0 113.672 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.454 ' CZ3' HD11 ' A' ' 80' ' ' ILE . 11.8 p-90 -82.93 -4.51 58.28 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 52.6 t -107.3 119.75 40.26 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.191 0.905 . . . . 0.0 111.945 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.88 -52.26 54.29 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-O 118.877 -0.957 . . . . 0.0 113.475 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -57.73 -35.9 98.62 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.779 2.319 . . . . 0.0 114.215 173.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 99.3 m -60.49 -46.69 89.18 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.624 1.102 . . . . 0.0 111.592 171.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.62 -29.19 70.2 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.384 1.074 . . . . 0.0 112.162 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 97.4 mmm -75.98 -37.67 58.29 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.004 1.322 . . . . 0.0 114.38 173.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.8 p -84.59 -23.01 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 CA-C-N 119.951 1.251 . . . . 0.0 113.556 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.05 -48.71 78.33 Favored Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -66.17 -30.24 46.59 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 CA-C-N 122.61 1.968 . . . . 0.0 113.37 176.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.9 t -67.23 -49.59 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-N 118.806 0.73 . . . . 0.0 109.834 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.7 mt -61.08 -37.36 82.41 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.343 1.057 . . . . 0.0 112.574 174.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -70.3 -40.44 74.25 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.969 0.908 . . . . 0.0 112.371 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -60.53 -47.2 87.21 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.514 -0.741 . . . . 0.0 111.085 168.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 76.0 mt -63.42 -36.82 77.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 O-C-N 121.649 -0.657 . . . . 0.0 111.286 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.13 -48.46 81.54 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 120.996 -1.065 . . . . 0.0 112.107 172.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.0 m -76.68 -32.92 58.21 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.171 0.988 . . . . 0.0 112.394 -172.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -99.29 -18.19 17.7 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.7 mmt-85 -122.45 28.27 7.48 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.056 1.342 . . . . 0.0 113.712 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.2 -27.68 22.91 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.889 0.876 . . . . 0.0 113.226 168.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.1 p -66.31 -26.92 67.54 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.057 2.143 . . . . 0.0 114.602 173.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -118.94 -23.71 6.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.363 1.465 . . . . 0.0 113.347 -171.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 80.5 mt -137.03 157.01 47.68 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.075 2.55 . . . . 0.0 110.258 -176.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 48.8 m -108.74 138.72 44.6 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 148.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.6 t -121.61 124.22 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 119.402 1.001 . . . . 0.0 110.68 -176.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -124.3 153.77 41.25 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.457 1.903 . . . . 0.0 112.632 -171.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.467 ' HE3' ' CD1' ' A' ' 33' ' ' TRP . 31.0 mmmt -116.39 132.81 56.57 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.775 2.03 . . . . 0.0 109.7 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -117.35 109.92 17.42 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.912 1.285 . . . . 0.0 108.169 170.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -82.62 100.27 10.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.598 -176.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.0 m -66.56 -16.24 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 120.771 -1.206 . . . . 0.0 112.753 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -70.69 -21.85 62.53 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.689 1.196 . . . . 0.0 113.268 171.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.0 p -118.79 -30.98 4.94 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -140.48 79.53 20.29 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 124.416 1.086 . . . . 0.0 111.279 175.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -70.76 -7.63 21.79 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.072 2.515 . . . . 0.0 113.249 174.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -56.82 -43.49 81.09 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.304 1.441 . . . . 0.0 112.816 -175.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.5 m -64.35 -44.53 91.17 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.54 0.736 . . . . 0.0 111.808 176.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.1 -35.89 82.58 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.537 -0.727 . . . . 0.0 112.358 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.5 ttp-105 -75.85 -34.23 60.05 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.554 0.742 . . . . 0.0 112.889 175.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -58.44 -37.47 75.49 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.38 1.072 . . . . 0.0 112.631 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -96.72 6.24 49.08 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.578 1.151 . . . . 0.0 113.376 174.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 59.94 -13.78 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 129.184 2.994 . . . . 0.0 116.814 -177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.4 m -78.77 55.59 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 126.979 2.111 . . . . 0.0 113.599 -177.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 m -72.94 -9.76 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.762 1.625 . . . . 0.0 114.677 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.6 m -78.29 65.4 3.63 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.974 1.709 . . . . 0.0 112.776 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.454 HD11 ' CZ3' ' A' ' 36' ' ' TRP . 39.4 pt -57.35 153.37 27.54 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 125.616 1.566 . . . . 0.0 114.831 -171.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.98 140.46 64.4 Favored 'Cis proline' 0 C--N 1.354 0.85 0 CA-C-N 119.495 0.855 . . . . 0.0 112.132 -3.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 33.6 m -128.97 121.04 27.16 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.677 0.791 . . . . 0.0 109.468 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.1 mp -107.8 125.75 51.8 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.982 1.313 . . . . 0.0 108.318 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.6 tt -128.21 130.1 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.201 1.0 . . . . 0.0 110.309 176.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.0 tp -108.16 128.22 54.51 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.823 1.249 . . . . 0.0 109.737 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -108.53 152.87 24.16 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.43 1.492 . . . . 0.0 110.205 170.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -135.26 122.31 21.37 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.261 1.824 . . . . 0.0 108.792 173.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.3 t70 50.9 35.64 12.92 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.172 0.989 . . . . 0.0 113.097 -168.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.2 7.75 68.21 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 125.604 1.573 . . . . 0.0 116.396 -176.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -106.42 137.67 19.5 Favored Pre-proline 0 N--CA 1.474 0.758 0 CA-C-N 119.541 1.671 . . . . 0.0 110.356 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.35 139.48 45.66 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.194 1.929 . . . . 0.0 112.0 -176.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.1 m -132.63 -18.41 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 125.163 1.385 . . . . 0.0 114.608 -176.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.9 tppm? -154.48 145.73 22.9 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.739 1.154 . . . . 0.0 111.006 171.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -138.33 134.94 34.88 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.142 0.977 . . . . 0.0 111.736 167.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.8 mp -130.44 144.27 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.34 2.256 . . . . 0.0 109.0 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.4 p -133.25 141.15 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.603 1.161 . . . . 0.0 110.336 170.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.26 156.14 27.59 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.506 1.05 . . . . 0.0 112.898 -167.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.31 141.59 41.56 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.744 0.817 . . . . 0.0 112.961 -175.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -132.85 148.94 52.3 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.97 1.708 . . . . 0.0 110.802 174.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.93 168.66 54.26 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 123.911 0.767 . . . . 0.0 111.318 173.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -56.35 -33.36 65.59 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -173.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.36 -53.75 47.7 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.924 0.392 . . . . 0.0 110.558 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.12 -34.91 66.41 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.515 -0.741 . . . . 0.0 112.776 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.3 tp -67.05 -38.48 85.92 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 120.136 1.335 . . . . 0.0 111.177 173.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . 0.254 0.1 OUTLIER -75.96 -11.1 59.9 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 116.863 -1.541 . . . . 0.0 113.99 169.182 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.79 -56.6 11.09 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 124.045 3.111 . . . . 0.0 110.607 158.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.19 -36.33 70.69 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.825 1.25 . . . . 0.0 111.997 -176.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 70.7 mt -91.47 -28.16 17.8 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 117.185 -1.388 . . . . 0.0 113.425 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 84.4 p -66.52 -18.69 65.51 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 121.793 2.088 . . . . 0.0 112.416 175.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -50.16 -22.34 1.66 Allowed 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 162.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.9 t -115.75 -34.08 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 127.876 2.47 . . . . 0.0 112.988 171.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.32 98.44 6.72 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 127.16 2.184 . . . . 0.0 110.997 -172.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -66.83 -16.1 49.08 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.138 1.892 . . . . 0.0 112.468 173.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -76.99 60.69 1.85 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.731 2.012 . . . . 0.0 111.463 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.3 tp -57.57 153.2 13.51 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.526 1.53 . . . . 0.0 112.706 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.232 0 C-N-CA 125.404 1.481 . . . . 0.0 110.878 171.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 tpt . . . . . 0 N--CA 1.486 1.366 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.1 t -147.19 159.81 43.2 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.647 1.179 . . . . 0.0 112.142 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -76.26 -24.47 54.51 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.926 1.291 . . . . 0.0 112.72 173.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.4 m -70.95 126.96 31.01 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.255 1.022 . . . . 0.0 111.937 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 52.37 34.2 14.52 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.062 1.345 . . . . 0.0 113.862 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -66.4 166.17 12.86 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.323 1.449 . . . . 0.0 114.375 -176.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.7 m 54.89 50.38 15.72 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.277 1.831 . . . . 0.0 113.152 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.42 37.91 0.53 Allowed 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -168.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.7 p -83.35 151.96 25.3 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.27 1.028 . . . . 0.0 111.67 172.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.1 pt -115.25 152.77 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.272 1.029 . . . . 0.0 111.864 172.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -92.26 138.17 31.75 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.907 0.883 . . . . 0.0 110.286 169.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.4 m -123.87 151.02 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.849 1.26 . . . . 0.0 110.746 171.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 81.4 p -135.96 158.52 44.21 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.299 1.44 . . . . 0.0 111.128 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.67 -27.53 62.95 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.907 1.076 . . . . 0.0 113.907 -172.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.33 -16.82 58.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.842 1.257 . . . . 0.0 114.348 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -131.45 -6.06 3.74 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.162 1.385 . . . . 0.0 113.844 -173.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -52.85 -40.7 63.6 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.715 1.606 . . . . 0.0 113.011 -175.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.11 -32.79 74.18 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.6 m -79.53 -32.89 42.32 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.824 0.849 . . . . 0.0 112.266 174.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -85.79 -41.28 15.19 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -174.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -105.83 -51.12 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.141 1.377 . . . . 0.0 111.211 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.3 mt -82.92 -13.2 56.51 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -170.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.9 m -95.88 5.9 50.17 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.583 1.153 . . . . 0.0 113.532 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.9 p -70.2 150.7 46.18 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.012 1.725 . . . . 0.0 114.94 -172.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.42 19.33 13.41 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 126.007 1.723 . . . . 0.0 111.854 172.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -143.99 146.18 33.15 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 128.927 2.891 . . . . 0.0 107.124 173.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -59.27 144.06 99.53 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 121.934 1.756 . . . . 0.0 113.255 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.9 t -128.21 125.09 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.339 1.456 . . . . 0.0 110.07 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 48.7 mt -87.92 135.0 33.59 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.388 0.675 . . . . 0.0 109.772 165.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.4 t -119.82 118.15 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 123.966 0.906 . . . . 0.0 109.366 168.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -89.89 109.27 20.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.625 1.57 . . . . 0.0 110.455 172.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -89.34 109.49 20.38 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.909 1.684 . . . . 0.0 108.64 171.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.9 p-90 -142.58 174.3 10.76 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.025 1.33 . . . . 0.0 111.757 -164.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.47 145.51 35.32 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.857 -0.527 . . . . 0.0 112.406 159.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.4 t -64.33 -22.6 67.01 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 -78.18 -4.64 48.63 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 174.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.8 t -107.17 129.36 54.86 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.242 1.017 . . . . 0.0 112.95 -173.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.62 -60.15 9.45 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.156 1.36 . . . . 0.0 114.499 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -61.84 -28.72 81.76 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 CA-C-N 120.386 2.093 . . . . 0.0 113.351 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 89.5 m -62.08 -48.55 79.71 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.511 1.051 . . . . 0.0 111.558 169.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -60.58 -34.37 74.1 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.116 0.966 . . . . 0.0 112.19 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 26.2 mmt -75.47 -36.01 60.74 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 p -87.28 -21.8 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 119.627 1.103 . . . . 0.0 113.52 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.55 -50.16 60.45 Favored Pre-proline 0 CA--C 1.551 1.007 0 CA-C-O 117.288 -1.339 . . . . 0.0 114.32 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -65.71 -30.19 50.67 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 CA-C-N 122.338 1.871 . . . . 0.0 113.666 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.408 HG13 ' HA ' ' A' ' 101' ' ' LYS . 13.1 t -68.21 -51.32 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 119.031 0.832 . . . . 0.0 110.771 177.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.9 pp -72.01 -22.74 61.37 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -69.99 -35.29 74.3 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.107 -0.996 . . . . 0.0 112.512 168.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -64.89 -42.87 94.42 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.868 -1.145 . . . . 0.0 111.508 166.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.4 mm -55.41 -45.95 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-N 119.969 1.259 . . . . 0.0 110.821 170.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.66 -42.85 93.74 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.052 0.941 . . . . 0.0 112.823 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.7 m -74.55 -40.73 61.52 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.66 0.784 . . . . 0.0 111.61 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -86.79 -23.56 25.36 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -173.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.3 mmt-85 -123.04 20.76 9.89 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 114.59 1.329 . . . . 0.0 114.59 -173.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.11 -27.74 15.22 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.311 1.444 . . . . 0.0 114.5 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.3 p -74.56 -23.07 58.72 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.072 1.349 . . . . 0.0 114.142 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -117.74 -25.85 6.72 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.614 1.166 . . . . 0.0 113.952 -176.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 82.6 mt -125.78 153.02 44.62 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.51 1.924 . . . . 0.0 110.248 172.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 38.3 m -101.16 138.48 38.14 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 151.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.4 t -118.68 117.76 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 118.59 0.632 . . . . 0.0 109.475 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -119.52 159.33 24.52 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.121 1.768 . . . . 0.0 112.246 -174.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -127.71 136.23 51.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.635 1.574 . . . . 0.0 111.664 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -125.93 113.46 17.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.831 2.052 . . . . 0.0 107.926 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -81.36 120.15 24.58 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.452 -0.78 . . . . 0.0 110.311 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.9 m -67.35 -17.38 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.13 -30.18 43.56 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.29 1.036 . . . . 0.0 112.711 173.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.2 p -97.21 -30.83 12.77 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.191 0.996 . . . . 0.0 112.608 -176.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -130.39 63.09 68.11 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 125.775 1.63 . . . . 0.0 111.442 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -61.66 -21.66 72.61 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.93 2.42 . . . . 0.0 113.307 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -61.9 -45.47 93.59 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.466 1.106 . . . . 0.0 111.443 174.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 m -71.77 -32.3 67.52 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.553 0.741 . . . . 0.0 111.442 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.09 -44.74 91.42 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.927 0.891 . . . . 0.0 112.607 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -77.88 -28.38 49.91 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -57.01 -42.8 81.01 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.924 0.89 . . . . 0.0 113.282 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -99.69 7.86 44.79 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.599 1.16 . . . . 0.0 113.404 176.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.321 15.5 pt20 42.07 47.08 3.82 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.072 1.749 . . . . 0.0 113.571 -166.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.0 m -98.97 36.76 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 127.604 2.362 . . . . 0.0 109.904 172.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.9 p -78.64 -25.17 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.08 1.752 . . . . 0.0 112.417 -173.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 51.0 m -74.35 144.37 44.48 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.443 1.097 . . . . 0.0 110.318 163.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.73 149.3 56.18 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 124.163 0.985 . . . . 0.0 113.332 -168.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.13 142.01 71.44 Favored 'Cis proline' 0 C--N 1.352 0.755 0 CA-C-N 119.021 0.686 . . . . 0.0 111.336 -8.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 51.7 m -132.28 121.64 23.9 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.201 1.0 . . . . 0.0 109.947 172.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.9 mp -96.52 135.99 37.65 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.38 1.072 . . . . 0.0 109.251 171.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 26.5 mm -115.62 135.56 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.626 1.171 . . . . 0.0 109.212 167.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.7 tp -92.67 117.32 29.86 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 123.223 0.327 . . . . 0.0 110.423 162.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -96.41 115.26 27.14 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.625 1.17 . . . . 0.0 108.343 165.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.7 tttm -100.31 108.6 20.69 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 50.03 43.55 25.58 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.688 1.195 . . . . 0.0 113.094 -167.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.16 15.19 80.79 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 117.059 1.584 . . . . 0.0 117.059 173.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -126.43 140.11 36.41 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-N 119.373 1.587 . . . . 0.0 111.41 168.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -69.29 138.93 40.54 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.778 2.318 . . . . 0.0 112.249 -174.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.4 t -130.5 -33.94 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 125.267 1.427 . . . . 0.0 113.072 -176.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -141.3 145.15 35.13 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.272 1.029 . . . . 0.0 111.753 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -123.05 136.15 54.71 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.927 2.091 . . . . 0.0 110.595 171.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.1 mt -129.75 130.78 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.91 1.684 . . . . 0.0 107.457 171.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.3 143.83 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 119.507 1.048 . . . . 0.0 111.845 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.17 157.66 28.36 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.188 1.375 . . . . 0.0 112.72 -169.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.6 138.1 48.48 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.839 -0.801 . . . . 0.0 112.033 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -131.98 153.99 49.77 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.875 1.67 . . . . 0.0 111.113 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.63 164.15 51.86 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 174.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.408 ' HA ' HG13 ' A' ' 46' ' ' VAL . 3.6 tmtp? -55.08 -34.12 63.35 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.823 1.249 . . . . 0.0 113.197 -178.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.02 -37.63 66.85 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.17 -46.25 43.4 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.259 1.024 . . . . 0.0 111.36 177.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 40.4 tp -64.6 -46.56 82.15 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.706 175.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 32.3 tp -69.78 -26.51 64.32 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-O 115.121 -2.371 . . . . 0.0 113.389 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -69.72 -44.04 71.13 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 125.005 3.548 . . . . 0.0 112.26 169.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -64.61 -23.43 67.26 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.4 mt -93.85 -26.64 16.83 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.061 1.344 . . . . 0.0 113.772 168.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.4 m -61.29 -25.8 67.36 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 120.269 1.395 . . . . 0.0 110.413 173.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -53.25 -23.14 8.08 Favored 'General case' 0 CA--C 1.558 1.265 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 166.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 68.8 t -114.51 -50.26 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 127.522 2.329 . . . . 0.0 111.344 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.2 t -79.79 115.87 56.94 Favored Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 128.146 2.578 . . . . 0.0 108.699 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -66.82 -6.03 14.72 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 121.523 1.482 . . . . 0.0 112.993 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 62.1 t30 68.2 151.76 0.08 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 128.483 2.713 . . . . 0.0 116.185 168.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.8 mt -120.04 -33.05 4.04 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -172.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 C--O 1.252 1.221 0 C-N-CA 126.265 1.826 . . . . 0.0 112.605 -179.132 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.8 ptm . . . . . 0 N--CA 1.485 1.301 0 N-CA-C 110.924 -0.028 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.9 m 55.5 38.28 30.02 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.811 1.244 . . . . 0.0 112.596 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -80.23 156.07 27.06 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.274 1.429 . . . . 0.0 112.922 -174.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 65.2 p -148.11 144.57 27.92 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.393 1.477 . . . . 0.0 111.248 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -77.14 -31.92 55.98 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.212 0.605 . . . . 0.0 112.258 178.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.0 pttm 38.96 45.24 0.95 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 127.799 2.44 . . . . 0.0 115.717 171.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.7 m -61.07 146.24 48.01 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.49 1.116 . . . . 0.0 113.464 -175.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -138.83 179.91 6.21 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.419 1.487 . . . . 0.0 112.729 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.264 19.4 p 74.33 149.91 0.11 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 129.686 3.195 . . . . 0.0 114.976 -171.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.0 pt -134.49 157.37 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.486 1.914 . . . . 0.0 110.631 172.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -105.44 139.08 40.6 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.62 0.768 . . . . 0.0 110.678 169.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.9 m -124.89 153.21 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.574 1.55 . . . . 0.0 111.058 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.6 p -132.48 170.59 14.93 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.474 1.51 . . . . 0.0 111.601 -174.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -56.5 -25.26 50.92 Favored 'General case' 0 CA--C 1.55 0.952 0 O-C-N 121.151 -0.968 . . . . 0.0 113.106 171.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.85 -13.52 50.75 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 115.043 1.498 . . . . 0.0 115.043 175.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.9 p -134.22 -12.49 2.46 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 -169.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -54.46 -42.77 71.04 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.898 1.279 . . . . 0.0 112.208 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.29 -36.34 82.7 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.298 -0.877 . . . . 0.0 112.95 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.0 m -79.2 -24.44 43.16 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.432 1.093 . . . . 0.0 113.139 -177.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -97.09 -46.97 5.96 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.351 -0.843 . . . . 0.0 113.084 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.07 -51.95 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.311 1.044 . . . . 0.0 112.046 -172.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.4 mt -84.19 -26.48 28.74 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -172.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.9 m -80.59 -11.08 59.7 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.569 1.148 . . . . 0.0 113.637 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.5 m -74.93 127.6 33.59 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.704 1.202 . . . . 0.0 112.32 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -71.62 -28.39 63.75 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.323 1.049 . . . . 0.0 112.113 172.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -84.64 164.31 43.08 Favored Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 125.384 1.473 . . . . 0.0 111.977 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.78 141.41 94.79 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.658 2.239 . . . . 0.0 113.351 170.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.0 t -135.68 126.12 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.554 1.142 . . . . 0.0 110.041 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 tt -100.43 121.31 41.32 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.543 1.937 . . . . 0.0 108.427 177.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 t -111.28 126.74 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 118.999 0.818 . . . . 0.0 111.129 174.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -99.06 111.41 23.82 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.456 1.502 . . . . 0.0 110.881 172.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -83.85 112.44 20.12 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.493 1.517 . . . . 0.0 108.657 173.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.3 p-90 -144.76 169.48 17.95 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.393 1.077 . . . . 0.0 113.017 -166.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.63 154.66 35.8 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.67 1.188 . . . . 0.0 111.015 163.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 t -67.91 -12.99 61.79 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.417 ' CZ3' HD11 ' A' ' 80' ' ' ILE . 13.2 p-90 -79.77 -3.68 48.69 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 174.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 50.5 t -111.06 117.52 33.52 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.429 1.091 . . . . 0.0 112.398 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.88 -48.34 86.57 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-O 118.72 -1.044 . . . . 0.0 113.097 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -56.78 -33.08 93.5 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.747 2.298 . . . . 0.0 114.765 170.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 89.7 m -64.12 -46.33 84.66 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.821 1.191 . . . . 0.0 111.384 170.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -58.46 -35.69 72.55 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.211 1.004 . . . . 0.0 111.865 173.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.8 mtt -73.3 -39.0 65.66 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.883 1.273 . . . . 0.0 113.954 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.8 p -83.08 -23.83 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 CA-C-N 119.661 1.118 . . . . 0.0 113.655 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.55 -49.04 80.47 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.17 -29.25 39.72 Favored 'Trans proline' 0 C--N 1.354 0.819 0 CA-C-N 122.387 1.888 . . . . 0.0 113.215 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.4 t -69.73 -45.43 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 121.51 -0.744 . . . . 0.0 110.22 175.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.3 mt -60.99 -36.14 78.68 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.415 1.086 . . . . 0.0 112.421 172.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -68.69 -39.05 80.72 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.089 0.859 . . . . 0.0 112.194 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -63.91 -46.12 86.22 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.189 -0.944 . . . . 0.0 111.62 170.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.2 mm -56.9 -42.97 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 121.674 -0.641 . . . . 0.0 110.941 173.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.56 -42.18 98.46 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.8 0.84 . . . . 0.0 112.261 177.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.2 m -69.52 -42.38 74.76 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.312 1.045 . . . . 0.0 111.299 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -95.01 -23.22 17.47 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -170.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -109.87 14.22 23.24 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.79 1.636 . . . . 0.0 113.403 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.99 -33.19 36.96 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.019 1.327 . . . . 0.0 114.268 -177.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.1 m -72.19 -26.05 61.91 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.054 1.342 . . . . 0.0 112.75 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -102.39 -34.15 9.29 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.479 1.512 . . . . 0.0 113.06 -175.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.0 pp -149.08 163.06 38.64 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.539 1.536 . . . . 0.0 112.185 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 58.5 m -108.31 138.51 44.46 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.194 0.998 . . . . 0.0 109.344 167.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.9 t -102.59 128.89 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.519 0.728 . . . . 0.0 110.398 175.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.45 158.77 36.47 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.553 1.941 . . . . 0.0 111.455 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -127.62 134.78 49.65 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.556 1.142 . . . . 0.0 111.697 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -113.64 117.25 31.06 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.742 1.617 . . . . 0.0 108.937 173.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.43 97.58 7.82 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.034 1.333 . . . . 0.0 108.757 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.5 m -65.01 -20.72 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -172.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -74.19 -22.49 59.37 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.135 0.974 . . . . 0.0 112.753 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.3 t -119.22 -13.6 9.32 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.931 1.292 . . . . 0.0 113.518 174.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -119.22 60.75 5.4 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 124.958 1.303 . . . . 0.0 112.076 171.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -65.46 -24.62 56.56 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.368 2.045 . . . . 0.0 112.29 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -66.91 -43.39 83.45 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.478 -0.764 . . . . 0.0 111.422 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 m -68.22 -38.36 81.8 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.163 0.985 . . . . 0.0 111.466 175.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.2 -38.52 91.48 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.419 0.688 . . . . 0.0 112.668 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 22.7 ttm105 -76.44 -35.75 58.33 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.361 0.664 . . . . 0.0 112.758 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -54.96 -39.02 68.49 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.866 1.267 . . . . 0.0 113.67 -175.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -99.93 1.79 43.05 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.088 0.955 . . . . 0.0 113.37 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 51.56 60.09 4.11 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.182 1.793 . . . . 0.0 112.322 -167.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.5 m -127.58 32.18 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 126.529 1.932 . . . . 0.0 111.491 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.6 m -70.88 -23.67 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.595 1.158 . . . . 0.0 113.726 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 54.0 m -79.51 139.49 37.56 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.479 1.112 . . . . 0.0 110.193 168.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.417 HD11 ' CZ3' ' A' ' 36' ' ' TRP . 48.4 pt -136.9 152.64 74.5 Favored Pre-proline 0 N--CA 1.475 0.817 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -167.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.37 140.73 64.16 Favored 'Cis proline' 0 C--N 1.353 0.789 0 CA-C-N 119.322 0.794 . . . . 0.0 111.81 -4.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.4 m -127.55 121.31 30.28 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.815 0.846 . . . . 0.0 109.443 169.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.3 mp -102.42 130.3 49.16 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.494 1.518 . . . . 0.0 107.942 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.22 130.69 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.824 0.849 . . . . 0.0 108.931 175.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.5 tp -106.54 120.91 43.18 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.401 1.08 . . . . 0.0 109.901 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -96.51 147.34 23.95 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.297 1.439 . . . . 0.0 109.834 169.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -119.9 130.11 54.67 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.721 1.208 . . . . 0.0 108.951 161.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.4 t0 47.82 44.57 18.14 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.303 1.041 . . . . 0.0 113.067 -174.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.39 10.86 58.33 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.11 1.338 . . . . 0.0 116.14 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -117.74 136.48 23.69 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 125.434 1.493 . . . . 0.0 110.071 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -70.56 139.74 38.11 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.71 2.273 . . . . 0.0 112.325 -171.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.5 t -128.83 -38.76 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.564 1.146 . . . . 0.0 113.198 -175.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -142.19 144.38 33.38 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.289 1.036 . . . . 0.0 111.682 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -129.27 139.71 51.7 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.669 1.588 . . . . 0.0 111.457 170.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.8 mt -133.87 139.06 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 126.946 2.098 . . . . 0.0 108.403 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.1 p -131.79 142.15 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.288 0.949 . . . . 0.0 110.882 171.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.11 153.47 24.48 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.632 1.11 . . . . 0.0 112.563 -167.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.68 143.03 48.25 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.975 -0.721 . . . . 0.0 112.487 -176.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -130.46 143.78 50.98 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.694 1.598 . . . . 0.0 110.409 173.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -78.6 170.29 54.72 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.154 0.883 . . . . 0.0 111.299 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -53.13 -35.84 60.15 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -175.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.35 -53.01 59.2 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 122.834 0.453 . . . . 0.0 111.375 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.67 -37.4 59.63 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.489 1.115 . . . . 0.0 113.241 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.7 tp -67.82 -35.17 78.12 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.248 0.931 . . . . 0.0 110.97 173.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.6 tp -74.14 -24.95 59.49 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-O 116.138 -1.887 . . . . 0.0 112.867 169.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 46.6 mmt-85 -59.84 -51.29 70.37 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 124.203 3.183 . . . . 0.0 110.572 164.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -61.0 -32.21 71.8 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.7 mt -99.03 -23.4 15.3 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.4 t -68.91 -21.28 64.23 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.326 0.966 . . . . 0.0 111.025 168.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -53.7 -20.02 4.89 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.333 1.053 . . . . 0.0 113.088 162.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.8 t -112.85 -28.89 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 127.143 2.177 . . . . 0.0 112.3 171.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.0 t -115.88 72.98 4.48 Favored Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 127.139 2.176 . . . . 0.0 110.882 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.03 -4.57 12.76 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.528 2.819 . . . . 0.0 114.012 -175.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -69.16 -24.29 64.05 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 177.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 71.7 mt 59.29 -50.27 0.07 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 128.84 2.856 . . . . 0.0 115.772 -173.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.24 0 C-N-CA 124.969 1.308 . . . . 0.0 110.913 166.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.7 t -159.2 167.78 28.21 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.519 1.128 . . . . 0.0 112.134 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -78.89 157.98 28.17 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.843 1.657 . . . . 0.0 113.675 176.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.2 m -128.95 157.51 41.42 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.667 1.587 . . . . 0.0 112.579 176.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -112.43 -2.55 14.69 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.591 1.157 . . . . 0.0 113.6 176.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -91.87 -7.0 50.55 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.883 1.673 . . . . 0.0 113.439 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 91.8 p -71.15 167.16 19.93 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.064 1.746 . . . . 0.0 113.398 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.88 56.54 1.57 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.057 0.943 . . . . 0.0 112.169 173.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.4 p -116.63 158.99 22.84 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.794 1.638 . . . . 0.0 112.627 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.7 pt -118.77 152.5 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.078 1.351 . . . . 0.0 111.33 170.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -97.65 132.67 43.09 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.231 1.012 . . . . 0.0 109.928 172.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.9 m -137.01 150.06 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.337 1.055 . . . . 0.0 112.112 -176.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 73.2 p -141.23 164.92 28.95 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.654 1.581 . . . . 0.0 111.399 176.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -51.25 -28.35 11.5 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.658 1.983 . . . . 0.0 114.673 -176.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.31 -22.46 65.62 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.0 m -135.26 -0.66 2.69 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.318 1.447 . . . . 0.0 114.224 -175.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -53.16 -42.57 66.28 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.674 1.99 . . . . 0.0 112.921 -175.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.12 -32.23 72.38 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.321 -0.862 . . . . 0.0 113.109 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.8 m -79.49 -30.22 41.94 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.279 1.431 . . . . 0.0 112.849 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -97.03 -41.44 8.37 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -171.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.7 m -124.4 -29.89 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -169.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.4 mt -80.7 -13.21 59.21 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.518 1.054 . . . . 0.0 113.258 170.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.9 p -75.62 -21.04 58.1 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -169.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.2 t -100.76 141.47 33.59 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -168.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -82.93 -13.89 55.19 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.801 1.24 . . . . 0.0 113.174 170.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -68.64 151.78 97.05 Favored Pre-proline 0 N--CA 1.473 0.722 0 C-N-CA 125.263 1.425 . . . . 0.0 109.15 162.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -65.15 134.41 39.3 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 CA-C-N 120.795 1.319 . . . . 0.0 111.297 171.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.6 t -135.69 121.92 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 124.045 0.938 . . . . 0.0 109.311 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 tt -104.42 130.42 52.31 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.226 2.21 . . . . 0.0 109.378 -169.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.4 t -120.63 125.48 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.353 1.061 . . . . 0.0 111.009 177.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -103.94 120.13 40.39 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.472 1.509 . . . . 0.0 112.04 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -100.48 112.81 25.21 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.959 2.104 . . . . 0.0 108.964 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 11.4 p-90 -143.51 177.12 8.68 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.894 1.278 . . . . 0.0 111.934 -168.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.98 143.72 32.04 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.398 -0.814 . . . . 0.0 112.641 165.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.5 t -63.25 -21.73 66.42 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 172.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.478 ' CZ3' HD11 ' A' ' 80' ' ' ILE . 6.3 p-90 -83.3 -3.65 57.68 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 174.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 46.2 t -106.55 120.1 41.03 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.233 1.013 . . . . 0.0 112.189 -174.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.79 -46.78 92.93 Favored Glycine 0 CA--C 1.54 1.615 0 CA-C-O 118.861 -0.966 . . . . 0.0 114.317 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -58.88 -31.78 96.03 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.788 2.325 . . . . 0.0 114.087 170.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 93.8 m -65.45 -47.13 77.19 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.961 0.801 . . . . 0.0 111.428 170.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -59.23 -31.93 69.5 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 118.712 0.687 . . . . 0.0 112.407 174.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -70.33 -48.45 56.41 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.9 1.28 . . . . 0.0 112.545 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.3 p -81.21 -23.21 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.91 -54.2 30.28 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-O 116.864 -1.541 . . . . 0.0 114.01 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.92 -26.71 66.79 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.367 2.045 . . . . 0.0 113.516 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.0 t -66.71 -51.74 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 119.04 0.836 . . . . 0.0 109.93 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . 0.25 4.2 pp -73.22 -19.09 61.16 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -65.67 -41.97 91.86 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.507 1.123 . . . . 0.0 111.577 166.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -64.92 -44.42 89.58 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.45 -0.781 . . . . 0.0 111.143 169.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.5 mm -54.1 -46.99 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 119.896 1.225 . . . . 0.0 110.88 172.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.58 -44.46 96.19 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.8 m -76.23 -37.45 57.68 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.643 0.777 . . . . 0.0 112.025 -175.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -86.72 -40.17 15.3 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -176.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -98.86 11.67 38.09 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.804 1.242 . . . . 0.0 113.316 -169.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.58 -32.15 39.68 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.48 1.512 . . . . 0.0 114.859 -173.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.8 p -82.99 -19.6 36.74 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.76 1.224 . . . . 0.0 113.619 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -94.12 -39.97 10.3 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.364 1.466 . . . . 0.0 112.217 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.9 pp -149.05 153.35 37.72 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.546 1.939 . . . . 0.0 111.893 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 31.8 m -99.47 138.94 35.86 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.15 -0.969 . . . . 0.0 109.502 175.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.7 t -113.3 131.11 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 119.348 0.976 . . . . 0.0 111.675 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.24 152.43 44.6 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.75 2.02 . . . . 0.0 111.503 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -130.67 140.25 50.37 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.7 1.2 . . . . 0.0 112.466 -175.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -134.6 116.31 14.86 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.946 2.098 . . . . 0.0 109.065 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -82.78 119.53 24.46 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 170.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.416 HG12 ' HB2' ' A' ' 72' ' ' ALA . 11.2 m -67.87 -16.94 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 121.386 -0.821 . . . . 0.0 112.976 -175.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -79.22 -28.07 42.51 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.261 1.024 . . . . 0.0 112.903 172.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.2 p -92.57 -29.04 16.38 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.73 0.812 . . . . 0.0 112.505 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -145.02 103.05 4.43 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 123.942 0.897 . . . . 0.0 111.191 161.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.68 -21.95 12.38 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.848 2.366 . . . . 0.0 113.805 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -72.78 -28.08 62.38 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.809 -1.182 . . . . 0.0 112.16 -175.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 m -64.2 -42.14 96.76 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.715 0.806 . . . . 0.0 110.886 171.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.416 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -68.19 -37.11 80.57 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.079 0.952 . . . . 0.0 112.909 174.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -68.06 -43.89 77.6 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.178 0.991 . . . . 0.0 112.499 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -59.56 -37.84 79.52 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.155 0.982 . . . . 0.0 113.583 -172.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -99.5 5.66 46.08 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.45 1.1 . . . . 0.0 113.692 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 49.56 60.63 3.64 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.209 1.804 . . . . 0.0 112.645 -172.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.6 m -129.18 30.25 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.256 1.823 . . . . 0.0 111.398 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.5 m -71.88 -14.56 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.011 1.324 . . . . 0.0 114.395 -173.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.5 m -68.69 -40.45 80.07 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -165.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.478 HD11 ' CZ3' ' A' ' 36' ' ' TRP 0.294 14.2 pt 56.07 147.34 0.05 OUTLIER Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 130.552 3.541 . . . . 0.0 119.051 177.394 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.9 136.78 24.94 Favored 'Cis proline' 0 C--N 1.354 0.818 0 N-CA-C 110.218 -0.724 . . . . 0.0 110.218 -16.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 25.7 m -135.7 121.19 19.33 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.597 0.759 . . . . 0.0 109.477 -177.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.0 mp -109.88 138.99 45.47 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.7 1.2 . . . . 0.0 108.797 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.1 tt -129.19 145.06 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.69 0.796 . . . . 0.0 110.715 169.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 32.5 tp -116.65 132.65 56.63 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.625 1.17 . . . . 0.0 109.854 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -112.08 148.02 34.81 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.714 1.606 . . . . 0.0 111.787 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -132.87 126.12 31.49 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.589 1.556 . . . . 0.0 109.007 159.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.0 t70 51.32 37.68 19.47 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.747 1.219 . . . . 0.0 113.358 -177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.23 -0.19 49.04 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.204 1.383 . . . . 0.0 115.735 -176.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -95.13 143.89 26.87 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 124.92 1.288 . . . . 0.0 110.153 178.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.51 140.81 40.7 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.716 2.277 . . . . 0.0 112.092 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 52.0 t -121.09 -45.61 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.925 1.69 . . . . 0.0 111.276 -174.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -143.9 150.75 38.87 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.09 1.756 . . . . 0.0 110.634 173.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -133.77 134.22 42.65 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.435 1.894 . . . . 0.0 109.77 167.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.9 mt -131.0 138.97 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.918 1.687 . . . . 0.0 108.625 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.3 p -133.68 141.51 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.037 0.935 . . . . 0.0 110.788 167.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.7 155.87 27.91 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.403 1.002 . . . . 0.0 112.746 -168.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.51 139.67 45.85 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.573 0.749 . . . . 0.0 112.577 -175.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -130.67 145.05 51.83 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.012 1.725 . . . . 0.0 110.56 173.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.72 166.5 53.24 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 123.83 0.729 . . . . 0.0 111.687 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.3 tmtp? -51.98 -34.43 42.38 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.056 1.342 . . . . 0.0 113.861 -174.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.04 -53.28 26.9 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 122.267 0.227 . . . . 0.0 110.97 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.1 -40.59 78.27 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.717 0.807 . . . . 0.0 112.757 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.98 -41.04 91.67 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.725 0.693 . . . . 0.0 110.523 176.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 20.1 tp -72.78 -24.88 60.99 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-O 115.69 -2.1 . . . . 0.0 113.399 172.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -63.64 -49.08 74.66 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 124.651 3.387 . . . . 0.0 111.002 166.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -54.56 -37.87 65.97 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.603 1.161 . . . . 0.0 112.735 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.4 mt -92.3 -25.99 18.32 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.0 t -66.74 -22.85 66.04 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.537 1.135 . . . . 0.0 110.99 175.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -51.1 -28.65 11.12 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 163.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 77.0 t -105.01 -24.64 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 127.278 2.231 . . . . 0.0 112.522 172.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.28 77.55 2.99 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 127.428 2.291 . . . . 0.0 110.168 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -73.32 20.42 0.36 Allowed 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 124.469 3.446 . . . . 0.0 113.77 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -61.54 -31.86 71.9 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.197 0.999 . . . . 0.0 111.772 172.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.8 mp -91.12 154.1 19.6 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.801 1.24 . . . . 0.0 111.629 167.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.036 0 C-N-CA 125.361 1.464 . . . . 0.0 110.986 170.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.487 1.41 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.2 p -66.97 -27.1 67.18 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.107 0.963 . . . . 0.0 113.309 176.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -85.21 -0.53 54.93 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.784 1.634 . . . . 0.0 113.358 173.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.8 t 62.99 143.57 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 128.301 2.64 . . . . 0.0 114.85 -166.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -68.42 -26.88 65.75 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.942 0.897 . . . . 0.0 111.315 167.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.276 16.8 pttm 42.63 30.83 0.25 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 128.08 2.552 . . . . 0.0 117.204 171.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.6 t -86.14 124.69 32.84 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.295 1.038 . . . . 0.0 110.866 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.23 66.54 9.6 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.409 0.55 . . . . 0.0 111.79 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.9 p -111.95 144.84 40.62 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.359 1.463 . . . . 0.0 113.351 -178.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.9 pt -141.43 157.5 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 126.342 1.857 . . . . 0.0 111.667 173.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -99.89 145.59 27.61 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.388 1.075 . . . . 0.0 111.186 162.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.3 m -131.11 151.55 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.459 1.503 . . . . 0.0 111.426 174.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.9 p -123.82 167.81 13.58 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.202 1.801 . . . . 0.0 110.592 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -59.91 -23.64 63.67 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 120.846 -1.159 . . . . 0.0 112.904 174.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.77 -13.72 50.35 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.45 1.5 . . . . 0.0 114.962 175.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.9 p -128.12 -12.16 5.21 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -173.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -52.83 -41.37 64.15 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.24 1.416 . . . . 0.0 112.459 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.12 -36.57 82.19 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.251 -0.906 . . . . 0.0 113.148 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.0 m -79.47 -26.02 41.77 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.25 1.02 . . . . 0.0 113.261 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -100.17 -37.47 8.92 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.5 t -99.34 -58.6 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.516 1.127 . . . . 0.0 111.308 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.8 mt -76.08 -22.14 55.94 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -171.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.0 m -81.55 -11.05 59.3 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.358 1.063 . . . . 0.0 113.392 175.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.5 t -84.28 132.9 34.58 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -174.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -90.49 -4.89 56.63 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.001 1.32 . . . . 0.0 113.027 171.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -90.02 144.12 30.9 Favored Pre-proline 0 N--CA 1.472 0.651 0 C-N-CA 125.152 1.381 . . . . 0.0 109.396 169.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -54.17 131.06 42.85 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.214 1.943 . . . . 0.0 111.872 168.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.0 p -139.37 130.16 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.853 1.261 . . . . 0.0 110.096 -172.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.2 tt -120.23 111.95 18.45 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.295 1.038 . . . . 0.0 109.622 -165.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.0 t -103.13 124.62 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.019 0.928 . . . . 0.0 111.223 -173.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -97.09 113.22 24.76 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.748 1.619 . . . . 0.0 110.787 172.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -87.32 109.39 19.49 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.265 1.826 . . . . 0.0 108.569 173.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -149.63 172.69 14.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.153 0.981 . . . . 0.0 113.333 -163.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -145.4 153.73 41.51 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.374 0.67 . . . . 0.0 112.611 159.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.6 p -58.19 -29.41 65.62 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.593 1.557 . . . . 0.0 113.263 174.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 15.4 p-90 -80.66 -6.4 58.31 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.3 t -102.12 116.25 32.27 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.044 0.938 . . . . 0.0 111.227 -176.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.24 -46.53 94.08 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-O 118.484 -1.176 . . . . 0.0 114.028 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -60.37 -32.49 94.07 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 CA-C-N 120.813 2.306 . . . . 0.0 114.305 172.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 97.3 m -65.31 -47.74 75.52 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.244 -0.91 . . . . 0.0 110.954 171.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.8 tptt -57.21 -32.55 66.62 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.947 1.699 . . . . 0.0 112.669 172.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 57.1 mtt -72.97 -42.2 63.59 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.45 1.1 . . . . 0.0 113.107 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -84.09 -23.15 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -47.24 -50.74 46.22 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 177.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.51 -30.01 52.59 Favored 'Trans proline' 0 C--N 1.352 0.713 0 CA-C-N 122.036 1.763 . . . . 0.0 113.105 176.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.9 t -73.53 -44.92 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.289 -0.882 . . . . 0.0 110.849 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.2 pp -72.67 -24.24 61.0 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.481 -0.762 . . . . 0.0 113.019 174.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -71.74 -36.11 70.33 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.162 0.892 . . . . 0.0 112.42 168.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -61.75 -42.53 99.09 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.553 -1.342 . . . . 0.0 111.256 167.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.33 -42.11 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 119.52 1.055 . . . . 0.0 111.559 170.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.78 -37.78 80.04 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.344 0.974 . . . . 0.0 112.937 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.1 m -82.23 -47.1 12.85 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.997 0.919 . . . . 0.0 112.095 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -85.97 -25.46 26.01 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -171.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -104.69 16.96 25.01 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.202 1.401 . . . . 0.0 112.455 176.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.02 -27.87 21.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.857 1.663 . . . . 0.0 114.549 -177.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.2 p -72.35 -20.11 61.53 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.375 1.47 . . . . 0.0 114.115 176.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -115.66 -39.33 3.54 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.094 1.358 . . . . 0.0 112.833 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.6 mt -113.73 148.02 37.19 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.453 1.901 . . . . 0.0 111.278 -175.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.8 m -112.59 134.41 54.14 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 152.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.1 t -99.56 138.3 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 123.734 0.814 . . . . 0.0 110.081 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.6 156.06 42.87 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.32 1.448 . . . . 0.0 111.991 -177.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -120.09 124.25 45.37 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.056 1.743 . . . . 0.0 110.743 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -109.47 114.51 28.22 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.279 1.031 . . . . 0.0 108.385 165.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -82.36 103.51 11.99 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.446 1.099 . . . . 0.0 109.615 -176.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 m -66.85 -17.5 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 O-C-N 120.703 -1.248 . . . . 0.0 113.024 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -71.74 -23.54 61.63 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.84 1.256 . . . . 0.0 113.107 175.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.3 p -118.61 -24.78 6.62 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -130.27 79.6 72.29 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 119.504 1.047 . . . . 0.0 113.521 168.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -66.93 -16.29 49.33 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.191 1.927 . . . . 0.0 112.927 166.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.1 mp0 -64.84 -42.3 95.03 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.901 -1.124 . . . . 0.0 111.439 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.5 m -70.92 -36.15 72.54 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.989 0.915 . . . . 0.0 111.436 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.3 -39.32 90.03 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.546 0.739 . . . . 0.0 112.196 171.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -72.85 -40.34 65.79 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 175.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -61.93 -34.71 76.59 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.307 1.043 . . . . 0.0 113.81 -174.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -96.76 1.4 50.8 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 175.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 52.22 56.4 7.79 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.908 1.683 . . . . 0.0 112.566 -170.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.47 36.81 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 127.082 2.153 . . . . 0.0 110.974 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.8 m -71.74 -22.29 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.654 1.182 . . . . 0.0 113.479 -176.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.2 m -70.78 145.56 50.32 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.363 1.065 . . . . 0.0 110.513 166.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 20.3 pt -137.26 145.48 50.04 Favored Pre-proline 0 N--CA 1.474 0.774 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -169.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.38 148.73 74.48 Favored 'Cis proline' 0 C--N 1.351 0.707 0 CA-C-N 118.678 0.564 . . . . 0.0 111.552 -12.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.1 m -131.86 124.04 28.74 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.413 0.685 . . . . 0.0 110.015 167.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.8 mp -99.39 132.49 44.68 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.512 1.525 . . . . 0.0 108.638 174.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.6 mm -115.67 132.42 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.873 1.269 . . . . 0.0 108.767 168.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.0 tp -96.26 125.32 40.7 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.276 0.23 . . . . 0.0 110.625 163.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -102.62 139.34 38.34 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.161 1.384 . . . . 0.0 108.966 163.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -99.75 -35.79 9.68 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -152.57 58.28 0.81 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.675 1.99 . . . . 0.0 109.393 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.69 16.41 58.93 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 124.93 1.252 . . . . 0.0 114.893 -172.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -134.7 133.71 21.5 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 126.522 1.929 . . . . 0.0 110.308 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.42 140.89 34.12 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.471 2.781 . . . . 0.0 112.02 -172.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.3 m -129.81 -23.67 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.079 1.352 . . . . 0.0 114.496 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -148.08 145.8 28.57 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.234 1.014 . . . . 0.0 111.789 175.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -123.72 135.1 53.66 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.388 1.875 . . . . 0.0 110.575 169.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.9 mt -131.68 129.51 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.621 1.569 . . . . 0.0 109.108 176.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.7 m -127.27 144.61 36.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 123.939 0.896 . . . . 0.0 112.3 -169.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.67 164.66 7.97 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.327 0.965 . . . . 0.0 112.951 -171.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.84 150.41 37.39 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.436 -1.037 . . . . 0.0 113.388 -175.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.6 mmtm -133.71 146.69 51.03 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.142 1.777 . . . . 0.0 110.838 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.62 164.16 34.28 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 162.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -51.27 -36.21 41.05 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.696 1.198 . . . . 0.0 113.894 -178.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.21 -36.58 71.94 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.64 -47.8 24.87 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.085 0.954 . . . . 0.0 111.489 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.6 tp -64.72 -44.04 91.48 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.908 -0.495 . . . . 0.0 110.835 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 23.0 tp -75.59 -25.57 57.13 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-O 115.207 -2.33 . . . . 0.0 113.392 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -65.85 -44.42 85.54 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 125.131 3.605 . . . . 0.0 111.185 166.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -66.11 -25.49 67.02 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.2 mt -103.18 -17.52 15.32 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 175.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.8 t -72.36 -22.2 61.19 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 120.962 -1.086 . . . . 0.0 110.633 166.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -52.56 -21.08 3.45 Favored 'General case' 0 CA--C 1.555 1.17 0 O-C-N 121.114 -0.991 . . . . 0.0 113.455 159.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 89.1 t -107.67 -34.15 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 126.999 2.12 . . . . 0.0 112.137 172.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.7 t -115.42 76.54 5.27 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 127.254 2.222 . . . . 0.0 110.594 177.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.16 -2.59 10.01 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.65 2.9 . . . . 0.0 113.857 -174.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -69.24 -23.78 63.91 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.4 mt 59.59 -50.8 0.07 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 128.817 2.847 . . . . 0.0 115.71 -173.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.175 0 C-N-CA 124.702 1.201 . . . . 0.0 110.653 164.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mmt . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 119.236 -0.412 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.9 p -69.46 -35.95 76.13 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.849 0.86 . . . . 0.0 112.121 174.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -101.3 151.44 21.88 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.025 1.73 . . . . 0.0 110.653 162.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.0 t -149.87 155.27 39.75 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.539 1.136 . . . . 0.0 112.04 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -91.7 10.69 27.25 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.28 1.432 . . . . 0.0 114.152 -171.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -63.52 140.75 58.9 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.82 1.248 . . . . 0.0 112.851 -175.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.5 p -89.72 161.97 15.8 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.859 1.663 . . . . 0.0 113.444 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -125.94 108.17 11.16 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.366 1.067 . . . . 0.0 113.012 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.9 p -143.73 162.29 36.37 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 126.262 1.825 . . . . 0.0 111.415 170.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.9 pt -129.19 155.12 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 125.827 1.651 . . . . 0.0 112.29 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -93.07 140.05 29.9 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.092 0.957 . . . . 0.0 111.497 173.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.4 150.34 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 125.08 1.352 . . . . 0.0 111.217 170.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 65.2 p -143.45 159.93 41.49 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.415 1.886 . . . . 0.0 110.338 178.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -51.45 -31.7 24.2 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.055 1.342 . . . . 0.0 114.55 -174.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.85 -21.44 66.8 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.9 m -131.69 -1.3 3.83 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.655 1.582 . . . . 0.0 113.711 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -59.51 -42.02 91.26 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.853 1.261 . . . . 0.0 112.514 -170.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.63 -32.4 72.23 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.8 m -79.18 -29.81 43.12 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.699 1.2 . . . . 0.0 112.578 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -94.71 -53.69 3.77 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.641 0.776 . . . . 0.0 112.803 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.3 -60.2 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.82 1.248 . . . . 0.0 110.732 -175.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.6 mt -75.43 -15.97 60.39 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -169.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.8 t -70.23 -22.91 62.86 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.566 1.146 . . . . 0.0 112.537 172.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.2 t -79.39 133.22 36.57 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -170.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -81.21 -23.84 37.84 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.584 1.154 . . . . 0.0 111.929 168.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -74.59 147.03 84.3 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 125.288 1.435 . . . . 0.0 110.044 176.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.88 132.43 51.63 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.196 1.931 . . . . 0.0 111.777 172.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.25 123.31 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.801 0.81 . . . . 0.0 110.798 -174.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 tt -101.93 132.07 47.95 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.581 1.952 . . . . 0.0 108.182 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 t -123.11 127.25 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.109 0.964 . . . . 0.0 110.6 174.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -100.24 118.84 37.37 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.487 1.515 . . . . 0.0 111.752 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.426 ' CD2' HD12 ' A' ' 63' ' ' LEU . 21.1 m-85 -99.66 109.26 21.75 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.156 2.182 . . . . 0.0 108.286 176.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.2 p-90 -142.61 178.46 7.6 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.954 1.302 . . . . 0.0 111.96 -164.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.53 140.03 30.06 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 121.521 -0.737 . . . . 0.0 112.971 167.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.7 t -64.98 -18.58 65.39 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 173.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -88.89 0.13 56.86 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 174.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.1 t -111.5 123.23 49.79 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.41 1.084 . . . . 0.0 112.893 -173.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.55 -49.44 73.57 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-O 118.868 -0.962 . . . . 0.0 114.348 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -58.16 -32.02 94.71 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.911 2.407 . . . . 0.0 114.04 171.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 97.4 m -65.1 -46.46 80.99 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.066 -1.022 . . . . 0.0 111.558 170.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -60.47 -29.95 69.37 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.766 0.712 . . . . 0.0 112.72 173.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.5 ttt -72.49 -44.23 62.55 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.556 1.142 . . . . 0.0 112.853 177.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.9 p -88.62 -24.67 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -176.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.23 -48.57 73.63 Favored Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.18 -29.01 47.81 Favored 'Trans proline' 0 C--N 1.352 0.73 0 CA-C-N 122.14 1.8 . . . . 0.0 113.324 176.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.5 t -70.11 -49.42 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 119.375 0.989 . . . . 0.0 110.565 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.1 pp -72.07 -26.85 62.33 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -72.52 -35.14 68.01 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.203 0.911 . . . . 0.0 112.931 171.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -61.76 -46.91 87.55 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 120.771 -1.206 . . . . 0.0 111.075 165.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 70.0 mt -58.23 -41.45 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 119.139 0.881 . . . . 0.0 110.942 174.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.47 -44.62 92.97 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.116 0.966 . . . . 0.0 113.506 175.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.4 m -76.65 -41.15 46.77 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.81 0.844 . . . . 0.0 111.718 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -86.04 -21.75 27.58 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -174.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -114.75 27.61 9.31 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.021 1.728 . . . . 0.0 113.273 176.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.84 -27.52 30.22 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.4 m -73.28 -37.0 66.41 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.584 1.154 . . . . 0.0 112.75 174.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -94.19 -29.61 15.03 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.724 1.21 . . . . 0.0 113.339 -174.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.1 mt -129.56 149.34 51.36 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.953 2.101 . . . . 0.0 110.6 -177.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.2 m -103.24 138.14 40.44 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 150.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.8 t -127.89 126.95 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.808 0.731 . . . . 0.0 111.381 -173.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.71 165.75 18.67 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.853 1.661 . . . . 0.0 113.145 -172.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -129.73 141.27 50.91 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.617 1.967 . . . . 0.0 112.455 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.426 HD12 ' CD2' ' A' ' 32' ' ' PHE . 2.7 tm? -133.65 113.69 12.66 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.113 2.165 . . . . 0.0 108.595 169.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -81.51 120.61 25.25 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 169.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.7 m -65.85 -16.32 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -169.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -83.16 -20.16 35.24 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 119.294 0.952 . . . . 0.0 113.334 171.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 43.1 p -92.03 -28.82 16.94 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -169.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -148.76 76.21 9.83 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 123.579 0.752 . . . . 0.0 110.602 166.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.97 -27.38 78.92 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 124.027 3.151 . . . . 0.0 115.47 -169.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -62.36 -26.0 68.21 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.761 0.824 . . . . 0.0 112.924 176.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -64.23 -46.91 81.77 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.998 0.817 . . . . 0.0 110.653 175.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.53 -37.0 86.05 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.667 0.787 . . . . 0.0 112.19 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -70.78 -45.96 63.74 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.455 0.702 . . . . 0.0 112.603 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -69.82 -27.02 64.52 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -174.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -99.75 10.14 41.85 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.673 1.189 . . . . 0.0 113.563 172.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 62.68 -8.51 0.12 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 128.542 2.737 . . . . 0.0 116.225 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.9 m -79.61 56.52 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 126.536 1.934 . . . . 0.0 112.889 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.7 m -76.22 -21.46 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.925 1.29 . . . . 0.0 113.539 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 51.1 m -67.85 150.29 48.77 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.448 1.099 . . . . 0.0 111.26 170.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.3 pt -139.69 145.8 44.79 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -174.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.58 146.11 64.81 Favored 'Cis proline' 0 CA--C 1.538 0.685 0 O-C-N 122.034 0.492 . . . . 0.0 111.44 -17.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 83.4 m -135.18 126.32 28.0 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.88 0.872 . . . . 0.0 110.872 171.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.8 134.2 39.03 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.535 1.134 . . . . 0.0 108.007 167.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.6 tt -117.36 143.97 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.485 1.114 . . . . 0.0 108.891 165.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.7 tt -123.71 134.66 53.66 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.663 0.785 . . . . 0.0 110.361 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -114.24 147.36 39.11 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.835 1.654 . . . . 0.0 111.344 173.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -126.49 135.09 50.9 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.6 1.16 . . . . 0.0 109.528 161.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.0 t0 47.0 41.8 11.55 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.639 1.176 . . . . 0.0 113.411 -174.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.38 14.06 63.72 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.138 1.352 . . . . 0.0 115.884 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -118.35 140.81 28.64 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 125.715 1.606 . . . . 0.0 109.88 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.81 140.36 42.31 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.798 2.332 . . . . 0.0 112.308 -174.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.2 t -125.94 -39.26 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.983 1.713 . . . . 0.0 112.185 -173.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -145.11 145.34 31.37 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.756 0.823 . . . . 0.0 111.89 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -129.26 132.31 47.17 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.072 1.749 . . . . 0.0 109.814 161.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.3 mt -135.55 129.53 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.618 1.567 . . . . 0.0 108.994 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.0 m -127.63 145.48 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 123.744 0.818 . . . . 0.0 112.568 -170.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.24 166.63 26.52 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.22 0.914 . . . . 0.0 113.506 -174.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.35 132.77 35.22 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.729 -0.865 . . . . 0.0 112.489 -176.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -133.83 156.53 47.87 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.912 1.685 . . . . 0.0 111.144 172.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -79.18 167.91 52.76 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 123.873 0.749 . . . . 0.0 112.169 173.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -47.91 -38.18 15.86 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.854 1.662 . . . . 0.0 114.673 -176.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.26 -49.57 54.93 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.78 0.324 . . . . 0.0 111.759 -177.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.42 -39.31 59.09 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.731 -0.606 . . . . 0.0 112.516 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.9 tp -68.07 -42.03 81.05 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.921 0.782 . . . . 0.0 111.052 176.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 23.6 tp -70.24 -24.68 63.12 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-O 115.513 -2.184 . . . . 0.0 112.315 171.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 44.6 mmt-85 -64.31 -49.51 71.49 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 124.51 3.323 . . . . 0.0 112.219 167.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.37 -31.22 65.56 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.464 0.706 . . . . 0.0 112.839 176.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 53.3 mt -97.26 -22.56 16.62 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 52.3 p -73.96 -20.2 60.43 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.893 1.277 . . . . 0.0 111.114 174.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -52.91 -27.83 20.52 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 160.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 93.3 t -100.86 -32.71 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 126.66 1.984 . . . . 0.0 112.008 171.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 28.5 t -110.1 79.77 1.65 Allowed Pre-proline 0 N--CA 1.477 0.903 0 C-N-CA 126.913 2.085 . . . . 0.0 110.942 -176.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.66 -16.7 54.59 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.784 2.323 . . . . 0.0 112.946 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -65.7 -18.3 65.23 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.821 1.648 . . . . 0.0 113.708 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.2 tp -137.54 42.15 2.35 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.61 1.164 . . . . 0.0 111.273 172.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.124 0 C-N-CA 124.73 1.212 . . . . 0.0 111.831 175.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.4 p -75.82 159.92 30.51 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.731 1.212 . . . . 0.0 112.618 175.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -143.7 150.86 39.29 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.279 1.432 . . . . 0.0 111.767 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.5 m -79.34 -1.36 36.56 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -176.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 58.56 32.21 21.89 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.22 1.808 . . . . 0.0 113.867 -177.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.5 163.06 28.64 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.079 1.352 . . . . 0.0 113.558 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.7 m -61.28 134.66 57.21 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.935 1.294 . . . . 0.0 112.139 176.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.49 57.85 3.45 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.665 -0.647 . . . . 0.0 112.053 176.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.3 p -102.65 138.36 39.65 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.371 1.468 . . . . 0.0 113.128 -174.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.2 pt -138.25 172.53 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 126.545 1.938 . . . . 0.0 111.381 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -125.48 142.91 51.25 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.106 0.962 . . . . 0.0 111.209 169.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -139.36 150.23 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.375 1.47 . . . . 0.0 111.0 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.7 p -139.51 161.48 37.38 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.15 1.38 . . . . 0.0 111.672 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -51.15 -30.38 16.41 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.936 2.095 . . . . 0.0 114.718 -176.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.0 -20.19 66.11 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 178.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.6 m -137.96 9.85 2.82 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.456 1.502 . . . . 0.0 113.411 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -63.13 -44.74 94.72 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.178 -0.951 . . . . 0.0 112.486 -168.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.26 -32.81 74.45 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.682 -0.636 . . . . 0.0 112.504 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.5 -9.46 59.62 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.84 1.656 . . . . 0.0 114.16 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -124.17 -50.86 1.78 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.18 0.992 . . . . 0.0 113.241 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.1 t -81.72 -52.97 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.356 1.062 . . . . 0.0 110.799 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 28.9 mt -81.33 -13.35 58.48 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -175.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.0 p -77.68 -21.61 51.79 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.805 1.242 . . . . 0.0 113.192 173.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.9 m -75.49 126.7 31.53 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.188 1.395 . . . . 0.0 112.544 -173.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -76.95 -25.14 52.5 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.319 0.647 . . . . 0.0 111.85 169.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -74.99 145.23 80.75 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 125.853 1.661 . . . . 0.0 110.255 173.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.33 137.28 77.56 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.156 1.904 . . . . 0.0 112.14 172.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.5 p -136.53 130.35 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.6 1.16 . . . . 0.0 110.526 -176.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 tt -112.47 116.84 30.91 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.021 1.728 . . . . 0.0 108.228 -174.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.65 124.94 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.445 0.698 . . . . 0.0 110.501 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -107.47 116.39 31.86 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.585 1.554 . . . . 0.0 111.481 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -93.4 108.85 20.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.466 1.906 . . . . 0.0 108.351 177.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -142.26 173.13 11.81 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.851 1.261 . . . . 0.0 112.347 -163.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.74 145.16 29.86 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.54 -0.725 . . . . 0.0 112.275 158.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -65.43 -19.53 65.98 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.8 p-90 -78.51 -13.62 59.75 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 175.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.8 t -98.16 129.84 44.93 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.143 0.977 . . . . 0.0 111.572 -174.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.13 -55.91 27.6 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.298 0.951 . . . . 0.0 113.721 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -57.65 -31.73 92.65 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.439 2.759 . . . . 0.0 114.531 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 96.3 m -67.64 -45.33 75.62 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.137 -0.977 . . . . 0.0 111.44 173.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.1 tppt? -61.37 -33.57 73.87 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.475 1.11 . . . . 0.0 111.819 172.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 50.8 ttm -70.01 -42.72 72.65 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.031 1.332 . . . . 0.0 112.942 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.2 p -81.34 -24.49 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.96 -49.97 77.5 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.9 -27.27 37.15 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.174 1.916 . . . . 0.0 113.125 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.9 t -72.47 -41.35 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.714 0.805 . . . . 0.0 110.525 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.3 mt -67.19 -35.9 80.63 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.111 0.964 . . . . 0.0 112.613 170.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -66.12 -40.58 90.81 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.223 0.92 . . . . 0.0 111.468 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -58.26 -49.54 76.75 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.743 168.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 tp -66.82 -33.28 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 120.34 1.427 . . . . 0.0 112.652 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.79 -40.0 93.66 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.212 -0.93 . . . . 0.0 111.954 172.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.3 m -76.07 -49.0 18.66 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.723 0.809 . . . . 0.0 112.092 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -85.57 -21.61 28.45 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -170.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -116.92 31.52 6.7 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.357 1.863 . . . . 0.0 112.657 173.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.75 -28.18 14.42 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 176.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.5 p -81.61 -29.44 33.27 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.68 1.592 . . . . 0.0 114.292 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -102.16 -27.06 13.11 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.734 1.214 . . . . 0.0 113.742 -175.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 81.5 mt -129.67 148.71 51.58 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.357 1.863 . . . . 0.0 110.196 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.5 m -109.02 131.61 54.91 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 153.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 83.1 t -106.35 130.19 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.494 0.718 . . . . 0.0 109.858 -175.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.35 146.86 50.31 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.897 1.279 . . . . 0.0 112.419 -171.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -120.16 136.39 54.64 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.333 1.453 . . . . 0.0 111.986 -176.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -130.65 116.81 18.59 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.598 1.559 . . . . 0.0 109.744 171.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.77 105.72 13.13 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.261 1.024 . . . . 0.0 110.594 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.5 m -65.14 -20.42 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -73.76 -27.83 61.37 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.322 1.449 . . . . 0.0 113.271 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.7 p -112.73 -22.02 10.92 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.38 1.072 . . . . 0.0 113.59 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -133.27 92.71 24.01 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.256 1.023 . . . . 0.0 111.577 168.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -71.26 -19.61 29.09 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.238 2.625 . . . . 0.0 113.844 172.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -67.61 -42.38 82.5 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.142 -0.973 . . . . 0.0 112.126 -171.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.6 m -67.15 -35.02 78.81 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.85 0.86 . . . . 0.0 111.248 176.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.26 -45.6 80.0 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.227 0.611 . . . . 0.0 111.955 174.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.0 ttm105 -72.57 -41.59 65.53 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -174.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -62.1 -38.33 88.45 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -96.89 7.53 46.41 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.364 1.066 . . . . 0.0 113.122 176.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.318 14.8 pt20 44.02 34.45 0.95 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.95 2.1 . . . . 0.0 114.415 -169.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.8 m -85.56 43.85 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 126.654 1.982 . . . . 0.0 110.406 175.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.4 m -85.23 -14.2 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.698 1.599 . . . . 0.0 113.993 -168.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.0 t -71.55 155.31 40.7 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.559 0.743 . . . . 0.0 111.038 170.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 14.4 pt -129.49 121.49 20.32 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -167.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -67.24 161.8 76.76 Favored 'Cis proline' 0 CA--C 1.54 0.8 0 CA-C-N 118.831 0.618 . . . . 0.0 111.709 -16.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.1 m -127.16 134.39 50.18 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.5 1.12 . . . . 0.0 108.713 161.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.4 mp -113.42 131.93 55.82 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.856 1.262 . . . . 0.0 108.709 174.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.5 tp -116.1 146.3 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.868 1.267 . . . . 0.0 109.307 167.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.4 tt -123.92 132.85 53.8 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.681 -0.637 . . . . 0.0 110.451 165.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -111.95 143.77 42.38 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.223 1.409 . . . . 0.0 110.368 170.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -126.94 125.48 41.62 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.391 1.476 . . . . 0.0 109.17 171.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.8 t70 50.41 34.34 9.04 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 124.41 1.084 . . . . 0.0 113.526 -168.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.12 8.48 61.76 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 125.781 1.658 . . . . 0.0 116.171 -175.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -102.34 141.3 22.25 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 119.364 1.582 . . . . 0.0 110.488 172.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -70.08 140.38 41.32 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.83 2.353 . . . . 0.0 112.592 -176.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 75.3 t -127.72 -36.49 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 125.854 1.662 . . . . 0.0 112.709 -175.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -142.14 139.14 32.04 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.687 1.195 . . . . 0.0 111.115 -177.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 24.5 ttt85 -141.4 115.83 9.51 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.62 1.968 . . . . 0.0 110.194 171.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.27 150.73 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.223 1.409 . . . . 0.0 112.8 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.8 m -124.08 155.65 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.474 1.51 . . . . 0.0 111.911 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.25 163.11 11.27 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.257 0.932 . . . . 0.0 112.983 -174.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.5 156.07 30.84 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.191 -1.182 . . . . 0.0 113.706 -176.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.81 147.58 52.49 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.587 1.555 . . . . 0.0 110.049 165.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.69 167.22 44.14 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 162.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.4 tmtp? -52.75 -34.29 52.26 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.769 1.228 . . . . 0.0 113.618 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.59 -53.97 34.31 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.91 0.484 . . . . 0.0 111.754 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.1 -36.27 66.76 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.465 -0.772 . . . . 0.0 112.601 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.1 tp -63.44 -40.23 96.61 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.644 -0.66 . . . . 0.0 110.179 172.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 26.5 tp -72.74 -23.76 60.88 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-O 117.041 -1.457 . . . . 0.0 113.298 173.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -58.52 -55.61 32.79 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 122.951 2.614 . . . . 0.0 109.988 164.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -69.56 -26.57 64.55 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -174.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 88.9 mt -97.06 -28.76 14.0 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 176.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.9 t -69.58 -24.37 63.68 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 120.584 1.538 . . . . 0.0 111.194 170.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.63 -22.7 47.02 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 164.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.5 t -100.53 -28.28 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 127.056 2.142 . . . . 0.0 111.805 171.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 32.9 t -126.62 84.77 61.88 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 127.389 2.276 . . . . 0.0 111.13 -170.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -63.08 -9.81 18.4 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.452 2.768 . . . . 0.0 114.868 176.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -64.94 -15.66 62.4 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -177.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 93.3 mt -114.79 14.4 17.41 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.176 1.391 . . . . 0.0 113.59 174.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.208 0 C-N-CA 125.108 1.363 . . . . 0.0 112.005 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.3 tpp . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 39.2 p -78.31 144.37 36.13 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.294 1.038 . . . . 0.0 112.558 179.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -79.89 86.04 5.46 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.593 1.157 . . . . 0.0 111.088 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.5 t -152.86 -179.2 7.43 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.686 1.594 . . . . 0.0 111.191 -177.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -74.14 102.72 4.34 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.511 1.524 . . . . 0.0 110.787 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.411 ' HE2' ' HA ' ' A' ' 6' ' ' LYS . 8.1 mmpt? -78.72 -11.79 59.99 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -172.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.7 t -127.36 155.73 43.13 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.379 1.472 . . . . 0.0 113.172 -174.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -105.8 14.4 28.24 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.724 1.61 . . . . 0.0 113.351 172.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.6 p -83.24 157.36 22.71 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 121.165 -0.959 . . . . 0.0 113.38 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.1 pt -115.85 155.11 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.642 1.577 . . . . 0.0 111.551 171.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -108.8 136.4 48.43 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.517 1.127 . . . . 0.0 110.479 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.9 m -132.14 154.25 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.664 1.186 . . . . 0.0 112.857 -172.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 66.5 p -142.22 161.3 38.36 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.289 1.835 . . . . 0.0 110.854 175.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -57.17 -28.57 62.9 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -172.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.33 -17.3 62.45 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.553 1.141 . . . . 0.0 114.074 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.1 m -136.06 3.2 2.89 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.302 1.441 . . . . 0.0 113.552 -175.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -56.09 -40.57 73.86 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.119 1.367 . . . . 0.0 112.533 -174.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.03 -34.6 78.46 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.317 -0.864 . . . . 0.0 113.044 177.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.8 m -79.51 -29.6 41.62 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.511 1.124 . . . . 0.0 112.846 177.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -94.63 -39.46 10.33 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.1 t -97.23 -64.85 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.186 1.394 . . . . 0.0 109.859 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.9 mt -73.82 -14.62 61.13 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -165.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.0 m -85.08 -3.67 58.88 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.659 1.184 . . . . 0.0 113.997 176.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.1 m -60.65 142.09 56.04 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.925 1.29 . . . . 0.0 113.565 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.8 p-10 -82.93 -3.99 57.68 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.797 1.239 . . . . 0.0 114.2 176.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -141.13 163.33 42.81 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 127.833 2.453 . . . . 0.0 110.558 176.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -53.45 147.08 39.12 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.231 2.621 . . . . 0.0 112.836 177.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.39 133.39 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.633 1.173 . . . . 0.0 111.711 -174.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.02 117.05 32.73 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.876 2.071 . . . . 0.0 108.422 -176.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.2 t -107.63 127.31 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.693 0.797 . . . . 0.0 110.396 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -104.53 117.08 33.26 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.0 1.32 . . . . 0.0 111.173 175.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -91.8 107.22 19.06 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.272 1.829 . . . . 0.0 107.964 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.466 ' CD1' ' HE3' ' A' ' 62' ' ' LYS . 2.1 p-90 -143.93 164.47 30.48 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -159.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.47 151.92 36.01 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.865 0.866 . . . . 0.0 111.359 162.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.3 t -66.19 -20.99 66.3 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 12.6 p-90 -75.39 -8.64 57.23 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 173.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 43.1 t -100.34 116.46 32.38 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.406 1.082 . . . . 0.0 110.914 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.62 -44.3 98.13 Favored Glycine 0 CA--C 1.54 1.642 0 CA-C-O 118.801 -1.0 . . . . 0.0 114.022 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -56.88 -39.51 90.89 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.863 2.376 . . . . 0.0 113.941 169.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 87.1 m -61.57 -43.34 99.03 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.989 -1.069 . . . . 0.0 111.503 171.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -62.97 -29.74 71.05 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.379 1.072 . . . . 0.0 112.512 176.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -74.96 -45.71 40.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.229 1.412 . . . . 0.0 112.681 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.1 p -81.37 -24.11 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.78 -50.06 79.82 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -65.91 -28.36 50.42 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 CA-C-N 122.353 1.876 . . . . 0.0 113.177 176.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.6 t -70.02 -45.98 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.479 -0.763 . . . . 0.0 110.154 175.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.8 mt -62.35 -34.26 76.33 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.258 1.023 . . . . 0.0 112.672 172.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -66.3 -41.33 89.89 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.987 0.915 . . . . 0.0 111.758 175.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -63.75 -44.86 92.23 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.382 -0.824 . . . . 0.0 111.648 170.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.3 mm -59.01 -43.37 88.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 119.248 0.931 . . . . 0.0 110.956 174.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.45 -42.66 92.45 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.836 0.854 . . . . 0.0 112.016 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.2 m -74.61 -42.61 58.31 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.979 0.912 . . . . 0.0 112.062 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -95.42 -22.07 17.94 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -169.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -112.26 17.97 19.0 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.654 1.581 . . . . 0.0 112.633 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.85 -28.46 50.01 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.981 1.313 . . . . 0.0 114.455 -176.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.9 p -69.21 -22.75 63.86 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.931 1.692 . . . . 0.0 114.1 174.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -117.83 -29.52 5.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.883 1.673 . . . . 0.0 112.98 -171.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.0 mt -130.16 149.34 51.91 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.69 1.996 . . . . 0.0 111.125 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.2 m -99.79 139.03 36.05 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 151.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 52.2 t -117.0 129.23 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 119.397 0.999 . . . . 0.0 110.3 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.32 157.73 41.74 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.698 1.599 . . . . 0.0 112.697 -170.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.466 ' HE3' ' CD1' ' A' ' 33' ' ' TRP . 30.8 mmmt -126.77 124.3 39.39 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.179 1.792 . . . . 0.0 110.422 -175.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -109.95 114.03 27.24 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.642 1.177 . . . . 0.0 108.908 169.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.72 99.4 9.61 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.613 1.165 . . . . 0.0 109.369 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.9 m -66.7 -17.06 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 O-C-N 120.856 -1.152 . . . . 0.0 113.156 -176.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -74.23 -24.84 59.37 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.339 1.056 . . . . 0.0 113.206 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.2 p -119.25 -25.51 6.11 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -133.31 74.16 72.69 Favored Pre-proline 0 CA--C 1.55 0.977 0 CA-C-N 119.598 1.09 . . . . 0.0 112.141 171.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -67.46 -11.57 32.62 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 122.846 2.364 . . . . 0.0 112.675 168.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -57.24 -41.73 80.13 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.834 1.253 . . . . 0.0 112.223 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.2 m -66.02 -42.71 89.27 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.742 0.701 . . . . 0.0 111.046 174.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.75 -37.98 86.29 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.516 -0.74 . . . . 0.0 112.994 -178.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -78.74 -38.6 38.4 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 173.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -69.09 -36.67 77.85 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.245 0.93 . . . . 0.0 112.607 -178.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -93.3 9.15 37.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.819 1.248 . . . . 0.0 112.482 174.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 61.16 -10.29 0.06 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 128.737 2.815 . . . . 0.0 116.87 177.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.3 m -76.73 52.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 126.317 1.847 . . . . 0.0 113.449 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.8 p -75.9 -20.97 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.428 1.491 . . . . 0.0 113.067 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.5 p -70.9 129.33 38.77 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.188 0.995 . . . . 0.0 110.821 165.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.4 pt -138.5 149.62 63.4 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 125.068 1.347 . . . . 0.0 112.809 -163.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -66.51 149.4 79.18 Favored 'Cis proline' 0 C--N 1.354 0.829 0 CA-C-N 119.373 0.812 . . . . 0.0 113.246 -2.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.1 m -128.67 130.28 46.98 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.271 1.028 . . . . 0.0 110.895 169.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.3 mp -103.49 119.32 38.66 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.828 1.651 . . . . 0.0 107.227 161.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.3 tp -120.39 126.48 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.701 1.201 . . . . 0.0 109.713 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.9 tp -110.24 121.04 44.34 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.153 1.381 . . . . 0.0 110.464 -172.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -106.8 131.13 54.26 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.864 1.665 . . . . 0.0 109.172 175.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -99.72 -29.74 12.48 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -175.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -154.45 56.93 0.7 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.786 1.634 . . . . 0.0 110.785 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.73 17.82 65.37 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.315 0.959 . . . . 0.0 114.554 -175.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -141.91 138.41 16.97 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 126.83 2.052 . . . . 0.0 110.139 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.86 142.69 35.62 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.254 2.636 . . . . 0.0 111.96 -174.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.8 t -129.6 -40.06 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.497 1.119 . . . . 0.0 112.939 -176.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -142.3 133.14 25.65 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.081 0.855 . . . . 0.0 111.791 -173.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -117.83 134.01 55.36 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.284 1.434 . . . . 0.0 110.841 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.11 144.12 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 126.422 1.889 . . . . 0.0 108.713 169.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.8 m -133.67 144.84 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 124.834 1.254 . . . . 0.0 111.001 -174.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.08 -162.84 46.73 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 122.869 0.271 . . . . 0.0 112.624 -167.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.8 139.68 51.96 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.89 1.276 . . . . 0.0 112.28 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -135.23 154.35 51.61 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.611 1.565 . . . . 0.0 112.129 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -80.73 171.12 53.76 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.415 1.007 . . . . 0.0 112.455 173.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -51.84 -37.42 51.86 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.437 1.495 . . . . 0.0 114.628 -175.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.9 -53.43 32.22 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 123.407 0.442 . . . . 0.0 110.924 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.39 -38.76 68.37 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 36.9 tp -63.76 -42.57 97.8 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 119.399 0.999 . . . . 0.0 111.043 173.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.7 tp -70.18 -25.03 63.24 Favored 'General case' 0 C--O 1.214 -0.786 0 CA-C-O 115.857 -2.021 . . . . 0.0 113.014 174.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -64.49 -49.96 69.3 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 124.258 3.208 . . . . 0.0 111.962 166.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.49 -28.63 68.51 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.499 0.72 . . . . 0.0 112.882 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 89.8 mt -91.52 -28.21 17.73 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.396 1.078 . . . . 0.0 113.303 172.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.3 m -60.18 -28.79 68.24 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.82 1.248 . . . . 0.0 110.669 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -52.69 -20.47 3.14 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 168.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.9 t -118.59 -27.32 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 127.407 2.283 . . . . 0.0 112.633 173.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.6 t -106.6 96.11 13.43 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 127.092 2.157 . . . . 0.0 110.939 -174.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -70.97 -9.89 26.55 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.707 2.271 . . . . 0.0 113.178 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -70.73 5.74 1.78 Allowed 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.561 1.544 . . . . 0.0 114.619 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.3 tt -63.54 -31.54 72.74 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 120.431 -1.418 . . . . 0.0 111.612 161.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.254 1.299 0 C-N-CA 125.814 1.645 . . . . 0.0 111.842 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.485 1.278 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.0 t -135.99 149.39 48.83 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.033 1.333 . . . . 0.0 111.608 173.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -99.55 -8.34 24.68 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.029 1.331 . . . . 0.0 113.42 169.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 72.7 m -81.83 -24.82 35.62 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.35 1.06 . . . . 0.0 113.548 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 61.55 -32.96 0.09 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 129.217 3.007 . . . . 0.0 119.047 168.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -95.17 108.74 20.88 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.204 1.402 . . . . 0.0 112.132 -168.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.9 m -70.98 133.05 46.06 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.453 1.501 . . . . 0.0 112.939 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.51 71.67 3.69 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.799 0.84 . . . . 0.0 110.682 167.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.5 p -108.62 150.57 27.34 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.046 1.338 . . . . 0.0 113.883 -175.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.4 pt -132.62 157.24 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 126.112 1.765 . . . . 0.0 111.353 169.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -112.06 140.38 46.79 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.636 1.174 . . . . 0.0 110.597 171.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.9 m -132.11 155.46 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.701 1.2 . . . . 0.0 112.509 -175.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.7 p -142.11 160.81 39.49 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.466 1.907 . . . . 0.0 110.577 176.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -57.95 -27.64 63.59 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -173.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.36 -19.56 63.03 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.0 m -132.77 -2.85 3.29 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.181 1.392 . . . . 0.0 114.17 -174.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -55.26 -40.39 70.91 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.257 1.423 . . . . 0.0 112.642 -174.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.38 -33.6 75.53 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.972 0.731 . . . . 0.0 112.972 177.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.7 m -79.51 -29.69 41.63 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.725 1.21 . . . . 0.0 112.873 176.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -92.64 -45.04 8.27 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -176.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.11 -59.05 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.916 1.286 . . . . 0.0 110.636 -176.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.4 mt -75.66 -18.72 59.56 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -169.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.8 m -79.38 -10.84 59.89 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.3 t -81.64 130.05 34.92 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.788 0.835 . . . . 0.0 112.469 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -81.6 -21.12 38.55 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.242 1.017 . . . . 0.0 112.341 170.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -75.36 147.74 82.79 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.354 1.462 . . . . 0.0 110.062 174.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -58.03 133.23 54.32 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.103 1.869 . . . . 0.0 111.396 171.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.88 132.51 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.225 1.01 . . . . 0.0 110.18 -174.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -122.73 113.84 19.74 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.171 1.389 . . . . 0.0 109.7 -170.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.61 125.19 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.888 1.275 . . . . 0.0 110.224 -173.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -103.88 120.78 41.71 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.267 1.027 . . . . 0.0 112.009 174.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -93.09 113.37 25.61 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.987 2.115 . . . . 0.0 108.076 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 6.8 p-90 -144.83 172.5 12.93 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.439 1.096 . . . . 0.0 113.235 -165.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -145.77 152.83 40.19 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.916 0.886 . . . . 0.0 112.419 167.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.9 p -63.71 -27.29 69.1 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.622 1.169 . . . . 0.0 113.119 174.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.501 ' CZ3' HD11 ' A' ' 80' ' ' ILE . 10.7 p-90 -79.0 -3.69 46.29 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 48.5 t -107.5 123.74 48.87 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.865 0.866 . . . . 0.0 113.271 -170.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.31 -58.4 14.79 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.205 1.384 . . . . 0.0 114.02 178.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.7 -27.09 68.47 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 CA-C-N 120.482 2.141 . . . . 0.0 113.534 177.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 85.3 m -61.91 -46.68 88.33 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.116 1.326 . . . . 0.0 111.238 168.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.89 -33.18 72.71 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.014 0.926 . . . . 0.0 112.631 175.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.4 mtt -74.77 -37.7 62.38 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.542 1.137 . . . . 0.0 113.83 177.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.4 p -88.13 -20.77 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.47 -49.38 77.98 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 174.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.5 -27.23 46.59 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 CA-C-N 122.303 1.858 . . . . 0.0 113.476 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 95.3 t -71.29 -49.46 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 119.059 0.845 . . . . 0.0 110.322 173.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.9 mt -61.52 -34.32 75.32 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.954 0.902 . . . . 0.0 113.029 176.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -62.61 -39.99 95.54 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.889 0.876 . . . . 0.0 111.504 173.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -71.34 -36.96 71.73 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.154 -0.966 . . . . 0.0 112.655 173.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.6 mm -61.21 -43.8 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 120.542 1.519 . . . . 0.0 110.559 171.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.27 -35.31 79.92 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.891 0.876 . . . . 0.0 112.504 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.4 m -73.46 -49.04 28.89 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.807 0.843 . . . . 0.0 112.012 176.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -92.7 -34.39 13.96 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -165.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -97.72 19.58 13.4 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.142 0.977 . . . . 0.0 113.328 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.37 -28.2 18.65 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.3 m -75.02 -31.68 61.41 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.767 1.227 . . . . 0.0 112.936 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -97.48 -34.89 10.83 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.035 1.334 . . . . 0.0 112.786 -174.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.3 mt -129.83 152.37 49.39 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.671 2.388 . . . . 0.0 110.518 -174.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.5 m -106.34 129.64 54.31 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 153.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.8 t -99.42 133.03 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.148 0.579 . . . . 0.0 110.193 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.2 155.94 44.73 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.359 1.464 . . . . 0.0 112.217 -173.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -127.64 134.54 49.64 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.305 1.442 . . . . 0.0 112.104 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -124.55 116.43 22.45 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.917 1.687 . . . . 0.0 109.08 169.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -81.94 113.03 19.58 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.482 0.713 . . . . 0.0 109.984 174.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.5 m -71.76 -16.56 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -177.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -85.84 -39.03 17.49 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.792 0.837 . . . . 0.0 111.991 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 72.3 p -96.38 -19.98 18.8 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -137.67 77.13 40.07 Favored Pre-proline 0 CA--C 1.552 1.021 0 CA-C-N 120.159 1.345 . . . . 0.0 111.82 163.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -65.56 -18.9 60.29 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.43 2.753 . . . . 0.0 113.871 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -63.61 -37.38 87.12 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.35 -0.844 . . . . 0.0 113.104 -174.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 m -65.06 -43.61 91.71 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.633 1.106 . . . . 0.0 111.256 174.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.7 -36.66 83.65 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.532 0.733 . . . . 0.0 112.08 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -70.1 -46.76 64.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.845 0.858 . . . . 0.0 112.12 173.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -63.05 -37.12 85.92 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.386 1.474 . . . . 0.0 112.617 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -96.48 8.8 43.2 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.497 1.119 . . . . 0.0 112.917 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 59.98 -11.43 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 128.539 2.736 . . . . 0.0 116.588 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.5 m -76.74 59.96 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.579 1.952 . . . . 0.0 112.667 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.0 m -74.84 -19.9 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.989 1.316 . . . . 0.0 113.423 176.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.6 t -79.27 148.09 32.28 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.555 1.142 . . . . 0.0 111.165 170.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.501 HD11 ' CZ3' ' A' ' 36' ' ' TRP . 46.7 pt -143.49 155.64 60.55 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -167.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.74 140.82 59.5 Favored 'Cis proline' 0 C--N 1.353 0.793 0 CA-C-N 119.093 0.712 . . . . 0.0 111.033 -9.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 98.2 m -133.34 120.96 21.68 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.432 0.634 . . . . 0.0 110.65 174.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 mp -96.62 134.93 39.23 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.782 1.633 . . . . 0.0 108.42 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.0 tt -130.57 129.24 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.775 1.23 . . . . 0.0 110.727 171.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.9 tt -103.46 133.69 48.09 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.914 1.286 . . . . 0.0 110.531 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -117.22 148.28 41.77 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.233 1.413 . . . . 0.0 111.228 171.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -124.77 131.03 53.49 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.007 1.323 . . . . 0.0 108.991 164.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.6 t70 49.13 33.27 4.73 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.22 13.36 83.69 Favored Glycine 0 CA--C 1.536 1.371 0 N-CA-C 116.909 1.524 . . . . 0.0 116.909 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -116.25 145.76 35.77 Favored Pre-proline 0 N--CA 1.474 0.743 0 CA-C-N 119.36 1.58 . . . . 0.0 111.588 167.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -72.18 148.71 50.48 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.381 2.721 . . . . 0.0 112.408 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.2 t -131.89 -43.2 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.325 1.45 . . . . 0.0 112.829 -168.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -148.84 146.55 28.02 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.083 1.353 . . . . 0.0 110.968 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 -129.02 144.59 51.24 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.513 1.525 . . . . 0.0 112.067 167.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.5 mt -136.51 136.36 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 126.369 1.868 . . . . 0.0 107.893 175.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 p -133.46 142.89 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 119.664 1.12 . . . . 0.0 111.685 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.16 161.11 30.47 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.017 1.294 . . . . 0.0 113.248 -171.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.85 134.39 39.04 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.792 -0.828 . . . . 0.0 112.57 -177.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -133.07 149.65 52.14 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.936 1.694 . . . . 0.0 109.905 172.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.77 167.01 54.7 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -45.11 -40.06 6.56 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.36 1.464 . . . . 0.0 114.62 -175.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.77 -48.86 57.74 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.037 0.535 . . . . 0.0 111.984 -177.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.57 -36.98 60.24 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.91 0.884 . . . . 0.0 112.712 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.72 -46.53 75.22 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.914 0.886 . . . . 0.0 110.046 175.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -66.12 -30.02 70.44 Favored 'General case' 0 C--O 1.208 -1.124 0 CA-C-O 115.651 -2.118 . . . . 0.0 111.587 171.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 4.5 mmt180 -62.2 -49.11 77.1 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 124.382 3.264 . . . . 0.0 112.849 171.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -59.05 -33.01 70.28 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.323 1.049 . . . . 0.0 112.434 177.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.4 mt -85.62 -22.95 27.74 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 169.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.4 p -67.38 -25.99 66.23 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.807 1.643 . . . . 0.0 110.096 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -49.6 -26.25 3.44 Favored 'General case' 0 CA--C 1.556 1.193 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 164.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.5 t -111.57 -23.52 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 127.337 2.255 . . . . 0.0 112.931 172.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.05 69.19 0.65 Allowed Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 127.858 2.463 . . . . 0.0 109.798 177.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -67.94 -13.38 38.2 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.274 2.65 . . . . 0.0 113.056 -176.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -73.67 -3.23 26.89 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.146 1.378 . . . . 0.0 113.842 170.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 tp 57.55 -154.64 0.35 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.299 1.84 . . . . 0.0 112.985 174.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 36.3 t30 . . . . . 0 C--O 1.253 1.288 0 C-N-CA 125.558 1.543 . . . . 0.0 112.342 -177.765 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ttt . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 119.323 -0.37 . . . . 0.0 110.361 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 66.9 p 43.02 -110.03 0.14 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 126.683 1.993 . . . . 0.0 113.696 173.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -156.16 -40.13 0.08 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.62 1.168 . . . . 0.0 113.183 174.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.6 p -131.4 166.14 21.95 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.683 1.193 . . . . 0.0 113.198 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -69.82 -23.83 63.38 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.455 0.702 . . . . 0.0 112.2 172.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -82.56 -41.32 19.75 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.696 1.199 . . . . 0.0 113.886 -176.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.1 p -121.37 162.62 20.06 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -163.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -101.93 34.48 2.66 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.886 0.875 . . . . 0.0 112.961 166.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.0 p -84.33 160.83 20.61 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.371 -0.83 . . . . 0.0 112.387 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.1 pt -125.02 164.52 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.57 1.548 . . . . 0.0 110.189 164.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -123.5 138.13 54.64 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.902 -1.124 . . . . 0.0 110.816 172.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.87 150.72 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.235 1.414 . . . . 0.0 112.085 -168.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.0 p -139.89 161.94 36.37 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.545 1.538 . . . . 0.0 111.496 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -51.6 -31.48 25.05 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.318 1.447 . . . . 0.0 114.599 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.71 -20.18 65.91 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.8 m -133.64 4.96 3.66 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.477 1.511 . . . . 0.0 113.425 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -59.45 -39.81 84.82 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.685 1.194 . . . . 0.0 112.969 -171.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.91 -32.64 74.04 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.533 -0.729 . . . . 0.0 112.889 175.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.1 m -79.62 -27.49 41.01 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.215 1.406 . . . . 0.0 113.234 177.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -101.34 -34.01 9.79 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -176.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.45 -54.47 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.843 1.257 . . . . 0.0 111.503 -172.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.4 mt -74.9 -12.59 60.4 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -176.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.5 p -71.16 -15.83 62.51 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.261 1.824 . . . . 0.0 113.942 173.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.7 p -66.75 149.05 51.1 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.804 1.642 . . . . 0.0 114.335 -172.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -109.62 -16.83 13.86 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.931 1.292 . . . . 0.0 112.225 160.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -90.53 166.6 18.96 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 125.95 1.7 . . . . 0.0 111.195 171.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.442 ' HB2' HD23 ' A' ' 58' ' ' LEU . 51.0 Cg_exo -59.49 138.68 85.38 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.29 1.994 . . . . 0.0 112.863 167.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.71 124.84 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.571 1.148 . . . . 0.0 111.104 172.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tt -100.3 128.73 46.3 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.796 2.038 . . . . 0.0 108.44 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.1 t -120.03 129.24 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.364 1.065 . . . . 0.0 110.571 173.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -106.8 116.93 32.78 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.061 1.344 . . . . 0.0 111.615 175.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.5 m-30 -88.22 111.69 21.93 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.992 1.717 . . . . 0.0 108.841 171.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 24.6 p-90 -134.23 170.96 14.91 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.236 1.414 . . . . 0.0 112.194 -171.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.86 140.27 24.46 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.83 0.852 . . . . 0.0 110.914 170.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 t -65.47 -12.5 53.13 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -168.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 55.3 p-90 -84.21 -14.02 51.15 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 172.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.2 t -90.7 106.49 18.54 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.1 0.96 . . . . 0.0 112.721 -166.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -52.75 -49.66 52.88 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.351 0.977 . . . . 0.0 114.234 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -60.59 -29.32 88.25 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.559 2.173 . . . . 0.0 114.487 174.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.73 -39.36 70.15 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.255 0.934 . . . . 0.0 111.294 172.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -63.45 -29.81 71.04 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.552 0.741 . . . . 0.0 112.308 172.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.6 mtt -71.02 -42.5 69.48 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.261 1.024 . . . . 0.0 113.11 174.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.6 p -86.09 -21.65 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.51 -49.09 79.92 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 176.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.86 -27.95 43.23 Favored 'Trans proline' 0 C--N 1.353 0.764 0 CA-C-N 122.32 1.864 . . . . 0.0 112.828 176.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.8 t -72.16 -46.04 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 121.601 -0.687 . . . . 0.0 110.371 176.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.4 mt -57.55 -40.53 79.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.422 1.089 . . . . 0.0 112.078 170.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.43 -41.02 85.47 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.179 0.992 . . . . 0.0 112.327 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -62.93 -49.35 75.11 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.299 -0.876 . . . . 0.0 111.692 169.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 17.0 mm -56.61 -42.09 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.44 0.696 . . . . 0.0 110.94 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.06 -49.96 75.58 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.992 0.917 . . . . 0.0 112.117 174.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.6 m -77.34 -32.86 55.44 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.706 0.802 . . . . 0.0 112.247 -170.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -86.14 -38.69 17.47 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.571 1.148 . . . . 0.0 113.916 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -107.52 26.75 9.87 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.542 1.137 . . . . 0.0 113.8 -173.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.75 -27.99 45.17 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.9 p -77.19 -19.88 56.14 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.416 1.487 . . . . 0.0 113.902 175.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -104.68 -35.53 7.77 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.268 1.427 . . . . 0.0 112.718 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.442 HD23 ' HB2' ' A' ' 27' ' ' PRO . 85.9 mt -129.61 149.14 51.5 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.168 2.187 . . . . 0.0 110.231 -176.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.8 m -99.54 138.87 36.02 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 150.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.7 t -125.02 127.9 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.247 0.931 . . . . 0.0 110.583 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -128.07 154.08 46.09 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.013 1.725 . . . . 0.0 112.915 -169.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -125.7 145.01 50.36 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.406 1.482 . . . . 0.0 112.916 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -135.98 118.58 15.96 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.499 1.92 . . . . 0.0 109.95 173.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -83.81 109.96 17.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.225 0.61 . . . . 0.0 110.727 174.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.4 m -70.7 -12.18 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -74.11 -19.33 60.62 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.734 1.152 . . . . 0.0 112.119 166.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.1 p -101.18 -43.76 5.89 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.615 1.166 . . . . 0.0 112.718 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -142.41 65.42 17.75 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 125.226 1.41 . . . . 0.0 111.311 -171.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -63.56 -23.17 70.58 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.617 2.878 . . . . 0.0 113.696 -176.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -57.0 -28.0 62.07 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.48 1.112 . . . . 0.0 112.576 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -66.79 -44.96 79.94 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.102 0.961 . . . . 0.0 112.06 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.55 -31.84 63.86 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.322 1.049 . . . . 0.0 112.651 173.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -71.1 -32.24 68.8 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.617 1.167 . . . . 0.0 113.496 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.6 t-20 -60.25 -41.81 93.97 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.757 1.223 . . . . 0.0 112.068 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -82.72 -8.38 59.59 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.026 0.93 . . . . 0.0 113.195 172.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 55.14 45.63 25.61 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.133 2.173 . . . . 0.0 113.056 -170.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.02 61.78 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.974 1.31 . . . . 0.0 109.507 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.9 p -82.55 -13.9 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -168.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.4 t -64.89 153.22 40.96 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.563 1.145 . . . . 0.0 112.849 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.7 mt -133.0 138.73 32.48 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 123.601 0.76 . . . . 0.0 112.371 -158.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.19 145.39 75.66 Favored 'Cis proline' 0 C--N 1.352 0.745 0 CA-C-N 119.183 0.744 . . . . 0.0 110.764 -16.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.4 m -117.03 122.28 43.75 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.577 0.751 . . . . 0.0 109.59 166.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.3 mp -102.97 120.14 40.09 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 171.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.8 tt -119.65 130.32 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.525 1.13 . . . . 0.0 110.162 176.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.3 tp -108.26 126.51 52.91 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.567 1.147 . . . . 0.0 109.766 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -105.21 152.07 23.3 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.472 1.509 . . . . 0.0 110.022 169.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -134.95 130.98 36.65 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.334 1.454 . . . . 0.0 108.682 166.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.5 t70 50.74 39.04 21.0 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.604 0.762 . . . . 0.0 113.002 -170.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.51 15.46 66.15 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.407 1.48 . . . . 0.0 115.777 -178.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -123.3 140.07 33.08 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 125.606 1.562 . . . . 0.0 110.133 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.32 141.24 46.47 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.95 2.433 . . . . 0.0 113.055 -172.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.8 t -127.94 -38.16 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.972 1.709 . . . . 0.0 112.943 -175.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -141.86 149.33 40.14 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.691 1.196 . . . . 0.0 111.582 175.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -130.69 136.44 48.79 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.028 1.331 . . . . 0.0 110.554 161.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.7 mt -130.1 145.52 35.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 127.089 2.155 . . . . 0.0 108.574 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.5 p -134.03 148.09 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.433 1.093 . . . . 0.0 111.877 171.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.16 164.6 30.39 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.771 1.177 . . . . 0.0 113.286 -176.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.3 146.52 39.22 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -174.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -136.03 145.97 46.62 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.278 1.831 . . . . 0.0 110.084 174.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.81 167.6 38.57 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 123.882 0.753 . . . . 0.0 111.336 166.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -50.82 -38.14 46.99 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.929 1.292 . . . . 0.0 113.742 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.29 -53.76 39.16 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.765 0.426 . . . . 0.0 111.572 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.07 -44.29 69.42 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.594 -0.691 . . . . 0.0 112.479 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.37 -44.64 94.18 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-O 119.076 -0.488 . . . . 0.0 110.254 177.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.1 tp -63.7 -36.64 84.51 Favored 'General case' 0 C--O 1.209 -1.04 0 CA-C-O 114.936 -2.459 . . . . 0.0 111.831 175.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.4 mmm-85 -63.13 -48.41 78.62 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 124.281 3.219 . . . . 0.0 112.599 176.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -57.57 -32.73 67.44 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 176.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 86.5 mt -85.79 -25.17 26.51 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.428 1.091 . . . . 0.0 113.577 171.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.6 p -67.9 -25.12 65.34 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.424 1.889 . . . . 0.0 110.163 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -55.34 -21.99 17.36 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 164.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 66.9 t -112.96 -20.57 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 127.434 2.294 . . . . 0.0 112.441 173.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 17.2 t -109.01 72.4 0.48 Allowed Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 127.729 2.412 . . . . 0.0 109.244 172.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -64.02 -13.39 37.26 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.513 2.809 . . . . 0.0 113.131 -175.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -61.35 -23.96 66.13 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.774 1.23 . . . . 0.0 113.083 174.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 76.6 mt -126.52 26.78 6.26 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.525 1.53 . . . . 0.0 112.6 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 . . . . . 0 C--O 1.252 1.193 0 C-N-CA 125.744 1.618 . . . . 0.0 112.373 -177.44 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 mmt . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.9 p -77.29 -36.11 54.47 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 121.137 -0.977 . . . . 0.0 113.33 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -90.0 -26.93 20.09 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.566 1.147 . . . . 0.0 113.616 -178.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 78.9 p -149.51 153.82 37.81 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.902 1.681 . . . . 0.0 111.748 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 51.36 51.86 15.98 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.758 1.223 . . . . 0.0 112.23 -175.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.77 -4.0 59.05 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -171.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.6 t -68.99 154.54 41.89 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.196 0.999 . . . . 0.0 113.156 -174.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -106.04 18.43 22.08 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.157 1.383 . . . . 0.0 113.367 171.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.3 p -76.58 151.66 36.21 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.056 -1.028 . . . . 0.0 113.478 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.4 pt -130.27 159.83 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 126.193 1.797 . . . . 0.0 111.781 176.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -105.76 143.84 33.34 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.185 0.994 . . . . 0.0 111.208 169.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.5 m -131.27 155.06 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.788 1.635 . . . . 0.0 111.215 176.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 60.3 p -137.44 168.41 19.7 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.331 1.852 . . . . 0.0 111.646 -172.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -61.36 -20.71 63.3 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.23 -13.51 49.64 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.364 1.466 . . . . 0.0 114.789 172.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 87.0 p -132.41 -12.58 3.1 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -168.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -56.02 -41.45 74.95 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.55 1.14 . . . . 0.0 112.649 -173.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.69 -36.76 83.26 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.252 -0.905 . . . . 0.0 112.921 178.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.5 m -79.6 -21.13 45.37 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.655 1.582 . . . . 0.0 113.784 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -111.33 -32.33 6.77 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 t -101.86 -59.12 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.645 1.178 . . . . 0.0 111.231 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 46.3 mt -73.67 -14.02 61.09 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -173.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 83.8 p -72.33 -19.23 61.68 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.273 1.829 . . . . 0.0 113.822 171.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.4 t -77.56 124.47 27.95 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.179 0.992 . . . . 0.0 113.223 -164.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -85.82 -14.62 44.5 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.793 1.237 . . . . 0.0 113.291 170.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -94.13 158.93 35.23 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 125.834 1.653 . . . . 0.0 110.346 168.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -57.06 138.52 86.65 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 121.282 1.321 . . . . 0.0 112.118 171.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.34 129.16 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.333 1.053 . . . . 0.0 110.243 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.71 115.73 29.57 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.458 1.903 . . . . 0.0 108.526 -170.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.0 t -110.02 125.72 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.44 0.696 . . . . 0.0 110.666 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -99.27 120.07 38.94 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.402 1.081 . . . . 0.0 110.849 169.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -86.79 116.71 25.05 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.36 1.464 . . . . 0.0 108.502 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -136.89 172.91 12.3 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.775 1.23 . . . . 0.0 112.928 -167.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.75 156.73 43.38 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.797 0.839 . . . . 0.0 111.934 168.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.2 p -58.5 -30.33 66.94 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.215 1.006 . . . . 0.0 112.572 170.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 29.8 p-90 -82.41 -8.04 59.63 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 177.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.1 t -97.0 93.34 6.55 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 119.642 1.11 . . . . 0.0 112.712 -173.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.77 -42.04 67.66 Favored Glycine 0 CA--C 1.541 1.689 0 CA-C-O 118.556 -1.135 . . . . 0.0 114.153 173.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -61.91 -31.08 84.59 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 CA-C-N 120.586 2.193 . . . . 0.0 114.287 171.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 72.3 m -66.62 -41.65 88.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.606 1.094 . . . . 0.0 110.88 169.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -61.23 -29.68 69.98 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 118.715 0.689 . . . . 0.0 112.759 172.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 88.6 mtp -72.78 -39.84 66.43 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.183 0.993 . . . . 0.0 113.432 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.1 p -86.07 -19.29 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 177.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.22 -48.31 80.27 Favored Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 176.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.58 -27.28 45.98 Favored 'Trans proline' 0 C--N 1.352 0.712 0 CA-C-N 122.4 1.893 . . . . 0.0 113.013 176.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.8 t -71.93 -46.14 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.476 -0.765 . . . . 0.0 110.059 175.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.9 mt -59.78 -37.24 78.51 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.457 1.103 . . . . 0.0 112.623 171.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -63.38 -39.98 96.0 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.206 0.602 . . . . 0.0 111.593 175.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -69.46 -40.11 77.34 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.043 -1.035 . . . . 0.0 112.416 173.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 36.5 mm -56.51 -44.48 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.784 1.174 . . . . 0.0 110.547 171.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.06 -47.34 85.13 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.618 0.767 . . . . 0.0 111.642 175.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.1 m -62.19 -41.78 98.66 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.948 1.299 . . . . 0.0 111.332 -177.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -89.4 -36.96 15.18 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -173.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -108.02 16.4 23.43 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -172.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.39 -34.23 23.51 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -178.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.6 t -72.65 -25.15 61.17 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.544 1.138 . . . . 0.0 113.016 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -95.0 -51.6 4.59 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.743 1.217 . . . . 0.0 111.664 178.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.16 153.15 52.07 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.286 1.434 . . . . 0.0 113.178 -174.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.3 m -104.23 137.45 42.13 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.288 1.035 . . . . 0.0 109.385 175.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.4 t -109.71 129.56 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.831 0.852 . . . . 0.0 110.5 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -132.55 160.03 37.73 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.9 1.68 . . . . 0.0 113.048 -169.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt -127.56 129.49 47.42 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.277 1.831 . . . . 0.0 111.741 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -117.8 116.47 27.06 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.204 1.402 . . . . 0.0 108.974 169.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -82.73 104.52 13.04 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.414 0.686 . . . . 0.0 110.879 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.409 HG12 ' HB2' ' A' ' 72' ' ' ALA . 4.3 m -65.46 -18.86 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -175.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -78.25 -19.41 53.76 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.412 0.685 . . . . 0.0 112.679 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 t -119.06 -18.68 8.69 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 175.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -123.55 59.31 15.7 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 125.415 1.486 . . . . 0.0 111.36 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -64.99 -27.97 57.92 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.002 2.468 . . . . 0.0 113.296 -174.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -72.12 -27.7 62.8 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.19 -0.944 . . . . 0.0 112.644 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.4 m -69.46 -39.14 77.93 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.348 -0.845 . . . . 0.0 111.155 171.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.409 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -64.14 -37.1 86.23 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.44 0.696 . . . . 0.0 112.294 171.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -71.7 -39.49 70.13 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.507 0.723 . . . . 0.0 112.653 177.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -56.71 -40.74 76.2 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.14 1.376 . . . . 0.0 113.874 -172.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -96.9 3.99 51.84 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.269 1.028 . . . . 0.0 113.052 178.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 48.0 54.97 9.28 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.202 1.801 . . . . 0.0 112.169 -167.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.9 m -113.67 15.0 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.772 1.629 . . . . 0.0 112.657 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.2 m -59.03 -23.07 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.763 1.625 . . . . 0.0 114.466 -174.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.4 m -79.83 53.05 1.57 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.666 1.986 . . . . 0.0 113.413 -174.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.5 pt -63.93 152.15 87.87 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -167.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -64.37 135.22 20.81 Favored 'Cis proline' 0 C--N 1.357 0.982 0 CA-C-N 119.855 0.984 . . . . 0.0 113.376 1.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.1 m -136.14 120.79 18.36 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.12 0.568 . . . . 0.0 110.186 172.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.1 mp -107.92 129.71 55.08 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.818 1.647 . . . . 0.0 107.93 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.46 132.49 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.965 0.906 . . . . 0.0 109.405 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.5 tp -110.23 129.32 55.74 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.008 1.323 . . . . 0.0 109.464 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -110.2 152.69 25.77 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.368 1.467 . . . . 0.0 111.044 173.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -130.77 137.07 49.29 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.651 1.58 . . . . 0.0 109.446 157.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.1 t70 51.17 33.38 9.35 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.505 1.122 . . . . 0.0 113.522 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.29 10.39 65.92 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.222 1.391 . . . . 0.0 116.093 -175.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -111.82 143.39 28.55 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 119.184 1.492 . . . . 0.0 111.236 176.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -58.92 144.86 98.72 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.358 2.706 . . . . 0.0 114.641 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 94.2 t -128.29 -48.74 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 126.1 1.76 . . . . 0.0 111.603 -178.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -142.19 148.92 39.0 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.688 1.595 . . . . 0.0 111.253 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -135.43 134.18 39.37 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.804 1.641 . . . . 0.0 110.737 171.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.6 mp -134.75 140.85 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 126.0 1.72 . . . . 0.0 109.594 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.5 m -130.44 144.46 37.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.794 1.238 . . . . 0.0 111.656 -176.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.7 161.42 8.4 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.368 0.985 . . . . 0.0 113.281 -170.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.14 152.1 33.94 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.693 -0.887 . . . . 0.0 112.99 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -136.18 152.3 50.64 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.969 1.708 . . . . 0.0 111.207 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.73 166.9 33.1 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.403 1.001 . . . . 0.0 111.46 163.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -52.62 -35.9 55.41 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.055 1.342 . . . . 0.0 113.736 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.28 -49.8 58.03 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 122.916 0.487 . . . . 0.0 111.829 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.45 -43.36 70.01 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.609 -0.682 . . . . 0.0 111.965 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.3 tp -63.45 -44.16 95.29 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 119.055 -0.498 . . . . 0.0 110.78 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 20.1 tp -71.76 -24.62 61.79 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-O 116.549 -1.691 . . . . 0.0 113.208 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 -61.24 -54.12 48.22 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 123.883 3.038 . . . . 0.0 110.859 166.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -61.47 -30.31 70.52 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.7 mt -90.26 -31.91 16.78 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 175.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.4 t -71.24 -11.11 60.75 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.704 1.602 . . . . 0.0 112.242 175.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -46.85 -27.6 1.29 Allowed 'General case' 0 CA--C 1.558 1.269 0 O-C-N 121.227 -0.921 . . . . 0.0 113.076 153.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.07 -49.67 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 128.156 2.582 . . . . 0.0 112.502 174.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.7 t -139.92 120.27 9.2 Favored Pre-proline 0 N--CA 1.482 1.145 0 C-N-CA 125.793 1.637 . . . . 0.0 113.632 -170.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -90.82 8.25 65.38 Favored 'Cis proline' 0 CA--C 1.538 0.716 0 N-CA-C 114.959 1.1 . . . . 0.0 114.959 9.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 49.0 t30 56.51 36.43 27.56 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.285 1.034 . . . . 0.0 111.293 -154.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 34.0 tp -134.76 149.56 50.44 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.725 1.61 . . . . 0.0 112.212 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.143 0 C-N-CA 126.124 1.77 . . . . 0.0 110.656 175.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 110.553 -0.166 . . . . 0.0 110.553 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.4 p -153.48 171.11 19.2 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.956 1.702 . . . . 0.0 110.944 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -70.09 -21.85 63.09 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 167.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.5 p -78.33 -26.37 46.82 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.054 0.942 . . . . 0.0 112.941 172.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -86.27 11.41 12.18 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.038 1.735 . . . . 0.0 112.489 164.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.385 0.0 OUTLIER 54.78 -28.09 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 131.462 3.905 . . . . 0.0 118.605 -170.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 72.2 m -82.82 84.46 7.36 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.811 1.244 . . . . 0.0 110.173 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.96 43.95 0.45 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.593 1.557 . . . . 0.0 113.952 -172.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.8 t -89.65 170.41 10.49 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.318 1.447 . . . . 0.0 111.177 169.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.3 pt -135.17 148.88 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.998 1.719 . . . . 0.0 110.61 176.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -92.66 139.62 30.37 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.651 -0.656 . . . . 0.0 110.581 168.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -115.46 164.15 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.732 1.213 . . . . 0.0 111.961 173.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 54.8 p -139.71 159.62 41.75 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.137 1.775 . . . . 0.0 110.681 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -58.7 -27.84 65.23 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 121.131 -0.981 . . . . 0.0 113.536 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.36 -18.18 52.94 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.9 m -128.8 -3.81 5.23 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.763 1.225 . . . . 0.0 114.052 -172.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -53.5 -41.35 66.21 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.351 1.461 . . . . 0.0 112.55 -177.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.77 -33.01 74.67 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.457 -0.777 . . . . 0.0 113.092 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.6 m -79.54 -30.83 41.91 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.397 1.079 . . . . 0.0 112.706 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -93.39 -32.97 14.04 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -174.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -111.13 -57.75 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.296 1.438 . . . . 0.0 110.707 -175.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 33.8 mt -76.63 -13.27 60.07 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -170.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.3 m -83.31 -13.1 55.84 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.62 0.971 . . . . 0.0 113.62 176.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.7 m -81.86 130.39 35.05 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.043 1.337 . . . . 0.0 112.817 -173.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -79.56 -23.55 42.73 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.266 0.626 . . . . 0.0 112.308 171.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -74.09 143.29 80.33 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 125.238 1.415 . . . . 0.0 109.485 171.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -53.44 138.95 65.81 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 121.805 1.67 . . . . 0.0 112.205 166.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p -136.41 132.32 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 C-N-CA 125.129 1.371 . . . . 0.0 110.337 -173.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.23 126.38 55.17 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.517 1.927 . . . . 0.0 108.441 -175.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.1 t -119.7 124.36 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.11 0.964 . . . . 0.0 110.557 177.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -101.16 113.38 26.37 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.954 1.702 . . . . 0.0 111.159 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -92.82 112.41 24.36 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.685 1.594 . . . . 0.0 108.734 176.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -143.13 171.94 13.39 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.766 1.226 . . . . 0.0 111.909 -166.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.41 151.16 40.05 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.867 0.867 . . . . 0.0 112.896 170.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 28.0 p -65.46 -25.56 67.56 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.604 1.162 . . . . 0.0 113.241 172.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 13.3 p-90 -88.62 4.62 46.4 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.509 1.524 . . . . 0.0 114.934 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.1 t -122.38 127.25 49.5 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.311 1.044 . . . . 0.0 112.953 -173.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.24 -53.69 40.35 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 118.7 -1.056 . . . . 0.0 114.882 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.78 -23.8 68.92 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 CA-C-N 121.079 2.44 . . . . 0.0 113.293 174.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 86.2 m -65.39 -46.46 79.98 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.827 -1.171 . . . . 0.0 111.615 167.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -59.31 -29.89 67.95 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.842 0.857 . . . . 0.0 112.932 172.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.6 mtt -74.09 -39.09 63.65 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 176.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -90.88 -29.42 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -175.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.93 -46.47 87.67 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.77 -25.94 28.03 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.357 2.038 . . . . 0.0 113.79 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.38 -45.52 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 119.44 1.018 . . . . 0.0 108.688 175.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -67.4 -31.65 72.02 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.996 1.318 . . . . 0.0 112.372 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -73.65 -36.94 65.43 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.037 0.835 . . . . 0.0 112.945 174.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -59.68 -45.16 92.92 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.995 -1.065 . . . . 0.0 111.162 165.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.4 mt -62.59 -40.21 87.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 O-C-N 121.603 -0.685 . . . . 0.0 110.594 176.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.76 -32.42 73.91 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.553 -1.342 . . . . 0.0 113.252 173.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.4 m -74.38 -48.08 30.18 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.752 0.821 . . . . 0.0 111.554 176.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -90.96 -24.71 20.05 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -169.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -117.01 15.13 15.12 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.152 1.381 . . . . 0.0 114.597 -172.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.4 -28.03 11.65 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 175.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.4 p -84.06 -21.89 31.4 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.658 1.583 . . . . 0.0 114.304 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -98.58 -31.97 11.68 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.217 1.407 . . . . 0.0 112.585 178.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.9 mt -139.18 149.35 44.32 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.203 2.601 . . . . 0.0 109.977 -177.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.4 m -91.22 134.96 34.13 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 157.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.1 t -128.63 120.13 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 121.516 -0.74 . . . . 0.0 109.987 -169.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.45 159.86 35.8 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.978 1.311 . . . . 0.0 113.422 -168.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -119.75 140.27 50.99 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.287 1.835 . . . . 0.0 111.56 176.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -122.64 111.15 16.41 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.223 1.409 . . . . 0.0 107.824 164.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -82.09 110.57 17.43 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.0 m -67.1 -16.37 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -174.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -76.87 -23.46 52.63 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.414 0.686 . . . . 0.0 112.569 171.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.5 p -93.57 -31.97 14.31 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.866 1.266 . . . . 0.0 112.563 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -138.43 79.98 28.63 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.324 1.449 . . . . 0.0 111.688 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -61.89 -28.73 81.49 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.809 2.339 . . . . 0.0 113.609 175.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -66.56 -41.39 88.69 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.077 0.951 . . . . 0.0 112.411 -176.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -61.86 -37.98 86.54 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.477 0.711 . . . . 0.0 111.651 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.99 -45.12 95.02 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.75 0.82 . . . . 0.0 112.496 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.9 ptm85 -78.13 -31.19 49.76 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -62.57 -41.43 98.92 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.284 1.034 . . . . 0.0 111.995 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -98.47 5.9 47.63 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 50.1 59.58 4.44 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.582 1.953 . . . . 0.0 113.169 -177.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.2 m -133.3 31.89 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 125.946 1.699 . . . . 0.0 111.45 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 m -70.68 -19.86 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.543 1.537 . . . . 0.0 115.005 -171.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 21.4 m -82.3 50.38 1.6 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.719 1.607 . . . . 0.0 113.767 -169.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -57.33 150.22 44.19 Favored Pre-proline 0 CA--C 1.556 1.205 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 -161.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.94 141.5 66.59 Favored 'Cis proline' 0 C--N 1.356 0.934 0 CA-C-N 118.758 0.592 . . . . 0.0 112.165 -4.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.9 m -136.39 137.79 40.9 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.968 0.907 . . . . 0.0 109.771 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.5 mp -122.5 140.63 52.53 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.146 0.978 . . . . 0.0 110.203 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.1 tp -127.9 131.3 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 124.82 1.248 . . . . 0.0 108.999 175.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.1 tt -111.56 129.52 56.04 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.425 1.09 . . . . 0.0 109.217 172.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -111.63 152.01 28.14 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.739 1.616 . . . . 0.0 109.863 172.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -134.92 126.91 29.62 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.324 1.45 . . . . 0.0 109.457 173.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t70 50.03 36.61 12.26 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.262 1.025 . . . . 0.0 113.365 -165.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.02 5.9 42.73 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.941 1.734 . . . . 0.0 116.032 -174.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 55.4 mm-40 -97.62 137.27 21.03 Favored Pre-proline 0 N--CA 1.472 0.643 0 CA-C-N 119.359 1.579 . . . . 0.0 109.573 175.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.63 139.54 48.88 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.025 1.816 . . . . 0.0 111.826 -178.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.3 t -123.43 -46.84 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.221 1.408 . . . . 0.0 112.331 -174.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -146.71 132.39 18.88 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.631 0.772 . . . . 0.0 112.539 -177.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -111.41 135.82 51.42 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.066 1.746 . . . . 0.0 110.484 168.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.9 mt -129.75 143.24 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.623 1.969 . . . . 0.0 108.57 -178.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.39 143.16 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.569 1.148 . . . . 0.0 111.224 174.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.83 158.97 29.95 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.925 1.25 . . . . 0.0 113.043 -171.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.43 140.88 39.95 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.905 -0.762 . . . . 0.0 112.509 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -130.7 146.43 52.18 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.88 1.672 . . . . 0.0 109.809 170.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.37 166.49 54.73 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 123.819 0.723 . . . . 0.0 111.62 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? -51.7 -33.99 36.76 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.974 1.31 . . . . 0.0 113.641 -175.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.85 -50.98 37.34 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.407 0.549 . . . . 0.0 111.752 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.14 -36.55 69.4 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.368 1.067 . . . . 0.0 112.549 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -41.14 93.86 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.517 -0.74 . . . . 0.0 110.127 171.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 29.8 tp -69.27 -23.19 63.81 Favored 'General case' 0 C--O 1.213 -0.821 0 CA-C-O 116.07 -1.919 . . . . 0.0 113.143 171.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.6 mmt-85 -64.35 -49.09 73.03 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 123.991 3.087 . . . . 0.0 111.542 165.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -59.23 -30.69 68.44 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 93.6 mt -93.33 -27.82 16.56 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.684 1.193 . . . . 0.0 113.927 173.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.8 p -67.07 -24.48 65.97 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.627 1.558 . . . . 0.0 110.922 177.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -51.39 -22.68 3.13 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 125.256 1.423 . . . . 0.0 113.978 163.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 69.5 t -112.97 -30.09 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 128.07 2.548 . . . . 0.0 111.992 172.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.2 t -110.34 87.86 6.73 Favored Pre-proline 0 N--CA 1.478 0.973 0 C-N-CA 127.967 2.507 . . . . 0.0 110.346 -175.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.1 -8.85 23.06 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.879 2.386 . . . . 0.0 113.346 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -83.05 23.67 0.84 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.359 1.864 . . . . 0.0 113.644 178.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -58.12 -22.44 50.95 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -174.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.26 0 C-N-CA 126.202 1.801 . . . . 0.0 111.087 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.487 1.425 0 N-CA-C 111.16 0.059 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 18.3 p -80.11 -36.69 35.02 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.206 1.002 . . . . 0.0 112.807 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -144.8 154.1 42.34 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.682 1.993 . . . . 0.0 110.843 176.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.3 t -79.18 -30.61 43.53 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.754 0.821 . . . . 0.0 112.9 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 56.06 32.48 20.08 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.286 1.834 . . . . 0.0 115.258 173.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -84.73 -14.36 48.56 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -176.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.9 p -98.56 157.29 16.33 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.154 1.782 . . . . 0.0 112.699 177.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -104.04 32.07 4.17 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -171.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 p -89.64 153.33 20.83 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.723 1.209 . . . . 0.0 113.227 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.2 pt -140.07 165.17 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 127.092 2.157 . . . . 0.0 110.84 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -119.05 152.44 36.44 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 164.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.3 m -122.6 169.81 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 126.485 1.914 . . . . 0.0 110.823 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 43.2 p -137.62 173.94 11.12 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.826 1.65 . . . . 0.0 111.39 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -54.98 -28.13 49.32 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.87 -1.144 . . . . 0.0 113.037 170.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.0 -13.34 57.54 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.852 1.261 . . . . 0.0 114.278 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.7 p -132.86 -4.92 3.17 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -174.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -60.21 -46.14 90.77 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 120.011 1.278 . . . . 0.0 111.636 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.42 -39.32 77.94 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.959 -1.088 . . . . 0.0 112.812 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.28 -16.62 56.13 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.614 1.566 . . . . 0.0 114.726 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -103.24 -50.85 3.37 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.17 0.988 . . . . 0.0 112.677 173.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.2 t -83.49 -59.22 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.536 1.134 . . . . 0.0 111.146 -173.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.2 mt -77.31 -25.98 51.75 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -172.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.4 m -79.17 -9.06 59.46 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.96 1.304 . . . . 0.0 113.677 175.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -67.23 139.93 57.39 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.812 0.845 . . . . 0.0 113.185 -177.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -86.69 2.28 49.07 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.234 1.413 . . . . 0.0 113.724 173.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -131.72 165.87 32.45 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 126.397 1.879 . . . . 0.0 111.357 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -66.44 144.2 72.57 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.188 1.925 . . . . 0.0 112.207 176.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.2 p -144.12 127.26 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.335 1.054 . . . . 0.0 111.694 -173.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 tt -99.71 129.46 45.84 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.259 2.224 . . . . 0.0 108.323 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 t -119.8 127.26 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.437 1.095 . . . . 0.0 110.443 173.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -105.02 115.09 29.68 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.079 1.352 . . . . 0.0 111.793 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -83.42 114.08 21.2 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.376 1.87 . . . . 0.0 108.93 171.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -145.99 177.21 9.12 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.301 1.041 . . . . 0.0 112.205 -165.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.94 148.1 30.42 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 122.774 0.43 . . . . 0.0 112.051 163.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -64.8 -18.54 65.19 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 173.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 9.5 p-90 -82.03 -4.39 56.66 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 173.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 33.8 t -107.07 119.9 40.64 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 119.316 0.962 . . . . 0.0 113.493 -168.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.71 -52.18 53.53 Favored Glycine 0 CA--C 1.54 1.606 0 C-N-CA 124.701 1.143 . . . . 0.0 115.182 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.77 -24.44 54.52 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 CA-C-N 121.006 2.403 . . . . 0.0 113.265 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 75.9 m -65.81 -45.19 83.26 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.693 -1.254 . . . . 0.0 111.602 167.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -61.25 -30.91 70.74 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.638 0.653 . . . . 0.0 112.418 172.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.3 ttt -70.3 -43.1 71.06 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.305 1.042 . . . . 0.0 113.162 176.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 p -86.98 -23.25 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.82 -49.64 72.54 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 176.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.51 -29.01 45.18 Favored 'Trans proline' 0 C--N 1.352 0.74 0 CA-C-N 122.376 1.884 . . . . 0.0 112.806 177.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.0 t -71.93 -45.63 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 O-C-N 121.554 -0.716 . . . . 0.0 110.181 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.1 mt -62.53 -33.73 75.48 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.937 0.895 . . . . 0.0 112.682 172.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -68.83 -38.73 80.04 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.119 0.872 . . . . 0.0 112.058 175.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -63.24 -45.28 92.32 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 121.344 -0.847 . . . . 0.0 111.649 168.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.0 mm -58.88 -41.93 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 119.497 1.044 . . . . 0.0 110.605 174.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.93 -46.74 87.21 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.289 -0.882 . . . . 0.0 111.971 176.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.7 m -76.36 -37.73 56.84 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.926 0.89 . . . . 0.0 112.409 -175.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -97.25 -21.79 17.06 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -172.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -111.45 19.84 17.81 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.633 1.573 . . . . 0.0 113.065 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.26 -28.08 25.77 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.062 1.345 . . . . 0.0 113.833 174.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.7 p -66.43 -23.89 66.37 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.837 1.655 . . . . 0.0 114.042 175.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -125.98 -23.46 3.94 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.634 1.574 . . . . 0.0 113.924 -169.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.4 mt -134.26 153.75 51.68 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.299 2.239 . . . . 0.0 110.56 -178.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 49.0 m -108.79 138.76 44.6 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 149.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.1 t -112.79 122.92 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 118.904 0.775 . . . . 0.0 110.549 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -124.49 165.4 17.85 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.695 1.998 . . . . 0.0 112.145 -176.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.2 mttt -130.7 152.28 50.23 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.175 1.79 . . . . 0.0 112.658 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.76 114.28 12.48 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.424 1.089 . . . . 0.0 108.597 162.076 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -80.9 118.65 22.58 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.2 m -67.82 -18.32 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -172.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -80.6 -25.75 38.27 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.929 0.892 . . . . 0.0 112.677 170.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.2 p -92.17 -26.74 18.08 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.989 0.916 . . . . 0.0 112.694 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -140.54 86.96 11.93 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.656 1.182 . . . . 0.0 111.305 171.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.07 -18.62 35.46 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.524 2.149 . . . . 0.0 113.097 177.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -68.56 -46.37 69.64 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.189 -0.945 . . . . 0.0 112.055 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 m -73.65 -29.86 62.58 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.49 -0.757 . . . . 0.0 112.162 175.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.66 -40.98 85.02 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.24 0.616 . . . . 0.0 112.424 169.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.2 ttm105 -75.98 -39.29 56.23 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.323 0.649 . . . . 0.0 112.475 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -54.31 -40.61 68.12 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.189 1.396 . . . . 0.0 114.506 -170.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -100.31 7.19 44.53 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.014 0.925 . . . . 0.0 113.479 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 49.78 59.53 4.45 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.355 1.462 . . . . 0.0 111.287 -164.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.9 m -125.33 28.65 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.414 1.886 . . . . 0.0 111.439 -176.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -68.55 -25.64 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.792 1.237 . . . . 0.0 112.349 175.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 52.7 m -79.96 136.53 36.65 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.265 1.426 . . . . 0.0 110.325 166.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 29.0 pt -143.15 154.66 61.54 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -166.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.33 140.66 60.53 Favored 'Cis proline' 0 C--N 1.355 0.872 0 CA-C-N 119.412 0.826 . . . . 0.0 111.923 -5.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.0 m -134.72 126.64 29.42 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.173 0.989 . . . . 0.0 109.709 174.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.8 mp -108.19 136.08 48.46 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.685 1.594 . . . . 0.0 108.908 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.0 tp -120.74 138.54 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.268 1.427 . . . . 0.0 108.703 167.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.9 tp -126.59 125.15 41.48 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.071 0.949 . . . . 0.0 110.095 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -105.87 143.37 34.1 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.734 2.013 . . . . 0.0 110.447 177.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -114.42 119.21 36.11 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.558 1.543 . . . . 0.0 107.929 168.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.4 t70 51.2 39.0 22.65 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.731 1.212 . . . . 0.0 113.631 -172.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.55 9.54 74.08 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 125.163 1.363 . . . . 0.0 116.125 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -109.35 134.26 20.55 Favored Pre-proline 0 N--CA 1.473 0.715 0 CA-C-N 119.514 1.657 . . . . 0.0 110.356 171.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.56 139.57 45.06 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.465 2.11 . . . . 0.0 111.991 -173.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.3 m -130.21 -27.84 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -177.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -152.28 139.55 19.4 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.721 1.146 . . . . 0.0 111.855 -177.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -129.13 140.05 51.7 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.43 1.892 . . . . 0.0 111.034 173.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.9 mt -137.24 143.17 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.965 1.706 . . . . 0.0 108.883 -178.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 p -133.85 143.64 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 119.723 1.147 . . . . 0.0 111.24 170.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.75 156.68 29.32 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.277 1.418 . . . . 0.0 113.248 -172.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.1 140.08 41.66 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.914 -0.757 . . . . 0.0 112.666 -176.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -132.63 145.45 51.09 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.87 1.668 . . . . 0.0 110.729 174.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -79.94 167.68 51.51 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.355 0.979 . . . . 0.0 110.896 173.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -50.22 -37.02 33.34 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -170.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.97 -47.99 55.85 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.173 0.511 . . . . 0.0 111.468 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.83 -44.77 69.26 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.377 1.071 . . . . 0.0 111.908 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.3 tp -64.89 -44.38 89.83 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.944 176.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 31.4 tp -69.93 -31.62 69.47 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-O 115.048 -2.406 . . . . 0.0 112.807 177.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -65.38 -42.93 92.17 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 124.861 3.482 . . . . 0.0 111.926 169.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -62.32 -32.07 72.78 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 178.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.4 mt -91.65 -24.98 19.35 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.888 1.275 . . . . 0.0 113.196 173.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.3 t -66.16 -25.41 66.94 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.983 1.313 . . . . 0.0 110.264 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -52.71 -22.14 4.87 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.519 1.128 . . . . 0.0 113.578 164.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.7 t -108.92 -24.95 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 127.487 2.315 . . . . 0.0 112.371 170.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.3 t -118.73 84.15 24.28 Favored Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 127.888 2.475 . . . . 0.0 111.797 -175.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -64.25 -12.79 34.48 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.063 2.509 . . . . 0.0 114.853 175.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -68.56 -28.28 66.82 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -172.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 28.0 tp -150.3 138.67 20.45 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.09 0.956 . . . . 0.0 112.008 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.6 t30 . . . . . 0 C--O 1.253 1.272 0 C-N-CA 126.206 1.802 . . . . 0.0 111.362 174.4 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.565 0.222 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.2 p -75.34 158.45 32.78 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.647 1.179 . . . . 0.0 112.497 174.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -145.32 146.4 31.61 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.146 1.378 . . . . 0.0 111.433 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 63.4 p -98.1 -3.97 36.79 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -174.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -123.91 7.97 8.7 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.495 1.518 . . . . 0.0 113.51 -174.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.05 2.41 20.66 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -177.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 65.1 p -71.06 149.63 46.35 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.29 1.436 . . . . 0.0 111.872 171.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -88.18 54.37 3.05 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.092 -1.005 . . . . 0.0 112.207 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.9 p -89.71 151.62 21.75 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.511 1.124 . . . . 0.0 112.475 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 45.0 pt -135.06 160.08 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.704 1.602 . . . . 0.0 111.091 169.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -108.01 139.03 43.25 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.906 0.882 . . . . 0.0 110.591 168.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.2 m -133.6 150.69 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.963 1.305 . . . . 0.0 110.934 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.1 p -141.05 174.24 10.71 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.783 1.633 . . . . 0.0 111.095 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -52.6 -26.15 12.68 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 120.919 -1.113 . . . . 0.0 113.611 172.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.26 -13.37 52.77 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 176.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.3 p -137.1 -12.66 1.65 Allowed 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -169.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -56.28 -41.96 76.71 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.405 1.482 . . . . 0.0 112.82 -174.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.53 -34.55 78.53 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 121.134 -0.979 . . . . 0.0 112.894 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.5 m -79.46 -14.33 58.98 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.535 1.534 . . . . 0.0 113.77 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -118.7 -32.36 4.57 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.92 -51.92 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.156 1.382 . . . . 0.0 111.452 -176.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.6 mt -78.53 -13.53 59.79 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.6 p -76.56 -11.04 59.81 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.209 1.804 . . . . 0.0 113.995 174.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.7 p -67.09 149.15 50.95 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 -164.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -118.19 15.64 14.05 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 126.401 1.88 . . . . 0.0 112.089 171.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -142.86 164.25 33.36 Favored Pre-proline 0 N--CA 1.475 0.782 0 C-N-CA 129.416 3.086 . . . . 0.0 108.809 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.76 138.56 54.05 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 CA-C-N 121.103 1.43 . . . . 0.0 111.257 166.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.8 m -136.63 138.53 46.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 126.317 1.847 . . . . 0.0 110.536 -177.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tt -118.68 115.7 25.05 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.79 1.236 . . . . 0.0 109.637 -167.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.11 126.96 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.999 0.92 . . . . 0.0 110.943 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -107.0 111.9 24.61 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.513 1.525 . . . . 0.0 111.48 177.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -84.25 108.66 17.25 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.909 1.684 . . . . 0.0 108.681 173.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -136.08 163.81 29.47 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.348 1.059 . . . . 0.0 113.14 -165.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.31 145.8 47.84 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.2 p -59.94 -29.99 68.77 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.356 1.862 . . . . 0.0 113.206 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.5 p-90 -86.94 -12.4 47.71 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 41.9 t -90.77 119.18 30.78 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -164.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.07 -49.33 76.15 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.879 1.228 . . . . 0.0 113.329 176.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -57.66 -29.47 85.51 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.922 2.414 . . . . 0.0 114.548 170.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 94.9 m -64.88 -44.37 89.87 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.781 1.173 . . . . 0.0 111.187 167.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -60.56 -29.44 69.16 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 172.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.3 mtt -71.64 -43.3 66.36 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.641 0.776 . . . . 0.0 112.859 176.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.8 p -88.74 -25.75 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.81 -48.09 92.44 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.72 -27.86 37.69 Favored 'Trans proline' 0 C--N 1.353 0.776 0 CA-C-N 122.448 1.91 . . . . 0.0 112.683 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.9 t -71.67 -46.01 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 121.572 -0.705 . . . . 0.0 110.288 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.0 mt -60.92 -35.69 77.36 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.073 0.949 . . . . 0.0 112.353 171.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -67.96 -38.49 82.85 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.015 0.825 . . . . 0.0 112.052 176.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -62.64 -45.35 93.22 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.018 -1.051 . . . . 0.0 111.537 169.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.3 mm -59.12 -43.05 88.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.656 1.117 . . . . 0.0 110.898 174.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.97 -35.31 78.09 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.181 0.992 . . . . 0.0 112.843 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.1 m -78.51 -48.85 14.45 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.412 0.685 . . . . 0.0 111.906 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -85.24 -32.83 22.38 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -169.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -108.02 16.69 23.17 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.313 1.445 . . . . 0.0 112.834 -171.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.66 -33.12 32.33 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.378 1.471 . . . . 0.0 114.363 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.8 m -68.03 -29.57 68.6 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.913 1.285 . . . . 0.0 112.389 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -102.61 -39.84 6.89 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.562 1.545 . . . . 0.0 112.66 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.5 mt -125.37 148.85 48.61 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 126.927 2.091 . . . . 0.0 110.663 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.4 m -109.14 127.2 53.99 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 157.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.6 t -99.51 128.97 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.585 0.754 . . . . 0.0 109.512 -177.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.26 150.73 48.23 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.89 1.676 . . . . 0.0 111.771 -173.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -128.63 143.45 50.95 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.434 1.094 . . . . 0.0 112.504 176.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -133.55 122.42 23.54 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.866 1.666 . . . . 0.0 110.033 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.63 96.89 7.64 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.18 1.792 . . . . 0.0 109.844 -176.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.8 m -69.49 -13.41 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 O-C-N 120.491 -1.381 . . . . 0.0 113.188 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -67.66 -27.49 66.9 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.756 0.822 . . . . 0.0 112.761 171.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.9 p -119.11 -29.74 5.16 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -136.99 76.09 46.58 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 124.646 1.178 . . . . 0.0 111.11 173.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -68.16 -13.88 39.15 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.196 2.598 . . . . 0.0 113.719 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -58.67 -33.05 69.69 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.673 1.189 . . . . 0.0 113.771 -172.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.5 m -64.21 -45.26 89.08 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.636 1.107 . . . . 0.0 111.856 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.12 -32.55 65.01 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.758 0.823 . . . . 0.0 112.47 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -73.26 -32.26 64.59 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.518 1.127 . . . . 0.0 113.022 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -58.31 -37.11 74.43 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.519 1.128 . . . . 0.0 112.596 175.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -96.74 9.91 40.32 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.067 1.347 . . . . 0.0 113.124 175.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.307 5.7 pt20 54.27 -9.19 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 130.15 3.38 . . . . 0.0 117.892 -173.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.6 m -80.27 58.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.549 1.94 . . . . 0.0 111.778 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.9 p -79.02 -4.22 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 126.004 1.721 . . . . 0.0 113.744 -174.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.3 m -57.06 157.19 6.11 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.599 1.96 . . . . 0.0 112.805 170.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 23.2 mt -140.14 137.46 18.07 Favored Pre-proline 0 N--CA 1.477 0.9 0 O-C-N 121.339 -0.85 . . . . 0.0 112.312 -164.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.98 143.58 66.48 Favored 'Cis proline' 0 C--N 1.353 0.787 0 CA-C-N 119.495 0.855 . . . . 0.0 110.628 -17.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 28.3 m -119.98 121.37 38.81 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.444 0.697 . . . . 0.0 110.078 169.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.9 mp -99.7 119.46 38.16 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.516 1.527 . . . . 0.0 107.749 172.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.7 tp -117.96 124.21 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 125.088 1.355 . . . . 0.0 109.073 176.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.6 tp -107.4 125.99 51.92 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.647 1.579 . . . . 0.0 108.908 -176.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -112.44 155.34 24.39 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.412 1.485 . . . . 0.0 109.987 174.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -141.75 126.56 18.12 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.998 1.719 . . . . 0.0 108.829 174.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.6 t70 54.79 25.36 6.53 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -169.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.72 5.39 68.84 Favored Glycine 0 CA--C 1.541 1.67 0 O-C-N 120.535 -1.353 . . . . 0.0 116.091 -172.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -95.16 140.46 22.43 Favored Pre-proline 0 N--CA 1.474 0.766 0 CA-C-N 119.815 1.807 . . . . 0.0 110.048 167.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -67.66 139.6 48.94 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.133 1.889 . . . . 0.0 111.11 176.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.1 m -127.61 -27.63 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 114.814 1.412 . . . . 0.0 114.814 -176.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -156.08 147.86 22.99 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.736 1.153 . . . . 0.0 111.575 175.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.0 ttp-105 -127.95 141.52 51.51 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.001 1.32 . . . . 0.0 111.511 167.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.4 mp -129.48 140.99 47.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 126.638 1.975 . . . . 0.0 108.278 171.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.6 p -132.42 140.8 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.161 0.984 . . . . 0.0 110.286 169.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.24 155.14 30.07 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.32 0.962 . . . . 0.0 112.608 -165.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.16 142.33 43.55 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.503 0.721 . . . . 0.0 112.791 -175.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -130.76 144.54 51.52 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.789 1.636 . . . . 0.0 110.553 172.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -79.31 170.67 54.58 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.391 0.996 . . . . 0.0 111.518 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -52.56 -36.47 55.88 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -175.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.95 -50.91 64.54 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.701 0.4 . . . . 0.0 111.33 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.47 -39.73 58.31 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.898 1.279 . . . . 0.0 113.142 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.3 tp -66.36 -36.36 82.68 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.244 -0.91 . . . . 0.0 110.737 173.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 28.1 tp -73.04 -24.93 60.77 Favored 'General case' 0 C--O 1.216 -0.68 0 CA-C-O 116.123 -1.894 . . . . 0.0 112.955 169.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -58.65 -53.84 53.86 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 123.972 3.078 . . . . 0.0 109.741 164.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -60.91 -32.09 71.58 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.799 1.24 . . . . 0.0 113.382 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.3 mt -97.42 -29.95 13.2 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.621 1.168 . . . . 0.0 113.745 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.6 t -61.33 -30.48 70.53 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 120.182 1.356 . . . . 0.0 110.63 171.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -54.86 -18.25 4.63 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 166.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.0 t -117.72 -18.8 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 127.781 2.433 . . . . 0.0 112.578 174.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -123.63 89.77 51.06 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 127.472 2.309 . . . . 0.0 110.432 -173.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -65.27 -7.93 17.19 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.453 2.768 . . . . 0.0 114.936 175.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -63.51 -27.7 69.45 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.52 1.128 . . . . 0.0 113.328 -175.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 49.6 tp -146.82 143.47 28.63 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.504 1.122 . . . . 0.0 111.044 167.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 . . . . . 0 C--O 1.253 1.257 0 C-N-CA 125.775 1.63 . . . . 0.0 111.422 173.867 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.8 p . . . . . 0 N--CA 1.477 0.879 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.9 pt -108.14 155.04 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.808 1.243 . . . . 0.0 111.271 166.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -112.15 128.17 56.14 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.542 1.137 . . . . 0.0 109.779 176.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -124.94 152.75 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.527 1.131 . . . . 0.0 111.605 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 44.6 p -132.12 169.59 16.17 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.452 1.901 . . . . 0.0 110.919 -175.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.405 ' H ' ' ND2' ' A' ' 68' ' ' ASN . 22.9 t70 -58.51 -27.0 64.08 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 120.909 -1.12 . . . . 0.0 113.168 176.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.11 -13.51 52.8 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.195 1.398 . . . . 0.0 114.518 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.0 p -127.5 -7.72 5.74 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 -173.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -56.01 -41.82 75.48 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.869 1.268 . . . . 0.0 112.603 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.76 -33.05 74.08 Favored 'General case' 0 CA--C 1.543 0.712 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 m -79.19 -14.96 58.75 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.784 1.634 . . . . 0.0 113.521 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -120.35 -54.55 2.08 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.127 0.971 . . . . 0.0 113.173 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.2 -51.97 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.479 0.712 . . . . 0.0 110.898 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 25.4 mt -76.96 -15.9 59.51 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.8 t -76.12 -28.91 57.66 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.414 1.486 . . . . 0.0 112.904 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.2 m -68.77 119.46 13.18 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.786 1.234 . . . . 0.0 112.418 -174.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -77.32 -20.19 55.29 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.352 1.061 . . . . 0.0 112.944 170.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -87.32 166.19 27.06 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 126.586 1.954 . . . . 0.0 111.363 173.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.62 137.24 79.09 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.135 1.89 . . . . 0.0 111.75 170.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -138.25 130.43 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.016 0.927 . . . . 0.0 111.004 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.04 113.79 27.55 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.396 1.878 . . . . 0.0 108.635 -174.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.3 t -100.19 122.73 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.547 0.739 . . . . 0.0 110.065 173.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -96.34 109.7 22.17 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.594 1.158 . . . . 0.0 110.291 166.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -81.45 115.99 21.04 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.052 1.341 . . . . 0.0 107.923 170.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -148.44 170.1 18.75 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.955 0.902 . . . . 0.0 112.536 -167.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -144.17 149.2 36.06 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.168 0.587 . . . . 0.0 112.026 161.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.7 t -63.96 -22.44 66.92 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.029 0.932 . . . . 0.0 113.291 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -78.94 -5.91 54.93 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 43.4 t -105.39 130.33 53.52 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.186 0.994 . . . . 0.0 112.142 -177.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.38 -56.98 20.39 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.408 1.004 . . . . 0.0 113.539 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -55.83 -34.71 92.16 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.024 2.483 . . . . 0.0 114.448 173.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 96.5 m -62.62 -45.97 90.4 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.04 0.836 . . . . 0.0 111.512 172.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -62.81 -33.55 75.45 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.682 1.193 . . . . 0.0 112.406 175.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 97.2 mmm -75.35 -36.64 60.95 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.383 1.073 . . . . 0.0 113.784 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.9 p -83.3 -23.36 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 119.581 1.082 . . . . 0.0 113.606 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.42 -50.51 71.02 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.98 -27.85 42.38 Favored 'Trans proline' 0 C--N 1.353 0.783 0 CA-C-N 122.538 1.942 . . . . 0.0 113.239 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.4 t -73.37 -42.94 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 121.338 -0.851 . . . . 0.0 110.385 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.1 mt -64.73 -33.28 75.59 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.77 1.228 . . . . 0.0 112.776 171.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.43 -45.44 87.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.273 1.029 . . . . 0.0 111.422 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -61.07 -47.77 84.82 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.61 -0.682 . . . . 0.0 110.889 170.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.09 -36.06 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 120.985 -1.072 . . . . 0.0 112.582 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.64 -41.85 92.15 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.172 0.989 . . . . 0.0 112.201 173.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.1 m -73.98 -35.29 64.46 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.444 0.698 . . . . 0.0 111.356 -176.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -87.57 -38.39 16.01 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.118 1.367 . . . . 0.0 114.332 -175.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -104.19 12.08 34.24 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.511 1.124 . . . . 0.0 114.027 -168.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.55 -33.42 45.61 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.564 1.545 . . . . 0.0 114.51 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 m -71.33 -25.54 62.44 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.849 1.26 . . . . 0.0 112.755 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -101.73 -36.69 8.62 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.486 1.514 . . . . 0.0 112.869 -176.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.5 pp -147.65 164.42 33.58 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.857 1.663 . . . . 0.0 111.781 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.1 m -107.95 143.18 36.95 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.463 1.105 . . . . 0.0 109.371 169.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.6 t -115.36 128.05 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 118.966 0.803 . . . . 0.0 110.559 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.76 154.25 47.4 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.179 1.792 . . . . 0.0 112.077 -172.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -123.04 135.5 54.46 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.716 1.207 . . . . 0.0 112.495 173.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.02 116.95 29.27 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.839 1.656 . . . . 0.0 108.441 168.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.7 101.11 11.94 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.889 1.275 . . . . 0.0 110.138 -176.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.7 m -66.2 -16.5 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -173.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.63 -26.17 63.35 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.366 1.067 . . . . 0.0 113.195 175.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.7 t -119.12 -20.36 8.05 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.601 1.16 . . . . 0.0 113.427 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.405 ' ND2' ' H ' ' A' ' 14' ' ' ASP . 36.5 m120 -123.29 63.98 25.86 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.6 1.16 . . . . 0.0 112.575 170.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.59 -18.34 58.91 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.584 2.189 . . . . 0.0 112.451 171.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -60.1 -46.68 88.79 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.598 1.159 . . . . 0.0 110.931 173.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.29 -31.31 60.66 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.503 1.121 . . . . 0.0 111.893 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.21 -44.99 96.39 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 123.99 0.916 . . . . 0.0 112.321 174.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.8 ptt-85 -82.08 -22.8 36.13 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 176.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -56.29 -40.8 74.87 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.311 0.96 . . . . 0.0 113.249 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -99.0 5.22 47.24 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.467 1.107 . . . . 0.0 113.077 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 47.12 55.3 8.24 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.312 1.845 . . . . 0.0 112.277 -166.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.6 m -113.73 19.52 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.862 1.665 . . . . 0.0 112.58 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.4 m -63.0 -16.85 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.772 1.629 . . . . 0.0 114.559 -175.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.2 m -78.47 48.61 0.79 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.801 2.041 . . . . 0.0 113.384 -176.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -59.83 155.17 43.49 Favored Pre-proline 0 CA--C 1.556 1.176 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 -163.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.74 141.96 68.03 Favored 'Cis proline' 0 C--N 1.355 0.878 0 CA-C-N 118.892 0.64 . . . . 0.0 111.85 -6.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.7 m -133.17 123.98 26.63 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.617 0.767 . . . . 0.0 109.868 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.4 mp -103.5 128.6 50.67 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.494 1.518 . . . . 0.0 108.981 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.1 mm -118.09 128.42 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.174 0.99 . . . . 0.0 109.065 167.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 17.3 tp -97.82 118.98 35.6 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 165.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -96.59 150.33 20.77 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.716 1.606 . . . . 0.0 109.739 170.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -128.52 134.18 48.61 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.606 1.163 . . . . 0.0 108.939 162.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.7 t0 48.67 41.47 17.79 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.197 0.999 . . . . 0.0 113.49 -175.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.02 15.97 70.1 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 124.72 1.153 . . . . 0.0 115.429 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -123.32 136.5 27.16 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.544 1.537 . . . . 0.0 109.574 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.38 139.37 45.27 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.633 2.222 . . . . 0.0 111.41 -177.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.6 t -126.19 -40.34 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.986 1.314 . . . . 0.0 112.517 -174.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -142.26 147.85 37.13 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 119.12 0.873 . . . . 0.0 112.854 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.8 ttt180 -126.2 137.89 53.59 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.056 2.143 . . . . 0.0 111.515 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.6 145.78 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.067 1.747 . . . . 0.0 109.744 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 p -137.05 149.47 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.374 1.069 . . . . 0.0 112.087 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.52 164.33 28.34 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.303 1.43 . . . . 0.0 112.527 -173.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.68 157.51 27.08 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 121.474 -1.016 . . . . 0.0 113.358 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -130.79 149.07 52.6 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.694 1.598 . . . . 0.0 110.464 169.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.89 166.69 41.26 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 160.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -50.49 -37.36 38.4 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.895 1.278 . . . . 0.0 114.03 -177.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.7 -47.79 68.4 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.195 0.598 . . . . 0.0 112.144 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.64 -43.5 72.52 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.464 -0.772 . . . . 0.0 111.982 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.7 tp -64.48 -45.66 86.43 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 122.044 -0.41 . . . . 0.0 110.81 177.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.8 tp -74.4 -18.37 60.67 Favored 'General case' 0 C--O 1.214 -0.807 0 CA-C-O 116.798 -1.572 . . . . 0.0 113.278 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -66.75 -52.75 40.71 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 123.359 2.8 . . . . 0.0 110.933 164.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -63.17 -24.36 67.85 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 86.4 mt -98.18 -19.62 17.77 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.076 0.95 . . . . 0.0 113.461 172.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.0 t -66.52 -23.08 66.18 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 120.584 -1.322 . . . . 0.0 110.809 167.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -54.69 -16.18 2.34 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.319 1.048 . . . . 0.0 113.54 164.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.37 -11.78 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.948 1.699 . . . . 0.0 114.043 169.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 N--CA 1.479 0.991 0 C-N-CA 128.164 2.586 . . . . 0.0 109.342 173.494 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.9 p . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.6 pt -139.51 155.25 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.02 1.728 . . . . 0.0 111.598 173.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -95.8 140.41 30.62 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.446 0.699 . . . . 0.0 110.117 161.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -117.33 150.7 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.403 1.481 . . . . 0.0 110.503 171.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.7 p -127.5 165.38 19.96 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.228 1.411 . . . . 0.0 111.354 -176.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -60.25 -27.79 67.52 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.91 -13.51 57.43 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.943 1.297 . . . . 0.0 114.188 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.4 m -126.55 -13.65 5.93 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -168.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -54.33 -42.08 69.77 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.228 1.411 . . . . 0.0 112.368 -173.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.33 -34.12 75.54 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.295 -0.878 . . . . 0.0 113.085 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.7 m -79.38 -28.09 41.88 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.476 1.11 . . . . 0.0 112.919 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -92.91 -40.9 10.34 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.352 -0.843 . . . . 0.0 113.234 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.4 t -99.39 -57.26 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.811 1.245 . . . . 0.0 111.191 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.1 mt -79.86 -18.69 50.11 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -171.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.8 m -85.56 -10.49 55.86 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.127 0.971 . . . . 0.0 113.045 174.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.4 t -79.9 130.4 35.27 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.787 0.835 . . . . 0.0 112.559 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -79.72 -21.29 44.74 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.964 0.906 . . . . 0.0 112.486 170.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -79.82 148.33 68.53 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 125.84 1.656 . . . . 0.0 110.517 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -58.51 132.55 49.09 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.035 1.824 . . . . 0.0 111.674 170.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.84 130.1 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.408 1.083 . . . . 0.0 110.647 -173.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.32 114.09 26.18 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.867 1.667 . . . . 0.0 108.665 -172.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.18 124.69 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.938 0.895 . . . . 0.0 110.727 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -104.28 116.3 31.91 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.421 1.089 . . . . 0.0 111.435 173.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -84.9 110.48 18.89 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.076 1.751 . . . . 0.0 108.375 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -143.63 171.28 14.4 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.56 1.144 . . . . 0.0 112.722 -164.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.54 154.81 39.32 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.791 0.836 . . . . 0.0 111.809 163.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.4 t -64.82 -20.88 66.63 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.957 0.903 . . . . 0.0 113.183 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.5 ' CZ3' HD11 ' A' ' 80' ' ' ILE . 11.7 p-90 -80.08 -1.56 40.55 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 177.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 50.8 t -109.77 117.31 33.53 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.226 1.01 . . . . 0.0 112.747 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.82 -47.72 89.0 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 124.363 0.983 . . . . 0.0 113.91 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -58.52 -31.6 94.73 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.925 2.417 . . . . 0.0 114.685 170.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 83.9 m -66.57 -45.02 80.68 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.481 1.037 . . . . 0.0 111.198 170.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -60.62 -29.69 69.38 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.552 0.741 . . . . 0.0 112.628 173.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 16.5 tpt -73.75 -42.64 60.81 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.757 1.223 . . . . 0.0 113.027 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.1 p -84.4 -21.33 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.32 -49.61 80.9 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -65.63 -30.13 51.41 Favored 'Trans proline' 0 C--N 1.353 0.764 0 CA-C-N 122.415 1.898 . . . . 0.0 113.003 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.4 t -68.23 -49.53 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 118.731 0.696 . . . . 0.0 110.124 175.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.5 mt -61.13 -34.93 75.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.136 0.975 . . . . 0.0 112.797 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -70.86 -40.29 72.42 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.218 0.917 . . . . 0.0 112.169 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -61.97 -42.51 99.21 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.09 -1.006 . . . . 0.0 111.516 169.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.7 mt -61.53 -43.76 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 118.771 0.714 . . . . 0.0 110.914 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.33 -37.65 81.27 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.988 0.915 . . . . 0.0 112.379 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.3 m -75.98 -47.18 26.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.776 0.83 . . . . 0.0 112.177 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -94.88 -21.81 18.42 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -167.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.41 16.61 23.72 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.591 1.556 . . . . 0.0 111.761 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.93 -27.93 47.09 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.1 1.76 . . . . 0.0 114.94 -173.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.9 p -78.35 -19.51 53.28 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.013 1.325 . . . . 0.0 113.845 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -111.17 -28.67 8.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.808 1.643 . . . . 0.0 113.57 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.7 mt -129.8 148.99 51.73 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.643 1.977 . . . . 0.0 111.04 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 57.8 m -108.62 133.01 53.32 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 153.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.0 t -103.18 130.96 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.477 0.711 . . . . 0.0 109.816 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.21 155.09 46.09 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.767 1.627 . . . . 0.0 112.011 -174.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -123.69 128.25 49.36 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.881 1.672 . . . . 0.0 110.548 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -108.16 113.86 27.31 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.6 102.24 10.52 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.116 0.966 . . . . 0.0 108.734 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.3 m -65.76 -17.18 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.887 -1.133 . . . . 0.0 112.787 -176.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -78.52 -20.0 51.72 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.941 1.296 . . . . 0.0 113.652 176.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.0 p -115.62 -22.42 9.22 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 174.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -129.46 62.61 64.01 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 125.641 1.576 . . . . 0.0 112.054 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -64.71 -20.71 65.24 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.804 2.336 . . . . 0.0 112.742 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -62.46 -39.92 94.98 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.897 0.879 . . . . 0.0 111.721 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -73.69 -37.24 65.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.842 0.857 . . . . 0.0 111.49 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.01 -43.78 95.01 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.496 0.719 . . . . 0.0 111.683 171.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.4 ttp-105 -73.74 -33.85 64.5 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -56.42 -42.43 78.03 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.505 1.122 . . . . 0.0 112.964 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -98.19 5.28 48.64 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.425 1.09 . . . . 0.0 113.334 174.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.36 15.8 pt20 46.81 25.74 0.48 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 128.298 2.639 . . . . 0.0 116.013 -168.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.2 m -80.46 39.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.744 2.017 . . . . 0.0 111.857 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.7 m -74.95 -21.66 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.966 1.306 . . . . 0.0 113.304 -172.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 54.2 m -80.92 137.94 36.13 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.773 1.229 . . . . 0.0 110.223 166.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.5 HD11 ' CZ3' ' A' ' 36' ' ' TRP . 48.1 pt -135.71 155.16 78.32 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -167.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -68.34 141.45 61.25 Favored 'Cis proline' 0 C--N 1.353 0.786 0 CA-C-N 119.212 0.754 . . . . 0.0 111.361 -6.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.4 m -126.94 120.57 29.46 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.274 0.63 . . . . 0.0 109.399 169.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.7 mp -102.57 126.11 49.53 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.942 1.697 . . . . 0.0 107.855 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.2 tt -118.25 139.22 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.228 1.011 . . . . 0.0 109.692 171.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.0 tp -113.16 129.7 56.43 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.408 1.083 . . . . 0.0 109.671 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -113.86 151.06 32.69 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.191 1.396 . . . . 0.0 110.402 171.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -132.48 127.99 36.43 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.305 1.442 . . . . 0.0 108.972 168.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.4 t70 49.05 41.49 19.37 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.297 1.039 . . . . 0.0 113.398 -168.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.33 9.7 55.36 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.626 1.584 . . . . 0.0 115.739 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -112.61 139.39 22.68 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 125.441 1.496 . . . . 0.0 109.845 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.14 140.03 43.91 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.536 2.157 . . . . 0.0 112.299 -171.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.8 t -117.71 -46.56 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.718 1.607 . . . . 0.0 111.469 -176.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -155.13 150.23 26.92 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.308 1.043 . . . . 0.0 112.052 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 67.6 ttp85 -129.81 139.17 51.29 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.061 1.345 . . . . 0.0 111.583 167.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 30.8 mt -132.25 142.58 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 127.388 2.275 . . . . 0.0 108.354 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 p -133.61 147.78 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.286 1.035 . . . . 0.0 112.022 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.98 161.92 24.54 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.541 1.543 . . . . 0.0 112.945 -175.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.73 151.71 28.72 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -136.66 153.19 50.98 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.353 1.861 . . . . 0.0 110.373 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.49 162.02 32.91 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 160.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -55.85 -34.12 65.15 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.81 -47.58 77.55 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 118.088 0.404 . . . . 0.0 111.18 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.13 -45.99 58.34 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.495 -0.753 . . . . 0.0 112.321 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.1 tp -65.73 -44.89 84.65 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 118.879 0.763 . . . . 0.0 110.685 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 16.7 tp -69.91 -24.93 63.46 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-O 115.825 -2.036 . . . . 0.0 112.753 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -65.24 -50.47 65.68 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 124.053 3.115 . . . . 0.0 111.644 168.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -62.54 -27.23 69.02 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 80.7 mt -87.57 -28.54 21.88 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.221 1.009 . . . . 0.0 113.439 169.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.3 m -62.37 -27.88 69.38 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.309 1.443 . . . . 0.0 110.608 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -49.49 -26.79 3.65 Favored 'General case' 0 CA--C 1.56 1.344 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 165.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.0 t -111.56 -22.36 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 128.223 2.609 . . . . 0.0 112.777 172.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.479 1.024 0 C-N-CA 127.632 2.373 . . . . 0.0 110.662 -179.787 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.9 p . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.2 pt -137.27 155.27 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 126.056 1.743 . . . . 0.0 111.546 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -93.61 139.13 31.13 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.389 0.675 . . . . 0.0 110.819 167.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.1 m -125.57 150.42 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.453 1.501 . . . . 0.0 110.571 172.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.3 p -143.28 157.33 44.57 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.302 1.441 . . . . 0.0 111.115 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -52.17 -28.09 16.85 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -174.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.06 -20.1 64.1 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.8 m -136.49 -3.87 2.1 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.386 1.474 . . . . 0.0 114.062 -176.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -53.51 -41.24 66.12 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.839 1.656 . . . . 0.0 112.526 -174.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.3 -33.16 74.71 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.6 m -79.51 -31.15 42.16 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.249 1.02 . . . . 0.0 112.643 175.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -88.81 -41.43 12.51 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -176.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.9 t -105.57 -52.46 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.106 1.363 . . . . 0.0 111.253 -172.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 29.3 mt -81.82 -13.45 57.66 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -171.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 74.6 m -89.21 -9.81 49.39 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.975 0.91 . . . . 0.0 113.346 175.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.3 t -77.58 140.47 39.69 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.044 0.938 . . . . 0.0 113.323 -174.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -98.78 -5.36 31.38 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.096 1.358 . . . . 0.0 113.559 176.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -98.56 162.84 20.41 Favored Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 124.588 1.155 . . . . 0.0 110.624 164.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -57.02 138.49 86.56 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.299 1.999 . . . . 0.0 113.448 170.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.7 t -132.62 131.41 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.451 1.5 . . . . 0.0 108.895 177.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -122.98 120.03 32.17 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.194 1.398 . . . . 0.0 109.279 -172.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.6 t -119.46 126.35 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.559 0.744 . . . . 0.0 111.138 -172.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -107.0 118.68 37.33 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.959 1.304 . . . . 0.0 112.455 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -94.08 111.57 23.3 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.582 1.953 . . . . 0.0 108.518 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -143.69 172.6 12.59 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.278 1.431 . . . . 0.0 112.884 -163.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -144.59 148.62 34.59 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 163.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 m -60.09 -27.85 67.35 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.675 1.19 . . . . 0.0 112.652 174.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 6.2 p-90 -76.61 -4.19 41.67 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 53.2 t -108.16 122.69 47.44 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.701 1.2 . . . . 0.0 111.792 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.38 -48.21 86.46 Favored Glycine 0 CA--C 1.539 1.543 0 CA-C-O 118.892 -0.949 . . . . 0.0 114.079 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -56.47 -36.24 97.37 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.045 2.497 . . . . 0.0 114.302 170.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 96.9 m -64.36 -45.18 88.87 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.279 -0.888 . . . . 0.0 111.88 173.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -62.39 -31.01 71.62 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.334 1.054 . . . . 0.0 112.397 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.4 ttp -75.69 -38.3 58.8 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.976 1.31 . . . . 0.0 113.376 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.2 p -83.91 -19.06 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.64 -51.42 76.45 Favored Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 175.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.85 -30.8 39.94 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.236 1.957 . . . . 0.0 113.058 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.521 HG13 ' HA ' ' A' ' 101' ' ' LYS . 30.0 t -64.28 -48.48 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.643 0.777 . . . . 0.0 110.68 173.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 38.9 mt -66.75 -32.94 74.57 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.453 0.701 . . . . 0.0 112.566 176.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -67.41 -42.05 83.89 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.136 0.88 . . . . 0.0 112.127 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.98 -47.86 81.34 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.314 -0.866 . . . . 0.0 111.635 170.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.4 -40.16 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 118.803 0.729 . . . . 0.0 110.822 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.8 -49.63 76.97 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.403 -0.811 . . . . 0.0 111.989 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.4 m -76.29 -31.32 58.16 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.55 0.74 . . . . 0.0 112.195 -171.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -95.74 -23.55 16.91 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -112.32 17.07 19.71 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.232 1.413 . . . . 0.0 113.292 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.04 -27.72 21.07 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.607 1.563 . . . . 0.0 114.351 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.3 p -67.79 -20.36 65.19 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.791 1.636 . . . . 0.0 113.87 176.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -117.29 -46.34 2.7 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.801 1.24 . . . . 0.0 112.72 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.9 mt -99.48 148.88 23.79 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.369 1.468 . . . . 0.0 111.126 -176.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.8 m -108.91 122.15 46.61 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 149.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 75.1 t -105.14 124.71 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.281 0.632 . . . . 0.0 110.126 -175.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.72 163.59 23.17 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.452 1.501 . . . . 0.0 112.326 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -130.31 147.3 52.01 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.694 1.598 . . . . 0.0 112.071 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -125.98 117.39 23.16 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.856 1.662 . . . . 0.0 108.83 169.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -81.75 113.24 19.59 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 122.883 0.473 . . . . 0.0 110.422 174.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.8 m -70.87 -16.95 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -172.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -84.17 -39.71 19.06 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.42 1.088 . . . . 0.0 112.43 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 36.3 p -92.66 -23.6 18.92 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.183 1.393 . . . . 0.0 113.893 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -134.88 69.69 71.1 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-N 119.499 1.045 . . . . 0.0 112.055 173.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -66.76 -26.72 45.1 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.153 2.569 . . . . 0.0 114.768 -172.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -64.11 -35.7 81.62 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.608 -0.683 . . . . 0.0 111.817 -175.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.2 m -64.05 -43.26 96.04 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.311 1.044 . . . . 0.0 111.309 176.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.35 -39.61 95.01 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.737 0.815 . . . . 0.0 112.018 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.34 -45.25 63.39 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.296 177.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -63.99 -32.73 74.38 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 118.878 0.763 . . . . 0.0 112.782 -171.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -98.45 8.04 45.4 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.344 1.058 . . . . 0.0 113.746 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.1 tp60 49.88 52.59 14.34 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.462 1.905 . . . . 0.0 113.35 -177.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.1 m -132.88 48.61 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.216 1.806 . . . . 0.0 109.647 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.5 m -78.42 -21.47 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.228 1.411 . . . . 0.0 113.657 -176.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.1 m -72.09 155.73 39.97 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.747 1.219 . . . . 0.0 111.112 168.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.61 149.28 49.96 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -174.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.43 136.65 41.25 Favored 'Cis proline' 0 C--N 1.353 0.771 0 N-CA-C 110.424 -0.644 . . . . 0.0 110.424 -14.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 98.7 m -127.88 121.38 29.89 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.851 0.86 . . . . 0.0 110.485 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.0 mp -102.26 132.31 48.29 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.368 1.467 . . . . 0.0 109.223 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.9 tp -121.9 128.13 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.992 1.317 . . . . 0.0 109.376 171.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 41.3 tp -108.23 127.97 54.31 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.005 1.322 . . . . 0.0 110.309 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -113.69 144.18 43.37 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.985 1.714 . . . . 0.0 109.535 172.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -107.22 -29.75 9.15 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -150.01 40.79 0.81 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.715 2.006 . . . . 0.0 109.913 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.92 -6.07 7.06 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 125.354 1.454 . . . . 0.0 115.141 -165.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -94.63 138.2 22.33 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 118.787 1.293 . . . . 0.0 110.607 167.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.51 146.07 38.74 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.353 2.702 . . . . 0.0 112.114 -176.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.6 m -132.99 -24.99 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -177.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 107' ' ' GLU . 33.0 tttp -153.59 143.81 22.23 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.715 1.143 . . . . 0.0 111.67 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -128.9 137.93 51.71 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.854 2.062 . . . . 0.0 110.783 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.6 mt -135.18 141.58 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.91 1.684 . . . . 0.0 108.721 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 p -133.81 142.18 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 119.398 0.999 . . . . 0.0 111.127 168.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 91.86 150.0 24.94 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.273 1.416 . . . . 0.0 112.955 -171.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.42 144.67 31.25 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.074 0.95 . . . . 0.0 113.147 -174.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -134.56 159.99 39.46 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.067 1.747 . . . . 0.0 110.7 172.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -74.88 166.36 54.86 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.429 -0.669 . . . . 0.0 111.429 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.521 ' HA ' HG13 ' A' ' 46' ' ' VAL . 3.0 tmtp? -51.0 -37.33 44.38 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.836 1.254 . . . . 0.0 113.384 -173.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.95 -49.41 52.08 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.05 0.386 . . . . 0.0 111.76 -177.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.73 -37.59 59.26 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.548 0.739 . . . . 0.0 112.792 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.29 -45.44 87.99 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.4 1.0 . . . . 0.0 109.733 174.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 21.4 tp -70.2 -20.09 63.13 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-O 116.402 -1.761 . . . . 0.0 112.989 171.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.72 -54.12 49.18 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 123.802 3.001 . . . . 0.0 110.239 166.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.407 ' HB3' ' HE2' ' A' ' 93' ' ' LYS . 40.3 mm-40 -63.62 -26.59 68.75 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 114.43 -1.259 . . . . 0.0 113.136 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 82.4 mt -91.34 -21.82 20.83 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 168.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 31.8 m -65.84 -20.73 66.35 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.785 -1.197 . . . . 0.0 111.214 172.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -47.1 -27.3 1.33 Allowed 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 160.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -116.79 -25.13 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.701 1.6 . . . . 0.0 113.749 177.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.484 1.235 0 C-N-CA 125.604 1.561 . . . . 0.0 112.667 171.337 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.474 0.754 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.2 pt -142.03 159.59 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 126.474 1.91 . . . . 0.0 111.278 174.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -100.04 140.15 34.68 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.64 0.776 . . . . 0.0 110.22 163.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.6 m -130.12 145.96 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.469 1.108 . . . . 0.0 111.557 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.0 p -140.35 159.27 42.57 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.39 1.476 . . . . 0.0 111.236 176.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -51.74 -27.95 13.6 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.615 1.966 . . . . 0.0 114.805 -173.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.23 -22.02 65.71 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.8 m -136.73 1.19 2.53 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.677 1.591 . . . . 0.0 113.547 -175.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -55.48 -42.68 74.71 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.461 1.504 . . . . 0.0 112.461 -170.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.12 -32.11 73.36 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.6 m -79.01 -32.76 45.23 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.493 -0.754 . . . . 0.0 111.892 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -87.97 -40.78 13.62 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t -101.52 -40.09 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.203 1.401 . . . . 0.0 112.406 -171.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -100.76 -20.07 15.73 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -170.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.8 m -94.18 8.13 42.8 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.041 1.336 . . . . 0.0 113.768 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.7 p -69.52 157.21 37.59 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.007 2.123 . . . . 0.0 114.591 -176.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -87.87 -6.57 58.02 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.525 1.13 . . . . 0.0 113.557 173.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -142.21 166.35 21.81 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 127.744 2.418 . . . . 0.0 110.769 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -56.33 148.24 62.57 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.978 2.452 . . . . 0.0 113.694 173.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.2 t -132.49 128.97 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.975 1.31 . . . . 0.0 110.347 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 tt -98.05 128.16 44.42 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.255 1.822 . . . . 0.0 108.64 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.9 t -116.02 125.42 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 119.516 1.053 . . . . 0.0 110.898 172.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -106.55 114.49 28.64 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.827 1.651 . . . . 0.0 111.315 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -92.39 109.0 20.38 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.927 2.091 . . . . 0.0 108.016 175.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -142.19 -178.5 5.75 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.1 1.36 . . . . 0.0 111.372 -163.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.61 141.14 30.49 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 166.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 46.9 m -56.73 -29.94 63.02 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.524 1.53 . . . . 0.0 112.117 172.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 35.6 p-90 -88.74 -0.9 57.76 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.85 1.66 . . . . 0.0 115.138 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 48.1 t -110.11 134.21 52.41 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.473 1.033 . . . . 0.0 113.238 -172.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.37 -57.06 14.2 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.17 1.367 . . . . 0.0 115.477 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.21 -27.36 72.53 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 CA-C-N 120.939 2.37 . . . . 0.0 112.903 175.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 93.0 m -63.76 -43.97 94.84 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.129 -0.982 . . . . 0.0 111.74 169.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.01 -30.48 71.55 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.195 0.998 . . . . 0.0 112.553 173.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 15.8 tpt -73.35 -38.47 65.73 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.657 1.183 . . . . 0.0 113.353 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.4 p -84.42 -20.82 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.09 -50.31 82.81 Favored Pre-proline 0 CA--C 1.552 1.022 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.22 -29.67 32.23 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.293 1.995 . . . . 0.0 113.147 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.466 HG13 ' HA ' ' A' ' 101' ' ' LYS . 41.9 t -65.26 -49.18 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.409 0.684 . . . . 0.0 110.21 173.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.6 mt -63.99 -33.61 76.11 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.802 0.841 . . . . 0.0 112.709 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -64.14 -44.85 90.9 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.302 0.955 . . . . 0.0 111.517 174.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -61.63 -45.39 94.28 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.325 -0.859 . . . . 0.0 111.492 173.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.4 mt -59.68 -43.74 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 121.415 -0.803 . . . . 0.0 111.068 176.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.55 -37.26 86.65 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.102 0.961 . . . . 0.0 112.642 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.4 m -73.62 -46.89 44.23 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.784 0.834 . . . . 0.0 111.236 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -87.27 -35.49 18.44 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.498 1.119 . . . . 0.0 114.004 -170.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -99.72 24.7 8.0 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.598 1.159 . . . . 0.0 113.273 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.88 -28.12 47.9 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.109 1.363 . . . . 0.0 114.311 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.0 p -83.25 -19.39 36.47 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.296 1.438 . . . . 0.0 113.834 175.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -102.62 -38.15 7.63 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.082 1.353 . . . . 0.0 112.79 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 79.8 mt -129.8 160.89 32.07 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.34 2.256 . . . . 0.0 110.944 -175.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.4 m -108.8 138.8 44.54 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 147.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.5 t -101.29 129.97 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.82 0.848 . . . . 0.0 109.5 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.4 151.83 48.3 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.275 1.43 . . . . 0.0 111.557 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -127.67 148.8 50.4 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.987 1.315 . . . . 0.0 113.123 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -135.33 114.47 12.25 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.644 1.977 . . . . 0.0 108.875 168.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -81.39 116.34 21.17 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 171.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.5 m -64.55 -20.25 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -167.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -79.88 -22.58 42.68 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 172.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.1 p -92.57 -29.1 16.34 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -171.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -145.53 92.58 5.5 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 123.932 0.893 . . . . 0.0 110.73 162.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -62.46 -26.48 76.49 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.255 2.636 . . . . 0.0 114.894 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -71.78 -31.72 66.9 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.048 -1.033 . . . . 0.0 111.858 -175.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.5 m -65.75 -41.12 92.49 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.449 0.7 . . . . 0.0 110.786 174.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.1 -35.6 80.13 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.022 0.929 . . . . 0.0 112.609 172.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.3 tpt85 -73.49 -36.63 65.81 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -65.4 -28.64 69.4 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -172.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -103.14 5.34 37.79 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.35 1.06 . . . . 0.0 113.207 174.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 48.56 57.05 6.69 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.835 1.654 . . . . 0.0 112.172 -169.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.6 m -124.81 36.03 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.645 1.978 . . . . 0.0 111.038 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.7 m -71.67 -19.3 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.344 1.058 . . . . 0.0 113.156 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.2 m -68.01 151.73 46.62 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.408 1.483 . . . . 0.0 111.507 169.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 13.5 pt -139.31 142.53 32.84 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -168.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -67.71 149.08 82.48 Favored 'Cis proline' 0 CA--C 1.54 0.797 0 CA-C-N 118.498 0.499 . . . . 0.0 111.121 -17.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 67.7 m -133.42 125.15 28.44 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.756 1.222 . . . . 0.0 109.399 171.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.6 mp -109.28 136.48 48.67 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.593 1.157 . . . . 0.0 109.334 177.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.0 tt -127.9 144.87 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.202 1.001 . . . . 0.0 110.284 169.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.5 tp -121.52 120.44 34.87 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.941 0.897 . . . . 0.0 110.54 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -98.4 131.08 44.97 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.559 1.144 . . . . 0.0 109.604 172.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -99.59 -33.49 10.61 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -175.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -154.49 57.11 0.7 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.215 1.806 . . . . 0.0 110.174 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.5 15.87 64.47 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.51 1.052 . . . . 0.0 114.551 -173.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -140.31 137.56 17.98 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 126.966 2.106 . . . . 0.0 110.546 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -76.14 142.72 24.82 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.193 2.595 . . . . 0.0 112.645 -173.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.1 t -128.66 -28.6 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.689 1.596 . . . . 0.0 112.697 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -135.16 142.15 46.06 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.07 1.348 . . . . 0.0 110.077 172.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.8 ttt85 -147.03 113.22 5.86 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.957 2.103 . . . . 0.0 109.6 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 33.9 pt -137.05 148.17 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.377 1.471 . . . . 0.0 113.152 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.9 m -121.64 145.77 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 125.637 1.575 . . . . 0.0 111.195 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.95 160.49 24.32 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 124.164 0.888 . . . . 0.0 113.557 -172.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.39 145.53 31.96 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.853 0.861 . . . . 0.0 112.769 -176.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -130.59 153.33 49.01 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.801 1.641 . . . . 0.0 110.056 169.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -74.18 165.54 54.78 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 175.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.466 ' HA ' HG13 ' A' ' 46' ' ' VAL . 3.0 tmtp? -51.69 -35.22 41.89 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.665 1.186 . . . . 0.0 113.308 -174.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.48 -53.99 29.03 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.0 0.364 . . . . 0.0 111.197 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.44 -33.13 60.87 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.53 -45.09 94.57 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.472 1.033 . . . . 0.0 109.631 171.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 25.7 tp -69.41 -24.23 63.82 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-O 115.691 -2.099 . . . . 0.0 113.112 173.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.76 -51.04 69.95 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 124.295 3.225 . . . . 0.0 111.524 167.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -57.39 -37.53 72.81 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.05 0.94 . . . . 0.0 111.73 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.8 mt -83.16 -28.35 29.43 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 172.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.4 m -62.56 -28.15 69.67 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.037 1.335 . . . . 0.0 110.641 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -52.5 -26.6 13.44 Favored 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 168.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 51.3 t -107.3 -24.41 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.886 2.074 . . . . 0.0 112.519 171.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.4 t . . . . . 0 N--CA 1.475 0.823 0 C-N-CA 126.537 1.935 . . . . 0.0 111.502 -177.587 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.6 p . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.9 pt -132.84 165.34 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 126.209 1.803 . . . . 0.0 111.413 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -117.28 145.42 43.98 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.88 0.872 . . . . 0.0 111.753 171.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.15 156.47 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 126.326 1.851 . . . . 0.0 110.964 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 65.2 p -123.85 168.57 12.58 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.912 1.685 . . . . 0.0 111.566 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -57.29 -27.58 62.28 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 121.018 -1.051 . . . . 0.0 113.136 175.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.6 -13.31 56.74 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.224 1.409 . . . . 0.0 114.515 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.1 p -128.88 -8.91 4.94 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -173.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -57.06 -47.91 79.82 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.282 1.433 . . . . 0.0 112.055 -176.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.61 -34.28 77.52 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.3 -0.875 . . . . 0.0 112.699 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.23 -8.71 59.24 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.755 1.622 . . . . 0.0 113.666 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -121.81 -47.87 2.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.501 1.12 . . . . 0.0 113.455 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.3 t -83.16 -51.45 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.15 1.38 . . . . 0.0 111.037 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 43.3 mt -84.67 -13.22 52.11 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -174.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.7 p -78.17 -18.8 55.08 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.955 1.302 . . . . 0.0 113.785 176.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.5 t -86.05 133.24 33.91 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.63 1.172 . . . . 0.0 113.459 -168.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -75.77 -31.62 59.6 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.389 1.076 . . . . 0.0 111.528 168.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -80.68 138.88 50.62 Favored Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 124.891 1.276 . . . . 0.0 108.85 174.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -59.07 142.44 99.35 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 121.388 1.392 . . . . 0.0 113.507 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.5 t -124.35 125.67 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.384 1.474 . . . . 0.0 109.354 -177.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -108.39 115.25 29.75 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.655 1.582 . . . . 0.0 109.303 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.2 t -108.76 122.42 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.186 0.994 . . . . 0.0 110.829 -175.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -92.33 109.3 20.68 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.732 1.613 . . . . 0.0 111.021 173.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -83.61 112.86 20.4 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.793 1.237 . . . . 0.0 108.497 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -146.41 168.57 20.82 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.22 1.008 . . . . 0.0 113.033 -164.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.18 155.27 38.52 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.755 1.222 . . . . 0.0 110.974 166.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.9 t -66.05 -19.18 65.77 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -75.56 -4.44 39.94 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 48.5 t -109.29 108.83 19.56 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.348 1.059 . . . . 0.0 112.535 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.59 -40.43 94.6 Favored Glycine 0 CA--C 1.54 1.633 0 CA-C-O 118.848 -0.973 . . . . 0.0 113.972 174.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -60.44 -33.08 94.42 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.44 2.093 . . . . 0.0 114.459 168.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 91.1 m -63.69 -44.75 92.76 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.812 1.187 . . . . 0.0 110.735 168.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -60.0 -36.31 76.93 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 175.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 13.2 ptm -80.44 -29.97 37.56 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.2 p -84.6 -24.01 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-N 119.8 1.182 . . . . 0.0 113.563 174.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.13 -48.72 63.45 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 176.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -65.83 -29.1 50.64 Favored 'Trans proline' 0 C--N 1.353 0.777 0 CA-C-N 122.216 1.827 . . . . 0.0 113.475 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.3 t -69.15 -51.34 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 119.374 0.988 . . . . 0.0 110.334 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.0 pp -70.22 -28.43 65.26 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -68.65 -40.22 80.31 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.147 0.979 . . . . 0.0 112.932 171.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -63.23 -47.21 83.46 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.928 -1.107 . . . . 0.0 111.348 170.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.22 -37.88 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 118.483 0.583 . . . . 0.0 110.679 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.65 -49.96 75.61 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.276 0.944 . . . . 0.0 112.752 172.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.1 m -76.05 -33.27 59.6 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.843 0.857 . . . . 0.0 111.681 -169.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -83.92 -34.08 24.57 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 176.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -108.1 27.71 9.0 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.946 1.298 . . . . 0.0 113.744 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.02 -28.33 62.39 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.4 m -69.47 -27.35 65.15 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.08 1.352 . . . . 0.0 112.523 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -103.57 -34.28 8.71 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.44 1.496 . . . . 0.0 112.816 -174.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.5 mt -129.85 152.72 49.02 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.141 2.176 . . . . 0.0 111.178 -174.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.5 m -108.65 133.85 52.18 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 150.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.5 t -110.62 121.44 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 122.993 0.517 . . . . 0.0 109.862 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -118.06 164.84 14.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.521 1.528 . . . . 0.0 112.19 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 46.0 mttm -124.86 136.53 53.89 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.066 1.747 . . . . 0.0 111.463 173.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -113.2 117.22 31.28 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.992 1.317 . . . . 0.0 108.496 167.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.81 98.07 8.3 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.905 1.282 . . . . 0.0 108.604 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.3 m -67.06 -19.29 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 O-C-N 121.362 -0.836 . . . . 0.0 112.992 -172.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -72.42 -23.22 61.05 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.429 1.092 . . . . 0.0 112.555 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.5 p -118.2 -15.56 9.79 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.469 1.508 . . . . 0.0 113.593 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -123.3 60.94 18.42 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 125.392 1.477 . . . . 0.0 111.864 176.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.69 -23.57 56.15 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.591 2.194 . . . . 0.0 112.546 178.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -64.76 -42.9 94.77 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.006 0.922 . . . . 0.0 111.815 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.68 -37.02 73.59 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.575 0.75 . . . . 0.0 111.121 176.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.83 -47.1 86.61 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.76 0.824 . . . . 0.0 112.34 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 -77.43 -24.61 50.35 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -57.49 -41.41 80.68 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.935 0.894 . . . . 0.0 112.858 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -101.1 6.02 43.1 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.892 1.277 . . . . 0.0 113.219 174.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.376 16.2 pt20 46.38 29.35 0.85 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 128.286 2.634 . . . . 0.0 115.84 -166.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.5 m -80.68 38.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 126.66 1.984 . . . . 0.0 111.93 174.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 m -75.13 -25.29 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.947 1.299 . . . . 0.0 112.606 -175.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 55.6 m -78.61 140.39 38.46 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.731 1.212 . . . . 0.0 110.051 165.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 48.9 pt -138.96 155.4 72.97 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 123.884 0.874 . . . . 0.0 113.183 -168.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.41 141.94 63.98 Favored 'Cis proline' 0 C--N 1.354 0.835 0 CA-C-N 119.393 0.819 . . . . 0.0 111.96 -5.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.6 m -131.68 121.59 24.54 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.628 0.771 . . . . 0.0 109.812 171.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.1 mp -108.07 119.46 39.54 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.856 1.662 . . . . 0.0 108.553 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.4 tt -116.64 133.2 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.413 1.085 . . . . 0.0 110.651 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.6 tt -104.43 125.0 50.23 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.036 0.934 . . . . 0.0 110.385 173.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -102.69 144.65 30.8 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.339 1.456 . . . . 0.0 109.942 166.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -130.2 129.43 43.38 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.479 1.511 . . . . 0.0 109.34 172.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.8 t0 47.62 37.59 6.92 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.359 1.064 . . . . 0.0 113.323 -167.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.15 18.68 71.33 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 125.048 1.309 . . . . 0.0 116.364 -178.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -122.92 143.1 39.65 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 119.461 1.631 . . . . 0.0 110.87 172.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.28 140.3 44.11 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.749 2.3 . . . . 0.0 112.24 -173.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.7 t -123.79 -44.79 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.124 1.37 . . . . 0.0 112.629 -175.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.6 tttm -148.83 152.52 36.64 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.944 0.793 . . . . 0.0 112.129 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -138.51 141.46 39.37 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.559 1.144 . . . . 0.0 112.382 173.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.8 mp -129.4 139.49 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 127.361 2.265 . . . . 0.0 108.393 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.3 p -132.03 142.86 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.355 1.062 . . . . 0.0 111.237 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.78 154.92 19.62 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.11 1.338 . . . . 0.0 112.549 -169.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.39 137.18 46.36 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.865 -0.785 . . . . 0.0 111.904 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -131.8 154.63 48.92 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.78 1.632 . . . . 0.0 110.946 174.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -76.13 166.53 54.41 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 172.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -54.6 -33.39 60.33 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.08 -56.06 25.31 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 123.219 0.324 . . . . 0.0 110.95 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.75 -37.89 58.92 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.313 -0.867 . . . . 0.0 113.286 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.5 tp -66.17 -36.04 82.04 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 119.905 1.23 . . . . 0.0 110.906 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 16.9 tp -74.17 -24.55 59.4 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-O 115.722 -2.085 . . . . 0.0 113.073 170.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -56.91 -54.21 49.16 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 124.319 3.236 . . . . 0.0 110.375 163.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -68.53 -26.02 65.23 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -174.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 93.3 mt -93.75 -25.6 17.35 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.043 0.937 . . . . 0.0 113.435 172.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.3 t -67.79 -21.61 65.23 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.418 1.087 . . . . 0.0 111.614 171.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -49.44 -25.69 2.76 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 161.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 70.6 t -111.07 -25.6 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 127.436 2.294 . . . . 0.0 112.496 172.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.4 t . . . . . 0 N--CA 1.482 1.14 0 C-N-CA 127.172 2.189 . . . . 0.0 111.186 177.702 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.8 p . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 45.5 pt -134.29 162.73 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 126.104 1.762 . . . . 0.0 110.484 171.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -120.04 146.6 45.74 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.579 -0.7 . . . . 0.0 112.7 165.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.3 m -120.19 155.06 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.446 1.898 . . . . 0.0 110.973 -176.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.5 p -131.79 161.99 31.6 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.793 1.237 . . . . 0.0 112.684 -174.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.83 -26.09 57.55 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.087 1.355 . . . . 0.0 114.629 -175.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.61 -16.15 52.42 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.701 1.2 . . . . 0.0 114.19 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.7 m -134.44 -5.57 2.59 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -168.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -53.97 -41.89 68.34 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.069 1.348 . . . . 0.0 112.653 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.67 -32.51 73.23 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.9 m -78.85 -32.11 45.94 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.292 1.037 . . . . 0.0 111.921 176.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -87.32 -44.54 11.32 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.5 t -98.83 -51.92 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.964 1.306 . . . . 0.0 111.592 -173.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 33.5 mt -84.56 -13.47 51.67 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -170.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.8 t -81.11 -12.07 59.34 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.263 1.025 . . . . 0.0 112.894 173.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.3 t -69.67 142.69 53.35 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -171.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.2 p-10 -94.62 3.24 55.33 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.792 1.637 . . . . 0.0 113.76 173.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -126.48 167.08 18.27 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 126.946 2.098 . . . . 0.0 111.043 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -58.21 138.78 87.71 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.318 2.012 . . . . 0.0 113.257 170.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.8 t -132.58 129.33 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.09 1.356 . . . . 0.0 109.139 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -116.93 115.52 25.64 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.359 1.464 . . . . 0.0 109.231 -173.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.7 t -110.65 121.19 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.454 0.702 . . . . 0.0 110.828 -174.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -91.24 106.34 18.44 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.539 1.535 . . . . 0.0 110.6 173.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -80.61 114.34 19.43 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.088 1.355 . . . . 0.0 108.68 173.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.6 p-90 -147.94 168.64 21.75 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.979 0.911 . . . . 0.0 113.021 -164.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.53 153.87 36.59 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.402 1.081 . . . . 0.0 110.672 161.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.3 t -65.6 -20.05 66.16 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -75.22 -10.47 59.5 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 173.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 45.2 t -98.19 110.98 23.46 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.919 0.888 . . . . 0.0 110.969 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.08 -49.03 69.77 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-O 118.768 -1.018 . . . . 0.0 113.306 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -57.62 -32.57 94.81 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.032 2.488 . . . . 0.0 114.829 172.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 68.6 m -67.24 -44.84 78.46 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.914 -1.116 . . . . 0.0 111.157 171.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -63.03 -29.66 70.99 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.284 1.034 . . . . 0.0 112.177 176.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 60.7 mtt -75.82 -36.69 59.61 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.566 1.547 . . . . 0.0 113.782 173.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -87.32 -22.81 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 119.432 1.015 . . . . 0.0 113.677 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.74 -47.31 72.36 Favored Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 174.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -66.61 -27.01 45.96 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 CA-C-N 122.338 1.871 . . . . 0.0 113.735 176.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 92.1 t -70.96 -47.02 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.452 1.024 . . . . 0.0 109.305 173.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.64 -37.62 82.1 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.219 1.408 . . . . 0.0 112.269 177.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -66.33 -39.36 89.18 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.156 0.982 . . . . 0.0 112.503 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -67.26 -44.13 80.14 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.522 -0.736 . . . . 0.0 111.64 172.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.2 mm -61.24 -39.95 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 119.548 1.067 . . . . 0.0 111.055 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.09 -46.96 86.94 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.32 -0.863 . . . . 0.0 112.104 175.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.9 m -76.32 -34.77 59.01 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.546 0.738 . . . . 0.0 112.716 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -98.92 -16.95 18.6 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -172.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 74.5 mmt-85 -121.48 21.32 11.0 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.314 1.445 . . . . 0.0 113.438 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.95 -27.63 19.81 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.68 1.592 . . . . 0.0 114.03 175.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.2 p -70.14 -21.39 63.09 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.575 1.55 . . . . 0.0 114.113 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -117.39 -35.3 4.05 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.497 1.119 . . . . 0.0 113.484 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 57.3 mt -119.5 155.17 32.62 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.978 1.711 . . . . 0.0 110.843 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 57.1 m -108.73 126.19 52.73 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 152.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.7 t -102.58 123.26 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.095 0.558 . . . . 0.0 110.404 -177.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.23 165.62 17.96 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.891 1.676 . . . . 0.0 111.769 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -126.72 140.55 52.31 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.221 1.408 . . . . 0.0 111.386 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -116.06 116.99 28.87 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.362 1.065 . . . . 0.0 108.93 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.95 97.62 7.54 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.179 1.392 . . . . 0.0 108.615 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.9 m -66.42 -19.85 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 121.391 -0.818 . . . . 0.0 113.139 -173.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -72.69 -22.94 60.83 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.123 0.969 . . . . 0.0 112.596 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.4 p -117.42 -16.02 10.26 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.601 1.561 . . . . 0.0 113.41 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -123.3 59.05 14.04 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 125.21 1.404 . . . . 0.0 112.301 176.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -65.32 -25.96 56.47 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.52 2.147 . . . . 0.0 112.542 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -63.94 -45.06 90.85 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.981 0.912 . . . . 0.0 111.533 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.3 m -66.77 -38.6 86.9 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.629 0.772 . . . . 0.0 111.363 175.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.56 -43.75 98.04 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.612 0.765 . . . . 0.0 112.686 177.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.9 ptt85 -78.09 -26.74 48.26 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -56.69 -40.83 76.29 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.184 0.994 . . . . 0.0 113.465 -177.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -98.56 4.65 48.16 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.085 0.954 . . . . 0.0 113.256 177.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 52.57 49.25 20.8 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.357 1.863 . . . . 0.0 112.944 -167.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.0 m -115.23 22.5 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.721 1.608 . . . . 0.0 113.144 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.1 m -61.79 -22.29 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.062 1.345 . . . . 0.0 113.444 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.6 m -77.38 70.15 3.73 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.404 1.881 . . . . 0.0 112.077 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.2 pt -73.37 148.01 87.97 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.14 138.35 44.0 Favored 'Cis proline' 0 C--N 1.353 0.797 0 CA-C-N 119.567 0.881 . . . . 0.0 112.798 -3.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.6 m -135.8 125.4 25.25 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.115 0.966 . . . . 0.0 109.873 167.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.2 mp -93.44 132.44 37.7 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.86 1.264 . . . . 0.0 108.16 161.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.14 126.17 73.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 168.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 40.2 tp -104.37 119.0 37.98 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.744 1.618 . . . . 0.0 109.874 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -98.08 147.75 24.23 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.595 1.558 . . . . 0.0 110.143 171.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -126.01 130.55 51.4 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.673 1.189 . . . . 0.0 109.033 165.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.7 t70 51.04 35.18 12.24 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.658 1.183 . . . . 0.0 113.592 -174.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.2 15.96 72.74 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 124.954 1.264 . . . . 0.0 115.986 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -116.68 140.73 27.14 Favored Pre-proline 0 N--CA 1.473 0.712 0 CA-C-N 119.064 1.432 . . . . 0.0 110.442 172.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.1 139.94 40.22 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.689 2.259 . . . . 0.0 111.833 -176.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 72.0 t -128.64 -43.2 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.423 1.089 . . . . 0.0 113.184 -174.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -145.48 152.47 39.82 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 119.445 1.021 . . . . 0.0 112.976 -175.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -128.08 140.17 52.1 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.862 1.665 . . . . 0.0 111.389 171.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.0 mt -133.4 139.12 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.266 1.826 . . . . 0.0 108.474 174.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.1 m -131.51 151.64 35.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 123.557 0.743 . . . . 0.0 112.987 -171.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.12 171.96 17.32 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 123.805 0.717 . . . . 0.0 113.406 -172.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.66 153.23 41.31 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.7 -0.882 . . . . 0.0 112.227 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.14 159.1 42.92 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.404 1.882 . . . . 0.0 109.855 165.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.48 161.49 50.15 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 159.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -50.75 -34.04 25.54 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -177.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.02 -49.21 75.52 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.5 -34.84 47.13 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.894 0.878 . . . . 0.0 113.091 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.03 -47.67 73.64 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.378 0.99 . . . . 0.0 110.037 175.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -62.93 -41.93 99.64 Favored 'General case' 0 C--O 1.206 -1.23 0 CA-C-O 115.497 -2.192 . . . . 0.0 110.413 171.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -53.32 -50.47 64.91 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 124.136 3.153 . . . . 0.0 112.03 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -67.63 -30.45 70.03 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.3 mt -83.09 -24.71 32.56 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.808 1.186 . . . . 0.0 113.525 169.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.9 t -72.45 -21.84 61.17 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 129.164 2.986 . . . . 0.0 111.186 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -45.94 -26.48 0.71 Allowed 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 156.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.9 t -111.13 -51.8 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 127.321 2.249 . . . . 0.0 113.022 166.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 92.3 t . . . . . 0 N--CA 1.482 1.16 0 C-N-CA 127.276 2.23 . . . . 0.0 110.829 -178.684 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.0 p . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.9 pt -129.41 155.43 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.699 1.6 . . . . 0.0 111.258 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -98.89 139.69 34.18 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.846 0.858 . . . . 0.0 111.275 170.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -126.43 155.57 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.923 1.689 . . . . 0.0 111.197 174.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 80.6 p -141.56 158.73 43.47 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.822 1.649 . . . . 0.0 110.48 173.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -52.64 -29.64 27.27 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.082 1.353 . . . . 0.0 114.254 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.09 -21.12 66.35 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.0 m -131.42 -4.43 3.79 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.623 1.569 . . . . 0.0 113.715 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -53.2 -40.67 64.6 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.29 1.836 . . . . 0.0 112.637 -175.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.23 -33.11 74.66 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.364 -0.835 . . . . 0.0 113.154 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.4 m -79.72 -31.4 41.14 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.254 1.022 . . . . 0.0 112.714 174.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -89.01 -39.46 13.67 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.302 -0.874 . . . . 0.0 113.194 -175.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.5 t -106.21 -53.43 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.116 1.366 . . . . 0.0 110.956 -173.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 46.7 mt -80.05 -18.36 50.3 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.179 1.178 . . . . 0.0 114.179 -173.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.6 m -91.92 -2.76 56.63 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.067 0.947 . . . . 0.0 113.293 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.0 t -69.39 141.0 54.23 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.046 0.939 . . . . 0.0 112.71 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.59 4.81 52.77 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.446 1.499 . . . . 0.0 112.7 176.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -130.83 166.94 23.73 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 126.918 2.087 . . . . 0.0 111.03 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.17 135.99 71.9 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 121.824 1.682 . . . . 0.0 112.164 171.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.5 p -139.46 122.73 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.443 1.097 . . . . 0.0 110.918 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.09 129.42 46.96 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.253 2.221 . . . . 0.0 108.503 -175.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.0 t -119.8 125.42 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.618 1.167 . . . . 0.0 110.162 175.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -107.23 112.97 26.1 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.607 1.163 . . . . 0.0 111.344 174.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -82.6 113.57 20.39 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.487 1.515 . . . . 0.0 108.052 174.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.467 ' CD1' ' HE3' ' A' ' 62' ' ' LYS . 1.3 p-90 -148.82 170.73 17.59 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -166.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.13 156.33 40.78 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.323 1.049 . . . . 0.0 111.7 165.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.6 p -64.47 -20.71 66.36 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.976 1.311 . . . . 0.0 113.672 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.454 ' CZ3' HD11 ' A' ' 80' ' ' ILE . 11.8 p-90 -82.93 -4.51 58.28 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 52.6 t -107.3 119.75 40.26 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.191 0.905 . . . . 0.0 111.945 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.88 -52.26 54.29 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-O 118.877 -0.957 . . . . 0.0 113.475 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -57.73 -35.9 98.62 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.779 2.319 . . . . 0.0 114.215 173.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 99.3 m -60.49 -46.69 89.18 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.624 1.102 . . . . 0.0 111.592 171.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.62 -29.19 70.2 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.384 1.074 . . . . 0.0 112.162 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 97.4 mmm -75.98 -37.67 58.29 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.004 1.322 . . . . 0.0 114.38 173.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.8 p -84.59 -23.01 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 CA-C-N 119.951 1.251 . . . . 0.0 113.556 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.05 -48.71 78.33 Favored Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -66.17 -30.24 46.59 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 CA-C-N 122.61 1.968 . . . . 0.0 113.37 176.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.9 t -67.23 -49.59 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-N 118.806 0.73 . . . . 0.0 109.834 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.7 mt -61.08 -37.36 82.41 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.343 1.057 . . . . 0.0 112.574 174.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -70.3 -40.44 74.25 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.969 0.908 . . . . 0.0 112.371 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -60.53 -47.2 87.21 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.514 -0.741 . . . . 0.0 111.085 168.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 76.0 mt -63.42 -36.82 77.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 O-C-N 121.649 -0.657 . . . . 0.0 111.286 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.13 -48.46 81.54 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 120.996 -1.065 . . . . 0.0 112.107 172.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.0 m -76.68 -32.92 58.21 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.171 0.988 . . . . 0.0 112.394 -172.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -99.29 -18.19 17.7 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.7 mmt-85 -122.45 28.27 7.48 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.056 1.342 . . . . 0.0 113.712 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.2 -27.68 22.91 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.889 0.876 . . . . 0.0 113.226 168.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.1 p -66.31 -26.92 67.54 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.057 2.143 . . . . 0.0 114.602 173.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -118.94 -23.71 6.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.363 1.465 . . . . 0.0 113.347 -171.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 80.5 mt -137.03 157.01 47.68 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.075 2.55 . . . . 0.0 110.258 -176.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 48.8 m -108.74 138.72 44.6 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 148.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.6 t -121.61 124.22 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 119.402 1.001 . . . . 0.0 110.68 -176.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -124.3 153.77 41.25 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.457 1.903 . . . . 0.0 112.632 -171.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.467 ' HE3' ' CD1' ' A' ' 33' ' ' TRP . 31.0 mmmt -116.39 132.81 56.57 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.775 2.03 . . . . 0.0 109.7 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -117.35 109.92 17.42 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.912 1.285 . . . . 0.0 108.169 170.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -82.62 100.27 10.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.598 -176.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.0 m -66.56 -16.24 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 120.771 -1.206 . . . . 0.0 112.753 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -70.69 -21.85 62.53 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.689 1.196 . . . . 0.0 113.268 171.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.0 p -118.79 -30.98 4.94 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -140.48 79.53 20.29 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 124.416 1.086 . . . . 0.0 111.279 175.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -70.76 -7.63 21.79 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.072 2.515 . . . . 0.0 113.249 174.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -56.82 -43.49 81.09 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.304 1.441 . . . . 0.0 112.816 -175.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.5 m -64.35 -44.53 91.17 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.54 0.736 . . . . 0.0 111.808 176.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.1 -35.89 82.58 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.537 -0.727 . . . . 0.0 112.358 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.5 ttp-105 -75.85 -34.23 60.05 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.554 0.742 . . . . 0.0 112.889 175.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -58.44 -37.47 75.49 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.38 1.072 . . . . 0.0 112.631 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -96.72 6.24 49.08 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.578 1.151 . . . . 0.0 113.376 174.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 59.94 -13.78 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 129.184 2.994 . . . . 0.0 116.814 -177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.4 m -78.77 55.59 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 126.979 2.111 . . . . 0.0 113.599 -177.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 m -72.94 -9.76 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.762 1.625 . . . . 0.0 114.677 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.6 m -78.29 65.4 3.63 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.974 1.709 . . . . 0.0 112.776 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.454 HD11 ' CZ3' ' A' ' 36' ' ' TRP . 39.4 pt -57.35 153.37 27.54 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 125.616 1.566 . . . . 0.0 114.831 -171.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.98 140.46 64.4 Favored 'Cis proline' 0 C--N 1.354 0.85 0 CA-C-N 119.495 0.855 . . . . 0.0 112.132 -3.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 33.6 m -128.97 121.04 27.16 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.677 0.791 . . . . 0.0 109.468 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.1 mp -107.8 125.75 51.8 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.982 1.313 . . . . 0.0 108.318 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.6 tt -128.21 130.1 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.201 1.0 . . . . 0.0 110.309 176.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.0 tp -108.16 128.22 54.51 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.823 1.249 . . . . 0.0 109.737 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -108.53 152.87 24.16 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.43 1.492 . . . . 0.0 110.205 170.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -135.26 122.31 21.37 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.261 1.824 . . . . 0.0 108.792 173.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.3 t70 50.9 35.64 12.92 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.172 0.989 . . . . 0.0 113.097 -168.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.2 7.75 68.21 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 125.604 1.573 . . . . 0.0 116.396 -176.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -106.42 137.67 19.5 Favored Pre-proline 0 N--CA 1.474 0.758 0 CA-C-N 119.541 1.671 . . . . 0.0 110.356 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.35 139.48 45.66 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.194 1.929 . . . . 0.0 112.0 -176.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.1 m -132.63 -18.41 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 125.163 1.385 . . . . 0.0 114.608 -176.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.9 tppm? -154.48 145.73 22.9 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.739 1.154 . . . . 0.0 111.006 171.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -138.33 134.94 34.88 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.142 0.977 . . . . 0.0 111.736 167.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.8 mp -130.44 144.27 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.34 2.256 . . . . 0.0 109.0 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.4 p -133.25 141.15 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.603 1.161 . . . . 0.0 110.336 170.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.26 156.14 27.59 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.506 1.05 . . . . 0.0 112.898 -167.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.31 141.59 41.56 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.744 0.817 . . . . 0.0 112.961 -175.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -132.85 148.94 52.3 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.97 1.708 . . . . 0.0 110.802 174.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.93 168.66 54.26 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 123.911 0.767 . . . . 0.0 111.318 173.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -56.35 -33.36 65.59 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -173.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.36 -53.75 47.7 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.924 0.392 . . . . 0.0 110.558 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.12 -34.91 66.41 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.515 -0.741 . . . . 0.0 112.776 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.3 tp -67.05 -38.48 85.92 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 120.136 1.335 . . . . 0.0 111.177 173.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . 0.254 0.1 OUTLIER -75.96 -11.1 59.9 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 116.863 -1.541 . . . . 0.0 113.99 169.182 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.79 -56.6 11.09 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 124.045 3.111 . . . . 0.0 110.607 158.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.19 -36.33 70.69 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.825 1.25 . . . . 0.0 111.997 -176.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 70.7 mt -91.47 -28.16 17.8 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 117.185 -1.388 . . . . 0.0 113.425 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 84.4 p -66.52 -18.69 65.51 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 121.793 2.088 . . . . 0.0 112.416 175.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -50.16 -22.34 1.66 Allowed 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 162.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.9 t -115.75 -34.08 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 127.876 2.47 . . . . 0.0 112.988 171.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 N--CA 1.477 0.899 0 C-N-CA 127.16 2.184 . . . . 0.0 110.997 -172.528 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.7 p . . . . . 0 N--CA 1.476 0.858 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.1 pt -115.25 152.77 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.272 1.029 . . . . 0.0 111.864 172.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -92.26 138.17 31.75 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.907 0.883 . . . . 0.0 110.286 169.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.4 m -123.87 151.02 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.849 1.26 . . . . 0.0 110.746 171.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 81.4 p -135.96 158.52 44.21 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.299 1.44 . . . . 0.0 111.128 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.67 -27.53 62.95 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.907 1.076 . . . . 0.0 113.907 -172.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.33 -16.82 58.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.842 1.257 . . . . 0.0 114.348 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -131.45 -6.06 3.74 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.162 1.385 . . . . 0.0 113.844 -173.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -52.85 -40.7 63.6 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.715 1.606 . . . . 0.0 113.011 -175.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.11 -32.79 74.18 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.6 m -79.53 -32.89 42.32 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.824 0.849 . . . . 0.0 112.266 174.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -85.79 -41.28 15.19 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -174.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -105.83 -51.12 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.141 1.377 . . . . 0.0 111.211 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.3 mt -82.92 -13.2 56.51 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -170.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.9 m -95.88 5.9 50.17 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.583 1.153 . . . . 0.0 113.532 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.9 p -70.2 150.7 46.18 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.012 1.725 . . . . 0.0 114.94 -172.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.42 19.33 13.41 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 126.007 1.723 . . . . 0.0 111.854 172.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -143.99 146.18 33.15 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 128.927 2.891 . . . . 0.0 107.124 173.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -59.27 144.06 99.53 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 121.934 1.756 . . . . 0.0 113.255 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.9 t -128.21 125.09 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.339 1.456 . . . . 0.0 110.07 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 48.7 mt -87.92 135.0 33.59 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.388 0.675 . . . . 0.0 109.772 165.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.4 t -119.82 118.15 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 123.966 0.906 . . . . 0.0 109.366 168.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -89.89 109.27 20.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.625 1.57 . . . . 0.0 110.455 172.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -89.34 109.49 20.38 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.909 1.684 . . . . 0.0 108.64 171.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.9 p-90 -142.58 174.3 10.76 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.025 1.33 . . . . 0.0 111.757 -164.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.47 145.51 35.32 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.857 -0.527 . . . . 0.0 112.406 159.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.4 t -64.33 -22.6 67.01 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 -78.18 -4.64 48.63 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 174.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.8 t -107.17 129.36 54.86 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.242 1.017 . . . . 0.0 112.95 -173.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.62 -60.15 9.45 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.156 1.36 . . . . 0.0 114.499 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -61.84 -28.72 81.76 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 CA-C-N 120.386 2.093 . . . . 0.0 113.351 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 89.5 m -62.08 -48.55 79.71 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.511 1.051 . . . . 0.0 111.558 169.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -60.58 -34.37 74.1 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.116 0.966 . . . . 0.0 112.19 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 26.2 mmt -75.47 -36.01 60.74 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 p -87.28 -21.8 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 119.627 1.103 . . . . 0.0 113.52 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.55 -50.16 60.45 Favored Pre-proline 0 CA--C 1.551 1.007 0 CA-C-O 117.288 -1.339 . . . . 0.0 114.32 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -65.71 -30.19 50.67 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 CA-C-N 122.338 1.871 . . . . 0.0 113.666 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.408 HG13 ' HA ' ' A' ' 101' ' ' LYS . 13.1 t -68.21 -51.32 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 119.031 0.832 . . . . 0.0 110.771 177.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.9 pp -72.01 -22.74 61.37 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -69.99 -35.29 74.3 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.107 -0.996 . . . . 0.0 112.512 168.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -64.89 -42.87 94.42 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.868 -1.145 . . . . 0.0 111.508 166.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.4 mm -55.41 -45.95 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-N 119.969 1.259 . . . . 0.0 110.821 170.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.66 -42.85 93.74 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.052 0.941 . . . . 0.0 112.823 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.7 m -74.55 -40.73 61.52 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.66 0.784 . . . . 0.0 111.61 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -86.79 -23.56 25.36 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -173.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.3 mmt-85 -123.04 20.76 9.89 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 114.59 1.329 . . . . 0.0 114.59 -173.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.11 -27.74 15.22 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.311 1.444 . . . . 0.0 114.5 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.3 p -74.56 -23.07 58.72 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.072 1.349 . . . . 0.0 114.142 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -117.74 -25.85 6.72 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.614 1.166 . . . . 0.0 113.952 -176.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 82.6 mt -125.78 153.02 44.62 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.51 1.924 . . . . 0.0 110.248 172.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 38.3 m -101.16 138.48 38.14 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 151.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.4 t -118.68 117.76 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 118.59 0.632 . . . . 0.0 109.475 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -119.52 159.33 24.52 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.121 1.768 . . . . 0.0 112.246 -174.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -127.71 136.23 51.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.635 1.574 . . . . 0.0 111.664 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -125.93 113.46 17.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.831 2.052 . . . . 0.0 107.926 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -81.36 120.15 24.58 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.452 -0.78 . . . . 0.0 110.311 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.9 m -67.35 -17.38 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.13 -30.18 43.56 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.29 1.036 . . . . 0.0 112.711 173.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.2 p -97.21 -30.83 12.77 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.191 0.996 . . . . 0.0 112.608 -176.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -130.39 63.09 68.11 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 125.775 1.63 . . . . 0.0 111.442 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -61.66 -21.66 72.61 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.93 2.42 . . . . 0.0 113.307 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -61.9 -45.47 93.59 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.466 1.106 . . . . 0.0 111.443 174.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 m -71.77 -32.3 67.52 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.553 0.741 . . . . 0.0 111.442 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.09 -44.74 91.42 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.927 0.891 . . . . 0.0 112.607 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -77.88 -28.38 49.91 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -57.01 -42.8 81.01 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.924 0.89 . . . . 0.0 113.282 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -99.69 7.86 44.79 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.599 1.16 . . . . 0.0 113.404 176.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.321 15.5 pt20 42.07 47.08 3.82 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.072 1.749 . . . . 0.0 113.571 -166.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.0 m -98.97 36.76 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 127.604 2.362 . . . . 0.0 109.904 172.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.9 p -78.64 -25.17 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.08 1.752 . . . . 0.0 112.417 -173.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 51.0 m -74.35 144.37 44.48 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.443 1.097 . . . . 0.0 110.318 163.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.73 149.3 56.18 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 124.163 0.985 . . . . 0.0 113.332 -168.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.13 142.01 71.44 Favored 'Cis proline' 0 C--N 1.352 0.755 0 CA-C-N 119.021 0.686 . . . . 0.0 111.336 -8.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 51.7 m -132.28 121.64 23.9 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.201 1.0 . . . . 0.0 109.947 172.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.9 mp -96.52 135.99 37.65 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.38 1.072 . . . . 0.0 109.251 171.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 26.5 mm -115.62 135.56 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.626 1.171 . . . . 0.0 109.212 167.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.7 tp -92.67 117.32 29.86 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 123.223 0.327 . . . . 0.0 110.423 162.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -96.41 115.26 27.14 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.625 1.17 . . . . 0.0 108.343 165.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.7 tttm -100.31 108.6 20.69 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 50.03 43.55 25.58 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.688 1.195 . . . . 0.0 113.094 -167.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.16 15.19 80.79 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 117.059 1.584 . . . . 0.0 117.059 173.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -126.43 140.11 36.41 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-N 119.373 1.587 . . . . 0.0 111.41 168.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -69.29 138.93 40.54 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.778 2.318 . . . . 0.0 112.249 -174.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.4 t -130.5 -33.94 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 125.267 1.427 . . . . 0.0 113.072 -176.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -141.3 145.15 35.13 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.272 1.029 . . . . 0.0 111.753 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -123.05 136.15 54.71 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.927 2.091 . . . . 0.0 110.595 171.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.1 mt -129.75 130.78 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.91 1.684 . . . . 0.0 107.457 171.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.3 143.83 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 119.507 1.048 . . . . 0.0 111.845 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.17 157.66 28.36 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.188 1.375 . . . . 0.0 112.72 -169.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.6 138.1 48.48 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.839 -0.801 . . . . 0.0 112.033 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -131.98 153.99 49.77 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.875 1.67 . . . . 0.0 111.113 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.63 164.15 51.86 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 174.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.408 ' HA ' HG13 ' A' ' 46' ' ' VAL . 3.6 tmtp? -55.08 -34.12 63.35 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.823 1.249 . . . . 0.0 113.197 -178.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.02 -37.63 66.85 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.17 -46.25 43.4 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.259 1.024 . . . . 0.0 111.36 177.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 40.4 tp -64.6 -46.56 82.15 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.706 175.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 32.3 tp -69.78 -26.51 64.32 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-O 115.121 -2.371 . . . . 0.0 113.389 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -69.72 -44.04 71.13 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 125.005 3.548 . . . . 0.0 112.26 169.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -64.61 -23.43 67.26 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.4 mt -93.85 -26.64 16.83 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.061 1.344 . . . . 0.0 113.772 168.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.4 m -61.29 -25.8 67.36 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 120.269 1.395 . . . . 0.0 110.413 173.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -53.25 -23.14 8.08 Favored 'General case' 0 CA--C 1.558 1.265 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 166.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 68.8 t -114.51 -50.26 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 127.522 2.329 . . . . 0.0 111.344 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 N--CA 1.471 0.605 0 C-N-CA 128.146 2.578 . . . . 0.0 108.699 178.882 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.264 19.4 p . . . . . 0 N--CA 1.483 1.224 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.0 pt -134.49 157.37 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.486 1.914 . . . . 0.0 110.631 172.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -105.44 139.08 40.6 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.62 0.768 . . . . 0.0 110.678 169.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.9 m -124.89 153.21 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.574 1.55 . . . . 0.0 111.058 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.6 p -132.48 170.59 14.93 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.474 1.51 . . . . 0.0 111.601 -174.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -56.5 -25.26 50.92 Favored 'General case' 0 CA--C 1.55 0.952 0 O-C-N 121.151 -0.968 . . . . 0.0 113.106 171.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.85 -13.52 50.75 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 115.043 1.498 . . . . 0.0 115.043 175.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.9 p -134.22 -12.49 2.46 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 -169.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -54.46 -42.77 71.04 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.898 1.279 . . . . 0.0 112.208 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.29 -36.34 82.7 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.298 -0.877 . . . . 0.0 112.95 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.0 m -79.2 -24.44 43.16 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.432 1.093 . . . . 0.0 113.139 -177.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -97.09 -46.97 5.96 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.351 -0.843 . . . . 0.0 113.084 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.07 -51.95 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.311 1.044 . . . . 0.0 112.046 -172.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.4 mt -84.19 -26.48 28.74 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -172.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.9 m -80.59 -11.08 59.7 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.569 1.148 . . . . 0.0 113.637 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.5 m -74.93 127.6 33.59 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.704 1.202 . . . . 0.0 112.32 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -71.62 -28.39 63.75 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.323 1.049 . . . . 0.0 112.113 172.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -84.64 164.31 43.08 Favored Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 125.384 1.473 . . . . 0.0 111.977 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.78 141.41 94.79 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.658 2.239 . . . . 0.0 113.351 170.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.0 t -135.68 126.12 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.554 1.142 . . . . 0.0 110.041 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 tt -100.43 121.31 41.32 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.543 1.937 . . . . 0.0 108.427 177.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 t -111.28 126.74 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 118.999 0.818 . . . . 0.0 111.129 174.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -99.06 111.41 23.82 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.456 1.502 . . . . 0.0 110.881 172.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -83.85 112.44 20.12 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.493 1.517 . . . . 0.0 108.657 173.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.3 p-90 -144.76 169.48 17.95 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.393 1.077 . . . . 0.0 113.017 -166.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.63 154.66 35.8 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.67 1.188 . . . . 0.0 111.015 163.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 t -67.91 -12.99 61.79 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.417 ' CZ3' HD11 ' A' ' 80' ' ' ILE . 13.2 p-90 -79.77 -3.68 48.69 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 174.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 50.5 t -111.06 117.52 33.52 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.429 1.091 . . . . 0.0 112.398 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.88 -48.34 86.57 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-O 118.72 -1.044 . . . . 0.0 113.097 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -56.78 -33.08 93.5 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.747 2.298 . . . . 0.0 114.765 170.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 89.7 m -64.12 -46.33 84.66 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.821 1.191 . . . . 0.0 111.384 170.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -58.46 -35.69 72.55 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.211 1.004 . . . . 0.0 111.865 173.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.8 mtt -73.3 -39.0 65.66 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.883 1.273 . . . . 0.0 113.954 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.8 p -83.08 -23.83 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 CA-C-N 119.661 1.118 . . . . 0.0 113.655 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.55 -49.04 80.47 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.17 -29.25 39.72 Favored 'Trans proline' 0 C--N 1.354 0.819 0 CA-C-N 122.387 1.888 . . . . 0.0 113.215 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.4 t -69.73 -45.43 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 121.51 -0.744 . . . . 0.0 110.22 175.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.3 mt -60.99 -36.14 78.68 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.415 1.086 . . . . 0.0 112.421 172.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -68.69 -39.05 80.72 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.089 0.859 . . . . 0.0 112.194 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -63.91 -46.12 86.22 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.189 -0.944 . . . . 0.0 111.62 170.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.2 mm -56.9 -42.97 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 121.674 -0.641 . . . . 0.0 110.941 173.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.56 -42.18 98.46 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.8 0.84 . . . . 0.0 112.261 177.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.2 m -69.52 -42.38 74.76 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.312 1.045 . . . . 0.0 111.299 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -95.01 -23.22 17.47 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -170.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -109.87 14.22 23.24 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.79 1.636 . . . . 0.0 113.403 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.99 -33.19 36.96 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.019 1.327 . . . . 0.0 114.268 -177.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.1 m -72.19 -26.05 61.91 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.054 1.342 . . . . 0.0 112.75 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -102.39 -34.15 9.29 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.479 1.512 . . . . 0.0 113.06 -175.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.0 pp -149.08 163.06 38.64 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.539 1.536 . . . . 0.0 112.185 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 58.5 m -108.31 138.51 44.46 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.194 0.998 . . . . 0.0 109.344 167.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.9 t -102.59 128.89 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.519 0.728 . . . . 0.0 110.398 175.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.45 158.77 36.47 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.553 1.941 . . . . 0.0 111.455 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -127.62 134.78 49.65 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.556 1.142 . . . . 0.0 111.697 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -113.64 117.25 31.06 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.742 1.617 . . . . 0.0 108.937 173.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.43 97.58 7.82 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.034 1.333 . . . . 0.0 108.757 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.5 m -65.01 -20.72 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -172.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -74.19 -22.49 59.37 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.135 0.974 . . . . 0.0 112.753 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.3 t -119.22 -13.6 9.32 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.931 1.292 . . . . 0.0 113.518 174.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -119.22 60.75 5.4 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 124.958 1.303 . . . . 0.0 112.076 171.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -65.46 -24.62 56.56 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.368 2.045 . . . . 0.0 112.29 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -66.91 -43.39 83.45 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.478 -0.764 . . . . 0.0 111.422 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 m -68.22 -38.36 81.8 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.163 0.985 . . . . 0.0 111.466 175.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.2 -38.52 91.48 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.419 0.688 . . . . 0.0 112.668 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 22.7 ttm105 -76.44 -35.75 58.33 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.361 0.664 . . . . 0.0 112.758 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -54.96 -39.02 68.49 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.866 1.267 . . . . 0.0 113.67 -175.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -99.93 1.79 43.05 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.088 0.955 . . . . 0.0 113.37 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 51.56 60.09 4.11 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.182 1.793 . . . . 0.0 112.322 -167.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.5 m -127.58 32.18 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 126.529 1.932 . . . . 0.0 111.491 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.6 m -70.88 -23.67 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.595 1.158 . . . . 0.0 113.726 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 54.0 m -79.51 139.49 37.56 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.479 1.112 . . . . 0.0 110.193 168.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.417 HD11 ' CZ3' ' A' ' 36' ' ' TRP . 48.4 pt -136.9 152.64 74.5 Favored Pre-proline 0 N--CA 1.475 0.817 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -167.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.37 140.73 64.16 Favored 'Cis proline' 0 C--N 1.353 0.789 0 CA-C-N 119.322 0.794 . . . . 0.0 111.81 -4.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.4 m -127.55 121.31 30.28 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.815 0.846 . . . . 0.0 109.443 169.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.3 mp -102.42 130.3 49.16 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.494 1.518 . . . . 0.0 107.942 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.22 130.69 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.824 0.849 . . . . 0.0 108.931 175.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.5 tp -106.54 120.91 43.18 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.401 1.08 . . . . 0.0 109.901 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -96.51 147.34 23.95 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.297 1.439 . . . . 0.0 109.834 169.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -119.9 130.11 54.67 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.721 1.208 . . . . 0.0 108.951 161.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.4 t0 47.82 44.57 18.14 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.303 1.041 . . . . 0.0 113.067 -174.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.39 10.86 58.33 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.11 1.338 . . . . 0.0 116.14 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -117.74 136.48 23.69 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 125.434 1.493 . . . . 0.0 110.071 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -70.56 139.74 38.11 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.71 2.273 . . . . 0.0 112.325 -171.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.5 t -128.83 -38.76 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.564 1.146 . . . . 0.0 113.198 -175.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -142.19 144.38 33.38 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.289 1.036 . . . . 0.0 111.682 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -129.27 139.71 51.7 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.669 1.588 . . . . 0.0 111.457 170.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.8 mt -133.87 139.06 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 126.946 2.098 . . . . 0.0 108.403 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.1 p -131.79 142.15 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.288 0.949 . . . . 0.0 110.882 171.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.11 153.47 24.48 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.632 1.11 . . . . 0.0 112.563 -167.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.68 143.03 48.25 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.975 -0.721 . . . . 0.0 112.487 -176.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -130.46 143.78 50.98 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.694 1.598 . . . . 0.0 110.409 173.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -78.6 170.29 54.72 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.154 0.883 . . . . 0.0 111.299 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -53.13 -35.84 60.15 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -175.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.35 -53.01 59.2 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 122.834 0.453 . . . . 0.0 111.375 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.67 -37.4 59.63 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.489 1.115 . . . . 0.0 113.241 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.7 tp -67.82 -35.17 78.12 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.248 0.931 . . . . 0.0 110.97 173.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.6 tp -74.14 -24.95 59.49 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-O 116.138 -1.887 . . . . 0.0 112.867 169.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 46.6 mmt-85 -59.84 -51.29 70.37 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 124.203 3.183 . . . . 0.0 110.572 164.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -61.0 -32.21 71.8 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.7 mt -99.03 -23.4 15.3 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.4 t -68.91 -21.28 64.23 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.326 0.966 . . . . 0.0 111.025 168.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -53.7 -20.02 4.89 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.333 1.053 . . . . 0.0 113.088 162.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.8 t -112.85 -28.89 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 127.143 2.177 . . . . 0.0 112.3 171.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.481 1.092 0 C-N-CA 127.139 2.176 . . . . 0.0 110.882 179.067 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.4 p . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.7 pt -118.77 152.5 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.078 1.351 . . . . 0.0 111.33 170.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -97.65 132.67 43.09 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.231 1.012 . . . . 0.0 109.928 172.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.9 m -137.01 150.06 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.337 1.055 . . . . 0.0 112.112 -176.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 73.2 p -141.23 164.92 28.95 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.654 1.581 . . . . 0.0 111.399 176.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -51.25 -28.35 11.5 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.658 1.983 . . . . 0.0 114.673 -176.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.31 -22.46 65.62 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.0 m -135.26 -0.66 2.69 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.318 1.447 . . . . 0.0 114.224 -175.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -53.16 -42.57 66.28 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.674 1.99 . . . . 0.0 112.921 -175.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.12 -32.23 72.38 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.321 -0.862 . . . . 0.0 113.109 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.8 m -79.49 -30.22 41.94 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.279 1.431 . . . . 0.0 112.849 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -97.03 -41.44 8.37 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -171.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.7 m -124.4 -29.89 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -169.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.4 mt -80.7 -13.21 59.21 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.518 1.054 . . . . 0.0 113.258 170.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.9 p -75.62 -21.04 58.1 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -169.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.2 t -100.76 141.47 33.59 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -168.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -82.93 -13.89 55.19 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.801 1.24 . . . . 0.0 113.174 170.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -68.64 151.78 97.05 Favored Pre-proline 0 N--CA 1.473 0.722 0 C-N-CA 125.263 1.425 . . . . 0.0 109.15 162.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -65.15 134.41 39.3 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 CA-C-N 120.795 1.319 . . . . 0.0 111.297 171.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.6 t -135.69 121.92 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 124.045 0.938 . . . . 0.0 109.311 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 tt -104.42 130.42 52.31 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.226 2.21 . . . . 0.0 109.378 -169.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.4 t -120.63 125.48 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.353 1.061 . . . . 0.0 111.009 177.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -103.94 120.13 40.39 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.472 1.509 . . . . 0.0 112.04 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -100.48 112.81 25.21 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.959 2.104 . . . . 0.0 108.964 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 11.4 p-90 -143.51 177.12 8.68 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.894 1.278 . . . . 0.0 111.934 -168.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.98 143.72 32.04 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.398 -0.814 . . . . 0.0 112.641 165.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.5 t -63.25 -21.73 66.42 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 172.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.478 ' CZ3' HD11 ' A' ' 80' ' ' ILE . 6.3 p-90 -83.3 -3.65 57.68 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 174.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 46.2 t -106.55 120.1 41.03 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.233 1.013 . . . . 0.0 112.189 -174.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.79 -46.78 92.93 Favored Glycine 0 CA--C 1.54 1.615 0 CA-C-O 118.861 -0.966 . . . . 0.0 114.317 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -58.88 -31.78 96.03 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.788 2.325 . . . . 0.0 114.087 170.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 93.8 m -65.45 -47.13 77.19 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.961 0.801 . . . . 0.0 111.428 170.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -59.23 -31.93 69.5 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 118.712 0.687 . . . . 0.0 112.407 174.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -70.33 -48.45 56.41 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.9 1.28 . . . . 0.0 112.545 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.3 p -81.21 -23.21 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.91 -54.2 30.28 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-O 116.864 -1.541 . . . . 0.0 114.01 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.92 -26.71 66.79 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.367 2.045 . . . . 0.0 113.516 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.0 t -66.71 -51.74 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 119.04 0.836 . . . . 0.0 109.93 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . 0.25 4.2 pp -73.22 -19.09 61.16 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -65.67 -41.97 91.86 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.507 1.123 . . . . 0.0 111.577 166.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -64.92 -44.42 89.58 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.45 -0.781 . . . . 0.0 111.143 169.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.5 mm -54.1 -46.99 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 119.896 1.225 . . . . 0.0 110.88 172.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.58 -44.46 96.19 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.8 m -76.23 -37.45 57.68 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.643 0.777 . . . . 0.0 112.025 -175.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -86.72 -40.17 15.3 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -176.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -98.86 11.67 38.09 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.804 1.242 . . . . 0.0 113.316 -169.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.58 -32.15 39.68 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.48 1.512 . . . . 0.0 114.859 -173.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.8 p -82.99 -19.6 36.74 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.76 1.224 . . . . 0.0 113.619 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -94.12 -39.97 10.3 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.364 1.466 . . . . 0.0 112.217 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.9 pp -149.05 153.35 37.72 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.546 1.939 . . . . 0.0 111.893 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 31.8 m -99.47 138.94 35.86 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.15 -0.969 . . . . 0.0 109.502 175.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.7 t -113.3 131.11 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 119.348 0.976 . . . . 0.0 111.675 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.24 152.43 44.6 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.75 2.02 . . . . 0.0 111.503 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -130.67 140.25 50.37 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.7 1.2 . . . . 0.0 112.466 -175.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -134.6 116.31 14.86 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.946 2.098 . . . . 0.0 109.065 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -82.78 119.53 24.46 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 170.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.416 HG12 ' HB2' ' A' ' 72' ' ' ALA . 11.2 m -67.87 -16.94 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 121.386 -0.821 . . . . 0.0 112.976 -175.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -79.22 -28.07 42.51 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.261 1.024 . . . . 0.0 112.903 172.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.2 p -92.57 -29.04 16.38 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.73 0.812 . . . . 0.0 112.505 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -145.02 103.05 4.43 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 123.942 0.897 . . . . 0.0 111.191 161.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.68 -21.95 12.38 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.848 2.366 . . . . 0.0 113.805 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -72.78 -28.08 62.38 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.809 -1.182 . . . . 0.0 112.16 -175.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 m -64.2 -42.14 96.76 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.715 0.806 . . . . 0.0 110.886 171.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.416 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -68.19 -37.11 80.57 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.079 0.952 . . . . 0.0 112.909 174.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -68.06 -43.89 77.6 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.178 0.991 . . . . 0.0 112.499 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -59.56 -37.84 79.52 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.155 0.982 . . . . 0.0 113.583 -172.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -99.5 5.66 46.08 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.45 1.1 . . . . 0.0 113.692 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 49.56 60.63 3.64 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.209 1.804 . . . . 0.0 112.645 -172.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.6 m -129.18 30.25 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.256 1.823 . . . . 0.0 111.398 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.5 m -71.88 -14.56 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.011 1.324 . . . . 0.0 114.395 -173.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.5 m -68.69 -40.45 80.07 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -165.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.478 HD11 ' CZ3' ' A' ' 36' ' ' TRP 0.294 14.2 pt 56.07 147.34 0.05 OUTLIER Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 130.552 3.541 . . . . 0.0 119.051 177.394 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.9 136.78 24.94 Favored 'Cis proline' 0 C--N 1.354 0.818 0 N-CA-C 110.218 -0.724 . . . . 0.0 110.218 -16.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 25.7 m -135.7 121.19 19.33 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.597 0.759 . . . . 0.0 109.477 -177.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.0 mp -109.88 138.99 45.47 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.7 1.2 . . . . 0.0 108.797 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.1 tt -129.19 145.06 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.69 0.796 . . . . 0.0 110.715 169.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 32.5 tp -116.65 132.65 56.63 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.625 1.17 . . . . 0.0 109.854 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -112.08 148.02 34.81 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.714 1.606 . . . . 0.0 111.787 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -132.87 126.12 31.49 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.589 1.556 . . . . 0.0 109.007 159.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.0 t70 51.32 37.68 19.47 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.747 1.219 . . . . 0.0 113.358 -177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.23 -0.19 49.04 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.204 1.383 . . . . 0.0 115.735 -176.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -95.13 143.89 26.87 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 124.92 1.288 . . . . 0.0 110.153 178.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.51 140.81 40.7 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.716 2.277 . . . . 0.0 112.092 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 52.0 t -121.09 -45.61 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.925 1.69 . . . . 0.0 111.276 -174.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -143.9 150.75 38.87 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.09 1.756 . . . . 0.0 110.634 173.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -133.77 134.22 42.65 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.435 1.894 . . . . 0.0 109.77 167.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.9 mt -131.0 138.97 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.918 1.687 . . . . 0.0 108.625 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.3 p -133.68 141.51 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.037 0.935 . . . . 0.0 110.788 167.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.7 155.87 27.91 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.403 1.002 . . . . 0.0 112.746 -168.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.51 139.67 45.85 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.573 0.749 . . . . 0.0 112.577 -175.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -130.67 145.05 51.83 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.012 1.725 . . . . 0.0 110.56 173.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.72 166.5 53.24 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 123.83 0.729 . . . . 0.0 111.687 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.3 tmtp? -51.98 -34.43 42.38 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.056 1.342 . . . . 0.0 113.861 -174.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.04 -53.28 26.9 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 122.267 0.227 . . . . 0.0 110.97 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.1 -40.59 78.27 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.717 0.807 . . . . 0.0 112.757 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.98 -41.04 91.67 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.725 0.693 . . . . 0.0 110.523 176.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 20.1 tp -72.78 -24.88 60.99 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-O 115.69 -2.1 . . . . 0.0 113.399 172.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -63.64 -49.08 74.66 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 124.651 3.387 . . . . 0.0 111.002 166.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -54.56 -37.87 65.97 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.603 1.161 . . . . 0.0 112.735 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.4 mt -92.3 -25.99 18.32 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.0 t -66.74 -22.85 66.04 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.537 1.135 . . . . 0.0 110.99 175.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -51.1 -28.65 11.12 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 163.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 77.0 t -105.01 -24.64 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 127.278 2.231 . . . . 0.0 112.522 172.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.477 0.885 0 C-N-CA 127.428 2.291 . . . . 0.0 110.168 178.871 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.9 p . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.9 pt -141.43 157.5 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 126.342 1.857 . . . . 0.0 111.667 173.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -99.89 145.59 27.61 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.388 1.075 . . . . 0.0 111.186 162.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.3 m -131.11 151.55 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.459 1.503 . . . . 0.0 111.426 174.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.9 p -123.82 167.81 13.58 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.202 1.801 . . . . 0.0 110.592 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -59.91 -23.64 63.67 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 120.846 -1.159 . . . . 0.0 112.904 174.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.77 -13.72 50.35 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.45 1.5 . . . . 0.0 114.962 175.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.9 p -128.12 -12.16 5.21 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -173.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -52.83 -41.37 64.15 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.24 1.416 . . . . 0.0 112.459 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.12 -36.57 82.19 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.251 -0.906 . . . . 0.0 113.148 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.0 m -79.47 -26.02 41.77 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.25 1.02 . . . . 0.0 113.261 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -100.17 -37.47 8.92 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.5 t -99.34 -58.6 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.516 1.127 . . . . 0.0 111.308 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.8 mt -76.08 -22.14 55.94 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -171.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.0 m -81.55 -11.05 59.3 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.358 1.063 . . . . 0.0 113.392 175.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.5 t -84.28 132.9 34.58 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -174.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -90.49 -4.89 56.63 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.001 1.32 . . . . 0.0 113.027 171.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -90.02 144.12 30.9 Favored Pre-proline 0 N--CA 1.472 0.651 0 C-N-CA 125.152 1.381 . . . . 0.0 109.396 169.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -54.17 131.06 42.85 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.214 1.943 . . . . 0.0 111.872 168.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.0 p -139.37 130.16 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.853 1.261 . . . . 0.0 110.096 -172.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.2 tt -120.23 111.95 18.45 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.295 1.038 . . . . 0.0 109.622 -165.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.0 t -103.13 124.62 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.019 0.928 . . . . 0.0 111.223 -173.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -97.09 113.22 24.76 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.748 1.619 . . . . 0.0 110.787 172.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -87.32 109.39 19.49 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.265 1.826 . . . . 0.0 108.569 173.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -149.63 172.69 14.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.153 0.981 . . . . 0.0 113.333 -163.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -145.4 153.73 41.51 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.374 0.67 . . . . 0.0 112.611 159.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.6 p -58.19 -29.41 65.62 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.593 1.557 . . . . 0.0 113.263 174.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 15.4 p-90 -80.66 -6.4 58.31 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.3 t -102.12 116.25 32.27 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.044 0.938 . . . . 0.0 111.227 -176.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.24 -46.53 94.08 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-O 118.484 -1.176 . . . . 0.0 114.028 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -60.37 -32.49 94.07 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 CA-C-N 120.813 2.306 . . . . 0.0 114.305 172.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 97.3 m -65.31 -47.74 75.52 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.244 -0.91 . . . . 0.0 110.954 171.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.8 tptt -57.21 -32.55 66.62 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.947 1.699 . . . . 0.0 112.669 172.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 57.1 mtt -72.97 -42.2 63.59 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.45 1.1 . . . . 0.0 113.107 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -84.09 -23.15 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -47.24 -50.74 46.22 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 177.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.51 -30.01 52.59 Favored 'Trans proline' 0 C--N 1.352 0.713 0 CA-C-N 122.036 1.763 . . . . 0.0 113.105 176.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.9 t -73.53 -44.92 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.289 -0.882 . . . . 0.0 110.849 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.2 pp -72.67 -24.24 61.0 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.481 -0.762 . . . . 0.0 113.019 174.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -71.74 -36.11 70.33 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.162 0.892 . . . . 0.0 112.42 168.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -61.75 -42.53 99.09 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.553 -1.342 . . . . 0.0 111.256 167.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.33 -42.11 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 119.52 1.055 . . . . 0.0 111.559 170.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.78 -37.78 80.04 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.344 0.974 . . . . 0.0 112.937 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.1 m -82.23 -47.1 12.85 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.997 0.919 . . . . 0.0 112.095 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -85.97 -25.46 26.01 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -171.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -104.69 16.96 25.01 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.202 1.401 . . . . 0.0 112.455 176.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.02 -27.87 21.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.857 1.663 . . . . 0.0 114.549 -177.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.2 p -72.35 -20.11 61.53 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.375 1.47 . . . . 0.0 114.115 176.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -115.66 -39.33 3.54 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.094 1.358 . . . . 0.0 112.833 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.6 mt -113.73 148.02 37.19 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.453 1.901 . . . . 0.0 111.278 -175.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.8 m -112.59 134.41 54.14 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 152.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.1 t -99.56 138.3 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 123.734 0.814 . . . . 0.0 110.081 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.6 156.06 42.87 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.32 1.448 . . . . 0.0 111.991 -177.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -120.09 124.25 45.37 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.056 1.743 . . . . 0.0 110.743 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -109.47 114.51 28.22 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.279 1.031 . . . . 0.0 108.385 165.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -82.36 103.51 11.99 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.446 1.099 . . . . 0.0 109.615 -176.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 m -66.85 -17.5 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 O-C-N 120.703 -1.248 . . . . 0.0 113.024 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -71.74 -23.54 61.63 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.84 1.256 . . . . 0.0 113.107 175.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.3 p -118.61 -24.78 6.62 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -130.27 79.6 72.29 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 119.504 1.047 . . . . 0.0 113.521 168.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -66.93 -16.29 49.33 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.191 1.927 . . . . 0.0 112.927 166.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.1 mp0 -64.84 -42.3 95.03 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.901 -1.124 . . . . 0.0 111.439 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.5 m -70.92 -36.15 72.54 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.989 0.915 . . . . 0.0 111.436 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.3 -39.32 90.03 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.546 0.739 . . . . 0.0 112.196 171.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -72.85 -40.34 65.79 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 175.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -61.93 -34.71 76.59 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.307 1.043 . . . . 0.0 113.81 -174.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -96.76 1.4 50.8 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 175.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 52.22 56.4 7.79 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.908 1.683 . . . . 0.0 112.566 -170.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.47 36.81 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 127.082 2.153 . . . . 0.0 110.974 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.8 m -71.74 -22.29 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.654 1.182 . . . . 0.0 113.479 -176.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.2 m -70.78 145.56 50.32 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.363 1.065 . . . . 0.0 110.513 166.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 20.3 pt -137.26 145.48 50.04 Favored Pre-proline 0 N--CA 1.474 0.774 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -169.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.38 148.73 74.48 Favored 'Cis proline' 0 C--N 1.351 0.707 0 CA-C-N 118.678 0.564 . . . . 0.0 111.552 -12.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.1 m -131.86 124.04 28.74 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.413 0.685 . . . . 0.0 110.015 167.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.8 mp -99.39 132.49 44.68 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.512 1.525 . . . . 0.0 108.638 174.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.6 mm -115.67 132.42 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.873 1.269 . . . . 0.0 108.767 168.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.0 tp -96.26 125.32 40.7 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.276 0.23 . . . . 0.0 110.625 163.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -102.62 139.34 38.34 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.161 1.384 . . . . 0.0 108.966 163.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -99.75 -35.79 9.68 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -152.57 58.28 0.81 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.675 1.99 . . . . 0.0 109.393 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.69 16.41 58.93 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 124.93 1.252 . . . . 0.0 114.893 -172.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -134.7 133.71 21.5 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 126.522 1.929 . . . . 0.0 110.308 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.42 140.89 34.12 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.471 2.781 . . . . 0.0 112.02 -172.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.3 m -129.81 -23.67 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.079 1.352 . . . . 0.0 114.496 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -148.08 145.8 28.57 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.234 1.014 . . . . 0.0 111.789 175.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -123.72 135.1 53.66 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.388 1.875 . . . . 0.0 110.575 169.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.9 mt -131.68 129.51 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.621 1.569 . . . . 0.0 109.108 176.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.7 m -127.27 144.61 36.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 123.939 0.896 . . . . 0.0 112.3 -169.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.67 164.66 7.97 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.327 0.965 . . . . 0.0 112.951 -171.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.84 150.41 37.39 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.436 -1.037 . . . . 0.0 113.388 -175.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.6 mmtm -133.71 146.69 51.03 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.142 1.777 . . . . 0.0 110.838 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.62 164.16 34.28 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 162.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -51.27 -36.21 41.05 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.696 1.198 . . . . 0.0 113.894 -178.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.21 -36.58 71.94 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.64 -47.8 24.87 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.085 0.954 . . . . 0.0 111.489 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.6 tp -64.72 -44.04 91.48 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.908 -0.495 . . . . 0.0 110.835 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 23.0 tp -75.59 -25.57 57.13 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-O 115.207 -2.33 . . . . 0.0 113.392 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -65.85 -44.42 85.54 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 125.131 3.605 . . . . 0.0 111.185 166.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -66.11 -25.49 67.02 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.2 mt -103.18 -17.52 15.32 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 175.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.8 t -72.36 -22.2 61.19 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 120.962 -1.086 . . . . 0.0 110.633 166.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -52.56 -21.08 3.45 Favored 'General case' 0 CA--C 1.555 1.17 0 O-C-N 121.114 -0.991 . . . . 0.0 113.455 159.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 89.1 t -107.67 -34.15 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 126.999 2.12 . . . . 0.0 112.137 172.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.481 1.122 0 C-N-CA 127.254 2.222 . . . . 0.0 110.594 177.432 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.9 p . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 120.458 0.171 . . . . 0.0 111.415 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.9 pt -129.19 155.12 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 125.827 1.651 . . . . 0.0 112.29 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -93.07 140.05 29.9 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.092 0.957 . . . . 0.0 111.497 173.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.4 150.34 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 125.08 1.352 . . . . 0.0 111.217 170.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 65.2 p -143.45 159.93 41.49 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.415 1.886 . . . . 0.0 110.338 178.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -51.45 -31.7 24.2 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.055 1.342 . . . . 0.0 114.55 -174.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.85 -21.44 66.8 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.9 m -131.69 -1.3 3.83 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.655 1.582 . . . . 0.0 113.711 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -59.51 -42.02 91.26 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.853 1.261 . . . . 0.0 112.514 -170.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.63 -32.4 72.23 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.8 m -79.18 -29.81 43.12 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.699 1.2 . . . . 0.0 112.578 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -94.71 -53.69 3.77 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.641 0.776 . . . . 0.0 112.803 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.3 -60.2 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.82 1.248 . . . . 0.0 110.732 -175.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.6 mt -75.43 -15.97 60.39 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -169.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.8 t -70.23 -22.91 62.86 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.566 1.146 . . . . 0.0 112.537 172.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.2 t -79.39 133.22 36.57 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -170.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -81.21 -23.84 37.84 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.584 1.154 . . . . 0.0 111.929 168.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -74.59 147.03 84.3 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 125.288 1.435 . . . . 0.0 110.044 176.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.88 132.43 51.63 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.196 1.931 . . . . 0.0 111.777 172.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.25 123.31 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.801 0.81 . . . . 0.0 110.798 -174.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 tt -101.93 132.07 47.95 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.581 1.952 . . . . 0.0 108.182 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 t -123.11 127.25 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.109 0.964 . . . . 0.0 110.6 174.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -100.24 118.84 37.37 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.487 1.515 . . . . 0.0 111.752 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.426 ' CD2' HD12 ' A' ' 63' ' ' LEU . 21.1 m-85 -99.66 109.26 21.75 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.156 2.182 . . . . 0.0 108.286 176.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.2 p-90 -142.61 178.46 7.6 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.954 1.302 . . . . 0.0 111.96 -164.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.53 140.03 30.06 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 121.521 -0.737 . . . . 0.0 112.971 167.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.7 t -64.98 -18.58 65.39 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 173.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -88.89 0.13 56.86 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 174.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.1 t -111.5 123.23 49.79 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.41 1.084 . . . . 0.0 112.893 -173.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.55 -49.44 73.57 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-O 118.868 -0.962 . . . . 0.0 114.348 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -58.16 -32.02 94.71 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.911 2.407 . . . . 0.0 114.04 171.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 97.4 m -65.1 -46.46 80.99 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.066 -1.022 . . . . 0.0 111.558 170.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -60.47 -29.95 69.37 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.766 0.712 . . . . 0.0 112.72 173.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.5 ttt -72.49 -44.23 62.55 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.556 1.142 . . . . 0.0 112.853 177.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.9 p -88.62 -24.67 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -176.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.23 -48.57 73.63 Favored Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.18 -29.01 47.81 Favored 'Trans proline' 0 C--N 1.352 0.73 0 CA-C-N 122.14 1.8 . . . . 0.0 113.324 176.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.5 t -70.11 -49.42 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 119.375 0.989 . . . . 0.0 110.565 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.1 pp -72.07 -26.85 62.33 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -72.52 -35.14 68.01 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.203 0.911 . . . . 0.0 112.931 171.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -61.76 -46.91 87.55 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 120.771 -1.206 . . . . 0.0 111.075 165.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 70.0 mt -58.23 -41.45 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 119.139 0.881 . . . . 0.0 110.942 174.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.47 -44.62 92.97 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.116 0.966 . . . . 0.0 113.506 175.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.4 m -76.65 -41.15 46.77 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.81 0.844 . . . . 0.0 111.718 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -86.04 -21.75 27.58 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -174.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -114.75 27.61 9.31 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.021 1.728 . . . . 0.0 113.273 176.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.84 -27.52 30.22 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.4 m -73.28 -37.0 66.41 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.584 1.154 . . . . 0.0 112.75 174.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -94.19 -29.61 15.03 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.724 1.21 . . . . 0.0 113.339 -174.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.1 mt -129.56 149.34 51.36 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.953 2.101 . . . . 0.0 110.6 -177.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.2 m -103.24 138.14 40.44 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 150.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.8 t -127.89 126.95 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.808 0.731 . . . . 0.0 111.381 -173.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.71 165.75 18.67 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.853 1.661 . . . . 0.0 113.145 -172.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -129.73 141.27 50.91 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.617 1.967 . . . . 0.0 112.455 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.426 HD12 ' CD2' ' A' ' 32' ' ' PHE . 2.7 tm? -133.65 113.69 12.66 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.113 2.165 . . . . 0.0 108.595 169.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -81.51 120.61 25.25 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 169.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.7 m -65.85 -16.32 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -169.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -83.16 -20.16 35.24 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 119.294 0.952 . . . . 0.0 113.334 171.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 43.1 p -92.03 -28.82 16.94 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -169.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -148.76 76.21 9.83 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 123.579 0.752 . . . . 0.0 110.602 166.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.97 -27.38 78.92 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 124.027 3.151 . . . . 0.0 115.47 -169.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -62.36 -26.0 68.21 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.761 0.824 . . . . 0.0 112.924 176.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -64.23 -46.91 81.77 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.998 0.817 . . . . 0.0 110.653 175.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.53 -37.0 86.05 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.667 0.787 . . . . 0.0 112.19 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -70.78 -45.96 63.74 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.455 0.702 . . . . 0.0 112.603 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -69.82 -27.02 64.52 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -174.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -99.75 10.14 41.85 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.673 1.189 . . . . 0.0 113.563 172.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 62.68 -8.51 0.12 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 128.542 2.737 . . . . 0.0 116.225 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.9 m -79.61 56.52 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 126.536 1.934 . . . . 0.0 112.889 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.7 m -76.22 -21.46 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.925 1.29 . . . . 0.0 113.539 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 51.1 m -67.85 150.29 48.77 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.448 1.099 . . . . 0.0 111.26 170.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.3 pt -139.69 145.8 44.79 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -174.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.58 146.11 64.81 Favored 'Cis proline' 0 CA--C 1.538 0.685 0 O-C-N 122.034 0.492 . . . . 0.0 111.44 -17.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 83.4 m -135.18 126.32 28.0 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.88 0.872 . . . . 0.0 110.872 171.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.8 134.2 39.03 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.535 1.134 . . . . 0.0 108.007 167.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.6 tt -117.36 143.97 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.485 1.114 . . . . 0.0 108.891 165.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.7 tt -123.71 134.66 53.66 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.663 0.785 . . . . 0.0 110.361 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -114.24 147.36 39.11 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.835 1.654 . . . . 0.0 111.344 173.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -126.49 135.09 50.9 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.6 1.16 . . . . 0.0 109.528 161.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.0 t0 47.0 41.8 11.55 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.639 1.176 . . . . 0.0 113.411 -174.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.38 14.06 63.72 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.138 1.352 . . . . 0.0 115.884 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -118.35 140.81 28.64 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 125.715 1.606 . . . . 0.0 109.88 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.81 140.36 42.31 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.798 2.332 . . . . 0.0 112.308 -174.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.2 t -125.94 -39.26 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.983 1.713 . . . . 0.0 112.185 -173.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -145.11 145.34 31.37 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.756 0.823 . . . . 0.0 111.89 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -129.26 132.31 47.17 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.072 1.749 . . . . 0.0 109.814 161.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.3 mt -135.55 129.53 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.618 1.567 . . . . 0.0 108.994 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.0 m -127.63 145.48 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 123.744 0.818 . . . . 0.0 112.568 -170.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.24 166.63 26.52 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.22 0.914 . . . . 0.0 113.506 -174.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.35 132.77 35.22 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.729 -0.865 . . . . 0.0 112.489 -176.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -133.83 156.53 47.87 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.912 1.685 . . . . 0.0 111.144 172.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -79.18 167.91 52.76 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 123.873 0.749 . . . . 0.0 112.169 173.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -47.91 -38.18 15.86 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.854 1.662 . . . . 0.0 114.673 -176.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.26 -49.57 54.93 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.78 0.324 . . . . 0.0 111.759 -177.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.42 -39.31 59.09 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.731 -0.606 . . . . 0.0 112.516 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.9 tp -68.07 -42.03 81.05 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.921 0.782 . . . . 0.0 111.052 176.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 23.6 tp -70.24 -24.68 63.12 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-O 115.513 -2.184 . . . . 0.0 112.315 171.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 44.6 mmt-85 -64.31 -49.51 71.49 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 124.51 3.323 . . . . 0.0 112.219 167.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.37 -31.22 65.56 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.464 0.706 . . . . 0.0 112.839 176.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 53.3 mt -97.26 -22.56 16.62 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 52.3 p -73.96 -20.2 60.43 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.893 1.277 . . . . 0.0 111.114 174.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -52.91 -27.83 20.52 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 160.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 93.3 t -100.86 -32.71 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 126.66 1.984 . . . . 0.0 112.008 171.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 28.5 t . . . . . 0 N--CA 1.477 0.903 0 C-N-CA 126.913 2.085 . . . . 0.0 110.942 -176.893 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.3 p . . . . . 0 N--CA 1.472 0.669 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.2 pt -138.25 172.53 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 126.545 1.938 . . . . 0.0 111.381 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -125.48 142.91 51.25 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.106 0.962 . . . . 0.0 111.209 169.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -139.36 150.23 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.375 1.47 . . . . 0.0 111.0 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.7 p -139.51 161.48 37.38 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.15 1.38 . . . . 0.0 111.672 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -51.15 -30.38 16.41 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.936 2.095 . . . . 0.0 114.718 -176.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.0 -20.19 66.11 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 178.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.6 m -137.96 9.85 2.82 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.456 1.502 . . . . 0.0 113.411 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -63.13 -44.74 94.72 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.178 -0.951 . . . . 0.0 112.486 -168.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.26 -32.81 74.45 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.682 -0.636 . . . . 0.0 112.504 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.5 -9.46 59.62 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.84 1.656 . . . . 0.0 114.16 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -124.17 -50.86 1.78 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.18 0.992 . . . . 0.0 113.241 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.1 t -81.72 -52.97 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.356 1.062 . . . . 0.0 110.799 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 28.9 mt -81.33 -13.35 58.48 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -175.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.0 p -77.68 -21.61 51.79 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.805 1.242 . . . . 0.0 113.192 173.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.9 m -75.49 126.7 31.53 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.188 1.395 . . . . 0.0 112.544 -173.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -76.95 -25.14 52.5 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.319 0.647 . . . . 0.0 111.85 169.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -74.99 145.23 80.75 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 125.853 1.661 . . . . 0.0 110.255 173.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.33 137.28 77.56 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.156 1.904 . . . . 0.0 112.14 172.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.5 p -136.53 130.35 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.6 1.16 . . . . 0.0 110.526 -176.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 tt -112.47 116.84 30.91 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.021 1.728 . . . . 0.0 108.228 -174.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.65 124.94 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.445 0.698 . . . . 0.0 110.501 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -107.47 116.39 31.86 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.585 1.554 . . . . 0.0 111.481 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -93.4 108.85 20.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.466 1.906 . . . . 0.0 108.351 177.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -142.26 173.13 11.81 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.851 1.261 . . . . 0.0 112.347 -163.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.74 145.16 29.86 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.54 -0.725 . . . . 0.0 112.275 158.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -65.43 -19.53 65.98 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.8 p-90 -78.51 -13.62 59.75 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 175.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.8 t -98.16 129.84 44.93 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.143 0.977 . . . . 0.0 111.572 -174.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.13 -55.91 27.6 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.298 0.951 . . . . 0.0 113.721 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -57.65 -31.73 92.65 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.439 2.759 . . . . 0.0 114.531 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 96.3 m -67.64 -45.33 75.62 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.137 -0.977 . . . . 0.0 111.44 173.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.1 tppt? -61.37 -33.57 73.87 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.475 1.11 . . . . 0.0 111.819 172.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 50.8 ttm -70.01 -42.72 72.65 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.031 1.332 . . . . 0.0 112.942 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.2 p -81.34 -24.49 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.96 -49.97 77.5 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.9 -27.27 37.15 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.174 1.916 . . . . 0.0 113.125 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.9 t -72.47 -41.35 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.714 0.805 . . . . 0.0 110.525 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.3 mt -67.19 -35.9 80.63 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.111 0.964 . . . . 0.0 112.613 170.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -66.12 -40.58 90.81 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.223 0.92 . . . . 0.0 111.468 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -58.26 -49.54 76.75 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.743 168.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 tp -66.82 -33.28 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 120.34 1.427 . . . . 0.0 112.652 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.79 -40.0 93.66 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.212 -0.93 . . . . 0.0 111.954 172.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.3 m -76.07 -49.0 18.66 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.723 0.809 . . . . 0.0 112.092 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -85.57 -21.61 28.45 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -170.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -116.92 31.52 6.7 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.357 1.863 . . . . 0.0 112.657 173.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.75 -28.18 14.42 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 176.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.5 p -81.61 -29.44 33.27 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.68 1.592 . . . . 0.0 114.292 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -102.16 -27.06 13.11 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.734 1.214 . . . . 0.0 113.742 -175.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 81.5 mt -129.67 148.71 51.58 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.357 1.863 . . . . 0.0 110.196 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.5 m -109.02 131.61 54.91 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 153.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 83.1 t -106.35 130.19 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.494 0.718 . . . . 0.0 109.858 -175.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.35 146.86 50.31 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.897 1.279 . . . . 0.0 112.419 -171.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -120.16 136.39 54.64 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.333 1.453 . . . . 0.0 111.986 -176.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -130.65 116.81 18.59 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.598 1.559 . . . . 0.0 109.744 171.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.77 105.72 13.13 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.261 1.024 . . . . 0.0 110.594 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.5 m -65.14 -20.42 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -73.76 -27.83 61.37 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.322 1.449 . . . . 0.0 113.271 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.7 p -112.73 -22.02 10.92 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.38 1.072 . . . . 0.0 113.59 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -133.27 92.71 24.01 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.256 1.023 . . . . 0.0 111.577 168.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -71.26 -19.61 29.09 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.238 2.625 . . . . 0.0 113.844 172.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -67.61 -42.38 82.5 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.142 -0.973 . . . . 0.0 112.126 -171.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.6 m -67.15 -35.02 78.81 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.85 0.86 . . . . 0.0 111.248 176.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.26 -45.6 80.0 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.227 0.611 . . . . 0.0 111.955 174.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.0 ttm105 -72.57 -41.59 65.53 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -174.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -62.1 -38.33 88.45 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -96.89 7.53 46.41 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.364 1.066 . . . . 0.0 113.122 176.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.318 14.8 pt20 44.02 34.45 0.95 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.95 2.1 . . . . 0.0 114.415 -169.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.8 m -85.56 43.85 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 126.654 1.982 . . . . 0.0 110.406 175.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.4 m -85.23 -14.2 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.698 1.599 . . . . 0.0 113.993 -168.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.0 t -71.55 155.31 40.7 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.559 0.743 . . . . 0.0 111.038 170.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 14.4 pt -129.49 121.49 20.32 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -167.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -67.24 161.8 76.76 Favored 'Cis proline' 0 CA--C 1.54 0.8 0 CA-C-N 118.831 0.618 . . . . 0.0 111.709 -16.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.1 m -127.16 134.39 50.18 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.5 1.12 . . . . 0.0 108.713 161.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.4 mp -113.42 131.93 55.82 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.856 1.262 . . . . 0.0 108.709 174.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.5 tp -116.1 146.3 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.868 1.267 . . . . 0.0 109.307 167.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.4 tt -123.92 132.85 53.8 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.681 -0.637 . . . . 0.0 110.451 165.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -111.95 143.77 42.38 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.223 1.409 . . . . 0.0 110.368 170.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -126.94 125.48 41.62 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.391 1.476 . . . . 0.0 109.17 171.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.8 t70 50.41 34.34 9.04 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 124.41 1.084 . . . . 0.0 113.526 -168.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.12 8.48 61.76 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 125.781 1.658 . . . . 0.0 116.171 -175.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -102.34 141.3 22.25 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 119.364 1.582 . . . . 0.0 110.488 172.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -70.08 140.38 41.32 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.83 2.353 . . . . 0.0 112.592 -176.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 75.3 t -127.72 -36.49 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 125.854 1.662 . . . . 0.0 112.709 -175.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -142.14 139.14 32.04 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.687 1.195 . . . . 0.0 111.115 -177.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 24.5 ttt85 -141.4 115.83 9.51 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.62 1.968 . . . . 0.0 110.194 171.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.27 150.73 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.223 1.409 . . . . 0.0 112.8 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.8 m -124.08 155.65 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.474 1.51 . . . . 0.0 111.911 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.25 163.11 11.27 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.257 0.932 . . . . 0.0 112.983 -174.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.5 156.07 30.84 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.191 -1.182 . . . . 0.0 113.706 -176.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.81 147.58 52.49 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.587 1.555 . . . . 0.0 110.049 165.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.69 167.22 44.14 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 162.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.4 tmtp? -52.75 -34.29 52.26 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.769 1.228 . . . . 0.0 113.618 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.59 -53.97 34.31 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.91 0.484 . . . . 0.0 111.754 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.1 -36.27 66.76 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.465 -0.772 . . . . 0.0 112.601 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.1 tp -63.44 -40.23 96.61 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.644 -0.66 . . . . 0.0 110.179 172.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 26.5 tp -72.74 -23.76 60.88 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-O 117.041 -1.457 . . . . 0.0 113.298 173.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -58.52 -55.61 32.79 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 122.951 2.614 . . . . 0.0 109.988 164.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -69.56 -26.57 64.55 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -174.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 88.9 mt -97.06 -28.76 14.0 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 176.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.9 t -69.58 -24.37 63.68 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 120.584 1.538 . . . . 0.0 111.194 170.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.63 -22.7 47.02 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 164.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.5 t -100.53 -28.28 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 127.056 2.142 . . . . 0.0 111.805 171.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 32.9 t . . . . . 0 N--CA 1.475 0.789 0 C-N-CA 127.389 2.276 . . . . 0.0 111.13 -170.955 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.6 p . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.1 pt -115.85 155.11 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.642 1.577 . . . . 0.0 111.551 171.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -108.8 136.4 48.43 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.517 1.127 . . . . 0.0 110.479 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.9 m -132.14 154.25 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.664 1.186 . . . . 0.0 112.857 -172.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 66.5 p -142.22 161.3 38.36 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.289 1.835 . . . . 0.0 110.854 175.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -57.17 -28.57 62.9 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -172.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.33 -17.3 62.45 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.553 1.141 . . . . 0.0 114.074 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.1 m -136.06 3.2 2.89 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.302 1.441 . . . . 0.0 113.552 -175.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -56.09 -40.57 73.86 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.119 1.367 . . . . 0.0 112.533 -174.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.03 -34.6 78.46 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.317 -0.864 . . . . 0.0 113.044 177.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.8 m -79.51 -29.6 41.62 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.511 1.124 . . . . 0.0 112.846 177.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -94.63 -39.46 10.33 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.1 t -97.23 -64.85 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.186 1.394 . . . . 0.0 109.859 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.9 mt -73.82 -14.62 61.13 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -165.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.0 m -85.08 -3.67 58.88 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.659 1.184 . . . . 0.0 113.997 176.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.1 m -60.65 142.09 56.04 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.925 1.29 . . . . 0.0 113.565 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.8 p-10 -82.93 -3.99 57.68 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.797 1.239 . . . . 0.0 114.2 176.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -141.13 163.33 42.81 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 127.833 2.453 . . . . 0.0 110.558 176.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -53.45 147.08 39.12 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.231 2.621 . . . . 0.0 112.836 177.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.39 133.39 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.633 1.173 . . . . 0.0 111.711 -174.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.02 117.05 32.73 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.876 2.071 . . . . 0.0 108.422 -176.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.2 t -107.63 127.31 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.693 0.797 . . . . 0.0 110.396 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -104.53 117.08 33.26 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.0 1.32 . . . . 0.0 111.173 175.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -91.8 107.22 19.06 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.272 1.829 . . . . 0.0 107.964 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.466 ' CD1' ' HE3' ' A' ' 62' ' ' LYS . 2.1 p-90 -143.93 164.47 30.48 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -159.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.47 151.92 36.01 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.865 0.866 . . . . 0.0 111.359 162.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.3 t -66.19 -20.99 66.3 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 12.6 p-90 -75.39 -8.64 57.23 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 173.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 43.1 t -100.34 116.46 32.38 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.406 1.082 . . . . 0.0 110.914 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.62 -44.3 98.13 Favored Glycine 0 CA--C 1.54 1.642 0 CA-C-O 118.801 -1.0 . . . . 0.0 114.022 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -56.88 -39.51 90.89 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.863 2.376 . . . . 0.0 113.941 169.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 87.1 m -61.57 -43.34 99.03 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.989 -1.069 . . . . 0.0 111.503 171.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -62.97 -29.74 71.05 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.379 1.072 . . . . 0.0 112.512 176.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -74.96 -45.71 40.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.229 1.412 . . . . 0.0 112.681 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.1 p -81.37 -24.11 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.78 -50.06 79.82 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -65.91 -28.36 50.42 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 CA-C-N 122.353 1.876 . . . . 0.0 113.177 176.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.6 t -70.02 -45.98 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.479 -0.763 . . . . 0.0 110.154 175.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.8 mt -62.35 -34.26 76.33 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.258 1.023 . . . . 0.0 112.672 172.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -66.3 -41.33 89.89 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.987 0.915 . . . . 0.0 111.758 175.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -63.75 -44.86 92.23 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.382 -0.824 . . . . 0.0 111.648 170.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.3 mm -59.01 -43.37 88.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 119.248 0.931 . . . . 0.0 110.956 174.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.45 -42.66 92.45 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.836 0.854 . . . . 0.0 112.016 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.2 m -74.61 -42.61 58.31 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.979 0.912 . . . . 0.0 112.062 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -95.42 -22.07 17.94 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -169.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -112.26 17.97 19.0 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.654 1.581 . . . . 0.0 112.633 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.85 -28.46 50.01 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.981 1.313 . . . . 0.0 114.455 -176.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.9 p -69.21 -22.75 63.86 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.931 1.692 . . . . 0.0 114.1 174.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -117.83 -29.52 5.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.883 1.673 . . . . 0.0 112.98 -171.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.0 mt -130.16 149.34 51.91 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.69 1.996 . . . . 0.0 111.125 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.2 m -99.79 139.03 36.05 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 151.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 52.2 t -117.0 129.23 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 119.397 0.999 . . . . 0.0 110.3 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.32 157.73 41.74 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.698 1.599 . . . . 0.0 112.697 -170.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.466 ' HE3' ' CD1' ' A' ' 33' ' ' TRP . 30.8 mmmt -126.77 124.3 39.39 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.179 1.792 . . . . 0.0 110.422 -175.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -109.95 114.03 27.24 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.642 1.177 . . . . 0.0 108.908 169.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.72 99.4 9.61 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.613 1.165 . . . . 0.0 109.369 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.9 m -66.7 -17.06 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 O-C-N 120.856 -1.152 . . . . 0.0 113.156 -176.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -74.23 -24.84 59.37 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.339 1.056 . . . . 0.0 113.206 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.2 p -119.25 -25.51 6.11 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -133.31 74.16 72.69 Favored Pre-proline 0 CA--C 1.55 0.977 0 CA-C-N 119.598 1.09 . . . . 0.0 112.141 171.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -67.46 -11.57 32.62 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 122.846 2.364 . . . . 0.0 112.675 168.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -57.24 -41.73 80.13 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.834 1.253 . . . . 0.0 112.223 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.2 m -66.02 -42.71 89.27 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.742 0.701 . . . . 0.0 111.046 174.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.75 -37.98 86.29 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.516 -0.74 . . . . 0.0 112.994 -178.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -78.74 -38.6 38.4 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 173.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -69.09 -36.67 77.85 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.245 0.93 . . . . 0.0 112.607 -178.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -93.3 9.15 37.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.819 1.248 . . . . 0.0 112.482 174.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 61.16 -10.29 0.06 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 128.737 2.815 . . . . 0.0 116.87 177.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.3 m -76.73 52.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 126.317 1.847 . . . . 0.0 113.449 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.8 p -75.9 -20.97 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.428 1.491 . . . . 0.0 113.067 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.5 p -70.9 129.33 38.77 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.188 0.995 . . . . 0.0 110.821 165.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.4 pt -138.5 149.62 63.4 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 125.068 1.347 . . . . 0.0 112.809 -163.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -66.51 149.4 79.18 Favored 'Cis proline' 0 C--N 1.354 0.829 0 CA-C-N 119.373 0.812 . . . . 0.0 113.246 -2.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.1 m -128.67 130.28 46.98 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.271 1.028 . . . . 0.0 110.895 169.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.3 mp -103.49 119.32 38.66 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.828 1.651 . . . . 0.0 107.227 161.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.3 tp -120.39 126.48 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.701 1.201 . . . . 0.0 109.713 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.9 tp -110.24 121.04 44.34 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.153 1.381 . . . . 0.0 110.464 -172.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -106.8 131.13 54.26 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.864 1.665 . . . . 0.0 109.172 175.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -99.72 -29.74 12.48 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -175.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -154.45 56.93 0.7 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.786 1.634 . . . . 0.0 110.785 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.73 17.82 65.37 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.315 0.959 . . . . 0.0 114.554 -175.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -141.91 138.41 16.97 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 126.83 2.052 . . . . 0.0 110.139 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.86 142.69 35.62 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.254 2.636 . . . . 0.0 111.96 -174.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.8 t -129.6 -40.06 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.497 1.119 . . . . 0.0 112.939 -176.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -142.3 133.14 25.65 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.081 0.855 . . . . 0.0 111.791 -173.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -117.83 134.01 55.36 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.284 1.434 . . . . 0.0 110.841 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.11 144.12 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 126.422 1.889 . . . . 0.0 108.713 169.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.8 m -133.67 144.84 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 124.834 1.254 . . . . 0.0 111.001 -174.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.08 -162.84 46.73 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 122.869 0.271 . . . . 0.0 112.624 -167.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.8 139.68 51.96 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.89 1.276 . . . . 0.0 112.28 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -135.23 154.35 51.61 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.611 1.565 . . . . 0.0 112.129 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -80.73 171.12 53.76 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.415 1.007 . . . . 0.0 112.455 173.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -51.84 -37.42 51.86 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.437 1.495 . . . . 0.0 114.628 -175.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.9 -53.43 32.22 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 123.407 0.442 . . . . 0.0 110.924 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.39 -38.76 68.37 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 36.9 tp -63.76 -42.57 97.8 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 119.399 0.999 . . . . 0.0 111.043 173.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.7 tp -70.18 -25.03 63.24 Favored 'General case' 0 C--O 1.214 -0.786 0 CA-C-O 115.857 -2.021 . . . . 0.0 113.014 174.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -64.49 -49.96 69.3 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 124.258 3.208 . . . . 0.0 111.962 166.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.49 -28.63 68.51 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.499 0.72 . . . . 0.0 112.882 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 89.8 mt -91.52 -28.21 17.73 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.396 1.078 . . . . 0.0 113.303 172.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.3 m -60.18 -28.79 68.24 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.82 1.248 . . . . 0.0 110.669 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -52.69 -20.47 3.14 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 168.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.9 t -118.59 -27.32 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 127.407 2.283 . . . . 0.0 112.633 173.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.475 0.814 0 C-N-CA 127.092 2.157 . . . . 0.0 110.939 -174.186 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.4 pt -132.62 157.24 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 126.112 1.765 . . . . 0.0 111.353 169.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -112.06 140.38 46.79 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.636 1.174 . . . . 0.0 110.597 171.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.9 m -132.11 155.46 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.701 1.2 . . . . 0.0 112.509 -175.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.7 p -142.11 160.81 39.49 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.466 1.907 . . . . 0.0 110.577 176.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -57.95 -27.64 63.59 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -173.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.36 -19.56 63.03 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.0 m -132.77 -2.85 3.29 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.181 1.392 . . . . 0.0 114.17 -174.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -55.26 -40.39 70.91 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.257 1.423 . . . . 0.0 112.642 -174.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.38 -33.6 75.53 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.972 0.731 . . . . 0.0 112.972 177.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.7 m -79.51 -29.69 41.63 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.725 1.21 . . . . 0.0 112.873 176.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -92.64 -45.04 8.27 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -176.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.11 -59.05 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.916 1.286 . . . . 0.0 110.636 -176.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.4 mt -75.66 -18.72 59.56 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -169.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.8 m -79.38 -10.84 59.89 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.3 t -81.64 130.05 34.92 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.788 0.835 . . . . 0.0 112.469 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -81.6 -21.12 38.55 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.242 1.017 . . . . 0.0 112.341 170.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -75.36 147.74 82.79 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.354 1.462 . . . . 0.0 110.062 174.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -58.03 133.23 54.32 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.103 1.869 . . . . 0.0 111.396 171.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.88 132.51 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.225 1.01 . . . . 0.0 110.18 -174.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -122.73 113.84 19.74 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.171 1.389 . . . . 0.0 109.7 -170.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.61 125.19 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.888 1.275 . . . . 0.0 110.224 -173.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -103.88 120.78 41.71 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.267 1.027 . . . . 0.0 112.009 174.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -93.09 113.37 25.61 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.987 2.115 . . . . 0.0 108.076 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 6.8 p-90 -144.83 172.5 12.93 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.439 1.096 . . . . 0.0 113.235 -165.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -145.77 152.83 40.19 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.916 0.886 . . . . 0.0 112.419 167.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.9 p -63.71 -27.29 69.1 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.622 1.169 . . . . 0.0 113.119 174.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.501 ' CZ3' HD11 ' A' ' 80' ' ' ILE . 10.7 p-90 -79.0 -3.69 46.29 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 48.5 t -107.5 123.74 48.87 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.865 0.866 . . . . 0.0 113.271 -170.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.31 -58.4 14.79 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.205 1.384 . . . . 0.0 114.02 178.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.7 -27.09 68.47 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 CA-C-N 120.482 2.141 . . . . 0.0 113.534 177.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 85.3 m -61.91 -46.68 88.33 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.116 1.326 . . . . 0.0 111.238 168.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.89 -33.18 72.71 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.014 0.926 . . . . 0.0 112.631 175.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.4 mtt -74.77 -37.7 62.38 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.542 1.137 . . . . 0.0 113.83 177.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.4 p -88.13 -20.77 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.47 -49.38 77.98 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 174.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.5 -27.23 46.59 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 CA-C-N 122.303 1.858 . . . . 0.0 113.476 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 95.3 t -71.29 -49.46 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 119.059 0.845 . . . . 0.0 110.322 173.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.9 mt -61.52 -34.32 75.32 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.954 0.902 . . . . 0.0 113.029 176.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -62.61 -39.99 95.54 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.889 0.876 . . . . 0.0 111.504 173.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -71.34 -36.96 71.73 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.154 -0.966 . . . . 0.0 112.655 173.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.6 mm -61.21 -43.8 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 120.542 1.519 . . . . 0.0 110.559 171.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.27 -35.31 79.92 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.891 0.876 . . . . 0.0 112.504 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.4 m -73.46 -49.04 28.89 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.807 0.843 . . . . 0.0 112.012 176.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -92.7 -34.39 13.96 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -165.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -97.72 19.58 13.4 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.142 0.977 . . . . 0.0 113.328 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.37 -28.2 18.65 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.3 m -75.02 -31.68 61.41 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.767 1.227 . . . . 0.0 112.936 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -97.48 -34.89 10.83 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.035 1.334 . . . . 0.0 112.786 -174.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.3 mt -129.83 152.37 49.39 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.671 2.388 . . . . 0.0 110.518 -174.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.5 m -106.34 129.64 54.31 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 153.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.8 t -99.42 133.03 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.148 0.579 . . . . 0.0 110.193 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.2 155.94 44.73 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.359 1.464 . . . . 0.0 112.217 -173.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -127.64 134.54 49.64 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.305 1.442 . . . . 0.0 112.104 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -124.55 116.43 22.45 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.917 1.687 . . . . 0.0 109.08 169.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -81.94 113.03 19.58 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.482 0.713 . . . . 0.0 109.984 174.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.5 m -71.76 -16.56 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -177.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -85.84 -39.03 17.49 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.792 0.837 . . . . 0.0 111.991 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 72.3 p -96.38 -19.98 18.8 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -137.67 77.13 40.07 Favored Pre-proline 0 CA--C 1.552 1.021 0 CA-C-N 120.159 1.345 . . . . 0.0 111.82 163.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -65.56 -18.9 60.29 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.43 2.753 . . . . 0.0 113.871 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -63.61 -37.38 87.12 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.35 -0.844 . . . . 0.0 113.104 -174.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 m -65.06 -43.61 91.71 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.633 1.106 . . . . 0.0 111.256 174.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.7 -36.66 83.65 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.532 0.733 . . . . 0.0 112.08 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -70.1 -46.76 64.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.845 0.858 . . . . 0.0 112.12 173.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -63.05 -37.12 85.92 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.386 1.474 . . . . 0.0 112.617 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -96.48 8.8 43.2 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.497 1.119 . . . . 0.0 112.917 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 59.98 -11.43 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 128.539 2.736 . . . . 0.0 116.588 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.5 m -76.74 59.96 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.579 1.952 . . . . 0.0 112.667 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.0 m -74.84 -19.9 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.989 1.316 . . . . 0.0 113.423 176.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.6 t -79.27 148.09 32.28 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.555 1.142 . . . . 0.0 111.165 170.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.501 HD11 ' CZ3' ' A' ' 36' ' ' TRP . 46.7 pt -143.49 155.64 60.55 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -167.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.74 140.82 59.5 Favored 'Cis proline' 0 C--N 1.353 0.793 0 CA-C-N 119.093 0.712 . . . . 0.0 111.033 -9.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 98.2 m -133.34 120.96 21.68 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.432 0.634 . . . . 0.0 110.65 174.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 mp -96.62 134.93 39.23 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.782 1.633 . . . . 0.0 108.42 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.0 tt -130.57 129.24 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.775 1.23 . . . . 0.0 110.727 171.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.9 tt -103.46 133.69 48.09 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.914 1.286 . . . . 0.0 110.531 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -117.22 148.28 41.77 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.233 1.413 . . . . 0.0 111.228 171.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -124.77 131.03 53.49 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.007 1.323 . . . . 0.0 108.991 164.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.6 t70 49.13 33.27 4.73 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.22 13.36 83.69 Favored Glycine 0 CA--C 1.536 1.371 0 N-CA-C 116.909 1.524 . . . . 0.0 116.909 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -116.25 145.76 35.77 Favored Pre-proline 0 N--CA 1.474 0.743 0 CA-C-N 119.36 1.58 . . . . 0.0 111.588 167.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -72.18 148.71 50.48 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.381 2.721 . . . . 0.0 112.408 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.2 t -131.89 -43.2 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.325 1.45 . . . . 0.0 112.829 -168.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -148.84 146.55 28.02 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.083 1.353 . . . . 0.0 110.968 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 -129.02 144.59 51.24 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.513 1.525 . . . . 0.0 112.067 167.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.5 mt -136.51 136.36 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 126.369 1.868 . . . . 0.0 107.893 175.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 p -133.46 142.89 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 119.664 1.12 . . . . 0.0 111.685 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.16 161.11 30.47 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.017 1.294 . . . . 0.0 113.248 -171.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.85 134.39 39.04 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.792 -0.828 . . . . 0.0 112.57 -177.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -133.07 149.65 52.14 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.936 1.694 . . . . 0.0 109.905 172.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.77 167.01 54.7 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -45.11 -40.06 6.56 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.36 1.464 . . . . 0.0 114.62 -175.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.77 -48.86 57.74 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.037 0.535 . . . . 0.0 111.984 -177.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.57 -36.98 60.24 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.91 0.884 . . . . 0.0 112.712 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.72 -46.53 75.22 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.914 0.886 . . . . 0.0 110.046 175.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -66.12 -30.02 70.44 Favored 'General case' 0 C--O 1.208 -1.124 0 CA-C-O 115.651 -2.118 . . . . 0.0 111.587 171.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 4.5 mmt180 -62.2 -49.11 77.1 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 124.382 3.264 . . . . 0.0 112.849 171.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -59.05 -33.01 70.28 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.323 1.049 . . . . 0.0 112.434 177.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.4 mt -85.62 -22.95 27.74 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 169.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.4 p -67.38 -25.99 66.23 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.807 1.643 . . . . 0.0 110.096 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -49.6 -26.25 3.44 Favored 'General case' 0 CA--C 1.556 1.193 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 164.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.5 t -111.57 -23.52 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 127.337 2.255 . . . . 0.0 112.931 172.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.48 1.046 0 C-N-CA 127.858 2.463 . . . . 0.0 109.798 177.205 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.0 p . . . . . 0 N--CA 1.478 0.933 0 CA-C-O 121.201 0.524 . . . . 0.0 112.387 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.1 pt -125.02 164.52 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.57 1.548 . . . . 0.0 110.189 164.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -123.5 138.13 54.64 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.902 -1.124 . . . . 0.0 110.816 172.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.87 150.72 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.235 1.414 . . . . 0.0 112.085 -168.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.0 p -139.89 161.94 36.37 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.545 1.538 . . . . 0.0 111.496 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -51.6 -31.48 25.05 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.318 1.447 . . . . 0.0 114.599 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.71 -20.18 65.91 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.8 m -133.64 4.96 3.66 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.477 1.511 . . . . 0.0 113.425 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -59.45 -39.81 84.82 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.685 1.194 . . . . 0.0 112.969 -171.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.91 -32.64 74.04 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.533 -0.729 . . . . 0.0 112.889 175.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.1 m -79.62 -27.49 41.01 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.215 1.406 . . . . 0.0 113.234 177.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -101.34 -34.01 9.79 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -176.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.45 -54.47 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.843 1.257 . . . . 0.0 111.503 -172.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.4 mt -74.9 -12.59 60.4 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -176.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.5 p -71.16 -15.83 62.51 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.261 1.824 . . . . 0.0 113.942 173.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.7 p -66.75 149.05 51.1 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.804 1.642 . . . . 0.0 114.335 -172.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -109.62 -16.83 13.86 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.931 1.292 . . . . 0.0 112.225 160.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -90.53 166.6 18.96 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 125.95 1.7 . . . . 0.0 111.195 171.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.442 ' HB2' HD23 ' A' ' 58' ' ' LEU . 51.0 Cg_exo -59.49 138.68 85.38 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.29 1.994 . . . . 0.0 112.863 167.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.71 124.84 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.571 1.148 . . . . 0.0 111.104 172.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tt -100.3 128.73 46.3 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.796 2.038 . . . . 0.0 108.44 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.1 t -120.03 129.24 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.364 1.065 . . . . 0.0 110.571 173.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -106.8 116.93 32.78 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.061 1.344 . . . . 0.0 111.615 175.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.5 m-30 -88.22 111.69 21.93 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.992 1.717 . . . . 0.0 108.841 171.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 24.6 p-90 -134.23 170.96 14.91 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.236 1.414 . . . . 0.0 112.194 -171.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.86 140.27 24.46 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.83 0.852 . . . . 0.0 110.914 170.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 t -65.47 -12.5 53.13 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -168.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 55.3 p-90 -84.21 -14.02 51.15 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 172.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.2 t -90.7 106.49 18.54 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.1 0.96 . . . . 0.0 112.721 -166.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -52.75 -49.66 52.88 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.351 0.977 . . . . 0.0 114.234 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -60.59 -29.32 88.25 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.559 2.173 . . . . 0.0 114.487 174.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.73 -39.36 70.15 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.255 0.934 . . . . 0.0 111.294 172.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -63.45 -29.81 71.04 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.552 0.741 . . . . 0.0 112.308 172.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.6 mtt -71.02 -42.5 69.48 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.261 1.024 . . . . 0.0 113.11 174.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.6 p -86.09 -21.65 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.51 -49.09 79.92 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 176.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.86 -27.95 43.23 Favored 'Trans proline' 0 C--N 1.353 0.764 0 CA-C-N 122.32 1.864 . . . . 0.0 112.828 176.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.8 t -72.16 -46.04 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 121.601 -0.687 . . . . 0.0 110.371 176.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.4 mt -57.55 -40.53 79.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.422 1.089 . . . . 0.0 112.078 170.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.43 -41.02 85.47 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.179 0.992 . . . . 0.0 112.327 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -62.93 -49.35 75.11 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.299 -0.876 . . . . 0.0 111.692 169.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 17.0 mm -56.61 -42.09 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.44 0.696 . . . . 0.0 110.94 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.06 -49.96 75.58 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.992 0.917 . . . . 0.0 112.117 174.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.6 m -77.34 -32.86 55.44 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.706 0.802 . . . . 0.0 112.247 -170.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -86.14 -38.69 17.47 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.571 1.148 . . . . 0.0 113.916 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -107.52 26.75 9.87 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.542 1.137 . . . . 0.0 113.8 -173.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.75 -27.99 45.17 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.9 p -77.19 -19.88 56.14 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.416 1.487 . . . . 0.0 113.902 175.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -104.68 -35.53 7.77 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.268 1.427 . . . . 0.0 112.718 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.442 HD23 ' HB2' ' A' ' 27' ' ' PRO . 85.9 mt -129.61 149.14 51.5 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.168 2.187 . . . . 0.0 110.231 -176.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.8 m -99.54 138.87 36.02 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 150.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.7 t -125.02 127.9 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.247 0.931 . . . . 0.0 110.583 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -128.07 154.08 46.09 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.013 1.725 . . . . 0.0 112.915 -169.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -125.7 145.01 50.36 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.406 1.482 . . . . 0.0 112.916 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -135.98 118.58 15.96 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.499 1.92 . . . . 0.0 109.95 173.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -83.81 109.96 17.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.225 0.61 . . . . 0.0 110.727 174.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.4 m -70.7 -12.18 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -74.11 -19.33 60.62 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.734 1.152 . . . . 0.0 112.119 166.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.1 p -101.18 -43.76 5.89 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.615 1.166 . . . . 0.0 112.718 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -142.41 65.42 17.75 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 125.226 1.41 . . . . 0.0 111.311 -171.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -63.56 -23.17 70.58 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.617 2.878 . . . . 0.0 113.696 -176.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -57.0 -28.0 62.07 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.48 1.112 . . . . 0.0 112.576 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -66.79 -44.96 79.94 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.102 0.961 . . . . 0.0 112.06 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.55 -31.84 63.86 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.322 1.049 . . . . 0.0 112.651 173.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -71.1 -32.24 68.8 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.617 1.167 . . . . 0.0 113.496 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.6 t-20 -60.25 -41.81 93.97 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.757 1.223 . . . . 0.0 112.068 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -82.72 -8.38 59.59 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.026 0.93 . . . . 0.0 113.195 172.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 55.14 45.63 25.61 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.133 2.173 . . . . 0.0 113.056 -170.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.02 61.78 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.974 1.31 . . . . 0.0 109.507 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.9 p -82.55 -13.9 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -168.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.4 t -64.89 153.22 40.96 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.563 1.145 . . . . 0.0 112.849 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.7 mt -133.0 138.73 32.48 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 123.601 0.76 . . . . 0.0 112.371 -158.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.19 145.39 75.66 Favored 'Cis proline' 0 C--N 1.352 0.745 0 CA-C-N 119.183 0.744 . . . . 0.0 110.764 -16.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.4 m -117.03 122.28 43.75 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.577 0.751 . . . . 0.0 109.59 166.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.3 mp -102.97 120.14 40.09 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 171.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.8 tt -119.65 130.32 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.525 1.13 . . . . 0.0 110.162 176.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.3 tp -108.26 126.51 52.91 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.567 1.147 . . . . 0.0 109.766 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -105.21 152.07 23.3 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.472 1.509 . . . . 0.0 110.022 169.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -134.95 130.98 36.65 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.334 1.454 . . . . 0.0 108.682 166.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.5 t70 50.74 39.04 21.0 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.604 0.762 . . . . 0.0 113.002 -170.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.51 15.46 66.15 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.407 1.48 . . . . 0.0 115.777 -178.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -123.3 140.07 33.08 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 125.606 1.562 . . . . 0.0 110.133 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.32 141.24 46.47 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.95 2.433 . . . . 0.0 113.055 -172.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.8 t -127.94 -38.16 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.972 1.709 . . . . 0.0 112.943 -175.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -141.86 149.33 40.14 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.691 1.196 . . . . 0.0 111.582 175.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -130.69 136.44 48.79 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.028 1.331 . . . . 0.0 110.554 161.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.7 mt -130.1 145.52 35.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 127.089 2.155 . . . . 0.0 108.574 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.5 p -134.03 148.09 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.433 1.093 . . . . 0.0 111.877 171.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.16 164.6 30.39 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.771 1.177 . . . . 0.0 113.286 -176.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.3 146.52 39.22 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -174.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -136.03 145.97 46.62 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.278 1.831 . . . . 0.0 110.084 174.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.81 167.6 38.57 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 123.882 0.753 . . . . 0.0 111.336 166.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -50.82 -38.14 46.99 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.929 1.292 . . . . 0.0 113.742 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.29 -53.76 39.16 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.765 0.426 . . . . 0.0 111.572 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.07 -44.29 69.42 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.594 -0.691 . . . . 0.0 112.479 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.37 -44.64 94.18 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-O 119.076 -0.488 . . . . 0.0 110.254 177.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.1 tp -63.7 -36.64 84.51 Favored 'General case' 0 C--O 1.209 -1.04 0 CA-C-O 114.936 -2.459 . . . . 0.0 111.831 175.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.4 mmm-85 -63.13 -48.41 78.62 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 124.281 3.219 . . . . 0.0 112.599 176.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -57.57 -32.73 67.44 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 176.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 86.5 mt -85.79 -25.17 26.51 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.428 1.091 . . . . 0.0 113.577 171.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.6 p -67.9 -25.12 65.34 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.424 1.889 . . . . 0.0 110.163 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -55.34 -21.99 17.36 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 164.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 66.9 t -112.96 -20.57 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 127.434 2.294 . . . . 0.0 112.441 173.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 17.2 t . . . . . 0 N--CA 1.477 0.918 0 C-N-CA 127.729 2.412 . . . . 0.0 109.244 172.131 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.3 p . . . . . 0 N--CA 1.476 0.831 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.4 pt -130.27 159.83 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 126.193 1.797 . . . . 0.0 111.781 176.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -105.76 143.84 33.34 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.185 0.994 . . . . 0.0 111.208 169.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.5 m -131.27 155.06 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.788 1.635 . . . . 0.0 111.215 176.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 60.3 p -137.44 168.41 19.7 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.331 1.852 . . . . 0.0 111.646 -172.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -61.36 -20.71 63.3 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.23 -13.51 49.64 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.364 1.466 . . . . 0.0 114.789 172.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 87.0 p -132.41 -12.58 3.1 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -168.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -56.02 -41.45 74.95 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.55 1.14 . . . . 0.0 112.649 -173.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.69 -36.76 83.26 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.252 -0.905 . . . . 0.0 112.921 178.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.5 m -79.6 -21.13 45.37 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.655 1.582 . . . . 0.0 113.784 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -111.33 -32.33 6.77 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 t -101.86 -59.12 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.645 1.178 . . . . 0.0 111.231 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 46.3 mt -73.67 -14.02 61.09 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -173.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 83.8 p -72.33 -19.23 61.68 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.273 1.829 . . . . 0.0 113.822 171.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.4 t -77.56 124.47 27.95 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.179 0.992 . . . . 0.0 113.223 -164.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -85.82 -14.62 44.5 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.793 1.237 . . . . 0.0 113.291 170.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -94.13 158.93 35.23 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 125.834 1.653 . . . . 0.0 110.346 168.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -57.06 138.52 86.65 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 121.282 1.321 . . . . 0.0 112.118 171.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.34 129.16 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.333 1.053 . . . . 0.0 110.243 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.71 115.73 29.57 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.458 1.903 . . . . 0.0 108.526 -170.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.0 t -110.02 125.72 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.44 0.696 . . . . 0.0 110.666 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -99.27 120.07 38.94 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.402 1.081 . . . . 0.0 110.849 169.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -86.79 116.71 25.05 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.36 1.464 . . . . 0.0 108.502 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -136.89 172.91 12.3 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.775 1.23 . . . . 0.0 112.928 -167.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.75 156.73 43.38 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.797 0.839 . . . . 0.0 111.934 168.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.2 p -58.5 -30.33 66.94 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.215 1.006 . . . . 0.0 112.572 170.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 29.8 p-90 -82.41 -8.04 59.63 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 177.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.1 t -97.0 93.34 6.55 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 119.642 1.11 . . . . 0.0 112.712 -173.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.77 -42.04 67.66 Favored Glycine 0 CA--C 1.541 1.689 0 CA-C-O 118.556 -1.135 . . . . 0.0 114.153 173.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -61.91 -31.08 84.59 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 CA-C-N 120.586 2.193 . . . . 0.0 114.287 171.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 72.3 m -66.62 -41.65 88.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.606 1.094 . . . . 0.0 110.88 169.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -61.23 -29.68 69.98 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 118.715 0.689 . . . . 0.0 112.759 172.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 88.6 mtp -72.78 -39.84 66.43 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.183 0.993 . . . . 0.0 113.432 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.1 p -86.07 -19.29 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 177.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.22 -48.31 80.27 Favored Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 176.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.58 -27.28 45.98 Favored 'Trans proline' 0 C--N 1.352 0.712 0 CA-C-N 122.4 1.893 . . . . 0.0 113.013 176.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.8 t -71.93 -46.14 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.476 -0.765 . . . . 0.0 110.059 175.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.9 mt -59.78 -37.24 78.51 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.457 1.103 . . . . 0.0 112.623 171.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -63.38 -39.98 96.0 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.206 0.602 . . . . 0.0 111.593 175.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -69.46 -40.11 77.34 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.043 -1.035 . . . . 0.0 112.416 173.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 36.5 mm -56.51 -44.48 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.784 1.174 . . . . 0.0 110.547 171.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.06 -47.34 85.13 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.618 0.767 . . . . 0.0 111.642 175.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.1 m -62.19 -41.78 98.66 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.948 1.299 . . . . 0.0 111.332 -177.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -89.4 -36.96 15.18 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -173.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -108.02 16.4 23.43 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -172.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.39 -34.23 23.51 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -178.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.6 t -72.65 -25.15 61.17 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.544 1.138 . . . . 0.0 113.016 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -95.0 -51.6 4.59 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.743 1.217 . . . . 0.0 111.664 178.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.16 153.15 52.07 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.286 1.434 . . . . 0.0 113.178 -174.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.3 m -104.23 137.45 42.13 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.288 1.035 . . . . 0.0 109.385 175.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.4 t -109.71 129.56 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.831 0.852 . . . . 0.0 110.5 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -132.55 160.03 37.73 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.9 1.68 . . . . 0.0 113.048 -169.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt -127.56 129.49 47.42 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.277 1.831 . . . . 0.0 111.741 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -117.8 116.47 27.06 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.204 1.402 . . . . 0.0 108.974 169.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -82.73 104.52 13.04 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.414 0.686 . . . . 0.0 110.879 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.409 HG12 ' HB2' ' A' ' 72' ' ' ALA . 4.3 m -65.46 -18.86 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -175.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -78.25 -19.41 53.76 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.412 0.685 . . . . 0.0 112.679 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 t -119.06 -18.68 8.69 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 175.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -123.55 59.31 15.7 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 125.415 1.486 . . . . 0.0 111.36 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -64.99 -27.97 57.92 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.002 2.468 . . . . 0.0 113.296 -174.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -72.12 -27.7 62.8 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.19 -0.944 . . . . 0.0 112.644 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.4 m -69.46 -39.14 77.93 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.348 -0.845 . . . . 0.0 111.155 171.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.409 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -64.14 -37.1 86.23 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.44 0.696 . . . . 0.0 112.294 171.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -71.7 -39.49 70.13 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.507 0.723 . . . . 0.0 112.653 177.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -56.71 -40.74 76.2 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.14 1.376 . . . . 0.0 113.874 -172.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -96.9 3.99 51.84 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.269 1.028 . . . . 0.0 113.052 178.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 48.0 54.97 9.28 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.202 1.801 . . . . 0.0 112.169 -167.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.9 m -113.67 15.0 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.772 1.629 . . . . 0.0 112.657 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.2 m -59.03 -23.07 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.763 1.625 . . . . 0.0 114.466 -174.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.4 m -79.83 53.05 1.57 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.666 1.986 . . . . 0.0 113.413 -174.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.5 pt -63.93 152.15 87.87 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -167.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -64.37 135.22 20.81 Favored 'Cis proline' 0 C--N 1.357 0.982 0 CA-C-N 119.855 0.984 . . . . 0.0 113.376 1.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.1 m -136.14 120.79 18.36 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.12 0.568 . . . . 0.0 110.186 172.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.1 mp -107.92 129.71 55.08 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.818 1.647 . . . . 0.0 107.93 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.46 132.49 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.965 0.906 . . . . 0.0 109.405 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.5 tp -110.23 129.32 55.74 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.008 1.323 . . . . 0.0 109.464 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -110.2 152.69 25.77 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.368 1.467 . . . . 0.0 111.044 173.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -130.77 137.07 49.29 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.651 1.58 . . . . 0.0 109.446 157.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.1 t70 51.17 33.38 9.35 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.505 1.122 . . . . 0.0 113.522 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.29 10.39 65.92 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.222 1.391 . . . . 0.0 116.093 -175.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -111.82 143.39 28.55 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 119.184 1.492 . . . . 0.0 111.236 176.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -58.92 144.86 98.72 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.358 2.706 . . . . 0.0 114.641 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 94.2 t -128.29 -48.74 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 126.1 1.76 . . . . 0.0 111.603 -178.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -142.19 148.92 39.0 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.688 1.595 . . . . 0.0 111.253 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -135.43 134.18 39.37 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.804 1.641 . . . . 0.0 110.737 171.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.6 mp -134.75 140.85 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 126.0 1.72 . . . . 0.0 109.594 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.5 m -130.44 144.46 37.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.794 1.238 . . . . 0.0 111.656 -176.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.7 161.42 8.4 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.368 0.985 . . . . 0.0 113.281 -170.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.14 152.1 33.94 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.693 -0.887 . . . . 0.0 112.99 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -136.18 152.3 50.64 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.969 1.708 . . . . 0.0 111.207 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.73 166.9 33.1 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.403 1.001 . . . . 0.0 111.46 163.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -52.62 -35.9 55.41 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.055 1.342 . . . . 0.0 113.736 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.28 -49.8 58.03 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 122.916 0.487 . . . . 0.0 111.829 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.45 -43.36 70.01 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.609 -0.682 . . . . 0.0 111.965 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.3 tp -63.45 -44.16 95.29 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 119.055 -0.498 . . . . 0.0 110.78 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 20.1 tp -71.76 -24.62 61.79 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-O 116.549 -1.691 . . . . 0.0 113.208 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 -61.24 -54.12 48.22 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 123.883 3.038 . . . . 0.0 110.859 166.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -61.47 -30.31 70.52 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.7 mt -90.26 -31.91 16.78 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 175.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.4 t -71.24 -11.11 60.75 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.704 1.602 . . . . 0.0 112.242 175.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -46.85 -27.6 1.29 Allowed 'General case' 0 CA--C 1.558 1.269 0 O-C-N 121.227 -0.921 . . . . 0.0 113.076 153.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.07 -49.67 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 128.156 2.582 . . . . 0.0 112.502 174.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.7 t . . . . . 0 N--CA 1.482 1.145 0 C-N-CA 125.793 1.637 . . . . 0.0 113.632 -170.1 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.8 t . . . . . 0 N--CA 1.473 0.677 0 CA-C-O 120.495 0.188 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.3 pt -135.17 148.88 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.998 1.719 . . . . 0.0 110.61 176.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -92.66 139.62 30.37 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.651 -0.656 . . . . 0.0 110.581 168.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -115.46 164.15 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.732 1.213 . . . . 0.0 111.961 173.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 54.8 p -139.71 159.62 41.75 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.137 1.775 . . . . 0.0 110.681 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -58.7 -27.84 65.23 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 121.131 -0.981 . . . . 0.0 113.536 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.36 -18.18 52.94 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.9 m -128.8 -3.81 5.23 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.763 1.225 . . . . 0.0 114.052 -172.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -53.5 -41.35 66.21 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.351 1.461 . . . . 0.0 112.55 -177.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.77 -33.01 74.67 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.457 -0.777 . . . . 0.0 113.092 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.6 m -79.54 -30.83 41.91 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.397 1.079 . . . . 0.0 112.706 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -93.39 -32.97 14.04 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -174.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -111.13 -57.75 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.296 1.438 . . . . 0.0 110.707 -175.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 33.8 mt -76.63 -13.27 60.07 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -170.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.3 m -83.31 -13.1 55.84 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.62 0.971 . . . . 0.0 113.62 176.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.7 m -81.86 130.39 35.05 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.043 1.337 . . . . 0.0 112.817 -173.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -79.56 -23.55 42.73 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.266 0.626 . . . . 0.0 112.308 171.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -74.09 143.29 80.33 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 125.238 1.415 . . . . 0.0 109.485 171.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -53.44 138.95 65.81 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 121.805 1.67 . . . . 0.0 112.205 166.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p -136.41 132.32 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 C-N-CA 125.129 1.371 . . . . 0.0 110.337 -173.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.23 126.38 55.17 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.517 1.927 . . . . 0.0 108.441 -175.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.1 t -119.7 124.36 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.11 0.964 . . . . 0.0 110.557 177.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -101.16 113.38 26.37 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.954 1.702 . . . . 0.0 111.159 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -92.82 112.41 24.36 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.685 1.594 . . . . 0.0 108.734 176.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -143.13 171.94 13.39 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.766 1.226 . . . . 0.0 111.909 -166.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.41 151.16 40.05 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.867 0.867 . . . . 0.0 112.896 170.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 28.0 p -65.46 -25.56 67.56 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.604 1.162 . . . . 0.0 113.241 172.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 13.3 p-90 -88.62 4.62 46.4 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.509 1.524 . . . . 0.0 114.934 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.1 t -122.38 127.25 49.5 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.311 1.044 . . . . 0.0 112.953 -173.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.24 -53.69 40.35 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 118.7 -1.056 . . . . 0.0 114.882 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.78 -23.8 68.92 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 CA-C-N 121.079 2.44 . . . . 0.0 113.293 174.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 86.2 m -65.39 -46.46 79.98 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.827 -1.171 . . . . 0.0 111.615 167.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -59.31 -29.89 67.95 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.842 0.857 . . . . 0.0 112.932 172.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.6 mtt -74.09 -39.09 63.65 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 176.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -90.88 -29.42 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -175.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.93 -46.47 87.67 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.77 -25.94 28.03 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.357 2.038 . . . . 0.0 113.79 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.38 -45.52 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 119.44 1.018 . . . . 0.0 108.688 175.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -67.4 -31.65 72.02 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.996 1.318 . . . . 0.0 112.372 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -73.65 -36.94 65.43 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.037 0.835 . . . . 0.0 112.945 174.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -59.68 -45.16 92.92 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.995 -1.065 . . . . 0.0 111.162 165.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.4 mt -62.59 -40.21 87.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 O-C-N 121.603 -0.685 . . . . 0.0 110.594 176.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.76 -32.42 73.91 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.553 -1.342 . . . . 0.0 113.252 173.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.4 m -74.38 -48.08 30.18 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.752 0.821 . . . . 0.0 111.554 176.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -90.96 -24.71 20.05 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -169.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -117.01 15.13 15.12 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.152 1.381 . . . . 0.0 114.597 -172.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.4 -28.03 11.65 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 175.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.4 p -84.06 -21.89 31.4 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.658 1.583 . . . . 0.0 114.304 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -98.58 -31.97 11.68 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.217 1.407 . . . . 0.0 112.585 178.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.9 mt -139.18 149.35 44.32 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.203 2.601 . . . . 0.0 109.977 -177.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.4 m -91.22 134.96 34.13 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 157.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.1 t -128.63 120.13 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 121.516 -0.74 . . . . 0.0 109.987 -169.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.45 159.86 35.8 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.978 1.311 . . . . 0.0 113.422 -168.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -119.75 140.27 50.99 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.287 1.835 . . . . 0.0 111.56 176.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -122.64 111.15 16.41 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.223 1.409 . . . . 0.0 107.824 164.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -82.09 110.57 17.43 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.0 m -67.1 -16.37 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -174.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -76.87 -23.46 52.63 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.414 0.686 . . . . 0.0 112.569 171.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.5 p -93.57 -31.97 14.31 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.866 1.266 . . . . 0.0 112.563 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -138.43 79.98 28.63 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.324 1.449 . . . . 0.0 111.688 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -61.89 -28.73 81.49 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.809 2.339 . . . . 0.0 113.609 175.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -66.56 -41.39 88.69 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.077 0.951 . . . . 0.0 112.411 -176.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -61.86 -37.98 86.54 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.477 0.711 . . . . 0.0 111.651 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.99 -45.12 95.02 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.75 0.82 . . . . 0.0 112.496 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.9 ptm85 -78.13 -31.19 49.76 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -62.57 -41.43 98.92 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.284 1.034 . . . . 0.0 111.995 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -98.47 5.9 47.63 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 50.1 59.58 4.44 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.582 1.953 . . . . 0.0 113.169 -177.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.2 m -133.3 31.89 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 125.946 1.699 . . . . 0.0 111.45 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 m -70.68 -19.86 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.543 1.537 . . . . 0.0 115.005 -171.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 21.4 m -82.3 50.38 1.6 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.719 1.607 . . . . 0.0 113.767 -169.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -57.33 150.22 44.19 Favored Pre-proline 0 CA--C 1.556 1.205 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 -161.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.94 141.5 66.59 Favored 'Cis proline' 0 C--N 1.356 0.934 0 CA-C-N 118.758 0.592 . . . . 0.0 112.165 -4.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.9 m -136.39 137.79 40.9 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.968 0.907 . . . . 0.0 109.771 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.5 mp -122.5 140.63 52.53 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.146 0.978 . . . . 0.0 110.203 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.1 tp -127.9 131.3 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 124.82 1.248 . . . . 0.0 108.999 175.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.1 tt -111.56 129.52 56.04 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.425 1.09 . . . . 0.0 109.217 172.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -111.63 152.01 28.14 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.739 1.616 . . . . 0.0 109.863 172.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -134.92 126.91 29.62 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.324 1.45 . . . . 0.0 109.457 173.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t70 50.03 36.61 12.26 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.262 1.025 . . . . 0.0 113.365 -165.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.02 5.9 42.73 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.941 1.734 . . . . 0.0 116.032 -174.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 55.4 mm-40 -97.62 137.27 21.03 Favored Pre-proline 0 N--CA 1.472 0.643 0 CA-C-N 119.359 1.579 . . . . 0.0 109.573 175.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.63 139.54 48.88 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.025 1.816 . . . . 0.0 111.826 -178.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.3 t -123.43 -46.84 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.221 1.408 . . . . 0.0 112.331 -174.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -146.71 132.39 18.88 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.631 0.772 . . . . 0.0 112.539 -177.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -111.41 135.82 51.42 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.066 1.746 . . . . 0.0 110.484 168.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.9 mt -129.75 143.24 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.623 1.969 . . . . 0.0 108.57 -178.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.39 143.16 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.569 1.148 . . . . 0.0 111.224 174.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.83 158.97 29.95 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.925 1.25 . . . . 0.0 113.043 -171.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.43 140.88 39.95 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.905 -0.762 . . . . 0.0 112.509 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -130.7 146.43 52.18 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.88 1.672 . . . . 0.0 109.809 170.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.37 166.49 54.73 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 123.819 0.723 . . . . 0.0 111.62 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? -51.7 -33.99 36.76 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.974 1.31 . . . . 0.0 113.641 -175.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.85 -50.98 37.34 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.407 0.549 . . . . 0.0 111.752 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.14 -36.55 69.4 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.368 1.067 . . . . 0.0 112.549 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -41.14 93.86 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.517 -0.74 . . . . 0.0 110.127 171.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 29.8 tp -69.27 -23.19 63.81 Favored 'General case' 0 C--O 1.213 -0.821 0 CA-C-O 116.07 -1.919 . . . . 0.0 113.143 171.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.6 mmt-85 -64.35 -49.09 73.03 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 123.991 3.087 . . . . 0.0 111.542 165.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -59.23 -30.69 68.44 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 93.6 mt -93.33 -27.82 16.56 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.684 1.193 . . . . 0.0 113.927 173.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.8 p -67.07 -24.48 65.97 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.627 1.558 . . . . 0.0 110.922 177.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -51.39 -22.68 3.13 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 125.256 1.423 . . . . 0.0 113.978 163.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 69.5 t -112.97 -30.09 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 128.07 2.548 . . . . 0.0 111.992 172.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.478 0.973 0 C-N-CA 127.967 2.507 . . . . 0.0 110.346 -175.771 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 p . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.2 pt -140.07 165.17 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 127.092 2.157 . . . . 0.0 110.84 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -119.05 152.44 36.44 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 164.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.3 m -122.6 169.81 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 126.485 1.914 . . . . 0.0 110.823 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 43.2 p -137.62 173.94 11.12 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.826 1.65 . . . . 0.0 111.39 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -54.98 -28.13 49.32 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.87 -1.144 . . . . 0.0 113.037 170.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.0 -13.34 57.54 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.852 1.261 . . . . 0.0 114.278 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.7 p -132.86 -4.92 3.17 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -174.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -60.21 -46.14 90.77 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 120.011 1.278 . . . . 0.0 111.636 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.42 -39.32 77.94 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.959 -1.088 . . . . 0.0 112.812 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.28 -16.62 56.13 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.614 1.566 . . . . 0.0 114.726 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -103.24 -50.85 3.37 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.17 0.988 . . . . 0.0 112.677 173.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.2 t -83.49 -59.22 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.536 1.134 . . . . 0.0 111.146 -173.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.2 mt -77.31 -25.98 51.75 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -172.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.4 m -79.17 -9.06 59.46 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.96 1.304 . . . . 0.0 113.677 175.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -67.23 139.93 57.39 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.812 0.845 . . . . 0.0 113.185 -177.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -86.69 2.28 49.07 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.234 1.413 . . . . 0.0 113.724 173.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -131.72 165.87 32.45 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 126.397 1.879 . . . . 0.0 111.357 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -66.44 144.2 72.57 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.188 1.925 . . . . 0.0 112.207 176.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.2 p -144.12 127.26 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.335 1.054 . . . . 0.0 111.694 -173.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 tt -99.71 129.46 45.84 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.259 2.224 . . . . 0.0 108.323 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 t -119.8 127.26 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.437 1.095 . . . . 0.0 110.443 173.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -105.02 115.09 29.68 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.079 1.352 . . . . 0.0 111.793 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -83.42 114.08 21.2 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.376 1.87 . . . . 0.0 108.93 171.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -145.99 177.21 9.12 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.301 1.041 . . . . 0.0 112.205 -165.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.94 148.1 30.42 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 122.774 0.43 . . . . 0.0 112.051 163.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -64.8 -18.54 65.19 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 173.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 9.5 p-90 -82.03 -4.39 56.66 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 173.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 33.8 t -107.07 119.9 40.64 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 119.316 0.962 . . . . 0.0 113.493 -168.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.71 -52.18 53.53 Favored Glycine 0 CA--C 1.54 1.606 0 C-N-CA 124.701 1.143 . . . . 0.0 115.182 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.77 -24.44 54.52 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 CA-C-N 121.006 2.403 . . . . 0.0 113.265 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 75.9 m -65.81 -45.19 83.26 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.693 -1.254 . . . . 0.0 111.602 167.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -61.25 -30.91 70.74 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.638 0.653 . . . . 0.0 112.418 172.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.3 ttt -70.3 -43.1 71.06 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.305 1.042 . . . . 0.0 113.162 176.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 p -86.98 -23.25 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.82 -49.64 72.54 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 176.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.51 -29.01 45.18 Favored 'Trans proline' 0 C--N 1.352 0.74 0 CA-C-N 122.376 1.884 . . . . 0.0 112.806 177.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.0 t -71.93 -45.63 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 O-C-N 121.554 -0.716 . . . . 0.0 110.181 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.1 mt -62.53 -33.73 75.48 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.937 0.895 . . . . 0.0 112.682 172.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -68.83 -38.73 80.04 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.119 0.872 . . . . 0.0 112.058 175.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -63.24 -45.28 92.32 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 121.344 -0.847 . . . . 0.0 111.649 168.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.0 mm -58.88 -41.93 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 119.497 1.044 . . . . 0.0 110.605 174.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.93 -46.74 87.21 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.289 -0.882 . . . . 0.0 111.971 176.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.7 m -76.36 -37.73 56.84 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.926 0.89 . . . . 0.0 112.409 -175.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -97.25 -21.79 17.06 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -172.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -111.45 19.84 17.81 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.633 1.573 . . . . 0.0 113.065 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.26 -28.08 25.77 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.062 1.345 . . . . 0.0 113.833 174.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.7 p -66.43 -23.89 66.37 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.837 1.655 . . . . 0.0 114.042 175.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -125.98 -23.46 3.94 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.634 1.574 . . . . 0.0 113.924 -169.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.4 mt -134.26 153.75 51.68 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.299 2.239 . . . . 0.0 110.56 -178.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 49.0 m -108.79 138.76 44.6 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 149.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.1 t -112.79 122.92 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 118.904 0.775 . . . . 0.0 110.549 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -124.49 165.4 17.85 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.695 1.998 . . . . 0.0 112.145 -176.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.2 mttt -130.7 152.28 50.23 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.175 1.79 . . . . 0.0 112.658 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.76 114.28 12.48 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.424 1.089 . . . . 0.0 108.597 162.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -80.9 118.65 22.58 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.2 m -67.82 -18.32 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -172.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -80.6 -25.75 38.27 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.929 0.892 . . . . 0.0 112.677 170.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.2 p -92.17 -26.74 18.08 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.989 0.916 . . . . 0.0 112.694 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -140.54 86.96 11.93 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.656 1.182 . . . . 0.0 111.305 171.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.07 -18.62 35.46 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.524 2.149 . . . . 0.0 113.097 177.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -68.56 -46.37 69.64 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.189 -0.945 . . . . 0.0 112.055 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 m -73.65 -29.86 62.58 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.49 -0.757 . . . . 0.0 112.162 175.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.66 -40.98 85.02 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.24 0.616 . . . . 0.0 112.424 169.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.2 ttm105 -75.98 -39.29 56.23 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.323 0.649 . . . . 0.0 112.475 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -54.31 -40.61 68.12 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.189 1.396 . . . . 0.0 114.506 -170.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -100.31 7.19 44.53 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.014 0.925 . . . . 0.0 113.479 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 49.78 59.53 4.45 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.355 1.462 . . . . 0.0 111.287 -164.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.9 m -125.33 28.65 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.414 1.886 . . . . 0.0 111.439 -176.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -68.55 -25.64 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.792 1.237 . . . . 0.0 112.349 175.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 52.7 m -79.96 136.53 36.65 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.265 1.426 . . . . 0.0 110.325 166.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 29.0 pt -143.15 154.66 61.54 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -166.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.33 140.66 60.53 Favored 'Cis proline' 0 C--N 1.355 0.872 0 CA-C-N 119.412 0.826 . . . . 0.0 111.923 -5.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.0 m -134.72 126.64 29.42 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.173 0.989 . . . . 0.0 109.709 174.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.8 mp -108.19 136.08 48.46 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.685 1.594 . . . . 0.0 108.908 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.0 tp -120.74 138.54 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.268 1.427 . . . . 0.0 108.703 167.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.9 tp -126.59 125.15 41.48 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.071 0.949 . . . . 0.0 110.095 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -105.87 143.37 34.1 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.734 2.013 . . . . 0.0 110.447 177.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -114.42 119.21 36.11 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.558 1.543 . . . . 0.0 107.929 168.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.4 t70 51.2 39.0 22.65 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.731 1.212 . . . . 0.0 113.631 -172.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.55 9.54 74.08 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 125.163 1.363 . . . . 0.0 116.125 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -109.35 134.26 20.55 Favored Pre-proline 0 N--CA 1.473 0.715 0 CA-C-N 119.514 1.657 . . . . 0.0 110.356 171.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.56 139.57 45.06 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.465 2.11 . . . . 0.0 111.991 -173.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.3 m -130.21 -27.84 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -177.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -152.28 139.55 19.4 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.721 1.146 . . . . 0.0 111.855 -177.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -129.13 140.05 51.7 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.43 1.892 . . . . 0.0 111.034 173.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.9 mt -137.24 143.17 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.965 1.706 . . . . 0.0 108.883 -178.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 p -133.85 143.64 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 119.723 1.147 . . . . 0.0 111.24 170.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.75 156.68 29.32 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.277 1.418 . . . . 0.0 113.248 -172.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.1 140.08 41.66 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.914 -0.757 . . . . 0.0 112.666 -176.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -132.63 145.45 51.09 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.87 1.668 . . . . 0.0 110.729 174.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -79.94 167.68 51.51 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.355 0.979 . . . . 0.0 110.896 173.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -50.22 -37.02 33.34 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -170.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.97 -47.99 55.85 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.173 0.511 . . . . 0.0 111.468 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.83 -44.77 69.26 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.377 1.071 . . . . 0.0 111.908 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.3 tp -64.89 -44.38 89.83 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.944 176.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 31.4 tp -69.93 -31.62 69.47 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-O 115.048 -2.406 . . . . 0.0 112.807 177.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -65.38 -42.93 92.17 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 124.861 3.482 . . . . 0.0 111.926 169.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -62.32 -32.07 72.78 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 178.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.4 mt -91.65 -24.98 19.35 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.888 1.275 . . . . 0.0 113.196 173.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.3 t -66.16 -25.41 66.94 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.983 1.313 . . . . 0.0 110.264 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -52.71 -22.14 4.87 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.519 1.128 . . . . 0.0 113.578 164.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.7 t -108.92 -24.95 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 127.487 2.315 . . . . 0.0 112.371 170.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.3 t . . . . . 0 N--CA 1.48 1.046 0 C-N-CA 127.888 2.475 . . . . 0.0 111.797 -175.365 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.9 p . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 45.0 pt -135.06 160.08 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.704 1.602 . . . . 0.0 111.091 169.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -108.01 139.03 43.25 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.906 0.882 . . . . 0.0 110.591 168.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.2 m -133.6 150.69 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.963 1.305 . . . . 0.0 110.934 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.1 p -141.05 174.24 10.71 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.783 1.633 . . . . 0.0 111.095 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -52.6 -26.15 12.68 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 120.919 -1.113 . . . . 0.0 113.611 172.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.26 -13.37 52.77 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 176.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.3 p -137.1 -12.66 1.65 Allowed 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -169.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -56.28 -41.96 76.71 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.405 1.482 . . . . 0.0 112.82 -174.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.53 -34.55 78.53 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 121.134 -0.979 . . . . 0.0 112.894 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.5 m -79.46 -14.33 58.98 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.535 1.534 . . . . 0.0 113.77 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -118.7 -32.36 4.57 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.92 -51.92 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.156 1.382 . . . . 0.0 111.452 -176.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.6 mt -78.53 -13.53 59.79 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.6 p -76.56 -11.04 59.81 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.209 1.804 . . . . 0.0 113.995 174.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.7 p -67.09 149.15 50.95 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 -164.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -118.19 15.64 14.05 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 126.401 1.88 . . . . 0.0 112.089 171.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -142.86 164.25 33.36 Favored Pre-proline 0 N--CA 1.475 0.782 0 C-N-CA 129.416 3.086 . . . . 0.0 108.809 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.76 138.56 54.05 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 CA-C-N 121.103 1.43 . . . . 0.0 111.257 166.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.8 m -136.63 138.53 46.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 126.317 1.847 . . . . 0.0 110.536 -177.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tt -118.68 115.7 25.05 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.79 1.236 . . . . 0.0 109.637 -167.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.11 126.96 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.999 0.92 . . . . 0.0 110.943 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -107.0 111.9 24.61 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.513 1.525 . . . . 0.0 111.48 177.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -84.25 108.66 17.25 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.909 1.684 . . . . 0.0 108.681 173.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -136.08 163.81 29.47 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.348 1.059 . . . . 0.0 113.14 -165.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.31 145.8 47.84 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.2 p -59.94 -29.99 68.77 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.356 1.862 . . . . 0.0 113.206 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.5 p-90 -86.94 -12.4 47.71 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 41.9 t -90.77 119.18 30.78 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -164.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.07 -49.33 76.15 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.879 1.228 . . . . 0.0 113.329 176.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -57.66 -29.47 85.51 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.922 2.414 . . . . 0.0 114.548 170.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 94.9 m -64.88 -44.37 89.87 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.781 1.173 . . . . 0.0 111.187 167.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -60.56 -29.44 69.16 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 172.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.3 mtt -71.64 -43.3 66.36 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.641 0.776 . . . . 0.0 112.859 176.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.8 p -88.74 -25.75 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.81 -48.09 92.44 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.72 -27.86 37.69 Favored 'Trans proline' 0 C--N 1.353 0.776 0 CA-C-N 122.448 1.91 . . . . 0.0 112.683 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.9 t -71.67 -46.01 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 121.572 -0.705 . . . . 0.0 110.288 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.0 mt -60.92 -35.69 77.36 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.073 0.949 . . . . 0.0 112.353 171.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -67.96 -38.49 82.85 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.015 0.825 . . . . 0.0 112.052 176.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -62.64 -45.35 93.22 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.018 -1.051 . . . . 0.0 111.537 169.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.3 mm -59.12 -43.05 88.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.656 1.117 . . . . 0.0 110.898 174.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.97 -35.31 78.09 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.181 0.992 . . . . 0.0 112.843 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.1 m -78.51 -48.85 14.45 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.412 0.685 . . . . 0.0 111.906 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -85.24 -32.83 22.38 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -169.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -108.02 16.69 23.17 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.313 1.445 . . . . 0.0 112.834 -171.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.66 -33.12 32.33 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.378 1.471 . . . . 0.0 114.363 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.8 m -68.03 -29.57 68.6 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.913 1.285 . . . . 0.0 112.389 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -102.61 -39.84 6.89 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.562 1.545 . . . . 0.0 112.66 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.5 mt -125.37 148.85 48.61 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 126.927 2.091 . . . . 0.0 110.663 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.4 m -109.14 127.2 53.99 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 157.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.6 t -99.51 128.97 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.585 0.754 . . . . 0.0 109.512 -177.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.26 150.73 48.23 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.89 1.676 . . . . 0.0 111.771 -173.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -128.63 143.45 50.95 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.434 1.094 . . . . 0.0 112.504 176.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -133.55 122.42 23.54 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.866 1.666 . . . . 0.0 110.033 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.63 96.89 7.64 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.18 1.792 . . . . 0.0 109.844 -176.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.8 m -69.49 -13.41 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 O-C-N 120.491 -1.381 . . . . 0.0 113.188 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -67.66 -27.49 66.9 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.756 0.822 . . . . 0.0 112.761 171.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.9 p -119.11 -29.74 5.16 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -136.99 76.09 46.58 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 124.646 1.178 . . . . 0.0 111.11 173.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -68.16 -13.88 39.15 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.196 2.598 . . . . 0.0 113.719 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -58.67 -33.05 69.69 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.673 1.189 . . . . 0.0 113.771 -172.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.5 m -64.21 -45.26 89.08 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.636 1.107 . . . . 0.0 111.856 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.12 -32.55 65.01 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.758 0.823 . . . . 0.0 112.47 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -73.26 -32.26 64.59 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.518 1.127 . . . . 0.0 113.022 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -58.31 -37.11 74.43 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.519 1.128 . . . . 0.0 112.596 175.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -96.74 9.91 40.32 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.067 1.347 . . . . 0.0 113.124 175.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.307 5.7 pt20 54.27 -9.19 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 130.15 3.38 . . . . 0.0 117.892 -173.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.6 m -80.27 58.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.549 1.94 . . . . 0.0 111.778 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.9 p -79.02 -4.22 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 126.004 1.721 . . . . 0.0 113.744 -174.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.3 m -57.06 157.19 6.11 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.599 1.96 . . . . 0.0 112.805 170.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 23.2 mt -140.14 137.46 18.07 Favored Pre-proline 0 N--CA 1.477 0.9 0 O-C-N 121.339 -0.85 . . . . 0.0 112.312 -164.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.98 143.58 66.48 Favored 'Cis proline' 0 C--N 1.353 0.787 0 CA-C-N 119.495 0.855 . . . . 0.0 110.628 -17.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 28.3 m -119.98 121.37 38.81 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.444 0.697 . . . . 0.0 110.078 169.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.9 mp -99.7 119.46 38.16 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.516 1.527 . . . . 0.0 107.749 172.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.7 tp -117.96 124.21 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 125.088 1.355 . . . . 0.0 109.073 176.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.6 tp -107.4 125.99 51.92 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.647 1.579 . . . . 0.0 108.908 -176.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -112.44 155.34 24.39 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.412 1.485 . . . . 0.0 109.987 174.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -141.75 126.56 18.12 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.998 1.719 . . . . 0.0 108.829 174.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.6 t70 54.79 25.36 6.53 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -169.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.72 5.39 68.84 Favored Glycine 0 CA--C 1.541 1.67 0 O-C-N 120.535 -1.353 . . . . 0.0 116.091 -172.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -95.16 140.46 22.43 Favored Pre-proline 0 N--CA 1.474 0.766 0 CA-C-N 119.815 1.807 . . . . 0.0 110.048 167.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -67.66 139.6 48.94 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.133 1.889 . . . . 0.0 111.11 176.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.1 m -127.61 -27.63 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 114.814 1.412 . . . . 0.0 114.814 -176.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -156.08 147.86 22.99 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.736 1.153 . . . . 0.0 111.575 175.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.0 ttp-105 -127.95 141.52 51.51 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.001 1.32 . . . . 0.0 111.511 167.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.4 mp -129.48 140.99 47.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 126.638 1.975 . . . . 0.0 108.278 171.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.6 p -132.42 140.8 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.161 0.984 . . . . 0.0 110.286 169.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.24 155.14 30.07 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.32 0.962 . . . . 0.0 112.608 -165.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.16 142.33 43.55 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.503 0.721 . . . . 0.0 112.791 -175.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -130.76 144.54 51.52 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.789 1.636 . . . . 0.0 110.553 172.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -79.31 170.67 54.58 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.391 0.996 . . . . 0.0 111.518 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -52.56 -36.47 55.88 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -175.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.95 -50.91 64.54 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.701 0.4 . . . . 0.0 111.33 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.47 -39.73 58.31 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.898 1.279 . . . . 0.0 113.142 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.3 tp -66.36 -36.36 82.68 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.244 -0.91 . . . . 0.0 110.737 173.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 28.1 tp -73.04 -24.93 60.77 Favored 'General case' 0 C--O 1.216 -0.68 0 CA-C-O 116.123 -1.894 . . . . 0.0 112.955 169.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -58.65 -53.84 53.86 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 123.972 3.078 . . . . 0.0 109.741 164.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -60.91 -32.09 71.58 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.799 1.24 . . . . 0.0 113.382 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.3 mt -97.42 -29.95 13.2 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.621 1.168 . . . . 0.0 113.745 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.6 t -61.33 -30.48 70.53 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 120.182 1.356 . . . . 0.0 110.63 171.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -54.86 -18.25 4.63 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 166.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.0 t -117.72 -18.8 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 127.781 2.433 . . . . 0.0 112.578 174.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t . . . . . 0 N--CA 1.475 0.798 0 C-N-CA 127.472 2.309 . . . . 0.0 110.432 -173.371 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.5 0.19 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.7 t -140.5 161.69 37.13 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.504 1.122 . . . . 0.0 112.37 176.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -151.4 151.35 31.59 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.977 1.711 . . . . 0.0 110.955 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 63.8 p -65.04 -16.77 63.83 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -108.12 9.72 28.21 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.417 1.487 . . . . 0.0 113.369 174.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -66.66 -25.16 66.44 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 121.007 -1.058 . . . . 0.0 113.443 177.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.9 t -127.44 154.88 44.52 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.378 1.871 . . . . 0.0 112.01 174.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -114.62 18.24 16.8 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.331 1.452 . . . . 0.0 113.314 167.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.8 p -76.68 157.16 32.01 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 120.96 -1.088 . . . . 0.0 112.619 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.9 pt -108.14 155.04 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.808 1.243 . . . . 0.0 111.271 166.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -112.15 128.17 56.14 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.542 1.137 . . . . 0.0 109.779 176.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.4 m -124.94 152.75 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.527 1.131 . . . . 0.0 111.605 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 44.6 p -132.12 169.59 16.17 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.452 1.901 . . . . 0.0 110.919 -175.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.405 ' H ' ' ND2' ' A' ' 68' ' ' ASN . 22.9 t70 -58.51 -27.0 64.08 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 120.909 -1.12 . . . . 0.0 113.168 176.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.11 -13.51 52.8 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.195 1.398 . . . . 0.0 114.518 176.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.0 p -127.5 -7.72 5.74 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 -173.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -56.01 -41.82 75.48 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.869 1.268 . . . . 0.0 112.603 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.76 -33.05 74.08 Favored 'General case' 0 CA--C 1.543 0.712 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 m -79.19 -14.96 58.75 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.784 1.634 . . . . 0.0 113.521 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -120.35 -54.55 2.08 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.127 0.971 . . . . 0.0 113.173 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.2 -51.97 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.479 0.712 . . . . 0.0 110.898 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 25.4 mt -76.96 -15.9 59.51 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.8 t -76.12 -28.91 57.66 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.414 1.486 . . . . 0.0 112.904 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.2 m -68.77 119.46 13.18 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.786 1.234 . . . . 0.0 112.418 -174.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -77.32 -20.19 55.29 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.352 1.061 . . . . 0.0 112.944 170.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -87.32 166.19 27.06 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 126.586 1.954 . . . . 0.0 111.363 173.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -58.62 137.24 79.09 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.135 1.89 . . . . 0.0 111.75 170.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -138.25 130.43 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.016 0.927 . . . . 0.0 111.004 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.04 113.79 27.55 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.396 1.878 . . . . 0.0 108.635 -174.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.3 t -100.19 122.73 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.547 0.739 . . . . 0.0 110.065 173.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -96.34 109.7 22.17 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.594 1.158 . . . . 0.0 110.291 166.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -81.45 115.99 21.04 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.052 1.341 . . . . 0.0 107.923 170.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -148.44 170.1 18.75 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.955 0.902 . . . . 0.0 112.536 -167.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -144.17 149.2 36.06 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.168 0.587 . . . . 0.0 112.026 161.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.7 t -63.96 -22.44 66.92 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.029 0.932 . . . . 0.0 113.291 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -78.94 -5.91 54.93 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 43.4 t -105.39 130.33 53.52 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.186 0.994 . . . . 0.0 112.142 -177.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.38 -56.98 20.39 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.408 1.004 . . . . 0.0 113.539 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -55.83 -34.71 92.16 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.024 2.483 . . . . 0.0 114.448 173.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 96.5 m -62.62 -45.97 90.4 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 119.04 0.836 . . . . 0.0 111.512 172.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -62.81 -33.55 75.45 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.682 1.193 . . . . 0.0 112.406 175.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 97.2 mmm -75.35 -36.64 60.95 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.383 1.073 . . . . 0.0 113.784 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.9 p -83.3 -23.36 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 119.581 1.082 . . . . 0.0 113.606 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.42 -50.51 71.02 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 115.259 1.578 . . . . 0.0 115.259 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.98 -27.85 42.38 Favored 'Trans proline' 0 C--N 1.353 0.783 0 CA-C-N 122.538 1.942 . . . . 0.0 113.239 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.4 t -73.37 -42.94 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 121.338 -0.851 . . . . 0.0 110.385 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.1 mt -64.73 -33.28 75.59 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.77 1.228 . . . . 0.0 112.776 171.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.43 -45.44 87.52 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.273 1.029 . . . . 0.0 111.422 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -61.07 -47.77 84.82 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.61 -0.682 . . . . 0.0 110.889 170.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.09 -36.06 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 120.985 -1.072 . . . . 0.0 112.582 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.64 -41.85 92.15 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.172 0.989 . . . . 0.0 112.201 173.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.1 m -73.98 -35.29 64.46 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.444 0.698 . . . . 0.0 111.356 -176.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -87.57 -38.39 16.01 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.118 1.367 . . . . 0.0 114.332 -175.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -104.19 12.08 34.24 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.511 1.124 . . . . 0.0 114.027 -168.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.55 -33.42 45.61 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.564 1.545 . . . . 0.0 114.51 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 m -71.33 -25.54 62.44 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.849 1.26 . . . . 0.0 112.755 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -101.73 -36.69 8.62 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.486 1.514 . . . . 0.0 112.869 -176.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.5 pp -147.65 164.42 33.58 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.857 1.663 . . . . 0.0 111.781 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.1 m -107.95 143.18 36.95 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.463 1.105 . . . . 0.0 109.371 169.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.6 t -115.36 128.05 72.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 118.966 0.803 . . . . 0.0 110.559 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.76 154.25 47.4 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.179 1.792 . . . . 0.0 112.077 -172.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -123.04 135.5 54.46 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.716 1.207 . . . . 0.0 112.495 173.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -115.02 116.95 29.27 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.839 1.656 . . . . 0.0 108.441 168.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.7 101.11 11.94 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.889 1.275 . . . . 0.0 110.138 -176.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.7 m -66.2 -16.5 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -173.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.63 -26.17 63.35 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.366 1.067 . . . . 0.0 113.195 175.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.7 t -119.12 -20.36 8.05 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.601 1.16 . . . . 0.0 113.427 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.405 ' ND2' ' H ' ' A' ' 14' ' ' ASP . 36.5 m120 -123.29 63.98 25.86 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.6 1.16 . . . . 0.0 112.575 170.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.59 -18.34 58.91 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.584 2.189 . . . . 0.0 112.451 171.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -60.1 -46.68 88.79 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.598 1.159 . . . . 0.0 110.931 173.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.29 -31.31 60.66 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.503 1.121 . . . . 0.0 111.893 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.21 -44.99 96.39 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 123.99 0.916 . . . . 0.0 112.321 174.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.8 ptt-85 -82.08 -22.8 36.13 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 176.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -56.29 -40.8 74.87 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.311 0.96 . . . . 0.0 113.249 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -99.0 5.22 47.24 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.467 1.107 . . . . 0.0 113.077 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 47.12 55.3 8.24 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.312 1.845 . . . . 0.0 112.277 -166.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.6 m -113.73 19.52 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.862 1.665 . . . . 0.0 112.58 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.4 m -63.0 -16.85 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.772 1.629 . . . . 0.0 114.559 -175.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.2 m -78.47 48.61 0.79 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.801 2.041 . . . . 0.0 113.384 -176.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.2 pp -59.83 155.17 43.49 Favored Pre-proline 0 CA--C 1.556 1.176 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 -163.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.74 141.96 68.03 Favored 'Cis proline' 0 C--N 1.355 0.878 0 CA-C-N 118.892 0.64 . . . . 0.0 111.85 -6.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.7 m -133.17 123.98 26.63 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.617 0.767 . . . . 0.0 109.868 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.4 mp -103.5 128.6 50.67 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.494 1.518 . . . . 0.0 108.981 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 23.1 mm -118.09 128.42 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.174 0.99 . . . . 0.0 109.065 167.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 17.3 tp -97.82 118.98 35.6 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 165.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -96.59 150.33 20.77 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.716 1.606 . . . . 0.0 109.739 170.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -128.52 134.18 48.61 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.606 1.163 . . . . 0.0 108.939 162.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.7 t0 48.67 41.47 17.79 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.197 0.999 . . . . 0.0 113.49 -175.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.02 15.97 70.1 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 124.72 1.153 . . . . 0.0 115.429 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -123.32 136.5 27.16 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 125.544 1.537 . . . . 0.0 109.574 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.38 139.37 45.27 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.633 2.222 . . . . 0.0 111.41 -177.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.6 t -126.19 -40.34 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.986 1.314 . . . . 0.0 112.517 -174.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.8 ttpt -142.26 147.85 37.13 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 119.12 0.873 . . . . 0.0 112.854 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 26.8 ttt180 -126.2 137.89 53.59 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.056 2.143 . . . . 0.0 111.515 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.6 145.78 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 126.067 1.747 . . . . 0.0 109.744 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.8 p -137.05 149.47 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.374 1.069 . . . . 0.0 112.087 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.52 164.33 28.34 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.303 1.43 . . . . 0.0 112.527 -173.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.68 157.51 27.08 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 121.474 -1.016 . . . . 0.0 113.358 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -130.79 149.07 52.6 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.694 1.598 . . . . 0.0 110.464 169.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -84.89 166.69 41.26 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 160.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -50.49 -37.36 38.4 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.895 1.278 . . . . 0.0 114.03 -177.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.7 -47.79 68.4 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.195 0.598 . . . . 0.0 112.144 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.64 -43.5 72.52 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 121.464 -0.772 . . . . 0.0 111.982 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.7 tp -64.48 -45.66 86.43 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 122.044 -0.41 . . . . 0.0 110.81 177.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.8 tp -74.4 -18.37 60.67 Favored 'General case' 0 C--O 1.214 -0.807 0 CA-C-O 116.798 -1.572 . . . . 0.0 113.278 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -66.75 -52.75 40.71 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 123.359 2.8 . . . . 0.0 110.933 164.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -63.17 -24.36 67.85 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 86.4 mt -98.18 -19.62 17.77 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.076 0.95 . . . . 0.0 113.461 172.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.0 t -66.52 -23.08 66.18 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 120.584 -1.322 . . . . 0.0 110.809 167.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -54.69 -16.18 2.34 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.319 1.048 . . . . 0.0 113.54 164.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.37 -11.78 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.948 1.699 . . . . 0.0 114.043 169.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.7 t -117.98 78.43 12.97 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 128.164 2.586 . . . . 0.0 109.342 173.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -66.03 -6.38 14.31 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.915 2.41 . . . . 0.0 113.887 -176.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -71.93 -38.01 69.93 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.192 0.997 . . . . 0.0 113.259 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 15.2 tp -162.75 140.75 8.31 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.684 1.594 . . . . 0.0 109.937 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 . . . . . 0 C--O 1.251 1.178 0 C-N-CA 130.44 3.496 . . . . 0.0 112.126 -2.985 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.8 ptm . . . . . 0 N--CA 1.487 1.411 0 N-CA-C 111.244 0.09 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.2 m 60.7 -73.2 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 127.674 2.389 . . . . 0.0 114.579 176.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -67.38 -21.81 65.59 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 120.85 -1.156 . . . . 0.0 112.818 177.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 78.5 p -85.95 -6.0 59.13 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.802 1.641 . . . . 0.0 113.986 170.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -119.81 -15.9 8.81 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.419 1.488 . . . . 0.0 114.144 -171.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -76.87 161.8 28.13 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.372 1.469 . . . . 0.0 113.777 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.7 m -68.03 132.97 48.24 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.51 1.124 . . . . 0.0 111.873 176.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.74 58.95 4.51 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 121.583 -0.698 . . . . 0.0 111.676 175.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.9 p -104.03 142.49 34.36 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.854 1.662 . . . . 0.0 112.969 -177.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.6 pt -139.51 155.25 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.02 1.728 . . . . 0.0 111.598 173.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -95.8 140.41 30.62 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.446 0.699 . . . . 0.0 110.117 161.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -117.33 150.7 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.403 1.481 . . . . 0.0 110.503 171.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.7 p -127.5 165.38 19.96 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.228 1.411 . . . . 0.0 111.354 -176.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -60.25 -27.79 67.52 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.91 -13.51 57.43 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.943 1.297 . . . . 0.0 114.188 175.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.4 m -126.55 -13.65 5.93 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -168.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -54.33 -42.08 69.77 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.228 1.411 . . . . 0.0 112.368 -173.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.33 -34.12 75.54 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.295 -0.878 . . . . 0.0 113.085 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.7 m -79.38 -28.09 41.88 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.476 1.11 . . . . 0.0 112.919 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -92.91 -40.9 10.34 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.352 -0.843 . . . . 0.0 113.234 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.4 t -99.39 -57.26 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.811 1.245 . . . . 0.0 111.191 -173.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.1 mt -79.86 -18.69 50.11 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -171.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.8 m -85.56 -10.49 55.86 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.127 0.971 . . . . 0.0 113.045 174.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.4 t -79.9 130.4 35.27 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.787 0.835 . . . . 0.0 112.559 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -79.72 -21.29 44.74 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.964 0.906 . . . . 0.0 112.486 170.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -79.82 148.33 68.53 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 125.84 1.656 . . . . 0.0 110.517 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -58.51 132.55 49.09 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.035 1.824 . . . . 0.0 111.674 170.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.84 130.1 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 124.408 1.083 . . . . 0.0 110.647 -173.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.32 114.09 26.18 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.867 1.667 . . . . 0.0 108.665 -172.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.18 124.69 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.938 0.895 . . . . 0.0 110.727 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -104.28 116.3 31.91 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.421 1.089 . . . . 0.0 111.435 173.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -84.9 110.48 18.89 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.076 1.751 . . . . 0.0 108.375 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -143.63 171.28 14.4 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.56 1.144 . . . . 0.0 112.722 -164.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.54 154.81 39.32 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.791 0.836 . . . . 0.0 111.809 163.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.4 t -64.82 -20.88 66.63 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.957 0.903 . . . . 0.0 113.183 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.5 ' CZ3' HD11 ' A' ' 80' ' ' ILE . 11.7 p-90 -80.08 -1.56 40.55 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 177.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 50.8 t -109.77 117.31 33.53 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.226 1.01 . . . . 0.0 112.747 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.82 -47.72 89.0 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 124.363 0.983 . . . . 0.0 113.91 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -58.52 -31.6 94.73 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.925 2.417 . . . . 0.0 114.685 170.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 83.9 m -66.57 -45.02 80.68 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.481 1.037 . . . . 0.0 111.198 170.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -60.62 -29.69 69.38 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.552 0.741 . . . . 0.0 112.628 173.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 16.5 tpt -73.75 -42.64 60.81 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.757 1.223 . . . . 0.0 113.027 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.1 p -84.4 -21.33 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.32 -49.61 80.9 Favored Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -65.63 -30.13 51.41 Favored 'Trans proline' 0 C--N 1.353 0.764 0 CA-C-N 122.415 1.898 . . . . 0.0 113.003 176.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.4 t -68.23 -49.53 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 118.731 0.696 . . . . 0.0 110.124 175.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.5 mt -61.13 -34.93 75.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.136 0.975 . . . . 0.0 112.797 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -70.86 -40.29 72.42 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.218 0.917 . . . . 0.0 112.169 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -61.97 -42.51 99.21 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.09 -1.006 . . . . 0.0 111.516 169.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.7 mt -61.53 -43.76 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 118.771 0.714 . . . . 0.0 110.914 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.33 -37.65 81.27 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.988 0.915 . . . . 0.0 112.379 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.3 m -75.98 -47.18 26.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.776 0.83 . . . . 0.0 112.177 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -94.88 -21.81 18.42 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -167.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.41 16.61 23.72 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.591 1.556 . . . . 0.0 111.761 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.93 -27.93 47.09 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.1 1.76 . . . . 0.0 114.94 -173.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.9 p -78.35 -19.51 53.28 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.013 1.325 . . . . 0.0 113.845 176.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -111.17 -28.67 8.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.808 1.643 . . . . 0.0 113.57 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.7 mt -129.8 148.99 51.73 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.643 1.977 . . . . 0.0 111.04 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 57.8 m -108.62 133.01 53.32 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 153.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.0 t -103.18 130.96 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 123.477 0.711 . . . . 0.0 109.816 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.21 155.09 46.09 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.767 1.627 . . . . 0.0 112.011 -174.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -123.69 128.25 49.36 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.881 1.672 . . . . 0.0 110.548 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -108.16 113.86 27.31 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -81.6 102.24 10.52 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.116 0.966 . . . . 0.0 108.734 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.3 m -65.76 -17.18 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 O-C-N 120.887 -1.133 . . . . 0.0 112.787 -176.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -78.52 -20.0 51.72 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.941 1.296 . . . . 0.0 113.652 176.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.0 p -115.62 -22.42 9.22 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 174.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -129.46 62.61 64.01 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 125.641 1.576 . . . . 0.0 112.054 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -64.71 -20.71 65.24 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.804 2.336 . . . . 0.0 112.742 175.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -62.46 -39.92 94.98 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.897 0.879 . . . . 0.0 111.721 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -73.69 -37.24 65.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.842 0.857 . . . . 0.0 111.49 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.01 -43.78 95.01 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.496 0.719 . . . . 0.0 111.683 171.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.4 ttp-105 -73.74 -33.85 64.5 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -56.42 -42.43 78.03 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.505 1.122 . . . . 0.0 112.964 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -98.19 5.28 48.64 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.425 1.09 . . . . 0.0 113.334 174.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.36 15.8 pt20 46.81 25.74 0.48 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 128.298 2.639 . . . . 0.0 116.013 -168.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.2 m -80.46 39.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.744 2.017 . . . . 0.0 111.857 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.7 m -74.95 -21.66 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.966 1.306 . . . . 0.0 113.304 -172.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 54.2 m -80.92 137.94 36.13 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.773 1.229 . . . . 0.0 110.223 166.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.5 HD11 ' CZ3' ' A' ' 36' ' ' TRP . 48.1 pt -135.71 155.16 78.32 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -167.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -68.34 141.45 61.25 Favored 'Cis proline' 0 C--N 1.353 0.786 0 CA-C-N 119.212 0.754 . . . . 0.0 111.361 -6.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.4 m -126.94 120.57 29.46 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.274 0.63 . . . . 0.0 109.399 169.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.7 mp -102.57 126.11 49.53 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.942 1.697 . . . . 0.0 107.855 -178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.2 tt -118.25 139.22 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.228 1.011 . . . . 0.0 109.692 171.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.0 tp -113.16 129.7 56.43 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.408 1.083 . . . . 0.0 109.671 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -113.86 151.06 32.69 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.191 1.396 . . . . 0.0 110.402 171.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -132.48 127.99 36.43 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.305 1.442 . . . . 0.0 108.972 168.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.4 t70 49.05 41.49 19.37 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.297 1.039 . . . . 0.0 113.398 -168.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.33 9.7 55.36 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.626 1.584 . . . . 0.0 115.739 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -112.61 139.39 22.68 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 125.441 1.496 . . . . 0.0 109.845 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.14 140.03 43.91 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.536 2.157 . . . . 0.0 112.299 -171.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.8 t -117.71 -46.56 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.718 1.607 . . . . 0.0 111.469 -176.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -155.13 150.23 26.92 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.308 1.043 . . . . 0.0 112.052 -175.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 67.6 ttp85 -129.81 139.17 51.29 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.061 1.345 . . . . 0.0 111.583 167.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 30.8 mt -132.25 142.58 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 127.388 2.275 . . . . 0.0 108.354 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.9 p -133.61 147.78 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.286 1.035 . . . . 0.0 112.022 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.98 161.92 24.54 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.541 1.543 . . . . 0.0 112.945 -175.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.73 151.71 28.72 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -136.66 153.19 50.98 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.353 1.861 . . . . 0.0 110.373 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.49 162.02 32.91 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 160.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -55.85 -34.12 65.15 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.81 -47.58 77.55 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 118.088 0.404 . . . . 0.0 111.18 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.13 -45.99 58.34 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.495 -0.753 . . . . 0.0 112.321 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.1 tp -65.73 -44.89 84.65 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 118.879 0.763 . . . . 0.0 110.685 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 16.7 tp -69.91 -24.93 63.46 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-O 115.825 -2.036 . . . . 0.0 112.753 175.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 -65.24 -50.47 65.68 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 124.053 3.115 . . . . 0.0 111.644 168.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -62.54 -27.23 69.02 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 80.7 mt -87.57 -28.54 21.88 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.221 1.009 . . . . 0.0 113.439 169.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.3 m -62.37 -27.88 69.38 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.309 1.443 . . . . 0.0 110.608 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -49.49 -26.79 3.65 Favored 'General case' 0 CA--C 1.56 1.344 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 165.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.0 t -111.56 -22.36 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 128.223 2.609 . . . . 0.0 112.777 172.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.9 t -112.04 75.55 1.59 Allowed Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 127.632 2.373 . . . . 0.0 110.662 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -70.38 3.23 3.19 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.883 3.056 . . . . 0.0 114.214 -177.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -61.25 -27.43 68.45 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.788 0.835 . . . . 0.0 112.709 172.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.6 tp -93.52 132.73 37.53 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.773 0.829 . . . . 0.0 110.482 162.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 33.5 m120 . . . . . 0 C--O 1.25 1.095 0 C-N-CA 125.095 1.358 . . . . 0.0 111.804 175.451 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.4 mtm . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 120.419 0.152 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.6 t -141.62 163.03 34.01 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.407 1.083 . . . . 0.0 112.511 177.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -150.15 151.81 33.72 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.086 1.754 . . . . 0.0 111.046 -177.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.3 m -59.38 -21.81 60.42 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -108.86 8.72 26.69 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.324 1.45 . . . . 0.0 113.554 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -66.48 133.73 51.01 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.321 1.048 . . . . 0.0 111.701 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.1 p -87.04 156.54 19.7 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.198 1.399 . . . . 0.0 113.033 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -99.28 26.44 5.97 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -168.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.9 p -89.34 154.51 20.02 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 121.013 -1.055 . . . . 0.0 112.964 177.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.2 pt -137.27 155.27 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 126.056 1.743 . . . . 0.0 111.546 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -93.61 139.13 31.13 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.389 0.675 . . . . 0.0 110.819 167.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.1 m -125.57 150.42 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.453 1.501 . . . . 0.0 110.571 172.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.3 p -143.28 157.33 44.57 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.302 1.441 . . . . 0.0 111.115 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -52.17 -28.09 16.85 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -174.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.06 -20.1 64.1 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.8 m -136.49 -3.87 2.1 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.386 1.474 . . . . 0.0 114.062 -176.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -53.51 -41.24 66.12 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.839 1.656 . . . . 0.0 112.526 -174.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.3 -33.16 74.71 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.6 m -79.51 -31.15 42.16 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.249 1.02 . . . . 0.0 112.643 175.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -88.81 -41.43 12.51 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -176.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.9 t -105.57 -52.46 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.106 1.363 . . . . 0.0 111.253 -172.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 29.3 mt -81.82 -13.45 57.66 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -171.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 74.6 m -89.21 -9.81 49.39 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.975 0.91 . . . . 0.0 113.346 175.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.3 t -77.58 140.47 39.69 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.044 0.938 . . . . 0.0 113.323 -174.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -98.78 -5.36 31.38 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.096 1.358 . . . . 0.0 113.559 176.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -98.56 162.84 20.41 Favored Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 124.588 1.155 . . . . 0.0 110.624 164.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -57.02 138.49 86.56 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.299 1.999 . . . . 0.0 113.448 170.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.7 t -132.62 131.41 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.451 1.5 . . . . 0.0 108.895 177.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -122.98 120.03 32.17 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 125.194 1.398 . . . . 0.0 109.279 -172.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.6 t -119.46 126.35 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.559 0.744 . . . . 0.0 111.138 -172.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -107.0 118.68 37.33 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.959 1.304 . . . . 0.0 112.455 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -94.08 111.57 23.3 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.582 1.953 . . . . 0.0 108.518 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -143.69 172.6 12.59 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.278 1.431 . . . . 0.0 112.884 -163.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -144.59 148.62 34.59 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 163.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 m -60.09 -27.85 67.35 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.675 1.19 . . . . 0.0 112.652 174.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 6.2 p-90 -76.61 -4.19 41.67 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 53.2 t -108.16 122.69 47.44 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.701 1.2 . . . . 0.0 111.792 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.38 -48.21 86.46 Favored Glycine 0 CA--C 1.539 1.543 0 CA-C-O 118.892 -0.949 . . . . 0.0 114.079 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 99.2 Cg_exo -56.47 -36.24 97.37 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.045 2.497 . . . . 0.0 114.302 170.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 96.9 m -64.36 -45.18 88.87 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.279 -0.888 . . . . 0.0 111.88 173.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -62.39 -31.01 71.62 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.334 1.054 . . . . 0.0 112.397 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.4 ttp -75.69 -38.3 58.8 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.976 1.31 . . . . 0.0 113.376 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.2 p -83.91 -19.06 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.64 -51.42 76.45 Favored Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 175.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.85 -30.8 39.94 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.236 1.957 . . . . 0.0 113.058 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.521 HG13 ' HA ' ' A' ' 101' ' ' LYS . 30.0 t -64.28 -48.48 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.643 0.777 . . . . 0.0 110.68 173.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 38.9 mt -66.75 -32.94 74.57 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.453 0.701 . . . . 0.0 112.566 176.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -67.41 -42.05 83.89 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.136 0.88 . . . . 0.0 112.127 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.98 -47.86 81.34 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.314 -0.866 . . . . 0.0 111.635 170.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.4 -40.16 83.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 118.803 0.729 . . . . 0.0 110.822 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.8 -49.63 76.97 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.403 -0.811 . . . . 0.0 111.989 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.4 m -76.29 -31.32 58.16 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.55 0.74 . . . . 0.0 112.195 -171.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -95.74 -23.55 16.91 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -112.32 17.07 19.71 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.232 1.413 . . . . 0.0 113.292 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.04 -27.72 21.07 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.607 1.563 . . . . 0.0 114.351 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.3 p -67.79 -20.36 65.19 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.791 1.636 . . . . 0.0 113.87 176.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -117.29 -46.34 2.7 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.801 1.24 . . . . 0.0 112.72 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.9 mt -99.48 148.88 23.79 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.369 1.468 . . . . 0.0 111.126 -176.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.8 m -108.91 122.15 46.61 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 149.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 75.1 t -105.14 124.71 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.281 0.632 . . . . 0.0 110.126 -175.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.72 163.59 23.17 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.452 1.501 . . . . 0.0 112.326 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.5 mttm -130.31 147.3 52.01 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.694 1.598 . . . . 0.0 112.071 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -125.98 117.39 23.16 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.856 1.662 . . . . 0.0 108.83 169.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -81.75 113.24 19.59 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 122.883 0.473 . . . . 0.0 110.422 174.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.8 m -70.87 -16.95 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -172.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -84.17 -39.71 19.06 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.42 1.088 . . . . 0.0 112.43 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 36.3 p -92.66 -23.6 18.92 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.183 1.393 . . . . 0.0 113.893 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -134.88 69.69 71.1 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-N 119.499 1.045 . . . . 0.0 112.055 173.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -66.76 -26.72 45.1 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 123.153 2.569 . . . . 0.0 114.768 -172.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -64.11 -35.7 81.62 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.608 -0.683 . . . . 0.0 111.817 -175.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.2 m -64.05 -43.26 96.04 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.311 1.044 . . . . 0.0 111.309 176.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.35 -39.61 95.01 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.737 0.815 . . . . 0.0 112.018 177.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.34 -45.25 63.39 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.296 177.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -63.99 -32.73 74.38 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-N 118.878 0.763 . . . . 0.0 112.782 -171.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -98.45 8.04 45.4 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.344 1.058 . . . . 0.0 113.746 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 36.1 tp60 49.88 52.59 14.34 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.462 1.905 . . . . 0.0 113.35 -177.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.1 m -132.88 48.61 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.216 1.806 . . . . 0.0 109.647 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.5 m -78.42 -21.47 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.228 1.411 . . . . 0.0 113.657 -176.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.1 m -72.09 155.73 39.97 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.747 1.219 . . . . 0.0 111.112 168.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.61 149.28 49.96 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -174.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.43 136.65 41.25 Favored 'Cis proline' 0 C--N 1.353 0.771 0 N-CA-C 110.424 -0.644 . . . . 0.0 110.424 -14.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 98.7 m -127.88 121.38 29.89 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.851 0.86 . . . . 0.0 110.485 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.0 mp -102.26 132.31 48.29 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.368 1.467 . . . . 0.0 109.223 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.9 tp -121.9 128.13 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.992 1.317 . . . . 0.0 109.376 171.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 41.3 tp -108.23 127.97 54.31 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.005 1.322 . . . . 0.0 110.309 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -113.69 144.18 43.37 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.985 1.714 . . . . 0.0 109.535 172.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -107.22 -29.75 9.15 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -177.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -150.01 40.79 0.81 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.715 2.006 . . . . 0.0 109.913 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.92 -6.07 7.06 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 125.354 1.454 . . . . 0.0 115.141 -165.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -94.63 138.2 22.33 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-N 118.787 1.293 . . . . 0.0 110.607 167.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.51 146.07 38.74 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.353 2.702 . . . . 0.0 112.114 -176.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.6 m -132.99 -24.99 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -177.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 107' ' ' GLU . 33.0 tttp -153.59 143.81 22.23 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 119.715 1.143 . . . . 0.0 111.67 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -128.9 137.93 51.71 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.854 2.062 . . . . 0.0 110.783 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.6 mt -135.18 141.58 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.91 1.684 . . . . 0.0 108.721 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 p -133.81 142.18 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 119.398 0.999 . . . . 0.0 111.127 168.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 91.86 150.0 24.94 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.273 1.416 . . . . 0.0 112.955 -171.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -81.42 144.67 31.25 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.074 0.95 . . . . 0.0 113.147 -174.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -134.56 159.99 39.46 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.067 1.747 . . . . 0.0 110.7 172.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -74.88 166.36 54.86 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.429 -0.669 . . . . 0.0 111.429 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.521 ' HA ' HG13 ' A' ' 46' ' ' VAL . 3.0 tmtp? -51.0 -37.33 44.38 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.836 1.254 . . . . 0.0 113.384 -173.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.95 -49.41 52.08 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.05 0.386 . . . . 0.0 111.76 -177.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.73 -37.59 59.26 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.548 0.739 . . . . 0.0 112.792 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.29 -45.44 87.99 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.4 1.0 . . . . 0.0 109.733 174.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 21.4 tp -70.2 -20.09 63.13 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-O 116.402 -1.761 . . . . 0.0 112.989 171.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.72 -54.12 49.18 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 123.802 3.001 . . . . 0.0 110.239 166.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.407 ' HB3' ' HE2' ' A' ' 93' ' ' LYS . 40.3 mm-40 -63.62 -26.59 68.75 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 114.43 -1.259 . . . . 0.0 113.136 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 82.4 mt -91.34 -21.82 20.83 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 168.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 31.8 m -65.84 -20.73 66.35 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 120.785 -1.197 . . . . 0.0 111.214 172.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -47.1 -27.3 1.33 Allowed 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 160.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -116.79 -25.13 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.701 1.6 . . . . 0.0 113.749 177.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.45 78.22 10.97 Favored Pre-proline 0 N--CA 1.484 1.235 0 C-N-CA 125.604 1.561 . . . . 0.0 112.667 171.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -62.79 -6.23 8.81 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 123.607 2.871 . . . . 0.0 115.662 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -61.99 -8.42 5.2 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.208 1.403 . . . . 0.0 114.451 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.3 tp -59.87 -31.39 69.74 Favored 'General case' 0 CA--C 1.55 0.946 0 O-C-N 120.934 -1.103 . . . . 0.0 112.524 165.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.253 1.25 0 C-N-CA 126.001 1.72 . . . . 0.0 112.313 -177.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 119.077 -0.487 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.0 t -161.79 155.98 22.16 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.892 1.277 . . . . 0.0 111.405 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -87.25 -30.26 21.05 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.349 1.059 . . . . 0.0 112.66 172.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.9 m -63.68 122.36 16.17 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.654 1.182 . . . . 0.0 113.538 -160.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 53.24 23.9 3.42 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.039 1.736 . . . . 0.0 114.267 -177.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -133.51 -58.49 0.88 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.183 1.393 . . . . 0.0 113.235 -167.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.2 m -97.66 139.19 33.93 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 124.741 1.217 . . . . 0.0 112.879 -168.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.87 58.34 3.82 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.212 0.605 . . . . 0.0 111.663 172.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.8 p -106.29 144.26 33.23 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.59 1.556 . . . . 0.0 113.38 -176.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.2 pt -142.03 159.59 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 126.474 1.91 . . . . 0.0 111.278 174.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -100.04 140.15 34.68 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.64 0.776 . . . . 0.0 110.22 163.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.6 m -130.12 145.96 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.469 1.108 . . . . 0.0 111.557 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.0 p -140.35 159.27 42.57 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.39 1.476 . . . . 0.0 111.236 176.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -51.74 -27.95 13.6 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.615 1.966 . . . . 0.0 114.805 -173.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.23 -22.02 65.71 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.8 m -136.73 1.19 2.53 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.677 1.591 . . . . 0.0 113.547 -175.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -55.48 -42.68 74.71 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.461 1.504 . . . . 0.0 112.461 -170.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.12 -32.11 73.36 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 16.6 m -79.01 -32.76 45.23 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.493 -0.754 . . . . 0.0 111.892 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -87.97 -40.78 13.62 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -176.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t -101.52 -40.09 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.203 1.401 . . . . 0.0 112.406 -171.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.3 mt -100.76 -20.07 15.73 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -170.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.8 m -94.18 8.13 42.8 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.041 1.336 . . . . 0.0 113.768 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.7 p -69.52 157.21 37.59 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 127.007 2.123 . . . . 0.0 114.591 -176.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -87.87 -6.57 58.02 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.525 1.13 . . . . 0.0 113.557 173.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -142.21 166.35 21.81 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 127.744 2.418 . . . . 0.0 110.769 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -56.33 148.24 62.57 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.978 2.452 . . . . 0.0 113.694 173.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.2 t -132.49 128.97 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.975 1.31 . . . . 0.0 110.347 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 tt -98.05 128.16 44.42 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.255 1.822 . . . . 0.0 108.64 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.9 t -116.02 125.42 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 119.516 1.053 . . . . 0.0 110.898 172.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -106.55 114.49 28.64 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.827 1.651 . . . . 0.0 111.315 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -92.39 109.0 20.38 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.927 2.091 . . . . 0.0 108.016 175.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -142.19 -178.5 5.75 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.1 1.36 . . . . 0.0 111.372 -163.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.61 141.14 30.49 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 166.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 46.9 m -56.73 -29.94 63.02 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.524 1.53 . . . . 0.0 112.117 172.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 35.6 p-90 -88.74 -0.9 57.76 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.85 1.66 . . . . 0.0 115.138 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 48.1 t -110.11 134.21 52.41 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.473 1.033 . . . . 0.0 113.238 -172.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -64.37 -57.06 14.2 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.17 1.367 . . . . 0.0 115.477 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.21 -27.36 72.53 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 CA-C-N 120.939 2.37 . . . . 0.0 112.903 175.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 93.0 m -63.76 -43.97 94.84 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.129 -0.982 . . . . 0.0 111.74 169.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.01 -30.48 71.55 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.195 0.998 . . . . 0.0 112.553 173.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 15.8 tpt -73.35 -38.47 65.73 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.657 1.183 . . . . 0.0 113.353 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.4 p -84.42 -20.82 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.09 -50.31 82.81 Favored Pre-proline 0 CA--C 1.552 1.022 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.22 -29.67 32.23 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.293 1.995 . . . . 0.0 113.147 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.466 HG13 ' HA ' ' A' ' 101' ' ' LYS . 41.9 t -65.26 -49.18 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.409 0.684 . . . . 0.0 110.21 173.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.6 mt -63.99 -33.61 76.11 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.802 0.841 . . . . 0.0 112.709 174.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -64.14 -44.85 90.9 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.302 0.955 . . . . 0.0 111.517 174.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -61.63 -45.39 94.28 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.325 -0.859 . . . . 0.0 111.492 173.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.4 mt -59.68 -43.74 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 121.415 -0.803 . . . . 0.0 111.068 176.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.55 -37.26 86.65 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.102 0.961 . . . . 0.0 112.642 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.4 m -73.62 -46.89 44.23 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.784 0.834 . . . . 0.0 111.236 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -87.27 -35.49 18.44 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.498 1.119 . . . . 0.0 114.004 -170.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -99.72 24.7 8.0 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.598 1.159 . . . . 0.0 113.273 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.88 -28.12 47.9 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.109 1.363 . . . . 0.0 114.311 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.0 p -83.25 -19.39 36.47 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.296 1.438 . . . . 0.0 113.834 175.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -102.62 -38.15 7.63 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.082 1.353 . . . . 0.0 112.79 -176.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 79.8 mt -129.8 160.89 32.07 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.34 2.256 . . . . 0.0 110.944 -175.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.4 m -108.8 138.8 44.54 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 147.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.5 t -101.29 129.97 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.82 0.848 . . . . 0.0 109.5 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.4 151.83 48.3 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.275 1.43 . . . . 0.0 111.557 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -127.67 148.8 50.4 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.987 1.315 . . . . 0.0 113.123 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -135.33 114.47 12.25 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.644 1.977 . . . . 0.0 108.875 168.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -81.39 116.34 21.17 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 171.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.5 m -64.55 -20.25 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -167.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -79.88 -22.58 42.68 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 172.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.1 p -92.57 -29.1 16.34 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -171.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -145.53 92.58 5.5 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 123.932 0.893 . . . . 0.0 110.73 162.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -62.46 -26.48 76.49 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.255 2.636 . . . . 0.0 114.894 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -71.78 -31.72 66.9 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.048 -1.033 . . . . 0.0 111.858 -175.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.5 m -65.75 -41.12 92.49 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.449 0.7 . . . . 0.0 110.786 174.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.1 -35.6 80.13 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.022 0.929 . . . . 0.0 112.609 172.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.3 tpt85 -73.49 -36.63 65.81 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -65.4 -28.64 69.4 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -172.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -103.14 5.34 37.79 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.35 1.06 . . . . 0.0 113.207 174.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 48.56 57.05 6.69 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.835 1.654 . . . . 0.0 112.172 -169.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 20.6 m -124.81 36.03 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.645 1.978 . . . . 0.0 111.038 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.7 m -71.67 -19.3 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.344 1.058 . . . . 0.0 113.156 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.2 m -68.01 151.73 46.62 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.408 1.483 . . . . 0.0 111.507 169.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 13.5 pt -139.31 142.53 32.84 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -168.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -67.71 149.08 82.48 Favored 'Cis proline' 0 CA--C 1.54 0.797 0 CA-C-N 118.498 0.499 . . . . 0.0 111.121 -17.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 67.7 m -133.42 125.15 28.44 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.756 1.222 . . . . 0.0 109.399 171.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.6 mp -109.28 136.48 48.67 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.593 1.157 . . . . 0.0 109.334 177.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.0 tt -127.9 144.87 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.202 1.001 . . . . 0.0 110.284 169.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.5 tp -121.52 120.44 34.87 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.941 0.897 . . . . 0.0 110.54 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -98.4 131.08 44.97 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.559 1.144 . . . . 0.0 109.604 172.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -99.59 -33.49 10.61 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -175.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -154.49 57.11 0.7 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.215 1.806 . . . . 0.0 110.174 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.5 15.87 64.47 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 124.51 1.052 . . . . 0.0 114.551 -173.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -140.31 137.56 17.98 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 126.966 2.106 . . . . 0.0 110.546 -176.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -76.14 142.72 24.82 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.193 2.595 . . . . 0.0 112.645 -173.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.1 t -128.66 -28.6 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.689 1.596 . . . . 0.0 112.697 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -135.16 142.15 46.06 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.07 1.348 . . . . 0.0 110.077 172.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.8 ttt85 -147.03 113.22 5.86 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.957 2.103 . . . . 0.0 109.6 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 33.9 pt -137.05 148.17 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 125.377 1.471 . . . . 0.0 113.152 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.9 m -121.64 145.77 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 125.637 1.575 . . . . 0.0 111.195 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.95 160.49 24.32 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 124.164 0.888 . . . . 0.0 113.557 -172.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -80.39 145.53 31.96 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.853 0.861 . . . . 0.0 112.769 -176.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -130.59 153.33 49.01 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.801 1.641 . . . . 0.0 110.056 169.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -74.18 165.54 54.78 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 175.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.466 ' HA ' HG13 ' A' ' 46' ' ' VAL . 3.0 tmtp? -51.69 -35.22 41.89 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.665 1.186 . . . . 0.0 113.308 -174.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.48 -53.99 29.03 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.0 0.364 . . . . 0.0 111.197 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.44 -33.13 60.87 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.53 -45.09 94.57 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.472 1.033 . . . . 0.0 109.631 171.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 25.7 tp -69.41 -24.23 63.82 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-O 115.691 -2.099 . . . . 0.0 113.112 173.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.76 -51.04 69.95 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 124.295 3.225 . . . . 0.0 111.524 167.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -57.39 -37.53 72.81 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.05 0.94 . . . . 0.0 111.73 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 87.8 mt -83.16 -28.35 29.43 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 172.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.4 m -62.56 -28.15 69.67 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.037 1.335 . . . . 0.0 110.641 178.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -52.5 -26.6 13.44 Favored 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 168.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 51.3 t -107.3 -24.41 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.886 2.074 . . . . 0.0 112.519 171.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.4 t -118.01 77.57 12.38 Favored Pre-proline 0 N--CA 1.475 0.823 0 C-N-CA 126.537 1.935 . . . . 0.0 111.502 -177.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -57.26 -24.97 62.43 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.769 2.313 . . . . 0.0 113.196 169.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -75.64 37.81 0.15 Allowed 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 127.2 2.2 . . . . 0.0 113.004 173.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -59.73 -22.02 61.46 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -170.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 45.3 t30 . . . . . 0 C--O 1.253 1.282 0 C-N-CA 126.299 1.839 . . . . 0.0 111.427 179.353 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.5 p -74.01 156.29 37.68 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.744 1.218 . . . . 0.0 113.008 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -147.78 149.02 31.58 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.333 1.453 . . . . 0.0 111.46 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.3 t -151.23 148.77 28.62 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.849 1.259 . . . . 0.0 111.936 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -93.98 -2.57 52.91 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.951 1.3 . . . . 0.0 113.303 176.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -71.14 146.04 49.4 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.58 1.152 . . . . 0.0 112.527 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.5 p -80.5 161.48 24.82 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.366 1.466 . . . . 0.0 113.151 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -99.37 24.5 7.99 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -173.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.6 p -89.24 152.04 21.79 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 121.089 -1.007 . . . . 0.0 112.856 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.9 pt -132.84 165.34 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 126.209 1.803 . . . . 0.0 111.413 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -117.28 145.42 43.98 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.88 0.872 . . . . 0.0 111.753 171.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.15 156.47 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 126.326 1.851 . . . . 0.0 110.964 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 65.2 p -123.85 168.57 12.58 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.912 1.685 . . . . 0.0 111.566 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -57.29 -27.58 62.28 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 121.018 -1.051 . . . . 0.0 113.136 175.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.6 -13.31 56.74 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.224 1.409 . . . . 0.0 114.515 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.1 p -128.88 -8.91 4.94 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -173.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -57.06 -47.91 79.82 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.282 1.433 . . . . 0.0 112.055 -176.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.61 -34.28 77.52 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.3 -0.875 . . . . 0.0 112.699 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.23 -8.71 59.24 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.755 1.622 . . . . 0.0 113.666 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -121.81 -47.87 2.17 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.501 1.12 . . . . 0.0 113.455 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.3 t -83.16 -51.45 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.15 1.38 . . . . 0.0 111.037 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 43.3 mt -84.67 -13.22 52.11 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -174.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 91.7 p -78.17 -18.8 55.08 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.955 1.302 . . . . 0.0 113.785 176.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.5 t -86.05 133.24 33.91 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.63 1.172 . . . . 0.0 113.459 -168.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -75.77 -31.62 59.6 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.389 1.076 . . . . 0.0 111.528 168.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -80.68 138.88 50.62 Favored Pre-proline 0 N--CA 1.476 0.83 0 C-N-CA 124.891 1.276 . . . . 0.0 108.85 174.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -59.07 142.44 99.35 Favored 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 121.388 1.392 . . . . 0.0 113.507 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.5 t -124.35 125.67 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.384 1.474 . . . . 0.0 109.354 -177.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -108.39 115.25 29.75 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.655 1.582 . . . . 0.0 109.303 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.2 t -108.76 122.42 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.186 0.994 . . . . 0.0 110.829 -175.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -92.33 109.3 20.68 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.732 1.613 . . . . 0.0 111.021 173.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -83.61 112.86 20.4 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.793 1.237 . . . . 0.0 108.497 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -146.41 168.57 20.82 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.22 1.008 . . . . 0.0 113.033 -164.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.18 155.27 38.52 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.755 1.222 . . . . 0.0 110.974 166.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.9 t -66.05 -19.18 65.77 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -75.56 -4.44 39.94 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 48.5 t -109.29 108.83 19.56 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.348 1.059 . . . . 0.0 112.535 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.59 -40.43 94.6 Favored Glycine 0 CA--C 1.54 1.633 0 CA-C-O 118.848 -0.973 . . . . 0.0 113.972 174.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -60.44 -33.08 94.42 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.44 2.093 . . . . 0.0 114.459 168.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 91.1 m -63.69 -44.75 92.76 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.812 1.187 . . . . 0.0 110.735 168.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -60.0 -36.31 76.93 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 175.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 13.2 ptm -80.44 -29.97 37.56 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.2 p -84.6 -24.01 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-N 119.8 1.182 . . . . 0.0 113.563 174.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.13 -48.72 63.45 Favored Pre-proline 0 CA--C 1.549 0.94 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 176.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -65.83 -29.1 50.64 Favored 'Trans proline' 0 C--N 1.353 0.777 0 CA-C-N 122.216 1.827 . . . . 0.0 113.475 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.3 t -69.15 -51.34 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 119.374 0.988 . . . . 0.0 110.334 178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.0 pp -70.22 -28.43 65.26 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -68.65 -40.22 80.31 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.147 0.979 . . . . 0.0 112.932 171.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -63.23 -47.21 83.46 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 120.928 -1.107 . . . . 0.0 111.348 170.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.22 -37.88 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 118.483 0.583 . . . . 0.0 110.679 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.65 -49.96 75.61 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.276 0.944 . . . . 0.0 112.752 172.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.1 m -76.05 -33.27 59.6 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.843 0.857 . . . . 0.0 111.681 -169.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -83.92 -34.08 24.57 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 176.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -108.1 27.71 9.0 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.946 1.298 . . . . 0.0 113.744 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -57.02 -28.33 62.39 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.4 m -69.47 -27.35 65.15 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.08 1.352 . . . . 0.0 112.523 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -103.57 -34.28 8.71 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.44 1.496 . . . . 0.0 112.816 -174.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.5 mt -129.85 152.72 49.02 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.141 2.176 . . . . 0.0 111.178 -174.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.5 m -108.65 133.85 52.18 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 150.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 98.5 t -110.62 121.44 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 122.993 0.517 . . . . 0.0 109.862 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -118.06 164.84 14.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.521 1.528 . . . . 0.0 112.19 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 46.0 mttm -124.86 136.53 53.89 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.066 1.747 . . . . 0.0 111.463 173.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -113.2 117.22 31.28 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.992 1.317 . . . . 0.0 108.496 167.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.81 98.07 8.3 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.905 1.282 . . . . 0.0 108.604 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.3 m -67.06 -19.29 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 O-C-N 121.362 -0.836 . . . . 0.0 112.992 -172.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -72.42 -23.22 61.05 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.429 1.092 . . . . 0.0 112.555 178.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.5 p -118.2 -15.56 9.79 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.469 1.508 . . . . 0.0 113.593 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 -123.3 60.94 18.42 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 125.392 1.477 . . . . 0.0 111.864 176.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.69 -23.57 56.15 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.591 2.194 . . . . 0.0 112.546 178.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -64.76 -42.9 94.77 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.006 0.922 . . . . 0.0 111.815 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.68 -37.02 73.59 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.575 0.75 . . . . 0.0 111.121 176.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.83 -47.1 86.61 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.76 0.824 . . . . 0.0 112.34 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 -77.43 -24.61 50.35 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -57.49 -41.41 80.68 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.935 0.894 . . . . 0.0 112.858 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -101.1 6.02 43.1 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.892 1.277 . . . . 0.0 113.219 174.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.376 16.2 pt20 46.38 29.35 0.85 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 128.286 2.634 . . . . 0.0 115.84 -166.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.5 m -80.68 38.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 126.66 1.984 . . . . 0.0 111.93 174.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 m -75.13 -25.29 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.947 1.299 . . . . 0.0 112.606 -175.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 55.6 m -78.61 140.39 38.46 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.731 1.212 . . . . 0.0 110.051 165.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 48.9 pt -138.96 155.4 72.97 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 123.884 0.874 . . . . 0.0 113.183 -168.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -68.41 141.94 63.98 Favored 'Cis proline' 0 C--N 1.354 0.835 0 CA-C-N 119.393 0.819 . . . . 0.0 111.96 -5.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.6 m -131.68 121.59 24.54 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.628 0.771 . . . . 0.0 109.812 171.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.1 mp -108.07 119.46 39.54 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.856 1.662 . . . . 0.0 108.553 -176.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.4 tt -116.64 133.2 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.413 1.085 . . . . 0.0 110.651 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 9.6 tt -104.43 125.0 50.23 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.036 0.934 . . . . 0.0 110.385 173.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -102.69 144.65 30.8 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.339 1.456 . . . . 0.0 109.942 166.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.5 tttm -130.2 129.43 43.38 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.479 1.511 . . . . 0.0 109.34 172.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.8 t0 47.62 37.59 6.92 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.359 1.064 . . . . 0.0 113.323 -167.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.15 18.68 71.33 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 125.048 1.309 . . . . 0.0 116.364 -178.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -122.92 143.1 39.65 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 119.461 1.631 . . . . 0.0 110.87 172.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.28 140.3 44.11 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.749 2.3 . . . . 0.0 112.24 -173.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 58.7 t -123.79 -44.79 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.124 1.37 . . . . 0.0 112.629 -175.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 23.6 tttm -148.83 152.52 36.64 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.944 0.793 . . . . 0.0 112.129 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -138.51 141.46 39.37 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.559 1.144 . . . . 0.0 112.382 173.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.8 mp -129.4 139.49 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 127.361 2.265 . . . . 0.0 108.393 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.3 p -132.03 142.86 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.355 1.062 . . . . 0.0 111.237 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.78 154.92 19.62 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.11 1.338 . . . . 0.0 112.549 -169.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.39 137.18 46.36 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.865 -0.785 . . . . 0.0 111.904 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -131.8 154.63 48.92 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.78 1.632 . . . . 0.0 110.946 174.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -76.13 166.53 54.41 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 172.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -54.6 -33.39 60.33 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.08 -56.06 25.31 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 123.219 0.324 . . . . 0.0 110.95 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.75 -37.89 58.92 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.313 -0.867 . . . . 0.0 113.286 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.5 tp -66.17 -36.04 82.04 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 119.905 1.23 . . . . 0.0 110.906 175.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 16.9 tp -74.17 -24.55 59.4 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-O 115.722 -2.085 . . . . 0.0 113.073 170.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -56.91 -54.21 49.16 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 124.319 3.236 . . . . 0.0 110.375 163.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -68.53 -26.02 65.23 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -174.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 93.3 mt -93.75 -25.6 17.35 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.043 0.937 . . . . 0.0 113.435 172.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.3 t -67.79 -21.61 65.23 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.418 1.087 . . . . 0.0 111.614 171.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -49.44 -25.69 2.76 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 161.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 70.6 t -111.07 -25.6 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 127.436 2.294 . . . . 0.0 112.496 172.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.4 t -112.56 71.77 1.24 Allowed Pre-proline 0 N--CA 1.482 1.14 0 C-N-CA 127.172 2.189 . . . . 0.0 111.186 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.37 -6.98 18.85 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.082 2.521 . . . . 0.0 113.931 -176.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -72.46 -22.68 61.04 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.7 tp -149.43 132.71 16.47 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.189 0.995 . . . . 0.0 111.995 178.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 . . . . . 0 C--O 1.253 1.255 0 C-N-CA 125.818 1.647 . . . . 0.0 111.348 175.83 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.8 tpt . . . . . 0 N--CA 1.486 1.373 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.4 m -62.25 -33.83 75.35 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -171.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -78.36 -21.93 48.7 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 -176.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.7 p -134.41 4.08 3.38 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.228 1.411 . . . . 0.0 114.787 -168.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 59.32 -68.39 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 127.707 2.403 . . . . 0.0 113.506 -164.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -76.44 135.37 39.41 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.761 1.224 . . . . 0.0 111.1 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.2 m -81.21 160.53 24.29 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.339 1.456 . . . . 0.0 112.19 173.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.41 29.68 0.43 Allowed 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 -164.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.8 p -89.37 155.94 19.02 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.002 1.321 . . . . 0.0 112.492 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 45.5 pt -134.29 162.73 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 126.104 1.762 . . . . 0.0 110.484 171.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -120.04 146.6 45.74 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.579 -0.7 . . . . 0.0 112.7 165.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.3 m -120.19 155.06 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.446 1.898 . . . . 0.0 110.973 -176.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.5 p -131.79 161.99 31.6 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.793 1.237 . . . . 0.0 112.684 -174.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.83 -26.09 57.55 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.087 1.355 . . . . 0.0 114.629 -175.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.61 -16.15 52.42 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.701 1.2 . . . . 0.0 114.19 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.7 m -134.44 -5.57 2.59 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -168.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -53.97 -41.89 68.34 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.069 1.348 . . . . 0.0 112.653 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.67 -32.51 73.23 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.9 m -78.85 -32.11 45.94 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.292 1.037 . . . . 0.0 111.921 176.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -87.32 -44.54 11.32 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 39.5 t -98.83 -51.92 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.964 1.306 . . . . 0.0 111.592 -173.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 33.5 mt -84.56 -13.47 51.67 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -170.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.8 t -81.11 -12.07 59.34 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.263 1.025 . . . . 0.0 112.894 173.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.3 t -69.67 142.69 53.35 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -171.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.2 p-10 -94.62 3.24 55.33 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.792 1.637 . . . . 0.0 113.76 173.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -126.48 167.08 18.27 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 126.946 2.098 . . . . 0.0 111.043 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -58.21 138.78 87.71 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.318 2.012 . . . . 0.0 113.257 170.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.8 t -132.58 129.33 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.09 1.356 . . . . 0.0 109.139 177.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -116.93 115.52 25.64 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.359 1.464 . . . . 0.0 109.231 -173.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.7 t -110.65 121.19 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.454 0.702 . . . . 0.0 110.828 -174.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -91.24 106.34 18.44 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.539 1.535 . . . . 0.0 110.6 173.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -80.61 114.34 19.43 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.088 1.355 . . . . 0.0 108.68 173.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 1.6 p-90 -147.94 168.64 21.75 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.979 0.911 . . . . 0.0 113.021 -164.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -150.53 153.87 36.59 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.402 1.081 . . . . 0.0 110.672 161.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.3 t -65.6 -20.05 66.16 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -75.22 -10.47 59.5 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 173.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 45.2 t -98.19 110.98 23.46 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.919 0.888 . . . . 0.0 110.969 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.08 -49.03 69.77 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-O 118.768 -1.018 . . . . 0.0 113.306 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -57.62 -32.57 94.81 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.032 2.488 . . . . 0.0 114.829 172.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 68.6 m -67.24 -44.84 78.46 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 120.914 -1.116 . . . . 0.0 111.157 171.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -63.03 -29.66 70.99 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.284 1.034 . . . . 0.0 112.177 176.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 60.7 mtt -75.82 -36.69 59.61 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.566 1.547 . . . . 0.0 113.782 173.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -87.32 -22.81 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 119.432 1.015 . . . . 0.0 113.677 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.74 -47.31 72.36 Favored Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 174.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -66.61 -27.01 45.96 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 CA-C-N 122.338 1.871 . . . . 0.0 113.735 176.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 92.1 t -70.96 -47.02 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.452 1.024 . . . . 0.0 109.305 173.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.64 -37.62 82.1 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.219 1.408 . . . . 0.0 112.269 177.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -66.33 -39.36 89.18 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.156 0.982 . . . . 0.0 112.503 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -67.26 -44.13 80.14 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.522 -0.736 . . . . 0.0 111.64 172.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.2 mm -61.24 -39.95 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 119.548 1.067 . . . . 0.0 111.055 173.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.09 -46.96 86.94 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.32 -0.863 . . . . 0.0 112.104 175.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.9 m -76.32 -34.77 59.01 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.546 0.738 . . . . 0.0 112.716 -176.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -98.92 -16.95 18.6 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 -172.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 74.5 mmt-85 -121.48 21.32 11.0 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.314 1.445 . . . . 0.0 113.438 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.95 -27.63 19.81 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.68 1.592 . . . . 0.0 114.03 175.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.2 p -70.14 -21.39 63.09 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.575 1.55 . . . . 0.0 114.113 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -117.39 -35.3 4.05 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.497 1.119 . . . . 0.0 113.484 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 57.3 mt -119.5 155.17 32.62 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.978 1.711 . . . . 0.0 110.843 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 57.1 m -108.73 126.19 52.73 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 152.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 63.7 t -102.58 123.26 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.095 0.558 . . . . 0.0 110.404 -177.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.23 165.62 17.96 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.891 1.676 . . . . 0.0 111.769 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -126.72 140.55 52.31 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.221 1.408 . . . . 0.0 111.386 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -116.06 116.99 28.87 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.362 1.065 . . . . 0.0 108.93 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.95 97.62 7.54 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.179 1.392 . . . . 0.0 108.615 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.9 m -66.42 -19.85 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 O-C-N 121.391 -0.818 . . . . 0.0 113.139 -173.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -72.69 -22.94 60.83 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.123 0.969 . . . . 0.0 112.596 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.4 p -117.42 -16.02 10.26 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.601 1.561 . . . . 0.0 113.41 176.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -123.3 59.05 14.04 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 125.21 1.404 . . . . 0.0 112.301 176.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -65.32 -25.96 56.47 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.52 2.147 . . . . 0.0 112.542 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -63.94 -45.06 90.85 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.981 0.912 . . . . 0.0 111.533 174.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.3 m -66.77 -38.6 86.9 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.629 0.772 . . . . 0.0 111.363 175.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.56 -43.75 98.04 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.612 0.765 . . . . 0.0 112.686 177.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.9 ptt85 -78.09 -26.74 48.26 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 177.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -56.69 -40.83 76.29 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.184 0.994 . . . . 0.0 113.465 -177.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -98.56 4.65 48.16 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.085 0.954 . . . . 0.0 113.256 177.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 52.57 49.25 20.8 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.357 1.863 . . . . 0.0 112.944 -167.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.0 m -115.23 22.5 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.721 1.608 . . . . 0.0 113.144 -177.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.1 m -61.79 -22.29 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.062 1.345 . . . . 0.0 113.444 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.6 m -77.38 70.15 3.73 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.404 1.881 . . . . 0.0 112.077 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.2 pt -73.37 148.01 87.97 Favored Pre-proline 0 CA--C 1.548 0.889 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.14 138.35 44.0 Favored 'Cis proline' 0 C--N 1.353 0.797 0 CA-C-N 119.567 0.881 . . . . 0.0 112.798 -3.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.6 m -135.8 125.4 25.25 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.115 0.966 . . . . 0.0 109.873 167.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.2 mp -93.44 132.44 37.7 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.86 1.264 . . . . 0.0 108.16 161.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.14 126.17 73.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 168.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 40.2 tp -104.37 119.0 37.98 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.744 1.618 . . . . 0.0 109.874 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -98.08 147.75 24.23 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.595 1.558 . . . . 0.0 110.143 171.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -126.01 130.55 51.4 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.673 1.189 . . . . 0.0 109.033 165.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.7 t70 51.04 35.18 12.24 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.658 1.183 . . . . 0.0 113.592 -174.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.2 15.96 72.74 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 124.954 1.264 . . . . 0.0 115.986 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -116.68 140.73 27.14 Favored Pre-proline 0 N--CA 1.473 0.712 0 CA-C-N 119.064 1.432 . . . . 0.0 110.442 172.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.1 139.94 40.22 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.689 2.259 . . . . 0.0 111.833 -176.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 72.0 t -128.64 -43.2 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.423 1.089 . . . . 0.0 113.184 -174.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -145.48 152.47 39.82 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 119.445 1.021 . . . . 0.0 112.976 -175.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -128.08 140.17 52.1 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.862 1.665 . . . . 0.0 111.389 171.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.0 mt -133.4 139.12 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.266 1.826 . . . . 0.0 108.474 174.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.1 m -131.51 151.64 35.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 123.557 0.743 . . . . 0.0 112.987 -171.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.12 171.96 17.32 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 123.805 0.717 . . . . 0.0 113.406 -172.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.66 153.23 41.31 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.7 -0.882 . . . . 0.0 112.227 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.14 159.1 42.92 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.404 1.882 . . . . 0.0 109.855 165.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.48 161.49 50.15 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 159.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -50.75 -34.04 25.54 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -177.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.02 -49.21 75.52 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.5 -34.84 47.13 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.894 0.878 . . . . 0.0 113.091 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.03 -47.67 73.64 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.378 0.99 . . . . 0.0 110.037 175.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -62.93 -41.93 99.64 Favored 'General case' 0 C--O 1.206 -1.23 0 CA-C-O 115.497 -2.192 . . . . 0.0 110.413 171.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -53.32 -50.47 64.91 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 124.136 3.153 . . . . 0.0 112.03 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -67.63 -30.45 70.03 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.3 mt -83.09 -24.71 32.56 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.808 1.186 . . . . 0.0 113.525 169.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.9 t -72.45 -21.84 61.17 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 129.164 2.986 . . . . 0.0 111.186 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -45.94 -26.48 0.71 Allowed 'General case' 0 CA--C 1.559 1.319 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 156.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.9 t -111.13 -51.8 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 127.321 2.249 . . . . 0.0 113.022 166.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 92.3 t -67.17 112.16 9.17 Favored Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 127.276 2.23 . . . . 0.0 110.829 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -71.38 -4.62 15.34 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 121.369 1.379 . . . . 0.0 112.848 177.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 40.7 t30 68.71 150.67 0.08 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 128.656 2.782 . . . . 0.0 115.877 170.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 94.3 mt -119.24 78.24 1.28 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.956 1.302 . . . . 0.0 111.406 175.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 . . . . . 0 C--O 1.251 1.173 0 C-N-CA 128.52 2.728 . . . . 0.0 112.022 -7.22 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.0 ttm . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.6 p -59.43 -33.15 70.9 Favored 'General case' 0 N--CA 1.482 1.175 0 O-C-N 120.683 -1.26 . . . . 0.0 112.563 170.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -66.38 -19.02 65.69 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.248 1.419 . . . . 0.0 113.691 173.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.4 m -75.56 -12.25 60.18 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.589 1.155 . . . . 0.0 113.488 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -83.05 29.32 0.48 Allowed 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.6 1.56 . . . . 0.0 114.065 -169.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -77.17 -15.01 59.69 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.768 -1.207 . . . . 0.0 114.105 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.2 p -127.41 157.65 39.43 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.729 2.012 . . . . 0.0 112.281 175.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -104.94 35.69 2.71 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 -168.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.0 p -88.87 156.13 19.11 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.376 1.07 . . . . 0.0 112.433 174.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.9 pt -129.41 155.43 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.699 1.6 . . . . 0.0 111.258 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -98.89 139.69 34.18 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.846 0.858 . . . . 0.0 111.275 170.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.9 m -126.43 155.57 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.923 1.689 . . . . 0.0 111.197 174.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 80.6 p -141.56 158.73 43.47 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.822 1.649 . . . . 0.0 110.48 173.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -52.64 -29.64 27.27 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.082 1.353 . . . . 0.0 114.254 -177.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.09 -21.12 66.35 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.0 m -131.42 -4.43 3.79 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.623 1.569 . . . . 0.0 113.715 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -53.2 -40.67 64.6 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.29 1.836 . . . . 0.0 112.637 -175.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.23 -33.11 74.66 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.364 -0.835 . . . . 0.0 113.154 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.4 m -79.72 -31.4 41.14 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.254 1.022 . . . . 0.0 112.714 174.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -89.01 -39.46 13.67 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.302 -0.874 . . . . 0.0 113.194 -175.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.5 t -106.21 -53.43 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.116 1.366 . . . . 0.0 110.956 -173.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 46.7 mt -80.05 -18.36 50.3 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.179 1.178 . . . . 0.0 114.179 -173.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.6 m -91.92 -2.76 56.63 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.067 0.947 . . . . 0.0 113.293 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.0 t -69.39 141.0 54.23 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.046 0.939 . . . . 0.0 112.71 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.59 4.81 52.77 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.446 1.499 . . . . 0.0 112.7 176.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -130.83 166.94 23.73 Favored Pre-proline 0 N--CA 1.478 0.951 0 C-N-CA 126.918 2.087 . . . . 0.0 111.03 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.17 135.99 71.9 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 121.824 1.682 . . . . 0.0 112.164 171.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.5 p -139.46 122.73 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.443 1.097 . . . . 0.0 110.918 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.09 129.42 46.96 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.253 2.221 . . . . 0.0 108.503 -175.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.0 t -119.8 125.42 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.618 1.167 . . . . 0.0 110.162 175.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -107.23 112.97 26.1 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.607 1.163 . . . . 0.0 111.344 174.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -82.6 113.57 20.39 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.487 1.515 . . . . 0.0 108.052 174.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.467 ' CD1' ' HE3' ' A' ' 62' ' ' LYS . 1.3 p-90 -148.82 170.73 17.59 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -166.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.13 156.33 40.78 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.323 1.049 . . . . 0.0 111.7 165.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.6 p -64.47 -20.71 66.36 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.976 1.311 . . . . 0.0 113.672 177.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.454 ' CZ3' HD11 ' A' ' 80' ' ' ILE . 11.8 p-90 -82.93 -4.51 58.28 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 52.6 t -107.3 119.75 40.26 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.191 0.905 . . . . 0.0 111.945 -177.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.88 -52.26 54.29 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-O 118.877 -0.957 . . . . 0.0 113.475 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -57.73 -35.9 98.62 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.779 2.319 . . . . 0.0 114.215 173.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 99.3 m -60.49 -46.69 89.18 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.624 1.102 . . . . 0.0 111.592 171.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.62 -29.19 70.2 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.384 1.074 . . . . 0.0 112.162 178.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 97.4 mmm -75.98 -37.67 58.29 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.004 1.322 . . . . 0.0 114.38 173.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.8 p -84.59 -23.01 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 CA-C-N 119.951 1.251 . . . . 0.0 113.556 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.05 -48.71 78.33 Favored Pre-proline 0 CA--C 1.548 0.875 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -66.17 -30.24 46.59 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 CA-C-N 122.61 1.968 . . . . 0.0 113.37 176.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.9 t -67.23 -49.59 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-N 118.806 0.73 . . . . 0.0 109.834 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.7 mt -61.08 -37.36 82.41 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.343 1.057 . . . . 0.0 112.574 174.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -70.3 -40.44 74.25 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.969 0.908 . . . . 0.0 112.371 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -60.53 -47.2 87.21 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.514 -0.741 . . . . 0.0 111.085 168.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 76.0 mt -63.42 -36.82 77.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 O-C-N 121.649 -0.657 . . . . 0.0 111.286 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.13 -48.46 81.54 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 120.996 -1.065 . . . . 0.0 112.107 172.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.0 m -76.68 -32.92 58.21 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.171 0.988 . . . . 0.0 112.394 -172.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -99.29 -18.19 17.7 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -175.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.7 mmt-85 -122.45 28.27 7.48 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.056 1.342 . . . . 0.0 113.712 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.2 -27.68 22.91 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.889 0.876 . . . . 0.0 113.226 168.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.1 p -66.31 -26.92 67.54 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.057 2.143 . . . . 0.0 114.602 173.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -118.94 -23.71 6.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.363 1.465 . . . . 0.0 113.347 -171.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 80.5 mt -137.03 157.01 47.68 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.075 2.55 . . . . 0.0 110.258 -176.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 48.8 m -108.74 138.72 44.6 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 148.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.6 t -121.61 124.22 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 119.402 1.001 . . . . 0.0 110.68 -176.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -124.3 153.77 41.25 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.457 1.903 . . . . 0.0 112.632 -171.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.467 ' HE3' ' CD1' ' A' ' 33' ' ' TRP . 31.0 mmmt -116.39 132.81 56.57 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 126.775 2.03 . . . . 0.0 109.7 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -117.35 109.92 17.42 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.912 1.285 . . . . 0.0 108.169 170.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -82.62 100.27 10.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.598 -176.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.0 m -66.56 -16.24 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 O-C-N 120.771 -1.206 . . . . 0.0 112.753 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -70.69 -21.85 62.53 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.689 1.196 . . . . 0.0 113.268 171.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.0 p -118.79 -30.98 4.94 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -140.48 79.53 20.29 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 124.416 1.086 . . . . 0.0 111.279 175.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -70.76 -7.63 21.79 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.072 2.515 . . . . 0.0 113.249 174.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -56.82 -43.49 81.09 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.304 1.441 . . . . 0.0 112.816 -175.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.5 m -64.35 -44.53 91.17 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.54 0.736 . . . . 0.0 111.808 176.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.1 -35.89 82.58 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.537 -0.727 . . . . 0.0 112.358 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.5 ttp-105 -75.85 -34.23 60.05 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.554 0.742 . . . . 0.0 112.889 175.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -58.44 -37.47 75.49 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.38 1.072 . . . . 0.0 112.631 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -96.72 6.24 49.08 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.578 1.151 . . . . 0.0 113.376 174.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 59.94 -13.78 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 129.184 2.994 . . . . 0.0 116.814 -177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.4 m -78.77 55.59 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 126.979 2.111 . . . . 0.0 113.599 -177.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 m -72.94 -9.76 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.762 1.625 . . . . 0.0 114.677 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.6 m -78.29 65.4 3.63 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.974 1.709 . . . . 0.0 112.776 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.454 HD11 ' CZ3' ' A' ' 36' ' ' TRP . 39.4 pt -57.35 153.37 27.54 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 125.616 1.566 . . . . 0.0 114.831 -171.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.98 140.46 64.4 Favored 'Cis proline' 0 C--N 1.354 0.85 0 CA-C-N 119.495 0.855 . . . . 0.0 112.132 -3.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 33.6 m -128.97 121.04 27.16 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.677 0.791 . . . . 0.0 109.468 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.1 mp -107.8 125.75 51.8 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.982 1.313 . . . . 0.0 108.318 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.6 tt -128.21 130.1 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.201 1.0 . . . . 0.0 110.309 176.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.0 tp -108.16 128.22 54.51 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.823 1.249 . . . . 0.0 109.737 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -108.53 152.87 24.16 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.43 1.492 . . . . 0.0 110.205 170.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -135.26 122.31 21.37 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.261 1.824 . . . . 0.0 108.792 173.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.3 t70 50.9 35.64 12.92 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.172 0.989 . . . . 0.0 113.097 -168.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.2 7.75 68.21 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 125.604 1.573 . . . . 0.0 116.396 -176.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -106.42 137.67 19.5 Favored Pre-proline 0 N--CA 1.474 0.758 0 CA-C-N 119.541 1.671 . . . . 0.0 110.356 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.35 139.48 45.66 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.194 1.929 . . . . 0.0 112.0 -176.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.1 m -132.63 -18.41 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 125.163 1.385 . . . . 0.0 114.608 -176.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.9 tppm? -154.48 145.73 22.9 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 119.739 1.154 . . . . 0.0 111.006 171.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -138.33 134.94 34.88 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.142 0.977 . . . . 0.0 111.736 167.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.8 mp -130.44 144.27 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.34 2.256 . . . . 0.0 109.0 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.4 p -133.25 141.15 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.603 1.161 . . . . 0.0 110.336 170.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.26 156.14 27.59 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.506 1.05 . . . . 0.0 112.898 -167.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.31 141.59 41.56 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.744 0.817 . . . . 0.0 112.961 -175.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -132.85 148.94 52.3 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.97 1.708 . . . . 0.0 110.802 174.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.93 168.66 54.26 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 123.911 0.767 . . . . 0.0 111.318 173.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -56.35 -33.36 65.59 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -173.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.36 -53.75 47.7 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 120.924 0.392 . . . . 0.0 110.558 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.12 -34.91 66.41 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.515 -0.741 . . . . 0.0 112.776 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.3 tp -67.05 -38.48 85.92 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 120.136 1.335 . . . . 0.0 111.177 173.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . 0.254 0.1 OUTLIER -75.96 -11.1 59.9 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 116.863 -1.541 . . . . 0.0 113.99 169.182 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.79 -56.6 11.09 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 124.045 3.111 . . . . 0.0 110.607 158.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.19 -36.33 70.69 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.825 1.25 . . . . 0.0 111.997 -176.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 70.7 mt -91.47 -28.16 17.8 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 117.185 -1.388 . . . . 0.0 113.425 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 84.4 p -66.52 -18.69 65.51 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 121.793 2.088 . . . . 0.0 112.416 175.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -50.16 -22.34 1.66 Allowed 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 113.934 1.086 . . . . 0.0 113.934 162.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.9 t -115.75 -34.08 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 127.876 2.47 . . . . 0.0 112.988 171.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.0 t -99.32 98.44 6.72 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 127.16 2.184 . . . . 0.0 110.997 -172.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -66.83 -16.1 49.08 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.138 1.892 . . . . 0.0 112.468 173.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -76.99 60.69 1.85 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.731 2.012 . . . . 0.0 111.463 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.3 tp -57.57 153.2 13.51 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.526 1.53 . . . . 0.0 112.706 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.232 0 C-N-CA 125.404 1.481 . . . . 0.0 110.878 171.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 tpt . . . . . 0 N--CA 1.486 1.366 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.1 t -147.19 159.81 43.2 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.647 1.179 . . . . 0.0 112.142 -176.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -76.26 -24.47 54.51 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.926 1.291 . . . . 0.0 112.72 173.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.4 m -70.95 126.96 31.01 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.255 1.022 . . . . 0.0 111.937 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 52.37 34.2 14.52 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.062 1.345 . . . . 0.0 113.862 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -66.4 166.17 12.86 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.323 1.449 . . . . 0.0 114.375 -176.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.7 m 54.89 50.38 15.72 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.277 1.831 . . . . 0.0 113.152 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -82.42 37.91 0.53 Allowed 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -168.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.7 p -83.35 151.96 25.3 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.27 1.028 . . . . 0.0 111.67 172.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.1 pt -115.25 152.77 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.272 1.029 . . . . 0.0 111.864 172.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -92.26 138.17 31.75 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.907 0.883 . . . . 0.0 110.286 169.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.4 m -123.87 151.02 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.849 1.26 . . . . 0.0 110.746 171.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 81.4 p -135.96 158.52 44.21 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.299 1.44 . . . . 0.0 111.128 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.67 -27.53 62.95 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.907 1.076 . . . . 0.0 113.907 -172.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.33 -16.82 58.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.842 1.257 . . . . 0.0 114.348 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -131.45 -6.06 3.74 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.162 1.385 . . . . 0.0 113.844 -173.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -52.85 -40.7 63.6 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.715 1.606 . . . . 0.0 113.011 -175.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.11 -32.79 74.18 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.6 m -79.53 -32.89 42.32 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.824 0.849 . . . . 0.0 112.266 174.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -85.79 -41.28 15.19 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -174.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.9 t -105.83 -51.12 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.141 1.377 . . . . 0.0 111.211 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.3 mt -82.92 -13.2 56.51 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -170.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.9 m -95.88 5.9 50.17 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.583 1.153 . . . . 0.0 113.532 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 79.9 p -70.2 150.7 46.18 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.012 1.725 . . . . 0.0 114.94 -172.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.42 19.33 13.41 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 126.007 1.723 . . . . 0.0 111.854 172.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -143.99 146.18 33.15 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 128.927 2.891 . . . . 0.0 107.124 173.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -59.27 144.06 99.53 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 121.934 1.756 . . . . 0.0 113.255 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.9 t -128.21 125.09 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.339 1.456 . . . . 0.0 110.07 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 48.7 mt -87.92 135.0 33.59 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.388 0.675 . . . . 0.0 109.772 165.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.4 t -119.82 118.15 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 123.966 0.906 . . . . 0.0 109.366 168.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -89.89 109.27 20.29 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.625 1.57 . . . . 0.0 110.455 172.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -89.34 109.49 20.38 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.909 1.684 . . . . 0.0 108.64 171.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.9 p-90 -142.58 174.3 10.76 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.025 1.33 . . . . 0.0 111.757 -164.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.47 145.51 35.32 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.857 -0.527 . . . . 0.0 112.406 159.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.4 t -64.33 -22.6 67.01 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 -78.18 -4.64 48.63 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 174.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.8 t -107.17 129.36 54.86 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.242 1.017 . . . . 0.0 112.95 -173.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.62 -60.15 9.45 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.156 1.36 . . . . 0.0 114.499 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -61.84 -28.72 81.76 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 CA-C-N 120.386 2.093 . . . . 0.0 113.351 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 89.5 m -62.08 -48.55 79.71 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.511 1.051 . . . . 0.0 111.558 169.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -60.58 -34.37 74.1 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.116 0.966 . . . . 0.0 112.19 176.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 26.2 mmt -75.47 -36.01 60.74 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 p -87.28 -21.8 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 119.627 1.103 . . . . 0.0 113.52 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.55 -50.16 60.45 Favored Pre-proline 0 CA--C 1.551 1.007 0 CA-C-O 117.288 -1.339 . . . . 0.0 114.32 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -65.71 -30.19 50.67 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 CA-C-N 122.338 1.871 . . . . 0.0 113.666 177.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.408 HG13 ' HA ' ' A' ' 101' ' ' LYS . 13.1 t -68.21 -51.32 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 119.031 0.832 . . . . 0.0 110.771 177.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.9 pp -72.01 -22.74 61.37 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 177.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -69.99 -35.29 74.3 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.107 -0.996 . . . . 0.0 112.512 168.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -64.89 -42.87 94.42 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.868 -1.145 . . . . 0.0 111.508 166.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 49.4 mm -55.41 -45.95 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 CA-C-N 119.969 1.259 . . . . 0.0 110.821 170.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.66 -42.85 93.74 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.052 0.941 . . . . 0.0 112.823 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.7 m -74.55 -40.73 61.52 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.66 0.784 . . . . 0.0 111.61 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -86.79 -23.56 25.36 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -173.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.3 mmt-85 -123.04 20.76 9.89 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 114.59 1.329 . . . . 0.0 114.59 -173.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.11 -27.74 15.22 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.311 1.444 . . . . 0.0 114.5 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.3 p -74.56 -23.07 58.72 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.072 1.349 . . . . 0.0 114.142 178.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -117.74 -25.85 6.72 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.614 1.166 . . . . 0.0 113.952 -176.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 82.6 mt -125.78 153.02 44.62 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.51 1.924 . . . . 0.0 110.248 172.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 38.3 m -101.16 138.48 38.14 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 151.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.4 t -118.68 117.76 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 118.59 0.632 . . . . 0.0 109.475 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -119.52 159.33 24.52 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.121 1.768 . . . . 0.0 112.246 -174.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -127.71 136.23 51.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.635 1.574 . . . . 0.0 111.664 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -125.93 113.46 17.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.831 2.052 . . . . 0.0 107.926 175.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -81.36 120.15 24.58 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.452 -0.78 . . . . 0.0 110.311 177.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.9 m -67.35 -17.38 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.13 -30.18 43.56 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.29 1.036 . . . . 0.0 112.711 173.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.2 p -97.21 -30.83 12.77 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.191 0.996 . . . . 0.0 112.608 -176.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -130.39 63.09 68.11 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 125.775 1.63 . . . . 0.0 111.442 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -61.66 -21.66 72.61 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.93 2.42 . . . . 0.0 113.307 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -61.9 -45.47 93.59 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.466 1.106 . . . . 0.0 111.443 174.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 m -71.77 -32.3 67.52 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.553 0.741 . . . . 0.0 111.442 177.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.09 -44.74 91.42 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.927 0.891 . . . . 0.0 112.607 175.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -77.88 -28.38 49.91 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -57.01 -42.8 81.01 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.924 0.89 . . . . 0.0 113.282 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -99.69 7.86 44.79 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.599 1.16 . . . . 0.0 113.404 176.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.321 15.5 pt20 42.07 47.08 3.82 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.072 1.749 . . . . 0.0 113.571 -166.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.0 m -98.97 36.76 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 127.604 2.362 . . . . 0.0 109.904 172.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.9 p -78.64 -25.17 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.08 1.752 . . . . 0.0 112.417 -173.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 51.0 m -74.35 144.37 44.48 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.443 1.097 . . . . 0.0 110.318 163.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.73 149.3 56.18 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 124.163 0.985 . . . . 0.0 113.332 -168.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.13 142.01 71.44 Favored 'Cis proline' 0 C--N 1.352 0.755 0 CA-C-N 119.021 0.686 . . . . 0.0 111.336 -8.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 51.7 m -132.28 121.64 23.9 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.201 1.0 . . . . 0.0 109.947 172.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.9 mp -96.52 135.99 37.65 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.38 1.072 . . . . 0.0 109.251 171.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 26.5 mm -115.62 135.56 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.626 1.171 . . . . 0.0 109.212 167.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.7 tp -92.67 117.32 29.86 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 123.223 0.327 . . . . 0.0 110.423 162.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -96.41 115.26 27.14 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.625 1.17 . . . . 0.0 108.343 165.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 40.7 tttm -100.31 108.6 20.69 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 50.03 43.55 25.58 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.688 1.195 . . . . 0.0 113.094 -167.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.16 15.19 80.79 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 117.059 1.584 . . . . 0.0 117.059 173.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -126.43 140.11 36.41 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-N 119.373 1.587 . . . . 0.0 111.41 168.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -69.29 138.93 40.54 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.778 2.318 . . . . 0.0 112.249 -174.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.4 t -130.5 -33.94 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 125.267 1.427 . . . . 0.0 113.072 -176.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -141.3 145.15 35.13 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.272 1.029 . . . . 0.0 111.753 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -123.05 136.15 54.71 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.927 2.091 . . . . 0.0 110.595 171.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.1 mt -129.75 130.78 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.91 1.684 . . . . 0.0 107.457 171.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.3 143.83 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 119.507 1.048 . . . . 0.0 111.845 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.17 157.66 28.36 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.188 1.375 . . . . 0.0 112.72 -169.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.6 138.1 48.48 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.839 -0.801 . . . . 0.0 112.033 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -131.98 153.99 49.77 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.875 1.67 . . . . 0.0 111.113 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.63 164.15 51.86 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 174.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.408 ' HA ' HG13 ' A' ' 46' ' ' VAL . 3.6 tmtp? -55.08 -34.12 63.35 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.823 1.249 . . . . 0.0 113.197 -178.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -73.02 -37.63 66.85 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.17 -46.25 43.4 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.259 1.024 . . . . 0.0 111.36 177.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 40.4 tp -64.6 -46.56 82.15 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.706 175.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 32.3 tp -69.78 -26.51 64.32 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-O 115.121 -2.371 . . . . 0.0 113.389 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -69.72 -44.04 71.13 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 125.005 3.548 . . . . 0.0 112.26 169.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -64.61 -23.43 67.26 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 177.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.4 mt -93.85 -26.64 16.83 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.061 1.344 . . . . 0.0 113.772 168.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.4 m -61.29 -25.8 67.36 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 120.269 1.395 . . . . 0.0 110.413 173.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -53.25 -23.14 8.08 Favored 'General case' 0 CA--C 1.558 1.265 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 166.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 68.8 t -114.51 -50.26 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 127.522 2.329 . . . . 0.0 111.344 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.2 t -79.79 115.87 56.94 Favored Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 128.146 2.578 . . . . 0.0 108.699 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -66.82 -6.03 14.72 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 121.523 1.482 . . . . 0.0 112.993 177.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 62.1 t30 68.2 151.76 0.08 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 128.483 2.713 . . . . 0.0 116.185 168.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.8 mt -120.04 -33.05 4.04 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -172.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 C--O 1.252 1.221 0 C-N-CA 126.265 1.826 . . . . 0.0 112.605 -179.132 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.8 ptm . . . . . 0 N--CA 1.485 1.301 0 N-CA-C 110.924 -0.028 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.9 m 55.5 38.28 30.02 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.811 1.244 . . . . 0.0 112.596 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -80.23 156.07 27.06 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.274 1.429 . . . . 0.0 112.922 -174.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 65.2 p -148.11 144.57 27.92 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.393 1.477 . . . . 0.0 111.248 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -77.14 -31.92 55.98 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.212 0.605 . . . . 0.0 112.258 178.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.0 pttm 38.96 45.24 0.95 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 127.799 2.44 . . . . 0.0 115.717 171.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.7 m -61.07 146.24 48.01 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.49 1.116 . . . . 0.0 113.464 -175.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -138.83 179.91 6.21 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.419 1.487 . . . . 0.0 112.729 -178.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.264 19.4 p 74.33 149.91 0.11 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 129.686 3.195 . . . . 0.0 114.976 -171.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 50.0 pt -134.49 157.37 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.486 1.914 . . . . 0.0 110.631 172.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -105.44 139.08 40.6 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.62 0.768 . . . . 0.0 110.678 169.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.9 m -124.89 153.21 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.574 1.55 . . . . 0.0 111.058 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.6 p -132.48 170.59 14.93 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.474 1.51 . . . . 0.0 111.601 -174.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -56.5 -25.26 50.92 Favored 'General case' 0 CA--C 1.55 0.952 0 O-C-N 121.151 -0.968 . . . . 0.0 113.106 171.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.85 -13.52 50.75 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 115.043 1.498 . . . . 0.0 115.043 175.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.9 p -134.22 -12.49 2.46 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 -169.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -54.46 -42.77 71.04 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.898 1.279 . . . . 0.0 112.208 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.29 -36.34 82.7 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.298 -0.877 . . . . 0.0 112.95 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.0 m -79.2 -24.44 43.16 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.432 1.093 . . . . 0.0 113.139 -177.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -97.09 -46.97 5.96 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 121.351 -0.843 . . . . 0.0 113.084 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.07 -51.95 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.311 1.044 . . . . 0.0 112.046 -172.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.4 mt -84.19 -26.48 28.74 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -172.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.9 m -80.59 -11.08 59.7 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.569 1.148 . . . . 0.0 113.637 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.5 m -74.93 127.6 33.59 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.704 1.202 . . . . 0.0 112.32 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.1 t30 -71.62 -28.39 63.75 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.323 1.049 . . . . 0.0 112.113 172.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -84.64 164.31 43.08 Favored Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 125.384 1.473 . . . . 0.0 111.977 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.78 141.41 94.79 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.658 2.239 . . . . 0.0 113.351 170.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.0 t -135.68 126.12 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.554 1.142 . . . . 0.0 110.041 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 tt -100.43 121.31 41.32 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.543 1.937 . . . . 0.0 108.427 177.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 t -111.28 126.74 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 118.999 0.818 . . . . 0.0 111.129 174.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -99.06 111.41 23.82 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.456 1.502 . . . . 0.0 110.881 172.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -83.85 112.44 20.12 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.493 1.517 . . . . 0.0 108.657 173.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 2.3 p-90 -144.76 169.48 17.95 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.393 1.077 . . . . 0.0 113.017 -166.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -152.63 154.66 35.8 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.67 1.188 . . . . 0.0 111.015 163.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 t -67.91 -12.99 61.79 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.739 1.014 . . . . 0.0 113.739 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.417 ' CZ3' HD11 ' A' ' 80' ' ' ILE . 13.2 p-90 -79.77 -3.68 48.69 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 174.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 50.5 t -111.06 117.52 33.52 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.429 1.091 . . . . 0.0 112.398 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.88 -48.34 86.57 Favored Glycine 0 CA--C 1.537 1.411 0 CA-C-O 118.72 -1.044 . . . . 0.0 113.097 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -56.78 -33.08 93.5 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.747 2.298 . . . . 0.0 114.765 170.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 89.7 m -64.12 -46.33 84.66 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.821 1.191 . . . . 0.0 111.384 170.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -58.46 -35.69 72.55 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.211 1.004 . . . . 0.0 111.865 173.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 58.8 mtt -73.3 -39.0 65.66 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.883 1.273 . . . . 0.0 113.954 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.8 p -83.08 -23.83 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 CA-C-N 119.661 1.118 . . . . 0.0 113.655 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.55 -49.04 80.47 Favored Pre-proline 0 CA--C 1.551 0.984 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.17 -29.25 39.72 Favored 'Trans proline' 0 C--N 1.354 0.819 0 CA-C-N 122.387 1.888 . . . . 0.0 113.215 176.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.4 t -69.73 -45.43 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 121.51 -0.744 . . . . 0.0 110.22 175.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.3 mt -60.99 -36.14 78.68 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.415 1.086 . . . . 0.0 112.421 172.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -68.69 -39.05 80.72 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.089 0.859 . . . . 0.0 112.194 177.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -63.91 -46.12 86.22 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.189 -0.944 . . . . 0.0 111.62 170.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.2 mm -56.9 -42.97 79.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 121.674 -0.641 . . . . 0.0 110.941 173.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.56 -42.18 98.46 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.8 0.84 . . . . 0.0 112.261 177.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.2 m -69.52 -42.38 74.76 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.312 1.045 . . . . 0.0 111.299 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -95.01 -23.22 17.47 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -170.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -109.87 14.22 23.24 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.79 1.636 . . . . 0.0 113.403 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.99 -33.19 36.96 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.019 1.327 . . . . 0.0 114.268 -177.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.1 m -72.19 -26.05 61.91 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.054 1.342 . . . . 0.0 112.75 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -102.39 -34.15 9.29 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.479 1.512 . . . . 0.0 113.06 -175.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.0 pp -149.08 163.06 38.64 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.539 1.536 . . . . 0.0 112.185 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 58.5 m -108.31 138.51 44.46 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.194 0.998 . . . . 0.0 109.344 167.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.9 t -102.59 128.89 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.519 0.728 . . . . 0.0 110.398 175.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.45 158.77 36.47 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.553 1.941 . . . . 0.0 111.455 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -127.62 134.78 49.65 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.556 1.142 . . . . 0.0 111.697 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -113.64 117.25 31.06 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.742 1.617 . . . . 0.0 108.937 173.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -81.43 97.58 7.82 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.034 1.333 . . . . 0.0 108.757 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.5 m -65.01 -20.72 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -172.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -74.19 -22.49 59.37 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.135 0.974 . . . . 0.0 112.753 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.3 t -119.22 -13.6 9.32 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.931 1.292 . . . . 0.0 113.518 174.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -119.22 60.75 5.4 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 124.958 1.303 . . . . 0.0 112.076 171.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -65.46 -24.62 56.56 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.368 2.045 . . . . 0.0 112.29 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -66.91 -43.39 83.45 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.478 -0.764 . . . . 0.0 111.422 176.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 m -68.22 -38.36 81.8 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.163 0.985 . . . . 0.0 111.466 175.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.2 -38.52 91.48 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.419 0.688 . . . . 0.0 112.668 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 22.7 ttm105 -76.44 -35.75 58.33 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.361 0.664 . . . . 0.0 112.758 177.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -54.96 -39.02 68.49 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.866 1.267 . . . . 0.0 113.67 -175.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -99.93 1.79 43.05 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.088 0.955 . . . . 0.0 113.37 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 51.56 60.09 4.11 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.182 1.793 . . . . 0.0 112.322 -167.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.5 m -127.58 32.18 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 126.529 1.932 . . . . 0.0 111.491 -178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.6 m -70.88 -23.67 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.595 1.158 . . . . 0.0 113.726 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 54.0 m -79.51 139.49 37.56 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.479 1.112 . . . . 0.0 110.193 168.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.417 HD11 ' CZ3' ' A' ' 36' ' ' TRP . 48.4 pt -136.9 152.64 74.5 Favored Pre-proline 0 N--CA 1.475 0.817 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -167.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.37 140.73 64.16 Favored 'Cis proline' 0 C--N 1.353 0.789 0 CA-C-N 119.322 0.794 . . . . 0.0 111.81 -4.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.4 m -127.55 121.31 30.28 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.815 0.846 . . . . 0.0 109.443 169.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.3 mp -102.42 130.3 49.16 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.494 1.518 . . . . 0.0 107.942 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.22 130.69 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.824 0.849 . . . . 0.0 108.931 175.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.5 tp -106.54 120.91 43.18 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.401 1.08 . . . . 0.0 109.901 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -96.51 147.34 23.95 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.297 1.439 . . . . 0.0 109.834 169.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -119.9 130.11 54.67 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.721 1.208 . . . . 0.0 108.951 161.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.4 t0 47.82 44.57 18.14 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.303 1.041 . . . . 0.0 113.067 -174.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.39 10.86 58.33 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.11 1.338 . . . . 0.0 116.14 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -117.74 136.48 23.69 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 125.434 1.493 . . . . 0.0 110.071 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -70.56 139.74 38.11 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.71 2.273 . . . . 0.0 112.325 -171.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.5 t -128.83 -38.76 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.564 1.146 . . . . 0.0 113.198 -175.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -142.19 144.38 33.38 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.289 1.036 . . . . 0.0 111.682 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.6 ttm180 -129.27 139.71 51.7 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.669 1.588 . . . . 0.0 111.457 170.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 6.8 mt -133.87 139.06 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 126.946 2.098 . . . . 0.0 108.403 177.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.1 p -131.79 142.15 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.288 0.949 . . . . 0.0 110.882 171.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.11 153.47 24.48 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.632 1.11 . . . . 0.0 112.563 -167.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -72.68 143.03 48.25 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.975 -0.721 . . . . 0.0 112.487 -176.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -130.46 143.78 50.98 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.694 1.598 . . . . 0.0 110.409 173.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -78.6 170.29 54.72 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 124.154 0.883 . . . . 0.0 111.299 174.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -53.13 -35.84 60.15 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -175.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.35 -53.01 59.2 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 122.834 0.453 . . . . 0.0 111.375 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.67 -37.4 59.63 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.489 1.115 . . . . 0.0 113.241 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.7 tp -67.82 -35.17 78.12 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.248 0.931 . . . . 0.0 110.97 173.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.6 tp -74.14 -24.95 59.49 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-O 116.138 -1.887 . . . . 0.0 112.867 169.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 46.6 mmt-85 -59.84 -51.29 70.37 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 124.203 3.183 . . . . 0.0 110.572 164.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -61.0 -32.21 71.8 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.7 mt -99.03 -23.4 15.3 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.4 t -68.91 -21.28 64.23 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.326 0.966 . . . . 0.0 111.025 168.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -53.7 -20.02 4.89 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.333 1.053 . . . . 0.0 113.088 162.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.8 t -112.85 -28.89 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 127.143 2.177 . . . . 0.0 112.3 171.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.0 t -115.88 72.98 4.48 Favored Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 127.139 2.176 . . . . 0.0 110.882 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.03 -4.57 12.76 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.528 2.819 . . . . 0.0 114.012 -175.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -69.16 -24.29 64.05 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 177.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 71.7 mt 59.29 -50.27 0.07 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 128.84 2.856 . . . . 0.0 115.772 -173.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.24 0 C-N-CA 124.969 1.308 . . . . 0.0 110.913 166.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.7 t -159.2 167.78 28.21 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.519 1.128 . . . . 0.0 112.134 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -78.89 157.98 28.17 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.843 1.657 . . . . 0.0 113.675 176.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.2 m -128.95 157.51 41.42 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.667 1.587 . . . . 0.0 112.579 176.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -112.43 -2.55 14.69 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.591 1.157 . . . . 0.0 113.6 176.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -91.87 -7.0 50.55 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.883 1.673 . . . . 0.0 113.439 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 91.8 p -71.15 167.16 19.93 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.064 1.746 . . . . 0.0 113.398 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.88 56.54 1.57 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.057 0.943 . . . . 0.0 112.169 173.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.4 p -116.63 158.99 22.84 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.794 1.638 . . . . 0.0 112.627 176.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.7 pt -118.77 152.5 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.078 1.351 . . . . 0.0 111.33 170.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -97.65 132.67 43.09 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.231 1.012 . . . . 0.0 109.928 172.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.9 m -137.01 150.06 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.337 1.055 . . . . 0.0 112.112 -176.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 73.2 p -141.23 164.92 28.95 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.654 1.581 . . . . 0.0 111.399 176.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -51.25 -28.35 11.5 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.658 1.983 . . . . 0.0 114.673 -176.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.31 -22.46 65.62 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.0 m -135.26 -0.66 2.69 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.318 1.447 . . . . 0.0 114.224 -175.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -53.16 -42.57 66.28 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.674 1.99 . . . . 0.0 112.921 -175.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.12 -32.23 72.38 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.321 -0.862 . . . . 0.0 113.109 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.8 m -79.49 -30.22 41.94 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.279 1.431 . . . . 0.0 112.849 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -97.03 -41.44 8.37 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -171.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.7 m -124.4 -29.89 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -169.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.4 mt -80.7 -13.21 59.21 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.518 1.054 . . . . 0.0 113.258 170.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.9 p -75.62 -21.04 58.1 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -169.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 7.2 t -100.76 141.47 33.59 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -168.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.2 p-10 -82.93 -13.89 55.19 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.801 1.24 . . . . 0.0 113.174 170.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -68.64 151.78 97.05 Favored Pre-proline 0 N--CA 1.473 0.722 0 C-N-CA 125.263 1.425 . . . . 0.0 109.15 162.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -65.15 134.41 39.3 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 CA-C-N 120.795 1.319 . . . . 0.0 111.297 171.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.6 t -135.69 121.92 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 124.045 0.938 . . . . 0.0 109.311 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 tt -104.42 130.42 52.31 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.226 2.21 . . . . 0.0 109.378 -169.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.4 t -120.63 125.48 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.353 1.061 . . . . 0.0 111.009 177.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -103.94 120.13 40.39 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.472 1.509 . . . . 0.0 112.04 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -100.48 112.81 25.21 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.959 2.104 . . . . 0.0 108.964 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 11.4 p-90 -143.51 177.12 8.68 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.894 1.278 . . . . 0.0 111.934 -168.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.98 143.72 32.04 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 121.398 -0.814 . . . . 0.0 112.641 165.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.5 t -63.25 -21.73 66.42 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 172.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.478 ' CZ3' HD11 ' A' ' 80' ' ' ILE . 6.3 p-90 -83.3 -3.65 57.68 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 174.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 46.2 t -106.55 120.1 41.03 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.233 1.013 . . . . 0.0 112.189 -174.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.79 -46.78 92.93 Favored Glycine 0 CA--C 1.54 1.615 0 CA-C-O 118.861 -0.966 . . . . 0.0 114.317 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -58.88 -31.78 96.03 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.788 2.325 . . . . 0.0 114.087 170.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 93.8 m -65.45 -47.13 77.19 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.961 0.801 . . . . 0.0 111.428 170.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -59.23 -31.93 69.5 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 118.712 0.687 . . . . 0.0 112.407 174.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -70.33 -48.45 56.41 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.9 1.28 . . . . 0.0 112.545 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.3 p -81.21 -23.21 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.91 -54.2 30.28 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-O 116.864 -1.541 . . . . 0.0 114.01 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -63.92 -26.71 66.79 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.367 2.045 . . . . 0.0 113.516 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.0 t -66.71 -51.74 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 119.04 0.836 . . . . 0.0 109.93 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . 0.25 4.2 pp -73.22 -19.09 61.16 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -65.67 -41.97 91.86 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.507 1.123 . . . . 0.0 111.577 166.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -64.92 -44.42 89.58 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.45 -0.781 . . . . 0.0 111.143 169.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 46.5 mm -54.1 -46.99 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 119.896 1.225 . . . . 0.0 110.88 172.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.58 -44.46 96.19 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.8 m -76.23 -37.45 57.68 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.643 0.777 . . . . 0.0 112.025 -175.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -86.72 -40.17 15.3 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -176.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -98.86 11.67 38.09 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.804 1.242 . . . . 0.0 113.316 -169.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.58 -32.15 39.68 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.48 1.512 . . . . 0.0 114.859 -173.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.8 p -82.99 -19.6 36.74 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.76 1.224 . . . . 0.0 113.619 176.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -94.12 -39.97 10.3 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.364 1.466 . . . . 0.0 112.217 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.9 pp -149.05 153.35 37.72 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.546 1.939 . . . . 0.0 111.893 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 31.8 m -99.47 138.94 35.86 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 121.15 -0.969 . . . . 0.0 109.502 175.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.7 t -113.3 131.11 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 119.348 0.976 . . . . 0.0 111.675 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.24 152.43 44.6 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.75 2.02 . . . . 0.0 111.503 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -130.67 140.25 50.37 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.7 1.2 . . . . 0.0 112.466 -175.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -134.6 116.31 14.86 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.946 2.098 . . . . 0.0 109.065 178.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -82.78 119.53 24.46 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 170.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.416 HG12 ' HB2' ' A' ' 72' ' ' ALA . 11.2 m -67.87 -16.94 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 121.386 -0.821 . . . . 0.0 112.976 -175.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -79.22 -28.07 42.51 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.261 1.024 . . . . 0.0 112.903 172.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.2 p -92.57 -29.04 16.38 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.73 0.812 . . . . 0.0 112.505 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -145.02 103.05 4.43 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 123.942 0.897 . . . . 0.0 111.191 161.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.68 -21.95 12.38 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.848 2.366 . . . . 0.0 113.805 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -72.78 -28.08 62.38 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.809 -1.182 . . . . 0.0 112.16 -175.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 m -64.2 -42.14 96.76 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.715 0.806 . . . . 0.0 110.886 171.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.416 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -68.19 -37.11 80.57 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.079 0.952 . . . . 0.0 112.909 174.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -68.06 -43.89 77.6 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.178 0.991 . . . . 0.0 112.499 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -59.56 -37.84 79.52 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.155 0.982 . . . . 0.0 113.583 -172.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -99.5 5.66 46.08 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.45 1.1 . . . . 0.0 113.692 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 49.56 60.63 3.64 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.209 1.804 . . . . 0.0 112.645 -172.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.6 m -129.18 30.25 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.256 1.823 . . . . 0.0 111.398 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.5 m -71.88 -14.56 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 125.011 1.324 . . . . 0.0 114.395 -173.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.5 m -68.69 -40.45 80.07 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -165.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.478 HD11 ' CZ3' ' A' ' 36' ' ' TRP 0.294 14.2 pt 56.07 147.34 0.05 OUTLIER Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 130.552 3.541 . . . . 0.0 119.051 177.394 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.9 136.78 24.94 Favored 'Cis proline' 0 C--N 1.354 0.818 0 N-CA-C 110.218 -0.724 . . . . 0.0 110.218 -16.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 25.7 m -135.7 121.19 19.33 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.597 0.759 . . . . 0.0 109.477 -177.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.0 mp -109.88 138.99 45.47 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.7 1.2 . . . . 0.0 108.797 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.1 tt -129.19 145.06 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.69 0.796 . . . . 0.0 110.715 169.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 32.5 tp -116.65 132.65 56.63 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.625 1.17 . . . . 0.0 109.854 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -112.08 148.02 34.81 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.714 1.606 . . . . 0.0 111.787 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -132.87 126.12 31.49 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.589 1.556 . . . . 0.0 109.007 159.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.0 t70 51.32 37.68 19.47 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.747 1.219 . . . . 0.0 113.358 -177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.23 -0.19 49.04 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 125.204 1.383 . . . . 0.0 115.735 -176.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -95.13 143.89 26.87 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 124.92 1.288 . . . . 0.0 110.153 178.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.51 140.81 40.7 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.716 2.277 . . . . 0.0 112.092 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 52.0 t -121.09 -45.61 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.925 1.69 . . . . 0.0 111.276 -174.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -143.9 150.75 38.87 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.09 1.756 . . . . 0.0 110.634 173.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -133.77 134.22 42.65 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.435 1.894 . . . . 0.0 109.77 167.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.9 mt -131.0 138.97 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.918 1.687 . . . . 0.0 108.625 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.3 p -133.68 141.51 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.037 0.935 . . . . 0.0 110.788 167.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.7 155.87 27.91 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.403 1.002 . . . . 0.0 112.746 -168.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -73.51 139.67 45.85 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.573 0.749 . . . . 0.0 112.577 -175.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -130.67 145.05 51.83 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.012 1.725 . . . . 0.0 110.56 173.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.72 166.5 53.24 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 123.83 0.729 . . . . 0.0 111.687 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.3 tmtp? -51.98 -34.43 42.38 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.056 1.342 . . . . 0.0 113.861 -174.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.04 -53.28 26.9 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 122.267 0.227 . . . . 0.0 110.97 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.1 -40.59 78.27 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.717 0.807 . . . . 0.0 112.757 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.98 -41.04 91.67 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 118.725 0.693 . . . . 0.0 110.523 176.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 20.1 tp -72.78 -24.88 60.99 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-O 115.69 -2.1 . . . . 0.0 113.399 172.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -63.64 -49.08 74.66 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 124.651 3.387 . . . . 0.0 111.002 166.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -54.56 -37.87 65.97 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.603 1.161 . . . . 0.0 112.735 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 84.4 mt -92.3 -25.99 18.32 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 176.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.0 t -66.74 -22.85 66.04 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.537 1.135 . . . . 0.0 110.99 175.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -51.1 -28.65 11.12 Favored 'General case' 0 CA--C 1.557 1.215 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 163.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 77.0 t -105.01 -24.64 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 127.278 2.231 . . . . 0.0 112.522 172.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.28 77.55 2.99 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 127.428 2.291 . . . . 0.0 110.168 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -73.32 20.42 0.36 Allowed 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 124.469 3.446 . . . . 0.0 113.77 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 34.5 m-20 -61.54 -31.86 71.9 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.197 0.999 . . . . 0.0 111.772 172.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.8 mp -91.12 154.1 19.6 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.801 1.24 . . . . 0.0 111.629 167.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.036 0 C-N-CA 125.361 1.464 . . . . 0.0 110.986 170.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.487 1.41 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.2 p -66.97 -27.1 67.18 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.107 0.963 . . . . 0.0 113.309 176.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -85.21 -0.53 54.93 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.784 1.634 . . . . 0.0 113.358 173.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.8 t 62.99 143.57 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 128.301 2.64 . . . . 0.0 114.85 -166.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -68.42 -26.88 65.75 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.942 0.897 . . . . 0.0 111.315 167.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.276 16.8 pttm 42.63 30.83 0.25 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 128.08 2.552 . . . . 0.0 117.204 171.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.6 t -86.14 124.69 32.84 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.295 1.038 . . . . 0.0 110.866 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.23 66.54 9.6 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.409 0.55 . . . . 0.0 111.79 -177.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.9 p -111.95 144.84 40.62 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.359 1.463 . . . . 0.0 113.351 -178.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 48.9 pt -141.43 157.5 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 126.342 1.857 . . . . 0.0 111.667 173.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -99.89 145.59 27.61 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.388 1.075 . . . . 0.0 111.186 162.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.3 m -131.11 151.55 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.459 1.503 . . . . 0.0 111.426 174.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.9 p -123.82 167.81 13.58 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.202 1.801 . . . . 0.0 110.592 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -59.91 -23.64 63.67 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 120.846 -1.159 . . . . 0.0 112.904 174.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.77 -13.72 50.35 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.45 1.5 . . . . 0.0 114.962 175.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.9 p -128.12 -12.16 5.21 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 -173.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -52.83 -41.37 64.15 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.24 1.416 . . . . 0.0 112.459 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.12 -36.57 82.19 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.251 -0.906 . . . . 0.0 113.148 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.0 m -79.47 -26.02 41.77 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.25 1.02 . . . . 0.0 113.261 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -100.17 -37.47 8.92 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.5 t -99.34 -58.6 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.516 1.127 . . . . 0.0 111.308 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.8 mt -76.08 -22.14 55.94 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -171.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.0 m -81.55 -11.05 59.3 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.358 1.063 . . . . 0.0 113.392 175.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.5 t -84.28 132.9 34.58 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -174.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -90.49 -4.89 56.63 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.001 1.32 . . . . 0.0 113.027 171.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -90.02 144.12 30.9 Favored Pre-proline 0 N--CA 1.472 0.651 0 C-N-CA 125.152 1.381 . . . . 0.0 109.396 169.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -54.17 131.06 42.85 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.214 1.943 . . . . 0.0 111.872 168.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.0 p -139.37 130.16 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.853 1.261 . . . . 0.0 110.096 -172.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.2 tt -120.23 111.95 18.45 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.295 1.038 . . . . 0.0 109.622 -165.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.0 t -103.13 124.62 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.019 0.928 . . . . 0.0 111.223 -173.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -97.09 113.22 24.76 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.748 1.619 . . . . 0.0 110.787 172.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -87.32 109.39 19.49 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.265 1.826 . . . . 0.0 108.569 173.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -149.63 172.69 14.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.153 0.981 . . . . 0.0 113.333 -163.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -145.4 153.73 41.51 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.374 0.67 . . . . 0.0 112.611 159.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.6 p -58.19 -29.41 65.62 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.593 1.557 . . . . 0.0 113.263 174.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 15.4 p-90 -80.66 -6.4 58.31 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.3 t -102.12 116.25 32.27 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.044 0.938 . . . . 0.0 111.227 -176.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.24 -46.53 94.08 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-O 118.484 -1.176 . . . . 0.0 114.028 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -60.37 -32.49 94.07 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 CA-C-N 120.813 2.306 . . . . 0.0 114.305 172.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 97.3 m -65.31 -47.74 75.52 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.244 -0.91 . . . . 0.0 110.954 171.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 41.8 tptt -57.21 -32.55 66.62 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.947 1.699 . . . . 0.0 112.669 172.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 57.1 mtt -72.97 -42.2 63.59 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.45 1.1 . . . . 0.0 113.107 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -84.09 -23.15 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -47.24 -50.74 46.22 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 177.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.51 -30.01 52.59 Favored 'Trans proline' 0 C--N 1.352 0.713 0 CA-C-N 122.036 1.763 . . . . 0.0 113.105 176.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.9 t -73.53 -44.92 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.289 -0.882 . . . . 0.0 110.849 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.2 pp -72.67 -24.24 61.0 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.481 -0.762 . . . . 0.0 113.019 174.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -71.74 -36.11 70.33 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 119.162 0.892 . . . . 0.0 112.42 168.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -61.75 -42.53 99.09 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.553 -1.342 . . . . 0.0 111.256 167.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.3 mp -60.33 -42.11 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 119.52 1.055 . . . . 0.0 111.559 170.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.78 -37.78 80.04 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.344 0.974 . . . . 0.0 112.937 177.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.1 m -82.23 -47.1 12.85 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.997 0.919 . . . . 0.0 112.095 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -85.97 -25.46 26.01 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -171.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -104.69 16.96 25.01 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.202 1.401 . . . . 0.0 112.455 176.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.02 -27.87 21.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.857 1.663 . . . . 0.0 114.549 -177.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.2 p -72.35 -20.11 61.53 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.375 1.47 . . . . 0.0 114.115 176.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -115.66 -39.33 3.54 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.094 1.358 . . . . 0.0 112.833 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 97.6 mt -113.73 148.02 37.19 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.453 1.901 . . . . 0.0 111.278 -175.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.8 m -112.59 134.41 54.14 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 152.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.1 t -99.56 138.3 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 123.734 0.814 . . . . 0.0 110.081 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.6 156.06 42.87 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.32 1.448 . . . . 0.0 111.991 -177.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.7 mmtt -120.09 124.25 45.37 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.056 1.743 . . . . 0.0 110.743 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -109.47 114.51 28.22 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.279 1.031 . . . . 0.0 108.385 165.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -82.36 103.51 11.99 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.446 1.099 . . . . 0.0 109.615 -176.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 m -66.85 -17.5 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 O-C-N 120.703 -1.248 . . . . 0.0 113.024 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -71.74 -23.54 61.63 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.84 1.256 . . . . 0.0 113.107 175.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.3 p -118.61 -24.78 6.62 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -130.27 79.6 72.29 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 119.504 1.047 . . . . 0.0 113.521 168.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -66.93 -16.29 49.33 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.191 1.927 . . . . 0.0 112.927 166.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.1 mp0 -64.84 -42.3 95.03 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.901 -1.124 . . . . 0.0 111.439 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.5 m -70.92 -36.15 72.54 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.989 0.915 . . . . 0.0 111.436 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.3 -39.32 90.03 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.546 0.739 . . . . 0.0 112.196 171.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -72.85 -40.34 65.79 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 175.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -61.93 -34.71 76.59 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.307 1.043 . . . . 0.0 113.81 -174.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -96.76 1.4 50.8 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.836 1.051 . . . . 0.0 113.836 175.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 52.22 56.4 7.79 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.908 1.683 . . . . 0.0 112.566 -170.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.47 36.81 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 127.082 2.153 . . . . 0.0 110.974 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.8 m -71.74 -22.29 21.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.654 1.182 . . . . 0.0 113.479 -176.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.2 m -70.78 145.56 50.32 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.363 1.065 . . . . 0.0 110.513 166.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 20.3 pt -137.26 145.48 50.04 Favored Pre-proline 0 N--CA 1.474 0.774 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -169.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.38 148.73 74.48 Favored 'Cis proline' 0 C--N 1.351 0.707 0 CA-C-N 118.678 0.564 . . . . 0.0 111.552 -12.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.1 m -131.86 124.04 28.74 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.413 0.685 . . . . 0.0 110.015 167.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.8 mp -99.39 132.49 44.68 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.512 1.525 . . . . 0.0 108.638 174.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 18.6 mm -115.67 132.42 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.873 1.269 . . . . 0.0 108.767 168.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.0 tp -96.26 125.32 40.7 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 122.276 0.23 . . . . 0.0 110.625 163.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -102.62 139.34 38.34 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.161 1.384 . . . . 0.0 108.966 163.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -99.75 -35.79 9.68 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -152.57 58.28 0.81 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.675 1.99 . . . . 0.0 109.393 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 63.69 16.41 58.93 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 124.93 1.252 . . . . 0.0 114.893 -172.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -134.7 133.71 21.5 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 126.522 1.929 . . . . 0.0 110.308 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.42 140.89 34.12 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.471 2.781 . . . . 0.0 112.02 -172.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.3 m -129.81 -23.67 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.079 1.352 . . . . 0.0 114.496 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -148.08 145.8 28.57 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.234 1.014 . . . . 0.0 111.789 175.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -123.72 135.1 53.66 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.388 1.875 . . . . 0.0 110.575 169.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 35.9 mt -131.68 129.51 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.621 1.569 . . . . 0.0 109.108 176.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.7 m -127.27 144.61 36.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 123.939 0.896 . . . . 0.0 112.3 -169.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 72.67 164.66 7.97 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.327 0.965 . . . . 0.0 112.951 -171.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.84 150.41 37.39 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.436 -1.037 . . . . 0.0 113.388 -175.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.6 mmtm -133.71 146.69 51.03 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.142 1.777 . . . . 0.0 110.838 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -87.62 164.16 34.28 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 162.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -51.27 -36.21 41.05 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.696 1.198 . . . . 0.0 113.894 -178.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.21 -36.58 71.94 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.64 -47.8 24.87 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.085 0.954 . . . . 0.0 111.489 175.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 32.6 tp -64.72 -44.04 91.48 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.908 -0.495 . . . . 0.0 110.835 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 23.0 tp -75.59 -25.57 57.13 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-O 115.207 -2.33 . . . . 0.0 113.392 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -65.85 -44.42 85.54 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 125.131 3.605 . . . . 0.0 111.185 166.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -66.11 -25.49 67.02 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.2 mt -103.18 -17.52 15.32 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 175.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.8 t -72.36 -22.2 61.19 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 120.962 -1.086 . . . . 0.0 110.633 166.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -52.56 -21.08 3.45 Favored 'General case' 0 CA--C 1.555 1.17 0 O-C-N 121.114 -0.991 . . . . 0.0 113.455 159.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 89.1 t -107.67 -34.15 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 126.999 2.12 . . . . 0.0 112.137 172.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 11.7 t -115.42 76.54 5.27 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 127.254 2.222 . . . . 0.0 110.594 177.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.16 -2.59 10.01 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.65 2.9 . . . . 0.0 113.857 -174.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -69.24 -23.78 63.91 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.4 mt 59.59 -50.8 0.07 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 128.817 2.847 . . . . 0.0 115.71 -173.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.175 0 C-N-CA 124.702 1.201 . . . . 0.0 110.653 164.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mmt . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 119.236 -0.412 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.9 p -69.46 -35.95 76.13 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.849 0.86 . . . . 0.0 112.121 174.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -101.3 151.44 21.88 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.025 1.73 . . . . 0.0 110.653 162.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.0 t -149.87 155.27 39.75 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.539 1.136 . . . . 0.0 112.04 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -91.7 10.69 27.25 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.28 1.432 . . . . 0.0 114.152 -171.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -63.52 140.75 58.9 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.82 1.248 . . . . 0.0 112.851 -175.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.5 p -89.72 161.97 15.8 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.859 1.663 . . . . 0.0 113.444 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -125.94 108.17 11.16 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.366 1.067 . . . . 0.0 113.012 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.9 p -143.73 162.29 36.37 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 126.262 1.825 . . . . 0.0 111.415 170.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.9 pt -129.19 155.12 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 125.827 1.651 . . . . 0.0 112.29 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -93.07 140.05 29.9 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.092 0.957 . . . . 0.0 111.497 173.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.4 150.34 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 125.08 1.352 . . . . 0.0 111.217 170.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 65.2 p -143.45 159.93 41.49 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.415 1.886 . . . . 0.0 110.338 178.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -51.45 -31.7 24.2 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.055 1.342 . . . . 0.0 114.55 -174.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.85 -21.44 66.8 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.9 m -131.69 -1.3 3.83 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.655 1.582 . . . . 0.0 113.711 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -59.51 -42.02 91.26 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.853 1.261 . . . . 0.0 112.514 -170.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.63 -32.4 72.23 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.8 m -79.18 -29.81 43.12 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.699 1.2 . . . . 0.0 112.578 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -94.71 -53.69 3.77 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.641 0.776 . . . . 0.0 112.803 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.3 -60.2 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.82 1.248 . . . . 0.0 110.732 -175.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.6 mt -75.43 -15.97 60.39 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -169.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.8 t -70.23 -22.91 62.86 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.566 1.146 . . . . 0.0 112.537 172.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.2 t -79.39 133.22 36.57 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -170.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -81.21 -23.84 37.84 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.584 1.154 . . . . 0.0 111.929 168.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -74.59 147.03 84.3 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 125.288 1.435 . . . . 0.0 110.044 176.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.88 132.43 51.63 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.196 1.931 . . . . 0.0 111.777 172.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.25 123.31 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.801 0.81 . . . . 0.0 110.798 -174.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.3 tt -101.93 132.07 47.95 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.581 1.952 . . . . 0.0 108.182 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 t -123.11 127.25 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.109 0.964 . . . . 0.0 110.6 174.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -100.24 118.84 37.37 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.487 1.515 . . . . 0.0 111.752 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.426 ' CD2' HD12 ' A' ' 63' ' ' LEU . 21.1 m-85 -99.66 109.26 21.75 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.156 2.182 . . . . 0.0 108.286 176.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.2 p-90 -142.61 178.46 7.6 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.954 1.302 . . . . 0.0 111.96 -164.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.53 140.03 30.06 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 121.521 -0.737 . . . . 0.0 112.971 167.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.7 t -64.98 -18.58 65.39 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 173.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -88.89 0.13 56.86 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 174.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 44.1 t -111.5 123.23 49.79 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.41 1.084 . . . . 0.0 112.893 -173.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.55 -49.44 73.57 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-O 118.868 -0.962 . . . . 0.0 114.348 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -58.16 -32.02 94.71 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.911 2.407 . . . . 0.0 114.04 171.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 97.4 m -65.1 -46.46 80.99 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.066 -1.022 . . . . 0.0 111.558 170.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -60.47 -29.95 69.37 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.766 0.712 . . . . 0.0 112.72 173.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.5 ttt -72.49 -44.23 62.55 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.556 1.142 . . . . 0.0 112.853 177.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.9 p -88.62 -24.67 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 -176.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.23 -48.57 73.63 Favored Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.18 -29.01 47.81 Favored 'Trans proline' 0 C--N 1.352 0.73 0 CA-C-N 122.14 1.8 . . . . 0.0 113.324 176.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.5 t -70.11 -49.42 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 119.375 0.989 . . . . 0.0 110.565 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.1 pp -72.07 -26.85 62.33 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -72.52 -35.14 68.01 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 119.203 0.911 . . . . 0.0 112.931 171.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -61.76 -46.91 87.55 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 120.771 -1.206 . . . . 0.0 111.075 165.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 70.0 mt -58.23 -41.45 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 119.139 0.881 . . . . 0.0 110.942 174.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.47 -44.62 92.97 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.116 0.966 . . . . 0.0 113.506 175.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.4 m -76.65 -41.15 46.77 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.81 0.844 . . . . 0.0 111.718 -176.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -86.04 -21.75 27.58 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -174.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -114.75 27.61 9.31 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.021 1.728 . . . . 0.0 113.273 176.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.84 -27.52 30.22 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.4 m -73.28 -37.0 66.41 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.584 1.154 . . . . 0.0 112.75 174.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -94.19 -29.61 15.03 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.724 1.21 . . . . 0.0 113.339 -174.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 93.1 mt -129.56 149.34 51.36 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.953 2.101 . . . . 0.0 110.6 -177.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.2 m -103.24 138.14 40.44 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 150.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.8 t -127.89 126.95 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.808 0.731 . . . . 0.0 111.381 -173.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.71 165.75 18.67 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.853 1.661 . . . . 0.0 113.145 -172.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -129.73 141.27 50.91 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.617 1.967 . . . . 0.0 112.455 -174.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.426 HD12 ' CD2' ' A' ' 32' ' ' PHE . 2.7 tm? -133.65 113.69 12.66 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.113 2.165 . . . . 0.0 108.595 169.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -81.51 120.61 25.25 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 169.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.7 m -65.85 -16.32 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -169.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -83.16 -20.16 35.24 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 119.294 0.952 . . . . 0.0 113.334 171.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 43.1 p -92.03 -28.82 16.94 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -169.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -148.76 76.21 9.83 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 123.579 0.752 . . . . 0.0 110.602 166.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.97 -27.38 78.92 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 124.027 3.151 . . . . 0.0 115.47 -169.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -62.36 -26.0 68.21 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.761 0.824 . . . . 0.0 112.924 176.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -64.23 -46.91 81.77 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.998 0.817 . . . . 0.0 110.653 175.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.53 -37.0 86.05 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.667 0.787 . . . . 0.0 112.19 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -70.78 -45.96 63.74 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.455 0.702 . . . . 0.0 112.603 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -69.82 -27.02 64.52 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -174.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -99.75 10.14 41.85 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.673 1.189 . . . . 0.0 113.563 172.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 62.68 -8.51 0.12 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 128.542 2.737 . . . . 0.0 116.225 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.9 m -79.61 56.52 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 126.536 1.934 . . . . 0.0 112.889 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.7 m -76.22 -21.46 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.925 1.29 . . . . 0.0 113.539 176.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 51.1 m -67.85 150.29 48.77 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.448 1.099 . . . . 0.0 111.26 170.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.3 pt -139.69 145.8 44.79 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -174.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.58 146.11 64.81 Favored 'Cis proline' 0 CA--C 1.538 0.685 0 O-C-N 122.034 0.492 . . . . 0.0 111.44 -17.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 83.4 m -135.18 126.32 28.0 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.88 0.872 . . . . 0.0 110.872 171.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.8 134.2 39.03 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 124.535 1.134 . . . . 0.0 108.007 167.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.6 tt -117.36 143.97 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.485 1.114 . . . . 0.0 108.891 165.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.7 tt -123.71 134.66 53.66 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.663 0.785 . . . . 0.0 110.361 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -114.24 147.36 39.11 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.835 1.654 . . . . 0.0 111.344 173.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -126.49 135.09 50.9 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.6 1.16 . . . . 0.0 109.528 161.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.0 t0 47.0 41.8 11.55 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.639 1.176 . . . . 0.0 113.411 -174.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.38 14.06 63.72 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.138 1.352 . . . . 0.0 115.884 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -118.35 140.81 28.64 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 125.715 1.606 . . . . 0.0 109.88 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -69.81 140.36 42.31 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.798 2.332 . . . . 0.0 112.308 -174.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.2 t -125.94 -39.26 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 125.983 1.713 . . . . 0.0 112.185 -173.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -145.11 145.34 31.37 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.756 0.823 . . . . 0.0 111.89 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -129.26 132.31 47.17 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.072 1.749 . . . . 0.0 109.814 161.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.3 mt -135.55 129.53 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.618 1.567 . . . . 0.0 108.994 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.0 m -127.63 145.48 34.92 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 123.744 0.818 . . . . 0.0 112.568 -170.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.24 166.63 26.52 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 124.22 0.914 . . . . 0.0 113.506 -174.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -82.35 132.77 35.22 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.729 -0.865 . . . . 0.0 112.489 -176.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -133.83 156.53 47.87 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.912 1.685 . . . . 0.0 111.144 172.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -79.18 167.91 52.76 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 123.873 0.749 . . . . 0.0 112.169 173.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -47.91 -38.18 15.86 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.854 1.662 . . . . 0.0 114.673 -176.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.26 -49.57 54.93 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.78 0.324 . . . . 0.0 111.759 -177.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.42 -39.31 59.09 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 121.731 -0.606 . . . . 0.0 112.516 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.9 tp -68.07 -42.03 81.05 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 118.921 0.782 . . . . 0.0 111.052 176.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 23.6 tp -70.24 -24.68 63.12 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-O 115.513 -2.184 . . . . 0.0 112.315 171.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 44.6 mmt-85 -64.31 -49.51 71.49 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 124.51 3.323 . . . . 0.0 112.219 167.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.37 -31.22 65.56 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.464 0.706 . . . . 0.0 112.839 176.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 53.3 mt -97.26 -22.56 16.62 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 52.3 p -73.96 -20.2 60.43 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.893 1.277 . . . . 0.0 111.114 174.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -52.91 -27.83 20.52 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 160.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 93.3 t -100.86 -32.71 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 126.66 1.984 . . . . 0.0 112.008 171.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 28.5 t -110.1 79.77 1.65 Allowed Pre-proline 0 N--CA 1.477 0.903 0 C-N-CA 126.913 2.085 . . . . 0.0 110.942 -176.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.66 -16.7 54.59 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.784 2.323 . . . . 0.0 112.946 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -65.7 -18.3 65.23 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.821 1.648 . . . . 0.0 113.708 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.2 tp -137.54 42.15 2.35 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.61 1.164 . . . . 0.0 111.273 172.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.124 0 C-N-CA 124.73 1.212 . . . . 0.0 111.831 175.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 110.479 -0.193 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.4 p -75.82 159.92 30.51 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.731 1.212 . . . . 0.0 112.618 175.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -143.7 150.86 39.29 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.279 1.432 . . . . 0.0 111.767 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.5 m -79.34 -1.36 36.56 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -176.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 58.56 32.21 21.89 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 126.22 1.808 . . . . 0.0 113.867 -177.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.5 163.06 28.64 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.079 1.352 . . . . 0.0 113.558 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.7 m -61.28 134.66 57.21 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.935 1.294 . . . . 0.0 112.139 176.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.49 57.85 3.45 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.665 -0.647 . . . . 0.0 112.053 176.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.3 p -102.65 138.36 39.65 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.371 1.468 . . . . 0.0 113.128 -174.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.2 pt -138.25 172.53 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 126.545 1.938 . . . . 0.0 111.381 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.5 mtpt -125.48 142.91 51.25 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.106 0.962 . . . . 0.0 111.209 169.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -139.36 150.23 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.375 1.47 . . . . 0.0 111.0 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 68.7 p -139.51 161.48 37.38 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 125.15 1.38 . . . . 0.0 111.672 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -51.15 -30.38 16.41 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.936 2.095 . . . . 0.0 114.718 -176.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.0 -20.19 66.11 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 178.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.6 m -137.96 9.85 2.82 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.456 1.502 . . . . 0.0 113.411 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -63.13 -44.74 94.72 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.178 -0.951 . . . . 0.0 112.486 -168.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.26 -32.81 74.45 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.682 -0.636 . . . . 0.0 112.504 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.5 -9.46 59.62 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.84 1.656 . . . . 0.0 114.16 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -124.17 -50.86 1.78 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.18 0.992 . . . . 0.0 113.241 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.1 t -81.72 -52.97 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.356 1.062 . . . . 0.0 110.799 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 28.9 mt -81.33 -13.35 58.48 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -175.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.0 p -77.68 -21.61 51.79 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.805 1.242 . . . . 0.0 113.192 173.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.9 m -75.49 126.7 31.53 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.188 1.395 . . . . 0.0 112.544 -173.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -76.95 -25.14 52.5 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.319 0.647 . . . . 0.0 111.85 169.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -74.99 145.23 80.75 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 125.853 1.661 . . . . 0.0 110.255 173.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.33 137.28 77.56 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.156 1.904 . . . . 0.0 112.14 172.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.5 p -136.53 130.35 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.6 1.16 . . . . 0.0 110.526 -176.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.7 tt -112.47 116.84 30.91 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.021 1.728 . . . . 0.0 108.228 -174.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.65 124.94 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.445 0.698 . . . . 0.0 110.501 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -107.47 116.39 31.86 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.585 1.554 . . . . 0.0 111.481 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -93.4 108.85 20.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.466 1.906 . . . . 0.0 108.351 177.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -142.26 173.13 11.81 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.851 1.261 . . . . 0.0 112.347 -163.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.74 145.16 29.86 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.54 -0.725 . . . . 0.0 112.275 158.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -65.43 -19.53 65.98 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.8 p-90 -78.51 -13.62 59.75 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 175.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.8 t -98.16 129.84 44.93 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.143 0.977 . . . . 0.0 111.572 -174.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.13 -55.91 27.6 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.298 0.951 . . . . 0.0 113.721 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -57.65 -31.73 92.65 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.439 2.759 . . . . 0.0 114.531 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 96.3 m -67.64 -45.33 75.62 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.137 -0.977 . . . . 0.0 111.44 173.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.1 tppt? -61.37 -33.57 73.87 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.475 1.11 . . . . 0.0 111.819 172.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 50.8 ttm -70.01 -42.72 72.65 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.031 1.332 . . . . 0.0 112.942 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.2 p -81.34 -24.49 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.96 -49.97 77.5 Favored Pre-proline 0 CA--C 1.55 0.945 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.9 -27.27 37.15 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.174 1.916 . . . . 0.0 113.125 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.9 t -72.47 -41.35 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.714 0.805 . . . . 0.0 110.525 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.3 mt -67.19 -35.9 80.63 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.111 0.964 . . . . 0.0 112.613 170.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -66.12 -40.58 90.81 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.223 0.92 . . . . 0.0 111.468 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -58.26 -49.54 76.75 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.743 168.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 tp -66.82 -33.28 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 120.34 1.427 . . . . 0.0 112.652 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.79 -40.0 93.66 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.212 -0.93 . . . . 0.0 111.954 172.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.3 m -76.07 -49.0 18.66 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.723 0.809 . . . . 0.0 112.092 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -85.57 -21.61 28.45 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -170.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -116.92 31.52 6.7 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 126.357 1.863 . . . . 0.0 112.657 173.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.75 -28.18 14.42 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 176.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.5 p -81.61 -29.44 33.27 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.68 1.592 . . . . 0.0 114.292 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -102.16 -27.06 13.11 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.734 1.214 . . . . 0.0 113.742 -175.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 81.5 mt -129.67 148.71 51.58 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.357 1.863 . . . . 0.0 110.196 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.5 m -109.02 131.61 54.91 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 153.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 83.1 t -106.35 130.19 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.494 0.718 . . . . 0.0 109.858 -175.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -127.35 146.86 50.31 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.897 1.279 . . . . 0.0 112.419 -171.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -120.16 136.39 54.64 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.333 1.453 . . . . 0.0 111.986 -176.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -130.65 116.81 18.59 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.598 1.559 . . . . 0.0 109.744 171.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.77 105.72 13.13 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.261 1.024 . . . . 0.0 110.594 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.5 m -65.14 -20.42 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -73.76 -27.83 61.37 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.322 1.449 . . . . 0.0 113.271 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.7 p -112.73 -22.02 10.92 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.38 1.072 . . . . 0.0 113.59 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -133.27 92.71 24.01 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.256 1.023 . . . . 0.0 111.577 168.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -71.26 -19.61 29.09 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.238 2.625 . . . . 0.0 113.844 172.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -67.61 -42.38 82.5 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 121.142 -0.973 . . . . 0.0 112.126 -171.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.6 m -67.15 -35.02 78.81 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.85 0.86 . . . . 0.0 111.248 176.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.26 -45.6 80.0 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.227 0.611 . . . . 0.0 111.955 174.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.0 ttm105 -72.57 -41.59 65.53 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -174.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -62.1 -38.33 88.45 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -173.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -96.89 7.53 46.41 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.364 1.066 . . . . 0.0 113.122 176.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.318 14.8 pt20 44.02 34.45 0.95 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.95 2.1 . . . . 0.0 114.415 -169.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.8 m -85.56 43.85 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 126.654 1.982 . . . . 0.0 110.406 175.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.4 m -85.23 -14.2 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.698 1.599 . . . . 0.0 113.993 -168.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.0 t -71.55 155.31 40.7 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.559 0.743 . . . . 0.0 111.038 170.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 14.4 pt -129.49 121.49 20.32 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -167.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -67.24 161.8 76.76 Favored 'Cis proline' 0 CA--C 1.54 0.8 0 CA-C-N 118.831 0.618 . . . . 0.0 111.709 -16.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.1 m -127.16 134.39 50.18 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.5 1.12 . . . . 0.0 108.713 161.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.4 mp -113.42 131.93 55.82 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.856 1.262 . . . . 0.0 108.709 174.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.5 tp -116.1 146.3 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.868 1.267 . . . . 0.0 109.307 167.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.4 tt -123.92 132.85 53.8 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.681 -0.637 . . . . 0.0 110.451 165.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -111.95 143.77 42.38 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.223 1.409 . . . . 0.0 110.368 170.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -126.94 125.48 41.62 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.391 1.476 . . . . 0.0 109.17 171.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.8 t70 50.41 34.34 9.04 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 124.41 1.084 . . . . 0.0 113.526 -168.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.12 8.48 61.76 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 125.781 1.658 . . . . 0.0 116.171 -175.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -102.34 141.3 22.25 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 119.364 1.582 . . . . 0.0 110.488 172.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -70.08 140.38 41.32 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.83 2.353 . . . . 0.0 112.592 -176.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 75.3 t -127.72 -36.49 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 125.854 1.662 . . . . 0.0 112.709 -175.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -142.14 139.14 32.04 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.687 1.195 . . . . 0.0 111.115 -177.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 24.5 ttt85 -141.4 115.83 9.51 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.62 1.968 . . . . 0.0 110.194 171.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.27 150.73 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 125.223 1.409 . . . . 0.0 112.8 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.8 m -124.08 155.65 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.474 1.51 . . . . 0.0 111.911 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.25 163.11 11.27 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.257 0.932 . . . . 0.0 112.983 -174.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.5 156.07 30.84 Favored 'General case' 0 CA--C 1.544 0.721 0 O-C-N 121.191 -1.182 . . . . 0.0 113.706 -176.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.81 147.58 52.49 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.587 1.555 . . . . 0.0 110.049 165.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -83.69 167.22 44.14 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 162.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.4 tmtp? -52.75 -34.29 52.26 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.769 1.228 . . . . 0.0 113.618 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.59 -53.97 34.31 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.91 0.484 . . . . 0.0 111.754 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.1 -36.27 66.76 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.465 -0.772 . . . . 0.0 112.601 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.1 tp -63.44 -40.23 96.61 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.644 -0.66 . . . . 0.0 110.179 172.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 26.5 tp -72.74 -23.76 60.88 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-O 117.041 -1.457 . . . . 0.0 113.298 173.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -58.52 -55.61 32.79 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 122.951 2.614 . . . . 0.0 109.988 164.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -69.56 -26.57 64.55 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 -174.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 88.9 mt -97.06 -28.76 14.0 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 176.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.9 t -69.58 -24.37 63.68 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 120.584 1.538 . . . . 0.0 111.194 170.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -57.63 -22.7 47.02 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 164.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.5 t -100.53 -28.28 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 127.056 2.142 . . . . 0.0 111.805 171.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 32.9 t -126.62 84.77 61.88 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 127.389 2.276 . . . . 0.0 111.13 -170.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -63.08 -9.81 18.4 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.452 2.768 . . . . 0.0 114.868 176.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -64.94 -15.66 62.4 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -177.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 93.3 mt -114.79 14.4 17.41 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.176 1.391 . . . . 0.0 113.59 174.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.208 0 C-N-CA 125.108 1.363 . . . . 0.0 112.005 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.3 tpp . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 39.2 p -78.31 144.37 36.13 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.294 1.038 . . . . 0.0 112.558 179.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -79.89 86.04 5.46 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.593 1.157 . . . . 0.0 111.088 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.5 t -152.86 -179.2 7.43 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.686 1.594 . . . . 0.0 111.191 -177.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -74.14 102.72 4.34 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.511 1.524 . . . . 0.0 110.787 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.411 ' HE2' ' HA ' ' A' ' 6' ' ' LYS . 8.1 mmpt? -78.72 -11.79 59.99 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -172.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.7 t -127.36 155.73 43.13 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.379 1.472 . . . . 0.0 113.172 -174.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -105.8 14.4 28.24 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.724 1.61 . . . . 0.0 113.351 172.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.6 p -83.24 157.36 22.71 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 121.165 -0.959 . . . . 0.0 113.38 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.1 pt -115.85 155.11 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.642 1.577 . . . . 0.0 111.551 171.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -108.8 136.4 48.43 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.517 1.127 . . . . 0.0 110.479 174.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.9 m -132.14 154.25 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.664 1.186 . . . . 0.0 112.857 -172.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 66.5 p -142.22 161.3 38.36 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.289 1.835 . . . . 0.0 110.854 175.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -57.17 -28.57 62.9 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -172.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.33 -17.3 62.45 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.553 1.141 . . . . 0.0 114.074 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 43.1 m -136.06 3.2 2.89 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.302 1.441 . . . . 0.0 113.552 -175.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -56.09 -40.57 73.86 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.119 1.367 . . . . 0.0 112.533 -174.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.03 -34.6 78.46 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.317 -0.864 . . . . 0.0 113.044 177.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.8 m -79.51 -29.6 41.62 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.511 1.124 . . . . 0.0 112.846 177.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -94.63 -39.46 10.33 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.1 t -97.23 -64.85 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.186 1.394 . . . . 0.0 109.859 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.9 mt -73.82 -14.62 61.13 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -165.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.0 m -85.08 -3.67 58.88 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.659 1.184 . . . . 0.0 113.997 176.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.1 m -60.65 142.09 56.04 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.925 1.29 . . . . 0.0 113.565 -176.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.8 p-10 -82.93 -3.99 57.68 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.797 1.239 . . . . 0.0 114.2 176.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -141.13 163.33 42.81 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 127.833 2.453 . . . . 0.0 110.558 176.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -53.45 147.08 39.12 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 123.231 2.621 . . . . 0.0 112.836 177.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.39 133.39 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.633 1.173 . . . . 0.0 111.711 -174.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.02 117.05 32.73 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.876 2.071 . . . . 0.0 108.422 -176.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.2 t -107.63 127.31 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.693 0.797 . . . . 0.0 110.396 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -104.53 117.08 33.26 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.0 1.32 . . . . 0.0 111.173 175.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -91.8 107.22 19.06 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.272 1.829 . . . . 0.0 107.964 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.466 ' CD1' ' HE3' ' A' ' 62' ' ' LYS . 2.1 p-90 -143.93 164.47 30.48 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -159.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -148.47 151.92 36.01 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.865 0.866 . . . . 0.0 111.359 162.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.3 t -66.19 -20.99 66.3 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 12.6 p-90 -75.39 -8.64 57.23 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 173.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 43.1 t -100.34 116.46 32.38 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.406 1.082 . . . . 0.0 110.914 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.62 -44.3 98.13 Favored Glycine 0 CA--C 1.54 1.642 0 CA-C-O 118.801 -1.0 . . . . 0.0 114.022 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -56.88 -39.51 90.89 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.863 2.376 . . . . 0.0 113.941 169.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 87.1 m -61.57 -43.34 99.03 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 120.989 -1.069 . . . . 0.0 111.503 171.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -62.97 -29.74 71.05 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.379 1.072 . . . . 0.0 112.512 176.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -74.96 -45.71 40.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.229 1.412 . . . . 0.0 112.681 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.1 p -81.37 -24.11 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.78 -50.06 79.82 Favored Pre-proline 0 CA--C 1.549 0.913 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -65.91 -28.36 50.42 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 CA-C-N 122.353 1.876 . . . . 0.0 113.177 176.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.6 t -70.02 -45.98 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.479 -0.763 . . . . 0.0 110.154 175.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.8 mt -62.35 -34.26 76.33 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.258 1.023 . . . . 0.0 112.672 172.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -66.3 -41.33 89.89 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.987 0.915 . . . . 0.0 111.758 175.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -63.75 -44.86 92.23 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.382 -0.824 . . . . 0.0 111.648 170.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.3 mm -59.01 -43.37 88.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 119.248 0.931 . . . . 0.0 110.956 174.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.45 -42.66 92.45 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.836 0.854 . . . . 0.0 112.016 176.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.2 m -74.61 -42.61 58.31 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.979 0.912 . . . . 0.0 112.062 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -95.42 -22.07 17.94 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -169.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -112.26 17.97 19.0 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.654 1.581 . . . . 0.0 112.633 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.85 -28.46 50.01 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.981 1.313 . . . . 0.0 114.455 -176.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.9 p -69.21 -22.75 63.86 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.931 1.692 . . . . 0.0 114.1 174.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -117.83 -29.52 5.66 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.883 1.673 . . . . 0.0 112.98 -171.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.0 mt -130.16 149.34 51.91 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.69 1.996 . . . . 0.0 111.125 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.2 m -99.79 139.03 36.05 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 151.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 52.2 t -117.0 129.23 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 119.397 0.999 . . . . 0.0 110.3 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.32 157.73 41.74 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.698 1.599 . . . . 0.0 112.697 -170.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.466 ' HE3' ' CD1' ' A' ' 33' ' ' TRP . 30.8 mmmt -126.77 124.3 39.39 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.179 1.792 . . . . 0.0 110.422 -175.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -109.95 114.03 27.24 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.642 1.177 . . . . 0.0 108.908 169.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.72 99.4 9.61 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.613 1.165 . . . . 0.0 109.369 -176.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.9 m -66.7 -17.06 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 O-C-N 120.856 -1.152 . . . . 0.0 113.156 -176.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -74.23 -24.84 59.37 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.339 1.056 . . . . 0.0 113.206 176.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.2 p -119.25 -25.51 6.11 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -133.31 74.16 72.69 Favored Pre-proline 0 CA--C 1.55 0.977 0 CA-C-N 119.598 1.09 . . . . 0.0 112.141 171.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -67.46 -11.57 32.62 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 122.846 2.364 . . . . 0.0 112.675 168.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -57.24 -41.73 80.13 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.834 1.253 . . . . 0.0 112.223 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.2 m -66.02 -42.71 89.27 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.742 0.701 . . . . 0.0 111.046 174.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.75 -37.98 86.29 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.516 -0.74 . . . . 0.0 112.994 -178.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -78.74 -38.6 38.4 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 173.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -69.09 -36.67 77.85 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 119.245 0.93 . . . . 0.0 112.607 -178.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -93.3 9.15 37.46 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.819 1.248 . . . . 0.0 112.482 174.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 61.16 -10.29 0.06 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 128.737 2.815 . . . . 0.0 116.87 177.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.3 m -76.73 52.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 126.317 1.847 . . . . 0.0 113.449 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.8 p -75.9 -20.97 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 125.428 1.491 . . . . 0.0 113.067 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.5 p -70.9 129.33 38.77 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.188 0.995 . . . . 0.0 110.821 165.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.4 pt -138.5 149.62 63.4 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 125.068 1.347 . . . . 0.0 112.809 -163.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -66.51 149.4 79.18 Favored 'Cis proline' 0 C--N 1.354 0.829 0 CA-C-N 119.373 0.812 . . . . 0.0 113.246 -2.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.1 m -128.67 130.28 46.98 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.271 1.028 . . . . 0.0 110.895 169.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.3 mp -103.49 119.32 38.66 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.828 1.651 . . . . 0.0 107.227 161.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.3 tp -120.39 126.48 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.701 1.201 . . . . 0.0 109.713 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.9 tp -110.24 121.04 44.34 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.153 1.381 . . . . 0.0 110.464 -172.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -106.8 131.13 54.26 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.864 1.665 . . . . 0.0 109.172 175.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -99.72 -29.74 12.48 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -175.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -154.45 56.93 0.7 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.786 1.634 . . . . 0.0 110.785 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.73 17.82 65.37 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.315 0.959 . . . . 0.0 114.554 -175.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -141.91 138.41 16.97 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 126.83 2.052 . . . . 0.0 110.139 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.86 142.69 35.62 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.254 2.636 . . . . 0.0 111.96 -174.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 97.8 t -129.6 -40.06 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.497 1.119 . . . . 0.0 112.939 -176.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -142.3 133.14 25.65 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.081 0.855 . . . . 0.0 111.791 -173.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -117.83 134.01 55.36 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.284 1.434 . . . . 0.0 110.841 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.11 144.12 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 126.422 1.889 . . . . 0.0 108.713 169.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.8 m -133.67 144.84 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 124.834 1.254 . . . . 0.0 111.001 -174.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.08 -162.84 46.73 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 122.869 0.271 . . . . 0.0 112.624 -167.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -119.8 139.68 51.96 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.89 1.276 . . . . 0.0 112.28 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -135.23 154.35 51.61 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.611 1.565 . . . . 0.0 112.129 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -80.73 171.12 53.76 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.415 1.007 . . . . 0.0 112.455 173.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -51.84 -37.42 51.86 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.437 1.495 . . . . 0.0 114.628 -175.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.9 -53.43 32.22 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 123.407 0.442 . . . . 0.0 110.924 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.39 -38.76 68.37 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 36.9 tp -63.76 -42.57 97.8 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 119.399 0.999 . . . . 0.0 111.043 173.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.7 tp -70.18 -25.03 63.24 Favored 'General case' 0 C--O 1.214 -0.786 0 CA-C-O 115.857 -2.021 . . . . 0.0 113.014 174.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -64.49 -49.96 69.3 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 124.258 3.208 . . . . 0.0 111.962 166.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.49 -28.63 68.51 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.499 0.72 . . . . 0.0 112.882 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 89.8 mt -91.52 -28.21 17.73 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.396 1.078 . . . . 0.0 113.303 172.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.3 m -60.18 -28.79 68.24 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.82 1.248 . . . . 0.0 110.669 174.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -52.69 -20.47 3.14 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 168.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.9 t -118.59 -27.32 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 127.407 2.283 . . . . 0.0 112.633 173.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.6 t -106.6 96.11 13.43 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 127.092 2.157 . . . . 0.0 110.939 -174.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -70.97 -9.89 26.55 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.707 2.271 . . . . 0.0 113.178 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -70.73 5.74 1.78 Allowed 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.561 1.544 . . . . 0.0 114.619 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.3 tt -63.54 -31.54 72.74 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 120.431 -1.418 . . . . 0.0 111.612 161.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.254 1.299 0 C-N-CA 125.814 1.645 . . . . 0.0 111.842 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.485 1.278 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.0 t -135.99 149.39 48.83 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.033 1.333 . . . . 0.0 111.608 173.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -99.55 -8.34 24.68 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.029 1.331 . . . . 0.0 113.42 169.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 72.7 m -81.83 -24.82 35.62 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.35 1.06 . . . . 0.0 113.548 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 61.55 -32.96 0.09 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 129.217 3.007 . . . . 0.0 119.047 168.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -95.17 108.74 20.88 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.204 1.402 . . . . 0.0 112.132 -168.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.9 m -70.98 133.05 46.06 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.453 1.501 . . . . 0.0 112.939 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.51 71.67 3.69 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.799 0.84 . . . . 0.0 110.682 167.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.5 p -108.62 150.57 27.34 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.046 1.338 . . . . 0.0 113.883 -175.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.4 pt -132.62 157.24 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 126.112 1.765 . . . . 0.0 111.353 169.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -112.06 140.38 46.79 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.636 1.174 . . . . 0.0 110.597 171.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.9 m -132.11 155.46 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.701 1.2 . . . . 0.0 112.509 -175.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.7 p -142.11 160.81 39.49 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.466 1.907 . . . . 0.0 110.577 176.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -57.95 -27.64 63.59 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -173.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.36 -19.56 63.03 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.0 m -132.77 -2.85 3.29 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.181 1.392 . . . . 0.0 114.17 -174.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -55.26 -40.39 70.91 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.257 1.423 . . . . 0.0 112.642 -174.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.38 -33.6 75.53 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.972 0.731 . . . . 0.0 112.972 177.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.7 m -79.51 -29.69 41.63 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.725 1.21 . . . . 0.0 112.873 176.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -92.64 -45.04 8.27 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -176.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.11 -59.05 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.916 1.286 . . . . 0.0 110.636 -176.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.4 mt -75.66 -18.72 59.56 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -169.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.8 m -79.38 -10.84 59.89 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.3 t -81.64 130.05 34.92 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.788 0.835 . . . . 0.0 112.469 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -81.6 -21.12 38.55 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.242 1.017 . . . . 0.0 112.341 170.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -75.36 147.74 82.79 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 125.354 1.462 . . . . 0.0 110.062 174.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -58.03 133.23 54.32 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.103 1.869 . . . . 0.0 111.396 171.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.88 132.51 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.225 1.01 . . . . 0.0 110.18 -174.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -122.73 113.84 19.74 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.171 1.389 . . . . 0.0 109.7 -170.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.1 t -107.61 125.19 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.888 1.275 . . . . 0.0 110.224 -173.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -103.88 120.78 41.71 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.267 1.027 . . . . 0.0 112.009 174.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -93.09 113.37 25.61 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.987 2.115 . . . . 0.0 108.076 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 6.8 p-90 -144.83 172.5 12.93 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.439 1.096 . . . . 0.0 113.235 -165.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -145.77 152.83 40.19 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.916 0.886 . . . . 0.0 112.419 167.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.9 p -63.71 -27.29 69.1 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.622 1.169 . . . . 0.0 113.119 174.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.501 ' CZ3' HD11 ' A' ' 80' ' ' ILE . 10.7 p-90 -79.0 -3.69 46.29 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 48.5 t -107.5 123.74 48.87 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.865 0.866 . . . . 0.0 113.271 -170.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.31 -58.4 14.79 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.205 1.384 . . . . 0.0 114.02 178.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.7 -27.09 68.47 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 CA-C-N 120.482 2.141 . . . . 0.0 113.534 177.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 85.3 m -61.91 -46.68 88.33 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 120.116 1.326 . . . . 0.0 111.238 168.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.89 -33.18 72.71 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.014 0.926 . . . . 0.0 112.631 175.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 61.4 mtt -74.77 -37.7 62.38 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.542 1.137 . . . . 0.0 113.83 177.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.4 p -88.13 -20.77 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.47 -49.38 77.98 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 174.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.5 -27.23 46.59 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 CA-C-N 122.303 1.858 . . . . 0.0 113.476 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 95.3 t -71.29 -49.46 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 119.059 0.845 . . . . 0.0 110.322 173.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.9 mt -61.52 -34.32 75.32 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.954 0.902 . . . . 0.0 113.029 176.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -62.61 -39.99 95.54 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.889 0.876 . . . . 0.0 111.504 173.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -71.34 -36.96 71.73 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.154 -0.966 . . . . 0.0 112.655 173.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.6 mm -61.21 -43.8 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 120.542 1.519 . . . . 0.0 110.559 171.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.27 -35.31 79.92 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.891 0.876 . . . . 0.0 112.504 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.4 m -73.46 -49.04 28.89 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.807 0.843 . . . . 0.0 112.012 176.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -92.7 -34.39 13.96 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -165.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -97.72 19.58 13.4 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.142 0.977 . . . . 0.0 113.328 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.37 -28.2 18.65 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.3 m -75.02 -31.68 61.41 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.767 1.227 . . . . 0.0 112.936 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -97.48 -34.89 10.83 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.035 1.334 . . . . 0.0 112.786 -174.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.3 mt -129.83 152.37 49.39 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.671 2.388 . . . . 0.0 110.518 -174.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.5 m -106.34 129.64 54.31 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 153.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.8 t -99.42 133.03 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.148 0.579 . . . . 0.0 110.193 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.2 155.94 44.73 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.359 1.464 . . . . 0.0 112.217 -173.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -127.64 134.54 49.64 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.305 1.442 . . . . 0.0 112.104 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -124.55 116.43 22.45 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.917 1.687 . . . . 0.0 109.08 169.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -81.94 113.03 19.58 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.482 0.713 . . . . 0.0 109.984 174.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.5 m -71.76 -16.56 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -177.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -85.84 -39.03 17.49 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.792 0.837 . . . . 0.0 111.991 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 72.3 p -96.38 -19.98 18.8 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -137.67 77.13 40.07 Favored Pre-proline 0 CA--C 1.552 1.021 0 CA-C-N 120.159 1.345 . . . . 0.0 111.82 163.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -65.56 -18.9 60.29 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.43 2.753 . . . . 0.0 113.871 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -63.61 -37.38 87.12 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.35 -0.844 . . . . 0.0 113.104 -174.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 m -65.06 -43.61 91.71 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.633 1.106 . . . . 0.0 111.256 174.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.7 -36.66 83.65 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.532 0.733 . . . . 0.0 112.08 178.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -70.1 -46.76 64.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.845 0.858 . . . . 0.0 112.12 173.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -63.05 -37.12 85.92 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.386 1.474 . . . . 0.0 112.617 -177.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -96.48 8.8 43.2 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.497 1.119 . . . . 0.0 112.917 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 59.98 -11.43 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 128.539 2.736 . . . . 0.0 116.588 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.5 m -76.74 59.96 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.579 1.952 . . . . 0.0 112.667 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.0 m -74.84 -19.9 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.989 1.316 . . . . 0.0 113.423 176.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.6 t -79.27 148.09 32.28 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.555 1.142 . . . . 0.0 111.165 170.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.501 HD11 ' CZ3' ' A' ' 36' ' ' TRP . 46.7 pt -143.49 155.64 60.55 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -167.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -68.74 140.82 59.5 Favored 'Cis proline' 0 C--N 1.353 0.793 0 CA-C-N 119.093 0.712 . . . . 0.0 111.033 -9.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 98.2 m -133.34 120.96 21.68 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.432 0.634 . . . . 0.0 110.65 174.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 mp -96.62 134.93 39.23 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.782 1.633 . . . . 0.0 108.42 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.0 tt -130.57 129.24 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.775 1.23 . . . . 0.0 110.727 171.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.9 tt -103.46 133.69 48.09 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.914 1.286 . . . . 0.0 110.531 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -117.22 148.28 41.77 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.233 1.413 . . . . 0.0 111.228 171.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -124.77 131.03 53.49 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.007 1.323 . . . . 0.0 108.991 164.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.6 t70 49.13 33.27 4.73 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.22 13.36 83.69 Favored Glycine 0 CA--C 1.536 1.371 0 N-CA-C 116.909 1.524 . . . . 0.0 116.909 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -116.25 145.76 35.77 Favored Pre-proline 0 N--CA 1.474 0.743 0 CA-C-N 119.36 1.58 . . . . 0.0 111.588 167.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -72.18 148.71 50.48 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.381 2.721 . . . . 0.0 112.408 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 89.2 t -131.89 -43.2 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.325 1.45 . . . . 0.0 112.829 -168.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -148.84 146.55 28.02 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.083 1.353 . . . . 0.0 110.968 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 -129.02 144.59 51.24 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.513 1.525 . . . . 0.0 112.067 167.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.5 mt -136.51 136.36 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 126.369 1.868 . . . . 0.0 107.893 175.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.4 p -133.46 142.89 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 119.664 1.12 . . . . 0.0 111.685 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.16 161.11 30.47 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.017 1.294 . . . . 0.0 113.248 -171.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.85 134.39 39.04 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.792 -0.828 . . . . 0.0 112.57 -177.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -133.07 149.65 52.14 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.936 1.694 . . . . 0.0 109.905 172.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.77 167.01 54.7 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -45.11 -40.06 6.56 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.36 1.464 . . . . 0.0 114.62 -175.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.77 -48.86 57.74 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.037 0.535 . . . . 0.0 111.984 -177.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.57 -36.98 60.24 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.91 0.884 . . . . 0.0 112.712 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.72 -46.53 75.22 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.914 0.886 . . . . 0.0 110.046 175.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -66.12 -30.02 70.44 Favored 'General case' 0 C--O 1.208 -1.124 0 CA-C-O 115.651 -2.118 . . . . 0.0 111.587 171.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 4.5 mmt180 -62.2 -49.11 77.1 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 124.382 3.264 . . . . 0.0 112.849 171.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -59.05 -33.01 70.28 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.323 1.049 . . . . 0.0 112.434 177.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.4 mt -85.62 -22.95 27.74 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 169.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.4 p -67.38 -25.99 66.23 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.807 1.643 . . . . 0.0 110.096 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -49.6 -26.25 3.44 Favored 'General case' 0 CA--C 1.556 1.193 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 164.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.5 t -111.57 -23.52 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 127.337 2.255 . . . . 0.0 112.931 172.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.05 69.19 0.65 Allowed Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 127.858 2.463 . . . . 0.0 109.798 177.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -67.94 -13.38 38.2 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.274 2.65 . . . . 0.0 113.056 -176.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -73.67 -3.23 26.89 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.146 1.378 . . . . 0.0 113.842 170.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 tp 57.55 -154.64 0.35 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.299 1.84 . . . . 0.0 112.985 174.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 36.3 t30 . . . . . 0 C--O 1.253 1.288 0 C-N-CA 125.558 1.543 . . . . 0.0 112.342 -177.765 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ttt . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 119.323 -0.37 . . . . 0.0 110.361 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 66.9 p 43.02 -110.03 0.14 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 126.683 1.993 . . . . 0.0 113.696 173.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -156.16 -40.13 0.08 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.62 1.168 . . . . 0.0 113.183 174.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 59.6 p -131.4 166.14 21.95 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.683 1.193 . . . . 0.0 113.198 -176.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -69.82 -23.83 63.38 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.455 0.702 . . . . 0.0 112.2 172.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -82.56 -41.32 19.75 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.696 1.199 . . . . 0.0 113.886 -176.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.1 p -121.37 162.62 20.06 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -163.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -101.93 34.48 2.66 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.886 0.875 . . . . 0.0 112.961 166.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.0 p -84.33 160.83 20.61 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.371 -0.83 . . . . 0.0 112.387 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.1 pt -125.02 164.52 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.57 1.548 . . . . 0.0 110.189 164.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -123.5 138.13 54.64 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.902 -1.124 . . . . 0.0 110.816 172.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.87 150.72 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.235 1.414 . . . . 0.0 112.085 -168.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 71.0 p -139.89 161.94 36.37 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.545 1.538 . . . . 0.0 111.496 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -51.6 -31.48 25.05 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.318 1.447 . . . . 0.0 114.599 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.71 -20.18 65.91 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 50.8 m -133.64 4.96 3.66 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.477 1.511 . . . . 0.0 113.425 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -59.45 -39.81 84.82 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.685 1.194 . . . . 0.0 112.969 -171.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.91 -32.64 74.04 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.533 -0.729 . . . . 0.0 112.889 175.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.1 m -79.62 -27.49 41.01 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.215 1.406 . . . . 0.0 113.234 177.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -101.34 -34.01 9.79 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -176.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.45 -54.47 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.843 1.257 . . . . 0.0 111.503 -172.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 26.4 mt -74.9 -12.59 60.4 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -176.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.5 p -71.16 -15.83 62.51 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.261 1.824 . . . . 0.0 113.942 173.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.7 p -66.75 149.05 51.1 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.804 1.642 . . . . 0.0 114.335 -172.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -109.62 -16.83 13.86 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.931 1.292 . . . . 0.0 112.225 160.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -90.53 166.6 18.96 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 125.95 1.7 . . . . 0.0 111.195 171.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.442 ' HB2' HD23 ' A' ' 58' ' ' LEU . 51.0 Cg_exo -59.49 138.68 85.38 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.29 1.994 . . . . 0.0 112.863 167.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.71 124.84 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.571 1.148 . . . . 0.0 111.104 172.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tt -100.3 128.73 46.3 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.796 2.038 . . . . 0.0 108.44 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.1 t -120.03 129.24 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.364 1.065 . . . . 0.0 110.571 173.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -106.8 116.93 32.78 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.061 1.344 . . . . 0.0 111.615 175.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.5 m-30 -88.22 111.69 21.93 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.992 1.717 . . . . 0.0 108.841 171.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 24.6 p-90 -134.23 170.96 14.91 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.236 1.414 . . . . 0.0 112.194 -171.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.86 140.27 24.46 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.83 0.852 . . . . 0.0 110.914 170.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 t -65.47 -12.5 53.13 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -168.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 55.3 p-90 -84.21 -14.02 51.15 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 172.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.2 t -90.7 106.49 18.54 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.1 0.96 . . . . 0.0 112.721 -166.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -52.75 -49.66 52.88 Favored Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.351 0.977 . . . . 0.0 114.234 178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -60.59 -29.32 88.25 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.559 2.173 . . . . 0.0 114.487 174.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.73 -39.36 70.15 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.255 0.934 . . . . 0.0 111.294 172.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -63.45 -29.81 71.04 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.552 0.741 . . . . 0.0 112.308 172.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 63.6 mtt -71.02 -42.5 69.48 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.261 1.024 . . . . 0.0 113.11 174.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.6 p -86.09 -21.65 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.51 -49.09 79.92 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 176.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.86 -27.95 43.23 Favored 'Trans proline' 0 C--N 1.353 0.764 0 CA-C-N 122.32 1.864 . . . . 0.0 112.828 176.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.8 t -72.16 -46.04 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 121.601 -0.687 . . . . 0.0 110.371 176.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.4 mt -57.55 -40.53 79.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.422 1.089 . . . . 0.0 112.078 170.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.43 -41.02 85.47 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.179 0.992 . . . . 0.0 112.327 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -62.93 -49.35 75.11 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 121.299 -0.876 . . . . 0.0 111.692 169.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 17.0 mm -56.61 -42.09 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.44 0.696 . . . . 0.0 110.94 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.06 -49.96 75.58 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.992 0.917 . . . . 0.0 112.117 174.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.6 m -77.34 -32.86 55.44 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.706 0.802 . . . . 0.0 112.247 -170.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -86.14 -38.69 17.47 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.571 1.148 . . . . 0.0 113.916 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -107.52 26.75 9.87 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.542 1.137 . . . . 0.0 113.8 -173.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -54.75 -27.99 45.17 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.9 p -77.19 -19.88 56.14 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.416 1.487 . . . . 0.0 113.902 175.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -104.68 -35.53 7.77 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.268 1.427 . . . . 0.0 112.718 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.442 HD23 ' HB2' ' A' ' 27' ' ' PRO . 85.9 mt -129.61 149.14 51.5 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.168 2.187 . . . . 0.0 110.231 -176.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.8 m -99.54 138.87 36.02 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 150.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.7 t -125.02 127.9 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.247 0.931 . . . . 0.0 110.583 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -128.07 154.08 46.09 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.013 1.725 . . . . 0.0 112.915 -169.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -125.7 145.01 50.36 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.406 1.482 . . . . 0.0 112.916 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -135.98 118.58 15.96 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.499 1.92 . . . . 0.0 109.95 173.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -83.81 109.96 17.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.225 0.61 . . . . 0.0 110.727 174.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.4 m -70.7 -12.18 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 113.769 1.025 . . . . 0.0 113.769 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -74.11 -19.33 60.62 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.734 1.152 . . . . 0.0 112.119 166.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.1 p -101.18 -43.76 5.89 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.615 1.166 . . . . 0.0 112.718 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -142.41 65.42 17.75 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 125.226 1.41 . . . . 0.0 111.311 -171.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -63.56 -23.17 70.58 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.617 2.878 . . . . 0.0 113.696 -176.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -57.0 -28.0 62.07 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.48 1.112 . . . . 0.0 112.576 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -66.79 -44.96 79.94 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.102 0.961 . . . . 0.0 112.06 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.55 -31.84 63.86 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.322 1.049 . . . . 0.0 112.651 173.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -71.1 -32.24 68.8 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.617 1.167 . . . . 0.0 113.496 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.6 t-20 -60.25 -41.81 93.97 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.757 1.223 . . . . 0.0 112.068 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -82.72 -8.38 59.59 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.026 0.93 . . . . 0.0 113.195 172.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 55.14 45.63 25.61 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.133 2.173 . . . . 0.0 113.056 -170.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.0 t -130.02 61.78 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.974 1.31 . . . . 0.0 109.507 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.9 p -82.55 -13.9 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -168.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.4 t -64.89 153.22 40.96 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.563 1.145 . . . . 0.0 112.849 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.7 mt -133.0 138.73 32.48 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 123.601 0.76 . . . . 0.0 112.371 -158.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.19 145.39 75.66 Favored 'Cis proline' 0 C--N 1.352 0.745 0 CA-C-N 119.183 0.744 . . . . 0.0 110.764 -16.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.4 m -117.03 122.28 43.75 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.577 0.751 . . . . 0.0 109.59 166.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.3 mp -102.97 120.14 40.09 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 171.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.8 tt -119.65 130.32 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.525 1.13 . . . . 0.0 110.162 176.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.3 tp -108.26 126.51 52.91 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.567 1.147 . . . . 0.0 109.766 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -105.21 152.07 23.3 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.472 1.509 . . . . 0.0 110.022 169.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -134.95 130.98 36.65 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.334 1.454 . . . . 0.0 108.682 166.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.5 t70 50.74 39.04 21.0 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 123.604 0.762 . . . . 0.0 113.002 -170.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 67.51 15.46 66.15 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 125.407 1.48 . . . . 0.0 115.777 -178.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -123.3 140.07 33.08 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 125.606 1.562 . . . . 0.0 110.133 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.32 141.24 46.47 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.95 2.433 . . . . 0.0 113.055 -172.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.8 t -127.94 -38.16 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.972 1.709 . . . . 0.0 112.943 -175.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -141.86 149.33 40.14 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.691 1.196 . . . . 0.0 111.582 175.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -130.69 136.44 48.79 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.028 1.331 . . . . 0.0 110.554 161.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.7 mt -130.1 145.52 35.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 127.089 2.155 . . . . 0.0 108.574 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.5 p -134.03 148.09 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.433 1.093 . . . . 0.0 111.877 171.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.16 164.6 30.39 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.771 1.177 . . . . 0.0 113.286 -176.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.3 146.52 39.22 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 -174.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -136.03 145.97 46.62 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.278 1.831 . . . . 0.0 110.084 174.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.81 167.6 38.57 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 123.882 0.753 . . . . 0.0 111.336 166.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -50.82 -38.14 46.99 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.929 1.292 . . . . 0.0 113.742 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.29 -53.76 39.16 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.765 0.426 . . . . 0.0 111.572 178.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.07 -44.29 69.42 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.594 -0.691 . . . . 0.0 112.479 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.37 -44.64 94.18 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-O 119.076 -0.488 . . . . 0.0 110.254 177.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.1 tp -63.7 -36.64 84.51 Favored 'General case' 0 C--O 1.209 -1.04 0 CA-C-O 114.936 -2.459 . . . . 0.0 111.831 175.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.4 mmm-85 -63.13 -48.41 78.62 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 124.281 3.219 . . . . 0.0 112.599 176.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -57.57 -32.73 67.44 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 176.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 86.5 mt -85.79 -25.17 26.51 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.428 1.091 . . . . 0.0 113.577 171.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.6 p -67.9 -25.12 65.34 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.424 1.889 . . . . 0.0 110.163 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -55.34 -21.99 17.36 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 164.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 66.9 t -112.96 -20.57 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 127.434 2.294 . . . . 0.0 112.441 173.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 17.2 t -109.01 72.4 0.48 Allowed Pre-proline 0 N--CA 1.477 0.918 0 C-N-CA 127.729 2.412 . . . . 0.0 109.244 172.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -64.02 -13.39 37.26 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.513 2.809 . . . . 0.0 113.131 -175.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -61.35 -23.96 66.13 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.774 1.23 . . . . 0.0 113.083 174.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 76.6 mt -126.52 26.78 6.26 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.525 1.53 . . . . 0.0 112.6 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 . . . . . 0 C--O 1.252 1.193 0 C-N-CA 125.744 1.618 . . . . 0.0 112.373 -177.44 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.8 mmt . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.9 p -77.29 -36.11 54.47 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 121.137 -0.977 . . . . 0.0 113.33 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -90.0 -26.93 20.09 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.566 1.147 . . . . 0.0 113.616 -178.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 78.9 p -149.51 153.82 37.81 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.902 1.681 . . . . 0.0 111.748 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 51.36 51.86 15.98 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.758 1.223 . . . . 0.0 112.23 -175.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.77 -4.0 59.05 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -171.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.6 t -68.99 154.54 41.89 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.196 0.999 . . . . 0.0 113.156 -174.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -106.04 18.43 22.08 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.157 1.383 . . . . 0.0 113.367 171.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.3 p -76.58 151.66 36.21 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.056 -1.028 . . . . 0.0 113.478 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.4 pt -130.27 159.83 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 126.193 1.797 . . . . 0.0 111.781 176.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -105.76 143.84 33.34 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.185 0.994 . . . . 0.0 111.208 169.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.5 m -131.27 155.06 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.788 1.635 . . . . 0.0 111.215 176.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 60.3 p -137.44 168.41 19.7 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.331 1.852 . . . . 0.0 111.646 -172.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -61.36 -20.71 63.3 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -85.23 -13.51 49.64 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.364 1.466 . . . . 0.0 114.789 172.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 87.0 p -132.41 -12.58 3.1 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -168.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -56.02 -41.45 74.95 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.55 1.14 . . . . 0.0 112.649 -173.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.69 -36.76 83.26 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.252 -0.905 . . . . 0.0 112.921 178.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.5 m -79.6 -21.13 45.37 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.655 1.582 . . . . 0.0 113.784 -178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -111.33 -32.33 6.77 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.6 t -101.86 -59.12 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.645 1.178 . . . . 0.0 111.231 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 46.3 mt -73.67 -14.02 61.09 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -173.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 83.8 p -72.33 -19.23 61.68 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.273 1.829 . . . . 0.0 113.822 171.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.4 t -77.56 124.47 27.95 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.179 0.992 . . . . 0.0 113.223 -164.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -85.82 -14.62 44.5 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.793 1.237 . . . . 0.0 113.291 170.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -94.13 158.93 35.23 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 125.834 1.653 . . . . 0.0 110.346 168.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -57.06 138.52 86.65 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 121.282 1.321 . . . . 0.0 112.118 171.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.34 129.16 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.333 1.053 . . . . 0.0 110.243 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.71 115.73 29.57 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.458 1.903 . . . . 0.0 108.526 -170.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.0 t -110.02 125.72 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.44 0.696 . . . . 0.0 110.666 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -99.27 120.07 38.94 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.402 1.081 . . . . 0.0 110.849 169.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -86.79 116.71 25.05 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.36 1.464 . . . . 0.0 108.502 174.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -136.89 172.91 12.3 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.775 1.23 . . . . 0.0 112.928 -167.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -146.75 156.73 43.38 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.797 0.839 . . . . 0.0 111.934 168.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 33.2 p -58.5 -30.33 66.94 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.215 1.006 . . . . 0.0 112.572 170.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 29.8 p-90 -82.41 -8.04 59.63 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 115.032 1.493 . . . . 0.0 115.032 177.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 14.1 t -97.0 93.34 6.55 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 119.642 1.11 . . . . 0.0 112.712 -173.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.77 -42.04 67.66 Favored Glycine 0 CA--C 1.541 1.689 0 CA-C-O 118.556 -1.135 . . . . 0.0 114.153 173.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -61.91 -31.08 84.59 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 CA-C-N 120.586 2.193 . . . . 0.0 114.287 171.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 72.3 m -66.62 -41.65 88.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.606 1.094 . . . . 0.0 110.88 169.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -61.23 -29.68 69.98 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 118.715 0.689 . . . . 0.0 112.759 172.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 88.6 mtp -72.78 -39.84 66.43 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.183 0.993 . . . . 0.0 113.432 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.1 p -86.07 -19.29 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 177.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.22 -48.31 80.27 Favored Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 176.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.58 -27.28 45.98 Favored 'Trans proline' 0 C--N 1.352 0.712 0 CA-C-N 122.4 1.893 . . . . 0.0 113.013 176.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.8 t -71.93 -46.14 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.476 -0.765 . . . . 0.0 110.059 175.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.9 mt -59.78 -37.24 78.51 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.457 1.103 . . . . 0.0 112.623 171.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -63.38 -39.98 96.0 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.206 0.602 . . . . 0.0 111.593 175.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -69.46 -40.11 77.34 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.043 -1.035 . . . . 0.0 112.416 173.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 36.5 mm -56.51 -44.48 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.784 1.174 . . . . 0.0 110.547 171.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.06 -47.34 85.13 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.618 0.767 . . . . 0.0 111.642 175.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 99.1 m -62.19 -41.78 98.66 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.948 1.299 . . . . 0.0 111.332 -177.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -89.4 -36.96 15.18 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.554 1.316 . . . . 0.0 114.554 -173.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -108.02 16.4 23.43 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -172.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.39 -34.23 23.51 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -178.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.6 t -72.65 -25.15 61.17 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.544 1.138 . . . . 0.0 113.016 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -95.0 -51.6 4.59 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.743 1.217 . . . . 0.0 111.664 178.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.16 153.15 52.07 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.286 1.434 . . . . 0.0 113.178 -174.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.3 m -104.23 137.45 42.13 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.288 1.035 . . . . 0.0 109.385 175.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.4 t -109.71 129.56 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.831 0.852 . . . . 0.0 110.5 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -132.55 160.03 37.73 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.9 1.68 . . . . 0.0 113.048 -169.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt -127.56 129.49 47.42 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.277 1.831 . . . . 0.0 111.741 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -117.8 116.47 27.06 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.204 1.402 . . . . 0.0 108.974 169.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -82.73 104.52 13.04 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.414 0.686 . . . . 0.0 110.879 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.409 HG12 ' HB2' ' A' ' 72' ' ' ALA . 4.3 m -65.46 -18.86 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -175.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -78.25 -19.41 53.76 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.412 0.685 . . . . 0.0 112.679 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 t -119.06 -18.68 8.69 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 175.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -123.55 59.31 15.7 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 125.415 1.486 . . . . 0.0 111.36 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -64.99 -27.97 57.92 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.002 2.468 . . . . 0.0 113.296 -174.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -72.12 -27.7 62.8 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.19 -0.944 . . . . 0.0 112.644 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.4 m -69.46 -39.14 77.93 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.348 -0.845 . . . . 0.0 111.155 171.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.409 ' HB2' HG12 ' A' ' 65' ' ' VAL . . . -64.14 -37.1 86.23 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.44 0.696 . . . . 0.0 112.294 171.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -71.7 -39.49 70.13 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.507 0.723 . . . . 0.0 112.653 177.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -56.71 -40.74 76.2 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.14 1.376 . . . . 0.0 113.874 -172.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -96.9 3.99 51.84 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.269 1.028 . . . . 0.0 113.052 178.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 48.0 54.97 9.28 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.202 1.801 . . . . 0.0 112.169 -167.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.9 m -113.67 15.0 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.772 1.629 . . . . 0.0 112.657 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.2 m -59.03 -23.07 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.763 1.625 . . . . 0.0 114.466 -174.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.4 m -79.83 53.05 1.57 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 126.666 1.986 . . . . 0.0 113.413 -174.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.5 pt -63.93 152.15 87.87 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -167.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -64.37 135.22 20.81 Favored 'Cis proline' 0 C--N 1.357 0.982 0 CA-C-N 119.855 0.984 . . . . 0.0 113.376 1.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.1 m -136.14 120.79 18.36 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.12 0.568 . . . . 0.0 110.186 172.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.1 mp -107.92 129.71 55.08 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.818 1.647 . . . . 0.0 107.93 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.46 132.49 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.965 0.906 . . . . 0.0 109.405 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.5 tp -110.23 129.32 55.74 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.008 1.323 . . . . 0.0 109.464 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -110.2 152.69 25.77 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.368 1.467 . . . . 0.0 111.044 173.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -130.77 137.07 49.29 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.651 1.58 . . . . 0.0 109.446 157.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.1 t70 51.17 33.38 9.35 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.505 1.122 . . . . 0.0 113.522 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.29 10.39 65.92 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.222 1.391 . . . . 0.0 116.093 -175.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -111.82 143.39 28.55 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 119.184 1.492 . . . . 0.0 111.236 176.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -58.92 144.86 98.72 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.358 2.706 . . . . 0.0 114.641 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 94.2 t -128.29 -48.74 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 126.1 1.76 . . . . 0.0 111.603 -178.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -142.19 148.92 39.0 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.688 1.595 . . . . 0.0 111.253 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -135.43 134.18 39.37 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.804 1.641 . . . . 0.0 110.737 171.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.6 mp -134.75 140.85 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 126.0 1.72 . . . . 0.0 109.594 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.5 m -130.44 144.46 37.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.794 1.238 . . . . 0.0 111.656 -176.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.7 161.42 8.4 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.368 0.985 . . . . 0.0 113.281 -170.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.14 152.1 33.94 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.693 -0.887 . . . . 0.0 112.99 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -136.18 152.3 50.64 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.969 1.708 . . . . 0.0 111.207 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -89.73 166.9 33.1 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.403 1.001 . . . . 0.0 111.46 163.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -52.62 -35.9 55.41 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.055 1.342 . . . . 0.0 113.736 -177.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.28 -49.8 58.03 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 122.916 0.487 . . . . 0.0 111.829 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.45 -43.36 70.01 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.609 -0.682 . . . . 0.0 111.965 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.3 tp -63.45 -44.16 95.29 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 119.055 -0.498 . . . . 0.0 110.78 177.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 20.1 tp -71.76 -24.62 61.79 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-O 116.549 -1.691 . . . . 0.0 113.208 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 23.9 mmt85 -61.24 -54.12 48.22 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 123.883 3.038 . . . . 0.0 110.859 166.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -61.47 -30.31 70.52 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.7 mt -90.26 -31.91 16.78 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 175.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.4 t -71.24 -11.11 60.75 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.704 1.602 . . . . 0.0 112.242 175.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -46.85 -27.6 1.29 Allowed 'General case' 0 CA--C 1.558 1.269 0 O-C-N 121.227 -0.921 . . . . 0.0 113.076 153.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.07 -49.67 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 128.156 2.582 . . . . 0.0 112.502 174.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 23.7 t -139.92 120.27 9.2 Favored Pre-proline 0 N--CA 1.482 1.145 0 C-N-CA 125.793 1.637 . . . . 0.0 113.632 -170.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -90.82 8.25 65.38 Favored 'Cis proline' 0 CA--C 1.538 0.716 0 N-CA-C 114.959 1.1 . . . . 0.0 114.959 9.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 49.0 t30 56.51 36.43 27.56 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.285 1.034 . . . . 0.0 111.293 -154.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 34.0 tp -134.76 149.56 50.44 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.725 1.61 . . . . 0.0 112.212 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.143 0 C-N-CA 126.124 1.77 . . . . 0.0 110.656 175.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 110.553 -0.166 . . . . 0.0 110.553 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.4 p -153.48 171.11 19.2 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.956 1.702 . . . . 0.0 110.944 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -70.09 -21.85 63.09 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.577 0.955 . . . . 0.0 113.577 167.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.5 p -78.33 -26.37 46.82 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.054 0.942 . . . . 0.0 112.941 172.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -86.27 11.41 12.18 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.038 1.735 . . . . 0.0 112.489 164.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.385 0.0 OUTLIER 54.78 -28.09 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 131.462 3.905 . . . . 0.0 118.605 -170.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 72.2 m -82.82 84.46 7.36 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 124.811 1.244 . . . . 0.0 110.173 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.96 43.95 0.45 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.593 1.557 . . . . 0.0 113.952 -172.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.8 t -89.65 170.41 10.49 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.318 1.447 . . . . 0.0 111.177 169.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.3 pt -135.17 148.88 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.998 1.719 . . . . 0.0 110.61 176.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -92.66 139.62 30.37 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.651 -0.656 . . . . 0.0 110.581 168.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.9 m -115.46 164.15 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.732 1.213 . . . . 0.0 111.961 173.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 54.8 p -139.71 159.62 41.75 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.137 1.775 . . . . 0.0 110.681 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -58.7 -27.84 65.23 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 121.131 -0.981 . . . . 0.0 113.536 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.36 -18.18 52.94 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.9 m -128.8 -3.81 5.23 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.763 1.225 . . . . 0.0 114.052 -172.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -53.5 -41.35 66.21 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.351 1.461 . . . . 0.0 112.55 -177.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.77 -33.01 74.67 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.457 -0.777 . . . . 0.0 113.092 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.6 m -79.54 -30.83 41.91 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.397 1.079 . . . . 0.0 112.706 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -93.39 -32.97 14.04 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -174.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -111.13 -57.75 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.296 1.438 . . . . 0.0 110.707 -175.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 33.8 mt -76.63 -13.27 60.07 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -170.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.3 m -83.31 -13.1 55.84 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.62 0.971 . . . . 0.0 113.62 176.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.7 m -81.86 130.39 35.05 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.043 1.337 . . . . 0.0 112.817 -173.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -79.56 -23.55 42.73 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.266 0.626 . . . . 0.0 112.308 171.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -74.09 143.29 80.33 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 125.238 1.415 . . . . 0.0 109.485 171.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -53.44 138.95 65.81 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 121.805 1.67 . . . . 0.0 112.205 166.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p -136.41 132.32 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 C-N-CA 125.129 1.371 . . . . 0.0 110.337 -173.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.23 126.38 55.17 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.517 1.927 . . . . 0.0 108.441 -175.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.1 t -119.7 124.36 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.11 0.964 . . . . 0.0 110.557 177.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -101.16 113.38 26.37 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.954 1.702 . . . . 0.0 111.159 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -92.82 112.41 24.36 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.685 1.594 . . . . 0.0 108.734 176.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -143.13 171.94 13.39 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.766 1.226 . . . . 0.0 111.909 -166.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.41 151.16 40.05 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.867 0.867 . . . . 0.0 112.896 170.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 28.0 p -65.46 -25.56 67.56 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.604 1.162 . . . . 0.0 113.241 172.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 13.3 p-90 -88.62 4.62 46.4 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.509 1.524 . . . . 0.0 114.934 -177.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 42.1 t -122.38 127.25 49.5 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.311 1.044 . . . . 0.0 112.953 -173.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.24 -53.69 40.35 Favored Glycine 0 CA--C 1.539 1.588 0 CA-C-O 118.7 -1.056 . . . . 0.0 114.882 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.78 -23.8 68.92 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 CA-C-N 121.079 2.44 . . . . 0.0 113.293 174.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 86.2 m -65.39 -46.46 79.98 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.827 -1.171 . . . . 0.0 111.615 167.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -59.31 -29.89 67.95 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.842 0.857 . . . . 0.0 112.932 172.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.6 mtt -74.09 -39.09 63.65 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 176.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.1 p -90.88 -29.42 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -175.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.93 -46.47 87.67 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 175.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.77 -25.94 28.03 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 122.357 2.038 . . . . 0.0 113.79 177.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.38 -45.52 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 119.44 1.018 . . . . 0.0 108.688 175.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -67.4 -31.65 72.02 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.996 1.318 . . . . 0.0 112.372 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -73.65 -36.94 65.43 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 119.037 0.835 . . . . 0.0 112.945 174.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -59.68 -45.16 92.92 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 120.995 -1.065 . . . . 0.0 111.162 165.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 50.4 mt -62.59 -40.21 87.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 O-C-N 121.603 -0.685 . . . . 0.0 110.594 176.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.76 -32.42 73.91 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 120.553 -1.342 . . . . 0.0 113.252 173.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.4 m -74.38 -48.08 30.18 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.752 0.821 . . . . 0.0 111.554 176.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -90.96 -24.71 20.05 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -169.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -117.01 15.13 15.12 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.152 1.381 . . . . 0.0 114.597 -172.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.4 -28.03 11.65 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 175.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.4 p -84.06 -21.89 31.4 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.658 1.583 . . . . 0.0 114.304 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -98.58 -31.97 11.68 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.217 1.407 . . . . 0.0 112.585 178.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.9 mt -139.18 149.35 44.32 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.203 2.601 . . . . 0.0 109.977 -177.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.4 m -91.22 134.96 34.13 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 157.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.1 t -128.63 120.13 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 121.516 -0.74 . . . . 0.0 109.987 -169.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.45 159.86 35.8 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.978 1.311 . . . . 0.0 113.422 -168.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -119.75 140.27 50.99 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.287 1.835 . . . . 0.0 111.56 176.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -122.64 111.15 16.41 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.223 1.409 . . . . 0.0 107.824 164.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -82.09 110.57 17.43 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.0 m -67.1 -16.37 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -174.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -76.87 -23.46 52.63 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.414 0.686 . . . . 0.0 112.569 171.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 21.5 p -93.57 -31.97 14.31 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.866 1.266 . . . . 0.0 112.563 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -138.43 79.98 28.63 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.324 1.449 . . . . 0.0 111.688 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -61.89 -28.73 81.49 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.809 2.339 . . . . 0.0 113.609 175.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -66.56 -41.39 88.69 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.077 0.951 . . . . 0.0 112.411 -176.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -61.86 -37.98 86.54 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.477 0.711 . . . . 0.0 111.651 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.99 -45.12 95.02 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.75 0.82 . . . . 0.0 112.496 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.9 ptm85 -78.13 -31.19 49.76 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -62.57 -41.43 98.92 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.284 1.034 . . . . 0.0 111.995 177.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -98.47 5.9 47.63 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 50.1 59.58 4.44 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.582 1.953 . . . . 0.0 113.169 -177.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.2 m -133.3 31.89 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 125.946 1.699 . . . . 0.0 111.45 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 m -70.68 -19.86 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.543 1.537 . . . . 0.0 115.005 -171.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 21.4 m -82.3 50.38 1.6 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.719 1.607 . . . . 0.0 113.767 -169.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.3 pp -57.33 150.22 44.19 Favored Pre-proline 0 CA--C 1.556 1.205 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 -161.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.94 141.5 66.59 Favored 'Cis proline' 0 C--N 1.356 0.934 0 CA-C-N 118.758 0.592 . . . . 0.0 112.165 -4.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.9 m -136.39 137.79 40.9 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.968 0.907 . . . . 0.0 109.771 -179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.5 mp -122.5 140.63 52.53 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.146 0.978 . . . . 0.0 110.203 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.1 tp -127.9 131.3 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 124.82 1.248 . . . . 0.0 108.999 175.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.1 tt -111.56 129.52 56.04 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.425 1.09 . . . . 0.0 109.217 172.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -111.63 152.01 28.14 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.739 1.616 . . . . 0.0 109.863 172.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -134.92 126.91 29.62 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.324 1.45 . . . . 0.0 109.457 173.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.9 t70 50.03 36.61 12.26 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.262 1.025 . . . . 0.0 113.365 -165.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 68.02 5.9 42.73 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.941 1.734 . . . . 0.0 116.032 -174.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 55.4 mm-40 -97.62 137.27 21.03 Favored Pre-proline 0 N--CA 1.472 0.643 0 CA-C-N 119.359 1.579 . . . . 0.0 109.573 175.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.63 139.54 48.88 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.025 1.816 . . . . 0.0 111.826 -178.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.3 t -123.43 -46.84 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.221 1.408 . . . . 0.0 112.331 -174.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -146.71 132.39 18.88 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.631 0.772 . . . . 0.0 112.539 -177.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -111.41 135.82 51.42 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.066 1.746 . . . . 0.0 110.484 168.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.9 mt -129.75 143.24 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.623 1.969 . . . . 0.0 108.57 -178.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.39 143.16 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.569 1.148 . . . . 0.0 111.224 174.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.83 158.97 29.95 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.925 1.25 . . . . 0.0 113.043 -171.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.43 140.88 39.95 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.905 -0.762 . . . . 0.0 112.509 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -130.7 146.43 52.18 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.88 1.672 . . . . 0.0 109.809 170.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -75.37 166.49 54.73 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 123.819 0.723 . . . . 0.0 111.62 177.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? -51.7 -33.99 36.76 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.974 1.31 . . . . 0.0 113.641 -175.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.85 -50.98 37.34 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.407 0.549 . . . . 0.0 111.752 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.14 -36.55 69.4 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.368 1.067 . . . . 0.0 112.549 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.42 -41.14 93.86 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.517 -0.74 . . . . 0.0 110.127 171.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 29.8 tp -69.27 -23.19 63.81 Favored 'General case' 0 C--O 1.213 -0.821 0 CA-C-O 116.07 -1.919 . . . . 0.0 113.143 171.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 52.6 mmt-85 -64.35 -49.09 73.03 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 123.991 3.087 . . . . 0.0 111.542 165.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -59.23 -30.69 68.44 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 93.6 mt -93.33 -27.82 16.56 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.684 1.193 . . . . 0.0 113.927 173.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 59.8 p -67.07 -24.48 65.97 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.627 1.558 . . . . 0.0 110.922 177.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -51.39 -22.68 3.13 Favored 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 125.256 1.423 . . . . 0.0 113.978 163.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 69.5 t -112.97 -30.09 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 128.07 2.548 . . . . 0.0 111.992 172.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.2 t -110.34 87.86 6.73 Favored Pre-proline 0 N--CA 1.478 0.973 0 C-N-CA 127.967 2.507 . . . . 0.0 110.346 -175.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.1 -8.85 23.06 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.879 2.386 . . . . 0.0 113.346 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -83.05 23.67 0.84 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.359 1.864 . . . . 0.0 113.644 178.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -58.12 -22.44 50.95 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -174.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.26 0 C-N-CA 126.202 1.801 . . . . 0.0 111.087 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.487 1.425 0 N-CA-C 111.16 0.059 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 18.3 p -80.11 -36.69 35.02 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.206 1.002 . . . . 0.0 112.807 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -144.8 154.1 42.34 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.682 1.993 . . . . 0.0 110.843 176.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.3 t -79.18 -30.61 43.53 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.754 0.821 . . . . 0.0 112.9 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 56.06 32.48 20.08 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 126.286 1.834 . . . . 0.0 115.258 173.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -84.73 -14.36 48.56 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -176.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.9 p -98.56 157.29 16.33 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.154 1.782 . . . . 0.0 112.699 177.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -104.04 32.07 4.17 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -171.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 p -89.64 153.33 20.83 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.723 1.209 . . . . 0.0 113.227 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.2 pt -140.07 165.17 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 127.092 2.157 . . . . 0.0 110.84 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -119.05 152.44 36.44 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 164.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.3 m -122.6 169.81 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 126.485 1.914 . . . . 0.0 110.823 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 43.2 p -137.62 173.94 11.12 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.826 1.65 . . . . 0.0 111.39 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -54.98 -28.13 49.32 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.87 -1.144 . . . . 0.0 113.037 170.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.0 -13.34 57.54 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.852 1.261 . . . . 0.0 114.278 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.7 p -132.86 -4.92 3.17 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -174.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -60.21 -46.14 90.77 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 120.011 1.278 . . . . 0.0 111.636 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.42 -39.32 77.94 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.959 -1.088 . . . . 0.0 112.812 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.28 -16.62 56.13 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.614 1.566 . . . . 0.0 114.726 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -103.24 -50.85 3.37 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.17 0.988 . . . . 0.0 112.677 173.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.2 t -83.49 -59.22 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.536 1.134 . . . . 0.0 111.146 -173.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.2 mt -77.31 -25.98 51.75 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -172.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.4 m -79.17 -9.06 59.46 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.96 1.304 . . . . 0.0 113.677 175.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -67.23 139.93 57.39 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.812 0.845 . . . . 0.0 113.185 -177.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -86.69 2.28 49.07 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.234 1.413 . . . . 0.0 113.724 173.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -131.72 165.87 32.45 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 126.397 1.879 . . . . 0.0 111.357 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -66.44 144.2 72.57 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.188 1.925 . . . . 0.0 112.207 176.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.2 p -144.12 127.26 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.335 1.054 . . . . 0.0 111.694 -173.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.4 tt -99.71 129.46 45.84 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.259 2.224 . . . . 0.0 108.323 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 t -119.8 127.26 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.437 1.095 . . . . 0.0 110.443 173.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -105.02 115.09 29.68 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.079 1.352 . . . . 0.0 111.793 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -83.42 114.08 21.2 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.376 1.87 . . . . 0.0 108.93 171.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -145.99 177.21 9.12 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.301 1.041 . . . . 0.0 112.205 -165.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -147.94 148.1 30.42 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 122.774 0.43 . . . . 0.0 112.051 163.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.2 t -64.8 -18.54 65.19 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 173.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 9.5 p-90 -82.03 -4.39 56.66 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 173.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 33.8 t -107.07 119.9 40.64 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 119.316 0.962 . . . . 0.0 113.493 -168.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.71 -52.18 53.53 Favored Glycine 0 CA--C 1.54 1.606 0 C-N-CA 124.701 1.143 . . . . 0.0 115.182 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.77 -24.44 54.52 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 CA-C-N 121.006 2.403 . . . . 0.0 113.265 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 75.9 m -65.81 -45.19 83.26 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 120.693 -1.254 . . . . 0.0 111.602 167.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -61.25 -30.91 70.74 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 118.638 0.653 . . . . 0.0 112.418 172.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.3 ttt -70.3 -43.1 71.06 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.305 1.042 . . . . 0.0 113.162 176.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.9 p -86.98 -23.25 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.82 -49.64 72.54 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 176.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.51 -29.01 45.18 Favored 'Trans proline' 0 C--N 1.352 0.74 0 CA-C-N 122.376 1.884 . . . . 0.0 112.806 177.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.0 t -71.93 -45.63 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 O-C-N 121.554 -0.716 . . . . 0.0 110.181 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.1 mt -62.53 -33.73 75.48 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.937 0.895 . . . . 0.0 112.682 172.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -68.83 -38.73 80.04 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.119 0.872 . . . . 0.0 112.058 175.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -63.24 -45.28 92.32 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 121.344 -0.847 . . . . 0.0 111.649 168.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.0 mm -58.88 -41.93 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 119.497 1.044 . . . . 0.0 110.605 174.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.93 -46.74 87.21 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.289 -0.882 . . . . 0.0 111.971 176.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.7 m -76.36 -37.73 56.84 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.926 0.89 . . . . 0.0 112.409 -175.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -97.25 -21.79 17.06 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -172.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -111.45 19.84 17.81 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.633 1.573 . . . . 0.0 113.065 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.26 -28.08 25.77 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.062 1.345 . . . . 0.0 113.833 174.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.7 p -66.43 -23.89 66.37 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.837 1.655 . . . . 0.0 114.042 175.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -125.98 -23.46 3.94 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.634 1.574 . . . . 0.0 113.924 -169.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.4 mt -134.26 153.75 51.68 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.299 2.239 . . . . 0.0 110.56 -178.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 49.0 m -108.79 138.76 44.6 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 149.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.1 t -112.79 122.92 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 118.904 0.775 . . . . 0.0 110.549 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -124.49 165.4 17.85 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.695 1.998 . . . . 0.0 112.145 -176.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.2 mttt -130.7 152.28 50.23 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.175 1.79 . . . . 0.0 112.658 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.76 114.28 12.48 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.424 1.089 . . . . 0.0 108.597 162.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -80.9 118.65 22.58 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.2 m -67.82 -18.32 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -172.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -80.6 -25.75 38.27 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.929 0.892 . . . . 0.0 112.677 170.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.2 p -92.17 -26.74 18.08 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.989 0.916 . . . . 0.0 112.694 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -140.54 86.96 11.93 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.656 1.182 . . . . 0.0 111.305 171.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.07 -18.62 35.46 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.524 2.149 . . . . 0.0 113.097 177.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -68.56 -46.37 69.64 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.189 -0.945 . . . . 0.0 112.055 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 m -73.65 -29.86 62.58 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.49 -0.757 . . . . 0.0 112.162 175.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.66 -40.98 85.02 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.24 0.616 . . . . 0.0 112.424 169.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.2 ttm105 -75.98 -39.29 56.23 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.323 0.649 . . . . 0.0 112.475 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -54.31 -40.61 68.12 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.189 1.396 . . . . 0.0 114.506 -170.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -100.31 7.19 44.53 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.014 0.925 . . . . 0.0 113.479 -178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 49.78 59.53 4.45 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.355 1.462 . . . . 0.0 111.287 -164.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.9 m -125.33 28.65 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.414 1.886 . . . . 0.0 111.439 -176.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -68.55 -25.64 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.792 1.237 . . . . 0.0 112.349 175.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 52.7 m -79.96 136.53 36.65 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.265 1.426 . . . . 0.0 110.325 166.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 29.0 pt -143.15 154.66 61.54 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -166.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.33 140.66 60.53 Favored 'Cis proline' 0 C--N 1.355 0.872 0 CA-C-N 119.412 0.826 . . . . 0.0 111.923 -5.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.0 m -134.72 126.64 29.42 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.173 0.989 . . . . 0.0 109.709 174.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.8 mp -108.19 136.08 48.46 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.685 1.594 . . . . 0.0 108.908 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.0 tp -120.74 138.54 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.268 1.427 . . . . 0.0 108.703 167.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.9 tp -126.59 125.15 41.48 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.071 0.949 . . . . 0.0 110.095 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -105.87 143.37 34.1 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.734 2.013 . . . . 0.0 110.447 177.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -114.42 119.21 36.11 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.558 1.543 . . . . 0.0 107.929 168.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.4 t70 51.2 39.0 22.65 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.731 1.212 . . . . 0.0 113.631 -172.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.55 9.54 74.08 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 125.163 1.363 . . . . 0.0 116.125 -177.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 63.8 mm-40 -109.35 134.26 20.55 Favored Pre-proline 0 N--CA 1.473 0.715 0 CA-C-N 119.514 1.657 . . . . 0.0 110.356 171.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.56 139.57 45.06 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.465 2.11 . . . . 0.0 111.991 -173.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.3 m -130.21 -27.84 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -177.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -152.28 139.55 19.4 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.721 1.146 . . . . 0.0 111.855 -177.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -129.13 140.05 51.7 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.43 1.892 . . . . 0.0 111.034 173.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.9 mt -137.24 143.17 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.965 1.706 . . . . 0.0 108.883 -178.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.0 p -133.85 143.64 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 119.723 1.147 . . . . 0.0 111.24 170.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 86.75 156.68 29.32 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.277 1.418 . . . . 0.0 113.248 -172.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.1 140.08 41.66 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.914 -0.757 . . . . 0.0 112.666 -176.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -132.63 145.45 51.09 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.87 1.668 . . . . 0.0 110.729 174.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -79.94 167.68 51.51 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.355 0.979 . . . . 0.0 110.896 173.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -50.22 -37.02 33.34 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -170.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.97 -47.99 55.85 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.173 0.511 . . . . 0.0 111.468 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.83 -44.77 69.26 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.377 1.071 . . . . 0.0 111.908 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.3 tp -64.89 -44.38 89.83 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.944 176.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 31.4 tp -69.93 -31.62 69.47 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-O 115.048 -2.406 . . . . 0.0 112.807 177.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -65.38 -42.93 92.17 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 124.861 3.482 . . . . 0.0 111.926 169.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -62.32 -32.07 72.78 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 178.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 92.4 mt -91.65 -24.98 19.35 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.888 1.275 . . . . 0.0 113.196 173.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.3 t -66.16 -25.41 66.94 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.983 1.313 . . . . 0.0 110.264 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -52.71 -22.14 4.87 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.519 1.128 . . . . 0.0 113.578 164.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.7 t -108.92 -24.95 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 127.487 2.315 . . . . 0.0 112.371 170.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.3 t -118.73 84.15 24.28 Favored Pre-proline 0 N--CA 1.48 1.046 0 C-N-CA 127.888 2.475 . . . . 0.0 111.797 -175.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -64.25 -12.79 34.48 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.063 2.509 . . . . 0.0 114.853 175.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -68.56 -28.28 66.82 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -172.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 28.0 tp -150.3 138.67 20.45 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.09 0.956 . . . . 0.0 112.008 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.6 t30 . . . . . 0 C--O 1.253 1.272 0 C-N-CA 126.206 1.802 . . . . 0.0 111.362 174.4 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.565 0.222 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 25.2 p -75.34 158.45 32.78 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.647 1.179 . . . . 0.0 112.497 174.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -145.32 146.4 31.61 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.146 1.378 . . . . 0.0 111.433 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 63.4 p -98.1 -3.97 36.79 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -174.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -123.91 7.97 8.7 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.495 1.518 . . . . 0.0 113.51 -174.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.05 2.41 20.66 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -177.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 65.1 p -71.06 149.63 46.35 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.29 1.436 . . . . 0.0 111.872 171.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -88.18 54.37 3.05 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.092 -1.005 . . . . 0.0 112.207 178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.9 p -89.71 151.62 21.75 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.511 1.124 . . . . 0.0 112.475 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 45.0 pt -135.06 160.08 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.704 1.602 . . . . 0.0 111.091 169.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -108.01 139.03 43.25 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.906 0.882 . . . . 0.0 110.591 168.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.2 m -133.6 150.69 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.963 1.305 . . . . 0.0 110.934 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.1 p -141.05 174.24 10.71 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.783 1.633 . . . . 0.0 111.095 -178.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -52.6 -26.15 12.68 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 120.919 -1.113 . . . . 0.0 113.611 172.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.26 -13.37 52.77 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 176.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 79.3 p -137.1 -12.66 1.65 Allowed 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -169.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -56.28 -41.96 76.71 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.405 1.482 . . . . 0.0 112.82 -174.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.53 -34.55 78.53 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 121.134 -0.979 . . . . 0.0 112.894 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.5 m -79.46 -14.33 58.98 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.535 1.534 . . . . 0.0 113.77 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -118.7 -32.36 4.57 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -177.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.2 t -103.92 -51.92 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.156 1.382 . . . . 0.0 111.452 -176.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 57.6 mt -78.53 -13.53 59.79 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.6 p -76.56 -11.04 59.81 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.209 1.804 . . . . 0.0 113.995 174.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.7 p -67.09 149.15 50.95 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 -164.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -118.19 15.64 14.05 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 126.401 1.88 . . . . 0.0 112.089 171.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -142.86 164.25 33.36 Favored Pre-proline 0 N--CA 1.475 0.782 0 C-N-CA 129.416 3.086 . . . . 0.0 108.809 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.76 138.56 54.05 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 CA-C-N 121.103 1.43 . . . . 0.0 111.257 166.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.8 m -136.63 138.53 46.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 126.317 1.847 . . . . 0.0 110.536 -177.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 tt -118.68 115.7 25.05 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.79 1.236 . . . . 0.0 109.637 -167.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.11 126.96 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.999 0.92 . . . . 0.0 110.943 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -107.0 111.9 24.61 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.513 1.525 . . . . 0.0 111.48 177.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -84.25 108.66 17.25 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.909 1.684 . . . . 0.0 108.681 173.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -136.08 163.81 29.47 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.348 1.059 . . . . 0.0 113.14 -165.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.31 145.8 47.84 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.2 p -59.94 -29.99 68.77 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.356 1.862 . . . . 0.0 113.206 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.5 p-90 -86.94 -12.4 47.71 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 41.9 t -90.77 119.18 30.78 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -164.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.07 -49.33 76.15 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.879 1.228 . . . . 0.0 113.329 176.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -57.66 -29.47 85.51 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.922 2.414 . . . . 0.0 114.548 170.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 94.9 m -64.88 -44.37 89.87 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.781 1.173 . . . . 0.0 111.187 167.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -60.56 -29.44 69.16 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 172.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.3 mtt -71.64 -43.3 66.36 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.641 0.776 . . . . 0.0 112.859 176.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.8 p -88.74 -25.75 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.81 -48.09 92.44 Favored Pre-proline 0 CA--C 1.548 0.883 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.72 -27.86 37.69 Favored 'Trans proline' 0 C--N 1.353 0.776 0 CA-C-N 122.448 1.91 . . . . 0.0 112.683 177.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.9 t -71.67 -46.01 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 121.572 -0.705 . . . . 0.0 110.288 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.0 mt -60.92 -35.69 77.36 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.073 0.949 . . . . 0.0 112.353 171.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -67.96 -38.49 82.85 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 119.015 0.825 . . . . 0.0 112.052 176.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -62.64 -45.35 93.22 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.018 -1.051 . . . . 0.0 111.537 169.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 37.3 mm -59.12 -43.05 88.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.656 1.117 . . . . 0.0 110.898 174.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.97 -35.31 78.09 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.181 0.992 . . . . 0.0 112.843 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.1 m -78.51 -48.85 14.45 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.412 0.685 . . . . 0.0 111.906 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -85.24 -32.83 22.38 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -169.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -108.02 16.69 23.17 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.313 1.445 . . . . 0.0 112.834 -171.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.66 -33.12 32.33 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.378 1.471 . . . . 0.0 114.363 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.8 m -68.03 -29.57 68.6 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.913 1.285 . . . . 0.0 112.389 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -102.61 -39.84 6.89 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.562 1.545 . . . . 0.0 112.66 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.5 mt -125.37 148.85 48.61 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 126.927 2.091 . . . . 0.0 110.663 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 51.4 m -109.14 127.2 53.99 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 157.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.6 t -99.51 128.97 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.585 0.754 . . . . 0.0 109.512 -177.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.26 150.73 48.23 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.89 1.676 . . . . 0.0 111.771 -173.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -128.63 143.45 50.95 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.434 1.094 . . . . 0.0 112.504 176.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -133.55 122.42 23.54 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.866 1.666 . . . . 0.0 110.033 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.63 96.89 7.64 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.18 1.792 . . . . 0.0 109.844 -176.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.8 m -69.49 -13.41 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 O-C-N 120.491 -1.381 . . . . 0.0 113.188 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -67.66 -27.49 66.9 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.756 0.822 . . . . 0.0 112.761 171.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.9 p -119.11 -29.74 5.16 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -136.99 76.09 46.58 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 124.646 1.178 . . . . 0.0 111.11 173.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -68.16 -13.88 39.15 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.196 2.598 . . . . 0.0 113.719 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -58.67 -33.05 69.69 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.673 1.189 . . . . 0.0 113.771 -172.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.5 m -64.21 -45.26 89.08 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.636 1.107 . . . . 0.0 111.856 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.12 -32.55 65.01 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.758 0.823 . . . . 0.0 112.47 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -73.26 -32.26 64.59 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.518 1.127 . . . . 0.0 113.022 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -58.31 -37.11 74.43 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.519 1.128 . . . . 0.0 112.596 175.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -96.74 9.91 40.32 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.067 1.347 . . . . 0.0 113.124 175.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . 0.307 5.7 pt20 54.27 -9.19 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 130.15 3.38 . . . . 0.0 117.892 -173.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 18.6 m -80.27 58.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 126.549 1.94 . . . . 0.0 111.778 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.9 p -79.02 -4.22 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 126.004 1.721 . . . . 0.0 113.744 -174.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.3 m -57.06 157.19 6.11 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.599 1.96 . . . . 0.0 112.805 170.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 23.2 mt -140.14 137.46 18.07 Favored Pre-proline 0 N--CA 1.477 0.9 0 O-C-N 121.339 -0.85 . . . . 0.0 112.312 -164.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.98 143.58 66.48 Favored 'Cis proline' 0 C--N 1.353 0.787 0 CA-C-N 119.495 0.855 . . . . 0.0 110.628 -17.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 28.3 m -119.98 121.37 38.81 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.444 0.697 . . . . 0.0 110.078 169.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.9 mp -99.7 119.46 38.16 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.516 1.527 . . . . 0.0 107.749 172.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 6.7 tp -117.96 124.21 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 125.088 1.355 . . . . 0.0 109.073 176.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.6 tp -107.4 125.99 51.92 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.647 1.579 . . . . 0.0 108.908 -176.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -112.44 155.34 24.39 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.412 1.485 . . . . 0.0 109.987 174.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -141.75 126.56 18.12 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.998 1.719 . . . . 0.0 108.829 174.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.6 t70 54.79 25.36 6.53 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -169.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.72 5.39 68.84 Favored Glycine 0 CA--C 1.541 1.67 0 O-C-N 120.535 -1.353 . . . . 0.0 116.091 -172.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -95.16 140.46 22.43 Favored Pre-proline 0 N--CA 1.474 0.766 0 CA-C-N 119.815 1.807 . . . . 0.0 110.048 167.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -67.66 139.6 48.94 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.133 1.889 . . . . 0.0 111.11 176.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.1 m -127.61 -27.63 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 114.814 1.412 . . . . 0.0 114.814 -176.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -156.08 147.86 22.99 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.736 1.153 . . . . 0.0 111.575 175.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 35.0 ttp-105 -127.95 141.52 51.51 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.001 1.32 . . . . 0.0 111.511 167.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.4 mp -129.48 140.99 47.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 126.638 1.975 . . . . 0.0 108.278 171.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.6 p -132.42 140.8 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.161 0.984 . . . . 0.0 110.286 169.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.24 155.14 30.07 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.32 0.962 . . . . 0.0 112.608 -165.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -75.16 142.33 43.55 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.503 0.721 . . . . 0.0 112.791 -175.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -130.76 144.54 51.52 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.789 1.636 . . . . 0.0 110.553 172.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -79.31 170.67 54.58 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 124.391 0.996 . . . . 0.0 111.518 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -52.56 -36.47 55.88 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -175.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.95 -50.91 64.54 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.701 0.4 . . . . 0.0 111.33 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -75.47 -39.73 58.31 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.898 1.279 . . . . 0.0 113.142 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.3 tp -66.36 -36.36 82.68 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.244 -0.91 . . . . 0.0 110.737 173.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 28.1 tp -73.04 -24.93 60.77 Favored 'General case' 0 C--O 1.216 -0.68 0 CA-C-O 116.123 -1.894 . . . . 0.0 112.955 169.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -58.65 -53.84 53.86 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 123.972 3.078 . . . . 0.0 109.741 164.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -60.91 -32.09 71.58 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.799 1.24 . . . . 0.0 113.382 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.3 mt -97.42 -29.95 13.2 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.621 1.168 . . . . 0.0 113.745 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.6 t -61.33 -30.48 70.53 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 120.182 1.356 . . . . 0.0 110.63 171.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -54.86 -18.25 4.63 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 166.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.0 t -117.72 -18.8 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 127.781 2.433 . . . . 0.0 112.578 174.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -123.63 89.77 51.06 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 127.472 2.309 . . . . 0.0 110.432 -173.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -65.27 -7.93 17.19 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.453 2.768 . . . . 0.0 114.936 175.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -63.51 -27.7 69.45 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.52 1.128 . . . . 0.0 113.328 -175.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 49.6 tp -146.82 143.47 28.63 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.504 1.122 . . . . 0.0 111.044 167.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 . . . . . 0 C--O 1.253 1.257 0 C-N-CA 125.775 1.63 . . . . 0.0 111.422 173.867 . . . . . . . . 0 0 . 1 stop_ save_